Citrus Sinensis ID: 010603
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | 2.2.26 [Sep-21-2011] | |||||||
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.839 | 0.721 | 0.648 | 1e-173 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.839 | 0.721 | 0.648 | 1e-172 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.950 | 0.789 | 0.604 | 1e-170 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.824 | 0.721 | 0.637 | 1e-156 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.845 | 0.458 | 0.580 | 1e-144 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.750 | 0.723 | 0.509 | 1e-114 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.743 | 0.762 | 0.504 | 1e-110 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.705 | 0.737 | 0.473 | 1e-102 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.750 | 0.867 | 0.472 | 1e-101 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.666 | 0.371 | 0.441 | 7e-95 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 607 bits (1565), Expect = e-173, Method: Compositional matrix adjust.
Identities = 290/447 (64%), Positives = 354/447 (79%), Gaps = 22/447 (4%)
Query: 74 ANEASFRSAC-----LSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVY 128
+++ S SAC ++KPHK ND +W+A+Q ++++DG LGL HF+LLKKLGCGDIGSVY
Sbjct: 151 SSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIGSVY 210
Query: 129 LAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188
L+EL FAMKVMDK LA RKKL+RAQTE+EIL LDHPFLPTLY+HFETDKFSCL
Sbjct: 211 LSELNGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKFSCL 270
Query: 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE 248
+MEFC GGDLHTLRQRQ GK+F EQA +FY +E+LLA+EYLHM+G++YRDLKPENVLVRE
Sbjct: 271 VMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVLVRE 330
Query: 249 DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRI----SSYCIQPSCIDPACKLPVCVEPSC 304
DGHIMLSDFDLSLRC VSP L++SS+ A + +YC+QP+C++P+C ++PSC
Sbjct: 331 DGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCVQPACVEPSC----MIQPSC 386
Query: 305 LQP-SCFKPRFLNSKTTKVKSEKTSLTNSDS-LPVLIAEPTSARSMSFVGTHEYLAPEII 362
P +CF PRF SK+ K + K + N S P LIAEP+ ARSMSFVGTHEYLAPEII
Sbjct: 387 ATPTTCFGPRFF-SKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEII 445
Query: 363 RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422
+G+GHGSAVDWWTFGIF YELL G+TPFKG+GNR TLFNV+GQPL+FPE +SF+A+DL
Sbjct: 446 KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDL 505
Query: 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTP 482
IRGLLVK+PQ+RLG KRGATEIKQHPFFE VNWALIR PPE+P+PV+ I K P
Sbjct: 506 IRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPRPVE---IERPPKQP 562
Query: 483 IPQNDKGAADSD---RSSGPFLDFEFF 506
+ ++ AA SD +SS +L+F+FF
Sbjct: 563 VSTSEPAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 606 bits (1563), Expect = e-172, Method: Compositional matrix adjust.
Identities = 290/447 (64%), Positives = 354/447 (79%), Gaps = 22/447 (4%)
Query: 74 ANEASFRSAC-----LSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVY 128
+++ S SAC ++KPHK ND +W+A+Q ++++DG LGL HF+LLKKLGCGDIGSVY
Sbjct: 151 SSDVSDESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIGSVY 210
Query: 129 LAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188
L+EL FAMKVMDK LA RKKL+RAQTE+EIL LDHPFLPTLY+HFETDKFSCL
Sbjct: 211 LSELSGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKFSCL 270
Query: 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE 248
+MEFC GGDLHTLRQRQ GK+F EQA +FY +E+LLA+EYLHM+G++YRDLKPENVLVRE
Sbjct: 271 VMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVLVRE 330
Query: 249 DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRI----SSYCIQPSCIDPACKLPVCVEPSC 304
DGHIMLSDFDLSLRC VSP L++SS+ A + +YC+QP+C++P+C ++PSC
Sbjct: 331 DGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCVQPACVEPSC----MIQPSC 386
Query: 305 LQP-SCFKPRFLNSKTTKVKSEKTSLTNSDS-LPVLIAEPTSARSMSFVGTHEYLAPEII 362
P +CF PRF SK+ K + K + N S P LIAEP+ ARSMSFVGTHEYLAPEII
Sbjct: 387 ATPTTCFGPRFF-SKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEII 445
Query: 363 RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422
+G+GHGSAVDWWTFGIF YELL G+TPFKG+GNR TLFNV+GQPL+FPE +SF+A+DL
Sbjct: 446 KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDL 505
Query: 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTP 482
IRGLLVK+PQ+RLG KRGATEIKQHPFFE VNWALIR PPE+P+PV+ I K P
Sbjct: 506 IRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPRPVE---IERPPKQP 562
Query: 483 IPQNDKGAADSD---RSSGPFLDFEFF 506
+ ++ AA SD +SS +L+F+FF
Sbjct: 563 VSTSEPAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 599 bits (1544), Expect = e-170, Method: Compositional matrix adjust.
Identities = 313/518 (60%), Positives = 376/518 (72%), Gaps = 37/518 (7%)
Query: 6 NSATNYDTESVTSISMHSVSFCSSSTVSGSDTSVSSNLSNATIEAKKGVDCLAHSE---- 61
N NY T + SF S++ S + S +N + VD SE
Sbjct: 112 NHGKNYSQPDATFCASPQNSFYSATVYSEAKES----FTNTEVSECASVDKSCESEVANS 167
Query: 62 ---EESGKSSL---STG-DANEASFRSA---CLSKPHKGNDMKWDAVQCVKSKDGDLGLG 111
ES K+S+ STG DA++ S S+ L KPHK ND++W+A+Q V+++DG L +
Sbjct: 168 SDFNESRKTSICRASTGSDASDESSTSSLSSVLYKPHKANDIRWEAIQAVRTRDGMLEMR 227
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
HFRLLKKLGCGDIGSVYLAEL FAMKVM+K LA RKKL+RAQTEREIL LDHP
Sbjct: 228 HFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMNKTELANRKKLLRAQTEREILQSLDHP 287
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FLPTLY+HFET+ FSCL+MEFC GGDLH LRQRQPGK+FSE A RFY +EVLL+LEYLHM
Sbjct: 288 FLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQPGKYFSEHAVRFYVAEVLLSLEYLHM 347
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291
+G++YRDLKPENVLVREDGHIMLSDFDLSLRC VSP LV+SS++ + S YC+QPSCI+
Sbjct: 348 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSVSPTLVKSSNNLQTKSSGYCVQPSCIE 407
Query: 292 PACKLPVCVEPSCLQPSCFKPRFL--NSKTTKVKSEKTSLTNSDS-LPVLIAEPTSARSM 348
P C ++P C++PSCF PRFL SK K K + N + LP LIAEPT+ARSM
Sbjct: 408 PTC----VMQPDCIKPSCFTPRFLSGKSKKDKKSKPKNDMHNQVTPLPELIAEPTNARSM 463
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
SFVGTHEYLAPEII+G+GHGSAVDWWTFGIF YELL GRTPFKG+ NR TLFNV+GQPL+
Sbjct: 464 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSANRATLFNVIGQPLR 523
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
FPE ++SFAA+DLIRGLLVK+PQ RL ++RGATEIKQHPFF++VNWALIR PPE+P+
Sbjct: 524 FPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQNVNWALIRCATPPEVPR 583
Query: 469 PVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
V IN +PQ +K + SG +LD +FF
Sbjct: 584 QV----IN------LPQTEKDLG--VKPSGNYLDIDFF 609
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 551 bits (1421), Expect = e-156, Method: Compositional matrix adjust.
Identities = 274/430 (63%), Positives = 326/430 (75%), Gaps = 13/430 (3%)
Query: 86 KPHK-GNDMKWDAVQCVKSKDGD-LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKV 143
KPH+ ND +W A+Q V+S+ G L F+L+KKLG GDIG+VYLAEL G FA+KV
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 144 MDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQ 203
M+K +A RKKL+RAQTE+EIL LDHPFLPTLYSHFET+ SCL+MEFC GGDLH+LRQ
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 204 RQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263
+Q GK+F EQA RFY +EVLLA+EYLHM+G++YRDLKPENVLVREDGHIMLSDFDLSLRC
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 264 FVSPKLVQ-SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKV 322
VSP LV+ ++ + SSYCIQP+C+D + V+P C+QP CF PRFL+ +
Sbjct: 333 AVSPTLVRFAAITLESKSSSYCIQPTCVDQSS---CIVQPDCIQPVCFTPRFLSKGKHRK 389
Query: 323 KSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYE 382
KS S LP LIAEPTSARSMSFVGTHEYLAPEII+G+GHGSAVDWWTFGIF YE
Sbjct: 390 KSNDMS-RQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYE 448
Query: 383 LLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGAT 442
LL G TPF+G NR TLFNVVGQPL+FPE ++SFAA+DLIRGLLVK+PQ RL ++RGAT
Sbjct: 449 LLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGAT 508
Query: 443 EIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQN------DKGAADSDRS 496
EIKQHPFF+SVNWALIR T PP+IP+PV H + Q DK +
Sbjct: 509 EIKQHPFFQSVNWALIRCTSPPQIPQPVKPMDQAHSVRHGFSQGHGHVGYDKPPTVDVKP 568
Query: 497 SGPFLDFEFF 506
SG +L+ +FF
Sbjct: 569 SGNYLEIDFF 578
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 264/455 (58%), Positives = 318/455 (69%), Gaps = 27/455 (5%)
Query: 28 SSSTVSGSDTSVSSNLSNATIEAKKGVDCLAHSEEESGKSSLSTGDANEASF-RSACLSK 86
SSS SG V N T K + S++ G S ST + E++ R +C +K
Sbjct: 454 SSSNNSGIGAMVEKETENPTSSEK--FEFSLSSKDSLGDYSRSTSISEESNLSRFSCGNK 511
Query: 87 PHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDK 146
PH D++W+A++ +K + G LGL HF LLKKLGCGDIG+VYLAEL CLFA+KVMD
Sbjct: 512 PHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMDN 571
Query: 147 GMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQP 206
LA RKK RAQ EREIL +LDHPFLPTLY+ F +D SCL+ME+C GGDLH LRQ+Q
Sbjct: 572 EFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQL 631
Query: 207 GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266
G+ F E A RFY +E+LLALEYLHM+G++YRDLKPEN+LVREDGHIML+DFDLSLRC V+
Sbjct: 632 GRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAVN 691
Query: 267 PKLVQSSDDPA---CRIS-----SYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318
P LV+S+ P RIS S CIQP CI EPSC Q SCF PR +++
Sbjct: 692 PTLVRSNSPPGKDPARISGPYNTSNCIQPFCI---------TEPSC-QVSCFSPRLSSNQ 741
Query: 319 TTKVKSE------KTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVD 372
K + KT S SLP L+AEPT ARS SFVGTHEYLAPEII+G+GHG+AVD
Sbjct: 742 QQGRKPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVD 801
Query: 373 WWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQ 432
WWTFG+ YELL G+TPFKG N ETL NVV Q LKFP+ +SF AKDLIRGLLVK+P+
Sbjct: 802 WWTFGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPE 861
Query: 433 KRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
RLG ++G+ EIK+HPFFE +NWALIR PPE+P
Sbjct: 862 NRLGSEKGSVEIKRHPFFEGLNWALIRCAIPPELP 896
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 219/430 (50%), Positives = 273/430 (63%), Gaps = 50/430 (11%)
Query: 85 SKPHKGNDMKWDAVQCVKSKDGD-LGLGHFRLLKKLGCGDIGSVYLAELRDM--GCLFAM 141
SKPHK N + W+A+ ++ G +GL HFRLLK+LG GDIGSVYL ++R +AM
Sbjct: 58 SKPHKANQVAWEAMARLRRCCGRAVGLEHFRLLKRLGSGDIGSVYLCQIRGSPETAFYAM 117
Query: 142 KVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL 201
KV+DK +A +KKL RA+ E++IL +LDHPF PTLY+ FE +S L+ME+C GGDL+ +
Sbjct: 118 KVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAV 177
Query: 202 RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261
R RQP K F+ +TRFYA+E L+ALEYLHMMG+VYRDLKPENVL+REDGH+MLSDFDLS
Sbjct: 178 RLRQPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSF 237
Query: 262 RCFVSPKLV--------QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPR 313
+C V P+ + DD I C PSC P+ SC P+ + R
Sbjct: 238 KCDVVPQFLSDNDRDRGHQEDDDDISIRRKCSTPSCT----TTPLNPVISCFSPTSSRRR 293
Query: 314 FLNSKTT-----------KVKSEKTSLTNSDS-----------------LPVLIAEPTSA 345
N TT VKS S T S S P + AEP +A
Sbjct: 294 KKNVVTTTIHENAAGTSDSVKSNDVSRTFSRSPSSCSRVSNGLRDISGGCPSIFAEPINA 353
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
RS SFVGTHEYLAPE+I G GHGSAVDWWT+GIF YE++ GRTPFKG+ N +TL N++
Sbjct: 354 RSKSFVGTHEYLAPEVISGQGHGSAVDWWTYGIFLYEMIFGRTPFKGDNNEKTLVNILKA 413
Query: 406 PLKFPEGSSIS-------FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458
PL FP+ S A+DLI LLVK+P+KRLG +G+ EIK+H FFE VNWALI
Sbjct: 414 PLTFPKVIVNSPKEYEDMVNAQDLIIKLLVKNPKKRLGSLKGSIEIKRHEFFEGVNWALI 473
Query: 459 RSTHPPEIPK 468
RS PP +PK
Sbjct: 474 RSIKPPWVPK 483
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 400 bits (1028), Expect = e-110, Method: Compositional matrix adjust.
Identities = 208/412 (50%), Positives = 275/412 (66%), Gaps = 36/412 (8%)
Query: 81 SACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRD------ 134
S+C KPHK N +W+A++ +++ G +GL HFRL+++LG GD+G+VYL LR+
Sbjct: 48 SSCRYKPHKANQAEWEAIRRLRAGAGRVGLEHFRLVRRLGSGDLGNVYLCRLREPWSSSS 107
Query: 135 -----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189
GCL+AMKV+DK LA RKKL RA+ ER+IL LDHPFLPTLY+ FE ++CL+
Sbjct: 108 MTTTAGGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEASHYACLV 167
Query: 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED 249
MEFC GGDLH RQRQPG+ F+ +TRFY +E +LALEYLHMMGVVYRDLKPENVLVR D
Sbjct: 168 MEFCPGGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPENVLVRGD 227
Query: 250 GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEP--SCLQP 307
GHIMLSDFDLSL+C V PKL++ + R ++ +P P+ +P ++P SC+
Sbjct: 228 GHIMLSDFDLSLKCDVVPKLLRPA-----RSAAAGGKPPLPPPSSCVPPTIQPVLSCIFR 282
Query: 308 SCFK----------PRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYL 357
K + +++ + T + V++ EP +ARS SFVGTHEYL
Sbjct: 283 GVHKCHHAKECAGGGAAAGNNGDGDGNDEEAETETAEPEVVVVEPVAARSKSFVGTHEYL 342
Query: 358 APEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISF 417
APE+I G GHGSAVDWWT G+F YE+L GRTPFKG N +TL N++ QP+ FP + +
Sbjct: 343 APEVISGQGHGSAVDWWTLGVFMYEMLYGRTPFKGESNEKTLINIIKQPVTFPRLAGAAA 402
Query: 418 --------AAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRST 461
A+DL+ LL K+P+KRLG G+ E+K+HPFF+ VNWAL+RS
Sbjct: 403 AGEWEEMKTAQDLMLQLLAKNPKKRLGSTMGSAEVKRHPFFKGVNWALVRSV 454
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-102, Method: Compositional matrix adjust.
Identities = 189/399 (47%), Positives = 250/399 (62%), Gaps = 42/399 (10%)
Query: 80 RSACLSKPHKGNDMKWDAVQCVKSKDG-DLGLGHFRLLKKLGCGDIGSVYLAELR----- 133
R++ L +PH+ D+ W A++ + LG F+L++++G GDIG+VYL LR
Sbjct: 77 RASVLLRPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPER 136
Query: 134 DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE-TDKFSCLLMEF 192
+ C++AMKV+D+ +A ++KL RA E+ IL LDHPFLPTL++ F+ T FSC +MEF
Sbjct: 137 ESPCMYAMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEF 196
Query: 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHI 252
C GGDLH+LR R P + F + RFYA+EVLLA+EYLHMMG+VYRDLKPENVL+R DGHI
Sbjct: 197 CPGGDLHSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHI 256
Query: 253 MLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKP 312
ML+DFDLSL+ SP L +D + + SCF
Sbjct: 257 MLTDFDLSLQSTTSPSLDGDTD------------------------TDDEASGGASCFPD 292
Query: 313 RFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVD 372
L + K + ++ P +AEP ARS SFVGTHEY+APE+ G HG+AVD
Sbjct: 293 HLL-----RFKRRRNAVAAPR--PRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVD 345
Query: 373 WWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSS----ISFAAKDLIRGLLV 428
WW +G+F YEL+ GRTPF G N TL N+V +PL FP GS A+DLI LL
Sbjct: 346 WWAYGVFLYELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADARDLIARLLA 405
Query: 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
KDP RLG +RGA ++K HPFF+S+N AL+RS+ PP +P
Sbjct: 406 KDPAARLGSRRGAADVKSHPFFKSLNLALLRSSRPPVVP 444
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 203/430 (47%), Positives = 262/430 (60%), Gaps = 50/430 (11%)
Query: 86 KPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAEL-----RDMGCLFA 140
KPH+ +D + ++ + K L FRL++++G GDIG+VYL L FA
Sbjct: 50 KPHRSSDFAYAEIR--RRKKQGLTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESRSSYFA 107
Query: 141 MKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT 200
MKV+DK LA +KK+ RA+ E+ IL +LDHPFLPTLY+ FE FSC++ME+CSGGDLH+
Sbjct: 108 MKVVDKEALALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHS 167
Query: 201 LRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LR RQP + FS + RFYA+EVL+ALEYLHM+G++YRDLKPEN+LVR DGHIMLSDFDLS
Sbjct: 168 LRHRQPHRRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLS 227
Query: 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTT 320
L C S ++ S P + F+ R L SK
Sbjct: 228 L----------------CSDSIAAVESSSSSPENQQLRSPRRFTRLARLFQ-RVLRSK-- 268
Query: 321 KVKS-EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIF 379
KV++ E T L +AEP +ARS SFVGTHEY+APE+ G HG+AVDWW FG+F
Sbjct: 269 KVQTLEPTRL--------FVAEPVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVF 320
Query: 380 FYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSIS---FAAKDLIRGLLVKDPQKRLG 436
YE++ G+TPF N L N+V + L FP S + A++LI GLL KDP KRLG
Sbjct: 321 LYEMIYGKTPFVAPTNDVILRNIVKRQLSFPTDSPATMFELHARNLISGLLNKDPTKRLG 380
Query: 437 FKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGAADSDRS 496
+RGA E+K HPFF+ +N+ALIR+ PPEIP V K P+ K A S RS
Sbjct: 381 SRRGAAEVKVHPFFKGLNFALIRTLTPPEIPSSV--------VKKPM----KSATFSGRS 428
Query: 497 SGPFLDFEFF 506
S F++F
Sbjct: 429 SNKPAAFDYF 438
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 7e-95, Method: Compositional matrix adjust.
Identities = 171/387 (44%), Positives = 231/387 (59%), Gaps = 50/387 (12%)
Query: 86 KPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD 145
KPHK N+ W A++ + +GL HF+ +K LGCGD GSV+L EL+ G LFAMK MD
Sbjct: 549 KPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMD 608
Query: 146 KGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQ 205
K ++ R K+ RA EREI +LLDHPFLPTLY+ F+T CL+ +FC GG+L + RQ
Sbjct: 609 KSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQ 668
Query: 206 PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265
P K F E+ RFYA+EV++ LEYLH +G++YRDLKPEN+L++ DGHI+L+DFDLS
Sbjct: 669 PMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTS 728
Query: 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSE 325
P ++++S R S + P+
Sbjct: 729 KPHVIKNSTSLKRRRSQEFLPPT------------------------------------- 751
Query: 326 KTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL 385
++EP++ S SFVGT EY+APE+I G GH SA+DWW GI YE+L
Sbjct: 752 ------------FVSEPSTP-SNSFVGTEEYIAPEVITGAGHTSAIDWWALGILLYEMLY 798
Query: 386 GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIK 445
GRTPF+G ++T +N++ + L FP +S AAK LI GLL +DP R+G GA +IK
Sbjct: 799 GRTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRDPSNRIGSNAGANDIK 858
Query: 446 QHPFFESVNWALIRSTHPPEIPKPVDL 472
QH FF+ +NW LIR PPE+ P+ L
Sbjct: 859 QHSFFQDINWPLIRCMSPPELDVPLKL 885
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | ||||||
| 255552792 | 504 | serine/threonine protein kinase, putativ | 0.974 | 0.978 | 0.814 | 0.0 | |
| 225452609 | 538 | PREDICTED: protein kinase PVPK-1-like [V | 0.978 | 0.920 | 0.758 | 0.0 | |
| 224141331 | 500 | predicted protein [Populus trichocarpa] | 0.972 | 0.984 | 0.800 | 0.0 | |
| 15242554 | 499 | protein kinase family protein [Arabidops | 0.954 | 0.967 | 0.729 | 0.0 | |
| 297805688 | 500 | hypothetical protein ARALYDRAFT_355985 [ | 0.954 | 0.966 | 0.729 | 0.0 | |
| 296087743 | 497 | unnamed protein product [Vitis vinifera] | 0.897 | 0.913 | 0.704 | 0.0 | |
| 449532394 | 607 | PREDICTED: protein kinase G11A-like [Cuc | 0.920 | 0.767 | 0.647 | 0.0 | |
| 148906315 | 545 | unknown [Picea sitchensis] | 0.889 | 0.825 | 0.659 | 0.0 | |
| 449443506 | 607 | PREDICTED: protein kinase G11A-like [Cuc | 0.920 | 0.767 | 0.645 | 0.0 | |
| 356532843 | 608 | PREDICTED: protein kinase G11A-like [Gly | 0.978 | 0.814 | 0.594 | 0.0 |
| >gi|255552792|ref|XP_002517439.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223543450|gb|EEF44981.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/517 (81%), Positives = 456/517 (88%), Gaps = 24/517 (4%)
Query: 1 MNKQLNSATNYDTESVTSISMHSVSFCSS-------STVSGSDTSVSSNLSNATIEAKKG 53
MNK+++ N DTES+TS S +SF +S ST+SGSD SVSSN+SNA+ A
Sbjct: 1 MNKKID---NGDTESLTS-SFQDLSFTNSVCISLCSSTISGSDNSVSSNISNASNAA--- 53
Query: 54 VDCLAHSEEESGKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVK--SKDGDLGLG 111
SE + + S ST D NE SFRS C SKPHKGND++WDA+Q VK +KDG+LGLG
Sbjct: 54 ------SEAKESEKSTSTLDPNEPSFRSFCPSKPHKGNDIRWDAIQYVKGSNKDGELGLG 107
Query: 112 --HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
HFRLLKKLGCGDIGSVYLAELR MGCLFAMKVMDKGMLAGRKKL+RAQTEREIL LLD
Sbjct: 108 LGHFRLLKKLGCGDIGSVYLAELRGMGCLFAMKVMDKGMLAGRKKLLRAQTEREILGLLD 167
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HPFLPTLYSHFET+KFSCLLMEFCSGGDLHTLRQRQPGKHF+EQA RFYASEVLLALEYL
Sbjct: 168 HPFLPTLYSHFETEKFSCLLMEFCSGGDLHTLRQRQPGKHFTEQAARFYASEVLLALEYL 227
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSC 289
HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV+P LVQSS +P+C+ISSYCIQPSC
Sbjct: 228 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVNPTLVQSSSEPSCKISSYCIQPSC 287
Query: 290 IDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349
IDP+CKLPVCVEPSCLQPSCFKPRF NS+T KVKSEK +L NSDSLPVLIAEPT+ARSMS
Sbjct: 288 IDPSCKLPVCVEPSCLQPSCFKPRFFNSRTAKVKSEKPNLANSDSLPVLIAEPTTARSMS 347
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
FVGTHEYLAPEIIRGDGHGSAVDWWTFGIF YELLLGRTPFKG GNRETLFNVVGQPLKF
Sbjct: 348 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFLYELLLGRTPFKGTGNRETLFNVVGQPLKF 407
Query: 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469
PEGSS+SF+AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP
Sbjct: 408 PEGSSVSFSAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 467
Query: 470 VDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
VD+S +NH K+ + +DKGA DSDRSSGP+LDFEFF
Sbjct: 468 VDISSLNHTLKSSLASSDKGAKDSDRSSGPYLDFEFF 504
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452609|ref|XP_002276011.1| PREDICTED: protein kinase PVPK-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/518 (75%), Positives = 434/518 (83%), Gaps = 23/518 (4%)
Query: 12 DTESVTSISMHSVSFCSSSTVS-GSD-TSVSSNLSNATIEAKKGVDCL------AHSEEE 63
D +++++ + S+ ++ G+D T+ + +SNA EAKK V+ A E
Sbjct: 21 DNNAISNVVDEATENLESAEINNGADETTKNVEISNAEDEAKKDVETTEISNGDAAEATE 80
Query: 64 SGKS---------------SLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDL 108
+G+S ++ DANE +FRS C SKPH+GND++WDA+QCVK+KDGD+
Sbjct: 81 NGESVDCVESEKSSLSSASYSNSSDANETNFRSFCASKPHRGNDIRWDAIQCVKAKDGDM 140
Query: 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
GL HFRLLKKLGCGDIGSVYLAELR M CLFAMKVMDKGML RKKLMRAQTEREIL LL
Sbjct: 141 GLCHFRLLKKLGCGDIGSVYLAELRGMSCLFAMKVMDKGMLEERKKLMRAQTEREILGLL 200
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
DHPFLPTLYSHFET+KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQA RFYASEVLLALEY
Sbjct: 201 DHPFLPTLYSHFETEKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAARFYASEVLLALEY 260
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPS 288
LHM+GVVYRDLKPENVLVREDGHIMLSDFDLSLRC+VSP LVQ+S DP+ RISSYCIQPS
Sbjct: 261 LHMLGVVYRDLKPENVLVREDGHIMLSDFDLSLRCYVSPTLVQTSSDPSFRISSYCIQPS 320
Query: 289 CIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348
CIDPACKL VCVEPSCLQPSCFKPR +K+ K +SE+ SLTN DSLP+LIAEPT ARSM
Sbjct: 321 CIDPACKLSVCVEPSCLQPSCFKPRLFKAKSRKPRSERLSLTNLDSLPMLIAEPTGARSM 380
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIF YELL GRTPFKGNGNRETLFNVVGQ LK
Sbjct: 381 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFLYELLHGRTPFKGNGNRETLFNVVGQSLK 440
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
F EGSSISFAAKDLIRGLLVKDPQKRLG+KRGATEIKQHPFFESVNWALIRSTHPP+IPK
Sbjct: 441 FAEGSSISFAAKDLIRGLLVKDPQKRLGYKRGATEIKQHPFFESVNWALIRSTHPPQIPK 500
Query: 469 PVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
PVDL +NH + + NDKGA DSDRSSGP+LDFEFF
Sbjct: 501 PVDLECLNHTSSSSMRLNDKGATDSDRSSGPYLDFEFF 538
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141331|ref|XP_002324027.1| predicted protein [Populus trichocarpa] gi|222867029|gb|EEF04160.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/497 (80%), Positives = 429/497 (86%), Gaps = 5/497 (1%)
Query: 12 DTESVTSISMHSVSFCSSSTVSGSDTSVSSNLSNATIEAKKGVDCLAHSEEESGKSSLST 71
+ ESV + S +SF +S+ G +SVS N + + G A +ES K+SL
Sbjct: 7 EAESVITSSFQDLSFTNSTVSIGLCSSVSDNSVSNSSNVSNGT--AASESKESEKASL-I 63
Query: 72 GDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLG--LGHFRLLKKLGCGDIGSVYL 129
D NEASFRS+ SKPHKGND +WDAVQCVK KDGD+G LGHFRLLKKLG GDIGSVYL
Sbjct: 64 CDPNEASFRSSYPSKPHKGNDFRWDAVQCVKGKDGDMGMGLGHFRLLKKLGVGDIGSVYL 123
Query: 130 AELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189
AELR MGCLFAMKVMDKGMLAGRKKL+RA+TEREIL LLDHPFLPTLYSHFETDKFSCLL
Sbjct: 124 AELRGMGCLFAMKVMDKGMLAGRKKLLRARTEREILGLLDHPFLPTLYSHFETDKFSCLL 183
Query: 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED 249
MEFCSGGDLH LRQRQPGKHFSEQA RFYASEVLLALEYLHMMGVVYRDLKPENVLVRED
Sbjct: 184 MEFCSGGDLHILRQRQPGKHFSEQAARFYASEVLLALEYLHMMGVVYRDLKPENVLVRED 243
Query: 250 GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSC 309
GHIMLSDFDLSLRC VSP LVQSS +C+ISSYCI+PSCIDPACKLPVCVEPSCLQPSC
Sbjct: 244 GHIMLSDFDLSLRCCVSPTLVQSSTVSSCKISSYCIEPSCIDPACKLPVCVEPSCLQPSC 303
Query: 310 FKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGS 369
KPRF KT KV++EK +L NS+SLPVL+AEPT+ARSMSFVGTHEYLAPEIIRGDGHGS
Sbjct: 304 LKPRFFKPKTAKVRNEKPNLANSNSLPVLVAEPTTARSMSFVGTHEYLAPEIIRGDGHGS 363
Query: 370 AVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429
AVDWWTFGIF YEL+LGRTPFKGNGNRETLFNVVGQPLKFPEGSS+SFAAKDLIRGLL+K
Sbjct: 364 AVDWWTFGIFLYELILGRTPFKGNGNRETLFNVVGQPLKFPEGSSVSFAAKDLIRGLLMK 423
Query: 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKG 489
DPQKRLGFKRGATEIKQHPFFE+VNWALIRSTHPPEIPKPVDL +N K+ + ND
Sbjct: 424 DPQKRLGFKRGATEIKQHPFFETVNWALIRSTHPPEIPKPVDLLSLNLAFKSSLAPNDNR 483
Query: 490 AADSDRSSGPFLDFEFF 506
A DSDRSSGPFLDFEFF
Sbjct: 484 ATDSDRSSGPFLDFEFF 500
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15242554|ref|NP_198819.1| protein kinase family protein [Arabidopsis thaliana] gi|8843803|dbj|BAA97351.1| protein kinase [Arabidopsis thaliana] gi|332007120|gb|AED94503.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1902), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/502 (72%), Positives = 415/502 (82%), Gaps = 19/502 (3%)
Query: 7 SATNYDTESVTSISMHSVSFCSSSTVSGSDTSVSSNLSNATIEAKKGVDCLAHSEEESGK 66
S++NY+ + + +S S SF +SS S D +++++S + + E+
Sbjct: 15 SSSNYNNANASPVS-GSASFKTSSNGS-EDVRLNNSISLSFCSS-------NSVSSEANL 65
Query: 67 SSLSTGDANEASF-RSACLSKPHKGNDMKWDAVQCVK-SKDGDLGLGHFRLLKKLGCGDI 124
+ DANEA+F R SKPHKGND++WDA+Q VK SK+ DLGLGHFRLLKKLGCGDI
Sbjct: 66 EKTQSFDANEANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDI 125
Query: 125 GSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184
GSVYLAELR+MGC FAMKVMDKGML GRKKL+RAQTEREIL LLDHPFLPTLYSHFET+K
Sbjct: 126 GSVYLAELREMGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEK 185
Query: 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244
FSCLLMEFCSGGDLH LRQ+QPGKHFSE A RFYASEVLLALEYLHMMGVVYRDLKPENV
Sbjct: 186 FSCLLMEFCSGGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENV 245
Query: 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSC 304
+VREDGHIMLSDFDLSL+ FVSP L+QS+ P+C I+SYCIQP CIDP+CKLPV +C
Sbjct: 246 MVREDGHIMLSDFDLSLQSFVSPTLIQSTSQPSCHIASYCIQPPCIDPSCKLPV----AC 301
Query: 305 LQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG 364
+QPSCFKPRFLN+K K K+EK SDSLP+LIAEPT+ARSMSFVGTHEYLAPEIIRG
Sbjct: 302 IQPSCFKPRFLNNKPRKAKTEKAG---SDSLPMLIAEPTAARSMSFVGTHEYLAPEIIRG 358
Query: 365 DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424
DGHGS+VDWWTFGIF YELL G+TPFKGNGNRETLFNVVGQPLKFPEG SISFAAKDLIR
Sbjct: 359 DGHGSSVDWWTFGIFLYELLTGKTPFKGNGNRETLFNVVGQPLKFPEG-SISFAAKDLIR 417
Query: 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIP 484
GLL KDP+KRLGFK+GATEIKQHPFF +VNWALIRST PPEIPKP+DLS +N K+ +
Sbjct: 418 GLLTKDPKKRLGFKKGATEIKQHPFFNNVNWALIRSTTPPEIPKPIDLSILNETLKSSVQ 477
Query: 485 QNDKGAADSDRSSGPFLDFEFF 506
Q K + SD SSGP+LDFEFF
Sbjct: 478 QQGKHSKQSDSSSGPYLDFEFF 499
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297805688|ref|XP_002870728.1| hypothetical protein ARALYDRAFT_355985 [Arabidopsis lyrata subsp. lyrata] gi|297316564|gb|EFH46987.1| hypothetical protein ARALYDRAFT_355985 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1899), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/502 (72%), Positives = 414/502 (82%), Gaps = 19/502 (3%)
Query: 7 SATNYDTESVTSISMHSVSFCSSSTVSGSDTSVSSNLSNATIEAKKGVDCLAHSEEESGK 66
S++NY+ + + +S S SF +SS S D +++++S + + E+
Sbjct: 16 SSSNYNNANASPVS-GSASFKTSSNGS-EDVRLNNSISLSFCSSNS-------VSSEANL 66
Query: 67 SSLSTGDANEASF-RSACLSKPHKGNDMKWDAVQCVK-SKDGDLGLGHFRLLKKLGCGDI 124
+ DANEA+F R SKPHKGND++WDA+Q VK SK+ DLGLGHFRLLKKLGCGDI
Sbjct: 67 EKSQSFDANEANFKRVFAPSKPHKGNDLRWDAIQSVKCSKNEDLGLGHFRLLKKLGCGDI 126
Query: 125 GSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184
GSVYLAELR+MGC FAMKVMDKGML GRKKL+RAQTEREIL LLDHPFLPTLYSHFET+K
Sbjct: 127 GSVYLAELREMGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEK 186
Query: 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244
FSCLLMEFCSGGDLH LRQ+QPGKHFSE A RFYASEVLLALEYLHMMGVVYRDLKPENV
Sbjct: 187 FSCLLMEFCSGGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENV 246
Query: 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSC 304
+VREDGHIMLSDFDLSL+ FVSP L+QS+ P+C I+SYCIQP CIDP+CKLPV +C
Sbjct: 247 MVREDGHIMLSDFDLSLQSFVSPTLIQSTSQPSCHIASYCIQPPCIDPSCKLPV----AC 302
Query: 305 LQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG 364
+QPSCFKPRFLN+K K K+EK SDSLP+LIAEPT ARSMSFVGTHEYLAPEIIRG
Sbjct: 303 IQPSCFKPRFLNNKPRKAKTEKAG---SDSLPMLIAEPTDARSMSFVGTHEYLAPEIIRG 359
Query: 365 DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424
DGHGS+VDWWTFGIF YELL G+TPFKGNGNRETLFNVVGQPLKFPEG SISFAAKDLIR
Sbjct: 360 DGHGSSVDWWTFGIFLYELLTGKTPFKGNGNRETLFNVVGQPLKFPEG-SISFAAKDLIR 418
Query: 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIP 484
GLL KDP+KRLGFK+GATEIKQHPFF +VNWALIRST PPEIPKP+DLS +N K+ +
Sbjct: 419 GLLTKDPKKRLGFKKGATEIKQHPFFNNVNWALIRSTTPPEIPKPIDLSILNETLKSSVQ 478
Query: 485 QNDKGAADSDRSSGPFLDFEFF 506
Q K + SD SSGP+LDFEFF
Sbjct: 479 QQGKHSKQSDSSSGPYLDFEFF 500
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296087743|emb|CBI34999.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/518 (70%), Positives = 403/518 (77%), Gaps = 64/518 (12%)
Query: 12 DTESVTSISMHSVSFCSSSTVS-GSD-TSVSSNLSNATIEAKKGVDCL------AHSEEE 63
D +++++ + S+ ++ G+D T+ + +SNA EAKK V+ A E
Sbjct: 21 DNNAISNVVDEATENLESAEINNGADETTKNVEISNAEDEAKKDVETTEISNGDAAEATE 80
Query: 64 SGKS---------------SLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDL 108
+G+S ++ DANE +FRS C SKPH+GND++WDA+QCVK+KDGD+
Sbjct: 81 NGESVDCVESEKSSLSSASYSNSSDANETNFRSFCASKPHRGNDIRWDAIQCVKAKDGDM 140
Query: 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
GL HFRLLKKLGCGDIGSVYLAELR M CLFAMKVMDKGML RKKLMRAQTEREIL LL
Sbjct: 141 GLCHFRLLKKLGCGDIGSVYLAELRGMSCLFAMKVMDKGMLEERKKLMRAQTEREILGLL 200
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
DHPFLPTLYSHFET+KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQA RFYASEVLLALEY
Sbjct: 201 DHPFLPTLYSHFETEKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAARFYASEVLLALEY 260
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPS 288
LHM+GVVYRDLKPENVLVREDGHIMLSDFDLSLRC+VSP LVQ+S DP+ RISSYCIQPS
Sbjct: 261 LHMLGVVYRDLKPENVLVREDGHIMLSDFDLSLRCYVSPTLVQTSSDPSFRISSYCIQPS 320
Query: 289 CIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348
CIDPACKL VC +K+ K +SE+ SLTN DSLP+LIAEPT ARSM
Sbjct: 321 CIDPACKLSVC-----------------AKSRKPRSERLSLTNLDSLPMLIAEPTGARSM 363
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIF YELL GRTPFKGNGNRETLFNVVGQ LK
Sbjct: 364 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFLYELLHGRTPFKGNGNRETLFNVVGQSLK 423
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
F EGSSISFAAKDLIRGLLVKDPQKRLG+KRGATEIKQHPFFESVNWALIRSTHPP+IPK
Sbjct: 424 FAEGSSISFAAKDLIRGLLVKDPQKRLGYKRGATEIKQHPFFESVNWALIRSTHPPQIPK 483
Query: 469 PVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
PVDL P+LDFEFF
Sbjct: 484 PVDLEC------------------------PYLDFEFF 497
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449532394|ref|XP_004173166.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/494 (64%), Positives = 379/494 (76%), Gaps = 28/494 (5%)
Query: 33 SGSDTSVSSNLSNAT--IEAKKGVDCLAHSEE--ESGKSSLSTG-------DANEASFRS 81
SG D+SVS+ +S+ T I G ++ E ESGKSS+ G D + S S
Sbjct: 122 SGKDSSVSAKVSDGTNSISKTSGSAKISDRVEMVESGKSSMCRGSTSSDISDESTCSSFS 181
Query: 82 ACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAM 141
+ +SKPHK ND++W+A+Q V+++DG LGLGHFRLLK+LGCGDIGSVYL+EL C FAM
Sbjct: 182 SSISKPHKANDLRWEAIQAVRARDGILGLGHFRLLKRLGCGDIGSVYLSELSGTKCYFAM 241
Query: 142 KVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL 201
KVMDKG LA RKKL+RAQTEREIL LDHPFLPTLY+HFETDKFSCL+MEFC GGDLHTL
Sbjct: 242 KVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL 301
Query: 202 RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261
RQRQPGKHF+EQA +FY +EVLLALEYLHM+G+VYRDLKPENVLVREDGHIMLSDFDLSL
Sbjct: 302 RQRQPGKHFTEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 361
Query: 262 RCFVSPKLVQSS---DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318
RC VSP LV+ S +P + S+YC+QP+CI+P+C P CV P+ +CF PR +SK
Sbjct: 362 RCAVSPTLVKGSCSESEPLRKNSTYCVQPACIEPSCIQPSCVVPT----TCFTPRLFSSK 417
Query: 319 TTKVKSEKTSLTNSDS-LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFG 377
+ K + KT + N + LP LIAEPT ARSMSFVGTHEYLAPEII+G+GHGSAVDWWTFG
Sbjct: 418 SKKDRKPKTEIGNQVTPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFG 477
Query: 378 IFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF 437
IF YELL G+TPFKG+GNR TLFNVVGQPL+FPE +SFAA+DLIRGLLVK+PQ RL +
Sbjct: 478 IFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 537
Query: 438 KRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGA-----AD 492
KRGATEIKQHPFFE VNWALIR PPE+PKPV++ I +P P A
Sbjct: 538 KRGATEIKQHPFFEGVNWALIRCASPPEVPKPVEIERI----PSPAPPVSGKAIMARPGP 593
Query: 493 SDRSSGPFLDFEFF 506
+SS +L+F+FF
Sbjct: 594 DSKSSDNYLEFDFF 607
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|148906315|gb|ABR16313.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/484 (65%), Positives = 370/484 (76%), Gaps = 34/484 (7%)
Query: 44 SNATIEAKKGVDCLAHSE---EESGKSSLSTGDANEASFRSAC--------------LSK 86
++A I K +D L + ESGKSSLS AS+RS+ L+K
Sbjct: 75 ADAKIPECKSIDNLKNERLECVESGKSSLSV-----ASYRSSVSDSNESNCSSLSSSLNK 129
Query: 87 PHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDK 146
PHKGND +WDA+Q VK +DG LGL HFRLLK++G GDIGSVYLAELR C FAMKVMDK
Sbjct: 130 PHKGNDPRWDAIQAVKVRDGFLGLSHFRLLKRVGSGDIGSVYLAELRGTNCFFAMKVMDK 189
Query: 147 GMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQP 206
G L R K +RAQTEREILS LDHPFLPTLYSHFETDKFSCL+MEFCSGGDLH+ RQ+QP
Sbjct: 190 GSLENRNKSLRAQTEREILSCLDHPFLPTLYSHFETDKFSCLVMEFCSGGDLHSFRQQQP 249
Query: 207 GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266
K FSE A+RFYA+E+LLALEYLHMMG+VYRDLKPENVLVR DGHIML DFDLSLRC VS
Sbjct: 250 WKRFSESASRFYAAEILLALEYLHMMGIVYRDLKPENVLVRGDGHIMLLDFDLSLRCVVS 309
Query: 267 PKLVQSSD---DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323
P LV+S+ DP+ R+ YC+QPSCI+P+ CV P CLQPSCF+PRFL ++ K++
Sbjct: 310 PTLVKSASPGLDPSRRVPVYCVQPSCIEPS-----CVTPVCLQPSCFRPRFLPQRSKKIR 364
Query: 324 SEKTSLTN-SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYE 382
K + N S+ LP LIAEPTSARSMSFVGTHEYLAPEII+G GHGSAVDWWTFGIF YE
Sbjct: 365 KPKNEMANQSNLLPELIAEPTSARSMSFVGTHEYLAPEIIKGQGHGSAVDWWTFGIFLYE 424
Query: 383 LLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGAT 442
LL G TPFKG GNRETL + GQ L+FP+ ++SFAA+DLIRGLL+KDPQ RL FKRGAT
Sbjct: 425 LLYGTTPFKGAGNRETLEKIAGQALRFPDSPTVSFAARDLIRGLLMKDPQHRLAFKRGAT 484
Query: 443 EIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLD 502
EIKQHPFF+ NWALIRST PP+IPKP+DLSF+ +K P + +K DSD +S D
Sbjct: 485 EIKQHPFFDGANWALIRSTTPPQIPKPIDLSFLTNKVTPPSARGEKKKVDSDANS---FD 541
Query: 503 FEFF 506
F+FF
Sbjct: 542 FDFF 545
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443506|ref|XP_004139518.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/494 (64%), Positives = 377/494 (76%), Gaps = 28/494 (5%)
Query: 33 SGSDTSVSSNLSNATIEAKKGVDCLAHSEE----ESGKSSLSTG-------DANEASFRS 81
SG D+SVS+ +S+ T K S+ ESGKSS+ G D + S S
Sbjct: 122 SGKDSSVSAKVSDGTNSISKTSGSAKISDRIEMVESGKSSMCRGSTSSDISDESTCSSFS 181
Query: 82 ACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAM 141
+ +SKPHK ND++W+A+Q V+++DG LGLGHFRLLK+LGCGDIGSVYL+EL C FAM
Sbjct: 182 SSISKPHKANDLRWEAIQAVRARDGILGLGHFRLLKRLGCGDIGSVYLSELSGTKCYFAM 241
Query: 142 KVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL 201
KVMDKG LA RKKL+RAQTEREIL LDHPFLPTLY+HFETDKFSCL+MEFC GGDLHTL
Sbjct: 242 KVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL 301
Query: 202 RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261
RQRQPGKHF+EQA +FY +EVLLALEYLHM+G+VYRDLKPENVLVREDGHIMLSDFDLSL
Sbjct: 302 RQRQPGKHFTEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 361
Query: 262 RCFVSPKLVQSS---DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318
RC VSP LV+ S +P + S+YC+QP+CI+P+C P CV P+ +CF PR +SK
Sbjct: 362 RCAVSPTLVKGSCSESEPLRKNSTYCVQPACIEPSCIQPSCVVPT----TCFTPRLFSSK 417
Query: 319 TTKVKSEKTSLTNSDS-LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFG 377
+ K + KT + N + LP LIAEPT ARSMSFVGTHEYLAPEII+G+GHGSAVDWWTFG
Sbjct: 418 SKKDRKPKTEIGNQVTPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFG 477
Query: 378 IFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF 437
IF YELL G+TPFKG+GNR TLFNVVGQPL+FPE +SFAA+DLIRGLLVK+PQ RL +
Sbjct: 478 IFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 537
Query: 438 KRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGA-----AD 492
KRGATEIKQHPFFE VNWALIR PPE+PKPV++ I +P P A
Sbjct: 538 KRGATEIKQHPFFEGVNWALIRCASPPEVPKPVEIERI----PSPAPPVSGKAIMARPGP 593
Query: 493 SDRSSGPFLDFEFF 506
+SS +L+F+FF
Sbjct: 594 DSKSSDNYLEFDFF 607
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532843|ref|XP_003534979.1| PREDICTED: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/538 (59%), Positives = 389/538 (72%), Gaps = 43/538 (7%)
Query: 2 NKQLNSATNYDTESVTSISMHSVSFCSSSTVSGSDTSVSSNLSNATIEAK--KGVDCLAH 59
NK + A++Y + + ++ S TS ++ N+++ AK G LA
Sbjct: 81 NKSGSGASSYVLDKSVRAANENIGSQESPIDQDKKTSEDGSVKNSSVSAKVSDGASSLAK 140
Query: 60 SEE-----------ESGKSSLSTG-------DANEASFRSACLSKPHKGNDMKWDAVQCV 101
+ ESGKSS+ G D + S S+ ++KPHK ND++W+A+Q V
Sbjct: 141 TSGSAKISNRADFVESGKSSICRGSTSSDVSDESTCSSFSSTINKPHKANDLRWEAIQAV 200
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
+S+DG LGLGHFRLLK+LGCGDIGSVYL+EL C FAMKVMDKG LA RKKL+RAQTE
Sbjct: 201 RSRDGVLGLGHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKGSLASRKKLLRAQTE 260
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASE 221
REIL LDHPFLPTLY+HFET+KFSCL+MEFC GGDLHTLRQ+QPGKHF EQA +FY +E
Sbjct: 261 REILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKHFPEQAVKFYVAE 320
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS---DDPAC 278
VLLALEYLHM+G+VYRDLKPENVLVR+DGHIMLSDFDLSLRC VSP LV++S +P
Sbjct: 321 VLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLVKTSSTDSEPLR 380
Query: 279 RISSYCIQPSCIDPACKLPVCVEPSCLQP-SCFKPRFLNSKTTKVKSEKTSLTNSDS-LP 336
+ S+YC+QP+CI+P P C++PSC+ P +CF PR +SK+ K + KT + N S LP
Sbjct: 381 KNSAYCVQPACIEP----PSCIQPSCVAPTTCFSPRLFSSKSKKDRKPKTEIGNQVSPLP 436
Query: 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR 396
LIAEPT ARSMSFVGTHEYLAPEII+G+GHGSAVDWWTFGIF YELL G+TPFKG+GNR
Sbjct: 437 ELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 496
Query: 397 ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456
TLFNVVGQPL+FPE +SFAA+DLIRGLLVK+PQ RL +KRGATEIKQHPFFE VNWA
Sbjct: 497 ATLFNVVGQPLRFPEAPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 556
Query: 457 LIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGAADS--------DRSSGPFLDFEFF 506
LIR PPEIPK V+ +K P P + G + + S +L+F+FF
Sbjct: 557 LIRCATPPEIPKAVEF------EKIPSPASSSGGEKAANHISIANQKGSDNYLEFDFF 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 506 | ||||||
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.875 | 0.887 | 0.770 | 5.4e-189 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.863 | 0.745 | 0.658 | 1.6e-159 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.865 | 0.625 | 0.642 | 1.4e-156 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.849 | 0.849 | 0.635 | 1.1e-151 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.867 | 0.881 | 0.634 | 2.3e-151 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.885 | 0.585 | 0.607 | 6.2e-149 | |
| TAIR|locus:2091443 | 578 | ATPK7 [Arabidopsis thaliana (t | 0.865 | 0.757 | 0.609 | 1.9e-140 | |
| TAIR|locus:2207470 | 555 | AGC1.7 "AGC kinase 1.7" [Arabi | 0.883 | 0.805 | 0.600 | 4e-138 | |
| TAIR|locus:2087785 | 577 | AGC1.5 "AGC kinase 1.5" [Arabi | 0.739 | 0.648 | 0.666 | 1.6e-134 | |
| TAIR|locus:2032785 | 499 | RSH3 "root hair specific 3" [A | 0.835 | 0.847 | 0.591 | 1.3e-132 |
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1832 (650.0 bits), Expect = 5.4e-189, P = 5.4e-189
Identities = 350/454 (77%), Positives = 386/454 (85%)
Query: 56 CLAHS-EEESGKSSLSTGDANEASFRSACL-SKPHKGNDMKWDAVQCVK-SKDGDLGLGH 112
C ++S E+ + DANEA+F+ SKPHKGND++WDA+Q VK SK+ DLGLGH
Sbjct: 54 CSSNSVSSEANLEKTQSFDANEANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGH 113
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
FRLLKKLGCGDIGSVYLAELR+MGC FAMKVMDKGML GRKKL+RAQTEREIL LLDHPF
Sbjct: 114 FRLLKKLGCGDIGSVYLAELREMGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPF 173
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
LPTLYSHFET+KFSCLLMEFCSGGDLH LRQ+QPGKHFSE A RFYASEVLLALEYLHMM
Sbjct: 174 LPTLYSHFETEKFSCLLMEFCSGGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMM 233
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
GVVYRDLKPENV+VREDGHIMLSDFDLSL+ FVSP L+QS+ P+C I+SYCIQP CIDP
Sbjct: 234 GVVYRDLKPENVMVREDGHIMLSDFDLSLQSFVSPTLIQSTSQPSCHIASYCIQPPCIDP 293
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNXXXXXXXXXXXXXXNSDSLPVLIAEPTSARSMSFVG 352
+CKLPV +C+QPSCFKPRFLN SDSLP+LIAEPT+ARSMSFVG
Sbjct: 294 SCKLPV----ACIQPSCFKPRFLNNKPRKAKTEKA---GSDSLPMLIAEPTAARSMSFVG 346
Query: 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG 412
THEYLAPEIIRGDGHGS+VDWWTFGIF YELL G+TPFKGNGNRETLFNVVGQPLKFPEG
Sbjct: 347 THEYLAPEIIRGDGHGSSVDWWTFGIFLYELLTGKTPFKGNGNRETLFNVVGQPLKFPEG 406
Query: 413 SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDL 472
S ISFAAKDLIRGLL KDP+KRLGFK+GATEIKQHPFF +VNWALIRST PPEIPKP+DL
Sbjct: 407 S-ISFAAKDLIRGLLTKDPKKRLGFKKGATEIKQHPFFNNVNWALIRSTTPPEIPKPIDL 465
Query: 473 SFINHKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
S +N K+ + Q K + SD SSGP+LDFEFF
Sbjct: 466 SILNETLKSSVQQQGKHSKQSDSSSGPYLDFEFF 499
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1554 (552.1 bits), Expect = 1.6e-159, P = 1.6e-159
Identities = 303/460 (65%), Positives = 355/460 (77%)
Query: 63 ESGKSSLSTGD-ANEASFRSACLS------KPHKGNDMKWDAVQCVKSKDGDLGLGHFRL 115
ESGKSS+ G +++ S S+C S KPHK ND++W+A+Q V+ +DG LGL HFRL
Sbjct: 134 ESGKSSICRGSTSSDVSDESSCSSFSSTVNKPHKANDLRWEAIQAVRVRDGLLGLSHFRL 193
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
LK+LGCGDIGSVYL+EL C FAMKVMDK LA RKKL+RAQTEREIL LDHPFLPT
Sbjct: 194 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKTSLASRKKLLRAQTEREILQSLDHPFLPT 253
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
LY+HFET+KFSCL+MEFC GGDLHTLRQRQPGKHFSEQA +FY +E LLALEYLHM+G+V
Sbjct: 254 LYTHFETEKFSCLVMEFCPGGDLHTLRQRQPGKHFSEQAVKFYIAESLLALEYLHMLGIV 313
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS---DDPACRISSYCIQPSCIDP 292
YRDLKPENVLVREDGHIMLSDFDLSLRC VSP LV+S+ DP R + YC+QP+CI+P
Sbjct: 314 YRDLKPENVLVREDGHIMLSDFDLSLRCLVSPTLVKSAAIESDPL-RKNVYCVQPACIEP 372
Query: 293 ACKLPVCVEPSCLQPS-CFKPRFLNXXXXXXXXXXXXXXNS-DSLPVLIAEPTSARSMSF 350
+C ++PSC P+ CF PR + N LP L+AEPT ARSMSF
Sbjct: 373 SC-----IQPSCTVPTTCFSPRLFSSKSKKDRKPKNDTANQVRPLPELVAEPTDARSMSF 427
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
VGTHEYLAPEII+G+GHGSAVDWWTFGIF YELL GRTPFKG+GNR+TLFNVVGQPL+FP
Sbjct: 428 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSGNRQTLFNVVGQPLRFP 487
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPV 470
E +SFAA+DLIRGLL+K+PQ+RLGFKRGATE+KQHPFFE VNWALIR PPEIPKPV
Sbjct: 488 ETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVKQHPFFEGVNWALIRCATPPEIPKPV 547
Query: 471 DLSFINHKQKTPIPQNDKGAA----DSDRSSGPFLDFEFF 506
+L P + K AA ++ + S +L+F+FF
Sbjct: 548 ELEK-GAVSVAEAPSSQKTAAGLVLNAQKGSDNYLEFDFF 586
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1526 (542.2 bits), Expect = 1.4e-156, P = 1.4e-156
Identities = 293/456 (64%), Positives = 358/456 (78%)
Query: 63 ESGKSSLS-----TGDANEASFRS--ACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRL 115
ESGK+SLS +G ++++++ + +KPHKGND +W A+ ++++DG LG+ HF+L
Sbjct: 251 ESGKTSLSRASDSSGLSDDSNWSNITGSANKPHKGNDPRWKAILAIRARDGILGMSHFKL 310
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
LK+LGCGDIGSVYL+EL C FAMKVMDK LA RKKL RAQTEREIL LLDHPFLPT
Sbjct: 311 LKRLGCGDIGSVYLSELSGTRCYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPT 370
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
LY+HFETD+FSCL+ME+C GGDLHTLRQRQPGKHFSE A RFYA+EVLLALEYLHM+GVV
Sbjct: 371 LYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVV 430
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ-SSDDPACRISSYCIQPSCIDPAC 294
YRDLKPENVLVR+DGHIMLSDFDLSLRC VSP L++ SSDDP+ R +++C+QP+CI+P
Sbjct: 431 YRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIRISSDDPSKRGAAFCVQPACIEPTT 490
Query: 295 KLPVCVEPSCLQPSCFKPRFLNXXXXXXXXXXXXXXNSDSLPVLIAEPTSARSMSFVGTH 354
VC++P+C P F P+ ++S+P L+AEPTSARSMSFVGTH
Sbjct: 491 ---VCMQPACFLPRLF-PQ--KSKKKTPKPRADSGFQANSMPELVAEPTSARSMSFVGTH 544
Query: 355 EYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSS 414
EYLAPEII+G+GHGSAVDWWTFGIF +ELL G+TPFKG+GNR TLFNVVGQ LKFP+ +
Sbjct: 545 EYLAPEIIKGEGHGSAVDWWTFGIFLHELLYGKTPFKGSGNRATLFNVVGQQLKFPDSPA 604
Query: 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSF 474
S+A++DLIRGLLVK+PQ RLG KRGATEIKQHPFFE VNWALIR + PPE+P+PV+ +
Sbjct: 605 TSYASRDLIRGLLVKEPQNRLGVKRGATEIKQHPFFEGVNWALIRCSTPPEVPRPVEPDY 664
Query: 475 -INHKQKTPIP--QNDKGAADSD-RSSGPFLDFEFF 506
+ Q P+ K +D +S G +LDFEFF
Sbjct: 665 PAKYGQVNPVGVGNTSKRVVGADAKSGGKYLDFEFF 700
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1480 (526.0 bits), Expect = 1.1e-151, P = 1.1e-151
Identities = 290/456 (63%), Positives = 344/456 (75%)
Query: 62 EESGKSSLST-GDANEASFRSACLS-----KPHKGNDMKWDAVQCVKSKDGDLGLGHFRL 115
++SGKS+ +++ S S C S KPHK ND++W+A+Q V++K G LGL HFRL
Sbjct: 66 DQSGKSNTCRPSTSSDISDESTCSSFSGNNKPHKANDVRWEAIQAVRTKHGVLGLNHFRL 125
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
LK+LGCGDIG+V+LAEL C FAMKVMDKG LA RKKL+RAQTEREIL LDHPFLPT
Sbjct: 126 LKRLGCGDIGTVHLAELHGTRCFFAMKVMDKGALASRKKLLRAQTEREILQCLDHPFLPT 185
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
LYSHFET+KFSCL+MEFC GGDLHTLRQRQPGK FSEQA +FY +EVLLA+EYLHM+G++
Sbjct: 186 LYSHFETEKFSCLVMEFCPGGDLHTLRQRQPGKRFSEQAAKFYVAEVLLAMEYLHMLGII 245
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS--DDPACRISSYCIQPSCIDPA 293
YRDLKPENVLVR+DGH+MLSDFDLSLRC VSP +V+S+ + S YC QP+CI
Sbjct: 246 YRDLKPENVLVRDDGHVMLSDFDLSLRCTVSPTVVRSTVLASEGQKNSGYCAQPACIQ-- 303
Query: 294 CKLPVCVEPSCLQ-PS-CFKPRFLNXXXXXXXXXXXXXXNSDS-LPVLIAEPTSARSMSF 350
+PSC+ P+ CF PR+ + N S LP L+AEPTSARSMSF
Sbjct: 304 -------QPSCISAPTTCFSPRYFSSKSKKDKKMKNETGNQVSPLPELVAEPTSARSMSF 356
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
VGTHEYLAPEII+G+GHGSAVDWWTFGIF YELL G+TPFKG+GNR TLFNVVGQPL+FP
Sbjct: 357 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 416
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPV 470
E +SFAA+DLIR LLVK+PQ RL +KRGATE+KQHPFFE VNWAL+R PPEIPKPV
Sbjct: 417 ESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEMKQHPFFEGVNWALVRCASPPEIPKPV 476
Query: 471 DLSFINHKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
D TP + SD+S+ +L+F+FF
Sbjct: 477 DYE---SAPATPAAATST-SVKSDQSN--YLEFDFF 506
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1477 (525.0 bits), Expect = 2.3e-151, P = 2.3e-151
Identities = 292/460 (63%), Positives = 348/460 (75%)
Query: 59 HSEEESGKSSL---STG----DANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLG 111
+ + ESGKSS ST D + S S+ ++KPHK ND++W+A+Q V++K G LGL
Sbjct: 48 NEQGESGKSSTCRPSTSSDISDESTCSSFSSSINKPHKANDVRWEAIQAVRTKHGGLGLN 107
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
HFRLLK+LGCGDIG+V+LAEL C FAMKVMDK LA RKKL+RAQTEREIL LDHP
Sbjct: 108 HFRLLKRLGCGDIGTVHLAELNGTRCYFAMKVMDKTALASRKKLLRAQTEREILQCLDHP 167
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FLPTLYSHFET+KFSCL+MEFC GGDLHTLRQRQPGK F+EQA +FY +EVLLA+EYLHM
Sbjct: 168 FLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQPGKRFTEQAAKFYVAEVLLAMEYLHM 227
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291
+G++YRDLKPENVLVR+DGH+MLSDFDLSLRC VS +V+S++ + +S + SC
Sbjct: 228 LGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTVSLSIVRSANVGSEGLSKNSV--SCSQ 285
Query: 292 -PAC-KLPVCVEPSCLQPSCFKPRFLNXXXXXXXXXXXXXXNSD--SLPVLIAEPTSARS 347
PAC + P C+ S SCF PRF + N LP L+AEPT ARS
Sbjct: 286 QPACIQQPSCI--SMAPTSCFGPRFFSSKSKKDKKPKTENGNHQVTPLPELVAEPTGARS 343
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
MSFVGTHEYLAPEII+G+GHGSAVDWWTFGIF YELL G+TPFKG+GNR TLFNVVGQPL
Sbjct: 344 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL 403
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
+FPE +SFAA+DLIR LLVK+PQ RL +KRGATEIKQHPFFE VNWAL+R PPEIP
Sbjct: 404 RFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALVRCASPPEIP 463
Query: 468 KPVDLSFINHKQKTP-IPQNDKGAADSDRSSGPFLDFEFF 506
KPVDL +N TP +P + SD+S+ +L+F+FF
Sbjct: 464 KPVDLEALN---PTPTVPAAASSSVRSDQSN--YLEFDFF 498
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1454 (516.9 bits), Expect = 6.2e-149, P = 6.2e-149
Identities = 285/469 (60%), Positives = 348/469 (74%)
Query: 54 VDCLAHSEEESGKSSLSTGDANEASFRS--ACLSKPHKGNDMKWDAVQCVKSKDGDLGLG 111
+D ++ + ++S S+G + E+S+ + L+KPHKGND W+A+ ++++DG LG+
Sbjct: 302 LDSFESTKTSASRASDSSGLSEESSWSNFTGSLNKPHKGNDPWWNAILAIRTRDGILGMS 361
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
HF+LLK+LGCGDIGSVYLAEL C FA+KVMDK L RKKL RAQTER+IL LLDHP
Sbjct: 362 HFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRKKLNRAQTERDILQLLDHP 421
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FLPTLY+HFETD+FSCL+ME+C GGDLHTLRQRQPGKHFSE A RFYA+EVLLALEYLHM
Sbjct: 422 FLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHM 481
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291
+GVVYRDLKPENVLVR+DGHIMLSDFDLSLRC VSP L+++ D R ++C+QP+C++
Sbjct: 482 LGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIKTFDSDPSRRGAFCVQPACME 541
Query: 292 PACKLPVCV-EPSCLQPSCFKPRFLNXXXXXXXXXXXXXXNSDSLPVLIAEPTSARSMSF 350
P C+ +PSC P P +S SLP L+AEP + RSMSF
Sbjct: 542 PTS---ACIIQPSCFLPRSIFPNKNKKNKSRKTQADFFKSHSGSLPELVAEPNT-RSMSF 597
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
VGTHEYLAPEII+G+GHGSAVDWWTFGIF +ELL G+TPFKG+GNR TLFNVVG+ LKFP
Sbjct: 598 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFVHELLYGKTPFKGSGNRATLFNVVGEQLKFP 657
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK-- 468
E + S+A +DLI+ LLVKDP+ RLG KRGATEIKQHPFFE VNWALIR + PPE+P+
Sbjct: 658 ESPATSYAGRDLIQALLVKDPKNRLGTKRGATEIKQHPFFEGVNWALIRCSTPPEVPRQM 717
Query: 469 ---------PVD-LSF-INHKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
P+D + F N K+ P AAD+ +S G FLDFEFF
Sbjct: 718 ETEPPPKYGPIDPVGFGSNSKRMMGPPAVSAAAADT-KSGGKFLDFEFF 765
|
|
| TAIR|locus:2091443 ATPK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1374 (488.7 bits), Expect = 1.9e-140, P = 1.9e-140
Identities = 275/451 (60%), Positives = 329/451 (72%)
Query: 65 GKSSLSTGDANEASFRSACLSKPHK-GNDMKWDAVQCVKSKDGD-LGLGHFRLLKKLGCG 122
G D + +S S KPH+ ND +W A+Q V+S+ G L F+L+KKLG G
Sbjct: 132 GSIGSDVSDESSSSGLSNAAYKPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGG 191
Query: 123 DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182
DIG+VYLAEL G FA+KVM+K +A RKKL+RAQTE+EIL LDHPFLPTLYSHFET
Sbjct: 192 DIGNVYLAELIGTGVSFAVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFET 251
Query: 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPE 242
+ SCL+MEFC GGDLH+LRQ+Q GK+F EQA RFY +EVLLA+EYLHM+G++YRDLKPE
Sbjct: 252 EMNSCLVMEFCPGGDLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPE 311
Query: 243 NVLVREDGHIMLSDFDLSLRCFVSPKLVQ-SSDDPACRISSYCIQPSCIDPACKLPVCVE 301
NVLVREDGHIMLSDFDLSLRC VSP LV+ ++ + SSYCIQP+C+D + + V+
Sbjct: 312 NVLVREDGHIMLSDFDLSLRCAVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCI---VQ 368
Query: 302 PSCLQPSCFKPRFLNXXXXXXXXXXXXXXNSDSLPVLIAEPTSARSMSFVGTHEYLAPEI 361
P C+QP CF PRFL+ LP LIAEPTSARSMSFVGTHEYLAPEI
Sbjct: 369 PDCIQPVCFTPRFLSKGKHRKKSNDMSR-QIRPLPELIAEPTSARSMSFVGTHEYLAPEI 427
Query: 362 IRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421
I+G+GHGSAVDWWTFGIF YELL G TPF+G NR TLFNVVGQPL+FPE ++SFAA+D
Sbjct: 428 IKGEGHGSAVDWWTFGIFLYELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARD 487
Query: 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKT 481
LIRGLLVK+PQ RL ++RGATEIKQHPFF+SVNWALIR T PP+IP+PV H +
Sbjct: 488 LIRGLLVKEPQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQIPQPVKPMDQAHSVRH 547
Query: 482 PIPQN------DKGAADSDRSSGPFLDFEFF 506
Q DK + SG +L+ +FF
Sbjct: 548 GFSQGHGHVGYDKPPTVDVKPSGNYLEIDFF 578
|
|
| TAIR|locus:2207470 AGC1.7 "AGC kinase 1.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1352 (481.0 bits), Expect = 4.0e-138, P = 4.0e-138
Identities = 274/456 (60%), Positives = 326/456 (71%)
Query: 45 NATIEAKKGVDCLAHSEEESGKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSK 104
N T E++ ++ ++ + S++S+ +N S+ SKPH G D++WDAV + SK
Sbjct: 80 NMT-ESQSNLNTKPNNNNSNNNSNMSSR-SNSIESTSSNPSKPHTGGDIRWDAVNTLTSK 137
Query: 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI 164
LG+ FRLLK+LG GDIGSVYL ELR FAMKVMDK LA R KL+RAQTEREI
Sbjct: 138 GVQLGISDFRLLKRLGYGDIGSVYLVELRGTITYFAMKVMDKASLASRNKLLRAQTEREI 197
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
LS LDHPFLPTLYSHFETDKF CL+MEFC GG+L++LRQ+QP K F+E A RF+ASEVLL
Sbjct: 198 LSQLDHPFLPTLYSHFETDKFYCLVMEFCGGGNLYSLRQKQPNKCFTEDAARFFASEVLL 257
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYC 284
ALEYLHM+G+VYRDLKPENVLVR+DGHIMLSDFDLSLRC VSP LV+SS A S
Sbjct: 258 ALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRCSVSPTLVKSSSVHAAGGGSGS 317
Query: 285 IQP-SCIDPACKLPVCVEPSCLQPSCFKPRFLNXXXXXXXXXXXXXXN-SDSLPVLIAEP 342
+P ID V+ C+QPS F PR L + S+P L+AEP
Sbjct: 318 SRPVGLIDE----DAAVQ-GCIQPSTFFPRILQSSKKNRKAKSDFGLFVNGSMPELMAEP 372
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T+ +SMSFVGTHEYLAPEIIRG+GHGSAVDWWTFGIF YELL G TPFKG GNR TL NV
Sbjct: 373 TNVKSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFIYELLYGATPFKGQGNRATLHNV 432
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTH 462
+GQ L+FPE +S AA+DLI+GLLVK+PQKR+ +KRGATEIKQHPFFE VNWALIRS
Sbjct: 433 IGQALRFPEVPHVSSAARDLIKGLLVKEPQKRIAYKRGATEIKQHPFFEGVNWALIRSAT 492
Query: 463 PPEIPKPVDLSFINHKQKTPIPQNDKGAADSDRSSG 498
PP +P+PVD S K K + D G ++ +G
Sbjct: 493 PPHVPEPVDFSCYASKDKESMAAVDGGGKKNNNGAG 528
|
|
| TAIR|locus:2087785 AGC1.5 "AGC kinase 1.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1318 (469.0 bits), Expect = 1.6e-134, P = 1.6e-134
Identities = 258/387 (66%), Positives = 293/387 (75%)
Query: 86 KPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD 145
KPH G D++WDA+ + SK +GL +FRLLK+LG GDIGSVYLA+LR +FAMKVMD
Sbjct: 158 KPHTGGDVRWDAINSIASKGPQIGLDNFRLLKRLGYGDIGSVYLADLRGTNAVFAMKVMD 217
Query: 146 KGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQ 205
K LA R KL+RAQTEREILSLLDHPFLPTLYS+FETDKF CL+MEFCSGG+LH+LRQ+Q
Sbjct: 218 KASLASRNKLLRAQTEREILSLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQKQ 277
Query: 206 PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265
P + F+E+A RFYASEVLLALEYLHM+GVVYRDLKPEN+LVR++GHIMLSDFDLSLRC
Sbjct: 278 PSRRFTEEAARFYASEVLLALEYLHMLGVVYRDLKPENILVRDEGHIMLSDFDLSLRCTF 337
Query: 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNXXXXXXXXX 325
+P LV+SS S C I V C+ PS F PR L
Sbjct: 338 NPTLVKSS--------SVCSGGGAI---LNEEFAVN-GCMHPSAFLPRLLPSKKTRKAKS 385
Query: 326 XXXXXNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL 385
S+P L+AEPT RSMSFVGTHEYLAPEIIRG+GHGSAVDWWTFGIF YELL
Sbjct: 386 DSGLGGL-SMPELMAEPTDVRSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFLYELLH 444
Query: 386 GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIK 445
G TPFKG GNR TL NVVGQPLKFP+ +S AA+DLIRGLLVKDP +R+ + RGATEIK
Sbjct: 445 GTTPFKGQGNRATLHNVVGQPLKFPDTPHVSSAARDLIRGLLVKDPHRRIAYTRGATEIK 504
Query: 446 QHPFFESVNWALIRSTHPPEIPKPVDL 472
QHPFFE VNWAL+RS PP IP PVDL
Sbjct: 505 QHPFFEGVNWALVRSAAPPHIPDPVDL 531
|
|
| TAIR|locus:2032785 RSH3 "root hair specific 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1300 (462.7 bits), Expect = 1.3e-132, P = 1.3e-132
Identities = 265/448 (59%), Positives = 318/448 (70%)
Query: 68 SLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSV 127
++S+ N S + SKPH G D++WDAV +KS+ LG+ FR+LK+LG GDIGSV
Sbjct: 68 NMSSQSNNSESTSTNNSSKPHTGGDIRWDAVNSLKSRGIKLGISDFRVLKRLGYGDIGSV 127
Query: 128 YLAELRDMG--CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185
YL EL+ FAMKVMDK L R KL+RAQTEREILS LDHPFLPTLYSHFETDKF
Sbjct: 128 YLVELKGANPTTYFAMKVMDKASLVSRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKF 187
Query: 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVL 245
CL+MEFCSGG+L++LRQ+QP K F+E A RF+ASEVLLALEYLHM+G+VYRDLKPENVL
Sbjct: 188 YCLVMEFCSGGNLYSLRQKQPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVL 247
Query: 246 VREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCL 305
VR+DGHIMLSDFDLSLRC V+P LV+S + ID + C
Sbjct: 248 VRDDGHIMLSDFDLSLRCSVNPTLVKSFNGGGTT--------GIIDDNAAVQ-----GCY 294
Query: 306 QPSCFKPRFLNXXXXXXXXXXXXXXNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD 365
QPS F PR L SLP L+AEPT+ +SMSFVGTHEYLAPEII+ +
Sbjct: 295 QPSAFFPRMLQSSKKNRKSKSDF---DGSLPELMAEPTNVKSMSFVGTHEYLAPEIIKNE 351
Query: 366 GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425
GHGSAVDWWTFGIF YELL G TPFKG GN+ TL+NV+GQPL+FPE S +S AKDLI+G
Sbjct: 352 GHGSAVDWWTFGIFIYELLHGATPFKGQGNKATLYNVIGQPLRFPEYSQVSSTAKDLIKG 411
Query: 426 LLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIP- 484
LLVK+PQ R+ +KRGATEIKQHPFFE VNWALIR PP +P+PVD S K+K +P
Sbjct: 412 LLVKEPQNRIAYKRGATEIKQHPFFEGVNWALIRGETPPHLPEPVDFSCYVKKEKESLPP 471
Query: 485 ----QNDKGAADSDRS-SGP-FLDFEFF 506
+ K ++++S S P ++ FE+F
Sbjct: 472 AATEKKSKMFDEANKSGSDPDYIVFEYF 499
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 506 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-177 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-73 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-73 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-66 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-65 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-57 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-52 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-49 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-47 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-47 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-45 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-43 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-40 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-39 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-39 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-34 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-34 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-33 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-33 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-33 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-32 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-32 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-31 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-31 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-30 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-30 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-29 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-29 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-29 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-28 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-28 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-27 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-27 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-27 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-27 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-26 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-26 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-26 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-26 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-26 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-25 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-25 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-25 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-24 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-24 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-23 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-23 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-23 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-21 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-12 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-09 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-08 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-05 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 3e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-05 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-05 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-04 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-04 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-04 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 7e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.001 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.002 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.002 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.002 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.002 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.003 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.003 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 0.004 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.004 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 0.004 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.004 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 499 bits (1288), Expect = e-177
Identities = 182/360 (50%), Positives = 223/360 (61%), Gaps = 48/360 (13%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
HF+ +K LG GD+G V+L L+ G LFA+KV+DK + R K+ R TE+EIL+ LDHP
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FLPTLY+ F+T+ + CL+M++C GG+L L QRQPGK SE+ RFYA+EVLLALEYLH+
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291
+G+VYRDLKPEN+L+ E GHIMLSDFDLS + V P V
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV--------------------- 160
Query: 292 PACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351
+ S T +E S RS SFV
Sbjct: 161 -------------------SKALRKGSRRSSVNSIPSET--------FSEEPSFRSNSFV 193
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE 411
GT EY+APE+I GDGHGSAVDWWT GI YE+L G TPFKG+ ET N++ + + FP
Sbjct: 194 GTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG 253
Query: 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVD 471
+S +A+DLIR LLVKDP KRLG KRGA EIKQHPFF VNWALIR T PP IP+P D
Sbjct: 254 SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 5e-73
Identities = 110/342 (32%), Positives = 163/342 (47%), Gaps = 68/342 (19%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HP 171
F+ K +G G +V LA+ ++ +A+K++DK L KK+ + E+E+L+ L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 172 FLPTLYSHFETDKFSCL--LMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+ LY F+ + L ++E+ G+L +R+ E+ TRFYA+E+LLALEY
Sbjct: 63 GIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEY 117
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPS 288
LH G+++RDLKPEN+L+ +D HI ++DF + K++ + P
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFG-------TAKVLDPNSSPE----------- 159
Query: 289 CIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348
S K TN DS E R
Sbjct: 160 -----------------------------------SNKGDATNIDSQI----EKNRRRFA 180
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
SFVGT EY++PE++ G + D W G Y++L G+ PF+G+ T ++
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
FP AKDLI LLV DPQ RLG G E+K HPFF
Sbjct: 241 FPPN--FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 6e-73
Identities = 122/403 (30%), Positives = 193/403 (47%), Gaps = 66/403 (16%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F ++K +G G G V+L +D G ++AMKV+ K + R ++ + ER+IL+ D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ LY F+ ++ L+ME+ GGDL L R+ F E+ RFY +E++LAL+ +H +
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
G ++RD+KP+N+L+ DGHI L+DF L K+ ++ D S+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK------KMNKAKDREYYLNDSH--------- 165
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352
V + R+ S VG
Sbjct: 166 ----------------------NLLFRDNVLVRRRDHKQ-----------RRVRANSTVG 192
Query: 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFP 410
T +Y+APE++RG +G DWW+ G+ YE+L G PF + +ET ++ + L+FP
Sbjct: 193 TPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFP 252
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK-- 468
+S A DLI LL DP+ RLG EIK HPFF+ ++W +R T PP +P+
Sbjct: 253 PDPPVSPEAIDLICRLLC-DPEDRLG---SFEEIKSHPFFKGIDWENLRETKPPFVPELS 308
Query: 469 -PVDLSFINHKQKT-----PIPQNDKGAADSDRSSGPFLDFEF 505
P+D S + + + QN K + F+ F +
Sbjct: 309 SPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQL--AFVGFTY 349
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 3e-66
Identities = 122/360 (33%), Positives = 186/360 (51%), Gaps = 40/360 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +K +G G G V L + +D G ++AMK + K + + +L + ER++L+ D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ +LY F+ ++ L+MEF GGDL T+ + FSE TRFY +E +LA+E +H +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
G ++RD+KP+N+L+ GHI LSDF LS D S+Y +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTG-------FHKQHD-----SAYYQKL----- 163
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF-- 350
LQ K R N + V S ++++ D + + R M++
Sbjct: 164 ------------LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK---NRRLMAYST 208
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLK 408
VGT +Y+APEI G+G DWW+ G +E L+G PF + ET ++ + L
Sbjct: 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY 268
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
FP+ +S A+DLIR L+ + + RLG + GA EIK HPFF V+W IR P IP+
Sbjct: 269 FPDDIHLSVEAEDLIRRLIT-NAENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQ 326
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 8e-65
Identities = 115/403 (28%), Positives = 191/403 (47%), Gaps = 55/403 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +K +G G G V L + +D G ++AMK + K + ++++ + ER+IL+ D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ LY F+ + + L+ME+ GGD+ TL ++ F+E+ TRFY +E +LA++ +H +
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS--LRCFVSPKLVQSSDDPACRISSYCIQPSCI 290
G ++RD+KP+N+L+ GHI LSDF L L+ + +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH--------------- 165
Query: 291 DPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350
PS KP K K + +L + S
Sbjct: 166 ---------ALPSNFLDFISKPMSSKRKAETWKRNRRAL-----------------AYST 199
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLK 408
VGT +Y+APE+ G+ DWW+ G+ YE+L+G PF + +ET ++ + L+
Sbjct: 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ 259
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
FP+ +S AKDLI+ L + ++RLG G EIK HPFF+ V+W IR P IP+
Sbjct: 260 FPDEVPLSPEAKDLIKRLCC-EAERRLGNN-GVNEIKSHPFFKGVDWEHIRERPAPIIPE 317
Query: 469 ---PVDLSFINHKQKTPIP---QNDKGAADSDRSSGPFLDFEF 505
D S + ++ + F+ + +
Sbjct: 318 LKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSKDLAFIGYTY 360
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 4e-57
Identities = 121/396 (30%), Positives = 178/396 (44%), Gaps = 57/396 (14%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F +K +G G G V L D L+AMK + K + R + + ER+IL+ D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
++ LY F+ +M++ GGD+ +L R F E RFY +E+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDL--SLRCFVSPKLVQSSDDPACRISSYCIQPSC 289
MG ++RD+KP+N+L+ DGHI L+DF L R K Q D R S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH--RQDSMEPSEEW 177
Query: 290 IDP-ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348
+ C+L K + + ++ + +
Sbjct: 178 SEIDRCRL---------------------KPLERRRKR--------------QHQRCLAH 202
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QP 406
S VGT Y+APE++ G+ DWW+ G+ YE+L+G+ PF + ET V+
Sbjct: 203 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT 262
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA-LIRSTHPPE 465
L P + +S A DLI L + RLG K GA EIK HPFF+ +++A LIR P
Sbjct: 263 LHIPSQAKLSREASDLILR-LCCGAEDRLG-KNGADEIKAHPFFKGIDFASLIRRQKAPY 320
Query: 466 IPKPVDLSFINHKQKT----PIPQNDKGAADSDRSS 497
IPK I H T P+ + DS SS
Sbjct: 321 IPK------ITHPTDTSNFDPVDPEKLRSDDSGESS 350
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 5e-54
Identities = 66/142 (46%), Positives = 97/142 (68%), Gaps = 2/142 (1%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G G V L +D G L+AMKV+ K + RK++ TER ILS ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238
F+T++ L++E+ GG+L + ++ FSE+ RFYA+E++LALEYLH +G++YRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 239 LKPENVLVREDGHIMLSDFDLS 260
LKPEN+L+ DGHI L+DF L+
Sbjct: 119 LKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 67/148 (45%), Positives = 92/148 (62%), Gaps = 4/148 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ +L+KLG G G VYLA + G L A+KV+ K + +K R E +IL L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ LY FE + L+ME+C GGDL L +++ SE RFY ++L ALEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK 116
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+V+RDLKPEN+L+ EDGH+ L+DF L+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 2e-49
Identities = 117/357 (32%), Positives = 178/357 (49%), Gaps = 49/357 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F LK +G G G V L + +D G ++AMK++ K + ++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ ++ F+ + L+MEF GGD+ TL ++ SE+AT+FY +E +LA++ +H +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
G ++RD+KP+N+L+ GH+ LSDF L + A R Y + +P
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLC-----------TGLKKAHRTEFY--RNLTHNP 167
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352
PS F + +NSK + +T N L + S VG
Sbjct: 168 --------------PSDFSFQNMNSK----RKAETWKKNRRQL-----------AYSTVG 198
Query: 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFP 410
T +Y+APE+ G+ DWW+ G+ YE+L+G PF +ET V+ + L FP
Sbjct: 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFP 258
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
IS AKDLI D + R+G G EIK HPFFE V+W IR P IP
Sbjct: 259 PEVPISEKAKDLILRFCT-DSENRIG-SNGVEEIKSHPFFEGVDWGHIRE-RPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-47
Identities = 61/146 (41%), Positives = 87/146 (59%), Gaps = 4/146 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +K LG G G V L + G +A+K++ K + K++ E+ IL + HPF
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L LY F+ D L+ME+ GG+L LR+ F E RFYA++V+LALEYLH
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHS 119
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
+ +VYRDLKPEN+L+ DG+I ++DF
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 118/369 (31%), Positives = 173/369 (46%), Gaps = 44/369 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +K LG G G V LA D L+AMK + K + R ++ + ER+IL+ D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ LY F+ +M++ GGD+ +L R F E RFY +E+ A+E +H M
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDL--SLRCFVSPKLVQSSDDPACRISSYCIQPSCI 290
G ++RD+KP+N+L+ DGHI L+DF L R K QS D R S
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV--RQDSMDFSNEWG 178
Query: 291 DPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350
DPA +C KP L + + + + S
Sbjct: 179 DPA---------NCRCGDRLKP--LERRAAR-------------------QHQRCLAHSL 208
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLK 408
VGT Y+APE++ G+ DWW+ G+ YE+L+G+ PF ET V+ L
Sbjct: 209 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH 268
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHP----P 464
P + +S A DLI L + P+ RLG K GA EIK HPFF++++++ P
Sbjct: 269 IPPQAKLSPEASDLIIK-LCRGPEDRLG-KNGADEIKAHPFFKTIDFSSDLRQQSAPYIP 326
Query: 465 EIPKPVDLS 473
+I P D S
Sbjct: 327 KITHPTDTS 335
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 8e-45
Identities = 122/397 (30%), Positives = 187/397 (47%), Gaps = 48/397 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +K LG G G V LA D L+AMK + K + R ++ + ER+IL+ D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ LY F+ +M++ GGD+ +L R + F E RFY +E+ LA+E +H M
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDL--SLRCFVSPKLVQSSDDPACRISSYCIQPSCI 290
G ++RD+KP+N+L+ DGHI L+DF L R + K Q S+ Q S
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK--------GSHIRQDS-- 170
Query: 291 DPACKLPVCVEPSCLQPSCFKPRFLNS-KTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349
+EPS L R + KT + ++ K + + S
Sbjct: 171 ---------MEPSDLWDDVSNCRCGDRLKTLEQRATK--------------QHQRCLAHS 207
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPL 407
VGT Y+APE++ G+ DWW+ G+ +E+L+G+ PF ET V+ L
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHP---- 463
P +S A DLI L ++RLG + GA +IK HPFF V+++ T P
Sbjct: 268 HIPPQVKLSPEAVDLI-TKLCCSAEERLG-RNGADDIKAHPFFSEVDFSSDIRTQPAPYV 325
Query: 464 PEIPKPVDLSFINHKQKTPIPQNDKGAADSDRSSGPF 500
P+I P+D S + ++ + G DS R+
Sbjct: 326 PKISHPMDTSNFDPVEEESPWNDASG--DSTRTWDTL 360
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 111/357 (31%), Positives = 176/357 (49%), Gaps = 49/357 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F LK +G G G V L + +D G ++AMK++ K + ++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ ++ F+ L+MEF GGD+ TL ++ +E+ T+FY +E +LA++ +H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
G ++RD+KP+N+L+ GH+ LSDF L L ++ R ++ +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGL------CTGLKKAHRTEFYRNLNHSL------- 167
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352
PS F + +NSK + +T N L + S VG
Sbjct: 168 --------------PSDFTFQNMNSK----RKAETWKRNRRQL-----------AFSTVG 198
Query: 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFP 410
T +Y+APE+ G+ DWW+ G+ YE+L+G PF +ET V+ + L FP
Sbjct: 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFP 258
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
IS AKDLI + + R+G G EIK +PFFE V+W IR P IP
Sbjct: 259 PEVPISEKAKDLILRFCC-EWEHRIG-APGVEEIKTNPFFEGVDWEHIRE-RPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 96/358 (26%), Positives = 146/358 (40%), Gaps = 91/358 (25%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G G V +++ G ++A K +DK L RK A E++IL + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 179 HFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVY 236
FET CL+M +GGDL H +PG F E FYA++++ LE
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLE--------- 109
Query: 237 RDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKL 296
L ++ R+ + P+ V D RIS L
Sbjct: 110 -HLHQRRIVYRD----------------LKPENVLLDDHGNVRISD-------------L 139
Query: 297 PVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356
+ VE K K GT Y
Sbjct: 140 GLAVE------------LKGGKKIK---------------------------GRAGTPGY 160
Query: 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG----NRETLFNVVGQPLKFPEG 412
+APE+++G+ + +VDW+ G YE++ GR+PF+ E + +++P+
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD- 219
Query: 413 SSISFAAKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIRS--THPPEIP 467
S AKDL LL KDP+KRLG + A E+++HP F+ +NW + + PP IP
Sbjct: 220 -KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 59/148 (39%), Positives = 85/148 (57%), Gaps = 3/148 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ LL+KLG G G+VY A+ + G + A+K++ K KK A+ E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L FE L+ME+C GGDL R G SE + A ++L LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+++RDLKPEN+L+ E+G + ++DF L+
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLA 145
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 9e-40
Identities = 55/108 (50%), Positives = 71/108 (65%), Gaps = 3/108 (2%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
+R+ +F GT EYLAPE++ G G+G AVDWW+ G+ YE+L G+ PF +E +
Sbjct: 146 EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ PL+FPE +S A+DLI GLL KDP KRLG GA EIK HPFF
Sbjct: 206 LKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGS-GGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 58/127 (45%), Positives = 73/127 (57%), Gaps = 5/127 (3%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
R+ + GT EYLAPEII G+G AVDWW GI YE+L G PF + + ++
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFESVNW-ALI-RSTH 462
++FP S S AKDLIR LL D KRLG K G +IK HP+F ++W AL+ R
Sbjct: 214 KVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIE 271
Query: 463 PPEIPKP 469
P IPK
Sbjct: 272 APFIPKV 278
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 56/139 (40%), Positives = 87/139 (62%), Gaps = 2/139 (1%)
Query: 122 GDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181
G G V+LA+ + G ++A+KV+ K + + ++ + TER+ILS P++ LY F+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKP 241
K L+ME+ GGDL +L G E R Y +E++LALEYLH G+++RDLKP
Sbjct: 64 GKKNLYLVMEYLPGGDLASL-LENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 242 ENVLVREDGHIMLSDFDLS 260
+N+L+ +GH+ L+DF LS
Sbjct: 122 DNILIDSNGHLKLTDFGLS 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 57/151 (37%), Positives = 93/151 (61%), Gaps = 6/151 (3%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
HF LL+ +G G G V + + RD +FAMK M+K + + ER IL L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
FL L+ F+ ++ L+++ GGDL H ++ FSE+ +F+ E++LALEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYL 116
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
H G+++RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 58/155 (37%), Positives = 83/155 (53%), Gaps = 4/155 (2%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G G+VYLA + G A+K++ K L E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238
FE + L+ME+C GG L L + GK SE ++L LEYLH G+++RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 239 LKPENVLV-REDGHIMLSDFDLSLRCFVSPKLVQS 272
LKPEN+L+ ++G + L+DF LS L+++
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 50/106 (47%), Positives = 65/106 (61%), Gaps = 1/106 (0%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
VGT +Y+APE+I G GH VDWW+ G YE L+G PF G E N++ +++
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW 220
Query: 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
PE +S A DLI LLV DP+KRLG K EIK HPFF+ ++W
Sbjct: 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAK-SIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 64/154 (41%), Positives = 99/154 (64%), Gaps = 9/154 (5%)
Query: 113 FRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKG-MLAGRKKLMRAQTEREILSLL 168
F LL+ LG G G V+L D G L+AMKV+ K ++ K +TER++L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 169 DH-PFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
PFL TL+ F+TD L++++ +GG+L T L QR+ HF+E R Y +E++LAL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLAL 118
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++LH +G++YRD+K EN+L+ +GH++L+DF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-35
Identities = 68/154 (44%), Positives = 99/154 (64%), Gaps = 9/154 (5%)
Query: 113 FRLLKKLGCGDIGSVYL---AELRDMGCLFAMKVMDKGMLAGRKKLMR-AQTEREILSLL 168
F LLK LG G G V+L D G L+AMKV+ K L + K + +TER +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 169 -DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
PFL TL+ F+T+ L++++ SGG++ T L QR +FSE RFY+ E++LAL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILAL 118
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
E+LH +G+VYRD+K EN+L+ +GH++L+DF LS
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 54/107 (50%), Positives = 67/107 (62%), Gaps = 6/107 (5%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+ +FVGT EY+APE++ G G+G AVD W+ G+ YELL G+ PF G+ LF +G+
Sbjct: 152 KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 211
Query: 406 PLK--FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
P P IS AKDLIR LLVKDP+KRL A E QHPFF
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 60/147 (40%), Positives = 89/147 (60%), Gaps = 7/147 (4%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPT 175
K LG G G V LAEL+ L+A+KV+ K ++ + TE+ +L+L HPFL
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
L+S F+T +ME+ +GGDL H R + F E RFYA+E++L L++LH G
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERG 116
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
++YRDLK +NVL+ +GHI ++DF +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 58/140 (41%), Positives = 83/140 (59%), Gaps = 4/140 (2%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G G V L +++ FA+K + K + + +E+EIL +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 179 HFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYR 237
F+ K+ +LME+C GG+L T LR R F E RFY + V+LA EYLH G++YR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 238 DLKPENVLVREDGHIMLSDF 257
DLKPEN+L+ +G++ L DF
Sbjct: 118 DLKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 52/152 (34%), Positives = 77/152 (50%), Gaps = 5/152 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ + LG G GSVYLA +D G L A+K ++ ++L + E ILS L HP
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG-DSEEELEALEREIRILSSLQHPN 60
Query: 173 LPTLYSHF--ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ Y E + +E+ SGG L +L ++ E R Y ++L L YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
G+V+RD+K N+LV DG + L+DF + R
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 56/146 (38%), Positives = 81/146 (55%), Gaps = 4/146 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+K +G G G V+L R +A+KVM + K+ E+ +L + HPF
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ L+ +F +LME+ GG+L + LR FS FYASE++ ALEYLH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHS 119
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
+VYRDLKPEN+L+ ++GHI L+DF
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 53/167 (31%), Positives = 91/167 (54%), Gaps = 12/167 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD-KGMLAGRKKLMRAQTEREILSLLDH 170
+ ++K++G G G VYL + G L+ +K +D M ++ A E +IL L+H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE--DALNEVKILKKLNH 58
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLALEY 228
P + Y FE C++ME+ GGDL +Q++ GK F E+ + ++ LAL+Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275
LH +++RD+KP+N+ + +G + L DF +S K++ S+ D
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS-------KVLSSTVD 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 65/129 (50%), Positives = 82/129 (63%), Gaps = 6/129 (4%)
Query: 346 RSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
R+ SF GT EY+APEIIRG GHG AVDWW+ GI +ELL G +PF G R T V
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 405 QPLKF--PEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--R 459
+ LK P S I A+DL+ LL KDP+KRLG +GA+EIK+HPFF+ ++W + R
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALR 281
Query: 460 STHPPEIPK 468
+PP P
Sbjct: 282 KVNPPFRPS 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 65/148 (43%), Positives = 98/148 (66%), Gaps = 6/148 (4%)
Query: 116 LKKLGCGDIGSVYLAEL---RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
LK LG G G V+L D G L+AMKV+ K L R + +R + ER+IL+ ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDR-VRTKMERDILAEVNHPF 59
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L+ F+T+ L+++F GGDL T ++ F+E+ +FY +E+ LAL++LH +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
G++YRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 58/150 (38%), Positives = 85/150 (56%), Gaps = 6/150 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--- 169
FR L LG G G V LAE + G L+A+K + KG + R ++ E+ I +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HPFL L++ F+T+ C +ME+ +GGDL FSE FYA+ V+L L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDL 259
H +VYRDLK +N+L+ +G + ++DF L
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 58/150 (38%), Positives = 86/150 (57%), Gaps = 2/150 (1%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
F++L ++G G G V+LA+ +D G + A+K M K +L ++ TER+IL+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+L L F+ D++ L ME+ GGD TL SE RFY +E+ A++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH 118
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+G ++RDLKPEN L+ GHI L+DF LS
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 59/141 (41%), Positives = 81/141 (57%), Gaps = 9/141 (6%)
Query: 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKG 392
L R+ SF GT EY+APE+IRG GH AVDWW+ G+ +ELL G +PF
Sbjct: 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
Query: 393 NGNRETLFNVVGQPLK----FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
+G + + + + LK FP ++S A+D I+ LL KDP+KRLG GA EIK HP
Sbjct: 211 DGEQNSQSEISRRILKSKPPFP--KTMSAEARDFIQKLLEKDPKKRLGAN-GADEIKNHP 267
Query: 449 FFESVNWALIRSTHPPEIPKP 469
FF+ ++W + + P KP
Sbjct: 268 FFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 55/174 (31%), Positives = 88/174 (50%), Gaps = 18/174 (10%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
+ +F GT +Y+APEI+ +G AVDWW G+ YE+L G++PF+G+ E +++
Sbjct: 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR-GATEIKQHPFFESVNWALI--RST 461
+++P +S AK +++ L K+P+KRLG G +IK HPFF ++W + +
Sbjct: 211 DEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEI 268
Query: 462 HPPEIPK---PVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGPFLDFEFF 506
PP PK D+S F K TP + D + F F +
Sbjct: 269 KPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEE----FRGFSYI 318
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 60/148 (40%), Positives = 92/148 (62%), Gaps = 2/148 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +K + G G+VYL ++ FAMK ++K L R ++ + ER+IL+ ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ +++ FET + C++ME+ GGD TL + G + A R Y +E +LALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATL-LKNIGALPVDMA-RMYFAETVLALEYLHNY 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+V+RDLKP+N+L+ GHI L+DF LS
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 57/160 (35%), Positives = 93/160 (58%), Gaps = 3/160 (1%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLP 174
LK + G GSVYLA+ R G FA+KV+ K + + ++ + ER I+ + P++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
LY F++ + L+ME+ +GGD +L + G E + Y +EV+L +E LH G+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274
++RD+KPEN+L+ + GH+ L+DF LS + K V + D
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-31
Identities = 65/155 (41%), Positives = 99/155 (63%), Gaps = 9/155 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAEL---RDMGCLFAMKVMDKGMLAGRKKLMR-AQTEREILS- 166
+F LLK LG G G V+L D G L+AMKV+ K + + K +TER++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLA 225
+ PFL TL+ F+TD L++++ +GG+L T L QR+ F EQ + Y+ E++LA
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLA 117
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LE+LH +G++YRD+K EN+L+ +GH++L+DF LS
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 56/149 (37%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
A+ R+ + GT EYLAPE+I+ GHG AVDWWT G+ YE + G PF +
Sbjct: 165 AKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224
Query: 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFESVNWALI 458
++ LKFP + A+DL++GLL D KRLG K G ++K HP+F NW +
Sbjct: 225 EKILAGRLKFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL 282
Query: 459 RSTH-PPEIP----KPVDLSFINHKQKTP 482
+ + P IP P D S +P
Sbjct: 283 YARYYPAPIPVRVKSPGDTSNFEKYPDSP 311
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 59/145 (40%), Positives = 84/145 (57%), Gaps = 6/145 (4%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTL 176
K LG G G V L + G +AMK++ K ++ + ++ TE +L HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 177 YSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
F+T C +ME+ +GG+L H R+R FSE RFY +E++ AL YLH V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALGYLHSCDV 116
Query: 235 VYRDLKPENVLVREDGHIMLSDFDL 259
VYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 47/115 (40%), Positives = 67/115 (58%), Gaps = 7/115 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFN 401
++ +F GT EY+APEII G+ +VD+W+ GI YELL GR PF +
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNW 455
L+FP + I AAKDLI+ LL ++P++RLG K G +IK+H +F +W
Sbjct: 208 KGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 61/148 (41%), Positives = 84/148 (56%), Gaps = 6/148 (4%)
Query: 116 LKKLGCGDIGSVYLAEL---RDMGCLFAMKVMDKGMLA-GRKKLMRAQTEREILSLLDHP 171
LK LG G G V+ D G +FAMKV+ K + +K + ER IL + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
F+ L F+T L++E+ SGG+L +R+ F E FY SE+ LALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDL 259
G++YRDLKPEN+L+ GH+ L+DF L
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 55/132 (41%), Positives = 76/132 (57%), Gaps = 5/132 (3%)
Query: 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
A+ R+ + GT EYLAPE+I+ GH AVDWW GI YE+L+G PF +
Sbjct: 148 AKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207
Query: 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFESVNWALI 458
++ L+FP + AKDLI+ LLV D +RLG K GA ++K H +F+SV+W +
Sbjct: 208 EKILAGKLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265
Query: 459 --RSTHPPEIPK 468
R PP +PK
Sbjct: 266 PQRKLKPPIVPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 59/134 (44%), Positives = 81/134 (60%), Gaps = 5/134 (3%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
E R+ SF GT EY+AP+I+RG GH AVDWW+ G+ YELL G +PF +G + +
Sbjct: 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
Query: 399 LFNVVGQPLKF--PEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNW 455
+ + LK P +S AKD+I+ LL+KDP+KRLG A EIK+HPFF+ +NW
Sbjct: 217 QAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276
Query: 456 ALIRSTHPPEIPKP 469
+ + P KP
Sbjct: 277 DDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/142 (42%), Positives = 87/142 (61%), Gaps = 3/142 (2%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHPFLPT 175
K LG G G V LAEL+ ++A+KV+ K ++ + TE+ IL+L HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ F+T +ME+ +GGDL + Q Q + F E +RFYA+EV LAL +LH GV+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 236 YRDLKPENVLVREDGHIMLSDF 257
YRDLK +N+L+ +GH L+DF
Sbjct: 119 YRDLKLDNILLDAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 56/126 (44%), Positives = 77/126 (61%), Gaps = 5/126 (3%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV 403
++ +F GT EYLAPE++ G G+ AVDWWT G+ YE+L G PF E ++
Sbjct: 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
Query: 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA--LIRST 461
+PL+FP+G AKDL+ GLL +DP +RLG+ GA EIK HPFF ++W L++
Sbjct: 207 QEPLRFPDG--FDRDAKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGI 263
Query: 462 HPPEIP 467
PP P
Sbjct: 264 QPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 58/151 (38%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+F GT EYLAPE++R + VDWW G YE+L G PF E N++ +PL+
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR 214
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA--LIRSTHPPEI 466
+IS +A+ L+ GLL KD KRLG K EIK H FF S+NW + + PP
Sbjct: 215 LK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFN 272
Query: 467 PK---PVDLSFINHK-QKTPIPQNDKGAADS 493
P P+DL + + + P+P + + DS
Sbjct: 273 PNVSGPMDLKHFDPEFTEEPVPNSVGKSPDS 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 56/145 (38%), Positives = 87/145 (60%), Gaps = 1/145 (0%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F + +G G G V + + G ++AMKVM K +L ++ + + ER+ILS+ + P+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+P L F+ L+ME+ GGDL +L R + F E +FY +E++LA+ +H M
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQM 121
Query: 233 GVVYRDLKPENVLVREDGHIMLSDF 257
G V+RD+KPENVL+ GHI L+DF
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADF 146
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 57/175 (32%), Positives = 96/175 (54%), Gaps = 14/175 (8%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L F + + LG G G V +A+ + G +A+K + K + K++ E+ IL L
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HPF+ + F+ + L+EF GG+L T R+ G+ F +FY +E++LA EYL
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFT-HLRKAGR-FPNDVAKFYHAELVLAFEYL 134
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR--------C----FVSPKLVQS 272
H ++YRDLKPEN+L+ GH+ ++DF + + C +++P+++QS
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQS 189
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 3/144 (2%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPT 175
K +G G G V LA+ + G +A+KV+ K + +K+ ER +L + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ F+T ++++ +GG+L QR+ + F E RFYA+E+ AL YLH + ++
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDL 259
YRDLKPEN+L+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 64/177 (36%), Positives = 97/177 (54%), Gaps = 13/177 (7%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHPFLPT 175
K LG G G V LAEL+ FA+K + K ++ + ER +L+L +HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ F+T + +ME+ +GGDL + Q F E RFYA+E++ L++LH G++
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
YRDLK +NVL+ +DGHI ++DF + K + + A S++C P I P
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMC-------KENMNGEGKA---STFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 58/145 (40%), Positives = 86/145 (59%), Gaps = 6/145 (4%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTL 176
K LG G G V L + G +AMK++ K ++ + ++ TE +L HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 177 YSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
F+T C +ME+ +GG+L H R+R F+E+ RFY +E++ ALEYLH V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRDV 116
Query: 235 VYRDLKPENVLVREDGHIMLSDFDL 259
VYRD+K EN+++ +DGHI ++DF L
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 60/145 (41%), Positives = 87/145 (60%), Gaps = 5/145 (3%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL---SLLDHPFLPT 175
+G G G VY +D ++AMKV+ K + +K++ ER IL L + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L F+TD L+ ++ SGG+L Q++ G+ FSE +FY +E++LALE+LH +V
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GR-FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDLS 260
YRDLKPEN+L+ GHI L DF LS
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 50/113 (44%), Positives = 68/113 (60%), Gaps = 10/113 (8%)
Query: 344 SARSMSFVGTHEYLAPEIIR-GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---ETL 399
S+ +FVGT Y+APE++ G+G+G VD W+ G+ YELL G+ PF G + +
Sbjct: 152 SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
Query: 400 FNVVGQPLKF--PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
++G PL+F P+ SS S AKDLI+ L KDP KR A EI QHP+F
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 61/142 (42%), Positives = 86/142 (60%), Gaps = 3/142 (2%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLY 177
LG G G V LA L++ G L+A+KV+ K ++ + TE+ ILSL +HPFL LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYR 237
F+T +MEF +GGDL + Q + F E RFYA+E+ AL +LH G++YR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 238 DLKPENVLVREDGHIMLSDFDL 259
DLK +NVL+ +GH L+DF +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 48/108 (44%), Positives = 58/108 (53%), Gaps = 3/108 (2%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
FVGT +YLAPE I G G DWW+ G +E L G PF N++ + + +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
Query: 410 PE--GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
PE S A DLI LL DP KRLG G EIK HPFF+S+NW
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/171 (36%), Positives = 90/171 (52%), Gaps = 18/171 (10%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
++ +F GT +Y+APEI++G + +VDWW+FG+ YE+L+G++PF G E +++
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RSTH 462
FP IS AKD + L +DP KRLG +I+QHPFF ++W + R
Sbjct: 211 DRPHFPR--WISKEAKDCLSKLFERDPTKRLGVD---GDIRQHPFFRGIDWERLEKREIP 265
Query: 463 PPEIPK---PVDLS-----FINHKQKTPIPQNDKGAADSDRSSGPFLDFEF 505
PP PK P D S F N K + P + K A D+ F F F
Sbjct: 266 PPFKPKVKSPSDASNFDREFTNEKVRLS-PVDKKLLASMDQEQ--FRGFSF 313
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 17/177 (9%)
Query: 343 TSARSMS-FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
+ +M F GT EYLAPE++ + +G AVDWW G+ YE++ GR PF N + E LF
Sbjct: 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFE 205
Query: 402 VV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL-GFKRGATEIKQHPFFESVNW-ALI 458
++ + ++FP ++S AK L+ GLL KDP++RL G A EI +H FF S+NW ++
Sbjct: 206 LILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVV 263
Query: 459 RSTHP----PEIPKPVDLSFINHK------QKTPIPQNDKGAADSDRSSGPFLDFEF 505
+ P++ D + + + TP + D F F +
Sbjct: 264 QKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSY 320
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 5e-27
Identities = 58/152 (38%), Positives = 85/152 (55%), Gaps = 4/152 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
FR + LG G G V ++R G ++A K ++K + RK A E++IL ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ L +ET CL++ +GGDL H PG F E+ FYA+E+L LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLH 119
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
VYRDLKPEN+L+ + GHI +SD L+++
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 57/152 (37%), Positives = 85/152 (55%), Gaps = 4/152 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
FR + LG G G V ++R G ++A K ++K + RK A E++IL ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ +L +ET CL++ +GGDL H PG F E+ FYA+E+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
+VYRDLKPEN+L+ + GHI +SD L++
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 57/142 (40%), Positives = 88/142 (61%), Gaps = 7/142 (4%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPTLY 177
+G G V L EL+ ++AMKV+ K ++ + + QTE+ + + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 178 SHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
S F+T+ ++EF SGGDL H RQR+ E+ RFY++E+ LAL +LH G++
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHERGII 118
Query: 236 YRDLKPENVLVREDGHIMLSDF 257
YRDLK +NVL+ +GHI L+D+
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 59/145 (40%), Positives = 87/145 (60%), Gaps = 6/145 (4%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTL 176
K LG G G V L + G +AMK++ K ++ + ++ TE +L HPFL +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 177 YSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
F+T C +ME+ +GG+L H R+R FSE TRFY +E++ AL+YLH +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 235 VYRDLKPENVLVREDGHIMLSDFDL 259
VYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 14/157 (8%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLD 169
F +L+K+G G G VY A + G A+KV+ K + + EI L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCK 55
Query: 170 HPFLPTLY-SHFETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASEVLLAL 226
HP + Y S+ + D+ ++MEFCSGG +L+ + + +E + E+L L
Sbjct: 56 HPNIVKYYGSYLKKDELW-IVMEFCSGG---SLKDLLKSTNQTLTESQIAYVCKELLKGL 111
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263
EYLH G+++RD+K N+L+ DG + L DF LS +
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 60/177 (33%), Positives = 92/177 (51%), Gaps = 13/177 (7%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPT 175
K LG G G V+LAEL+ FA+K + K ++ + E+ +LSL +HPFL
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
LY F+T + +ME+ +GGDL + Q F FYA+E++ L++LH G+V
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
YRDLK +N+L+ DGHI ++DF + + + ++C P I P
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGD----------AKTCTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 63/158 (39%), Positives = 88/158 (55%), Gaps = 7/158 (4%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPT 175
+G G G VY D G ++AMK +DK + ++ A ER +LSL+ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
+ F T +++ +GGDLH Q G FSE RFYA+E++L LE++H VV
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273
YRDLKP N+L+ E GH+ +S DL L C S K +S
Sbjct: 120 YRDLKPANILLDEHGHVRIS--DLGLACDFSKKKPHAS 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 56/148 (37%), Positives = 88/148 (59%), Gaps = 2/148 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F ++K + G G VYL ++ L+A+KV+ K + + + + Q ER+ L+L PF
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ LY ++ L+ME+ GGD+ +L +F E+ Y SEV LAL+YLH
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH 123
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+++RDLKP+N+L+ +GHI L+DF LS
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 61/193 (31%), Positives = 107/193 (55%), Gaps = 27/193 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT-----EREILSL 167
F +LK +G G G V + ++++ G ++AMK+++K + L RA+T ER++L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVN 57
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
D ++ L+ F+ + L+M++ GGDL TL + E RFY +E++LA++
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAID 116
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC----------------FVSPKLVQ 271
+H +G V+RD+KP+NVL+ ++GHI L+DF LR ++SP+++Q
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 272 SSDDPACRISSYC 284
+ +D R C
Sbjct: 177 AMEDGKGRYGPEC 189
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 49/134 (36%), Positives = 80/134 (59%), Gaps = 8/134 (5%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
R+ +F GT E+LAPE++ + AVDWW G+ YE+L+G +PF G+ E ++V
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWA--LIRSTH 462
+++P +S A ++R LL ++P++RLG ++ A ++K+ PFF +NW L R
Sbjct: 217 EVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
Query: 463 PPEIPK---PVDLS 473
PP +P P D+S
Sbjct: 275 PPFVPTIKGPEDVS 288
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 55/146 (37%), Positives = 84/146 (57%), Gaps = 3/146 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP- 171
F L LG G G V LAE + L+A+K++ K ++ + E+ +L+L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FL L+S F+T +ME+ +GGDL +Q GK F E FYA+E+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHS 119
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
G++YRDLK +NV++ +GHI ++DF
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADF 145
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 56/166 (33%), Positives = 90/166 (54%), Gaps = 8/166 (4%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
++ SF GT EY+APE++ GH + DWW+FG+ +E+L G PF+G +ET+ ++
Sbjct: 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RSTH 462
L P+ +S A+ L+R L ++P RLG G EIK+HPFF +++W + R
Sbjct: 214 KLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
Query: 463 PPEIP---KPVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDFEF 505
PP P +P D + + + + P++ G S + F F F
Sbjct: 272 PPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQLFRGFSF 317
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 49/110 (44%), Positives = 68/110 (61%), Gaps = 3/110 (2%)
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE 411
GT EY+APE+I G+G VDWW GI YE L+G PF G+ E V+ +++PE
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 412 G-SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW-ALIR 459
G ++ A+DLI LL ++P +RLG GA E+KQH FF ++W L+R
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLG-TGGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 59/146 (40%), Positives = 86/146 (58%), Gaps = 7/146 (4%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTL 176
K LG G G V L + + G +AMK++ K ++ + ++ TE +L HPFL L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 177 YSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MG 233
F+T C +ME+ +GG+L H R+R FSE RFY +E++ AL+YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEKN 116
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDL 259
VVYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/165 (36%), Positives = 89/165 (53%), Gaps = 11/165 (6%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+F GT EY+APEI+ GHG AVDWW+ G Y++L G PF ++T+ ++ L
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRG-ATEIKQHPFFESVNW--ALIRSTHPPE 465
P ++ A+DL++ LL ++P RLG G A E++ HPFF VNW L R PP
Sbjct: 219 LP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPF 276
Query: 466 IPKPV---DLSFINHK--QKTPIPQNDKGAADSDRSSGPFLDFEF 505
P D+S + K ++TP+ D S+ ++ FL F +
Sbjct: 277 KPLLQSEEDVSQFDSKFTRQTPVDSPDDSTL-SESANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 52/146 (35%), Positives = 87/146 (59%), Gaps = 15/146 (10%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
A++ +F GT +Y+APEI+ G + ++VDWW+FG+ YE+L+G++PF G+ E ++
Sbjct: 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RSTH 462
+P ++ AKD++ L V++P++RLG K +I+QHPFF ++W+ + R
Sbjct: 211 DNPCYPR--WLTREAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREIE 265
Query: 463 PPEIPK---PVDLS-----FINHKQK 480
PP PK D S F+N K +
Sbjct: 266 PPFKPKVKSANDCSNFDKEFLNEKPR 291
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 65/175 (37%), Positives = 88/175 (50%), Gaps = 13/175 (7%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
EP S +F GT EYLAPE++R + + VDWW G YE+L G PF +
Sbjct: 148 EPEETTS-TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
Query: 401 NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI-- 458
N++ +PL+ P G ++ AA DL+ GLL KD ++RLG K EIK H FF +NW +
Sbjct: 207 NILHKPLQLPGGKTV--AACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYH 264
Query: 459 -RSTHP--PEIPKPVDL-----SFINHKQKTPIPQNDKGAADSDRSSGPFLDFEF 505
R T P P + P DL F + + Q A S +S FL F +
Sbjct: 265 KRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 81 SACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCL-F 139
S +P + N MK++ F ++ LG G G V LA ++
Sbjct: 15 SDSTKEPKRKNKMKYE---------------DFNFIRTLGTGSFGRVILATYKNEDFPPV 59
Query: 140 AMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLH 199
A+K +K + +K++ +ER+IL+ ++HPF LY F+ + + L++EF GG+
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 200 TLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259
T +R K F FYA++++L EYL + +VYRDLKPEN+L+ +DG I ++DF
Sbjct: 120 TFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPV 298
+ K+V + R + C P I P L V
Sbjct: 178 A-------KVVDT------RTYTLCGTPEYIAPEILLNV 203
|
Length = 340 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 61/177 (34%), Positives = 97/177 (54%), Gaps = 13/177 (7%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPT 175
K +G G G V LA+ + G +A+KV+ K + +K+ ER +L L HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ F+T + ++++ +GG+L QR+ + F E RFYA+EV A+ YLH + ++
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
YRDLKPEN+L+ GH++L+DF L + +P S++C P + P
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFG----------LCKEGVEPEETTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/152 (38%), Positives = 89/152 (58%), Gaps = 6/152 (3%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+R+L+KLG G G VYLA R L A+KV+ K + + K++ R E +IL+ L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 172 -FLPTLYSHFETDKFSCLLMEFCSGGDLHTL-RQRQPGKHFSEQATRFYASEVLLALEYL 229
+ LY F+ + L+ME+ GG L L ++ SE F +++L ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 230 HMMGVVYRDLKPENVLVREDGH-IMLSDFDLS 260
H G+++RD+KPEN+L+ DG + L DF L+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 60/171 (35%), Positives = 96/171 (56%), Gaps = 20/171 (11%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
R+ +F GT +Y+APEI++G + +VDWW+FG+ YE+L+G++PF G+ E ++
Sbjct: 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RSTHP 463
+P I+ +KD++ L +DP +RLG I+ HPFF+++NW + R P
Sbjct: 212 TPHYPRW--ITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKRELDP 266
Query: 464 PEIPK---PVDLS-----FINHKQKTPIPQNDKGAADS-DRSSGPFLDFEF 505
P PK P D S F++ K + + +DK DS D+S+ F F F
Sbjct: 267 PFKPKVKSPSDYSNFDREFLSEKPR--LSYSDKNLIDSMDQSA--FAGFSF 313
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 58/144 (40%), Positives = 88/144 (61%), Gaps = 3/144 (2%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPT 175
K +G G G V LA+ + G +A+KV+ K ++ RK+ ER +L + HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ F+T + +++F +GG+L QR+ + F E RFYA+E+ AL YLH + +V
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDL 259
YRDLKPEN+L+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 50/134 (37%), Positives = 74/134 (55%), Gaps = 7/134 (5%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
I + R+ F GT +Y+APEII +G +VDWW FG+ YE+L G+ PF G E
Sbjct: 152 IFGGKTTRT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
Query: 399 LFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWAL 457
+++ + +P+ S+S A + +GLL K P KRLG G +I++H FF ++W
Sbjct: 210 FQSIMEHNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267
Query: 458 I--RSTHPPEIPKP 469
+ R PP PK
Sbjct: 268 LERREIQPPFKPKV 281
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 54/147 (36%), Positives = 83/147 (56%), Gaps = 6/147 (4%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G G V ++R G L+A K ++K L RK A E+ IL+ + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 179 HFETDKFSCLLMEFCSGGDL----HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
F+T CL+M +GGDL + + + PG F E FY ++++ LE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLSL 261
+YRDLKPENVL+ DG++ +SD L++
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAV 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 64/158 (40%), Positives = 90/158 (56%), Gaps = 7/158 (4%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPT 175
+G G G VY D G ++AMK +DK + ++ A ER +LSL+ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
+ F T C +++ +GGDLH Q G FSE+ RFYA+E++L LE++H VV
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273
YRDLKP N+L+ E GH+ +S DL L C S K +S
Sbjct: 120 YRDLKPANILLDEHGHVRIS--DLGLACDFSKKKPHAS 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/174 (34%), Positives = 92/174 (52%), Gaps = 12/174 (6%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
+G G G V RD ++A+K + K + R ++ ER +L+ ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238
F++ + L++ F +GG+L QR+ G+ F RFY +E+L ALE LH V+YRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-GR-FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 239 LKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
LKPEN+L+ GHI L DF L KL DD + +++C P + P
Sbjct: 119 LKPENILLDYQGHIALCDFGLC-------KLNMKDDD---KTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/133 (36%), Positives = 77/133 (57%), Gaps = 15/133 (11%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET--------LF 400
+F GT Y+APEI+RG+ +G +VDWW G+ +E++ GR+PF G + LF
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214
Query: 401 NVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR--GATEIKQHPFFESVNWAL 457
V+ + ++ P S+S A +++G L KDP++RLG G +IK HPFF +++W L
Sbjct: 215 QVILEKQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
Query: 458 I--RSTHPPEIPK 468
+ + PP P
Sbjct: 273 LEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 49/130 (37%), Positives = 68/130 (52%), Gaps = 10/130 (7%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGH----GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
R + VGT +Y++PE+++ G G DWW+ G+F YE+L+G TPF + T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 402 VVGQ--PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF--ESVNWAL 457
++ L FP+ IS AKDLI L RLG + G EIK HPFF + +
Sbjct: 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREV-RLG-RNGVDEIKSHPFFKNDQWTFDN 316
Query: 458 IRSTHPPEIP 467
IR T P +P
Sbjct: 317 IRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/175 (34%), Positives = 96/175 (54%), Gaps = 13/175 (7%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLY 177
+G G V L L+ ++AMKV+ K ++ + + QTE+ + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYR 237
S F+T+ ++E+ +GGDL QRQ + E+ RFY++E+ LAL YLH G++YR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 238 DLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
DLK +NVL+ +GHI L+D+ + + P S++C P+ I P
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYG----------MCKEGLRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 60/177 (33%), Positives = 95/177 (53%), Gaps = 13/177 (7%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPT 175
K +G G G V LA + +A+KV+ K + +K+ +ER +L + HPFL
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ F+T ++++ +GG+L QR+ + F E RFYA+E+ AL YLH + +V
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
YRDLKPEN+L+ GHI+L+DF L + + + S++C P + P
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFG----------LCKENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 58/131 (44%), Positives = 80/131 (61%), Gaps = 8/131 (6%)
Query: 343 TSARSM-SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
T A +M +F GT EYLAPE++ + +G AVDWW G+ YE++ GR PF N + E LF
Sbjct: 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFE 205
Query: 402 -VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL-GFKRGATEIKQHPFFESVNWALI- 458
++ + +KFP ++S AK L+ GLL+KDP KRL G A EI +H FF VNW +
Sbjct: 206 LILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVY 263
Query: 459 -RSTHPPEIPK 468
+ PP P+
Sbjct: 264 DKKLVPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 60/175 (34%), Positives = 95/175 (54%), Gaps = 13/175 (7%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLY 177
+G G V L L+ ++AMKV+ K ++ + + QTE+ + +PFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYR 237
S F+T L++E+ +GGDL QRQ + E+ RFYA+E+ +AL +LH G++YR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 238 DLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
DLK +NVL+ DGHI L+D+ + + P S++C P+ I P
Sbjct: 121 DLKLDNVLLDADGHIKLTDYG----------MCKEGLGPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 51/150 (34%), Positives = 75/150 (50%), Gaps = 7/150 (4%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA-QTEREILSLLDHPFL 173
K+G G G VY A D G L A+K + + K ++ E ++L LL HP L
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 174 PTLYS-HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
Y +K + ME+CSGG L L + G+ E R Y ++L L YLH
Sbjct: 62 VKYYGVEVHREKV-YIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
G+V+RD+KP N+ + +G I L DF +++
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 57/159 (35%), Positives = 81/159 (50%), Gaps = 9/159 (5%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
E S +F GT EYLAPE++ + VDWW G YE+L G PF E
Sbjct: 148 EHNGTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
Query: 401 NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI-- 458
N++ +PL+ +I+ +A+ L+ GLL KD KRLG K EIK H FF +NW +
Sbjct: 207 NILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLIN 264
Query: 459 -RSTHP--PEIPKPVDLSFINHK-QKTPIPQNDKGAADS 493
+ T P P + P DL + + + P+P + + DS
Sbjct: 265 KKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDS 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 49/134 (36%), Positives = 79/134 (58%), Gaps = 13/134 (9%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFK------GNGNRETLFNV 402
+F GT Y+APEI+RG+ +G +VDWW G+ +E++ GR+PF + LF V
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
Query: 403 V-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG--FKRGATEIKQHPFFESVNWALI- 458
+ +P++ P +S A +++G L KDP++RLG + G ++IK H FF S++W L+
Sbjct: 215 ILEKPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE 272
Query: 459 -RSTHPPEIPKPVD 471
+ PP P+ D
Sbjct: 273 KKQVTPPFKPQITD 286
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 56/151 (37%), Positives = 84/151 (55%), Gaps = 4/151 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
FR + LG G G V ++R G ++A K ++K + RK A E++IL ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ +L +ET CL++ +GGDL H + G F E FYA+E+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261
+VYRDLKPEN+L+ + GHI +SD L++
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD-KGMLAGRKKLMRAQTEREILSLLDH 170
+K LG G G VY + G ++A+K + G RK+L+R E + L +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCES 58
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P++ Y F + +++E+ GG L L ++ E + A ++L L+YLH
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH 116
Query: 231 -MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RD+KP N+L+ G + ++DF +S
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 47/126 (37%), Positives = 69/126 (54%), Gaps = 10/126 (7%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN------V 402
S VG+ +Y+APE++RG G+ VD+W+ G YE L G PF G+ ET N
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTH 462
+ +P+ ++S A DLI L+ DP +R G +IK HPFF+ V+W +R
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLITKLI-NDPSRRFG---SLEDIKNHPFFKEVDWNELRELK 272
Query: 463 PPEIPK 468
PP +P+
Sbjct: 273 PPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 48/129 (37%), Positives = 75/129 (58%), Gaps = 13/129 (10%)
Query: 347 SMSFVGTHEYLAPEI---IRGDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
S VGT +Y+APE+ + GDG +G DWW+ G+ YE++ GR+PF + +T
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219
Query: 401 NVVG--QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458
N++ + LKFPE +S DLI+ LL ++RLG++ + HPFF ++W I
Sbjct: 220 NIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEG----LCCHPFFSKIDWNNI 274
Query: 459 RSTHPPEIP 467
R++ PP +P
Sbjct: 275 RNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/141 (37%), Positives = 80/141 (56%), Gaps = 13/141 (9%)
Query: 344 SARSMSFVGTHEYLAPEIIR--GDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
+ +S VGT +Y++PEI++ DG +G DWW+ G+ YE+L G TPF ET
Sbjct: 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 399 LFNVVGQP--LKFP-EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
++ +FP + + +S AKDLIR L+ P+ RLG + G + K HPFFE ++W
Sbjct: 217 YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLG-RNGLQDFKDHPFFEGIDW 274
Query: 456 ALIRSTHPPEIPK---PVDLS 473
IR++ P +P+ P D S
Sbjct: 275 DNIRNSTAPYVPEVSSPTDTS 295
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 61/177 (34%), Positives = 92/177 (51%), Gaps = 13/177 (7%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPT 175
K LG G G V LAEL+ G FA+K + K ++ + E+ +L+L ++PFL
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
LY F+T + +MEF +GGDL + Q F FYA+E++ L++LH G++
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
YRDLK +NV++ DGHI ++DF + R S++C P I P
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN----------RASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 52/124 (41%), Positives = 77/124 (62%), Gaps = 7/124 (5%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN-VVGQPL 407
+F GT EYLAPE++ + +G AVDWW G+ YE++ GR PF N + E LF ++ + +
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILMEEI 212
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRL-GFKRGATEIKQHPFFESVNW--ALIRSTHPP 464
+FP ++S AK L+ GLL KDP++RL G A E+ +H FF S+NW + + PP
Sbjct: 213 RFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270
Query: 465 EIPK 468
P+
Sbjct: 271 FKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 43/122 (35%), Positives = 72/122 (59%), Gaps = 4/122 (3%)
Query: 349 SFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
+F GT EYLAPE++ + G+ VD+W+ G+ +E+ G +PF ++ N+ +
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RSTHPPE 465
+FP+ +S + ++GLL ++PQ RLG R A E+K+HPFF ++W L+ + PP
Sbjct: 215 RFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPF 273
Query: 466 IP 467
P
Sbjct: 274 KP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 55/188 (29%), Positives = 105/188 (55%), Gaps = 17/188 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +LK +G G G V + +L++ +FAMK+++K + R + + ER++L D+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ TL+ F+ + L+M++ GGDL TL + + E RFY +E+++A++ +H +
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQL 121
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRC----------------FVSPKLVQSSDDP 276
V+RD+KP+N+L+ +GHI L+DF L+ ++SP+++Q+ +D
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 277 ACRISSYC 284
+ C
Sbjct: 182 KGKYGPEC 189
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-23
Identities = 57/152 (37%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
FR + LG G G V ++R G ++A K ++K + RK A E+ IL ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ +L +ET CL++ +GGDL H PG F EQ FYA+E+ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQ 119
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
+VYRDLKPEN+L+ + GHI +SD L+++
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 50/119 (42%), Positives = 69/119 (57%), Gaps = 3/119 (2%)
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406
+ +F GT EYLAPE+IR + + VDWW G YE+L G PF E N++ +P
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA-LIRSTHPP 464
L G+S+ A ++ LL KD Q+RLG K EI++HPFFES++W L + PP
Sbjct: 213 LVLRPGASL--TAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 9e-23
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 7/153 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKK--LMRAQTEREILSLLD 169
+++L +G G G VY + G A+K + L K+ L E ++L L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS---LEKIKEEALKSIMQEIDLLKNLK 57
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HP + ET +++E+ G L + ++ F E Y +VL L YL
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYL 115
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
H GV++RD+K N+L +DG + L+DF ++ +
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN--RETL 399
+ S GT Y+APE++ G+ AVDWW+ G+ YE L G+ P++G+ R+ +
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 400 FNV-VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ +P S A D I LL +DPQKRLG ++K HP+F
Sbjct: 211 RAKQETADVLYPATWST--EAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 52/124 (41%), Positives = 75/124 (60%), Gaps = 7/124 (5%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN-VVGQPL 407
+F GT EYLAPE++ + +G AVDWW G+ YE++ GR PF N + E LF ++ + +
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILMEEI 213
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRL-GFKRGATEIKQHPFFESVNWALI--RSTHPP 464
+FP ++S AK L+ GLL KDP++RL G A EI QH FF + W + + PP
Sbjct: 214 RFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPP 271
Query: 465 EIPK 468
P+
Sbjct: 272 FKPQ 275
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 57/148 (38%), Positives = 86/148 (58%), Gaps = 3/148 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP- 171
F L LG G G V LAE + L+A+K++ K ++ + E+ +L+L D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FL L+S F+T +ME+ +GGDL Q Q GK F E FYA+E+ + L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGK-FKEPQAVFYAAEISVGLFFLHR 119
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDL 259
G++YRDLK +NV++ +GHI ++DF +
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 47/126 (37%), Positives = 72/126 (57%), Gaps = 5/126 (3%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+F GT +Y+APEII +G +VDWW FG+ YE+L G+ PF+G E +++ +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RSTHPPE 465
+P+ S+S A + +GL+ K P KRLG G +IK+H FF ++W + + PP
Sbjct: 220 YPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPY 277
Query: 466 IPKPVD 471
PK
Sbjct: 278 KPKACG 283
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 9/129 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG----NRETLFN 401
++ + GT ++APE+++G+ + +VD++ G+ YE++ R PF+ G N+E
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 212
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGA-TEIKQHPFFESVNWALIRS 460
++ + +P+ S A+K LL KDP+KRLGF+ G ++ HP F +NW + +
Sbjct: 213 ILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270
Query: 461 --THPPEIP 467
PP +P
Sbjct: 271 GMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 49/150 (32%), Positives = 86/150 (57%), Gaps = 3/150 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F ++K +G G G V L + ++AMK++ K + R ER+I++ + +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L+ F+ DK+ ++ME+ GGDL L E+ RFY +EV+LAL+ +H M
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM 161
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
G ++RD+KP+N+L+ + GH+ L+DF ++
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 44/124 (35%), Positives = 67/124 (54%), Gaps = 5/124 (4%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
VGT Y+APE+++ + + + DWW G YE++ G++PF+ + V + +
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 411 EGSSISF--AAKDLIRGLLVKDPQKRLGFKR-GATEIKQHPFFESVNWALIRS--THPPE 465
E S F AA+ + R LL KDP RLG + GA E+K HPFF + N+ + + PP
Sbjct: 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281
Query: 466 IPKP 469
P P
Sbjct: 282 CPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-22
Identities = 53/179 (29%), Positives = 100/179 (55%), Gaps = 17/179 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F ++K +G G G V + +++ ++AMK+++K + R + + ER +L D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ TL+ F+ + + L+M++ GGDL TL + + E RFY +E++LA+ +H +
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRC----------------FVSPKLVQSSDD 275
V+RD+KP+NVL+ +GHI L+DF L+ ++SP+++Q+ +D
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-22
Identities = 49/122 (40%), Positives = 71/122 (58%), Gaps = 5/122 (4%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
+GT +YLAPE++ G HG AVDWW G+ +E L G PF ++ N++ + + +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 411 EG-SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469
EG +S A++ I LL DP KR G K E+KQHP F V+W +++ P IP+P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK----ELKQHPLFHGVDWENLQNQTMPFIPQP 656
Query: 470 VD 471
D
Sbjct: 657 DD 658
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 9e-22
Identities = 54/148 (36%), Positives = 84/148 (56%), Gaps = 3/148 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP- 171
F L LG G G V LAE + L+A+K++ K ++ + E+ +L+L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FL L+S F+T +ME+ +GGDL + Q Q F E FYA+E+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDL 259
G++YRDLK +NV++ +GHI ++DF +
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 46/123 (37%), Positives = 71/123 (57%), Gaps = 5/123 (4%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+F GT +Y+APEII +G +VDWW +G+ YE+L G+ PF G E +++ +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RSTHPPE 465
+P+ S+S A + +GL+ K P KRLG G +I++H FF ++W + R PP
Sbjct: 220 YPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPF 277
Query: 466 IPK 468
PK
Sbjct: 278 KPK 280
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPFLPTL 176
LG G GSVY D G FA+K + + Q E+EI LS L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 177 YSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVY 236
+ + +E GG L L ++ F E R Y ++LL LEYLH V+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 237 RDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
RD+K N+LV +G + L+DF + + ++V+ S + + S Y + P I
Sbjct: 126 RDIKGANILVDTNGVVKLADFGM------AKQVVEFSFAKSFKGSPYWMAPEVIAQ 175
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 56/189 (29%), Positives = 102/189 (53%), Gaps = 23/189 (12%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
K +D + + ++K +G G G V L + ++AMK++ K + R E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYA 219
R+I++ + P++ L+ F+ D++ ++ME+ GGDL L P K RFY
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-----ARFYT 148
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF--------DLSLRC-------- 263
+EV+LAL+ +H MG ++RD+KP+N+L+ + GH+ L+DF + +RC
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 264 FVSPKLVQS 272
++SP++++S
Sbjct: 209 YISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 50/132 (37%), Positives = 73/132 (55%), Gaps = 5/132 (3%)
Query: 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
A+ R+ + GT EY+APEI+ GHG A DWWT GIF YE+L+G PF N
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237
Query: 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFESVNWA-- 456
++ + FP+ + K L++ LL D KR G K+GA +K+HP+F +++W
Sbjct: 238 QKILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295
Query: 457 LIRSTHPPEIPK 468
L ++ P PK
Sbjct: 296 LHKNVEVPYKPK 307
|
Length = 340 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 7e-21
Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
L KKLG G G VY L+ G A+K + +G R++ + E I+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE---EASIMKK 57
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
L HP + L + ++ E+ GGDL LR+ + + A ++ +
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGM 115
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
EYL V+RDL N LV E+ + +SDF LS
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 26/177 (14%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET--------LFN 401
F GT Y+APEI+RG+ +G +VDWW G+ +E++ GR+PF G+ + LF
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 402 VV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF--KRGATEIKQHPFFESVNWALI 458
V+ + ++ P S+S A +++ L KDP++RLG + G +I+ HPFF +V+W L+
Sbjct: 216 VILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM 273
Query: 459 RSTH--PPEIPK--------PVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDFEF 505
PP P D F N + P +D D+S F FE+
Sbjct: 274 EQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQL-TPDDDDIVRKIDQSE--FEGFEY 327
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 7/148 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLDH 170
F +L K+G G G V+ + ++AMK +D L+ + R + E +L+ LD
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQID---LSKMNRREREEAIDEARVLAKLDS 58
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSE-QATRFYASEVLLALEYL 229
++ Y F ++ME+ GDLH L + Q G+ E Q RF+ ++LL L +L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHL 117
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDF 257
H +++RD+K N+ + ++ + D
Sbjct: 118 HSKKILHRDIKSLNLFLDAYDNVKIGDL 145
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 48/150 (32%), Positives = 88/150 (58%), Gaps = 3/150 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ ++K +G G G V L + ++AMK++ K + R ER+I++ + P+
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L+ F+ DK+ ++ME+ GGDL L E+ +FY +EV+LAL+ +H M
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
G+++RD+KP+N+L+ + GH+ L+DF ++
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 53/126 (42%), Positives = 74/126 (58%), Gaps = 10/126 (7%)
Query: 351 VGTHEYLAPEIIR---GDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ- 405
VGT +Y++PE+++ GDG+ G DWW+ G+F +E+L+G TPF + T ++
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 406 -PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF--ESVNWALIRSTH 462
L FPE IS AK+LI L D + RLG + G EIKQHPFF + NW IR T
Sbjct: 264 NSLNFPEDVEISKHAKNLICAFLT-DREVRLG-RNGVEEIKQHPFFKNDQWNWDNIRETA 321
Query: 463 PPEIPK 468
P +P+
Sbjct: 322 APVVPE 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 8/152 (5%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF----AMKVMDKG-MLAGRKKLMRAQTEREILSLL 168
L KKLG G G VY L+ G A+K + + ++ +R E I+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKL 58
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
DHP + L ++ ++ME+ GGDL ++ K S +A ++ +EY
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L ++RDL N LV E+ + +SDF LS
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 50/140 (35%), Positives = 78/140 (55%), Gaps = 7/140 (5%)
Query: 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG 394
L V I E S R VGT Y+APE++ + + D+W G YE++ G++PF+G
Sbjct: 148 LAVKIPEGESIRGR--VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
Query: 395 NRETLFNVVGQPLKFPEGSSISFA--AKDLIRGLLVKDPQKRLGFKR-GATEIKQHPFFE 451
+ V + L+ E S F+ AK + + LL KDP++RLG + GA E+K+HPFF
Sbjct: 206 EKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265
Query: 452 SVNWALIRS--THPPEIPKP 469
++N+ + + PP +P P
Sbjct: 266 NMNFKRLEAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 60/179 (33%), Positives = 94/179 (52%), Gaps = 26/179 (14%)
Query: 346 RSMSFVGTHEYLAPEIIR---GDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
R + VGT +Y++PE+++ GDG+ G DWW+ G+F YE+L+G TPF + T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 402 VVGQ--PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL-- 457
++ L FP+ + IS AK+LI L D + RLG + G EIK+H FF++ WA
Sbjct: 259 IMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLG-RNGVEEIKRHLFFKNDQWAWET 316
Query: 458 IRSTHPPEIPK---PVDLSFIN-------HKQKTPIPQNDKGAADSDRSSGPFLDFEFF 506
+R T P +P +D S + ++ PIP+ G + PF+ F ++
Sbjct: 317 LRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPIPKAFVG------NQLPFVGFTYY 369
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 46/126 (36%), Positives = 76/126 (60%), Gaps = 9/126 (7%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVVGQPL 407
+F GT +Y+APEI++ +G +VDWW G+ YE++ G+ PF+ + N + LF +++ +
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-NEDDLFESILHDDV 213
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLG---FKRGATEIKQHPFFESVNWALI--RSTH 462
+P +S A +++ + K+P KRLG + G IKQHPFF+ ++W L+ R
Sbjct: 214 LYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIK 271
Query: 463 PPEIPK 468
PP PK
Sbjct: 272 PPFKPK 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 7e-20
Identities = 53/152 (34%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---D 169
++++K+LG G GSVYLA ++ G L A+K M K ++ M RE+ SL +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMN---LREVKSLRKLNE 56
Query: 170 HPFLPTLYSHF-ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
HP + L F E D+ + E+ G +L+ L + + GK FSE R ++L L +
Sbjct: 57 HPNIVKLKEVFRENDEL-YFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+H G +RDLKPEN+LV + ++DF L+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 8e-20
Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 4/146 (2%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G G V ++++ G ++A K +DK L + A E+EIL ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 179 HFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVY 236
FE+ CL+M +GGDL H + G Y++++ + +LH M +VY
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER--VIHYSAQITCGILHLHSMDIVY 118
Query: 237 RDLKPENVLVREDGHIMLSDFDLSLR 262
RD+KPENVL+ + G+ LSD L++
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVE 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF----AMKVMDKG-MLAGRKKLMRAQTEREILSLL 168
L KKLG G G VY +L+ G A+K + + ++ +R E I+ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKL 58
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
DHP + L ++ ++ME+ GGDL + LR+ +P S +A ++ +E
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGME 116
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL ++RDL N LV E+ + +SDF LS
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 43/125 (34%), Positives = 71/125 (56%), Gaps = 8/125 (6%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN-VVGQPL 407
+F GT +Y+APEI++ +G +VDWW G+ YE+L G PF+ N + LF ++ +
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAILNDEV 213
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGF--KRGATEIKQHPFFESVNWALI--RSTHP 463
+P + +S A D+++ + K+P RLG G I +HPFF+ ++W + R P
Sbjct: 214 VYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEP 271
Query: 464 PEIPK 468
P P+
Sbjct: 272 PFRPR 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 51/141 (36%), Positives = 78/141 (55%), Gaps = 13/141 (9%)
Query: 344 SARSMSFVGTHEYLAPEIIRG--DG---HGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
+ +S VGT +Y++PEI++ DG +G DWW+ G+ YE+L G TPF ET
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 399 LFNVVG--QPLKFPEG-SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
++ + +FP + +S AKDLI+ L+ ++RLG + G + K+H FFE ++W
Sbjct: 217 YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLG-QNGIEDFKKHAFFEGIDW 274
Query: 456 ALIRSTHPPEIP---KPVDLS 473
IR+ P IP P D S
Sbjct: 275 ENIRNLEAPYIPDVSSPSDTS 295
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 54/146 (36%), Positives = 81/146 (55%), Gaps = 13/146 (8%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRG--DG---HGSAVDWWTFGIFFYELLLGRTPFKGN 393
+ E + +S VGT +Y++PEI++ DG +G DWW+ G+ YE+L G TPF
Sbjct: 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 394 GNRETLFNVVG--QPLKFP-EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
ET ++ + +FP + + +S AKDLIR L+ + RLG + G + KQHPFF
Sbjct: 212 SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLG-QNGIEDFKQHPFF 269
Query: 451 ESVNWALIRSTHPPEIPK---PVDLS 473
++W IR+ P IP+ P D S
Sbjct: 270 TGIDWDNIRNCEAPYIPEVSSPTDTS 295
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 49/140 (35%), Positives = 75/140 (53%), Gaps = 7/140 (5%)
Query: 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG 394
L V I E + R VGT Y+APE+I + + + DWW G YE++ G++PF+
Sbjct: 148 LAVQIPEGETVRGR--VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
Query: 395 NRETLFNVVGQPLKFPEGSSISFA--AKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFE 451
R V + + E S F+ AK + R LL K+P++RLG + GA +KQHP F+
Sbjct: 206 ERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265
Query: 452 SVNWALIRST--HPPEIPKP 469
++N+ + + PP P P
Sbjct: 266 NINFKRLEANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 44/124 (35%), Positives = 74/124 (59%), Gaps = 9/124 (7%)
Query: 351 VGTHEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP 406
VGTH Y+APE++ +G + S+ DW++ G ++LL G +PF+ + ++ +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALI--RSTHP 463
++ P+ S S + L+ GLL +D +RLG RGA E+K+HPFF S++W ++ + P
Sbjct: 216 VELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273
Query: 464 PEIP 467
P IP
Sbjct: 274 PLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 52/155 (33%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-----REI--L 165
F LL+ +G G G VY A + + A+KV+D L A+ E +EI L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---------LEEAEDEIEDIQQEIQFL 53
Query: 166 SLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
S P++ Y F ++ME+C GG L + E F EVLL
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLG 110
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LEYLH G ++RD+K N+L+ E+G + L+DF +S
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 49/150 (32%), Positives = 79/150 (52%), Gaps = 3/150 (2%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMR-AQTEREILSLLDH 170
H+ ++ LG G G L + L K ++ L+ +K R A E ILSLL H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS--EKERRDALNEIVILSLLQH 58
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P + Y+HF D + ME+ +GG L+ RQ G+ F E+ +Y +++ A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+++RD+K N+ + + G I L DF +S
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 5/146 (3%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
++ L+K+G G G VY A R G A+K M ++ E I+ HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ Y + ++ME+ GG L T Q +E + EVL LEYLH
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
V++RD+K +N+L+ +DG + L+DF
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 14/152 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD-KGMLAGRKKLMRAQTEREILSLLDHP 171
F +L+KLG G GSVY A ++ G + A+KV+ + L K E IL D P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK------EISILKQCDSP 58
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGG---DLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
++ Y + + ++ME+C G D+ + + +E+ + L LEY
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLEY 114
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LH ++RD+K N+L+ E+G L+DF +S
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 45/127 (35%), Positives = 72/127 (56%), Gaps = 11/127 (8%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF---KGNGNRETLFNVVGQPL 407
VGT Y+APE+++ + + + DWW G YE++ G++PF K RE + +V +
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-- 219
Query: 408 KFPEGSSISFA--AKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIRS--TH 462
E S F+ A+ L + LL KDP++RLG + GA E+K+HP F+ +N+ + +
Sbjct: 220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLE 278
Query: 463 PPEIPKP 469
PP P P
Sbjct: 279 PPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 3/150 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F++LKKLG G GSVY + +A+K +D G ++ +++ A E IL+ ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVNEIRILASVNHPN 60
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ + F C++ME+ GDL ++++ K EQ ++L L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RDLK N+L+ + + + D +S
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ +L+ +G G G+V + G + K +D G + ++K +E IL L HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV-SEVNILRELKHP 59
Query: 172 FLPTLYSHF--ETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLALE 227
+ Y +++ ++ME+C GGDL L + ++ K+ E+ +++LLAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 228 YLHM-----MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
H V++RDLKP N+ + + ++ L DF L+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 16/156 (10%)
Query: 117 KKLGCGDIGSVYLAELRDMG---CLFAMKVMDKG-MLAGRKKLMRAQTEREILSLLDHPF 172
KKLG G G VY +L+ A+K + + RK ++ E ++ L HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57
Query: 173 LPTLYSHFETDKFS-CLLMEFCSGGDLHT-LRQRQPGKHFSEQAT------RFYASEVLL 224
+ L T++ L++E+ GGDL LR+ +P E++T +A ++
Sbjct: 58 VVRLL-GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+EYL V+RDL N LV ED + +SDF LS
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 4/149 (2%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ ++ +LG G G VY A+ ++ G A K++ + M E +ILS HP
Sbjct: 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFM---VEIDILSECKHP 62
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ LY + + +L+EFC GG L ++ + + +E R+ ++L AL +LH
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
V++RDLK N+L+ DG + L+DF +S
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-----REI-- 164
+ L++ +G G VY A A+K +D L + QT +E+
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID---------LEKCQTSVDELRKEVQA 52
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGD-LHTLRQRQPGKHFSEQATRFYASEVL 223
+S +HP + Y+ F L+M + SGG L ++ P E EVL
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LEYLH G ++RD+K N+L+ EDG + ++DF +S
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ L++++G G G VY A G L A+KV+ L Q E +L HP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRHP 60
Query: 172 FLPTLY-SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ + S+ DK ++ME+C GG L + Q G SE + E L L YLH
Sbjct: 61 NIVAYFGSYLRRDKL-WIVMEYCGGGSLQDIYQVTRG-PLSELQIAYVCRETLKGLAYLH 118
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
G ++RD+K N+L+ EDG + L+DF +S
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 36/173 (20%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--------- 163
+ + ++G G G VY A + G L A+K K +R + E+E
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----------K-IRMENEKEGFPITAIRE 48
Query: 164 --ILSLLDHPFLPTLY----SHFETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQAT 215
+L L HP + L S + + ++ E+ H L P F+E
Sbjct: 49 IKLLQKLRHPNIVRLKEIVTSKGKGSIY--MVFEYMD----HDLTGLLDSPEVKFTESQI 102
Query: 216 RFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268
+ Y ++L L+YLH G+++RD+K N+L+ DG + L+DF L+ R +
Sbjct: 103 KCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA-RPYTKRN 154
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ ++ +LG G G VY A+ ++ G L A KV++ ++L E EIL+ +HP+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIET---KSEEELEDYMVEIEILATCNHPY 70
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L F D +++EFC GG + + + + +E + ++L AL+YLH M
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
+++RDLK NVL+ DG I L+DF +S +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLD 169
G F L++ +G G G VY A + G L A+K+MD ++ ++ + E IL +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEE--EIKEEYNILRKYSN 61
Query: 170 HPFLPTLYSHFETDKFSC------LLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASE 221
HP + T Y F L+ME C GG + L + R+ GK E+ + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L L YLH V++RD+K +N+L+ ++ + L DF +S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 7e-17
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 22/165 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------REI- 164
+ L+KLG G G VY A + G + A+K + + + E REI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI----------RLDNEEEGIPSTALREIS 50
Query: 165 -LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
L L HP + L T++ L+ E+C DL ++PG S + ++L
Sbjct: 51 LLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLL 108
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268
L Y H +++RDLKP+N+L+ DG + L+DF L+ R F P
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-RAFGIPL 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 39/123 (31%), Positives = 68/123 (55%), Gaps = 7/123 (5%)
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR----ETLFNVVGQPL 407
GT+ Y+APEI++ + + VDW+ G YE++ GRTPFK + + E + +
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRS--THPPE 465
KF E + + +KD+ R L K P+ RLG + + ++H FF+++N+ + + PP
Sbjct: 216 KF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPF 274
Query: 466 IPK 468
+P
Sbjct: 275 VPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKL--MRAQTEREILSL--L 168
+++L ++G G G V+ A+ R+ G A+K +A R+ + Q REI +L
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALK-----KVALRRLEGGIPNQALREIKALQAC 56
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLAL 226
HP++ L F L+ME+ DL + + +P E + Y +L +
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERP---LPEAQVKSYMRMLLKGV 112
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
Y+H G+++RDLKP N+L+ DG + ++DF L+
Sbjct: 113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGM-LAGRKKLMRAQTEREILSLLDHP 171
L +LG G+ G V R G + A+K + + A +K+++R E +IL + P
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSP 59
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH- 230
++ Y F + + ME+ GG L + + G+ E+ A VL L YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHE 118
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272
+++RD+KP N+LV G I L DF VS +LV S
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFG------VSGQLVNS 154
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 49/129 (37%), Positives = 72/129 (55%), Gaps = 19/129 (14%)
Query: 351 VGTHEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-------NRETLFNV 402
VGTH Y+APE++ +G + S+ DW++ G ++LL G +PF+ + +R TL
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215
Query: 403 VGQPLKF-PEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFESVNW--ALI 458
V P F PE K L+ GLL +D KRLG RGA E+K+H FF+ ++W +
Sbjct: 216 VELPDSFSPE-------LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268
Query: 459 RSTHPPEIP 467
+ PP IP
Sbjct: 269 QKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMK-VMDKGMLAGRKKLMRAQTEREILSLLD 169
L +LG G GSV L++ G +FA+K + +K+++R E EI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCK 57
Query: 170 HPFLPTLYSHFETDKFSCL--LMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLA 225
P++ Y F + S + ME+C GG L ++ + ++ G E+ A VL
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L YLH +++RD+KP N+L+ G + L DF +S
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 52/153 (33%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ ++ +LG G G VY A+ ++ G L A KV+D ++L E +IL+ DHP
Sbjct: 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT---KSEEELEDYMVEIDILASCDHP 62
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGG--DLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
+ L F + +L+EFC+GG D L +P +E R + L AL YL
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYL 119
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
H +++RDLK N+L DG I L+DF +S +
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 45/173 (26%), Positives = 85/173 (49%), Gaps = 18/173 (10%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMD-KGMLAGRKKLMRAQTEREILSLLDHPFLP 174
++ +G G G V+L + L +K + + M + + + AQ E ++L LL HP +
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT--KDERLAAQNECQVLKLLSHPNII 62
Query: 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
Y +F DK ++ME+ GG L Q++ E + ++LLAL ++H +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122
Query: 235 VYRDLKPENVLVREDGHIM-LSDFDLS--------------LRCFVSPKLVQS 272
++RDLK +N+L+ + ++ + DF +S C++SP+L +
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 7/114 (6%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-- 396
+ E T + +FVGT Y++PE I+G+ + A D W+ G+ E LG+ PF G
Sbjct: 149 VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208
Query: 397 -ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
E + + P S +D I L KDP+KR A E+ QHPF
Sbjct: 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR----PSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 31/104 (29%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQ 405
+ VGT ++APE+I G + D W+ GI EL G+ P+ + LF +
Sbjct: 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG 213
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
P S KD ++ L K+P+KR A ++ +HPF
Sbjct: 214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 51/155 (32%), Positives = 71/155 (45%), Gaps = 5/155 (3%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPFL 173
KKLG G VY A ++ G + A+K + G K + REI L L HP +
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
L F L+ EF DL + + + + Y L LEYLH
Sbjct: 65 IGLLDVFGHKSNINLVFEFMET-DLEKV-IKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268
+++RDLKP N+L+ DG + L+DF L+ R F SP
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLA-RSFGSPN 156
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMK-VMDKGMLAGRKKLMRAQT------EREILSLLDHP 171
+G G G VYLA G + A+K V +AGR + E E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ T+++ + +E+ GG + + R G+ F EQ RF+ +VL L YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSC-LRTYGR-FEEQLVRFFTEQVLEGLAYLHS 126
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+++RDLK +N+LV DG +SDF +S
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL--LDHPFL 173
L K+G G G VY A + G + A+K + + + REI L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNI 60
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
L F L+ EF ++ RQ + E + Y ++L L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
+++RDLKPEN+L+ +G + L+DF L+ R F SP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLA-RSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 39/145 (26%), Positives = 80/145 (55%), Gaps = 1/145 (0%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
+KK+G G G L + ++ G + +K ++ ++ +++ ++ E +LS + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQ 63
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
FE + ++M++C GGDL+ Q G F E + ++ LAL+++H ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 236 YRDLKPENVLVREDGHIMLSDFDLS 260
+RD+K +N+ + +DG I L DF ++
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 41/146 (28%), Positives = 82/146 (56%), Gaps = 2/146 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ ++KK+G G G +YLA+ + +K +D + ++K ++ E +L+ + HP
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ T ++ F+ + ++ME+C GGDL RQ G FSE + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 233 GVVYRDLKPENVLVREDGHIM-LSDF 257
+++RD+K +N+ + ++G + L DF
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 3/155 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ +L+ +G G G L + + +AMK + + + ++ E +L+ + HP
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ FE D ++ME+C GGDL + Q GK F E + ++ L ++++H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
V++RD+K +N+ + ++G + L DF S R SP
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSP 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
++ L+ +G G G+VY + G + A+K+++ + + Q E +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN--LDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 173 LPTL---YSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
P + Y + ++ME+ GG + TL + P +E+ EVL+AL+Y+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKYI 117
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273
H +GV++RD+K N+LV G++ L DF V+ L Q+S
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFG------VAALLNQNS 155
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 6/153 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG--RKKLMRAQTEREILSLLDH 170
+R K LG G G VYL D G A+K + + +K++ + E ++L L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL 229
+ Y D+ + ME+ GG + L+ +E TR Y ++L +EYL
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYL 120
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
H +V+RD+K N+L G++ L DF S R
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKK---LMRAQTEREILSLLDHP 171
L ++LG G G+VYL + + +KV+ K + G ++A E ++LS LDHP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 172 FLPTLYSHF-ETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASEVLLALEY 228
+ ++ F E D F C++ E+C G DL + + GK SE + ++LL + Y
Sbjct: 63 AIVKFHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+H +++RDLK +N+ ++ + + + DF +S
Sbjct: 122 MHQRRILHRDLKAKNIFLKNN-LLKIGDFGVS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 38/106 (35%), Positives = 53/106 (50%), Gaps = 9/106 (8%)
Query: 349 SFVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNV-V 403
S GT Y+APE+I G GHG A D W+ G E+ G+ P+ N + +F+V
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221
Query: 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
G P+ +S KD + L DP+KR A+E+ QHPF
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP----TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 2/147 (1%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP 174
++ +G G G V L R G + +K ++ A R++ A+ E ++LS L HP +
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 175 TLYSHFE-TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
+E D ++M FC GGDL+ + Q GK E + ++ +AL+YLH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RDLK +NV + I + D ++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIA 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 8e-13
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 7/149 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L++++G G G VY A + G L A+KV+ L + Q E ++ H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 173 LPTLY-SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ + S+ DK + MEFC GG L + SE + + E L L YLH
Sbjct: 68 IVAYFGSYLRRDKL-WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS 124
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
G ++RD+K N+L+ ++GH+ L+DF +S
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 34/175 (19%)
Query: 96 DAVQCVKSK-DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKK 154
A+Q V D L +F K+G G G V +A + G A+K MD
Sbjct: 6 AALQLVVDPGDPRSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMD--------- 53
Query: 155 LMRAQTERE-------ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-----HTLR 202
+R Q RE I+ HP + +YS + ++MEF GG L HT
Sbjct: 54 -LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT-- 110
Query: 203 QRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+E+ VL AL +LH GV++RD+K +++L+ DG + LSDF
Sbjct: 111 ------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 32/167 (19%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDM--GCLFAMKVM-----DKGMLAGRKKLMRAQTEREIL 165
+ L ++G G G+VY A RD+ G A+K + ++G+ T REI
Sbjct: 1 YEELAEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGI--------PLSTLREIA 50
Query: 166 SL-----LDHPFLPTLY--SHF-----ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQ 213
L +HP + L H E L+ E DL T + P +
Sbjct: 51 LLKQLESFEHPNIVRLLDVCHGPRTDRELKLT--LVFEHVDQ-DLATYLSKCPKPGLPPE 107
Query: 214 ATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ ++L +++LH +V+RDLKP+N+LV DG + ++DF L+
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMK--VMDKGMLAG--RKKLMRAQTEREI--LSLLDHP- 171
+G G GSVYL G L A+K + + RK+ M REI L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ L S + D + L E+ GG + L F E R + ++L L YLH
Sbjct: 68 IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHN 124
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+++RD+K N+LV G I +SDF +S
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGIS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 48/156 (30%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
G F L++ +G G G VY G L A+KVMD + G ++ Q + H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHH 62
Query: 171 PFLPTLYSHF------ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
+ T Y F D L+MEFC G + L + G E+ + E+L
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L +LH V++RD+K +NVL+ E+ + L DF +S
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 47/173 (27%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA--------QTERE 163
+ LLK +G G G V A + G A+K K+ + RE
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK-----------KISNVFDDLIDAKRILRE 49
Query: 164 I--LSLLDHP--------FLPTLYSHFE-----TDKFSCLLMEFCSGGDLHT-LRQRQPG 207
I L L H P F T+ LME DLH ++ QP
Sbjct: 50 IKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE-----LME----TDLHKVIKSPQP- 99
Query: 208 KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ +++ ++L L+YLH V++RDLKP N+LV + + + DF L+
Sbjct: 100 --LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 78/333 (23%), Positives = 124/333 (37%), Gaps = 89/333 (26%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L +FR+ KK+G G VY A G A+K + L K E ++L L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDL-----HTLRQRQPGKHFSEQATRFYASEVLL 224
HP + Y+ F D +++E GDL H +Q+ + E+ Y ++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK---RLIPEKTVWKYFVQLCS 117
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYC 284
ALE++H V++RD+KP NV + G + L D L
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG------------------------ 153
Query: 285 IQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344
RF +SKTT S L+ P
Sbjct: 154 ----------------------------RFFSSKTTAAHS-------------LVGTPY- 171
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-NRETLFNVV 403
Y++PE I +G+ D W+ G YE+ ++PF G+ N +L +
Sbjct: 172 -----------YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220
Query: 404 GQPLKFPEGSSISFAA--KDLIRGLLVKDPQKR 434
Q +P S ++ + L+ + DP+KR
Sbjct: 221 EQ-CDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
LG+F++ KK+G G VY A G + A+K + + K E ++L LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRF-------YASEV 222
HP + + F + +++E GDL + KHF +Q Y ++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTIWKYFVQL 115
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266
ALE++H +++RD+KP NV + G + L D L R F S
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG-RFFSS 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN--VVGQP 406
+ VGT YL+PE+ + + D W+ G YEL + PF+G N L + GQ
Sbjct: 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQY 220
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKR 434
P S ++L+ LL KDP++R
Sbjct: 221 PPIPSQYSSEL--RNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 23/163 (14%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI---LSL 167
G F L++ +G G G VY G L A+KVMD + E EI +++
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----------VTEDEEEEIKLEINM 65
Query: 168 LD----HPFLPTLYSHF------ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRF 217
L H + T Y F D L+MEFC G + L + G E +
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 218 YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
E+L L +LH V++RD+K +NVL+ E+ + L DF +S
Sbjct: 126 ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 10/110 (9%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T ++ +FVGT ++APE+I+ G+ D W+ GI EL G P LF +
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 403 VGQPLKFP---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
P P EG+ S KD + L KDP++R A E+ +H F
Sbjct: 211 ---PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP----SAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------REI- 164
F+ ++K+G G G VY A + G + A+K K + +TE REI
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALK----------KIRLDTETEGVPSTAIREIS 51
Query: 165 -LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
L L+HP + L T+ L+ EF DL P + Y ++L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
L + H V++RDLKP+N+L+ +G I L+DF L+ R F P
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 17/181 (9%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--I 164
DL + LG G+ GSV + G + A KV+ G K +R Q RE I
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVV----HIGAKSSVRKQILRELQI 56
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLH-TLRQRQPGKHFSEQATRFYASEVL 223
+ P++ + Y F + C+ MEF G L ++ P + A V+
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVV 113
Query: 224 LALEYLH-MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISS 282
L YL+ + +++RD+KP N+LV G I L DF VS +L+ S D S+
Sbjct: 114 EGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG------VSGELINSIADTFVGTST 167
Query: 283 Y 283
Y
Sbjct: 168 Y 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 7e-12
Identities = 37/131 (28%), Positives = 55/131 (41%), Gaps = 37/131 (28%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
THE Y APEI+ G H +AVD W+ G F E++ G+ F G+ + L F ++
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215
Query: 404 GQP--------LKFPEGS----------------SISFAAKDLIRGLLVKDPQKRLGFKR 439
G P K P+ + DL+ +L +P KR+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---- 271
Query: 440 GATEIKQHPFF 450
A E +HP+F
Sbjct: 272 SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 9/155 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAE---LRD-MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
H + +K+LG G G V L L D G A+K ++ + + E EIL
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--EEQHRSDFEREIEILRT 62
Query: 168 LDHPFLPTL--YSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
LDH + + L+ME+ G L QR + ++ F +S++
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF-SSQICKG 121
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++YL ++RDL N+LV + + +SDF L+
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDK----GMLAGRK----KLMRAQTERE 163
++ L +G G G V A G A+K + + + A R +L++
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 164 ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
++ LLD F P S E + L+ G DL+ + + Q S+ +F ++L
Sbjct: 76 VIGLLD-VFTPA--SSLEDFQDVYLVTHL-MGADLNNIVKCQK---LSDDHIQFLVYQIL 128
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L+Y+H G+++RDLKP N+ V ED + + DF L+
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM-----DKGMLAGRKKLMRAQTEREILSL 167
+ +L +G G G V + G + A+K D+ + +K +R E ++L
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV---KKTALR---EVKVLRQ 56
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
L H + L F L+ E+ L L G A R Y ++L A+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQLLQAIA 114
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
Y H +++RD+KPEN+LV E G + L DF
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 9/111 (8%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T + S GT ++APE+IRG+ +G A D W+ G E+ G+ P+ GN
Sbjct: 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK 215
Query: 403 VG---QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+G +P + PE +S AKD +R L +DP+KR A E+ QHPF
Sbjct: 216 IGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRP----TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 11/104 (10%)
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR----ETLFNVVGQPL 407
GT +Y +PE I+G + + DWW G+ YELL G+ PFK + + E+L + L
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRL-GFKRGATEIKQHPFF 450
F ++S A D ++ +L + RL + EI +HPF
Sbjct: 228 PFI--KNVSKNANDFVQSMLKYNINYRLTNYN----EIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMK--VMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173
L K+G G G V+ R+ G + A+K V + +K +R E +L L HP L
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKHPNL 62
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
L F + L+ E+C L+ L + G E + + L A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 234 VVYRDLKPENVLVREDGHIMLSDF 257
++RD+KPEN+L+ + G I L DF
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 117 KKLGCGDIGSVYLAELRDMGCL---FAMKVMDKG-MLAGRKKLMRAQTEREILSLLDHPF 172
K+LG G+ GSV A+K + + + AG+K+ +R E +++ LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPC 57
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ L + + L+ME G L L++R+ + A +V + + YL
Sbjct: 58 IVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES 113
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL NVL+ +SDF +S
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 48/175 (27%), Positives = 74/175 (42%), Gaps = 34/175 (19%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------RE-- 163
+ L K+G G G V+ A + + A+K K LM + E RE
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK----------KVLMENEKEGFPITALREIK 63
Query: 164 ILSLLDHP----------FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQ 213
IL LL H T Y+ ++ + L+ EFC DL L F+
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFY--LVFEFCEH-DLAGLLS-NKNVKFTLS 119
Query: 214 ATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268
+ +L L Y+H +++RD+K N+L+ +DG + L+DF L+ R F K
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA-RAFSLSK 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 65.1 bits (157), Expect = 3e-11
Identities = 40/125 (32%), Positives = 53/125 (42%), Gaps = 18/125 (14%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGH---GSAVDWWTFGIFFYELLLGRTPFKGNGN--- 395
A + VGT Y+APE++ G S+ D W+ GI YELL G PF+G N
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 396 --------RETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
E + PL IS AA DL++ LL KDP+ RL ++ H
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL----SSSSDLSH 275
Query: 448 PFFES 452
Sbjct: 276 DLLAH 280
|
Length = 384 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 5/148 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L+K+G G G V+ + A+K++D + ++ Q E +LS D P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ Y + D ++ME+ GG L + P E E+L L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RD+K NVL+ E G + L+DF ++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGM-LAGRKKLMRAQTEREILSLLDHPF 172
+ + LG G+ G+VY A + A+KV+ + + +K++M +E EIL D P+
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM---SELEILYKCDSPY 60
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ Y F + + EF GG L R+ E A V+ L YL +
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272
+++RD+KP N+LV G + L DF VS +LV S
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFG------VSTQLVNS 148
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL---SLLD 169
+++L K+G G V A+ R G +A+K M K K L + REI L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSP 56
Query: 170 HPFLPTLYSHFETDKFSCL-----LMEFCSGGDLHTL-RQRQPGKHFSEQATRFYASEVL 223
HP + L K L LM+ +L+ L + R+ + E+ + Y ++L
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRK--RPLPEKRVKSYMYQLL 110
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+L+++H G+ +RD+KPEN+L+++D + L+DF
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 51/180 (28%), Positives = 79/180 (43%), Gaps = 28/180 (15%)
Query: 114 RLLKKLGCGDIGSVYLAEL-----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
R L++LG G G VY EL R A+K + + A K + E E++S L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDL 65
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQP------------GKHFSEQAT 215
HP + L ++ +C+L E+ + GDLH L + P K + +
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 216 RFY-ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274
+ A ++ +EYL V+RDL N LV E + +SDF LS + + S+D
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS-------RDIYSAD 178
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--HPFLPT 175
K+G G G V +A ++ G L A+K MD RK+ R E++ + D H +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
+Y+ + ++MEF GG L + +E+ VL AL LH GV+
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 236 YRDLKPENVLVREDGHIMLSDF 257
+RD+K +++L+ DG + LSDF
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMG-CLFAMKVMDKGMLA-GRKKLMRAQTEREILS---- 166
+ +L+ LG G G VY ++ G L A+K ++ A G+ K R ++ +I+S
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 167 ---LLDHPFLPTLYSHF-ETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYAS 220
L HP + Y F E D+ ++M+ G L H ++ + F+E+
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLY-IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 221 EVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++LAL YLH +V+RDL P N+++ ED + ++DF L+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 35/140 (25%), Positives = 61/140 (43%), Gaps = 5/140 (3%)
Query: 120 GCGDIGSVYLAELRDMGCLFAMKV--MDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLY 177
D+ V+LA+ + L A+K +D ++ L Q E L HP +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYR 237
+ F D ++ + G L + + E A F +VL AL+Y+H G ++R
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 238 DLKPENVLVREDGHIMLSDF 257
+K ++L+ DG ++LS
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--HPFLPT 175
K+G G G V +A + G A+K+MD RK+ R E++ + D H +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
+Y + + +LMEF GG L + + +E+ VL AL YLH GV+
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 236 YRDLKPENVLVREDGHIMLSDF 257
+RD+K +++L+ DG + LSDF
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 6/155 (3%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM--DKGMLAGRKKLMRAQTEREILSLLD 169
++RL K LG G G VYL D G A+K + D K++ + E ++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 170 HPFLPTLYSHFE--TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
H + Y +K + +E+ GG + Q + +E TR Y ++L +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD--QLKAYGALTENVTRRYTRQILQGVS 120
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
YLH +V+RD+K N+L G++ L DF S R
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--HPFLPT 175
K+G G G V +A + G A+K MD RK+ R E++ + D H +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
+Y+ + ++MEF GG L + +E+ VL AL YLH GV+
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 236 YRDLKPENVLVREDGHIMLSDF 257
+RD+K +++L+ DG I LSDF
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 7/177 (3%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMK--VMD-KGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
LG G G+VY L + G L A+K +D +LA K+ + Q E ++L L H +
Sbjct: 8 LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
D + MEF GG + ++ R E Y ++L + YLH VV
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 236 YRDLKPENVLVREDGHIMLSDFDLSLR-CFVSPKLVQSSDDPACRISSYCIQPSCID 291
+RD+K NV++ +G I L DF + R +V S+ + + Y + P I+
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 5/148 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L+++G G G V+ + A+K++D + ++ Q E +LS D P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ Y + ++ME+ GG L + P F E E+L L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSE 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RD+K NVL+ E G + L+DF ++
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 34/125 (27%), Positives = 54/125 (43%), Gaps = 13/125 (10%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV-VG 404
R S VGT ++APE+I +G+ VD W+ GI E++ G P+ + + +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPP 464
P K +S + + +LV+DP +R A E+ HPF + PP
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA----TAAELLNHPF--------LAKAGPP 278
Query: 465 EIPKP 469
P
Sbjct: 279 SSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 5/102 (4%)
Query: 349 SFVGTHEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
SF G+ ++APE+I + G+G A D W+ G E+ G+ P+ +F +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
P +S AKD I L +DP R A E+ +HPF
Sbjct: 220 LPPIPDHLSDEAKDFILKCLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 44/117 (37%), Positives = 60/117 (51%), Gaps = 11/117 (9%)
Query: 340 AEPTSARSM--SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
A+ T +S S VGT ++APE+I+ +G VD W+ GI E+ G P+
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223
Query: 398 TLFNVVGQ---PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
LF + + PLK PE S F KD + LVKDP+KR A E+ QHPF +
Sbjct: 224 ALFLITTKGIPPLKNPEKWSPEF--KDFLNKCLVKDPEKRP----SAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 11/109 (10%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKG-NGNRETLFN----- 401
+FVGT Y+APE I+G+ + D W+ G+ EL GR P+ N + +F
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
V P + P S +D + L+KDP++R +K E+ +HPF
Sbjct: 217 VNEPPPRLP-SGKFSPDFQDFVNLCLIKDPRERPSYK----ELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L+++G G G VY + A+K++D + ++ Q E +LS D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ Y + ++ME+ GG L + P E E+L L+YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RD+K NVL+ E G + L+DF ++
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 9/86 (10%)
Query: 189 LMEFCSGGDLH-TLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR 247
LME DLH + QP +E+ R++ ++L L+Y+H V++RDLKP N+LV
Sbjct: 89 LME----SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN 141
Query: 248 EDGHIMLSDFDLSLRCFVSPKLVQSS 273
ED + + DF ++ R S
Sbjct: 142 EDCELRIGDFGMA-RGLSSSPTEHKY 166
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPFL 173
+ ++G G G+VY R G L+A+KV+ + +R Q REI L ++HP +
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHF-SEQATRFYASEVLLALEYLHMM 232
+ F+ + +L+EF GG L G H EQ A ++L + YLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLHRR 187
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
+V+RD+KP N+L+ ++ ++DF +S
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 43/129 (33%), Positives = 54/129 (41%), Gaps = 33/129 (25%)
Query: 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP 406
V T Y APE++ G VD W G F ELL G F G + E L F +G P
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 407 L--------KFPEGSSISF-----------------AAKDLIRGLLVKDPQKRLGFKRGA 441
P+ + I+F A DL++GLLV DP KRL A
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL----SA 276
Query: 442 TEIKQHPFF 450
E +HP+F
Sbjct: 277 AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 17/161 (10%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
L + +L KLG G G VY A G + A+K K ++ K REI L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILKK 63
Query: 168 LDHP-FLPTL-----YSHFETDKFSCLLMEF---CSGGDLHTLRQRQPGKHFSEQATRFY 218
L HP +P + K + M DL L + P +E + Y
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH--DLSGLLE-NPSVKLTESQIKCY 120
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259
++L + YLH +++RD+K N+L+ G + ++DF L
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP 174
LK+LG G G V+L + R + A+K++ +G ++ + E +++ L HP L
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFI----EEAKVMMKLSHPNLV 62
Query: 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
LY + ++ E+ + G L + + GK +E S+V A+EYL G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-CSDVCEAMEYLESNGF 121
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV ED + +SDF L+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 39/151 (25%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMD--KGMLAGRKKLMRA-QTEREILSLLDHPFL 173
++LG G S Y A G L A+K + + + +++++ A + E +++ L+HP +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ D L +E+ +GG + H L + F E Y ++L L YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN 122
Query: 233 GVVYRDLKPENVLVREDGHIM-LSDFDLSLR 262
+++RD+K N+L+ G + ++DF + R
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 73/341 (21%), Positives = 128/341 (37%), Gaps = 105/341 (30%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK----KLMRAQT----- 160
L +F++ KK+G G VY A CL +D+ +A +K ++M A+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRAT-----CL-----LDRKPVALKKVQIFEMMDAKARQDCV 50
Query: 161 -EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRF 217
E ++L L+HP + F D +++E GDL + + ++ + E+
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110
Query: 218 YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPA 277
Y ++ A+E++H V++RD+KP NV + G + L D L
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG----------------- 153
Query: 278 CRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337
RF +SKTT S
Sbjct: 154 -----------------------------------RFFSSKTTAAHS------------- 165
Query: 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
L+ P Y++PE I +G+ D W+ G YE+ ++PF G++
Sbjct: 166 LVGTPY------------YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKM 211
Query: 398 TLFNVVG--QPLKFP--EGSSISFAAKDLIRGLLVKDPQKR 434
LF++ + +P S ++L+ + DP +R
Sbjct: 212 NLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 36/104 (34%), Positives = 51/104 (49%), Gaps = 7/104 (6%)
Query: 349 SFVGTHEYLAPEII-RG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406
+F GT +Y+APE+I +G G+G+ D W+ G E+ G+ PF G + VG
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF 227
Query: 407 LKFPE-GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
PE S+S AK+ I DP KR A ++ Q PF
Sbjct: 228 KIHPEIPESLSAEAKNFILRCFEPDPDKR----ASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 36/118 (30%), Positives = 60/118 (50%), Gaps = 13/118 (11%)
Query: 153 KKLMRA--------QTEREI--LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLR 202
KK+M+ +T RE+ L L H + +L F + + G DLH L
Sbjct: 41 KKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL 100
Query: 203 QRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+P +Q +++ ++L L+Y+H GVV+RDLKP N+L+ E+ + + DF L+
Sbjct: 101 TSRP---LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLD 169
+ +++ +G G G VY + G L A+K++D + E IL SL +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD----PISDVDEEIEAEYNILQSLPN 77
Query: 170 HPFLPTLYSHF-ETDKFS----CLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASEV 222
HP + Y F + DK L++E C+GG + L + G+ E +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LL L++LH +++RD+K N+L+ +G + L DF +S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 31/100 (31%), Positives = 57/100 (57%), Gaps = 8/100 (8%)
Query: 162 REILSLLDH--PFLPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRF 217
RE L+++ H P + L+ + ++ L+++ GG L H + + E+ +
Sbjct: 34 RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF----LNIPEECVKR 89
Query: 218 YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+A+E+++AL+ LH G+V RDL P N+L+ + GHI L+ F
Sbjct: 90 WAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 18/151 (11%)
Query: 148 MLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-----LR 202
ML ++ A++E L+ DH + + F++D L+ME+ SGGDL+ L+
Sbjct: 102 MLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 203 QRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
+ P + + E FY +++LAL+ +H +++RDLK N+ + G I L DF S
Sbjct: 162 EHLPFQEY-EVGLLFY--QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS-- 216
Query: 263 CFVSPKLVQSSDDPACRI-SSYCIQPSCIDP 292
Q SD + + SS+C P + P
Sbjct: 217 -------KQYSDSVSLDVASSFCGTPYYLAP 240
|
Length = 478 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 9/107 (8%)
Query: 349 SFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQP 406
+FVGT ++APE++ G+ D W+FGI EL G P+ + L + P
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP 224
Query: 407 LKFPEGSSI---SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
G+ S + + +I L KDP KR A E+ +H FF
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 5e-09
Identities = 36/134 (26%), Positives = 51/134 (38%), Gaps = 34/134 (25%)
Query: 350 FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQ 405
+V T Y APE++ A+D W+ G F ELL + F G + L V+G
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 406 P----LKFPEGSS-------------ISFA---------AKDLIRGLLVKDPQKRLGFKR 439
P LKF + A DL+ +LV DP+KR+
Sbjct: 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI---- 281
Query: 440 GATEIKQHPFFESV 453
A E HP+ +
Sbjct: 282 TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 7/118 (5%)
Query: 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFK 391
S L + T RS++ GT +++PE+I G+G+G D W+ G E+L + P+
Sbjct: 153 SKRLQTICMSGTGIRSVT--GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
Query: 392 GNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
+F + QP S IS A+D + + V+ + A E+ +HPF
Sbjct: 211 EYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARH-----RPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 4/148 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ L+KLG G +VY + + G L A+KV+ G A E +L L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP--FTAIREASLLKGLKHAN 64
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L+ T + L+ E+ DL + PG E + + ++L L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPEN-VKLFLFQLLRGLSYIHQR 122
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RDLKP+N+L+ + G + L+DF L+
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 35/103 (33%), Positives = 47/103 (45%), Gaps = 7/103 (6%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-L 407
S VGT ++APE+I G +A D W+ G ELL G P+ LF +V
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
PEG IS KD + KDP R A ++ +HP+
Sbjct: 218 PLPEG--ISPELKDFLMQCFQKDPNLRP----TAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 23/169 (13%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
DLG + L+ LGCG G V+ A D A+K K +L + + A E +I+
Sbjct: 2 DLG-SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIR 57
Query: 167 LLDHPFLPTLY------SHFETDKFS--------CLLMEFCSGGDLHTLRQRQPGKHFSE 212
LDH + +Y T+ ++ E DL + ++ P SE
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLEQGP---LSE 113
Query: 213 QATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-EDGHIMLSDFDLS 260
+ R + ++L L+Y+H V++RDLKP NV + ED + + DF L+
Sbjct: 114 EHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 33/130 (25%)
Query: 350 FVGTHEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF---NVVGQ 405
+V T Y APEI+ R + S VD W G EL R F G+ + L+ +V+G
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT 217
Query: 406 P----------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFKRG 440
P +FP+ + S A DLI+ +L DP+KR
Sbjct: 218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP----T 273
Query: 441 ATEIKQHPFF 450
A++ QHP+F
Sbjct: 274 ASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-NRETLFNVVGQPL 407
S VGT Y++PE I +G+ D W+ G YE+ ++PF G+ N +L + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-C 223
Query: 408 KFPEGSSISFAA--KDLIRGLLVKDPQKRL 435
+P + ++ +DL+ + DP+KR
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 34/87 (39%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQPL 407
SF GT YLAPE+ + D W+ G+ YELL PFKG RE + V+ G+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKR 434
FP S A L+ LL K+P R
Sbjct: 290 PFPCPVSSGMKA--LLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 10/151 (6%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+L +G G+ G V L + R G A+K + A + L A ++ L HP
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASV----MTTLRHP 60
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRF-YASEVLLALEYL 229
L L ++ E+ + G L LR R G+ A + +A +V +EYL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYL 118
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL NVLV ED +SDF L+
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 32/103 (31%), Positives = 42/103 (40%), Gaps = 38/103 (36%)
Query: 347 SMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+ VGT Y+APE++ G G+ D W+ G+ YEL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
PE KDLIR +L KDP+KR K EI +H
Sbjct: 188 ----PE-------LKDLIRKMLQKDPEKRPSAK----EILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 6/157 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDH 170
+ ++K+G G G VY + G + AMK K L ++ + + REI L L H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P + L + L+ EF S L G++ + + Y ++L + + H
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
V++RDLKP+N+L+ G I L+DF L+ R F P
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIP 154
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 9e-09
Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 24/179 (13%)
Query: 285 IQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTT---KVKSEKTSLTNSDSLPV---- 337
+ +C+D A VC E CLQ FL++ +KS+ L S+ +
Sbjct: 107 VTETCMDEAQIAAVCRE--CLQAL----EFLHANQVIHRDIKSDNVLLGMDGSVKLTDFG 160
Query: 338 LIAE--PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN 395
A+ P ++ + VGT ++APE++ +G VD W+ GI E++ G P+
Sbjct: 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
Query: 396 RETLFNVV--GQP-LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
L+ + G P L+ PE S F +D + L D +KR A E+ QHPF +
Sbjct: 221 LRALYLIATNGTPELQNPEKLSPIF--RDFLNRCLEMDVEKR----GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 6/155 (3%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM--DKGMLAGRKKLMRAQTEREILSLLD 169
++RL K LG G G VYL D G A+K + D K++ + E ++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 170 HPFLPTLYSHFE--TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
H + Y ++ + ME GG + Q + +E TR Y ++L +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD--QLKSYGALTENVTRKYTRQILEGVS 120
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
YLH +V+RD+K N+L G++ L DF S R
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 4/102 (3%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
S GT +++PE+I G+G+G D W+ G E+L + P+ +F + QP
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
S +S A++ +R V++ +KR A E+ +H F
Sbjct: 226 PQLPSHVSPDARNFLRRTFVENAKKR----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN-----------GNRE 397
+FVGT Y++PE I+G + D W+ GI EL LG+ PF + G +
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 398 TLFNVVGQPL-KFPEGSSISFAAKDLIRGLLVKDPQKR 434
L +V +P + P S +D + L+KDP +R
Sbjct: 221 LLQQIVQEPPPRLPS-SDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PL 407
S VGT ++APE+I +G+ VD W+ GI E++ G P+ + + + + P
Sbjct: 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP 235
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
K IS +D + +L ++PQ+R A E+ HPF
Sbjct: 236 KLKNAHKISPVLRDFLERMLTREPQER----ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVM-----DKGMLAGRKKLMRAQTEREILSLLDH 170
L+K+G G G+V+ A+ R+ + A+K + D+G+ + A E +L L H
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS------ALREICLLKELKH 58
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ LY +DK L+ E+C DL G + + + ++L L + H
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCH 116
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS------LRCF 264
V++RDLKP+N+L+ ++G + L+DF L+ +RC+
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMD-KGMLAGRKKLMRAQTEREILSLLDHPFLPTLY 177
LG G G+V A+ G FA+KV+D +GM K RAQ E + LL+ F +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK--NRAQAE--VCCLLNCDFFSIVK 95
Query: 178 SHFETDK----------FSCLLMEFCSGGDL-HTLRQR-QPGKHFSEQATRFYASEVLLA 225
H + K L++++ + GDL ++ R + + F E +VLLA
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ ++H +++RD+K N+L+ +G + L DF S
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 39/130 (30%), Positives = 54/130 (41%), Gaps = 33/130 (25%)
Query: 350 FVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF---NVVGQ 405
+V T Y APE++ GD G+ + VD W+ G F ELL R F G + LF +G
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT 217
Query: 406 P----------------LKFPEG---------SSISFAAKDLIRGLLVKDPQKRLGFKRG 440
P FP+ + S A DL+ +L DP KR+
Sbjct: 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI----T 273
Query: 441 ATEIKQHPFF 450
A + HP+F
Sbjct: 274 AEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 3/93 (3%)
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
D+P LY T K L+M++ GDL L +++ SE + +++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALND 124
Query: 229 LHMMGVVYRDLKPENVL-VREDGHIMLSDFDLS 260
LH +++ D+K ENVL R I L D+ L
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 13/99 (13%)
Query: 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG---NRETLFNVVGQPLKFPEG 412
Y APE+ A DWW+ G +ELL G+T + + N T N+ PE
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNI-------PE- 199
Query: 413 SSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFF 450
+S A+ L++ LL +P +RLG G +IK HPFF
Sbjct: 200 -WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 77/374 (20%), Positives = 127/374 (33%), Gaps = 108/374 (28%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQ---------TERE--IL 165
LG G G V A G + A+K + ++ R T RE I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 166 SLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
+ + H + L + F L+M+ + DL + R+ +E + ++L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRK--IRLTESQVKCILLQILNG 131
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCI 285
L LH ++RDL P N+ + G C+I+ + +
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKG--------------------------ICKIADFGL 165
Query: 286 QPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345
P + K +T + + E TS
Sbjct: 166 ARRYGYPP-----------YSDTLSK-----DETMQRREEMTSK---------------- 193
Query: 346 RSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FN 401
V T Y APE++ G + + AVD W+ G F ELL G+ F G + L F
Sbjct: 194 -----VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 402 VVGQP--------LKFPEGSSISFAAK---------------DLIRGLLVKDPQKRLGFK 438
++G P K P + + DL++ LL +P +R+
Sbjct: 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI--- 305
Query: 439 RGATEIKQHPFFES 452
A E +H +F+S
Sbjct: 306 -SAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-----LSLLDHPF 172
++G G G+VY A G A+K + + + + T RE+ L DHP
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSV---RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 173 LPTLY---SHFETDKFSCLLMEFCS-GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+ L + TD+ + + + F DL T + P + + + L L++
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LH +V+RDLKPEN+LV G + L+DF L+
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDK----GMLAGRK----KLMRAQTEREI 164
+R LK++G G G+V A R G A+K + + + A R +L++ +
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 165 LSLLDHPFLPTLYSHFETDKFS--CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
+ LLD F P L D+F L+M F G DL L + + SE +F ++
Sbjct: 77 IGLLD-VFTPDL----SLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQM 127
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L L+Y+H G+++RDLKP N+ V ED + + DF L+
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 5/150 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ L++++G G G VY A G L A+K++ L Q E ++ H
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ + + + + + ME+C GG L + SE + E L L YLH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK 125
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
G ++RD+K N+L+ ++G + L+DF ++ +
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 51/184 (27%), Positives = 70/184 (38%), Gaps = 55/184 (29%)
Query: 331 NSDS-LPVL---IAEPTSARSMSFVGTHEYLAPEIIRGDGHGS-AVDWWTFGIFFYELLL 385
N D L +L +A T +V T Y APEI+ H + VD W+ G ELL
Sbjct: 152 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 386 GRTPFKGNGNRETL---FNVVGQPLK-----------------------------FPEGS 413
G+T F G+ + + L N+VG P + F +
Sbjct: 212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGAN 271
Query: 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPE---IPKPV 470
+ A DL+ +LV DP KR+ A E HP+ H PE + P
Sbjct: 272 PL---AIDLLEKMLVLDPDKRI----TAAEALAHPYLAEY--------HDPEDEPVAPPY 316
Query: 471 DLSF 474
D SF
Sbjct: 317 DQSF 320
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 42/148 (28%), Positives = 59/148 (39%), Gaps = 8/148 (5%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLF---AMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173
KKLG G G V E G A+K + L+ + E I+ LDH L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENL 58
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
LY T ++ E G L LR+ G HF YA ++ + YL
Sbjct: 59 IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYLESK 116
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N+L+ D + + DF L
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 24/154 (15%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD------KGMLAGRKKLMRAQTEREILS 166
+ +K+G G G+VY A G A+K M+ K ++ +MR I++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGG---DLHTLRQRQPGKHFSEQATRFYASEVL 223
LD S+ D+ ++ME+ +GG D+ T G+ + E L
Sbjct: 81 YLD--------SYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECL 125
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
ALE+LH V++RD+K +N+L+ DG + L+DF
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 4/145 (2%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
L+KLG G +VY R G L A+KV+ M A E +L L H +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVIS--MKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ T + + E+ DL + PG R + ++L L Y+H ++
Sbjct: 68 LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIHGQHIL 125
Query: 236 YRDLKPENVLVREDGHIMLSDFDLS 260
+RDLKP+N+L+ G + L+DF L+
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 13/160 (8%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F+ L+KLG G +VY R G + A+K + G A E ++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS--TAIREISLMKELKHEN 59
Query: 173 LPTLYSHFETDKFSCLLMEFCSGG-----DLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
+ L+ T+ L+ E+ D H +R + + ++L +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD-----PNTVKSFTYQLLKGIA 114
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
+ H V++RDLKP+N+L+ + G + L+DF L+ R F P
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIP 153
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 38/127 (29%), Positives = 55/127 (43%), Gaps = 29/127 (22%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQ 405
S V T Y APE++ + + VD W+ G F EL R F+G + L F+V+G
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224
Query: 406 PLK-------------FPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKRGATE 443
P + FP + SF DL++ +L +P KR+ A E
Sbjct: 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI----SAFE 280
Query: 444 IKQHPFF 450
QHP+F
Sbjct: 281 ALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHP 171
+ +++ +G G G V+ + G A+K++D + + E IL +L DHP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILKALSDHP 75
Query: 172 FLPTLYS-HFETDKFS----CLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASEVLL 224
+ Y +++ D + L++E C+GG + L + + G+ E + E L+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L++LH+ ++RD+K N+L+ +G + L DF +S
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---D 169
++ ++K+G G G VY A + G + A+K K L + + + REI SLL +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK---KIRLETEDEGVPSTAIREI-SLLKELN 56
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HP + L ++ L+ EF DL P + Y ++L + Y
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
H V++RDLKP+N+L+ +G + L+DF L+ R F P
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVP 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM--DKGMLAGRKKLMRAQTEREILSLLDH 170
+R K LG G G VYL D G A K + D K++ + E ++L L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 171 PFLPTLYSHFE--TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+ Y +K + ME+ GG + Q + +E TR Y ++L + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD--QLKAYGALTESVTRKYTRQILEGMSY 121
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
LH +V+RD+K N+L G++ L DF S R
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 6e-08
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 285 IQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTT---KVKSEKTSLTNSDSLPV---- 337
+ +C+D VC E CLQ FL+S +KS+ L S+ +
Sbjct: 107 VTETCMDEGQIAAVCRE--CLQAL----DFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 160
Query: 338 LIAE--PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN 395
A+ P ++ + VGT ++APE++ +G VD W+ GI E++ G P+
Sbjct: 161 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
Query: 396 RETLFNVV--GQP-LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
L+ + G P L+ PE S F +D + L D +R A E+ QHPF +
Sbjct: 221 LRALYLIATNGTPELQNPERLSAVF--RDFLNRCLEMDVDRR----GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVM----DKGMLAGRKKLMRAQTEREILSLLDHP 171
L +G G G V + ++ G + A+K D M+ +K MR E +L L H
Sbjct: 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV--KKIAMR---EIRMLKQLRHE 60
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L L F K L+ EF L L + G E R Y ++L +E+ H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHS 118
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
+++RD+KPEN+LV + G + L DF
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKK--LMRAQTEREILSLLDH 170
L ++G G G VY + G + A+K M + K LM +L D
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV---VLKSHDC 73
Query: 171 PFLPTLYSHF--ETDKFSCL-LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
P++ Y +F ++D F C+ LM C L L +R G E ++ AL
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTC----LDKLLKRIQGP-IPEDILGKMTVAIVKALH 128
Query: 228 YL---HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
YL H GV++RD+KP N+L+ G++ L DF +S R
Sbjct: 129 YLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 9e-08
Identities = 39/145 (26%), Positives = 54/145 (37%), Gaps = 43/145 (29%)
Query: 345 ARSMSFVG---------THEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNG 394
AR + T Y PE++ G G VD W+ G EL LG+ F+G+
Sbjct: 147 ARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206
Query: 395 NRETL---FNVVGQP----------------LKFPE----------GSSISFAAKDLIRG 425
E L F + G P LK + I +A DL+
Sbjct: 207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266
Query: 426 LLVKDPQKRLGFKRGATEIKQHPFF 450
LL DP+KR+ A + QH +F
Sbjct: 267 LLTLDPKKRI----SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 35/111 (31%), Positives = 57/111 (51%), Gaps = 9/111 (8%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T A+ + +GT ++APE+I+ G+ + D W+ GI E+ G+ P+ +F +
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
Query: 403 VGQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+P L PE S F D ++ LVKDP++R A ++ QHPF
Sbjct: 212 PNKPPPTLSDPEKWSPEF--NDFVKKCLVKDPEER----PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 7/112 (6%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
P ++ + VGT ++APE++ +G VD W+ GI E++ G P+ L+
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 402 VV--GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
+ G P + +S +D + L D +KR A E+ QHPF +
Sbjct: 227 IATNGTP-ELQNPEKLSAIFRDFLNRCLEMDVEKRG----SAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
L+KLG G +V+ + L A+K + G A E +L L H + T
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVT 68
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMG 233
L+ TDK L+ E+ L+Q G S + + ++L L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
V++RDLKP+N+L+ E G + L+DF L+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 13/99 (13%)
Query: 175 TLYSHFETDKFSCLLMEFCSGGDLHTLR-------------QRQPGKHFSEQATRFYASE 221
TL H + + LL F S + Q+ G SE ++ +
Sbjct: 66 TLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ 125
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+L L+Y+H G+++RDLKP N+ V ED + + DF L+
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 40/145 (27%), Positives = 60/145 (41%), Gaps = 2/145 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L+++G G G+VY A + A+K M +K E L L HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ + + L+ME+C G L + E A L L YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA--ICHGALQGLAYLHSH 134
Query: 233 GVVYRDLKPENVLVREDGHIMLSDF 257
++RD+K N+L+ E G + L+DF
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 40/140 (28%), Positives = 59/140 (42%), Gaps = 37/140 (26%)
Query: 356 YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPF-KGNGNRETL---FNVVGQP---- 406
Y APE++ G H G VD W+ G F ELLL R PF G+ + + L F +G P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 407 ----------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
++F A DL++ LL +P KR+ A + +H
Sbjct: 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI----TARQALEH 282
Query: 448 PFFESVNWALIRSTHPPEIP 467
P+F + T P ++P
Sbjct: 283 PYFSN----DPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
R S VGT ++APE+I +G VD W+ GI E++ G P+ + + +
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231
Query: 406 -PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
P K +S + K + LLV+DP +R A E+ +HPF
Sbjct: 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQR----ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 285 IQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTT---KVKSEKTSLTNSDSLPV---- 337
+ +C+D VC E CLQ FL+S +KS+ L S+ +
Sbjct: 108 VTETCMDEGQIAAVCRE--CLQAL----EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 338 LIAE--PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN 395
A+ P ++ + VGT ++APE++ +G VD W+ GI E++ G P+
Sbjct: 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
Query: 396 RETLFNVV--GQP-LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
L+ + G P L+ PE S F +D + L D +KR A E+ QH F +
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIF--RDFLNRCLDMDVEKR----GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 22/177 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLDH 170
F + +LG G+ G V + + G + A K++ + K +R Q RE +L +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNS 62
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL- 229
P++ Y F +D + ME GG L + + K E+ + VL L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLR 120
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS-------------LRCFVSPKLVQSS 273
+++RD+KP N+LV G I L DF +S R ++SP+ +Q +
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 21/179 (11%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAEL----RDMGCLFAMKVMDKGMLAGRKKLMRAQTER 162
+L L R +++LG G +Y L D L A+K + + ++ Q E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEA 58
Query: 163 EILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQP----GKHFSEQAT-- 215
+++ L HP + L ++ C+L E+ + GDLH L R P G E T
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 216 --------RFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266
A ++ +EYL V++DL N+L+ E H+ +SD LS + +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 64/252 (25%), Positives = 91/252 (36%), Gaps = 86/252 (34%)
Query: 205 QPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263
G E A ++ ALEYLH + V++RD+KP NVL+ +G + L DF
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG----- 149
Query: 264 FVSPKLVQS---SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTT 320
+S LV S + D C+ Y + P I+P LN K
Sbjct: 150 -ISGYLVDSVAKTIDAGCK--PY-MAPERINPE---------------------LNQKGY 184
Query: 321 KVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFF 380
VKS+ SL + +I T G Y D W
Sbjct: 185 DVKSDVWSLGIT-----MIELAT--------GRFPY---------------DSW------ 210
Query: 381 YELLLGRTPFKGNGNRETLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR 439
+TPF + L VV + P S +D + L K+ ++R +
Sbjct: 211 ------KTPF------QQLKQVVEEPSPQLPAE-KFSPEFQDFVNKCLKKNYKERPNY-- 255
Query: 440 GATEIKQHPFFE 451
E+ QHPFFE
Sbjct: 256 --PELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 9/151 (5%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLDH 170
F L +LG G+ G V R G + A K++ + K +R Q RE +L +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNS 58
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P++ Y F +D + ME GG L + ++ E + VL L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLR 116
Query: 231 -MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RD+KP N+LV G I L DF +S
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
LK+LG G G V + R + A+K++ +G ++ + + A+ ++ L H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAK----VMMKLSHE 59
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L LY + ++ E+ S G L R+ GK F +V + YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNY-LREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV + G + +SDF LS
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 112 HFRLLKKLGCGDIGSVYLA-ELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-----L 165
+ + ++G G G V+ A +L++ G A+K + + ++ M T RE+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 166 SLLDHPFLPTLY---SHFETDKFSCLLMEFCS-GGDLHTLRQRQPGKHFSEQATRFYASE 221
+HP + L+ + TD+ + L + F DL T + P + + +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+L L++LH VV+RDLKP+N+LV G I L+DF L+
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 40/144 (27%), Positives = 58/144 (40%), Gaps = 37/144 (25%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
+ ++ +V T Y APE++ GD +G VD W G ELL G F G+ + +
Sbjct: 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209
Query: 398 TLF---NVVGQPL-----------------KFPEGSSI-----------SFAAKDLIRGL 426
L+ +G PL FPE S S A D ++
Sbjct: 210 QLYLIQKCLG-PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKAC 268
Query: 427 LVKDPQKRLGFKRGATEIKQHPFF 450
L DP++RL E+ QHP+F
Sbjct: 269 LRMDPKERL----TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 2/142 (1%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
L ++G G G+VY A + A+K M +K E + L L HP
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
+ + + L+ME+C G L + K E L L YLH ++
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 236 YRDLKPENVLVREDGHIMLSDF 257
+RD+K N+L+ E G + L+DF
Sbjct: 144 HRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
+K+LG G G V+L + R A+K +++G ++ + E +++ L HP L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFI----EEAKVMMKLSHPKLVQ 63
Query: 176 LYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
LY K ++ EF G L + LRQRQ S+ +V +EYL
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV G + +SDF ++
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 31/177 (17%)
Query: 112 HFRLLKKLGCGDIGSVYLAEL--RDMGCLFAMK----VMDKGMLAGRK----KLMRA-QT 160
+ L+K+LG G G V A A+K V K +LA R KL+R +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 161 EREILSL--LDHPF---LPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQA 214
+ I L +D F LY + E LME DLH +R QP ++
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEE-------LMEA----DLHQIIRSGQP---LTDAH 106
Query: 215 TRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271
+ + ++L L+Y+H V++RDLKP N+LV D + + DF L+ +P
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 31/113 (27%), Positives = 47/113 (41%), Gaps = 14/113 (12%)
Query: 349 SFVGTHEYLAPEII-----RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV 403
+F+GT ++APE++ + + + D W+ GI EL P L ++
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221
Query: 404 GQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453
L P S SF D ++ LVKDP R A E+ +HPF
Sbjct: 222 KSEPPTLDQPSKWSSSF--NDFLKSCLVKDPDDRP----TAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 44/168 (26%), Positives = 63/168 (37%), Gaps = 39/168 (23%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGS-AVDWWTFGIFFYELLLGRTPFKGNGNRE 397
+A T + +V T Y APE+I H + VD W+ G E+L G+ FKG+ + +
Sbjct: 164 LARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223
Query: 398 TL---FNVVGQPLK-----------------FPEGSSISFA---------AKDLIRGLLV 428
L V G P K P F A +++ +LV
Sbjct: 224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLV 283
Query: 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFIN 476
D + R+ A E HP+FE + E P P D SF
Sbjct: 284 LDAESRI----TAAEALAHPYFEEFH----DPEDETEAP-PYDDSFDE 322
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 4/148 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L +KLG G G V+ ++ A+K++ L K Q E + L L H
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKH 63
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
L +L++ + ++ E G L + G+ + A +V + YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N+LV ED ++DF L+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 38/132 (28%), Positives = 53/132 (40%), Gaps = 37/132 (28%)
Query: 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP 406
V T Y APE++ G +A+D W+ G F ELL + F G + L F ++G P
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226
Query: 407 ----------------------------LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
KFP S+S DL+ LL DP KR+
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRI--- 282
Query: 439 RGATEIKQHPFF 450
A + +HP+F
Sbjct: 283 -SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 47/185 (25%), Positives = 73/185 (39%), Gaps = 31/185 (16%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAEL---RDMGCL-FAMKVMDKGMLAGRKKLMRAQT-- 160
GH +KLG G G V+L E+ +D+ L F V L K++R
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 161 --------EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL------HTLRQRQ- 205
E +ILS L P + L + C++ E+ GDL H L ++
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 206 ----------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLS 255
S + A ++ ++YL + V+RDL N LV E+ I ++
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 256 DFDLS 260
DF +S
Sbjct: 181 DFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 8/146 (5%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-RKKLMRAQTEREILSLLDHPFLPT 175
+K+G G+ G VY L+ A+K + ++K ++ E EIL DHP +
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQ---EAEILKQYDHPNIVK 56
Query: 176 LYSHFETDKFSCLL-MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
L K + ME GG L T +++ + ++ + + + +EYL
Sbjct: 57 LIG-VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESKNC 114
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV E+ + +SDF +S
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 4/142 (2%)
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G+ G V+ L+D + A+K + + K ++ +E IL DHP + L
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKLIG 59
Query: 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238
+ ++ME GGD + +++ + ++Q +F A + + YL ++RD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-ALDAAAGMAYLESKNCIHRD 118
Query: 239 LKPENVLVREDGHIMLSDFDLS 260
L N LV E+ + +SDF +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 22/177 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLDH 170
F + +LG G+ G V+ + G + A K++ + K +R Q RE +L +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNS 62
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL- 229
P++ Y F +D + ME GG L + ++ G+ EQ + V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GR-IPEQILGKVSIAVIKGLTYLR 120
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS-------------LRCFVSPKLVQSS 273
+++RD+KP N+LV G I L DF +S R ++SP+ +Q +
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDH-PF 172
L+K+G G G VY A ++ G L A+K K L ++ + REI L +L +
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 173 LPTLYS--HFETDKFSCLL---MEFCSGGDLHT---LRQRQPGKHFSEQATRFYASEVLL 224
+ L H E L E+ DL R PG+ + + + ++L
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIM-LSDFDLSLRCFVSP 267
+ + H GV++RDLKP+N+LV + ++ ++D L R F P
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIP 164
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 2/145 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L+++G G G+VY A + A+K M +K E + L + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ + + L+ME+C G L + K E L L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH 144
Query: 233 GVVYRDLKPENVLVREDGHIMLSDF 257
+++RD+K N+L+ E G + L+DF
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 19/172 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMK-VMDKGMLAGRKKLMRAQ-TEREIL---SL 167
+ +L+KLG G G V+ A R + A+K + D A R AQ T REI+ L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD----AFRNA-TDAQRTFREIMFLQEL 63
Query: 168 LDHPFLPTLYSHF--ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
DHP + L + E DK L+ E+ DLH + + + R+ ++L A
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKA 119
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPA 277
L+Y+H V++RDLKP N+L+ D + L+DF L+ R L ++ ++P
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA-RSLSE--LEENPENPV 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 37/113 (32%), Positives = 50/113 (44%), Gaps = 10/113 (8%)
Query: 343 TSARSMSFVGTHEYLAPEII---RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
T A+ SF+GT ++APE+ R G+ D W GI EL + P L
Sbjct: 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213
Query: 400 FNV---VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
F + P K + S D I+ L KDP+KR AT++ QHPF
Sbjct: 214 FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR----PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 37/119 (31%), Positives = 54/119 (45%), Gaps = 14/119 (11%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---- 396
E ++ + +F GT Y+APE I+G + D W+ G+ E+ R PF G
Sbjct: 154 ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213
Query: 397 -ETLFNVVGQP---LKFPEGSSI--SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
E L +V P LK G+ I S KD I+ L KDP +R + +HP+
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD----MLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 6e-07
Identities = 49/192 (25%), Positives = 73/192 (38%), Gaps = 56/192 (29%)
Query: 327 TSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGS-AVDWWTFGIFFYELLL 385
+ L + PVL +V T Y APEI+ G + VD W+ G E+LL
Sbjct: 158 SELEENPENPVL---------TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 386 GRTPFKGNG--NR-ETLFNVVGQP-------LKFPEGSSI-------------------S 416
G+ F G N+ E + V+G P +K P +++ S
Sbjct: 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKAS 268
Query: 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFIN 476
A DL++ LLV +P KRL A E +HP+ + P D +
Sbjct: 269 DDALDLLKKLLVFNPNKRL----TAEEALEHPYVA-------------QFHNPSDEPVLP 311
Query: 477 HKQKTPIPQNDK 488
+ P+ N K
Sbjct: 312 YPITIPLDDNVK 323
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 188 LLMEFCSGGDLHTLRQRQPGK-HFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV 246
+ ME GG L L + + G +EQ FY ++L L+YLH +V+RD+K +NVLV
Sbjct: 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141
Query: 247 RE-DGHIMLSDFDLSLR 262
G + +SDF S R
Sbjct: 142 NTYSGVVKISDFGTSKR 158
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 40/145 (27%), Positives = 60/145 (41%), Gaps = 2/145 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F L+++G G G+VY A + A+K M +K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ + + L+ME+C G L + K E L L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 233 GVVYRDLKPENVLVREDGHIMLSDF 257
+++RD+K N+L+ E G + L DF
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 25/99 (25%), Positives = 47/99 (47%), Gaps = 11/99 (11%)
Query: 343 TSARSMSFVGTHEYLAPEIIR-GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
S++ +FVGT ++APE+I G + + D W+ GI YE+ G P+ F
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFR 209
Query: 402 VV-----GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435
+ +P + + S ++ + L ++P++RL
Sbjct: 210 AMMLIPKSKPPRLE-DNGYSKLLREFVAACLDEEPKERL 247
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 28/103 (27%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
S GT +++PE+I G+G+G D W+ E+L + P+ +F + QP K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227
Query: 409 --FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
P+G +S A +D ++ + V++ ++ A + +HPF
Sbjct: 228 PMLPDG--VSDACRDFLKQIFVEEKRRPT-----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 4/145 (2%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
L KLG G +V+ + L A+K + G A E +L L H + T
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKNLKHANIVT 67
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ T++ L+ E+ L G S + + ++L L Y H ++
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125
Query: 236 YRDLKPENVLVREDGHIMLSDFDLS 260
+RDLKP+N+L+ E G + L+DF L+
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 42/173 (24%), Positives = 65/173 (37%), Gaps = 23/173 (13%)
Query: 111 GHFRLLKKLGCGDIGSVYLAE-------LRDMGCLFAMK-----VMDKGMLAGRKKLMRA 158
++KLG G G V+L E V K + R
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 159 QTERE--ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQP-------GK 208
+E ILS L P + L D C++ME+ GDL L++
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 209 HFSEQATRFY-ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+T Y A+++ + YL + V+RDL N LV ++ I ++DF +S
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 8/149 (5%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
L +LG G+ GSVY R G AMK + + K + E +IL P++
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVD 63
Query: 176 LYSHF--ETDKFSCLLMEFCSGGDLHTLR-QRQPGKHFSEQATRFYASEVLLALEYL-HM 231
Y F E + C ME+ G L L + E R V+ L++L
Sbjct: 64 FYGAFFIEGAVYMC--MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RD+KP NVLV +G + L DF +S
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 8/146 (5%)
Query: 118 KLGCGDIGSVY--LAELRDMGCLFAMKVMDKGM-LAGRKKLMRAQTEREILSLLDHPFLP 174
+LG G+ G V + ++R A+KV+ + R ++MR E EI+ LD+P++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMR---EAEIMHQLDNPYIV 58
Query: 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
+ E + L+ME SGG L+ + + +V + ++YL
Sbjct: 59 RMIGVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELM-HQVSMGMKYLEGKNF 116
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL NVL+ + +SDF LS
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 36/138 (26%), Positives = 56/138 (40%), Gaps = 33/138 (23%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL- 399
+ + + V T Y PE++ G+ + +AVD W G F E+ R +G + + L
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 400 --FNVVGQPLK--FPEGSS-------ISFAAK----------------DLIRGLLVKDPQ 432
F + G P + +P S SF DL+ LL DP
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 433 KRLGFKRGATEIKQHPFF 450
KRL A++ +HP+F
Sbjct: 298 KRL----TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 5/147 (3%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173
+LL+KLG G G V+ L + A+K + G + + L AQ I+ L HP L
Sbjct: 9 QLLRKLGAGQFGEVW-EGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ----IMKKLRHPKL 63
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
LY+ ++ ++ E G L Q G+ A++V + YL
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL NVLV E+ ++DF L+
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 7/99 (7%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
+GT Y+APE+ +G + D W+ G YE+ PF+ ++ + V K+P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYP 219
Query: 411 EGSSI-SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
I S ++ IR +L P+ R +I P
Sbjct: 220 PIPPIYSQDLQNFIRSMLQVKPKLRP----NCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 37/115 (32%), Positives = 52/115 (45%), Gaps = 15/115 (13%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF-KGNGNRETLFN------ 401
++VGT+ Y+APE I G+ +G D W+ GI F EL LGR P+ + N+ +L
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211
Query: 402 -VVGQPLKFPEGS-SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454
V P P G S F I + K P++R + HPF N
Sbjct: 212 IVDEDPPVLPVGQFSEKFV--HFITQCMRKQPKERP----APENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 5/104 (4%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PL 407
S VGT ++APE+I +G+ VD W+ GI E++ G P+ + + + P
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
+ + +S + + +LV++P +R A E+ QHPF +
Sbjct: 237 RVKDSHKVSSVLRGFLDLMLVREPSQR----ATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 29/105 (27%), Positives = 47/105 (44%), Gaps = 7/105 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV-VG 404
+SM GT ++APE+I G+G D W+ G +E+ G+ P +F +
Sbjct: 166 KSMH--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
+ L S S AA D + L +D +R A ++ +H F
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHER----PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKK--LMRAQTERE 163
G + F ++ ++G G G VY A +D G L A+K K L K+ + A E +
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIK 58
Query: 164 ILSLLDHPFLPTLYS---------HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQA 214
IL L+H + L F+ DK + L+ DL L + HFSE
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDH 117
Query: 215 TRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ + ++L L Y H ++RD+K N+L+ G I L+DF L+
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKV--MDKGMLAGRKKLMRAQTEREILSLLD- 169
F L ++G G G VY A G + A+K MD + + + REI LL+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-----ERDGIPISSLREITLLLNL 63
Query: 170 -HPFLPTLY-----SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
HP + L H ++ F L+ME+C DL +L P FSE + ++L
Sbjct: 64 RHPNIVELKEVVVGKHLDS-IF--LVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQLL 118
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
L+YLH +++RDLK N+L+ + G + ++DF L+ R + P
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA-RTYGLP 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 116 LKKLGCGDIGSV---YLAELRDMGCLFAMKVMDKGMLAGRK-----KLMRAQTEREILSL 167
L +G G GSV Y LR + + + ++ R+ +L++ ++ L
Sbjct: 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 168 LDHPFLP-TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
LD F P T +F LM G DL+ + + Q S++ +F ++L L
Sbjct: 80 LD-VFTPATSIENFNEVYLVTNLM----GADLNNIVKCQ---KLSDEHVQFLIYQLLRGL 131
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+Y+H G+++RDLKP NV V ED + + DF L+
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKK------- 154
K DG+ L + ++KK+G G G V+L + + F K + L R+K
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV 63
Query: 155 -LMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQ---RQPGKHF 210
+MR + I+ +D FL + ++ +LMEFC GDL Q + GK
Sbjct: 64 NVMRELKHKNIVRYIDR-FLN------KANQKLYILMEFCDAGDLSRNIQKCYKMFGK-I 115
Query: 211 SEQATRFYASEVLLALEYLHMMG-------VVYRDLKPENVLV 246
E A ++L AL Y H + V++RDLKP+N+ +
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
|
Length = 1021 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 8/147 (5%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
L KLG G +VY + L A+K + G A E +L L H + T
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVT 68
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASEVLLALEYLHMMG 233
L+ T+K L+ E+ L+Q G + + + ++L L Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
V++RDLKP+N+L+ E G + L+DF L+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 38/131 (29%), Positives = 51/131 (38%), Gaps = 37/131 (28%)
Query: 353 THE-----YLAPEIIRGDGHGS-AVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
THE Y APEI+ G S VD W+ G F E++ R F G+ + L F +
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216
Query: 404 GQP---------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFKR 439
G P FP+ + DL+ +LV DP KR+ K
Sbjct: 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276
Query: 440 GATEIKQHPFF 450
QHP+F
Sbjct: 277 AL----QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMD------KGMLAGRKKLMRAQTEREILSLLD 169
+K+G G G+VY A G A++ M+ K ++ +MR I++ LD
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
S+ D+ ++ME+ +GG L + E E L ALE+L
Sbjct: 85 --------SYLVGDEL-WVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFL 132
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDF 257
H V++RD+K +N+L+ DG + L+DF
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 112 HFRLLKKLGCGDIGSVYLAE---LRD-MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
H + +++LG G+ GSV L L+D G + A+K + + L + E EIL
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKS 61
Query: 168 LDHPFLPTLYSHFETDKFSC---------LLMEFCSGGDLHTLRQRQPGKHFSEQATRFY 218
L H + K C L+ME+ G L Q+ + + Y
Sbjct: 62 LQHDNIVKY-------KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHRKLLLY 113
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
AS++ +EYL V+RDL N+LV + + + DF L+
Sbjct: 114 ASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 40/164 (24%), Positives = 62/164 (37%), Gaps = 21/164 (12%)
Query: 115 LLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLA-GRKKLMRAQTEREILSLL 168
L ++LG G G V+L E + L A+K + + RK R E E+L+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTNF 65
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LR-----------QRQPGKHFSEQATR 216
H + Y ++ E+ GDL+ LR P +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 217 FYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A ++ + YL V+RDL N LV D + + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE--------RE--IL 165
L KLG G +VY + G L A+K + R + E RE +L
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKEI------------RLEHEEGAPFTAIREASLL 57
Query: 166 SLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
L H + TL+ T K L+ E+ DL G S R + ++L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGG-LSMHNVRLFLFQLLRG 115
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L Y H V++RDLKP+N+L+ E G + L+DF L+
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 6/147 (4%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173
L++++G G G V+L L KV K + G E +++ L HP L
Sbjct: 7 TLVQEIGSGQFGLVWLGYW-----LEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL 61
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
LY CL+ EF G L + Q GK FS++ +V + YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN 120
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
V++RDL N LV E+ + +SDF ++
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 1/86 (1%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+F GT Y+APEI R + D ++ G+ YELL + PF G E + +
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKR 434
P SIS ++++ LL DP++R
Sbjct: 264 -PLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 21/161 (13%)
Query: 118 KLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+LG G G V+LAE ++ L A+K + + + R+ R E E+L++L H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQH 68
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF------------YA 219
+ Y + ++ E+ GDL+ LR P A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
S++ + YL + V+RDL N LV + + + DF +S
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 33/172 (19%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK---------KLMRAQT------- 160
+KLG G G V+L E M K MDK K++R
Sbjct: 11 EKLGEGQFGEVHLCEAEGM-----EKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 161 ---EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAT-- 215
E +I+S L P + L + T C++ E+ GDL+ R + +E+A
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 216 -------RFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
F A+++ ++YL + V+RDL N LV ++ I ++DF +S
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 4e-06
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMD------KGMLAGRKKLMRAQTEREILSLLD 169
+K+G G G+VY A G A+K M+ K ++ +MR I++ LD
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
S+ D+ ++ME+ +GG L + E E L AL++L
Sbjct: 84 --------SYLVGDEL-WVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFL 131
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDF 257
H V++RD+K +N+L+ DG + L+DF
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 44/158 (27%), Positives = 60/158 (37%), Gaps = 40/158 (25%)
Query: 348 MSFVGTHEYLAPE-IIRGDGHGSAVDWWTFGIFFYELLLGRTP-FKGNG--NRETLF-NV 402
+V T Y APE ++ + +A+D W+ G F E LLGR P F G ++ L +
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE-LLGRKPLFPGKDYVHQLKLITEL 224
Query: 403 VGQP----LKF-------------PEGSSISFAAK---------DLIRGLLVKDPQKRLG 436
+G P L F P SFA DL+ +LV DP KR+
Sbjct: 225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI- 283
Query: 437 FKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSF 474
E HP+ S L + P P F
Sbjct: 284 ---TVEEALAHPYLAS----LHDPSDEPVCQTPFSFDF 314
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 7/149 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCL-FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+L +KLG G G V++ G A+K + G ++ L AQ I+ L H
Sbjct: 8 LKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTMSPEAFLQEAQ----IMKKLRHD 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L LY+ ++ ++ E+ S G L + GK A+++ + YL
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N+LV E+ ++DF L+
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 47/183 (25%), Positives = 70/183 (38%), Gaps = 29/183 (15%)
Query: 113 FRLLKKLGCGDIGSVYLAEL--RDMGCLFAMKVM--DKGMLAGRKKLMRAQTEREI--LS 166
+ + +G G G VY A+ G +A+K DK G + REI L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG----ISQSACREIALLR 57
Query: 167 LLDHPFLPTLYSHFETDKFSC--LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV-- 222
L H + +L F LL ++ ++ H + S V
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-----HRQAKRVSIPPSMVKS 112
Query: 223 -----LLALEYLHMMGVVYRDLKPENVLV----REDGHIMLSDFDLSLRCFVSPKLVQSS 273
L + YLH V++RDLKP N+LV E G + + D L+ R F +P +
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFNAPLKPLAD 171
Query: 274 DDP 276
DP
Sbjct: 172 LDP 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 35/113 (30%), Positives = 50/113 (44%), Gaps = 12/113 (10%)
Query: 345 ARSMSFVGTHEYLAPEII---RGDGHGSAVDWWTFGIFFYELLLGRTPF-KGNGNRETLF 400
A++ G Y+APE I DG+ D W+ GI YE+ G+ P+ K N + L
Sbjct: 163 AKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT 221
Query: 401 NVV-GQPLKFPEGSSISFAA--KDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
VV G P F+ + I L+KD KR +K + +HPF
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE----LLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 22/171 (12%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAM---KVMDKGMLAGRKKLMRAQT-------- 160
RL +KLG G G V+L E + + + +L K L T
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 161 -EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHF-------- 210
E +I+S L +P + L +D C++ E+ GDL+ L QR+ F
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 211 -SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
S + A ++ ++YL + V+RDL N LV I ++DF +S
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 38/110 (34%), Positives = 53/110 (48%), Gaps = 15/110 (13%)
Query: 349 SFVGTHEYLAPEIIRGD-GHGS----AVDWWTFGIFFYELLLGRTPFK--GNGNRETLFN 401
S VGT Y++PE I D HG+ A D W+ G+ E LGR PF G+ +L
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC 286
Query: 402 VV--GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
+ QP + P +S F + I L ++P KR A ++ QHPF
Sbjct: 287 AICMSQPPEAPATASREF--RHFISCCLQREPAKR----WSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 33/126 (26%), Positives = 53/126 (42%), Gaps = 8/126 (6%)
Query: 140 AMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-DKFSCLLMEFCSGGDL 198
A+K++ + R + E + + L HP + L E + E+ G
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG--- 63
Query: 199 HTLRQR-QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIML 254
TLR+ T +VL AL H G+V+RDLKP+N++V + G H +
Sbjct: 64 RTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKV 123
Query: 255 SDFDLS 260
DF +
Sbjct: 124 LDFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 40/148 (27%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 117 KKLGCGDIGSVY--LAELRDMGCLFAMKVM--DKGMLAGRKKLMRAQTEREILSLLDHPF 172
+LG G+ G+V + +++ A+K++ D A + +L+R E ++ LD+P+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---EANVMQQLDNPY 57
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ + E + + L+ME G L+ Q+ KH +E+ +V + ++YL
Sbjct: 58 IVRMIGICEAESW-MLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET 114
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL NVL+ + +SDF LS
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 6/148 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
RL KLG G G V++ + A+K + G + L AQ I+ L H
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQEAQ----IMKKLRHDK 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
L LY+ + ++ EF G L + GK+ A+++ + Y+ M
Sbjct: 63 LVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL+ N+LV ++ ++DF L+
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 35/131 (26%), Positives = 54/131 (41%), Gaps = 36/131 (27%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
THE Y APE++ G H + VD W+ G F E+ + F G+ + L F ++
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 404 GQPLK--------------FPEGS---------SISFAAKDLIRGLLVKDPQKRLGFKRG 440
G P + FP+ +S DL++ +L DP KR+
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI----S 284
Query: 441 ATEIKQHPFFE 451
A HP+F+
Sbjct: 285 AKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 46/180 (25%), Positives = 71/180 (39%), Gaps = 38/180 (21%)
Query: 106 GDLGLGHF-RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE- 163
D+G G F R+ + G L + A+K++ + A M+A +RE
Sbjct: 11 RDIGQGAFGRVFQARAPG------LLPYEPF-TMVAVKMLKEEASAD----MQADFQREA 59
Query: 164 -ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFY--- 218
+++ DHP + L K CLL E+ + GDL+ LR R P +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSP--RAQCSLSHSTSSA 117
Query: 219 ------------------ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A +V + YL V+RDL N LV E+ + ++DF LS
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 28/86 (32%), Positives = 39/86 (45%), Gaps = 1/86 (1%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+ VGT Y++PE+ +G + D W G YELL + F N L + Q
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNY 218
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKR 434
P S S L+ LL +DP+KR
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 33/107 (30%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T + +FVGT ++APE+I+ + S D W+ GI EL G P LF +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
G S K+ I L KDP F+ A E+ +H F
Sbjct: 214 PKNNPPTLTG-EFSKPFKEFIDACLNKDP----SFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 25/102 (24%), Positives = 46/102 (45%), Gaps = 5/102 (4%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
S GT +++PE+I G+G+G D W+ G E+L + P+ +F + QP
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 226
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
+S +D ++ + V+ + A E+ +H F
Sbjct: 227 NPVLPPHVSDHCRDFLKRIFVEAKL-----RPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 22/165 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-----REILSL 167
+L K LG G+ GSV +L +KV K M K + +E E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQ-LKVAVKTM----KLDIHTYSEIEEFLSEAACM 55
Query: 168 --LDHPFLPTLY------SHFETDKFSCLLMEFCSGGDLHT--LRQRQPG--KHFSEQAT 215
DHP + L S + +++ F GDLH+ L R G + Q
Sbjct: 56 KDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL 115
Query: 216 RFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ ++ L +EYL ++RDL N ++RED + ++DF LS
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 161 EREILSLLDHPFLPTLYSHFETDKFSCLLM-EFCSGGDLHTLRQRQPGKHFSEQATRFYA 219
E +L L HP + L +CL++ ++ S DL+T + Q T A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAV-A 266
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265
++L A++Y+H G+++RD+K ENVLV I L DF + CF
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA--CFA 310
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 17/105 (16%)
Query: 160 TEREILSLLDHPFLPTLYSHFETDKFSCLLME------FCSGGDLHTLRQRQP-GKHFSE 212
TE IL ++HP + L F +KF+CL++ +C ++ +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA----KRNIAICDILAI 187
Query: 213 QATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+ + VL A++YLH +++RD+K EN+ + G + L DF
Sbjct: 188 ERS------VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 40/143 (27%), Positives = 58/143 (40%), Gaps = 36/143 (25%)
Query: 341 EPTSARSMSF-VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
EP ++ M+ V T Y APEI+ G H SAVD W+ G F ELL R F+ +
Sbjct: 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213
Query: 399 L---FNVVGQP--------------------LKFPEGSSI-------SFAAKDLIRGLLV 428
L +++G P K P + + A L+ +LV
Sbjct: 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLV 273
Query: 429 KDPQKRLGFKRGATEIKQHPFFE 451
DP KR+ A + HP+ +
Sbjct: 274 FDPDKRI----SAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 34/147 (23%), Positives = 65/147 (44%), Gaps = 5/147 (3%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173
+L+KKLG G G V++ + + KV K + G + E ++ L H L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNN-----STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
LY+ ++ ++ E+ + G L + G +++++ + Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL+ NVLV E ++DF L+
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 36/110 (32%), Positives = 54/110 (49%), Gaps = 18/110 (16%)
Query: 162 REI--LSLLDHP--------FLPTLYSHFETDKFSCL-LMEFCSGGDLHTLRQRQPGKHF 210
REI L LL HP LP F+ D + LME DLH + +
Sbjct: 48 REIKLLRLLRHPDIVEIKHIMLPPSRREFK-DIYVVFELME----SDLHQVIK--ANDDL 100
Query: 211 SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ + +F+ ++L AL+Y+H V +RDLKP+N+L D + + DF L+
Sbjct: 101 TPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 3/90 (3%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
A ++ VGT YL+PE+ + D W G+ YE G+ PF N N+ L +
Sbjct: 158 ANTI--VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKII 214
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434
+ + P S LI L KD ++R
Sbjct: 215 RGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 11/106 (10%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF---KGNGNRETLFNVVG-- 404
+GT ++APE++RG+ +G + D W+ G E+ + P+ K + + +F +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
PE +S +D+ L P+ + + E+ +HP F
Sbjct: 228 TAPSIPE--HLSPGLRDVTLRCLELQPE----DRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 18/147 (12%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMD------KGMLAGRKKLMRAQTEREILSLLDH 170
+K+G G G+V+ A G A+K ++ K ++ +M+ I++ LD
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD- 83
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
S D+ ++ME+ +GG L + E E L ALE+LH
Sbjct: 84 -------SFLVGDELF-VVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFLH 132
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDF 257
V++RD+K +NVL+ DG + L+DF
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 43/147 (29%), Positives = 56/147 (38%), Gaps = 40/147 (27%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
+A A +V T Y APE+I H VD W+ G E+L G+T FKG +
Sbjct: 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 398 TL---FNVVGQP-----------------------------LKFPEGSSISFAAKDLIRG 425
L V G P FP+ S A DL+
Sbjct: 223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQ---AVDLLEK 279
Query: 426 LLVKDPQKRLGFKRGATEIKQHPFFES 452
+L D KRL ATE +HP+F+S
Sbjct: 280 MLELDVDKRL----TATEALEHPYFDS 302
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 9/108 (8%)
Query: 154 KLMRAQTEREILSLLDHPFLP-TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSE 212
+L++ ++ LLD F P F LM G DL+ + + Q ++
Sbjct: 68 RLLKHMKHENVIGLLD-VFTPARSLEEFNDVYLVTHLM----GADLNNIVKCQ---KLTD 119
Query: 213 QATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+F ++L L+Y+H +++RDLKP N+ V ED + + DF L+
Sbjct: 120 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
RL KLG G G V++ A+K + G ++ L AQ ++ L H
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQ----VMKKLRHEK 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
L LY+ + ++ E+ S G L + + GK+ A+++ + Y+ M
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL+ N+LV E+ ++DF L+
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 30/170 (17%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL------ 168
L K LG G G V AE + ++ K L TE+++ L+
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDN------PNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 169 ----DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQP--------GKHFSEQAT 215
H + L + +++E+ + G+L LR R+P E+
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 216 RFY-----ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A +V +E+L ++RDL NVLV ED + ++DF L+
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 62/271 (22%), Positives = 104/271 (38%), Gaps = 30/271 (11%)
Query: 9 TNYDTESVTSISMHSVSFCSSSTVSGSDTSVSSNLSNATIEAKKGVDCLAHSEEESGKSS 68
+ D+ V+ +++ S G+DTS S + + + D L S++ + +
Sbjct: 3 CHTDSSKVSDSNINLGYEAIFSLTGGTDTSDSKDTTGDKFD---DCDELGDSDDVTHATD 59
Query: 69 LSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVY 128
+ + + C + D V+ + + +L L G G V+
Sbjct: 60 YDADEESLSPQTDVCQEPCETTSSS--DPASVVRMQ--------YNILSSLTPGSEGEVF 109
Query: 129 LAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188
+ G KV+ K + G+ E +IL + H + L + C+
Sbjct: 110 VCTKH--GDEQRKKVIVKAVTGGKT----PGREIDILKTISHRAIINLIHAYRWKSTVCM 163
Query: 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL-ALEYLHMMGVVYRDLKPENVLVR 247
+M DL T R G EQA LL AL YLH G+++RD+K EN+ +
Sbjct: 164 VMPKYKC-DLFTYVDRS-GPLPLEQA--ITIQRRLLEALAYLHGRGIIHRDVKTENIFLD 219
Query: 248 EDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278
E + +L DF + C KL D P C
Sbjct: 220 EPENAVLGDFGAA--C----KLDAHPDTPQC 244
|
Length = 392 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 19/37 (51%), Positives = 27/37 (72%)
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+VL L LH +G+V+RD+KPEN+LV DG + + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 37/139 (26%), Positives = 52/139 (37%), Gaps = 40/139 (28%)
Query: 345 ARSMS-FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL--- 399
A+ M+ V T Y APE++ G + +A+D W G ELL + G E L
Sbjct: 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
Query: 400 -----------------------FNVVGQPL-----KFPEGSSISFAAKDLIRGLLVKDP 431
F + QP KFP +S A L+ LL+ DP
Sbjct: 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP---WLSEAGLRLLNFLLMYDP 278
Query: 432 QKRLGFKRGATEIKQHPFF 450
+KR A E + +F
Sbjct: 279 KKRA----TAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 15/147 (10%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH--PFL 173
+K L G VYL +D + +K + R+K + E IL LL +
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLK-----INPSREKGADREREVAILQLLARKGLPV 55
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
P + + E+D +S LLME+ G L + + + + +EQ E+L L L ++
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEK-EDIAEQLA-----ELLAKLHQLPLLV 109
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
+ + DL P N+LV + + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 29/97 (29%), Positives = 45/97 (46%)
Query: 159 QTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFY 218
Q E + L +HP + + F D ++ F + G L SE A +
Sbjct: 47 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLS 255
VL AL+Y+H MG V+R +K ++L+ DG + LS
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 4/143 (2%)
Query: 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLY 177
KLG G G VY + A+K + + + + L A +EI HP L L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI----KHPNLVQLL 68
Query: 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYR 237
+ ++ EF + G+L + + + + A+++ A+EYL ++R
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 238 DLKPENVLVREDGHIMLSDFDLS 260
DL N LV E+ + ++DF LS
Sbjct: 129 DLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-05
Identities = 20/37 (54%), Positives = 23/37 (62%), Gaps = 1/37 (2%)
Query: 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKP 312
P+C S C QPSC P+C P C +PSC QPSC P
Sbjct: 4 PSCCQPSCC-QPSCCQPSCCQPSCCQPSCCQPSCCVP 39
|
Length = 45 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 38/131 (29%), Positives = 57/131 (43%), Gaps = 34/131 (25%)
Query: 350 FVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGN-------RETLFN 401
+V T Y APE++ GD +G VD W G F ELL G+ + G + R+TL +
Sbjct: 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD 219
Query: 402 VV--------------GQPLKFPEG--------SSISFAAKDLIRGLLVKDPQKRLGFKR 439
++ G + PE +IS A ++G L DP +RL
Sbjct: 220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL---- 275
Query: 440 GATEIKQHPFF 450
E+ +HP+F
Sbjct: 276 SCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T + +FVGT ++APE+I+ + D W+ GI EL G P LF +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
EG S K+ + L KDP+ F+ A E+ +H F
Sbjct: 214 PKNSPPTLEGQY-SKPFKEFVEACLNKDPR----FRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 45/169 (26%), Positives = 62/169 (36%), Gaps = 45/169 (26%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
+A T +V T Y APEI+ H VD W+ G ELL GRT F G + +
Sbjct: 166 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225
Query: 398 TL---FNVVGQP-----------------LKFPEGSSISFA---------AKDLIRGLLV 428
L +VG P + ++FA A DL+ +LV
Sbjct: 226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 285
Query: 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPE---IPKPVDLSF 474
D KR+ A + H +F H P+ + P D SF
Sbjct: 286 LDSDKRI----TAAQALAHAYFAQY--------HDPDDEPVADPYDQSF 322
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 19/162 (11%)
Query: 115 LLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L ++LG G G V+LAE ++ L A+K + RK R E E+L+ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQ 65
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-----------LRQRQPGKHFSEQATRFY 218
H + Y ++ E+ GDL+ + + ++
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A ++ + YL V+RDL N LV E+ + + DF +S
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 38/131 (29%), Positives = 56/131 (42%), Gaps = 37/131 (28%)
Query: 353 THE-----YLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV---V 403
THE Y APEI+ G + +AVD W+ G F E++ R F G+ + LF + +
Sbjct: 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 217
Query: 404 GQPLK---------------FPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKR 439
G P + FP+ + F+ +DL+ +L DP KR+ K
Sbjct: 218 GTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277
Query: 440 GATEIKQHPFF 450
HPFF
Sbjct: 278 ALA----HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 36/133 (27%), Positives = 54/133 (40%), Gaps = 37/133 (27%)
Query: 351 VGTHE-----YLAPEIIRGDGHGSA-VDWWTFGIFFYELLLGRTPFKGNGNRETLF---N 401
V THE Y APE++ G S VD W+ G F E+ + F G+ + LF
Sbjct: 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR 216
Query: 402 VVGQPLK---------------FPEGSSISFAAK---------DLIRGLLVKDPQKRLGF 437
++G P + FP+ S + DL+ +L+ DP KR+
Sbjct: 217 ILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA 276
Query: 438 KRGATEIKQHPFF 450
K+ HP+F
Sbjct: 277 KKALN----HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 40/164 (24%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLM-RAQTEREILSLL 168
+ + +++ +G G +G VYLA A+K + + L+ L R E +I + L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADL 59
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL----RQRQPGKHFSEQATRFYA----- 219
HP + +YS M + G L +L Q++ + T A
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263
++ +EY+H GV++RDLKP+N+L+ G +++ D+ ++
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
|
Length = 932 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 21/174 (12%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA----GRKKLMRAQTERE 163
L L L + +G G+ G+V E G A+K + + A +M +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN 60
Query: 164 ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEV 222
++ LL LY ++ME S G+L + LR R Q +F + +V
Sbjct: 61 LVRLLGVILHNGLY----------IVMELMSKGNLVNFLRTRGRALVSVIQLLQF-SLDV 109
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276
+EYL +V+RDL N+LV EDG +SDF L+ V V +S P
Sbjct: 110 AEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLAR---VGSMGVDNSKLP 160
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 36/144 (25%), Positives = 58/144 (40%), Gaps = 3/144 (2%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTL 176
+++G G+ G V+ LR A+K + + K + E IL HP + L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIVRL 58
Query: 177 YSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVY 236
+ ++ME GGD T + + G + +EYL ++
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 237 RDLKPENVLVREDGHIMLSDFDLS 260
RDL N LV E + +SDF +S
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 41/152 (26%), Positives = 61/152 (40%), Gaps = 10/152 (6%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD---KGMLAGRKKLMRAQ--TEREILSLL 168
+ K +G G+ G V L+ L K +D K + AG R TE I+
Sbjct: 7 TIEKVIGGGEFGEVCRGRLK----LPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
DHP + L + ++ E+ G L + GK Q + ++Y
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-LRGIASGMKY 121
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L M V+RDL N+LV + +SDF LS
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 2/97 (2%)
Query: 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
L+ P A + ++VGT Y+ PEI + + D W+ G YEL + PF+ N +
Sbjct: 149 LLTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
Query: 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434
+ V K P S S+ + LI+ + ++P+ R
Sbjct: 208 LILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 37/115 (32%), Positives = 51/115 (44%), Gaps = 14/115 (12%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAV-----DWWTFGIFFYELLLGRTPFKGNGNRE 397
T R +F+GT ++APE+I D A D W+ GI EL G+ P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225
Query: 398 TLFNVVGQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
LF + P LK PE S F D I L+K+ ++R E+ +HPF
Sbjct: 226 ALFKIPRNPPPTLKSPENWSKKF--NDFISECLIKNYEQR----PFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 32/107 (29%), Positives = 49/107 (45%), Gaps = 5/107 (4%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T + +FVGT ++APE+I+ + S D W+ GI EL G P + LF +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
EG + S K+ + L K+P F+ A E+ +H F
Sbjct: 214 PKNNPPTLEG-NYSKPLKEFVEACLNKEPS----FRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 34/141 (24%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEI-IRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--N 395
+A + +V T Y APEI + + VD W+ G F E+L G+ F G N
Sbjct: 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213
Query: 396 RETLF-NVVGQP-------------LKF----PEGSSISFA---------AKDLIRGLLV 428
+ ++ +++G P L+F P+ + F+ A DL+ +LV
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLV 273
Query: 429 KDPQKRLGFKRGATEIKQHPF 449
DPQKR+ A E HP+
Sbjct: 274 FDPQKRI----SAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 32/111 (28%), Positives = 46/111 (41%), Gaps = 11/111 (9%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSA----VDWWTFGIFFYELLLGRTPFKG-NGNRETL 399
A++ S G Y+APE I D W+ GI EL G+ P+K E L
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 400 FNVVGQ-PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
++ + P P S + L KD +KR ++ E+ QHPF
Sbjct: 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR----ELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 18/112 (16%)
Query: 160 TEREI--LSLLDHPFL--------PTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGK 208
T REI L LDH + P F LM+ DLH +R Q
Sbjct: 51 TLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQT-- 104
Query: 209 HFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
S+ +++ ++L L+Y+H V++RDLKP N+L+ + + + DF L+
Sbjct: 105 -LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 27/98 (27%), Positives = 43/98 (43%), Gaps = 4/98 (4%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
T R+ +GT Y APE +RG+ D + +G+ F E L G+ +G E
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEI 197
Query: 399 LFNVVG-QPLKFPEGSSI-SFAAKDLIRGLLVKDPQKR 434
L+ + + P I ++R L KDP++R
Sbjct: 198 LYQQLSPVDVSLP--PWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 38/134 (28%), Positives = 55/134 (41%), Gaps = 37/134 (27%)
Query: 353 THE-----YLAPEIIRGDGHGSA-VDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
THE Y APEI+ G H S VD W+ G F E++ + F G+ + L F ++
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220
Query: 404 GQPLK---------------FPEGSSISFAAK---------DLIRGLLVKDPQKRLGFKR 439
G P + FP+ A DL+ +L DP KR+ R
Sbjct: 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT-AR 279
Query: 440 GATEIKQHPFFESV 453
A E H +F+ +
Sbjct: 280 AALE---HEYFKDL 290
|
Length = 294 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 111 GHFRLLKKLGCGDIGSVY----LAELRDMGCLFAMKVM-DKGMLAGRKKLMRAQTEREIL 165
+K LG G G+VY + E + A+KV+ ++ K+++ E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD---EAYVM 63
Query: 166 SLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQ-RQPGKHFSEQATRFYASEVLL 224
+ +DHP + L + + L+ + G L L R + Q + ++
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+L+KKLG G G V++ + A+K + G ++ L AQ I+ L H
Sbjct: 8 LQLIKKLGNGQFGEVWMG-TWNGNTKVAVKTLKPGTMSPESFLEEAQ----IMKKLRHDK 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
L LY+ + ++ E+ S G L + G+ A++V + Y+ M
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL+ N+LV + ++DF L+
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 36/161 (22%), Positives = 58/161 (36%), Gaps = 38/161 (23%)
Query: 349 SFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGN---GNRETLFNVVG 404
+V T Y APE++ + +A+D W+ G F E+L R F G + + +V+G
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229
Query: 405 QP-----------------LKFPEGSSISFA---------AKDLIRGLLVKDPQKRLGFK 438
P P + ++ A DL+ +L DP++R+
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI--- 286
Query: 439 RGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQ 479
+ QHPF P P P D F +
Sbjct: 287 -TVEQALQHPFLAQ----YHDPDDEPTCPPPFDFDFEAIEL 322
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 42/158 (26%), Positives = 64/158 (40%), Gaps = 14/158 (8%)
Query: 112 HFRLLKK---LGCGDIGSV----YLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI 164
H R LKK LG G G V Y G + A+K + + G++ + E I
Sbjct: 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINI 59
Query: 165 LSLLDHPFLPTLYSHFET--DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
L L H + K L+ME+ L +LR P + +A ++
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP---LGSLRDYLPKHKLNLAQLLLFAQQI 116
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ YLH ++RDL NVL+ D + + DF L+
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 22/165 (13%)
Query: 115 LLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L ++LG G G V+LAE ++ L A+K + LA RK R E E+L+ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQ 65
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL--------------RQRQPGKHFSEQAT 215
H + Y ++ E+ GDL+ + RQ
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 216 RFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
AS++ + YL V+RDL N LV + + + DF +S
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 13/105 (12%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV-VGQPL 407
++VGT Y++PE + + D W+ G YEL PF + + G+
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR 228
Query: 408 KFPEGSSISFAAKDL---IRGLLVKDPQKRLGFKRGATEIKQHPF 449
+ P S +L I+ +L DP KR E+ Q P
Sbjct: 229 RIPYRYS-----SELNEVIKSMLNVDPDKR----PSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 32/100 (32%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
VGT YL+PEI + + + D W+ G YEL + PF+GN N L + Q P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP 221
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ S + LI L P+ R T I + PF
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDR----PSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 42/161 (26%), Positives = 63/161 (39%), Gaps = 52/161 (32%)
Query: 347 SM--SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF--KGNGNRETLFN- 401
SM SFVGT Y++PE ++G + D W+ G+ E+ +GR P E +F
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 402 ----------------------------------VVGQPLKFPEGS-SISFAAKDLIRGL 426
V P K P G+ S F +D +
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF--QDFVDKC 270
Query: 427 LVKDPQKRLGFKRGATEIKQHPFF-----ESVNWA-LIRST 461
L K+P++R K E+ +HPF E V++A + ST
Sbjct: 271 LKKNPKERADLK----ELTKHPFIKRAELEEVDFAGWVCST 307
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 30/114 (26%), Positives = 47/114 (41%), Gaps = 20/114 (17%)
Query: 351 VGTHEYLAPEIIRGDGHGSAV------DWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
+G Y+APE I+ G D W+ G+ E+ LGR P+ ET N+
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFA 217
Query: 405 QPLKFPEG------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
Q +G S S A+D + L K P +R + ++ +HP+
Sbjct: 218 QLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTY----AQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 2/146 (1%)
Query: 120 GCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH 179
G ++ SVYLA G L +++ D + L Q E + HP + T ++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHPNIMTSWTV 67
Query: 180 FETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDL 239
F T + ++ F + G ++L + + SE L L YLH G ++R++
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNI 127
Query: 240 KPENVLVREDGHIMLSDFDLSLRCFV 265
K ++L+ DG + LS L V
Sbjct: 128 KASHILISGDGLVSLSGLS-HLYSLV 152
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM---DKGMLAGRK----KLMRAQTEREI 164
++ L +G G G V A + G A+K + + R K++R I
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
+ +LD P+ S + L ME DL+ L + Q H S +++ ++L
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQEL-ME----TDLYKLIKTQ---HLSNDHIQYFLYQILR 117
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L+Y+H V++RDLKP N+L+ + + + DF L+
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 29/101 (28%), Positives = 44/101 (43%), Gaps = 4/101 (3%)
Query: 161 EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYA 219
E I+ DHP + L T+ ++ME G+L L+ + + Y+
Sbjct: 57 EAYIMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYS 113
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ AL YL V+RD+ NVLV + L DF LS
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 10/112 (8%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHG-SA-VDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
+ ++MS G+ ++APE+I G SA VD W+ G E+ GR P+ +F
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 402 VVGQ----PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
+ + P+ ++S A D + +P R A E+ QHPF
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR----PTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 32/128 (25%)
Query: 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP 406
V T Y AP+++ G + +++D W+ G E++ GR F G N + L F ++G P
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP 220
Query: 407 ---------------LKFPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKRGAT 442
FP DL+ LL +P+ R+ A
Sbjct: 221 TESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI----SAH 276
Query: 443 EIKQHPFF 450
+ QHP+F
Sbjct: 277 DALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 25/71 (35%), Positives = 38/71 (53%), Gaps = 4/71 (5%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL- 407
SFVGT Y++PE ++G + D W+ G+ EL +GR P +E L + G+P+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVV 219
Query: 408 --KFPEGSSIS 416
+ E SIS
Sbjct: 220 DGEEGEPHSIS 230
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 28/101 (27%), Positives = 47/101 (46%), Gaps = 15/101 (14%)
Query: 164 ILSLLD--HPFLPTLYSHFE--TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYA 219
+LS LD P + T+ LM+ DLH + S + +
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTE-----LMQ----SDLHKIIVSPQ--PLSSDHVKVFL 109
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L L+YLH G+++RD+KP N+LV + + + DF L+
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 2e-04
Identities = 19/38 (50%), Positives = 23/38 (60%), Gaps = 1/38 (2%)
Query: 275 DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKP 312
P+C S C QPSC P+C P C +PSC PSC +P
Sbjct: 8 QPSCCQPS-CCQPSCCQPSCCQPSCCQPSCCVPSCCQP 44
|
Length = 45 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 26/69 (37%), Positives = 36/69 (52%), Gaps = 4/69 (5%)
Query: 372 DWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVK 429
D W+FGI EL+ GR P+ G NRE L V G + P+ IS +L+ K
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL--HELMLQCWKK 242
Query: 430 DPQKRLGFK 438
DP++R F+
Sbjct: 243 DPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 33/133 (24%), Positives = 48/133 (36%), Gaps = 34/133 (25%)
Query: 350 FVGTHEYLAPEI-IRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQ 405
+V T Y APEI + G+ A+D W+ G E+L R F G L V+G
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 406 PLK-----------------FPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKR 439
P + P + + A DL+ +L +P KR+
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI---- 284
Query: 440 GATEIKQHPFFES 452
E HP+ E
Sbjct: 285 TVEEALAHPYLEQ 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 118 KLGCGDIGSVYLAELRDMG--CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
K+G G G VY A+ +D +A+K ++ G M A E +L L HP +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIE-----GTGISMSACREIALLRELKHPNVIA 62
Query: 176 LYSHF--ETDKFSCLLMEFCSGGDLHTLRQRQPGK------HFSEQATRFYASEVLLALE 227
L F +D+ LL ++ H ++ + K + ++L +
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 228 YLHMMGVVYRDLKPENVLVR----EDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276
YLH V++RDLKP N+LV E G + ++D + R F SP + DP
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDP 174
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 21/64 (32%), Positives = 34/64 (53%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
++E ++A +V T Y +PE++ G +G AVD W+ G EL G+ F G +
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
Query: 399 LFNV 402
LF +
Sbjct: 210 LFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 23/163 (14%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL------ 168
L+++LG G G VY G + + K + + RE + L
Sbjct: 10 LIRELGQGSFGMVYE------GLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM 63
Query: 169 ---DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSE-----QATRFY- 218
+ + L T + + ++ME + GDL + LR R+P + +F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 219 -ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A+E+ + YL V+RDL N +V ED + + DF ++
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 16/158 (10%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT---EREI 164
L + +LL+ +G G+ G V L + R G A+K + K AQ E +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI--------KNDATAQAFLAEASV 52
Query: 165 LSLLDHPFLPTLYSHFETDKFSC-LLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEV 222
++ L H L L +K ++ E+ + G L LR R + +F + +V
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDV 111
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A+EYL V+RDL NVLV ED +SDF L+
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 35/147 (23%), Positives = 62/147 (42%), Gaps = 6/147 (4%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173
+L+KKLG G G V++ KV K + G E ++ L HP L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNG-----HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRL 63
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
LY+ T + ++ E+ G L + G + A+++ + ++
Sbjct: 64 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL+ N+LV E ++DF L+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 118 KLGCGDIGSVYLAELRDM--GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
K+G G G VY A+ +D +A+K ++ G M A E +L L HP + +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIE-----GTGISMSACREIALLRELKHPNVIS 62
Query: 176 LYSHF--ETDKFSCLLMEFCSGGDLHTLRQRQPGK------HFSEQATRFYASEVLLALE 227
L F D+ LL ++ H ++ + K + ++L +
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 228 YLHMMGVVYRDLKPENVLVR----EDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276
YLH V++RDLKP N+LV E G + ++D + R F SP + DP
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDP 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 114 RLLKK---LGCGDIGSV----YLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
R LK+ LG G G V Y E + G A+K + +G + + E EIL
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILR 61
Query: 167 LLDHPFLPTLYSHFETDKFSC--LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
L H + D + L+MEF G L R K +Q + YA ++
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICK 120
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++YL V+RDL NVLV + + + DF L+
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 29/188 (15%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCL-----FAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L K LG G+ G V A + A+K++ + A +L +E +L ++
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVN 61
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL----RQRQPG-------------KHFSE 212
HP + LY D L++E+ G L + R+ P + E
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 213 QATRF-----YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
+A +A ++ ++YL M +V+RDL NVLV E + +SDF LS +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 268 KLVQSSDD 275
V+ S
Sbjct: 182 SYVKRSKG 189
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 7/102 (6%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQPL 407
+F GT Y++PE ++ G+ S D W+ G YE+ F+G + +V G
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
PE S + +++ +L KDP R A EI ++PF
Sbjct: 224 SLPETYSRQLNS--IMQSMLNKDPSLRP----SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 8/107 (7%)
Query: 154 KLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQ 213
LM+ + I+ LL+ F P E + L+ME +L + Q +
Sbjct: 67 VLMKLVNHKNIIGLLN-VFTPQ--KSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHE 118
Query: 214 ATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ ++L +++LH G+++RDLKP N++V+ D + + DF L+
Sbjct: 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 25/84 (29%), Positives = 37/84 (44%), Gaps = 4/84 (4%)
Query: 357 LAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVV-GQPLKFPEGSS 414
+APE ++ S D W+FG+ +E+ LG P+ G N E L + G L PE
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCP 230
Query: 415 ISFAAKDLIRGLLVKDPQKRLGFK 438
+L+ DP+ R F
Sbjct: 231 DELY--ELMLQCWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 50/184 (27%), Positives = 78/184 (42%), Gaps = 39/184 (21%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELR----------DMGCLFAMKVMDKGMLAG 151
K K D L HFR++ L G G +++ LR + K + ++A
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 152 R-KKLMRA--QTEREILSL--LDHPFLPTL--------YSHFETDKFSCLLMEFCSGGDL 198
R K RA Q E EIL+L L+H + + ++ T K+ L F
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF 258
Query: 199 H-----TLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIM 253
L+Q TR ++L A+EY+H +++RD+K EN+ + DG I+
Sbjct: 259 DWKDRPLLKQ-----------TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307
Query: 254 LSDF 257
L DF
Sbjct: 308 LGDF 311
|
Length = 501 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 34/113 (30%), Positives = 50/113 (44%), Gaps = 10/113 (8%)
Query: 343 TSARSMSFVGTHEYLAPEII---RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
T A+ SF+GT ++APE+ R G+ D W GI EL + P L
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
Query: 400 FNVVG---QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
F + QP K + S + ++ L K+P+KR A ++ QHPF
Sbjct: 219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR----PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 43/159 (27%), Positives = 58/159 (36%), Gaps = 46/159 (28%)
Query: 350 FVGTHEYLAPEI-IRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-------------- 394
+V T Y APEI + + A+D W+ G ELL + FKG
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 395 -NRETLFNV-----------VGQPLKFPEGSSISFA---AKDLIRGLLVKDPQKRLGFKR 439
+ ETL + + K P S A A DL+ LL DP KR+ +
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE- 287
Query: 440 GATEIKQHPFFESVNWALIRSTHPPE----IPKPVDLSF 474
E +HP+ H P+ KP D SF
Sbjct: 288 ---EALEHPYLAIW--------HDPDDEPVCQKPFDFSF 315
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPFL 173
++K+G G G VY A R A+K K L + + + REI L + H +
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAT--RFYASEVLLALEYLHM 231
L ++K L+ E+ DL + F++ + Y ++L + Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 232 MGVVYRDLKPENVLV-REDGHIMLSDFDLSLRCFVSP 267
V++RDLKP+N+L+ R + L+DF L+ R F P
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGIP 156
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 155 LMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQA 214
LM+ + I+SLL+ F P E + L+ME ++ +
Sbjct: 69 LMKCVNHKNIISLLN-VFTPQ--KSLEEFQDVYLVMELMDANLCQVIQME-----LDHER 120
Query: 215 TRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ ++L +++LH G+++RDLKP N++V+ D + + DF L+
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 15/40 (37%), Positives = 29/40 (72%)
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L +++LH G+++RDLKP N++V+ D + + DF L+
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL- 407
S G+ ++APE+++ + D W+ G E+L G+ PF + +F +
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP 230
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
+ P S+IS A D + D KR A E+ +HPF
Sbjct: 231 EIP--SNISSEAIDFLEKTFEIDHNKR----PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 34/129 (26%), Positives = 55/129 (42%), Gaps = 32/129 (24%)
Query: 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQ 405
++ T Y APE + DG +G +D W G F+E+L F G + + +V+G
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT 217
Query: 406 P---------------LKFP--EGSSI-------SFAAKDLIRGLLVKDPQKRLGFKRGA 441
P FP +G+ + S DL++ LL DP +R+ A
Sbjct: 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI----TA 273
Query: 442 TEIKQHPFF 450
+ +HP+F
Sbjct: 274 KQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 7e-04
Identities = 17/29 (58%), Positives = 20/29 (68%)
Query: 284 CIQPSCIDPACKLPVCVEPSCLQPSCFKP 312
C QPSC P+C P C +PSC QPSC +P
Sbjct: 1 CCQPSCCQPSCCQPSCCQPSCCQPSCCQP 29
|
Length = 45 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 19/61 (31%), Positives = 32/61 (52%), Gaps = 3/61 (4%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQ 405
S V T Y APE++ + + VD W+ G F E+ + F+G+ + + L +V+G
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227
Query: 406 P 406
P
Sbjct: 228 P 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 42/154 (27%), Positives = 65/154 (42%), Gaps = 14/154 (9%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG---CLFAMKVMDKG-MLAGRKKLMRAQTEREILSLLD 169
++ K +G G+ G V L+ G A+K + G R+ + E I+ D
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS---EASIMGQFD 63
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAT---RFYASEVLLAL 226
HP + L K ++ E+ G L ++ G+ Q R AS +
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS----GM 119
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+YL MG V+RDL N+LV + +SDF LS
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 1/92 (1%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
+ +++ + VGT Y++PE+ G + D W G YEL + F+ N L
Sbjct: 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLK 212
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434
+ P S + LI +L DP KR
Sbjct: 213 IMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 29/125 (23%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP- 406
V T Y APE++ + + VD W+ G F E+ + F GN + L F+++G P
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227
Query: 407 -------LKFPEGS--------------SISFAAKDLIRGLLVKDPQKRLGFKRGATEIK 445
+ P G+ I + L+ +L +P KR+ A
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI----SAFRAL 283
Query: 446 QHPFF 450
QHPFF
Sbjct: 284 QHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 17/87 (19%)
Query: 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV-------LLALEYLHMMGVVYRDLK 240
++ME+ DL +L + F SEV L + +LH +++RDLK
Sbjct: 83 MVMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLK 133
Query: 241 PENVLVREDGHIMLSDFDLSLRCFVSP 267
N+L+ G + + DF L+ R + SP
Sbjct: 134 TSNLLLNNRGILKICDFGLA-REYGSP 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 1/60 (1%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
SFVGT Y++PE ++G + D W+ G+ E+ +GR P +E L + G P++
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPVE 219
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 37/140 (26%), Positives = 55/140 (39%), Gaps = 44/140 (31%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE---TLFNVVGQP 406
+V T Y APE+I G G+ VD W+ G EL+ G F+G + + + +G P
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
Query: 407 -LKF---------------PEGSSISFA---------------------AKDLIRGLLVK 429
+F P+ ISF A+DL+ +LV
Sbjct: 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 430 DPQKRLGFKRGATEIKQHPF 449
DP KR+ E +HP+
Sbjct: 302 DPDKRISVD----EALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 113 FRLLKKLGCGDIGSVY----LAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
+ +K LG G G+VY + E + A+K++++ G K + E I++ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE--TTGPKANVEFMDEALIMASM 66
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
DHP L L + + G L + + + + Q + ++ + Y
Sbjct: 67 DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMY 124
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L +V+RDL NVLV+ H+ ++DF L+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 15/40 (37%), Positives = 29/40 (72%)
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L +++LH G+++RDLKP N++V+ D + + DF L+
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLF--AMKVMDKGMLAGRKKLMRAQTEREILSLLDHP- 171
L K LG G+ GSV +L + A+K M K + R ++ +E + DHP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 172 ---FLPTLYSHFETDKFSC--LLMEFCSGGDLHTL----RQRQPGKHFSEQATRFYASEV 222
+ E++ + +++ F GDLH+ R ++ Q + +++
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264
+EYL ++RDL N ++ E+ ++ ++DF LS + +
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAEL-----RDMGCLFAMKVM-DKGMLAGRKKLMRAQT 160
++ L R +++LG G VY L + A+K + DK R++ +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEF---KH 57
Query: 161 EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPG------------ 207
E + S L HP + L ++ ++ +CS DLH L R P
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 208 KHFSEQATRFY-ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259
K E A + +++ +E+L VV++DL NVLV + ++ +SD L
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 115 LLKKLGCGDIGSVYLAEL-------RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
L K LG G G V AE D A+K++ A K L +E E++ L
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADLISEMELMKL 73
Query: 168 LD-HPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQP--------GKHFSEQATRF 217
+ H + L + +++E+ + G+L LR R+P E+ F
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 218 Y-----ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A +V +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 32/113 (28%), Positives = 47/113 (41%), Gaps = 11/113 (9%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAV-----DWWTFGIFFYELLLGRTPFKGNGNRE 397
T R +F+GT ++APE+I D + A D W+ GI E+ G P
Sbjct: 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223
Query: 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATE-IKQHPF 449
LF + P + S + I LVK+ +R TE + +HPF
Sbjct: 224 ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHS-----QRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 36/131 (27%), Positives = 52/131 (39%), Gaps = 34/131 (25%)
Query: 350 FVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGN-------------GN 395
+V T Y APE++ GD +G AVD W G E+L G F G+ GN
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN 219
Query: 396 ----RETLF--NVVGQPLKFPEGSSI----------SFAAKDLIRGLLVKDPQKRLGFKR 439
+ +F N + ++ PE I S DL + L DP R
Sbjct: 220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP---- 275
Query: 440 GATEIKQHPFF 450
++++ H FF
Sbjct: 276 SSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 27/88 (30%), Positives = 36/88 (40%), Gaps = 17/88 (19%)
Query: 372 DWWTFGIFFYELL-LGRTPFKGNGNRETLFNV-VGQPLKFPEGSSISFAAKDLIRGLLVK 429
D W+FGI E++ GR P+ G NRE L V G + P DL+ K
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL--YDLMLQCWDK 243
Query: 430 DPQKRLGFKRGATEIKQHPFFESVNWAL 457
DP++R P FE + L
Sbjct: 244 DPEER-------------PTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 42/145 (28%), Positives = 54/145 (37%), Gaps = 49/145 (33%)
Query: 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNR------------E 397
V T Y APE++ G H A+D W G F ELL FKG + E
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 398 TLFNVVGQP--------LKFPEGSSISFAAK------------------------DLIRG 425
+F V+G P K PE ++ K DL+R
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295
Query: 426 LLVKDPQKRLGFKRGATEIKQHPFF 450
LL DP KR+ A E +HP+F
Sbjct: 296 LLEYDPTKRI----TAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 17/44 (38%), Positives = 23/44 (52%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN 393
+V T Y APE+I G G+ VD W+ G E++ G F G
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 20/159 (12%)
Query: 119 LGCGDIGSVYLAELRDMGCL------FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP- 171
LG G G VY D+ A+K + KG KK E ++S +HP
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK--EAHLMSNFNHPN 60
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLR----QRQPGKHFSEQATRFYASEVLLAL 226
+ L + ++ME GGDL LR +R + + +V
Sbjct: 61 IVKLLGVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 227 EYLHMMGVVYRDLKPENVLVREDGH-----IMLSDFDLS 260
YL M ++RDL N LV E G+ + + DF L+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 24/168 (14%)
Query: 115 LLKKLGCGDIGSVYLAELRDMG-------CLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
L K LG G G V +AE + A+K++ A K L +E E++ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKM 79
Query: 168 L-DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPG--------KHFSEQATRF 217
+ H + L D +++E+ S G+L LR R+P E+ F
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 218 Y-----ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A +V +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 41/149 (27%), Positives = 55/149 (36%), Gaps = 49/149 (32%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL---------------------LGR 387
+ V T Y +PE++ G G + D W+ G YEL LGR
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363
Query: 388 TPFK-----GNGNRETLFNVVGQ--PLKFPEGSSISFAAK------------DLIRGLLV 428
P + G L+N GQ P P+ + A+ DLI GLL
Sbjct: 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423
Query: 429 KDPQKRLGFKRGAT---------EIKQHP 448
D QKRL ++ T E +QHP
Sbjct: 424 YDRQKRLNARQMTTHPYVLKYYPECRQHP 452
|
Length = 467 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 29/102 (28%), Positives = 40/102 (39%), Gaps = 17/102 (16%)
Query: 358 APEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNV-VGQPLKFPEGSSI 415
APE + D W+FGI E++ GR P+ G N E L V G + P G
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK 231
Query: 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457
D++ +DP R P FE++ W L
Sbjct: 232 EL--YDIMLDCWKEDPDDR-------------PTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 10/76 (13%)
Query: 208 KHFSEQATRFYASEVLLALEYL-HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266
E+ A + AL YL + +++RD+KP N+L+ +G+I L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG------IS 155
Query: 267 PKLVQS---SDDPACR 279
+LV S + D CR
Sbjct: 156 GQLVDSIAKTRDAGCR 171
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 17/155 (10%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMK-VMDKGMLAGRKKL-MRAQTEREILSLLDH 170
++L +G G G VY A D A+K V+ R+ L M+ I+ L D+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQ-------ATRFYASEVL 223
+ + E + F ++MEF T+ + KH++ + Y+ ++
Sbjct: 128 YYTECFKKN-EKNIFLNVVMEFIP----QTVHKYM--KHYARNNHALPLFLVKLYSYQLC 180
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIM-LSDF 257
AL Y+H + +RDLKP+N+L+ + H + L DF
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 14/87 (16%)
Query: 188 LLMEFCSGGDLHT-LRQRQP-GKHFSEQATRF------------YASEVLLALEYLHMMG 233
+L+E+ S G+L LR R+P G +S + A +V +EYL
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK 154
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL NVLV ED + ++DF L+
Sbjct: 155 CIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVV-GQPLKFPEGS 413
++APE ++ S D W+FG+ +E+ LG P+ G N E L + G L P
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC 229
Query: 414 SISFAAKDLIRGLLVKDPQKRLGFK 438
L+ +DP+ R F
Sbjct: 230 PPELY--KLMLQCWAEDPEDRPTFS 252
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 26/69 (37%), Positives = 36/69 (52%), Gaps = 4/69 (5%)
Query: 372 DWWTFGIFFYELLL-GRTPFKGNGNRETLFNV-VGQPLKFPEGSSISFAAKDLIRGLLVK 429
D W+FGI EL+ GR P+ G NRE L V G + P+G S +L++ K
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL--HELMKLCWKK 242
Query: 430 DPQKRLGFK 438
DP +R F+
Sbjct: 243 DPDERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 35.0 bits (81), Expect = 0.004
Identities = 19/46 (41%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPS 308
C S P+C S C QPSC P+C P C PSC QP
Sbjct: 1 CCQPSCCQPSCCQPSCCQPSCC-QPSCCQPSCCQPSCCVPSCCQPV 45
|
Length = 45 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 12/148 (8%)
Query: 119 LGCGDIGSVYLAELRDMG---CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175
+G G+ G V L+ G A+K + G +++ + E I+ DHP +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS--EASIMGQFDHPNIIH 69
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAT---RFYASEVLLALEYLHMM 232
L + ++ EF G L + ++ G+ Q R A+ ++YL M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA----GMKYLSEM 125
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL N+LV + +SDF LS
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 45/152 (29%), Positives = 65/152 (42%), Gaps = 13/152 (8%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDK-----GMLAGRKKLMRAQTEREILSLLDHP 171
K++G G G V L E+ + G A V+ + + K L AQ R SL
Sbjct: 1 KEIGNGWFGKVILGEV-NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYR---SLQHSN 56
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF--YASEVLLALEY 228
L L E + L+MEFC GDL LR + + + T A E+ L L +
Sbjct: 57 LLQCLGQCTEVTPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LH ++ DL N L+ D + + D+ LS
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.7 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.51 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.44 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.32 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.18 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.09 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.85 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.74 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.54 | |
| PLN02236 | 344 | choline kinase | 97.18 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.17 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.13 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.09 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.03 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.0 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.88 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.72 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.57 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.5 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.39 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.34 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.2 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.07 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.78 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.54 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.52 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-78 Score=588.03 Aligned_cols=404 Identities=70% Similarity=1.154 Sum_probs=348.9
Q ss_pred cccCCCCCCCCCcchhhhhcc-cCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHH
Q 010603 82 ACLSKPHKGNDMKWDAVQCVK-SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT 160 (506)
Q Consensus 82 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~ 160 (506)
....+|+...+..|+.++... ...+.+.+++|++++.||+|.-|+||+|+.+.+++.+|+|+|.|..+..++.+.+++.
T Consensus 47 ~~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~t 126 (459)
T KOG0610|consen 47 SSGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQT 126 (459)
T ss_pred cccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHH
Confidence 445788999999999998766 6888999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCC
Q 010603 161 EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLK 240 (506)
Q Consensus 161 E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLK 240 (506)
|.+||+.++||+++.||..|+++.+.|||||||+||+|+.++++++++.|+++.+++|+.+|+.||+|||..|||+||||
T Consensus 127 E~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLK 206 (459)
T KOG0610|consen 127 EREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLK 206 (459)
T ss_pred HHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccc
Q 010603 241 PENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTT 320 (506)
Q Consensus 241 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (506)
||||||.++|||.|+||.|+.++...|..+..+....... +++|. + .+++||.++.......
T Consensus 207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~-----~~~~~----------~---~~~s~f~~r~~~~~~~ 268 (459)
T KOG0610|consen 207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS-----QPSCR----------S---RQPSCFSPRCLSSSKK 268 (459)
T ss_pred cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC-----Ccccc----------c---ccccccccchhccccc
Confidence 9999999999999999999999987777776543221110 22221 1 3577888876665444
Q ss_pred ccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHH
Q 010603 321 KVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400 (506)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~ 400 (506)
..+ .........|...+++...+++++|||-.|+|||++.|.+++.++|||+|||+|||||+|..||++.+..+++.
T Consensus 269 ~~k---~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~ 345 (459)
T KOG0610|consen 269 RKK---KDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR 345 (459)
T ss_pred ccc---ccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH
Confidence 333 22222366777889999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCCCCCCccCccCC
Q 010603 401 NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQK 480 (506)
Q Consensus 401 ~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 480 (506)
+|+.+++.||....++.+++|||+++|.+||.+|++.++.|+||++||||++++|++++...||++|.+.+.........
T Consensus 346 NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~~~~~~~ 425 (459)
T KOG0610|consen 346 NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGLKPHASH 425 (459)
T ss_pred HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccCccccccc
Confidence 99999999999889999999999999999999999999999999999999999999999999999999988765311110
Q ss_pred --CCC------CCCCCCCCCCCCCCCCCCCcccC
Q 010603 481 --TPI------PQNDKGAADSDRSSGPFLDFEFF 506 (506)
Q Consensus 481 --~~~------~~~~~~~~~~~~~~~~~~~~~~~ 506 (506)
.+. ..+...........+...+|+||
T Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~F 459 (459)
T KOG0610|consen 426 KSDVKGLVSKKLKNMPSKLSDDKVSENYNPFEYF 459 (459)
T ss_pred ccccccccccccccccccccCCccccCCcCcccC
Confidence 010 11112222345556788999988
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-67 Score=528.01 Aligned_cols=339 Identities=35% Similarity=0.618 Sum_probs=272.8
Q ss_pred hhcccCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeE
Q 010603 99 QCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178 (506)
Q Consensus 99 ~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 178 (506)
++.......+.+++|++++.||+|+||.||+|+.+.||..||+|+++|..+....++..++.|+.||...++|+||+|+.
T Consensus 129 e~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 129 EYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred HHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 34555566789999999999999999999999999999999999999999998999999999999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecC
Q 010603 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFD 258 (506)
Q Consensus 179 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG 258 (506)
.|++.+++||||||++|||+..+|.+. ..++|+.+++|+.+++.||+-||++|+|||||||+|+|||..||+||+|||
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccc
Confidence 999999999999999999999999887 789999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccc
Q 010603 259 LSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVL 338 (506)
Q Consensus 259 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (506)
|+..+...........+.......... .+. .-.....++............
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~w---------------- 337 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEA----------KPS---DFPKFNTPRSTMSRREQLQTW---------------- 337 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccC----------CCc---cccccccccchhhHHHHHHHH----------------
Confidence 985433221111000000000000000 000 000000000000000000000
Q ss_pred ccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCC
Q 010603 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSIS 416 (506)
Q Consensus 339 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s 416 (506)
.........+.+|||.|||||+|.+.+|+..+||||||||+||||.|.+||.+.+..+++.+|+.- .+.+|....++
T Consensus 338 -~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s 416 (550)
T KOG0605|consen 338 -KRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLS 416 (550)
T ss_pred -HhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCccc
Confidence 001112234679999999999999999999999999999999999999999999999999999864 47888888999
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVD 471 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~~~ 471 (506)
++++|||.+||. ||++|++ ...++||.+||||++++|+.++...+|++|...+
T Consensus 417 ~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 417 DEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred HHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCCC
Confidence 999999999999 9999998 5689999999999999999999999999987543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-66 Score=500.41 Aligned_cols=282 Identities=40% Similarity=0.772 Sum_probs=254.0
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+..++|+++++||+|+||+||+++.++|++.||+|+|+|......+.......|+.||..++||+||.++..|++.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35567899999999999999999999999999999999999888888888999999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||+||+.||+|+..+++. +.|+|..+++|+.+|+.||.|||++||||||||||||||+.+|+++|+||||++....
T Consensus 101 ylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999999887 7899999999999999999999999999999999999999999999999999853100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
....
T Consensus 178 ----------------------------------------------------------------------------~~~~ 181 (357)
T KOG0598|consen 178 ----------------------------------------------------------------------------DGDA 181 (357)
T ss_pred ----------------------------------------------------------------------------CCCc
Confidence 1122
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
+.++|||+.|||||++.+.+|+..+|||||||++|||++|.+||.+.+....+.+|+..+...+. ..++.++++||+++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~L 260 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKKL 260 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHHH
Confidence 34579999999999999999999999999999999999999999999999999999988844443 25999999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCCCcchh--ccCCCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RSTHPPEIPK 468 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~--~~~~~~~~p~ 468 (506)
|..||++|++-...+.++.+||||..++|+.+ +...||+.|.
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~ 304 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPN 304 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecC
Confidence 99999999975557999999999999999865 3445666664
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-65 Score=475.44 Aligned_cols=276 Identities=41% Similarity=0.776 Sum_probs=256.1
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
..+.+|++++.||.|+||+|.+++++.+|..||+|++++..+-..++++...+|..||+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 77889999999999999999999999999999999999998888888899999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
|||||++||.|+.++++. ++|++..+++|++||+.||+|||+++||+|||||||||||.+|++||+|||+|++..
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999886 789999999999999999999999999999999999999999999999999996531
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.++
T Consensus 196 -----------------------------------------------------------------------------~rT 198 (355)
T KOG0616|consen 196 -----------------------------------------------------------------------------GRT 198 (355)
T ss_pred -----------------------------------------------------------------------------CcE
Confidence 124
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
.++||||.|+|||+++..+|+.++|||||||++|||+.|.+||.+.+...++.+|+.+.+.+|. .++.++++||+++|
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~--~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS--YFSSDAKDLLKKLL 276 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc--ccCHHHHHHHHHHH
Confidence 4679999999999999999999999999999999999999999999999999999999999998 69999999999999
Q ss_pred hcCCCCccC-CCCChHHhhcCCCCCCCCcchhcc--CCCCCCC
Q 010603 428 VKDPQKRLG-FKRGATEIKQHPFFESVNWALIRS--THPPEIP 467 (506)
Q Consensus 428 ~~dP~~R~s-~~~~a~ell~hp~f~~~~~~~~~~--~~~~~~p 467 (506)
+.|-.+|.+ ++....+|..||||++++|..+.. ..+|..|
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 999999965 455789999999999999986643 3455555
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-64 Score=514.96 Aligned_cols=319 Identities=39% Similarity=0.738 Sum_probs=275.8
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 184 (506)
+.+.+.+|+++++||+|+||+|++|..+.+++.||||+++|+.+-.+..++..+.|.+|+.... ||++++|+.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 5788999999999999999999999999999999999999999888899999999999998885 999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
++|+||||+.|||+..+++. +.|++..+++|+++|+.||.|||++||||||||.+|||||.+|++||+||||++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999996544433 689999999999999999999999999999999999999999999999999985311
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..+
T Consensus 520 -----------------------------------------------------------------------------~~g 522 (694)
T KOG0694|consen 520 -----------------------------------------------------------------------------GQG 522 (694)
T ss_pred -----------------------------------------------------------------------------CCC
Confidence 122
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
.++.++||||.|||||++.+..|+.++|||||||+|||||.|+.||.++++.+.+..|+.....+|. .++.++.+||+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~--~ls~ea~~il~ 600 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSKEAIAIMR 600 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--cccHHHHHHHH
Confidence 3466789999999999999999999999999999999999999999999999999999999999988 69999999999
Q ss_pred HHhhcCCCCccCC-CCChHHhhcCCCCCCCCcchh--ccCCCCCCCC---CCCCCccCccCCCCCCCCCCC--CCCCCCC
Q 010603 425 GLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RSTHPPEIPK---PVDLSFINHKQKTPIPQNDKG--AADSDRS 496 (506)
Q Consensus 425 ~~L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~--~~~~~~~~p~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 496 (506)
++|.+||++|++. ...+++|++||||..++|+.+ +...||++|. |.|.+..+..-...-|...+. ..-....
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l~~~~ 680 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPLTEEE 680 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCccccchhh
Confidence 9999999999996 245899999999999999866 4456777665 555565555444444443331 1112223
Q ss_pred CCCCCCcccC
Q 010603 497 SGPFLDFEFF 506 (506)
Q Consensus 497 ~~~~~~~~~~ 506 (506)
...|+||+|+
T Consensus 681 q~~F~~Fs~~ 690 (694)
T KOG0694|consen 681 QEAFRDFSFV 690 (694)
T ss_pred HHHhcCcccc
Confidence 4589999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-62 Score=489.94 Aligned_cols=288 Identities=37% Similarity=0.656 Sum_probs=258.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 186 (506)
....||.+++.||+|+|++|++|+++.+++.||||++.|..+..++.++-+..|.++|..| +||.||+|+..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4567899999999999999999999999999999999999888888888889999999999 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+|+||+++|+|.++|.+. +.|++..+++|+.||+.||+|||++||||||||||||||+++|++||+|||-|+.+...
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999987 78999999999999999999999999999999999999999999999999998654333
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
........+ ......+
T Consensus 228 ~~~~~~~~~----------------------------------------------------------------~~~a~s~ 243 (604)
T KOG0592|consen 228 QKSQENPVD----------------------------------------------------------------PNQASSR 243 (604)
T ss_pred hccccCccC----------------------------------------------------------------cccccCc
Confidence 222110000 0001122
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
..++|||..|.+||+|.....+..+|||+||||||.|+.|++||.+.++.-++++|+...+.||. .+++.++|||+++
T Consensus 244 ~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~--~fp~~a~dLv~KL 321 (604)
T KOG0592|consen 244 RSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE--GFPEDARDLIKKL 321 (604)
T ss_pred ccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC--CCCHHHHHHHHHH
Confidence 36789999999999999999999999999999999999999999999999999999999899988 6999999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p 467 (506)
|..||.+|+| +++|.+||||++++|..+....||.+-
T Consensus 322 Lv~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 322 LVRDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKLQ 358 (604)
T ss_pred HccCcccccc----HHHHhhCcccccCChhhhhhcCCCccc
Confidence 9999999998 899999999999999988877777664
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-63 Score=482.41 Aligned_cols=261 Identities=31% Similarity=0.487 Sum_probs=230.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchh----HHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK----KLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
.+.|.+.+.||+|+||.|-+|..+.||+.||||++++....... ....+++|++||++|+|||||+++++|+.++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35589999999999999999999999999999999997765522 34456899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC---CCEEEeecCCccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED---GHIMLSDFDLSLR 262 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFGla~~ 262 (506)
.||||||+.||+|.+.+..+ +.+.|...+.+++|++.||.|||++||+||||||+|||+..+ ..+||+|||||+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999998876 789999999999999999999999999999999999999876 6899999999953
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
. .
T Consensus 329 ~------------------------------------------------------------------------------g 330 (475)
T KOG0615|consen 329 S------------------------------------------------------------------------------G 330 (475)
T ss_pred c------------------------------------------------------------------------------c
Confidence 1 0
Q ss_pred CCCCccccccCCCCccchhhcCCC---CCcchhHHHHHHHHHHHhcCCCCCCCCCcHH-HHHHHhCCCCCC--CCCCCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGNRE-TLFNVVGQPLKF--PEGSSIS 416 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--p~~~~~s 416 (506)
....+.++||||.|.|||++.+.+ |..++||||||||||-+|+|.+||.+..... ...+|..+.+.+ +.|..++
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Is 410 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRIS 410 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhh
Confidence 223456789999999999999775 3458999999999999999999998876665 677888776655 4567899
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
.++++||.+||..||++||+ +.|+|+||||+..+
T Consensus 411 eea~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 99999999999999999998 99999999999765
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-61 Score=488.28 Aligned_cols=256 Identities=33% Similarity=0.584 Sum_probs=241.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|...+.||+|||++||.+++..+|+.||+|++.|..+......+++.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999998888888999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|+|..++|..+++++ +.++|..|++|++||+.||.|||+++|||||||..||||+++.+|||+|||||..+.
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le------ 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE------ 169 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec------
Confidence 999999999999865 799999999999999999999999999999999999999999999999999995431
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
...++..++
T Consensus 170 -----------------------------------------------------------------------~~~Erk~Tl 178 (592)
T KOG0575|consen 170 -----------------------------------------------------------------------YDGERKKTL 178 (592)
T ss_pred -----------------------------------------------------------------------Cccccccee
Confidence 123456678
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
||||.|+|||++...+++..+||||+|||||-||+|++||+..+-.+.+..|....+.+|. .++.++++||.+||..|
T Consensus 179 CGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 179 CGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPN 256 (592)
T ss_pred cCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCC
Confidence 9999999999999999999999999999999999999999999999999999999999988 79999999999999999
Q ss_pred CCCccCCCCChHHhhcCCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f~ 451 (506)
|.+||+ +++||.|+||.
T Consensus 257 P~~Rps----l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 257 PSERPS----LDEVLDHPFFK 273 (592)
T ss_pred cccCCC----HHHHhcCHhhh
Confidence 999998 99999999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-58 Score=446.29 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=229.4
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe-E
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF-S 186 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~ 186 (506)
+.+.+.+.++.||+|..|+||+|+++.|++.||+|+|... ......+++.+|++||+..+|||||.+|+.|..++. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 5667788999999999999999999999999999999433 224566778899999999999999999999999995 9
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+||||+||+|.+++... ++++|.....++.+|++||.|||. ++||||||||+||||+..|.|||||||.+..+..
T Consensus 154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999998876 789999999999999999999995 9999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
+
T Consensus 232 S------------------------------------------------------------------------------- 232 (364)
T KOG0581|consen 232 S------------------------------------------------------------------------------- 232 (364)
T ss_pred h-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC-----CcHHHHHHHhCC-CCCCCCCCCCCHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN-----GNRETLFNVVGQ-PLKFPEGSSISFAA 419 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~~~~s~~~ 419 (506)
...+++||..|||||.+.+..|+.++||||||+.++||++|+.||... ...+.+..|+.+ +..+|.. .+|+++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef 311 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEF 311 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHH
Confidence 134679999999999999999999999999999999999999999774 456777888875 4455553 699999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
++||..||++||.+|++ +.|+++|||+....
T Consensus 312 ~~FV~~CL~Kdp~~R~s----~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPS----AKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHhcCCcccCCC----HHHHhcCHHHhhcc
Confidence 99999999999999997 99999999997543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-57 Score=441.88 Aligned_cols=260 Identities=28% Similarity=0.530 Sum_probs=227.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
..++|.+.+.||.|+||+||+|+++.++..||||.|.+..+. .+..+.+..|+.||+.++|||||+|+++.+.++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 356799999999999999999999999999999999987653 5666778899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC------CCEEEeecCCccc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED------GHIMLSDFDLSLR 262 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~------~~vkl~DFGla~~ 262 (506)
|||||.||||.+|++++ +.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.
T Consensus 87 VMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999999999987 689999999999999999999999999999999999999875 3589999999976
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
+...
T Consensus 165 L~~~---------------------------------------------------------------------------- 168 (429)
T KOG0595|consen 165 LQPG---------------------------------------------------------------------------- 168 (429)
T ss_pred CCch----------------------------------------------------------------------------
Confidence 4211
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC-CCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE-GSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~~~s~~~~~ 421 (506)
....+.||+|.|||||++..+.|+.|+|+||+|+|||+|++|++||+..+..+.+..+.......|. ...++....+
T Consensus 169 --~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~ 246 (429)
T KOG0595|consen 169 --SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRE 246 (429)
T ss_pred --hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhh
Confidence 1123468999999999999999999999999999999999999999999999888877654433332 2356777889
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
|+..+|..+|..|.+ ..+-+.|+++..-
T Consensus 247 Ll~~ll~~~~~~~~~----~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 247 LLISLLQRNPKDRIS----FEDFFDHPFLAAN 274 (429)
T ss_pred hhhHHHhcCccccCc----hHHhhhhhhcccC
Confidence 999999999999987 5778888888653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=488.79 Aligned_cols=285 Identities=38% Similarity=0.707 Sum_probs=255.6
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..-.+...||.|+++||+|+||.|.+++++.|++.||+|+++|.....+.....|..|+.||..-+.+.||+|+.+|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34456668899999999999999999999999999999999997666666677789999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.++|+||||++||||-.++.+. .++||..|++|+.+|+.||+-||+.|+|||||||+|||||..|||||+|||-+..+
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 9999999999999999999887 38999999999999999999999999999999999999999999999999977543
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
... +
T Consensus 226 ~~d----------------------------------------------------------------------------G 229 (1317)
T KOG0612|consen 226 DAD----------------------------------------------------------------------------G 229 (1317)
T ss_pred CCC----------------------------------------------------------------------------C
Confidence 211 1
Q ss_pred CCCccccccCCCCccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCC
Q 010603 344 SARSMSFVGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSIS 416 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s 416 (506)
..++..-||||.|++||+|.. +.|+..+||||+||++|||++|..||..++-.+++-+|+.. .+.||....+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 223344589999999999962 46999999999999999999999999999999999999866 68889777899
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~ 468 (506)
.++++||.++|. +|+.|++ +.+++++..||||.+++|..++...||.+|.
T Consensus 310 eeakdLI~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred HHHHHHHHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 999999999987 8899987 3469999999999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-57 Score=424.50 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=220.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
++.|+.+.++|+|+||+||+|+++.||+.||||.+..... .....+-+.+|+++|+.|+|||+|.|+++|.....++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 3569999999999999999999999999999999875432 123334568999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
+|||+..-|.+ +++.+ ..++++.++.|++|++.|+.|||++++||||||||||||+.+|.+||||||+|+.+..
T Consensus 80 FE~~dhTvL~e-Le~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~---- 153 (396)
T KOG0593|consen 80 FEYCDHTVLHE-LERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA---- 153 (396)
T ss_pred eeecchHHHHH-HHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC----
Confidence 99997766655 45554 5799999999999999999999999999999999999999999999999999964311
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.+...+.
T Consensus 154 -------------------------------------------------------------------------pgd~YTD 160 (396)
T KOG0593|consen 154 -------------------------------------------------------------------------PGDNYTD 160 (396)
T ss_pred -------------------------------------------------------------------------Ccchhhh
Confidence 1122456
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-------------------CCCC
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-------------------PLKF 409 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~ 409 (506)
++.|.||+|||++.+ ..|+..+||||+||++.||++|.+.|++.++.++++.|... .+.+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l 240 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL 240 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence 799999999999998 57999999999999999999999999999999888766421 1223
Q ss_pred CCC----------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 410 PEG----------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 410 p~~----------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.. ..++..+.||+++||..||.+|++ .+|+|.||||.+
T Consensus 241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~ 289 (396)
T KOG0593|consen 241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDG 289 (396)
T ss_pred CCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHHHH
Confidence 322 246677899999999999999998 899999999953
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=448.72 Aligned_cols=262 Identities=35% Similarity=0.584 Sum_probs=233.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch--hHHHHHHHHHHHHHhcC-CCCccceeEEEEeC
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR--KKLMRAQTEREILSLLD-HPFLPTLYSHFETD 183 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~ 183 (506)
....+.|.+.+.||+|+||+|++|.+..++..||+|++++...... .....+.+|+.+++.++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3556789999999999999999999999999999998887533211 34456678999999998 99999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecCCccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLSLR 262 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFGla~~ 262 (506)
..+|+|||||.||+|.+++... +++.|..++.+|+||+.||+|||++||+||||||||||++.+ +++||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999999884 789999999999999999999999999999999999999999 9999999999843
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.. .
T Consensus 171 ~~-----------------------------------------------------------------------------~ 173 (370)
T KOG0583|consen 171 SP-----------------------------------------------------------------------------G 173 (370)
T ss_pred cC-----------------------------------------------------------------------------C
Confidence 21 0
Q ss_pred CCCCccccccCCCCccchhhcCCC-C-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDG-H-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~-~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
......+.+||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+...++..+....+.+|.... +++++
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~-S~~~~ 252 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL-SPEAR 252 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC-CHHHH
Confidence 112234569999999999999988 8 58999999999999999999999998888888899989899998533 99999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+||.+||..||.+|++ +.++++||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t----~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRIT----LLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCC----HHHHhhChhhcc
Confidence 9999999999999997 899999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-56 Score=453.99 Aligned_cols=260 Identities=30% Similarity=0.540 Sum_probs=235.6
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.++-|++++.||.|+-|.|-+|++..||+.+|||+|.+...........+.+|+-||+.+.||||++||++|++..++||
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35669999999999999999999999999999999998744444556678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
|.||++||.|++++.++ ++++|..+.++++||+.||.|||..+|+||||||+|+||+..++|||+|||+|..-.
T Consensus 90 vlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---- 163 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---- 163 (786)
T ss_pred EEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc----
Confidence 99999999999999887 789999999999999999999999999999999999999999999999999994210
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
.+.-..
T Consensus 164 --------------------------------------------------------------------------~gklLe 169 (786)
T KOG0588|consen 164 --------------------------------------------------------------------------PGKLLE 169 (786)
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 011112
Q ss_pred ccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
+-||+|.|.|||++.|.+| +.++||||.|||||.||||++||++++....+.++..+.+.+|. .++.++++||++||
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRML 247 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHh
Confidence 3379999999999999998 78999999999999999999999999988899999999999885 79999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
..||++|+| .+||++|||+....
T Consensus 248 ~VDp~~RiT----~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 248 DVDPSTRIT----TEEILKHPFLSGYT 270 (786)
T ss_pred ccCcccccc----HHHHhhCchhhcCC
Confidence 999999998 89999999998765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=444.13 Aligned_cols=260 Identities=32% Similarity=0.520 Sum_probs=226.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCC-e
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDK-F 185 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-~ 185 (506)
..+++|.++++||.|+||.||+|+.+.+|..||||.|++.... .+... -.+|+.-|++|+ |||||+|++++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 3567899999999999999999999999999999999876543 23332 256999999998 999999999998887 9
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+||||| ..+|+++++.+ ++.|+|..++.|+.||+.||+|+|.+|++||||||||||+.....|||+||||||.+..
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 77999999887 78999999999999999999999999999999999999999888999999999986543
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.+.
T Consensus 163 kpP----------------------------------------------------------------------------- 165 (538)
T KOG0661|consen 163 KPP----------------------------------------------------------------------------- 165 (538)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 322
Q ss_pred CccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC---------------
Q 010603 346 RSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP--------------- 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~--------------- 406 (506)
.+.+|-|++|+|||+|+.. .|+.++||||+|||++|+++-++.|.|.++.+++.+|. +.+
T Consensus 166 -YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 166 -YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred -cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 3457999999999998765 48999999999999999999999999999999887765 322
Q ss_pred -CCCCCC---------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 -LKFPEG---------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 -~~~p~~---------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+.+|.. ..++.++.+||.+||.+||.+||| |+|+|+||||+.-
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCcccccc
Confidence 223321 247889999999999999999997 9999999999854
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-56 Score=422.37 Aligned_cols=283 Identities=40% Similarity=0.727 Sum_probs=254.2
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
...+.+++|..+++||+|.||+|.+++.+.+++.||||+++|+.+-.+..+..-..|-++|+..+||++..|...|++.+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34578899999999999999999999999999999999999998877788888889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
++|+||||+.||.|+-.+.+. +.|+|..+++|-.+|+.||.|||+++||+||||.+|+|||.+|++||+||||++.-.
T Consensus 242 rlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999998877765 789999999999999999999999999999999999999999999999999974210
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..+
T Consensus 320 -----------------------------------------------------------------------------~~g 322 (516)
T KOG0690|consen 320 -----------------------------------------------------------------------------KYG 322 (516)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 012
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
..+.++||||.|+|||+|....|+.++|||.+||++|||++|++||...+....+..|+-..++||. .++++++.|+.
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr--~ls~eAktLLs 400 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR--TLSPEAKTLLS 400 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc--cCCHHHHHHHH
Confidence 3356789999999999999999999999999999999999999999999888888888889999997 79999999999
Q ss_pred HHhhcCCCCccCCC-CChHHhhcCCCCCCCCcchh--ccCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALI--RSTHPPEIPK 468 (506)
Q Consensus 425 ~~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~--~~~~~~~~p~ 468 (506)
.+|.+||.+|++-. ..|.||.+|+||.+++|... +...||.-|+
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPq 447 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQ 447 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCC
Confidence 99999999999852 35899999999999999754 3344555443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-54 Score=434.36 Aligned_cols=269 Identities=37% Similarity=0.732 Sum_probs=238.6
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+.+++|++.+.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|+.++||||+++++++..++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999876554445566788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 9999999999999988765 5789999999999999999999999999999999999999999999999999853200
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.
T Consensus 171 -------------------------------------------------------------------------------~ 171 (329)
T PTZ00263 171 -------------------------------------------------------------------------------R 171 (329)
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+....+.+|. .++..+++||.+|
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~ 249 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--WFDGRARDLVKGL 249 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC--CCCHHHHHHHHHH
Confidence 11236999999999999999999999999999999999999999988887778888877766665 5899999999999
Q ss_pred hhcCCCCccCC-CCChHHhhcCCCCCCCCcchhc
Q 010603 427 LVKDPQKRLGF-KRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 427 L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~ 459 (506)
|+.||.+|++. .+++++++.||||...+|..+.
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 99999999973 3468999999999999998653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=403.54 Aligned_cols=262 Identities=36% Similarity=0.597 Sum_probs=243.6
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+.+++|++.+.||+|.||.||+|+.+.++-.||+|++.|..+.......++.+|++|...|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45778899999999999999999999999999999999999887777777888999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+||++||..+|+|+..++..+...+++..+..|++|++.||.|||.++||||||||+|+|++..|.+||+|||++...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 999999999999999999877889999999999999999999999999999999999999999999999999998431
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
+ ..
T Consensus 175 ----------------------------------------------------------------------------p-~~ 177 (281)
T KOG0580|consen 175 ----------------------------------------------------------------------------P-SN 177 (281)
T ss_pred ----------------------------------------------------------------------------C-CC
Confidence 0 12
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
+..+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+.+|....+.+|. .++.++.|||.+
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~--~is~~a~dlI~~ 255 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS--TISGGAADLISR 255 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc--ccChhHHHHHHH
Confidence 345679999999999999999999999999999999999999999999999999999988888885 799999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||.++|.+|+. ..|++.|||+..
T Consensus 256 ll~~~p~~r~~----l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLA----LTEVMDHPWIVA 278 (281)
T ss_pred HhccCcccccc----HHHHhhhHHHHh
Confidence 99999999987 899999999853
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=442.34 Aligned_cols=256 Identities=30% Similarity=0.539 Sum_probs=233.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|.+.+.||+|+||+||+|+.+.|.+.||||.+.|..- ..+.++.+.+|++|++.|+|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3579999999999999999999999999999999988643 345677889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
+|||.| +|+.++... +.++|+.++.++.|++.||.|||+++|+|||+||.||||..+|++|+||||+|+.+..
T Consensus 80 te~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---- 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---- 152 (808)
T ss_pred ehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc----
Confidence 999966 999999876 7899999999999999999999999999999999999999999999999999964311
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....++
T Consensus 153 -------------------------------------------------------------------------~t~vlts 159 (808)
T KOG0597|consen 153 -------------------------------------------------------------------------NTSVLTS 159 (808)
T ss_pred -------------------------------------------------------------------------Cceeeee
Confidence 0112345
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
+.|||.|||||++.+++|+..+|+||||||||||++|++||......+.+..|+..+..+|. .++..+++||+.+|.+
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIK 237 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhc
Confidence 68999999999999999999999999999999999999999999888888999999888887 7999999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||.+|++ ..+++.|||+++
T Consensus 238 dP~~Rlt----W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 238 DPAQRLT----WTDLLGHPFWKG 256 (808)
T ss_pred Chhhccc----HHHHhcChHHhh
Confidence 9999998 679999999975
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=433.25 Aligned_cols=280 Identities=36% Similarity=0.715 Sum_probs=240.9
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCC-ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMG-CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
..+.+++|++++.||+|+||.||+|.++.++ ..||+|++.+...........+.+|+++|+.++|||||++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3456778999999999999999999987655 689999998765544555667888999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999999998775 579999999999999999999999999999999999999999999999999984310
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.
T Consensus 183 ~------------------------------------------------------------------------------- 183 (340)
T PTZ00426 183 T------------------------------------------------------------------------------- 183 (340)
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
.....+||+.|||||++.+..++.++|||||||+||||++|..||.+.+....+..+......+|. .+++.+++||+
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~ 260 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK--FLDNNCKHLMK 260 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHH
Confidence 011236999999999999999999999999999999999999999988877777788777666665 58999999999
Q ss_pred HHhhcCCCCccC-CCCChHHhhcCCCCCCCCcchhcc--CCCCCCCCC
Q 010603 425 GLLVKDPQKRLG-FKRGATEIKQHPFFESVNWALIRS--THPPEIPKP 469 (506)
Q Consensus 425 ~~L~~dP~~R~s-~~~~a~ell~hp~f~~~~~~~~~~--~~~~~~p~~ 469 (506)
+||+.||++|++ +.++++++++||||..++|..+.. ..+|..|+.
T Consensus 261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~ 308 (340)
T PTZ00426 261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308 (340)
T ss_pred HHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 999999999974 234699999999999999976543 234455543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=432.89 Aligned_cols=305 Identities=33% Similarity=0.596 Sum_probs=237.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+..|+.+++.++||||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36999999999999999999999999999999998765544555667888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+++.+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999998765 679999999999999999999999999999999999999999999999999986432111000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.... ..+ .++ ..+... ... ...................
T Consensus 159 ~~~~------~~~-----------~~~----------~~~~~~--------------~~~-~~~~~~~~~~~~~~~~~~~ 196 (363)
T cd05628 159 FYRN------LNH-----------SLP----------SDFTFQ--------------NMN-SKRKAETWKRNRRQLAFST 196 (363)
T ss_pred cccc------ccc-----------ccc----------cccccc--------------ccc-cccccchhhhccccccccc
Confidence 0000 000 000 000000 000 0000000000011122356
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC--CCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++.. ..+.+|....+++++++||.+|+.
T Consensus 197 ~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~ 276 (363)
T cd05628 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC 276 (363)
T ss_pred cCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC
Confidence 899999999999999999999999999999999999999998888887777765 345566666789999999999886
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCCCcchhccC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRST 461 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~ 461 (506)
+|.+|++ +++++|+++||||++++|..+...
T Consensus 277 -~~~~r~~-r~~~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 277 -EWEHRIG-APGVEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred -ChhhcCC-CCCHHHHhCCCCCCCCCHHHHHhC
Confidence 6777754 235999999999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=399.93 Aligned_cols=259 Identities=31% Similarity=0.463 Sum_probs=221.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|..+++||+|.||.||+|++..||+.||||.|+.....+ .....+.+|+..|+.++|+||+.|+++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46899999999999999999999999999999998764432 22345678999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||| ..||...++.. ...++...++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||||+.+....
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--- 155 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--- 155 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC---
Confidence 999 67999888765 4789999999999999999999999999999999999999999999999999996532110
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
...+..
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (318)
T KOG0659|consen 156 --------------------------------------------------------------------------RIQTHQ 161 (318)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011122
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC--CCCCCC------------
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP--LKFPEG------------ 412 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~--~~~p~~------------ 412 (506)
|-|.+|+|||++.|. .|+..+||||+|||+.||+-|.+.|.+.++.+++..|. +.+ -.||+.
T Consensus 162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~ 241 (318)
T KOG0659|consen 162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF 241 (318)
T ss_pred eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence 789999999999886 49999999999999999999999999999988876554 332 112211
Q ss_pred ---------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 413 ---------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 413 ---------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...+.++.||+.+||..||.+|++ |.|+|+|+||.+.
T Consensus 242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSL 287 (318)
T ss_pred CCCccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcC
Confidence 135678899999999999999997 9999999999863
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-55 Score=428.33 Aligned_cols=285 Identities=36% Similarity=0.661 Sum_probs=253.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+..+.|+.-++||+|+||.||-++.+.||+.||+|.+.|..+..+.-...+.+|..||.+++.++||.|-.+|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45667799999999999999999999999999999999998888777778889999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
||||..|.||||.-.|.+..+..|+|+.+++|+++|+.||++||+.+||+|||||+|||||+.|+|+|+|+|||..+...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999999888887789999999999999999999999999999999999999999999999999999543111
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 341 ------------------------------------------------------------------------------~~ 342 (591)
T KOG0986|consen 341 ------------------------------------------------------------------------------KP 342 (591)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 11
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH----HHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR----ETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
....+||.+|||||++..+.|+..+|||||||+||||+.|+.||...... +.-..++..+..++. .+|+++++|
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eaksl 420 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKSL 420 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHHH
Confidence 12338999999999999999999999999999999999999999765443 334556667777775 799999999
Q ss_pred HHHHhhcCCCCccCCC-CChHHhhcCCCCCCCCcchhc--cCCCCCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIR--STHPPEIPKPVD 471 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~~~ 471 (506)
.+.+|.+||.+|++.. ++++++.+||||+++||..+. ...||.+|.|..
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence 9999999999999986 679999999999999998663 457888887753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-54 Score=425.20 Aligned_cols=270 Identities=35% Similarity=0.592 Sum_probs=230.9
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch-----------hHHHHHHHHHHHHHhcCCCC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR-----------KKLMRAQTEREILSLLDHPF 172 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~hpn 172 (506)
..+...+++|++++.||+|.||+|-+|++..+++.||||++.|..+... ..++++++||.||++|+|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3456778999999999999999999999999999999999987654321 22457899999999999999
Q ss_pred ccceeEEEEeC--CeEEEEEeecCCCChHHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC
Q 010603 173 LPTLYSHFETD--KFSCLLMEFCSGGDLHTLRQRQPGKH-FSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED 249 (506)
Q Consensus 173 Iv~l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~-~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~ 249 (506)
||+|+++..+. +.+|||+|||..|.+... ...+. +.++++++|+++++.||+|||.+|||||||||.|+||+++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence 99999999875 589999999999988653 22345 9999999999999999999999999999999999999999
Q ss_pred CCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccC
Q 010603 250 GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSL 329 (506)
Q Consensus 250 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (506)
|+|||+|||.+...... ...
T Consensus 247 g~VKIsDFGVs~~~~~~--~~~---------------------------------------------------------- 266 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQG--SDE---------------------------------------------------------- 266 (576)
T ss_pred CcEEeeccceeeecccC--Ccc----------------------------------------------------------
Confidence 99999999987321100 000
Q ss_pred CCCCCCcccccCCCCCCccccccCCCCccchhhcCCC---C-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC
Q 010603 330 TNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG---H-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405 (506)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 405 (506)
.........+|||.|||||++.++. | +.+.||||+||+||.|+.|+.||.++...+.+.+|++.
T Consensus 267 ------------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 267 ------------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ------------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 0000111248999999999998732 3 78999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 406 ~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
++.||....+.++++|||.+||++||++|++ +.+|..|||...
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTR 377 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheee----hhhheecceecc
Confidence 9999998889999999999999999999998 789999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=431.39 Aligned_cols=263 Identities=32% Similarity=0.464 Sum_probs=223.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFS 186 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 186 (506)
....|+.+++||+|+||.||+|++..||+.||+|.++.+... ......+.+||.||++|+||||++|.+..... +.+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 445699999999999999999999999999999999876543 34556678899999999999999999998876 689
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||+|||+ -||.-++.. ++-.|++.+++.|++||+.||+|||++||+|||||..|||||.+|.+||+|||||+.+...
T Consensus 194 YlVFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 194 YLVFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99999995 588877654 4578999999999999999999999999999999999999999999999999999754222
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 272 ~~----------------------------------------------------------------------------~~ 275 (560)
T KOG0600|consen 272 GS----------------------------------------------------------------------------AP 275 (560)
T ss_pred CC----------------------------------------------------------------------------cc
Confidence 11 11
Q ss_pred ccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC-------CCCCC----
Q 010603 347 SMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP-------LKFPE---- 411 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~-------~~~p~---- 411 (506)
.+..|-|++|+|||+|+|. .|+.++|+||+||||.||++|++.|++.++.+++..|. +.+ ..+|.
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 3345899999999999987 59999999999999999999999999999998886654 322 11221
Q ss_pred -------------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 412 -------------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 412 -------------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
...++..+.+|+.+||..||.+|.| |.++|+|+||....
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~t~p 407 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFTTEP 407 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCcccccCC
Confidence 1246788999999999999999987 99999999995443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=422.95 Aligned_cols=265 Identities=39% Similarity=0.713 Sum_probs=234.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|.++.+++.||||++.............+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36999999999999999999999999999999998654444445566788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999998765 5799999999999999999999999999999999999999999999999999843100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.....
T Consensus 154 ---------------------------------------------------------------------------~~~~~ 158 (291)
T cd05612 154 ---------------------------------------------------------------------------RTWTL 158 (291)
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 01123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++..+++||.+||+.|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~d 236 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAKDLIKKLLVVD 236 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc--cCCHHHHHHHHHHcCCC
Confidence 6999999999999999999999999999999999999999998888888888877777765 57999999999999999
Q ss_pred CCCccC-CCCChHHhhcCCCCCCCCcchhc
Q 010603 431 PQKRLG-FKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 431 P~~R~s-~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
|.+|++ ++.++++++.||||..++|....
T Consensus 237 p~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 266 (291)
T cd05612 237 RTRRLGNMKNGADDVKNHRWFKSVDWDDVP 266 (291)
T ss_pred HHHccCCccCCHHHHhcCccccCCCHHHHh
Confidence 999995 34469999999999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=437.92 Aligned_cols=324 Identities=35% Similarity=0.635 Sum_probs=242.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|||||+++++|.+.+++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36999999999999999999999999999999998765444555677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998765 679999999999999999999999999999999999999999999999999996432111000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.... ... ...+..+........... ... ........ ..............
T Consensus 159 ~~~~-----~~~--------~~~~~~~~~~~~~~~~~~---~~~-------------~~~~~~~~-~~~~~~~~~~~~~~ 208 (377)
T cd05629 159 YYQK-----LLQ--------GKSNKNRIDNRNSVAVDS---INL-------------TMSSKDQI-ATWKKNRRLMAYST 208 (377)
T ss_pred cccc-----ccc--------cccccccccccccccccc---ccc-------------cccchhhh-hhhhhccccccccc
Confidence 0000 000 000000000000000000 000 00000000 00000001111245
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC--CCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+||+.|+|||++.+..|+.++|||||||+||||++|++||.+....+.+..+.. ..+.+|....++.++++||.+||.
T Consensus 209 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred CCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc
Confidence 899999999999999999999999999999999999999998877777766654 345566655789999999999997
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~ 468 (506)
+|.+|++- .++.+++.||||.+++|+.++...++.+|.
T Consensus 289 -~~~~r~~r-~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~ 326 (377)
T cd05629 289 -NAENRLGR-GGAHEIKSHPFFRGVDWDTIRQIRAPFIPQ 326 (377)
T ss_pred -CHhhcCCC-CCHHHHhcCCCcCCCCHHHHccCCCCcccC
Confidence 88888642 359999999999999999887766666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-55 Score=411.62 Aligned_cols=252 Identities=28% Similarity=0.448 Sum_probs=219.2
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeE-EEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS-HFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~ 184 (506)
+...+.+|+|+++||.|+||.||++++..+|+.+|.|.|+-+.+. .+..+....|+.+|+.|+|||||++++ -|..+.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 445677899999999999999999999999999999999865544 455567788999999999999999999 455554
Q ss_pred -eEEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--eEEccCCCCcEEEecCCCEEEeec
Q 010603 185 -FSCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHM--MG--VVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~--~g--iiHrDLKp~NILl~~~~~vkl~DF 257 (506)
.++||||||.+|||..++++ ...+.++|..+|.++.|++.||.+||+ .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 49999999999999998876 345789999999999999999999999 44 999999999999999999999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
||++.+..
T Consensus 173 GL~r~l~s------------------------------------------------------------------------ 180 (375)
T KOG0591|consen 173 GLGRFLSS------------------------------------------------------------------------ 180 (375)
T ss_pred hhHhHhcc------------------------------------------------------------------------
Confidence 99965311
Q ss_pred cccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC-CCCCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK-FPEGSSIS 416 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~s 416 (506)
......++||||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-.+...+|.++.+. +| ...+|
T Consensus 181 -----~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-~~~YS 254 (375)
T KOG0591|consen 181 -----KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-DEHYS 254 (375)
T ss_pred -----hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc-HHHhh
Confidence 111245679999999999999999999999999999999999999999999777777788777554 33 24689
Q ss_pred HHHHHHHHHHhhcCCCCccC
Q 010603 417 FAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s 436 (506)
.++..||..|+..||+.||+
T Consensus 255 ~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred hHHHHHHHHHccCCcccCCC
Confidence 99999999999999999997
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-53 Score=427.72 Aligned_cols=262 Identities=40% Similarity=0.729 Sum_probs=229.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 196 (506)
+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++||||+++++++...+.+||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555667788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCc
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 276 (506)
+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------
Confidence 999988765 67999999999999999999999999999999999999999999999999998431000
Q ss_pred ccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCC
Q 010603 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356 (506)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 356 (506)
.......+||+.|
T Consensus 149 -------------------------------------------------------------------~~~~~~~~gt~~y 161 (323)
T cd05571 149 -------------------------------------------------------------------GATMKTFCGTPEY 161 (323)
T ss_pred -------------------------------------------------------------------CCcccceecCccc
Confidence 0001234799999
Q ss_pred ccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccC
Q 010603 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 357 ~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s 436 (506)
||||++.+..|+.++|||||||++|||++|+.||...+....+..+......+|. .++.++.+||.+||..||++||+
T Consensus 162 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999988777777777777666665 68999999999999999999995
Q ss_pred CCC-ChHHhhcCCCCCCCCcchhc
Q 010603 437 FKR-GATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 437 ~~~-~a~ell~hp~f~~~~~~~~~ 459 (506)
... ++.++++||||..++|....
T Consensus 240 ~~~~~~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 240 GGPEDAKEIMEHRFFASINWQDVV 263 (323)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHH
Confidence 321 49999999999999998664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-53 Score=432.25 Aligned_cols=315 Identities=35% Similarity=0.648 Sum_probs=242.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++||||++++++|.+.+++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36999999999999999999999999999999998765444555667788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998765 579999999999999999999999999999999999999999999999999986432111000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....... ..+. .....+..+ .... .................
T Consensus 159 ~~~~~~~-----------------~~~~-----~~~~~~~~~----------------~~~~-~~~~~~~~~~~~~~~~~ 199 (364)
T cd05599 159 FYRILSH-----------------ALPS-----NFLDFISKP----------------MSSK-RKAETWKRNRRALAYST 199 (364)
T ss_pred ccccccc-----------------cccc-----ccccccccc----------------cccc-ccccchhhccccccccc
Confidence 0000000 0000 000000000 0000 00000000011112345
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCCHHHHHHHHHHhh
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+||+.|||||++.+..|+.++|||||||++|||++|..||...+..+.+..+... .+.+|....+++++++||.+||.
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~ 279 (364)
T cd05599 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC 279 (364)
T ss_pred ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence 8999999999999999999999999999999999999999988877777776643 34455555689999999999996
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~ 468 (506)
+|.+|++. +++.++++||||+.++|..+....++.+|.
T Consensus 280 -~p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 280 -EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred -CHhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 99999975 469999999999999998776655555554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-54 Score=435.74 Aligned_cols=328 Identities=34% Similarity=0.606 Sum_probs=258.7
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+.-.-|..++.||-|+||.|.++...+|...||+|.++|.....++++..++.|+.||...+.+.||+||..|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 44456999999999999999999999999999999999988888889999999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc--
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV-- 265 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~-- 265 (506)
+||+|++|||+..+|-+. +.|+|+++++|++++..||+++|..|+|||||||+|||||.+|+|||+||||+..+.-
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999988776 7899999999999999999999999999999999999999999999999999854321
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
..+.-+..+.. +-.+--..+.+.+.+ .|.+ .++. +....-...
T Consensus 784 dskYYq~gdH~--RqDSmep~~e~~d~~--------------~~lk--vL~~-------------------ra~~~h~r~ 826 (1034)
T KOG0608|consen 784 DSKYYQEGDHH--RQDSMEPSPEWADIS--------------KCLK--VLER-------------------RAMRQHQRI 826 (1034)
T ss_pred ccccccCCCcc--ccccCCCchhhcccc--------------ccch--HHHH-------------------HHHhhhhhh
Confidence 11111110000 000000000000000 0000 0000 000011122
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC--CCCCCCCCCCCCHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~~~li 423 (506)
...+.+||+.|+|||+|...+|+..+||||.|||||||+.|++||-..+..+...++++ .-+.++....++.++.+||
T Consensus 827 ~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li 906 (1034)
T KOG0608|consen 827 LAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLI 906 (1034)
T ss_pred hhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHH
Confidence 34578999999999999999999999999999999999999999998888777766553 4466777778999999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC---CCCCCccC
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK---PVDLSFIN 476 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~---~~~~~~~~ 476 (506)
.+|. .+++.|++- ..++|++.||||++++|..++.+..+.||. |.|.+..+
T Consensus 907 ~kLc-~sad~RLGk-ng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFd 960 (1034)
T KOG0608|consen 907 QKLC-CSADSRLGK-NGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFD 960 (1034)
T ss_pred HHHh-cChhhhhcc-cchhhhhcCccccccchHhhhhccCCcCccccCCCccccCC
Confidence 9975 588999983 468889999999999999998887777775 44444443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=424.37 Aligned_cols=264 Identities=38% Similarity=0.741 Sum_probs=228.3
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHH---HhcCCCCccceeEEEEeCCeEEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL---SLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
|++++.||+|+||.||+|.++.+++.||||++++...........+..|++++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544444555666676665 566899999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--- 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---
Confidence 999999999887754 46999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (324)
T cd05589 155 --------------------------------------------------------------------------GDRTST 160 (324)
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 001123
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.+||+.|||||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++..+.+||.+||..
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~ 238 (324)
T cd05589 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLRR 238 (324)
T ss_pred cccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhc
Confidence 47999999999999999999999999999999999999999988888777777777666665 5899999999999999
Q ss_pred CCCCccCCCC-ChHHhhcCCCCCCCCcchh
Q 010603 430 DPQKRLGFKR-GATEIKQHPFFESVNWALI 458 (506)
Q Consensus 430 dP~~R~s~~~-~a~ell~hp~f~~~~~~~~ 458 (506)
||.+||+.++ ++.++++||||+.++|...
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 9999997543 5999999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=432.83 Aligned_cols=321 Identities=33% Similarity=0.557 Sum_probs=236.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|||||++++++.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 59999999999999999999999999999999987665555666778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999998765 5799999999999999999999999999999999999999999999999999854321100000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
...... .... .+.+......+...... .... .+.. ..............+
T Consensus 160 ~~~~~~--~~~~---------------~~~~~~~~~~~~~~~~~----~~~~----~~~~-----~~~~~~~~~~~~~~~ 209 (381)
T cd05626 160 YQKGSH--IRQD---------------SMEPSDLWDDVSNCRCG----DRLK----TLEQ-----RATKQHQRCLAHSLV 209 (381)
T ss_pred cccccc--cccc---------------ccCcccccccccccccc----cccc----hhhc-----ccccccccccccccc
Confidence 000000 0000 00000000000000000 0000 0000 000001111234568
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC--CCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+....+.. ..+.+|....+++++++||.+||..
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred CCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999999999999999999999999998877666666653 3455666567899999999997654
Q ss_pred --CCCCccCCCCChHHhhcCCCCCCCCcchh-ccCCCCCCCC
Q 010603 430 --DPQKRLGFKRGATEIKQHPFFESVNWALI-RSTHPPEIPK 468 (506)
Q Consensus 430 --dP~~R~s~~~~a~ell~hp~f~~~~~~~~-~~~~~~~~p~ 468 (506)
+|..|++ ++++++||||+.++|... ....+|.+|.
T Consensus 290 ~~~~~~R~~----~~~~l~hp~f~~~~~~~~~~~~~~~~~p~ 327 (381)
T cd05626 290 AEERLGRNG----ADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327 (381)
T ss_pred cccccCCCC----HHHHhcCcccCCCChhHHhhcCCCCccCc
Confidence 4445876 999999999999999753 3333344443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=428.40 Aligned_cols=305 Identities=35% Similarity=0.628 Sum_probs=238.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+++.||||++++...........+..|+.++..++||||+++++.+.+.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999998765544556677888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998765 579999999999999999999999999999999999999999999999999986432111000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
..... +... +..+......... ................
T Consensus 159 ~~~~~-------------~~~~--------------~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~ 196 (360)
T cd05627 159 FYRNL-------------THNP--------------PSDFSFQNMNSKR---------------KAETWKKNRRQLAYST 196 (360)
T ss_pred ccccc-------------ccCC--------------ccccccccccccc---------------cccccccccccccccc
Confidence 00000 0000 0000000000000 0000000111123356
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC--CCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.. ..+.+|....++.++++||.+|+
T Consensus 197 ~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~- 275 (360)
T cd05627 197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC- 275 (360)
T ss_pred CCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-
Confidence 899999999999999999999999999999999999999998888777777764 33456655568999999999987
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCCCcchhccC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRST 461 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~ 461 (506)
.||.+|++. .++.++++||||+.++|..+...
T Consensus 276 ~~p~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 276 TDSENRIGS-NGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred cChhhcCCC-CCHHHHhcCCCCCCCCHHHHhcC
Confidence 499999973 35899999999999999877544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-55 Score=401.60 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=231.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.+.|++.+.||+|.|+.||++.++.||+.||+|+++...+... ..+.+.+|++|-+.|+|||||+|++.+...+..|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3569999999999999999999999999999999998776654 667889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC---CCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED---GHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFGla~~~~~~ 266 (506)
+|+|.|++|..-|..+ ..++|..+-.+++||+.||+|+|.+||||||+||+|+||-.. --+||+|||+|..+..
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 9999999997655544 578999999999999999999999999999999999999753 3599999999965320
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
+..
T Consensus 166 -----------------------------------------------------------------------------g~~ 168 (355)
T KOG0033|consen 166 -----------------------------------------------------------------------------GEA 168 (355)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 111
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~li~ 424 (506)
...++|||.|||||++...+|+..+|||+.|||||-||.|++||.+.+....+.+|..+.+.++ .+..+++++++||+
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr 248 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR 248 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence 2345899999999999999999999999999999999999999999999999999998877765 56899999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+||..||.+|+| |.|+|+|||+.+-
T Consensus 249 rML~~dP~kRIt----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 249 RMLTVNPKKRIT----ADEALKHPWICNR 273 (355)
T ss_pred HHhccChhhhcc----HHHHhCCchhcch
Confidence 999999999998 9999999999753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=405.60 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=221.7
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--Ce
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KF 185 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~ 185 (506)
-.+++|+.+.+|++|+||.||+|+++.|++.||+|.++.+... ...--...+||.+|.+++|||||.+.+++... +.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 3456799999999999999999999999999999999865421 12223356899999999999999999998754 47
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+||||||| .-||..++..-+ .+|.+.+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||||+.+..
T Consensus 152 iy~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 152 IYIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999999 559999998764 6899999999999999999999999999999999999999999999999999976422
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.. .
T Consensus 230 p~-----------------------------------------------------------------------------k 232 (419)
T KOG0663|consen 230 PL-----------------------------------------------------------------------------K 232 (419)
T ss_pred Cc-----------------------------------------------------------------------------c
Confidence 11 1
Q ss_pred CccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC---------------
Q 010603 346 RSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP--------------- 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~--------------- 406 (506)
..+..+.|.+|+|||+|.+.. |+.++|+||+|||+.||+++++.|.+.++.+++.+|. +.+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 134568999999999999875 9999999999999999999999999999988876654 222
Q ss_pred -CCCCCC-----------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 407 -LKFPEG-----------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 407 -~~~p~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
..++.. ..+++...+|+..+|.+||.+|.| |.|+|+|.||.+..
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRETP 368 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccCC
Confidence 111110 125688999999999999999997 99999999998754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=420.91 Aligned_cols=258 Identities=40% Similarity=0.764 Sum_probs=227.8
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||+|+||+||+|++..+++.||||++.+...........+..|+++|+.++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999876544455566778899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCccc
Q 010603 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278 (506)
Q Consensus 199 ~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 278 (506)
.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9998765 57999999999999999999999999999999999999999999999999998421000
Q ss_pred ccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCcc
Q 010603 279 RISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLA 358 (506)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 358 (506)
.......+||+.|+|
T Consensus 147 -----------------------------------------------------------------~~~~~~~~gt~~y~a 161 (312)
T cd05585 147 -----------------------------------------------------------------DDKTNTFCGTPEYLA 161 (312)
T ss_pred -----------------------------------------------------------------CCccccccCCcccCC
Confidence 001123479999999
Q ss_pred chhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCC
Q 010603 359 PEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 359 PE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~ 438 (506)
||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+......+|. .+++++++||.+||..||.+||++
T Consensus 162 PE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~- 238 (312)
T cd05585 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGY- 238 (312)
T ss_pred HHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCC-
Confidence 99999999999999999999999999999999988888878888877777765 689999999999999999999985
Q ss_pred CChHHhhcCCCCCCCCcchh
Q 010603 439 RGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 439 ~~a~ell~hp~f~~~~~~~~ 458 (506)
.+|.++|.||||...+|...
T Consensus 239 ~~~~e~l~hp~~~~~~~~~~ 258 (312)
T cd05585 239 NGAQEIKNHPFFSQLSWKKL 258 (312)
T ss_pred CCHHHHHcCCCcCCCCHHHH
Confidence 35899999999999988654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=432.34 Aligned_cols=322 Identities=33% Similarity=0.556 Sum_probs=238.8
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|||||++++.|.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 59999999999999999999999999999999987655445566778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
||++|+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999998765 5789999999999999999999999999999999999999999999999999854321110000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......... . ..+. .+......|... .. ... .................+
T Consensus 160 ~~~~~~~~~~-----------~--~~~~-~~~~~~~~~~~~-------~~-------~~~--~~~~~~~~~~~~~~~~~~ 209 (382)
T cd05625 160 YQSGDHVRQD-----------S--MDFS-NEWGDPANCRCG-------DR-------LKP--LERRAARQHQRCLAHSLV 209 (382)
T ss_pred cccccccccc-----------c--cccc-cccccccccccc-------cc-------ccc--hhhhhccccccccccccc
Confidence 0000000000 0 0000 000000000000 00 000 000000001111223568
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC--CCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+....+.. ....+|....+++++.+||.+|+ .
T Consensus 210 gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 210 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-R 288 (382)
T ss_pred cCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-c
Confidence 99999999999999999999999999999999999999998887777766664 33455655678999999999986 5
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCCcchh-ccCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVNWALI-RSTHPPEIP 467 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~~~~~-~~~~~~~~p 467 (506)
+|.+|++. .+++++++||||+.++|... ....++.+|
T Consensus 289 ~p~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 326 (382)
T cd05625 289 GPEDRLGK-NGADEIKAHPFFKTIDFSSDLRQQSAPYIP 326 (382)
T ss_pred CHhHcCCC-CCHHHHhcCCCcCCcChHHHHhcCCCCccC
Confidence 99999973 45999999999999999753 333333333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=427.57 Aligned_cols=304 Identities=37% Similarity=0.696 Sum_probs=244.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+..|+++|+.++||||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36999999999999999999999999999999998766555556677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998876 679999999999999999999999999999999999999999999999999986532211000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....... ...+ .. ..... ..............
T Consensus 159 ~~~~~~~----------------------------~~~~-----~~--~~~~~-------------~~~~~~~~~~~~~~ 190 (350)
T cd05573 159 YYLNDSH----------------------------NLLF-----RD--NVLVR-------------RRDHKQRRVRANST 190 (350)
T ss_pred ccccccc----------------------------cccc-----cc--ccccc-------------cccccccccccccc
Confidence 0000000 0000 00 00000 00000011112345
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC--CCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--QPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+||+.|+|||++.+..++.++|||||||+||||++|+.||......+....+.. ....+|....+++++.+||.+||.
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~ 270 (350)
T cd05573 191 VGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC 270 (350)
T ss_pred ccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc
Confidence 799999999999999999999999999999999999999998887777777776 556666666689999999999997
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~ 468 (506)
||.+|++ +++++++||||+.++|.......++.+|.
T Consensus 271 -dp~~R~~---s~~~ll~hp~~~~~~~~~~~~~~~~~~~~ 306 (350)
T cd05573 271 -DPEDRLG---SFEEIKSHPFFKGIDWENLRETKPPFVPE 306 (350)
T ss_pred -ChhhcCC---CHHHHhcCCCcCCCCHHHHhhCCCCcCCC
Confidence 9999986 48999999999999998777666655554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=413.09 Aligned_cols=276 Identities=34% Similarity=0.600 Sum_probs=230.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++++.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+|+.++|+||+.+++++.+.+.+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 88999999999999999999999999999999876544444445667899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+++|+|..++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~------ 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG------ 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC------
Confidence 99999998876654557999999999999999999999999999999999999999999999999998532100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
......+|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05631 156 ------------------------------------------------------------------------ETVRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CeecCCCC
Confidence 00112369
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHH---HH-HHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET---LF-NVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~---~~-~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
|+.|||||++.+..|+.++|||||||+||||++|+.||........ +. .+......++ ..++.++.+||.+||.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~ 241 (285)
T cd05631 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLT 241 (285)
T ss_pred CCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhh
Confidence 9999999999999999999999999999999999999987654322 22 2222223333 3689999999999999
Q ss_pred cCCCCccCCC-CChHHhhcCCCCCCCCcchhccC--CCCCCCC
Q 010603 429 KDPQKRLGFK-RGATEIKQHPFFESVNWALIRST--HPPEIPK 468 (506)
Q Consensus 429 ~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~~--~~~~~p~ 468 (506)
.||.+||+.+ .+++++++||||+.++|..+... .||..|.
T Consensus 242 ~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 242 KNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred cCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 9999999853 35899999999999999877543 4454443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=417.76 Aligned_cols=267 Identities=36% Similarity=0.703 Sum_probs=232.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+|++++.||+|+||+||+|+++.+++.||||++.+..............|+.++..+ +|++|+.+++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544444555667788888777 5899999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999988765 57999999999999999999999999999999999999999999999999998431100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (323)
T cd05616 155 -------------------------------------------------------------------------GVTTKTF 161 (323)
T ss_pred -------------------------------------------------------------------------CCccccC
Confidence 0001234
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||+.|
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHcccC
Confidence 7999999999999999999999999999999999999999988888888888877766665 68999999999999999
Q ss_pred CCCccCCC-CChHHhhcCCCCCCCCcchhc
Q 010603 431 PQKRLGFK-RGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 431 P~~R~s~~-~~a~ell~hp~f~~~~~~~~~ 459 (506)
|.+|++.. ....++++||||..++|....
T Consensus 240 p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~ 269 (323)
T cd05616 240 PGKRLGCGPEGERDIKEHAFFRYIDWEKLE 269 (323)
T ss_pred HHhcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 99999852 246899999999999998664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=419.41 Aligned_cols=272 Identities=38% Similarity=0.642 Sum_probs=235.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|++..+++.||||++.+...........+..|+++|+.++||||+++++++...+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998765544455667788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999998765 5789999999999999999999999999999999999999999999999999843110
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.....
T Consensus 154 ---------------------------------------------------------------------------~~~~~ 158 (333)
T cd05600 154 ---------------------------------------------------------------------------YANSV 158 (333)
T ss_pred ---------------------------------------------------------------------------ccCCc
Confidence 01234
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC--CCCCCC----CCCCHHHHHHHH
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP--LKFPEG----SSISFAAKDLIR 424 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~----~~~s~~~~~li~ 424 (506)
+||+.|+|||++.+..++.++|||||||+||||++|..||...+..+.+..+.... +..|.. ..++.++.+||.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 79999999999999999999999999999999999999999887776665554322 222222 256899999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~ 468 (506)
+||..+|.+|++ +.++++||||..++|..+....++.+|.
T Consensus 239 ~~l~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T cd05600 239 KLINDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPPFVPE 278 (333)
T ss_pred HHhhChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCCC
Confidence 999999999987 9999999999999998877666666554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=428.83 Aligned_cols=320 Identities=32% Similarity=0.556 Sum_probs=238.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+++|+.++||||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999998765544455667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998765 578999999999999999999999999999999999999999999999999985432110000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
............ .. .+. ........... ..................
T Consensus 159 ~~~~~~~~~~~~--~~--------------~~~---------~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 204 (376)
T cd05598 159 YYQKGDHHRQDS--ME--------------PSE---------EWSEIDRCRLK---------PLERRRKRQHQRCLAHSL 204 (376)
T ss_pred cccccccccccc--cc--------------ccc---------ccccccccccc---------chhhhhhhhccccccccc
Confidence 000000000000 00 000 00000000000 000000000111122356
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCCHHHHHHHHHHhh
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+||+.|||||++.+..++.++|||||||+||||++|+.||.+....+....+... ...++....++.++.+||.+|+
T Consensus 205 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 205 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC- 283 (376)
T ss_pred CCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-
Confidence 8999999999999999999999999999999999999999988877766665543 3344555578999999999976
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCCCcchhc-cCCCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIR-STHPPEIPK 468 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~-~~~~~~~p~ 468 (506)
.+|.+|++. .++.++++||||+.++|.... ...++.+|.
T Consensus 284 ~~p~~R~~~-~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~ 323 (376)
T cd05598 284 CGAEDRLGK-NGADEIKAHPFFKGIDFASLIRRQKAPYIPK 323 (376)
T ss_pred cCHhhcCCC-CCHHHHhCCCCcCCCCHHHHhhcCCCCCCCc
Confidence 599999942 149999999999999998763 333444443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-52 Score=425.95 Aligned_cols=281 Identities=34% Similarity=0.662 Sum_probs=232.3
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
...+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34556688999999999999999999999999999999998754444444556778999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999999998653 58999999999999999999999999999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
... .
T Consensus 194 ~~~----------------------------------------------------------------------------~ 197 (370)
T cd05621 194 ETG----------------------------------------------------------------------------M 197 (370)
T ss_pred cCC----------------------------------------------------------------------------c
Confidence 000 0
Q ss_pred CCccccccCCCCccchhhcCCC----CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCCHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDG----HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSISFA 418 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s~~ 418 (506)
......+||+.|||||++.+.. ++.++|||||||+||||++|+.||.+.+....+.++... .+.+|....++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 0112347999999999997643 788999999999999999999999988877777777653 3556666678999
Q ss_pred HHHHHHHHhhcCCCC--ccCCCCChHHhhcCCCCCCCCcc--hhccCCCCCCCC
Q 010603 419 AKDLIRGLLVKDPQK--RLGFKRGATEIKQHPFFESVNWA--LIRSTHPPEIPK 468 (506)
Q Consensus 419 ~~~li~~~L~~dP~~--R~s~~~~a~ell~hp~f~~~~~~--~~~~~~~~~~p~ 468 (506)
+++||.+||..++.+ |++ +.|+++||||+...|. ..+...++..|.
T Consensus 278 ~~~li~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVPE 327 (370)
T ss_pred HHHHHHHHccCchhccCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCCC
Confidence 999999999844433 555 9999999999987664 333334444443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=413.28 Aligned_cols=254 Identities=30% Similarity=0.531 Sum_probs=234.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|++.+.||+|+||+|-+|.....|+.||||.|+|+.+.....+..+++|++||..|+||||+.+|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 46999999999999999999999999999999999999998999999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||..+|+|++|+..+ +.++|..++.+|+||+.|+.|||.++|+|||||.+|||||.++++||+||||+..+.
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~------ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA------ 204 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc------
Confidence 999999999999887 789999999999999999999999999999999999999999999999999984321
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......++
T Consensus 205 ------------------------------------------------------------------------~~kfLqTF 212 (668)
T KOG0611|consen 205 ------------------------------------------------------------------------DKKFLQTF 212 (668)
T ss_pred ------------------------------------------------------------------------cccHHHHh
Confidence 11123467
Q ss_pred ccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
||+|.|.+||++.|.+| ++.+|-|||||+||-|+.|..||++.+....+.+|..+.+.-|. -+.++.-||+.||..
T Consensus 213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmV 289 (668)
T KOG0611|consen 213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMV 289 (668)
T ss_pred cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhc
Confidence 99999999999999998 88999999999999999999999999999999999888777665 566788999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~ 451 (506)
||++|.| +++|-.|-|++
T Consensus 290 NP~RRAT----ieDiAsHWWvN 307 (668)
T KOG0611|consen 290 NPERRAT----IEDIASHWWVN 307 (668)
T ss_pred Ccccchh----HHHHhhhheee
Confidence 9999987 89999999973
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=424.39 Aligned_cols=281 Identities=34% Similarity=0.638 Sum_probs=236.5
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
...+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+..|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34566788999999999999999999999999999999998755444445556778999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999999998865 358999999999999999999999999999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
... .
T Consensus 194 ~~~----------------------------------------------------------------------------~ 197 (370)
T cd05596 194 ANG----------------------------------------------------------------------------M 197 (370)
T ss_pred CCC----------------------------------------------------------------------------c
Confidence 000 0
Q ss_pred CCccccccCCCCccchhhcCC----CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCCHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGD----GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSISFA 418 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~----~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s~~ 418 (506)
......+||+.|||||++.+. .++.++|||||||+||||++|+.||.+.+....+.++... .+.+|....++.+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 001124799999999999754 3789999999999999999999999988887777777654 3556666678999
Q ss_pred HHHHHHHHhhcCCCC--ccCCCCChHHhhcCCCCCCCCcch--hccCCCCCCCC
Q 010603 419 AKDLIRGLLVKDPQK--RLGFKRGATEIKQHPFFESVNWAL--IRSTHPPEIPK 468 (506)
Q Consensus 419 ~~~li~~~L~~dP~~--R~s~~~~a~ell~hp~f~~~~~~~--~~~~~~~~~p~ 468 (506)
+++||.+||..+|.+ |++ ++++++||||+..+|.. .+...++.+|.
T Consensus 278 ~~~li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred HHHHHHHHccChhhccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCccCc
Confidence 999999999999987 876 99999999999988864 33444444443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-52 Score=419.75 Aligned_cols=276 Identities=37% Similarity=0.673 Sum_probs=236.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||+|+||+||+|+++.+|+.||||++++...........+..|+.+++.++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36999999999999999999999999999999998765544455667888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 999999999998765 25799999999999999999999999999999999999999999999999999854211000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (330)
T cd05601 158 --------------------------------------------------------------------------VNSKLP 163 (330)
T ss_pred --------------------------------------------------------------------------eeeecc
Confidence 001123
Q ss_pred ccCCCCccchhhc------CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCCHHHHHH
Q 010603 351 VGTHEYLAPEIIR------GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSISFAAKDL 422 (506)
Q Consensus 351 ~GT~~Y~APE~l~------~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s~~~~~l 422 (506)
+||+.|+|||++. ...++.++|||||||+||||++|+.||...+....+.++... ...+|....++.++.+|
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 243 (330)
T cd05601 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDL 243 (330)
T ss_pred cCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHH
Confidence 6999999999997 456789999999999999999999999988877777776543 34556555789999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~ 468 (506)
|.+||. +|.+||+ ++++++||||..++|..+....++..|.
T Consensus 244 i~~ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~~ 284 (330)
T cd05601 244 IQSLLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFVPT 284 (330)
T ss_pred HHHHcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCc
Confidence 999998 9999998 8999999999999999877655555443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=414.23 Aligned_cols=267 Identities=36% Similarity=0.710 Sum_probs=231.8
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC-CccceeEEEEeCCeEEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP-FLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~ 190 (506)
+|++++.||+|+||.||+|+++.+++.||||++.+...........+..|+++++.++|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 599999999999999999999999999999999876554445566778899999999765 6889999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC----
Confidence 999999999988765 57899999999999999999999999999999999999999999999999997421100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (324)
T cd05587 155 -------------------------------------------------------------------------GKTTRTF 161 (324)
T ss_pred -------------------------------------------------------------------------CCceeee
Confidence 0001234
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..|
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTKH 239 (324)
T ss_pred cCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcC
Confidence 7999999999999999999999999999999999999999988888888888777666665 68999999999999999
Q ss_pred CCCccCCC-CChHHhhcCCCCCCCCcchhc
Q 010603 431 PQKRLGFK-RGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 431 P~~R~s~~-~~a~ell~hp~f~~~~~~~~~ 459 (506)
|.+|++.. ...+++++||||+.++|..+.
T Consensus 240 P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~ 269 (324)
T cd05587 240 PAKRLGCGPTGERDIREHAFFRRIDWEKLE 269 (324)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 99999853 235899999999999997653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=416.07 Aligned_cols=263 Identities=38% Similarity=0.740 Sum_probs=228.9
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+++.||||++.+...........+..|++++..+ +||||++++++|...+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554445556677899998866 899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--------- 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---------
Confidence 9999888765 57999999999999999999999999999999999999999999999999998431100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (321)
T cd05591 150 --------------------------------------------------------------------GVTTTTFCGTPD 161 (321)
T ss_pred --------------------------------------------------------------------CccccccccCcc
Confidence 000122469999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|+|||++.+..|+.++|||||||++|||++|+.||...+..+.+..+......+|. .++.++.+||.+||..||++|+
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred ccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcC
Confidence 99999999999999999999999999999999999998888888888877666665 5899999999999999999999
Q ss_pred CCCC---ChHHhhcCCCCCCCCcchhcc
Q 010603 436 GFKR---GATEIKQHPFFESVNWALIRS 460 (506)
Q Consensus 436 s~~~---~a~ell~hp~f~~~~~~~~~~ 460 (506)
+... +++++++||||..++|..+..
T Consensus 240 ~~~~~~~~~~~~~~hp~~~~~~~~~~~~ 267 (321)
T cd05591 240 GCVASQGGEDAIKQHPFFKEIDWVLLEQ 267 (321)
T ss_pred CCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 6543 699999999999999986643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-53 Score=427.53 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=227.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
..|....+||+|+-|.||.|....+++.||||.|+.... ...+.+.+|+.+|+.++|+|||.+++.|...+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 458889999999999999999999999999999987643 33345678999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++... .++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||++.++..
T Consensus 350 Eym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~----- 421 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE----- 421 (550)
T ss_pred eecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc-----
Confidence 999999999988764 599999999999999999999999999999999999999999999999999854311
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
...+..+.
T Consensus 422 ------------------------------------------------------------------------~~~KR~Tm 429 (550)
T KOG0578|consen 422 ------------------------------------------------------------------------EQSKRSTM 429 (550)
T ss_pred ------------------------------------------------------------------------ccCccccc
Confidence 11134466
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
+|||+|||||++....|++++||||||++++||+-|++||-..+....+..|. ++.+.+.....+|+.++|||.+||+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999999877776666665 45566777778999999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|+++|++ |.|||+||||+.
T Consensus 510 dv~~Ras----A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 510 DVEQRAS----AKELLEHPFLKM 528 (550)
T ss_pred chhcCCC----HHHHhcChhhhh
Confidence 9999987 999999999953
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=414.89 Aligned_cols=262 Identities=37% Similarity=0.729 Sum_probs=226.7
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+++.||||++.+...........+..|++++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544445566677888888876 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999988765 57999999999999999999999999999999999999999999999999997431100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (320)
T cd05590 150 --------------------------------------------------------------------GKTTSTFCGTPD 161 (320)
T ss_pred --------------------------------------------------------------------CCcccccccCcc
Confidence 000122469999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|||||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++++||.+||+.||.+|+
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred ccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHCC
Confidence 99999999999999999999999999999999999998888888888877666665 5899999999999999999999
Q ss_pred CCCC--ChHHhhcCCCCCCCCcchhc
Q 010603 436 GFKR--GATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~~--~a~ell~hp~f~~~~~~~~~ 459 (506)
+... ..+++++||||+.++|..+.
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~~~~~~~ 265 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKELDWEKLN 265 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 8311 13899999999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-52 Score=408.27 Aligned_cols=269 Identities=30% Similarity=0.454 Sum_probs=233.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+..++|++...||.|.-++||+|++..++..||||+++.+.... .+..+++|+..|+.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 345677999999999999999999999999999999999776543 377889999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||.||.+|++.++++......++|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..++..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999999999877778999999999999999999999999999999999999999999999999987443221
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. .....+
T Consensus 180 G-------------------------------------------------------------------------~R~~~r 186 (516)
T KOG0582|consen 180 G-------------------------------------------------------------------------DRQVTR 186 (516)
T ss_pred C-------------------------------------------------------------------------ceeeEe
Confidence 1 001112
Q ss_pred ccccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--------CCCCCC
Q 010603 347 SMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--------EGSSIS 416 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--------~~~~~s 416 (506)
..+++||++|||||++.. .+|+.|+||||||+...||.+|..||........+..-+++....+ ....++
T Consensus 187 f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ 266 (516)
T KOG0582|consen 187 FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFS 266 (516)
T ss_pred eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhc
Confidence 256799999999999764 4799999999999999999999999999888888877666654422 223567
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
..++.+|..||++||.+||| |+++|+|+||+...
T Consensus 267 ksf~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 267 KSFREMIALCLVKDPSKRPT----ASKLLKHAFFKKAK 300 (516)
T ss_pred HHHHHHHHHHhhcCcccCCC----HHHHhccHHHhhcc
Confidence 78999999999999999997 99999999998653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=416.46 Aligned_cols=261 Identities=41% Similarity=0.748 Sum_probs=227.8
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 196 (506)
+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555667788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCc
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 276 (506)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999888765 57999999999999999999999999999999999999999999999999998431000
Q ss_pred ccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCC
Q 010603 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356 (506)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 356 (506)
.......+||+.|
T Consensus 149 -------------------------------------------------------------------~~~~~~~~gt~~y 161 (328)
T cd05593 149 -------------------------------------------------------------------AATMKTFCGTPEY 161 (328)
T ss_pred -------------------------------------------------------------------ccccccccCCcCc
Confidence 0001224799999
Q ss_pred ccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccC
Q 010603 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 357 ~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s 436 (506)
+|||++.+..++.++|||||||+||||++|+.||...+..+....+......+|. .++.++.+||.+||..||.+|++
T Consensus 162 ~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred cChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999999999999999999999999999999888777777777666666665 68999999999999999999985
Q ss_pred C-CCChHHhhcCCCCCCCCcchh
Q 010603 437 F-KRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 437 ~-~~~a~ell~hp~f~~~~~~~~ 458 (506)
. .+++.++++||||...+|..+
T Consensus 240 ~~~~~~~~il~h~~~~~~~~~~~ 262 (328)
T cd05593 240 GGPDDAKEIMRHSFFTGVNWQDV 262 (328)
T ss_pred CCCCCHHHHhcCCCcCCCCHHHH
Confidence 3 235999999999999999755
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-53 Score=410.39 Aligned_cols=283 Identities=36% Similarity=0.688 Sum_probs=253.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
..+...+|.++.+||+|+||+|.+|..+.+.+.||||+++|+.+-....++--..|.++|... +-|++++|+.+|++-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 357778899999999999999999999999999999999998877667777677899999887 5689999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+||||+.||||...++.. +.+-|..|.+|+++|+-||=|||++|||+||||.+||||+.+|+|||+|||+++.-.
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999998888776 789999999999999999999999999999999999999999999999999974310
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..+
T Consensus 502 -----------------------------------------------------------------------------~~~ 504 (683)
T KOG0696|consen 502 -----------------------------------------------------------------------------FDG 504 (683)
T ss_pred -----------------------------------------------------------------------------cCC
Confidence 012
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
..+.+++|||.|+|||++..++|+..+||||+||+|||||.|++||++.++.+.+..|......+|. .+|.++.++++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK--slSkEAv~ick 582 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK--SLSKEAVAICK 582 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc--cccHHHHHHHH
Confidence 2355789999999999999999999999999999999999999999999999999999999989987 69999999999
Q ss_pred HHhhcCCCCccCCCC-ChHHhhcCCCCCCCCcchhc--cCCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKR-GATEIKQHPFFESVNWALIR--STHPPEIPKP 469 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~-~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~ 469 (506)
.+|.+.|.+|++..+ .-.+|..||||..++|..+. ...||.-|+.
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 999999999998633 35789999999999998764 4456666665
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=412.22 Aligned_cols=261 Identities=32% Similarity=0.500 Sum_probs=217.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC--eEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK--FSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~l 188 (506)
.+|...+.||+|+||.||++.+.++|..+|||.+..... ...+.+.+|+.+|+.|+|||||+++|...... .++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 347888999999999999999999999999999876521 12666889999999999999999999855444 6999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCccccccCC
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla~~~~~~~ 267 (506)
+|||+++|+|.+++.+..+ .++|..++.|.+||+.||+|||++|||||||||+||||+. +|.+||+|||++.......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999865 8999999999999999999999999999999999999999 7999999999985422100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. .....
T Consensus 173 ~--------------------------------------------------------------------------~~~~~ 178 (313)
T KOG0198|consen 173 T--------------------------------------------------------------------------KSDSE 178 (313)
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 01112
Q ss_pred cccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCC-CCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKG-NGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
..+.||+.|||||++..+. .+.++|||||||++.||+||+.||.. ....+.+..+.......+.+..++.++++||.+
T Consensus 179 ~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~ 258 (313)
T KOG0198|consen 179 LSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRK 258 (313)
T ss_pred ccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHH
Confidence 3458999999999999632 34599999999999999999999987 455555566554431112334699999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||..||++||| |+++|+|||....
T Consensus 259 C~~~~p~~Rpt----a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 259 CFKRDPEKRPT----AEELLEHPFLKQN 282 (313)
T ss_pred HhhcCcccCcC----HHHHhhChhhhcc
Confidence 99999999997 9999999999754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=414.34 Aligned_cols=262 Identities=39% Similarity=0.727 Sum_probs=228.0
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 196 (506)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+++|+.++||||++++++|...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544455667788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCc
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 276 (506)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------
Confidence 999888765 57999999999999999999999999999999999999999999999999987421000
Q ss_pred ccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCC
Q 010603 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356 (506)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 356 (506)
.......+||+.|
T Consensus 149 -------------------------------------------------------------------~~~~~~~~gt~~y 161 (323)
T cd05595 149 -------------------------------------------------------------------GATMKTFCGTPEY 161 (323)
T ss_pred -------------------------------------------------------------------CCccccccCCcCc
Confidence 0001124699999
Q ss_pred ccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccC
Q 010603 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 357 ~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s 436 (506)
+|||++.+..++.++|||||||+||||++|+.||...+....+..+......+|. .+++++.+||.+||..||.+|++
T Consensus 162 ~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred CCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCC
Confidence 9999999999999999999999999999999999988877777777766666665 68999999999999999999985
Q ss_pred CC-CChHHhhcCCCCCCCCcchhc
Q 010603 437 FK-RGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 437 ~~-~~a~ell~hp~f~~~~~~~~~ 459 (506)
.. .++.++++||||..++|....
T Consensus 240 ~~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHH
Confidence 32 259999999999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=420.05 Aligned_cols=284 Identities=35% Similarity=0.671 Sum_probs=235.3
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
...++..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34566678999999999999999999999999999999999875444444455677899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+.+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999999999988753 5899999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
....
T Consensus 193 ~~~~---------------------------------------------------------------------------- 196 (371)
T cd05622 193 NKEG---------------------------------------------------------------------------- 196 (371)
T ss_pred CcCC----------------------------------------------------------------------------
Confidence 1000
Q ss_pred CCCccccccCCCCccchhhcCCC----CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC--CCCCCCCCCCH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDG----HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP--LKFPEGSSISF 417 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~s~ 417 (506)
.......+||+.|||||++.+.. ++.++|||||||+||||++|+.||.+.+....+..+.... +.+|....++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 00112347999999999997643 7899999999999999999999999888777777776543 55666667999
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc--hhccCCCCCCCC
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA--LIRSTHPPEIPK 468 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~--~~~~~~~~~~p~ 468 (506)
.+++||.+||. +|..|++. .+++++++||||+..+|. .++...++.+|.
T Consensus 277 ~~~~li~~~L~-~~~~r~~r-~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T cd05622 277 EAKNLICAFLT-DREVRLGR-NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPD 327 (371)
T ss_pred HHHHHHHHHcC-ChhhhcCC-CCHHHHhcCcccCCCChhHHhcCCCCCCCCCC
Confidence 99999999998 66665542 359999999999987664 444444444443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=419.63 Aligned_cols=259 Identities=38% Similarity=0.609 Sum_probs=235.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 188 (506)
...|++.+.||.|.||+||+|+++.||+.||+|++.|...........+.+|+.||+.+. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 345999999999999999999999999999999999988766666678899999999998 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC----CCEEEeecCCccccc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED----GHIMLSDFDLSLRCF 264 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----~~vkl~DFGla~~~~ 264 (506)
|||+|.||+|++.+... .++|..+..++.||+.|+.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999998876 39999999999999999999999999999999999999753 479999999996421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
. .
T Consensus 191 ~------------------------------------------------------------------------------~ 192 (382)
T KOG0032|consen 191 P------------------------------------------------------------------------------G 192 (382)
T ss_pred C------------------------------------------------------------------------------C
Confidence 1 2
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKDL 422 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~l 422 (506)
.+...++||+.|+|||++...+|+..+||||+||++|.|++|.+||.+.+..+...++....+.++ .+..++..+++|
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~ 272 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF 272 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence 234567999999999999999999999999999999999999999999999999999988876654 557899999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
|++||..||.+|++ |.++|+|||++..
T Consensus 273 i~~ll~~dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred HHHhcccCcccCCC----HHHHhcCccccCC
Confidence 99999999999997 9999999999865
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=410.08 Aligned_cols=268 Identities=36% Similarity=0.713 Sum_probs=232.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+|++.+.||+|+||+||+|+++.+|+.||||++.+...........+..|+++++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444455566778899988885 578889999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~---- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC----
Confidence 999999999988765 57999999999999999999999999999999999999999999999999998431100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (323)
T cd05615 155 -------------------------------------------------------------------------GVTTRTF 161 (323)
T ss_pred -------------------------------------------------------------------------CccccCc
Confidence 0001124
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
+||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..+......+|. .++.++.+|+.+||..|
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTKH 239 (323)
T ss_pred cCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccC
Confidence 6999999999999999999999999999999999999999988887778888777766665 58999999999999999
Q ss_pred CCCccCCC-CChHHhhcCCCCCCCCcchhcc
Q 010603 431 PQKRLGFK-RGATEIKQHPFFESVNWALIRS 460 (506)
Q Consensus 431 P~~R~s~~-~~a~ell~hp~f~~~~~~~~~~ 460 (506)
|.+|++.. ..++++++||||+.++|..+..
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~ 270 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence 99999853 2478999999999999987643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=409.37 Aligned_cols=259 Identities=37% Similarity=0.746 Sum_probs=222.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||.||+|+++.+|+.||||++++..............|++++..+ +||||+++++++.+.+++|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876443334455567788888754 899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---------
Confidence 9999988764 57899999999999999999999999999999999999999999999999987421000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (316)
T cd05620 150 --------------------------------------------------------------------DNRASTFCGTPD 161 (316)
T ss_pred --------------------------------------------------------------------CCceeccCCCcC
Confidence 001123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++++||.+||..||.+|+
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred ccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcC
Confidence 99999999999999999999999999999999999988877777776655555554 5899999999999999999999
Q ss_pred CCCCChHHhhcCCCCCCCCcchhc
Q 010603 436 GFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
++ ++++++||||+.++|..+.
T Consensus 240 ~~---~~~~~~h~~f~~~~~~~~~ 260 (316)
T cd05620 240 GV---VGNIRGHPFFKTINWTALE 260 (316)
T ss_pred CC---hHHHHcCCCcCCCCHHHHH
Confidence 83 4789999999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=411.36 Aligned_cols=263 Identities=38% Similarity=0.765 Sum_probs=223.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+++.||||++++...........+..|+.+++.+ +||||++++++|.+.+.+|||||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555566778899999888 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--------- 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC---------
Confidence 9999888765 67999999999999999999999999999999999999999999999999997421000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (329)
T cd05588 150 --------------------------------------------------------------------GDTTSTFCGTPN 161 (329)
T ss_pred --------------------------------------------------------------------CCccccccCCcc
Confidence 001123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC--------cHH-HHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--------NRE-TLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~--------~~~-~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
|+|||++.+..++.++|||||||++|||++|+.||.... ..+ ....+......+|. .++..+.+||.+|
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~ 239 (329)
T cd05588 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGF 239 (329)
T ss_pred ccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHH
Confidence 999999999999999999999999999999999996321 112 33445555566665 6899999999999
Q ss_pred hhcCCCCccCCC--CChHHhhcCCCCCCCCcchhcc
Q 010603 427 LVKDPQKRLGFK--RGATEIKQHPFFESVNWALIRS 460 (506)
Q Consensus 427 L~~dP~~R~s~~--~~a~ell~hp~f~~~~~~~~~~ 460 (506)
|..||.+|++.. .+++++++||||..++|..+..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence 999999999843 3589999999999999986643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-51 Score=410.56 Aligned_cols=262 Identities=40% Similarity=0.716 Sum_probs=226.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHH-HHHhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE-ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|+. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443444445555655 46789999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--------- 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---------
Confidence 9999988765 57999999999999999999999999999999999999999999999999997421000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (323)
T cd05575 150 --------------------------------------------------------------------SKTTSTFCGTPE 161 (323)
T ss_pred --------------------------------------------------------------------CCccccccCChh
Confidence 001123469999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|+|||++.+..++.++|||||||+||||++|+.||...+..+.+..+......++. .++..+.+||.+||+.||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP--NISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHhCC
Confidence 99999999999999999999999999999999999988887777888777666654 5799999999999999999999
Q ss_pred CCCCChHHhhcCCCCCCCCcchhc
Q 010603 436 GFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
+.++...+++.||||..++|..+.
T Consensus 240 ~~~~~~~~il~~~~~~~~~~~~~~ 263 (323)
T cd05575 240 GAKDDFLEIKNHVFFSSINWDDLV 263 (323)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHh
Confidence 977677899999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=411.61 Aligned_cols=262 Identities=40% Similarity=0.704 Sum_probs=226.0
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHH-HHHhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE-ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|+. +++.++||||+++++++..++.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765443444445555655 47789999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--------- 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--------- 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---------
Confidence 9999888764 67999999999999999999999999999999999999999999999999997421000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (325)
T cd05604 150 --------------------------------------------------------------------SDTTTTFCGTPE 161 (325)
T ss_pred --------------------------------------------------------------------CCCcccccCChh
Confidence 001123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|||||++.+..++.++|||||||++|||++|+.||...+..+.+..+......++. .++..+.++|.+||..||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP--GASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC--CCCHHHHHHHHHHhccCHHhcC
Confidence 99999999999999999999999999999999999988887777777776655544 5889999999999999999999
Q ss_pred CCCCChHHhhcCCCCCCCCcchhc
Q 010603 436 GFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
+.+....++++||||+.++|..+.
T Consensus 240 ~~~~~~~~i~~h~~f~~~~~~~~~ 263 (325)
T cd05604 240 GAKEDFLEIQEHPFFESLSWTDLE 263 (325)
T ss_pred CCCCCHHHHhcCCCcCCCCHHHHH
Confidence 988788999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=400.83 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=220.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-----CCe
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-----DKF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~ 185 (506)
..|..++.||.|+||.|+.|.++.+|+.||||.|... +......++..+|+.+|+.++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3466689999999999999999999999999998642 3445677888999999999999999999999865 357
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+|+|+| +.||...++.. ..++++.+++++.||+.||.|+|+.||+||||||.|||++.+..+||+|||||+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999 88999999875 5599999999999999999999999999999999999999999999999999964311
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. ....
T Consensus 178 ~---------------------------------------------------------------------------~~~~ 182 (359)
T KOG0660|consen 178 F---------------------------------------------------------------------------FEDG 182 (359)
T ss_pred c---------------------------------------------------------------------------Cccc
Confidence 0 1122
Q ss_pred CccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC---------------
Q 010603 346 RSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP--------------- 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~--------------- 406 (506)
..+.++.|.+|+|||++.. ..|+.++||||+||||+|||+|++.|.+.+..+++..++. .+
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~ 262 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP 262 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence 3567899999999999865 4699999999999999999999999999987776655442 11
Q ss_pred -----CCCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 -----LKFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 -----~~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...|. -...++.+.|||.+||..||.+|+| |+|+|+||||...
T Consensus 263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAPY 316 (359)
T ss_pred HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHhcChhhhhh
Confidence 01111 1257889999999999999999998 9999999999864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=408.01 Aligned_cols=259 Identities=39% Similarity=0.785 Sum_probs=222.6
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh-cCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|++..+++.||||++++..............|++++.. ++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999987654434445555667777765 4899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999988765 57999999999999999999999999999999999999999999999999998531100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (316)
T cd05592 150 --------------------------------------------------------------------EGKASTFCGTPD 161 (316)
T ss_pred --------------------------------------------------------------------CCccccccCCcc
Confidence 001123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||.+|+
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--WISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred ccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcC
Confidence 99999999999999999999999999999999999988887777777766555554 5899999999999999999999
Q ss_pred CCCCChHHhhcCCCCCCCCcchhc
Q 010603 436 GFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
++ +.++++||||..++|..+.
T Consensus 240 ~~---~~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05592 240 GV---DGDIRQHPFFRGIDWERLE 260 (316)
T ss_pred CC---hHHHHcCcccCCCCHHHHH
Confidence 73 5789999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=407.49 Aligned_cols=262 Identities=39% Similarity=0.771 Sum_probs=225.9
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|.++.+++.||||++.+...........+..|+++++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876554455566677899999887 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--------- 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---------
Confidence 9999888765 57999999999999999999999999999999999999999999999999987421000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~g~~~ 161 (318)
T cd05570 150 --------------------------------------------------------------------GVTTSTFCGTPD 161 (318)
T ss_pred --------------------------------------------------------------------CCcccceecCcc
Confidence 000122469999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+|. .++..+.+||.+||..||.+||
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred ccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcC
Confidence 99999999999999999999999999999999999988877777777776666664 6899999999999999999999
Q ss_pred CCC-CChHHhhcCCCCCCCCcchhc
Q 010603 436 GFK-RGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~-~~a~ell~hp~f~~~~~~~~~ 459 (506)
+.. ..+.+++.||||..++|....
T Consensus 240 s~~~~~~~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREIDWDKLE 264 (318)
T ss_pred CCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 831 113999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=410.59 Aligned_cols=262 Identities=39% Similarity=0.728 Sum_probs=227.2
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 196 (506)
+.||+|+||+||+|.++.+|+.||+|++.+...........+..|+++++.++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555667788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
+|..++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999888765 579999999999999999999997 79999999999999999999999999997431100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (325)
T cd05594 150 --------------------------------------------------------------------GATMKTFCGTPE 161 (325)
T ss_pred --------------------------------------------------------------------CcccccccCCcc
Confidence 000112469999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|||||++.+..++.++|||||||+||||++|+.||.+.+..+....+......+|. .+++++.+||.+||+.||++|+
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred cCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhC
Confidence 99999999999999999999999999999999999888777777777666666665 6899999999999999999998
Q ss_pred CCC-CChHHhhcCCCCCCCCcchhc
Q 010603 436 GFK-RGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~-~~a~ell~hp~f~~~~~~~~~ 459 (506)
+.. +++.++++||||..+.|....
T Consensus 240 ~~~~~~~~~il~h~~~~~~~~~~~~ 264 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGIVWQDVY 264 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 532 359999999999999997553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=407.52 Aligned_cols=263 Identities=40% Similarity=0.745 Sum_probs=224.9
Q ss_pred EeEEeecCceEEEEEEEc---cCCceEEEEEeccchhh-chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 116 LKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLA-GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
++.||+|+||.||+|++. .+++.||||++.+.... .......+..|+++|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 46889999999875432 22334556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999988765 57899999999999999999999999999999999999999999999999998431100
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......+
T Consensus 154 ------------------------------------------------------------------------~~~~~~~~ 161 (323)
T cd05584 154 ------------------------------------------------------------------------GTVTHTFC 161 (323)
T ss_pred ------------------------------------------------------------------------CCcccccC
Confidence 00012246
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
||+.|+|||++.+..++.++|||||||+||||++|+.||...+....+..+......+|. .+++++.+||.+||..||
T Consensus 162 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP--YLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcccCH
Confidence 999999999999989999999999999999999999999988887777788777666655 689999999999999999
Q ss_pred CCccCC-CCChHHhhcCCCCCCCCcchhc
Q 010603 432 QKRLGF-KRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 432 ~~R~s~-~~~a~ell~hp~f~~~~~~~~~ 459 (506)
++||+. ..++++++.||||...+|....
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 999942 2249999999999999997653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=407.56 Aligned_cols=278 Identities=35% Similarity=0.660 Sum_probs=229.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998754444445556788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC---
Confidence 999999999998763 2578999999999999999999999999999999999999999999999999984321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (332)
T cd05623 157 -------------------------------------------------------------------------TVQSSVA 163 (332)
T ss_pred -------------------------------------------------------------------------cceeccc
Confidence 0001123
Q ss_pred ccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC--CCCCC-CCCCHHHHHH
Q 010603 351 VGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL--KFPEG-SSISFAAKDL 422 (506)
Q Consensus 351 ~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~-~~~s~~~~~l 422 (506)
+||+.|||||++. ...++.++|||||||+||||++|+.||...+..+.+..+..... .+|.. ..+++++++|
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~l 243 (332)
T cd05623 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDL 243 (332)
T ss_pred ccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHH
Confidence 6999999999986 34588999999999999999999999998888787777765543 23332 3579999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p 467 (506)
|.+||..++.+ ++ +.+++++++||||..++|..+....++.+|
T Consensus 244 i~~ll~~~~~r-~~-r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~ 286 (332)
T cd05623 244 IRRLICSREHR-LG-QNGIEDFKQHPFFTGIDWDNIRNCEAPYIP 286 (332)
T ss_pred HHHHccChhhh-cC-CCCHHHHhCCCCcCCCCHHHHhhCCCCccC
Confidence 99999865444 32 124999999999999999887665544444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=407.38 Aligned_cols=262 Identities=36% Similarity=0.738 Sum_probs=220.5
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999886555455566778899888766 899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--------- 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---------
Confidence 9999887765 57999999999999999999999999999999999999999999999999998431000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (329)
T cd05618 150 --------------------------------------------------------------------GDTTSTFCGTPN 161 (329)
T ss_pred --------------------------------------------------------------------CCccccccCCcc
Confidence 000123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC--------CcH-HHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN--------GNR-ETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~--------~~~-~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
|+|||++.+..++.++|||||||++|||++|+.||... ... .....+......+|. .++..+.+||.+|
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~ 239 (329)
T cd05618 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSF 239 (329)
T ss_pred ccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHH
Confidence 99999999999999999999999999999999999521 111 223345555566665 6899999999999
Q ss_pred hhcCCCCccCCC--CChHHhhcCCCCCCCCcchhc
Q 010603 427 LVKDPQKRLGFK--RGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 427 L~~dP~~R~s~~--~~a~ell~hp~f~~~~~~~~~ 459 (506)
|..||.+|++.. .+++++++||||+.++|....
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~ 274 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLME 274 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence 999999999842 236899999999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=405.30 Aligned_cols=261 Identities=39% Similarity=0.711 Sum_probs=224.9
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHH-HHHhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE-ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|++..+++.||||++.+...........+..|+. +++.++||||+++++++.+.+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443344445555554 57889999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--------- 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---------
Confidence 9999887764 57899999999999999999999999999999999999999999999999987421000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (321)
T cd05603 150 --------------------------------------------------------------------EETTSTFCGTPE 161 (321)
T ss_pred --------------------------------------------------------------------CCccccccCCcc
Confidence 000123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|+|||++.+..++.++|||||||++|||++|+.||...+....+..+...+..+|. ..+.++.++|.+||+.||.+|+
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG--GKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred cCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHhhcC
Confidence 99999999989999999999999999999999999988877777788877766665 5789999999999999999999
Q ss_pred CCCCChHHhhcCCCCCCCCcchh
Q 010603 436 GFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 436 s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
+....+.++++|+||..++|..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T cd05603 240 GAKADFLEIKNHVFFSPINWDDL 262 (321)
T ss_pred CCCCCHHHHhCCCCcCCCCHHHH
Confidence 97667889999999999999765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=406.20 Aligned_cols=262 Identities=39% Similarity=0.687 Sum_probs=224.4
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHH-HHHhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE-ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998754433333334444444 57889999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--------- 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--------- 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---------
Confidence 9999988765 57899999999999999999999999999999999999999999999999998431100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (325)
T cd05602 150 --------------------------------------------------------------------NGTTSTFCGTPE 161 (325)
T ss_pred --------------------------------------------------------------------CCCcccccCCcc
Confidence 000123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|||||++.+..++.++|||||||++|||++|++||.+.+..+.+..+......++. .++..+.+||.+||+.||.+|+
T Consensus 162 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred ccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCC--CCCHHHHHHHHHHcccCHHHCC
Confidence 99999999999999999999999999999999999988888877777766655544 6899999999999999999999
Q ss_pred CCCCChHHhhcCCCCCCCCcchhc
Q 010603 436 GFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
+..+...++++|+||..++|..+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 240 GAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred CCCCCHHHHhcCcccCCCCHHHHH
Confidence 987778899999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=405.76 Aligned_cols=264 Identities=36% Similarity=0.734 Sum_probs=223.5
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|+++.+++.||||++.+...........+..|+.++..+ +||||+.+++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999886655555667788899998887 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------- 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--------- 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---------
Confidence 9999888765 57999999999999999999999999999999999999999999999999987421000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (327)
T cd05617 150 --------------------------------------------------------------------GDTTSTFCGTPN 161 (327)
T ss_pred --------------------------------------------------------------------CCceecccCCcc
Confidence 000123479999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC------CcHH-HHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN------GNRE-TLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~------~~~~-~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
|+|||++.+..++.++|||||||+||||++|+.||... ...+ ....+...+..+|. .++..+.+||.+||.
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 239 (327)
T cd05617 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLKGFLN 239 (327)
T ss_pred cCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999532 1222 33444555555655 689999999999999
Q ss_pred cCCCCccCCC--CChHHhhcCCCCCCCCcchhccC
Q 010603 429 KDPQKRLGFK--RGATEIKQHPFFESVNWALIRST 461 (506)
Q Consensus 429 ~dP~~R~s~~--~~a~ell~hp~f~~~~~~~~~~~ 461 (506)
.||.+|++.. ...++++.||||+.++|..+...
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~ 274 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK 274 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhC
Confidence 9999999853 34689999999999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=403.68 Aligned_cols=278 Identities=36% Similarity=0.703 Sum_probs=228.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+++.++|+||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36999999999999999999999999999999998754444455566788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--- 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC---
Confidence 999999999998763 3579999999999999999999999999999999999999999999999999984321100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (331)
T cd05597 157 -------------------------------------------------------------------------TVQSNVA 163 (331)
T ss_pred -------------------------------------------------------------------------Cccccce
Confidence 0001123
Q ss_pred ccCCCCccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC--CCCCC-CCCCCHHHHHH
Q 010603 351 VGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP--LKFPE-GSSISFAAKDL 422 (506)
Q Consensus 351 ~GT~~Y~APE~l~~-----~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~-~~~~s~~~~~l 422 (506)
+||+.|||||++.+ ..++.++|||||||+||||++|+.||.+....+.+..+.... ..++. ...++..+++|
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 243 (331)
T cd05597 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDL 243 (331)
T ss_pred eccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHH
Confidence 69999999999973 457889999999999999999999999887777776665432 23332 23589999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p 467 (506)
|.+||.. |.+|++ +.++.++++||||..++|.......++.+|
T Consensus 244 i~~ll~~-~~~r~~-r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~ 286 (331)
T cd05597 244 IRRLICS-PETRLG-RNGLQDFKDHPFFEGIDWDNIRNSTAPYVP 286 (331)
T ss_pred HHHHccC-cccccC-CCCHHHHhcCCCCCCCCHHHHhhCCCCccC
Confidence 9999975 444432 124999999999999999877665555444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=402.22 Aligned_cols=259 Identities=37% Similarity=0.772 Sum_probs=221.0
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh-cCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+||+||+|++..+++.||||++++..............|+.++.. ++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987644333444556678888876 4999999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999988764 57899999999999999999999999999999999999999999999999998431000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (316)
T cd05619 150 --------------------------------------------------------------------DAKTCTFCGTPD 161 (316)
T ss_pred --------------------------------------------------------------------CCceeeecCCcc
Confidence 000123469999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++++||.+||..||.+|+
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred ccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcC
Confidence 99999999999999999999999999999999999988777766666555545554 5899999999999999999999
Q ss_pred CCCCChHHhhcCCCCCCCCcchhc
Q 010603 436 GFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 436 s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
++ .+++++||||+.++|..+.
T Consensus 240 ~~---~~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05619 240 GV---KGDIRQHPFFREIDWSALE 260 (316)
T ss_pred CC---hHHHHcCcccCCCCHHHHH
Confidence 83 3599999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=406.20 Aligned_cols=279 Identities=34% Similarity=0.656 Sum_probs=231.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|+.+++.++|+||+++++++.+.+..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998754443444556788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--- 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC---
Confidence 999999999998763 2578999999999999999999999999999999999999999999999999985321100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (331)
T cd05624 157 -------------------------------------------------------------------------TVQSSVA 163 (331)
T ss_pred -------------------------------------------------------------------------ceeeccc
Confidence 0001123
Q ss_pred ccCCCCccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC--CCCCCC-CCCCHHHHHH
Q 010603 351 VGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP--LKFPEG-SSISFAAKDL 422 (506)
Q Consensus 351 ~GT~~Y~APE~l~~-----~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~-~~~s~~~~~l 422 (506)
+||+.|||||++.+ ..++.++|||||||+||||++|+.||...+..+.+..+.... +.+|.. ..++.++++|
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~l 243 (331)
T cd05624 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDL 243 (331)
T ss_pred cCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHH
Confidence 69999999999976 467899999999999999999999999888777777776543 333332 3578999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~ 468 (506)
|.+||..++ +|+. ..+++++++||||+.++|..++...++.+|.
T Consensus 244 i~~ll~~~~-~~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~ 287 (331)
T cd05624 244 IQRLICSRE-RRLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYIPD 287 (331)
T ss_pred HHHHccCch-hhcC-CCCHHHHhcCCCcCCCCHHHHhhCCCCccCC
Confidence 999999655 4443 2359999999999999999887666555554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=401.17 Aligned_cols=312 Identities=57% Similarity=0.993 Sum_probs=254.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|++.+.||+|+||.||+|.+..+++.||||.+.+...........+..|+++|+.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36999999999999999999999999999999998765554456677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+.|++|.+++....+..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999887666789999999999999999999999999999999999999999999999999985432111000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....... .... .....................
T Consensus 161 ~~~~~~~--------------------------------------~~~~----------~~~~~~~~~~~~~~~~~~~~~ 192 (316)
T cd05574 161 SKALRKG--------------------------------------SRRS----------SVNSIPSETFSEEPSFRSNSF 192 (316)
T ss_pred ccccccc--------------------------------------cccc----------cccccchhhhcccccCCCCCC
Confidence 0000000 0000 000000011111222233456
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+......++....++..+++||.+||..|
T Consensus 193 ~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 272 (316)
T cd05574 193 VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKD 272 (316)
T ss_pred cCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCC
Confidence 89999999999999889999999999999999999999999888888888887777777765568999999999999999
Q ss_pred CCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPV 470 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~~ 470 (506)
|++||+.+..++++|+||||+..+|..++...+|.+|.+.
T Consensus 273 p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 273 PSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred HhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 9999987777999999999999999999888777776653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=387.51 Aligned_cols=259 Identities=32% Similarity=0.497 Sum_probs=227.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh-----chhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA-----GRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
..|.-.+.||.|..++|-++.++.+|+.+|+|+|...... .....+.-.+|+.||+.+ .||+|++|.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3477778999999999999999999999999999753221 122334457899999987 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+++|+|+|+.|.|++++... -.++|..++.|++|++.|++|||.++||||||||+|||++++.++||+|||+|.++.
T Consensus 97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999999876 679999999999999999999999999999999999999999999999999985432
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
. +
T Consensus 175 ~------------------------------------------------------------------------------G 176 (411)
T KOG0599|consen 175 P------------------------------------------------------------------------------G 176 (411)
T ss_pred C------------------------------------------------------------------------------c
Confidence 2 2
Q ss_pred CCccccccCCCCccchhhcC------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC--CCCCCCC
Q 010603 345 ARSMSFVGTHEYLAPEIIRG------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF--PEGSSIS 416 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~s 416 (506)
.+....||||.|+|||.+.+ .+|+..+|+|++|||||.||.|.+||......-++..|..+.+.| |+|.+++
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis 256 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADIS 256 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhcc
Confidence 23445699999999999974 368999999999999999999999999888777888888887766 6778999
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...+|||.+||+.||.+|+| ++|+|+||||..+
T Consensus 257 ~~~KdLIsrlLqVdp~~Rit----ake~LaHpff~q~ 289 (411)
T KOG0599|consen 257 ATVKDLISRLLQVDPTKRIT----AKEALAHPFFIQI 289 (411)
T ss_pred ccHHHHHHHHHeeCchhccc----HHHHhcChHHHHH
Confidence 99999999999999999998 9999999999654
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=404.30 Aligned_cols=268 Identities=46% Similarity=0.820 Sum_probs=220.6
Q ss_pred CeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhh-chhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLA-GRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 186 (506)
+|++++.||+|+||+||+|++. .+++.||+|++.+.... .......+..|+.+|+.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4999999999999999999874 47899999999865432 223445677899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999988765 57999999999999999999999999999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. ...
T Consensus 159 ~----------------------------------------------------------------------------~~~ 162 (332)
T cd05614 159 E----------------------------------------------------------------------------KER 162 (332)
T ss_pred C----------------------------------------------------------------------------CCc
Confidence 0 001
Q ss_pred ccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
....+||+.|||||++.+.. ++.++|||||||+||||++|+.||..... ......+......++. .++..+.+
T Consensus 163 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 240 (332)
T cd05614 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS--FIGPEAQD 240 (332)
T ss_pred cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHH
Confidence 12347999999999998754 78999999999999999999999964322 2233344444444443 68999999
Q ss_pred HHHHHhhcCCCCccCCC-CChHHhhcCCCCCCCCcchhc
Q 010603 422 LIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~ 459 (506)
||.+||..||++||+.. .+++++++||||+..+|....
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 99999999999999642 258999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=397.21 Aligned_cols=263 Identities=33% Similarity=0.643 Sum_probs=220.7
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||+|+||+||+|.++.+++.||+|++.+...........+..|+++|+.++||||+++++++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999876554444556678899999999999999999999999999999999999999
Q ss_pred HHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCc
Q 010603 199 HTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276 (506)
Q Consensus 199 ~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 276 (506)
..++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 8877542 33579999999999999999999999999999999999999999999999999984321000
Q ss_pred ccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCC
Q 010603 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356 (506)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 356 (506)
.......||+.|
T Consensus 152 --------------------------------------------------------------------~~~~~~~g~~~y 163 (280)
T cd05608 152 --------------------------------------------------------------------SKTKGYAGTPGF 163 (280)
T ss_pred --------------------------------------------------------------------ccccccCCCcCc
Confidence 001123689999
Q ss_pred ccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH----HHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 010603 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR----ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQ 432 (506)
Q Consensus 357 ~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~ 432 (506)
+|||++.+..++.++|||||||++|||++|+.||...... .....+......++. .++.++.+|+.+||+.||+
T Consensus 164 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~ 241 (280)
T cd05608 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPE 241 (280)
T ss_pred cCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc--cCCHHHHHHHHHHhcCCHH
Confidence 9999999999999999999999999999999999765432 222333334334433 6899999999999999999
Q ss_pred CccCCCC-ChHHhhcCCCCCCCCcchhcc
Q 010603 433 KRLGFKR-GATEIKQHPFFESVNWALIRS 460 (506)
Q Consensus 433 ~R~s~~~-~a~ell~hp~f~~~~~~~~~~ 460 (506)
+||+++. +++++++||||+.++|..+..
T Consensus 242 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 242 KRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred HhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence 9998754 799999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=407.30 Aligned_cols=261 Identities=38% Similarity=0.714 Sum_probs=223.9
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc---CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
||+|+||+||+|+++.+++.||||++.+..............|..++..+ +||||+.+++++...+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999875544444455556677777655 799999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--------- 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--------- 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---------
Confidence 9999888765 67999999999999999999999999999999999999999999999999998431100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+||+.
T Consensus 150 --------------------------------------------------------------------~~~~~~~~gt~~ 161 (330)
T cd05586 150 --------------------------------------------------------------------NKTTNTFCGTTE 161 (330)
T ss_pred --------------------------------------------------------------------CCCccCccCCcc
Confidence 000123479999
Q ss_pred CccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 356 YLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 356 Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
|||||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..+......++.. .+++++.+||.+||..||.+|
T Consensus 162 y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred ccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHcCCCHHHC
Confidence 9999999765 48999999999999999999999999888777777777666666643 579999999999999999999
Q ss_pred cCCCCChHHhhcCCCCCCCCcchhc
Q 010603 435 LGFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 435 ~s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
|+..+++.++++||||...+|....
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~~~~~~ 265 (330)
T cd05586 241 LGAHRDAVELKEHPFFADIDWDLLS 265 (330)
T ss_pred CCCCCCHHHHhcCccccCCCHHHHH
Confidence 9887789999999999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=384.89 Aligned_cols=320 Identities=35% Similarity=0.692 Sum_probs=260.8
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETD 183 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 183 (506)
.+.+.+.+|.++++||+|+|++|.++++++|.+.||+|+++|+.+...+.+.-++.|..+.... +||++|-|+.+|+++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3457889999999999999999999999999999999999999988888888899999997765 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..+++|.||++||+|.-.++++ +.++|+.+++|..+|+.||.|||++|||+||||.+|+||+..|++||+|+|+.+.-
T Consensus 324 srlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999998777765 78999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
. ..
T Consensus 402 l-----------------------------------------------------------------------------~~ 404 (593)
T KOG0695|consen 402 L-----------------------------------------------------------------------------GP 404 (593)
T ss_pred C-----------------------------------------------------------------------------CC
Confidence 0 01
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC-------CCcHHHHHH-HhCCCCCCCCCCCC
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKG-------NGNRETLFN-VVGQPLKFPEGSSI 415 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~-------~~~~~~~~~-i~~~~~~~p~~~~~ 415 (506)
+..+.++||||.|+|||++.+..|+..+|||+|||+++||+.|+.||+- .+..+.+++ |+.+.+++|. .+
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--sl 482 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SL 482 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--ee
Confidence 1224568999999999999999999999999999999999999999952 223344554 5566777776 68
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCC--ChHHhhcCCCCCCCCcchhccC--CCCCCCCCC---CCCccCccCCCCCCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKR--GATEIKQHPFFESVNWALIRST--HPPEIPKPV---DLSFINHKQKTPIPQNDK 488 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~--~a~ell~hp~f~~~~~~~~~~~--~~~~~p~~~---~~~~~~~~~~~~~~~~~~ 488 (506)
+-.+..+++..|.+||.+|++..+ ...++..|+||..++|+.+... .||.-|.-. .....++.-....+|...
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltp 562 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTP 562 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCC
Confidence 888889999999999999998743 4789999999999999977443 455555422 233333333334444444
Q ss_pred CCCCCCC--CCCCCCCccc
Q 010603 489 GAADSDR--SSGPFLDFEF 505 (506)
Q Consensus 489 ~~~~~~~--~~~~~~~~~~ 505 (506)
...+..+ -...|-.|||
T Consensus 563 dd~d~i~ridqsefegfey 581 (593)
T KOG0695|consen 563 DDEDAIKRIDQSEFEGFEY 581 (593)
T ss_pred CCHHHHHhcchhhcCccee
Confidence 3332211 1235677776
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=404.36 Aligned_cols=262 Identities=41% Similarity=0.799 Sum_probs=224.9
Q ss_pred EeEEeecCceEEEEEEEc---cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 116 LKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
++.||+|+||.||++++. .+|+.||+|++.+..... .....+..|+++|+.++||||+++++++.+.+.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 368999999999999873 578999999998754332 2334567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------ 151 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------ 151 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC------
Confidence 9999999988764 57999999999999999999999999999999999999999999999999998431100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......+|
T Consensus 152 -----------------------------------------------------------------------~~~~~~~~g 160 (318)
T cd05582 152 -----------------------------------------------------------------------EKKAYSFCG 160 (318)
T ss_pred -----------------------------------------------------------------------CCceecccC
Confidence 000123479
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQ 432 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~ 432 (506)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+......+|. .+++.+.+||.+||+.||.
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHh
Confidence 99999999999989999999999999999999999999988887777777776666665 5899999999999999999
Q ss_pred CccCCCC-ChHHhhcCCCCCCCCcchhc
Q 010603 433 KRLGFKR-GATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 433 ~R~s~~~-~a~ell~hp~f~~~~~~~~~ 459 (506)
+||+..+ .+.+++.||||..++|..+.
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTIDWNKLY 266 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence 9998532 37889999999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=394.82 Aligned_cols=271 Identities=34% Similarity=0.590 Sum_probs=226.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|++.+.||+|+||+||++.+..+++.||||++.+...........+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 38999999999999999999999999999999987554433444556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 999999998887654567999999999999999999999999999999999999999999999999998432100
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
......+
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (285)
T cd05605 156 -------------------------------------------------------------------------ETIRGRV 162 (285)
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0011236
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHH----HhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN----VVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~----i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+......... +......++ ..++..+.+||.+||
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l 240 (285)
T cd05605 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLL 240 (285)
T ss_pred CCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHc
Confidence 89999999999988899999999999999999999999987655433222 222223333 358999999999999
Q ss_pred hcCCCCccCCC-CChHHhhcCCCCCCCCcchhccCC
Q 010603 428 VKDPQKRLGFK-RGATEIKQHPFFESVNWALIRSTH 462 (506)
Q Consensus 428 ~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~~~ 462 (506)
..||.+||++. .+++++++||||...+|..+....
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05605 241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276 (285)
T ss_pred cCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCC
Confidence 99999999542 248999999999999998775443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=418.10 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=219.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-C-----CCccceeEEEEeCC
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-H-----PFLPTLYSHFETDK 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~ 184 (506)
.+|.|++.||+|+||+|.+|.+..|++.||||+++.. .....+.+.|+.||..|+ | -|||+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 4799999999999999999999999999999999865 466777889999999997 4 38999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC--CEEEeecCCccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG--HIMLSDFDLSLR 262 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~--~vkl~DFGla~~ 262 (506)
|+|||+|++ ..+|+++++.+.-..++...++.++.||+.||.+||++||||+|||||||||.+-+ .|||+|||.|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 88999999998888999999999999999999999999999999999999998754 699999998732
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.
T Consensus 341 ~------------------------------------------------------------------------------- 341 (586)
T KOG0667|consen 341 E------------------------------------------------------------------------------- 341 (586)
T ss_pred c-------------------------------------------------------------------------------
Confidence 1
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL------------ 407 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~------------ 407 (506)
..+..+++.++.|+|||+|.|.+|+.++||||||||++||++|.+.|.++++.+++..|+. .+.
T Consensus 342 -~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 342 -SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred -CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 1112356899999999999999999999999999999999999999999999888876652 110
Q ss_pred ------C-------------------------------CC-CCC--------CCCHHHHHHHHHHhhcCCCCccCCCCCh
Q 010603 408 ------K-------------------------------FP-EGS--------SISFAAKDLIRGLLVKDPQKRLGFKRGA 441 (506)
Q Consensus 408 ------~-------------------------------~p-~~~--------~~s~~~~~li~~~L~~dP~~R~s~~~~a 441 (506)
. .| ... .-...+.|||++||..||.+|+| +
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t----p 496 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT----P 496 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC----H
Confidence 0 01 000 01124789999999999999997 9
Q ss_pred HHhhcCCCCCCC
Q 010603 442 TEIKQHPFFESV 453 (506)
Q Consensus 442 ~ell~hp~f~~~ 453 (506)
.++|+||||...
T Consensus 497 ~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 497 AQALNHPFLTGT 508 (586)
T ss_pred HHHhcCcccccc
Confidence 999999999853
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=390.63 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=220.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC-ccceeEEEEeCC----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF-LPTLYSHFETDK---- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~---- 184 (506)
+..|+.+++||+|+||+||+|+.+.+|+.||+|.++..... +..-....+|+.+|+.|+|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45588889999999999999999999999999999865432 123344678999999999999 999999999887
Q ss_pred --eEEEEEeecCCCChHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 185 --FSCLLMEFCSGGDLHTLRQRQPG--KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 185 --~~~lV~E~~~gg~L~~~l~~~~~--~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
.++|||||+ .-||..++...+. ..++...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 7799999988653 46888999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+......
T Consensus 168 ra~~ip~------------------------------------------------------------------------- 174 (323)
T KOG0594|consen 168 RAFSIPM------------------------------------------------------------------------- 174 (323)
T ss_pred HHhcCCc-------------------------------------------------------------------------
Confidence 6421110
Q ss_pred CCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC--CC------
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP--LK------ 408 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~--~~------ 408 (506)
...+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+..+.+++..|. +.+ ..
T Consensus 175 ----~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 175 ----RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred ----ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 002234899999999999988 68999999999999999999999999999988876654 322 11
Q ss_pred -------CCCC----------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 409 -------FPEG----------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 409 -------~p~~----------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
++.+ ...++++.+++.+||+.+|.+|.+ |..+|.||||....
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSELP 309 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhcccc
Confidence 1111 123357899999999999999998 99999999998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=404.36 Aligned_cols=252 Identities=27% Similarity=0.452 Sum_probs=215.8
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCce-EEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCL-FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK- 184 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 184 (506)
.+...+..+.+.||.|+||+||+|.++ |.. ||||++......... ...+.+|+.+|.+|+|||||+++|++..+.
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344455667777999999999999999 666 999999876555444 778999999999999999999999999888
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEccCCCCcEEEecCC-CEEEeecCCccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG-VVYRDLKPENVLVREDG-HIMLSDFDLSLR 262 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g-iiHrDLKp~NILl~~~~-~vkl~DFGla~~ 262 (506)
.++|||||+++|+|..++.......++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 7999999999999999998854578999999999999999999999999 99999999999999998 999999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 194 ~~~~~--------------------------------------------------------------------------- 198 (362)
T KOG0192|consen 194 KVISK--------------------------------------------------------------------------- 198 (362)
T ss_pred ecccc---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCCCccccccCCCCccchhhc--CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIR--GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~--~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.+....+....++....+.+....+++.+.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 0112247999999999999 568999999999999999999999999999887666666655444444445999999
Q ss_pred HHHHHHhhcCCCCccCCC
Q 010603 421 DLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~ 438 (506)
.||.+||..||..||++.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFL 294 (362)
T ss_pred HHHHHhCCCCCCcCCCHH
Confidence 999999999999999964
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=403.56 Aligned_cols=259 Identities=32% Similarity=0.511 Sum_probs=233.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+-|.+.+.||+|.|++|-+|++.-||..||||+|+|..+... ....+.+|++.|+.++|||||+||++..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 448899999999999999999999999999999999776543 3345677999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe-cCCCEEEeecCCccccccCCcc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-EDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|+=.+|||++||.++. ..+.|+.+++||+||+.||.|||+..||||||||+|+++- +-|-|||.|||++-.+...
T Consensus 97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--- 172 (864)
T ss_pred EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc---
Confidence 9999999999998874 6799999999999999999999999999999999998765 5689999999998432211
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
...++
T Consensus 173 ---------------------------------------------------------------------------~kL~T 177 (864)
T KOG4717|consen 173 ---------------------------------------------------------------------------KKLTT 177 (864)
T ss_pred ---------------------------------------------------------------------------chhhc
Confidence 12345
Q ss_pred cccCCCCccchhhcCCCCC-cchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHG-SAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~-~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
.||++.|-|||+|.|..|+ +++||||||||||.|++|++||+..++.+.+..|+...+..|. .++.+|+|||..||.
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs--hvS~eCrdLI~sMLv 255 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS--HVSKECRDLIQSMLV 255 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch--hhhHHHHHHHHHHHh
Confidence 6899999999999999995 5899999999999999999999999999999999999999887 699999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
.||.+|.+ .++|..|+|++.++-
T Consensus 256 RdPkkRAs----lEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 256 RDPKKRAS----LEEIVSTSWLQAGDR 278 (864)
T ss_pred cCchhhcc----HHHHhccccccCCCC
Confidence 99999987 899999999998873
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=405.49 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=225.7
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|+.++.||+|+||.||+|.+..+++.||||+++.+.. ...+..+++|+.+|..++++||.++|+.|..+..++++|||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 8888999999999999999999999999999987643 45567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
|.||++.++++.. ..+.|..+..++++++.||.|||..+.||||||+.|||+..+|.|||+|||.+.++..
T Consensus 93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~------- 163 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN------- 163 (467)
T ss_pred hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-------
Confidence 9999999998764 4559999999999999999999999999999999999999999999999999854211
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
...+..+++|
T Consensus 164 ----------------------------------------------------------------------~~~rr~tfvG 173 (467)
T KOG0201|consen 164 ----------------------------------------------------------------------TVKRRKTFVG 173 (467)
T ss_pred ----------------------------------------------------------------------hhhccccccc
Confidence 1122356799
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQ 432 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~ 432 (506)
||.|||||++.+.+|+.++||||||++.+||++|.+||........++.|-...++.-+. .+++.+++||..||.+||+
T Consensus 174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~ 252 (467)
T KOG0201|consen 174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKEFVEACLDKNPE 252 (467)
T ss_pred cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHHHHHHHhhcCcc
Confidence 999999999999899999999999999999999999999888866666655444333333 7999999999999999999
Q ss_pred CccCCCCChHHhhcCCCCCCC
Q 010603 433 KRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 433 ~R~s~~~~a~ell~hp~f~~~ 453 (506)
.||+ |.++|+|+|++..
T Consensus 253 ~Rps----A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 253 FRPS----AKELLKHKFIKRA 269 (467)
T ss_pred cCcC----HHHHhhhHHHHhc
Confidence 9998 9999999999863
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=388.97 Aligned_cols=263 Identities=31% Similarity=0.561 Sum_probs=219.5
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||+|+||.||+++++.+|+.||+|++.+...........+..|+++|+.++||||++++++++.+.++|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999865544333444556799999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCccc
Q 010603 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278 (506)
Q Consensus 199 ~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 278 (506)
.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------ 148 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------ 148 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence 98887665567899999999999999999999999999999999999999999999999998432100
Q ss_pred ccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCcc
Q 010603 279 RISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLA 358 (506)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 358 (506)
.......||+.|+|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~~~y~a 162 (277)
T cd05607 149 ------------------------------------------------------------------KTITQRAGTNGYMA 162 (277)
T ss_pred ------------------------------------------------------------------ceeeccCCCCCccC
Confidence 00011258999999
Q ss_pred chhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH----HHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 359 PEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR----ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 359 PE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
||++.+..++.++|||||||++|||++|+.||...... +...........++. ..++.++++||.+||+.||++|
T Consensus 163 PE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R 241 (277)
T cd05607 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH-QNFTEESKDICRLFLAKKPEDR 241 (277)
T ss_pred HHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc-ccCCHHHHHHHHHHhccCHhhC
Confidence 99999989999999999999999999999999764332 222333333333322 3689999999999999999999
Q ss_pred cCCCCChHHhhcCCCCCCCCcchhcc
Q 010603 435 LGFKRGATEIKQHPFFESVNWALIRS 460 (506)
Q Consensus 435 ~s~~~~a~ell~hp~f~~~~~~~~~~ 460 (506)
|+.++..++++.||||+.++|..+..
T Consensus 242 ~~~~~~~~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 242 LGSREKNDDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred CCCccchhhhhcChhhcCCCHHHHhc
Confidence 99665568999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=391.51 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=212.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+++.||||++...... ......+.+|+++++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 3699999999999999999999999999999999765322 233456778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++++.|..+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 99988877655443 2579999999999999999999999999999999999999999999999999985321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (287)
T cd07848 155 -------------------------------------------------------------------------NANYTEY 161 (287)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001124
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-------------------CCCCCC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-------------------PLKFPE 411 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~p~ 411 (506)
.||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+... ...++.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07848 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPA 241 (287)
T ss_pred ccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCc
Confidence 6899999999999989999999999999999999999999887665544332211 011111
Q ss_pred C-----------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 G-----------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 ~-----------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
. ..++.++.+||++||+.||++||+ ++++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred ccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 0 136788999999999999999998 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=393.90 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=209.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+++.||||++..... ......+.+|+.+++.++||||+++++++.++...|+||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 569999999999999999999999999999999976432 122335677999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 157 (303)
T cd07869 83 EYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--- 157 (303)
T ss_pred ECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence 999 56888777654 2568999999999999999999999999999999999999999999999999984311000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (303)
T cd07869 158 --------------------------------------------------------------------------HTYSNE 163 (303)
T ss_pred --------------------------------------------------------------------------ccCCCC
Confidence 001123
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHH---hCCCC--CC--------------
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNV---VGQPL--KF-------------- 409 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i---~~~~~--~~-------------- 409 (506)
.||+.|+|||++.+. .++.++|||||||+||||++|..||.+.... +.+..+ ...+. .+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 689999999998764 5899999999999999999999999875443 222222 11110 00
Q ss_pred ----CC-------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 410 ----PE-------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 410 ----p~-------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
+. ...++.++.+||.+||+.||.+||| +.|+|+||||+.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~ 296 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPP 296 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCCh
Confidence 00 0124578899999999999999998 999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=404.91 Aligned_cols=284 Identities=37% Similarity=0.663 Sum_probs=253.6
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
...++.+.+++++..||-|+||.|-++..+.....+|+|+++|...-..++...+..|..||..++.|+||+||-.|.+.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 34567888999999999999999999999876667999999998887788888899999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.++|++||-|-||.|+..++.+ +.|++..+++|+..++.|++|||++|||+|||||+|+||+.+|.+||.|||+|+.+
T Consensus 493 kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999999998876 78999999999999999999999999999999999999999999999999999764
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 571 ~~------------------------------------------------------------------------------ 572 (732)
T KOG0614|consen 571 GS------------------------------------------------------------------------------ 572 (732)
T ss_pred cc------------------------------------------------------------------------------
Confidence 22
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
+.++-++||||.|.|||++...+++.++|.||||+++||||+|.+||.+.++...+..|+.+.-.+..+..++..+.+||
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 22344679999999999999999999999999999999999999999999999999888876433333357999999999
Q ss_pred HHHhhcCCCCccCC-CCChHHhhcCCCCCCCCcchhccC--CCCCCC
Q 010603 424 RGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALIRST--HPPEIP 467 (506)
Q Consensus 424 ~~~L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~~~--~~~~~p 467 (506)
+++...+|.+|++. +..+.+|.+|.||.++||.-++.. .||.+|
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~ 699 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIP 699 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccc
Confidence 99999999999985 457999999999999999976543 444444
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=414.26 Aligned_cols=255 Identities=26% Similarity=0.356 Sum_probs=203.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC------CCCccceeEEEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD------HPFLPTLYSHFE 181 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~l~~~~~ 181 (506)
+..++|+++++||+|+||+||+|.+..+++.||||+++... ........|+++++.++ |.+|+.++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44578999999999999999999999999999999996531 22233455777776664 456889999987
Q ss_pred eC-CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCC---------
Q 010603 182 TD-KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDG--------- 250 (506)
Q Consensus 182 ~~-~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~--------- 250 (506)
.. .++|||||++ |++|.+++... +.+++..++.|+.||+.||+|||+ .|||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 65 5899999998 88898888765 579999999999999999999998 5999999999999998766
Q ss_pred -------CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 251 -------HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 251 -------~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
.+||+|||++....
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~----------------------------------------------------------- 299 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER----------------------------------------------------------- 299 (467)
T ss_pred ccCCCCceEEECCCCccccCc-----------------------------------------------------------
Confidence 49999999863200
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV 403 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~ 403 (506)
.....++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.
T Consensus 300 ---------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 300 ---------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred ---------------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 00123479999999999999999999999999999999999999998877655443332
Q ss_pred CCCCCCCC----------------------------------------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHH
Q 010603 404 GQPLKFPE----------------------------------------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATE 443 (506)
Q Consensus 404 ~~~~~~p~----------------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~e 443 (506)
.....+|. ....++.+.|||.+||++||.+||+ |+|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e 434 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQ 434 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHH
Confidence 11000000 0012456789999999999999997 999
Q ss_pred hhcCCCCCCC
Q 010603 444 IKQHPFFESV 453 (506)
Q Consensus 444 ll~hp~f~~~ 453 (506)
+|+||||...
T Consensus 435 ~L~Hp~~~~~ 444 (467)
T PTZ00284 435 MTTHPYVLKY 444 (467)
T ss_pred HhcCcccccc
Confidence 9999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=391.20 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=211.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|+++++||.|+||+||+|+++.+++.||+|+++.... ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5679999999999999999999999999999999975432 12234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+. |+|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 99996 5999887654 2468999999999999999999999999999999999999999999999999984311000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (288)
T cd07871 158 ---------------------------------------------------------------------------KTYSN 162 (288)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 00112
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC----------------CCC
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP----------------LKF 409 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~----------------~~~ 409 (506)
..||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+.. .+ ..+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 368999999999876 4689999999999999999999999988776655544321 11 011
Q ss_pred CC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 410 PE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 410 p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
|. ...++.++++||.+||..||.+||| |+|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 11 1246889999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=386.47 Aligned_cols=252 Identities=30% Similarity=0.539 Sum_probs=211.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----eEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK-----FSC 187 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~ 187 (506)
|+-.+++|.|+||.||+|....+++.||||.+-.+. . -..+|+++|+.++|||||+|..+|.... ++.
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----R---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----C---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 888999999999999999999999999999876432 1 2246999999999999999999986432 556
Q ss_pred EEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecCCccccc
Q 010603 188 LLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLSLRCF 264 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFGla~~~~ 264 (506)
+||||| ..+|..+++. ..+..++...++.|.+||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 99 lVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 999999 5699888774 234689999999999999999999999999999999999999976 899999999986532
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 178 ~~------------------------------------------------------------------------------ 179 (364)
T KOG0658|consen 178 KG------------------------------------------------------------------------------ 179 (364)
T ss_pred cC------------------------------------------------------------------------------
Confidence 11
Q ss_pred CCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC--------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP-------------- 406 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~-------------- 406 (506)
+...++..|+.|+|||++.|. .|+.++||||.|||++||+-|++.|.+.+..+++..|+ +.+
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 113456789999999999986 49999999999999999999999999998888776554 221
Q ss_pred CCCC----------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 407 LKFP----------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 407 ~~~p----------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
..+| ....+++++.+|+.++|..+|.+|.+ |.|++.||||....
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDELR 313 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHhh
Confidence 1111 11357899999999999999999997 99999999998654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=385.68 Aligned_cols=278 Identities=34% Similarity=0.622 Sum_probs=227.6
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|++.+.||+|+||.||+|.++.+++.||||.+.+...........+..|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 38889999999999999999999999999999987554434444556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+.|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 999999999887655567999999999999999999999999999999999999999999999999987431000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (285)
T cd05630 156 -------------------------------------------------------------------------QTIKGRV 162 (285)
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0011236
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH---HHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHh
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---ETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L 427 (506)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +....+... ...++ ..+++++.+||.+||
T Consensus 163 g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l 240 (285)
T cd05630 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS--EKFSPDARSLCKMLL 240 (285)
T ss_pred CCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC--ccCCHHHHHHHHHHh
Confidence 899999999999999999999999999999999999999865432 222222211 11222 358899999999999
Q ss_pred hcCCCCccCCC-CChHHhhcCCCCCCCCcchhcc--CCCCCCCCC
Q 010603 428 VKDPQKRLGFK-RGATEIKQHPFFESVNWALIRS--THPPEIPKP 469 (506)
Q Consensus 428 ~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~--~~~~~~p~~ 469 (506)
+.||++||++. ..++|+++||||+.++|..+.. ..|+..|.|
T Consensus 241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 241 CKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred hcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 99999999742 2389999999999999986643 345555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=402.59 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=233.4
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe-EEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF-SCL 188 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~l 188 (506)
+++|..++.+|+|+||.+++++++..++.|++|.|+......+.. +.+.+|+.+++++.|||||.+.+.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 567999999999999999999999999999999998876654443 367889999999999999999999998887 999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||+||+||+|.+.+....+..|+|+.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 999999999999999987889999999999999999999999999999999999999999999999999999653211
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
.....
T Consensus 160 ---------------------------------------------------------------------------~~~a~ 164 (426)
T KOG0589|consen 160 ---------------------------------------------------------------------------DSLAS 164 (426)
T ss_pred ---------------------------------------------------------------------------hhhhh
Confidence 11234
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|.+.+-.+.+.++.... -.|....++.+++.||..||.
T Consensus 165 tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~ 243 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLR 243 (426)
T ss_pred eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhh
Confidence 5689999999999999999999999999999999999999999999888888887665 344445799999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
.+|+.||+ |.++|.+|.+.
T Consensus 244 ~~P~~RPs----a~~LL~~P~l~ 262 (426)
T KOG0589|consen 244 KNPEHRPS----ALELLRRPHLL 262 (426)
T ss_pred cCCccCCC----HHHHhhChhhh
Confidence 99999998 99999999886
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=391.26 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=216.3
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++++.||+|+||.||+|++..++..||+|++.... .......+.+|+++|+.++||||+++++++..++.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45678999999999999999999999999999999997642 1234456888999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 999999999999998765 5689999999999999999999986 699999999999999999999999999743100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 157 ------------------------------------------------------------------------------~~ 158 (331)
T cd06649 157 ------------------------------------------------------------------------------SM 158 (331)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC--------------------
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-------------------- 406 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------------- 406 (506)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ..++..+
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccccCCccccCccccccc
Confidence 1123699999999999999999999999999999999999999976544332 2221110
Q ss_pred ---------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 407 ---------------------------LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 407 ---------------------------~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
........+++++++||.+||+.||++||+ +.+|++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~~ 308 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhcc
Confidence 000011246889999999999999999997 99999999998644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=381.87 Aligned_cols=277 Identities=35% Similarity=0.603 Sum_probs=229.6
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+++|+.++|+||+.+++++..++.+|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 88899999999999999999999999999999876544444445567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~------ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG------ 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC------
Confidence 99999998887655567999999999999999999999999999999999999999999999999987431100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05632 156 ------------------------------------------------------------------------ESIRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CcccCCCC
Confidence 00112368
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh----CCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV----GQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
++.|+|||++.+..++.++|||||||++|||++|..||...........+. .....++ ..++.++.+|+.+||.
T Consensus 164 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~ 241 (285)
T cd05632 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLT 241 (285)
T ss_pred CcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHHHHHHcc
Confidence 999999999999899999999999999999999999998766543333322 2222222 3588999999999999
Q ss_pred cCCCCccCCCC-ChHHhhcCCCCCCCCcchhc--cCCCCCCCCC
Q 010603 429 KDPQKRLGFKR-GATEIKQHPFFESVNWALIR--STHPPEIPKP 469 (506)
Q Consensus 429 ~dP~~R~s~~~-~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~ 469 (506)
.||++||+..+ .+.++++|+||..++|..+. ...|+.+|.|
T Consensus 242 ~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 242 KDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred CCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 99999998643 38999999999999987543 3345555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=392.73 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=209.9
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----CeE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-----KFS 186 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 186 (506)
+|++.+.||+|+||.||+|+++.+|+.||||++..... ......++.+|+++|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 59999999999999999999999999999999875322 123345678899999999999999999988643 358
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 57999888765 57999999999999999999999999999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ....
T Consensus 157 ~~--------------------------------------------------------------------------~~~~ 162 (338)
T cd07859 157 TP--------------------------------------------------------------------------TAIF 162 (338)
T ss_pred cC--------------------------------------------------------------------------cccc
Confidence 00 0000
Q ss_pred ccccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---C-----------------
Q 010603 347 SMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---G----------------- 404 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~----------------- 404 (506)
....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+. +
T Consensus 163 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 242 (338)
T cd07859 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARR 242 (338)
T ss_pred ccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence 123479999999999976 578999999999999999999999998766443322111 0
Q ss_pred ------CCCCCC---CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 405 ------QPLKFP---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 405 ------~~~~~p---~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
.....+ ....+++.+.+||.+||..||++||+ ++|+++||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~ 298 (338)
T cd07859 243 YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAK 298 (338)
T ss_pred HHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCc
Confidence 000000 01246788999999999999999997 999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=399.08 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=206.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++++.||+|+||.||+|.+..+++.||||.... ..+.+|+++|+.|+|||||+++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 455779999999999999999999999999999997532 23467999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+|||++ +++|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 999999 57898887665 57899999999999999999999999999999999999999999999999998421000
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.....
T Consensus 236 ---------------------------------------------------------------------------~~~~~ 240 (391)
T PHA03212 236 ---------------------------------------------------------------------------NANKY 240 (391)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC-------cHHHHHHHhC----------------
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-------NRETLFNVVG---------------- 404 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~---------------- 404 (506)
...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.... ....+..++.
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 23479999999999999999999999999999999999998875321 1111111110
Q ss_pred ----------CCCCCCC-------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 405 ----------QPLKFPE-------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 405 ----------~~~~~p~-------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.....+. ...++.++.+||.+||+.||.+||+ |.|+|+||||+.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~ 382 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhccC
Confidence 0000000 0134668999999999999999997 9999999999764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.90 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=207.6
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD----- 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 183 (506)
..++|++++.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3467999999999999999999999999999999886431 1234699999999999999999987432
Q ss_pred ---CeEEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeec
Q 010603 184 ---KFSCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDF 257 (506)
Q Consensus 184 ---~~~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DF 257 (506)
..+++||||++ ++|.+++.. ..+..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 25789999996 577776653 2346799999999999999999999999999999999999999765 6999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|+|+.+...
T Consensus 216 Gla~~~~~~----------------------------------------------------------------------- 224 (440)
T PTZ00036 216 GSAKNLLAG----------------------------------------------------------------------- 224 (440)
T ss_pred ccchhccCC-----------------------------------------------------------------------
Confidence 998532100
Q ss_pred cccCCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC-------
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP------- 406 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~------- 406 (506)
......+||+.|||||++.+. .|+.++|||||||+||||++|++||.+.+..+.+..++. .+
T Consensus 225 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 225 -------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred -------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 011234689999999998764 689999999999999999999999998877666554432 11
Q ss_pred -------CCCCC----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 407 -------LKFPE----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 407 -------~~~p~----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
+.+|. ....+.++++||.+||..||.+||+ |.|+|+||||..+..
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRD 359 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhc
Confidence 11111 1136789999999999999999997 999999999987654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=380.10 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=208.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcc-CCceEEEEEeccchhhchhHHHHHHHHHHHHHhc---CCCCccceeEEEE-----
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRD-MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPTLYSHFE----- 181 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~----- 181 (506)
.+|++++.||+|+||+||+|++.. +++.||||+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999864 46889999987643222 2223445677776655 6999999999885
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457899999995 699999887666679999999999999999999999999999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 159 ~~~~~--------------------------------------------------------------------------- 163 (290)
T cd07862 159 IYSFQ--------------------------------------------------------------------------- 163 (290)
T ss_pred eccCC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-----CCCCC-----
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-----LKFPE----- 411 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p~----- 411 (506)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+.+..++... ..++.
T Consensus 164 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd07862 164 ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240 (290)
T ss_pred ---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc
Confidence 00112368999999999999899999999999999999999999999888777666554211 00100
Q ss_pred ---------------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 ---------------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 ---------------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
...++..+++||.+||+.||++||+ +.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 241 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 0246788899999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=376.19 Aligned_cols=265 Identities=41% Similarity=0.760 Sum_probs=232.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+++|+.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36999999999999999999999999999999998765544556677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998775 67999999999999999999999999999999999999999999999999997432100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....
T Consensus 155 ----------------------------------------------------------------------------~~~~ 158 (290)
T cd05580 155 ----------------------------------------------------------------------------TYTL 158 (290)
T ss_pred ----------------------------------------------------------------------------CCCC
Confidence 1123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
.|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+......+|. .++..++++|.+||..|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAKDLIRNLLQVD 236 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--cCCHHHHHHHHHHccCC
Confidence 5889999999998888899999999999999999999999887766666677666666655 57899999999999999
Q ss_pred CCCccCC-CCChHHhhcCCCCCCCCcchhc
Q 010603 431 PQKRLGF-KRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 431 P~~R~s~-~~~a~ell~hp~f~~~~~~~~~ 459 (506)
|.+|++. .++++|+++||||+.++|..+.
T Consensus 237 p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 266 (290)
T cd05580 237 LTKRLGNLKNGVNDIKNHPWFAGIDWIALL 266 (290)
T ss_pred HHHccCcccCCHHHHHcCcccccCCHHHHh
Confidence 9999842 3469999999999999997664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=385.28 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=214.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++.++||+|+||.||+|.+..++..+|+|++.... .......+.+|+++|+.++|||||+++++|..++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45578999999999999999999999999999999987642 1233456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||||+.+|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999998765 5689999999999999999999975 7999999999999999999999999998432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.
T Consensus 158 -------------------------------------------------------------------------------~ 158 (333)
T cd06650 158 -------------------------------------------------------------------------------M 158 (333)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHH-------------------------
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN------------------------- 401 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~------------------------- 401 (506)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 1123689999999999998899999999999999999999999976543322111
Q ss_pred -------------------HhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 402 -------------------VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 402 -------------------i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+............++.++++||.+||+.||++||+ +.|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 01110000011236788999999999999999998 8999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=390.55 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=211.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEc--cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELR--DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
+...+|++++.||+|+||.||+|... .+++.||+|.+.+.. ...+|+++|+.++|||||++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 44567999999999999999999865 356789999886531 23569999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+|||++ +++|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++.....
T Consensus 161 ~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999999 57888888543 6799999999999999999999999999999999999999999999999999853211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.. ...
T Consensus 238 ~~---------------------------------------------------------------------------~~~ 242 (392)
T PHA03207 238 HP---------------------------------------------------------------------------DTP 242 (392)
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 000
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc---HHHHHHHhC----CCCCC---------
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN---RETLFNVVG----QPLKF--------- 409 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~---~~~~~~i~~----~~~~~--------- 409 (506)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+... ...+..++. .+..+
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 11234799999999999999999999999999999999999999976532 122222211 01111
Q ss_pred ----------------CC---CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhc
Q 010603 410 ----------------PE---GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 410 ----------------p~---~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
+. ...++.++.+||.+||..||++||+ |.++|.||||...+|+.++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLN 387 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhc
Confidence 10 1235678899999999999999997 9999999999988887654
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=375.19 Aligned_cols=294 Identities=37% Similarity=0.663 Sum_probs=237.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.++.+++.||||.+.+...........+.+|+++++.++||||+++++.+..++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765444455567788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999998765 578999999999999999999999999999999999999999999999999875311100000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
. ..... ............
T Consensus 159 ~--------------------------------------~~~~~------------------------~~~~~~~~~~~~ 176 (305)
T cd05609 159 L--------------------------------------YEGHI------------------------EKDTREFLDKQV 176 (305)
T ss_pred c--------------------------------------ccccc------------------------ccchhhccccCC
Confidence 0 00000 000000001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC-CCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG-SSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-~~~s~~~~~li~~~L~~ 429 (506)
.|+..|+|||.+.+..++.++|+|||||++|||++|..||.+....+.+..+......++.. ..++.++.+||.+||..
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 256 (305)
T cd05609 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQ 256 (305)
T ss_pred ccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhcc
Confidence 68889999999998889999999999999999999999999887777677666554444432 25789999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~ 469 (506)
||++||+.. .+.++|+||||...+|+.........+|.+
T Consensus 257 ~P~~R~~~~-~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 295 (305)
T cd05609 257 NPLERLGTG-GAFEVKQHRFFLGLDWNGLLRQKAEFIPQL 295 (305)
T ss_pred ChhhccCcc-CHHHHHhCccccCCCHHHHhhcCCCCCCCC
Confidence 999999853 589999999999999987655544444543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=390.34 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=212.8
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----eE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK-----FS 186 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 186 (506)
+|++++.||+|+||+||+|.+..+|+.||||++.... .......++.+|+++|+.++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4889999999999999999999999999999986532 12234566788999999999999999999998876 89
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+. ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999995 6888877654 57999999999999999999999999999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. ...
T Consensus 157 ~----------------------------------------------------------------------------~~~ 160 (372)
T cd07853 157 E----------------------------------------------------------------------------SKH 160 (372)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 000
Q ss_pred ccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---------------------
Q 010603 347 SMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG--------------------- 404 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~--------------------- 404 (506)
....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 240 (372)
T cd07853 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240 (372)
T ss_pred CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence 1123689999999999875 479999999999999999999999988776554433321
Q ss_pred --CCCCCC-------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 405 --QPLKFP-------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 405 --~~~~~p-------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
.....+ .....++++.+||.+||+.||.+||+ +.|+|+||||+...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~ 296 (372)
T cd07853 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRL 296 (372)
T ss_pred HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcc
Confidence 111111 11246889999999999999999997 999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=397.74 Aligned_cols=259 Identities=30% Similarity=0.492 Sum_probs=228.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|+|+..||.|+||+||+|..+.++-..|.|+|.... ...+..+.-||+||..++||+||+|++.|..++.++|+.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4889999999999999999999999999999997543 4566777889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
||.||-...++-.. ++.+.+.+++.+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+....
T Consensus 110 FC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------- 181 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------- 181 (1187)
T ss_pred ecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-------
Confidence 99999998876654 4789999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
....+..+++
T Consensus 182 ----------------------------------------------------------------------~t~qkRDsFI 191 (1187)
T KOG0579|consen 182 ----------------------------------------------------------------------STRQKRDSFI 191 (1187)
T ss_pred ----------------------------------------------------------------------hHHhhhcccc
Confidence 0112344679
Q ss_pred cCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHH
Q 010603 352 GTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG-QPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 352 GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~s~~~~~li~~ 425 (506)
|||+|||||+.. ..+|+.++||||||+.|.||.-+.+|-...+....+..|.. .+..+-.+..++..+.|||.+
T Consensus 192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~ 271 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKR 271 (1187)
T ss_pred CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHH
Confidence 999999999976 45799999999999999999999999988888888888764 455666667899999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
||.+||..||+ |+++|+||||+.++-
T Consensus 272 cL~Knp~~Rp~----aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 272 CLVKNPRNRPP----AAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHhcCCccCCC----HHHHhhCcccccCCc
Confidence 99999999997 999999999986653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=386.55 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=208.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD----- 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 183 (506)
.+++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45789999999999999999999999999999999976432 233445677899999999999999999988643
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 184 -KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 184 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
..+|+||||+. ++|..++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 35799999995 577776653 488999999999999999999999999999999999999999999999999843
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 176 ~~~~---------------------------------------------------------------------------- 179 (364)
T cd07875 176 AGTS---------------------------------------------------------------------------- 179 (364)
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC----------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP---------------- 406 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 406 (506)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++...
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred --CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 00112368999999999999999999999999999999999999998877665554443210
Q ss_pred ------CC--------------CC----CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 407 ------LK--------------FP----EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 407 ------~~--------------~p----~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.. ++ .....+..+++||.+||+.||.+||| +.|+|+||||..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINV 323 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCccccc
Confidence 00 00 00123567899999999999999997 999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=386.81 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=206.9
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK---- 184 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 184 (506)
.+++|++++.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45789999999999999999999999999999999976432 2344556778999999999999999999986543
Q ss_pred --eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 185 --FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 185 --~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.+|+||||+. ++|...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 5799999995 46666554 3488999999999999999999999999999999999999999999999999843
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 173 ~~~~---------------------------------------------------------------------------- 176 (359)
T cd07876 173 ACTN---------------------------------------------------------------------------- 176 (359)
T ss_pred cccC----------------------------------------------------------------------------
Confidence 1000
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC------------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG------------------ 404 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~------------------ 404 (506)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred --ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 001123689999999999999999999999999999999999999987665433322111
Q ss_pred ----CCCCCC--------------C----CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 405 ----QPLKFP--------------E----GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 405 ----~~~~~p--------------~----~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
....++ . ....+.++++||.+||..||++||+ +.|+|+||||..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 111110 0 0124678999999999999999997 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=374.13 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=206.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc---CCCCccceeEEEEe-----C
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPTLYSHFET-----D 183 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~ 183 (506)
+|++++.||+|+||+||+|+++.+++.||+|++....... .......+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4999999999999999999999999999999987643221 2222345577776655 79999999998864 3
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999996 58988887765567999999999999999999999999999999999999999999999999998431
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 159 ~~~----------------------------------------------------------------------------- 161 (288)
T cd07863 159 SCQ----------------------------------------------------------------------------- 161 (288)
T ss_pred cCc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC--CCCCC-------
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP--LKFPE------- 411 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~--~~~p~------- 411 (506)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+.+..+.. .+ ..++.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07863 162 -MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240 (288)
T ss_pred -ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccc
Confidence 001123689999999999998999999999999999999999999988776655544432 10 00000
Q ss_pred -------------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 -------------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 -------------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
...++..+.+||.+||+.||++||+ +.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 241 AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred ccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 1246788999999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=388.35 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=206.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
..+.+|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+++|+.++|+||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34567899999999999999999999999999999996542 1233456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.+|+|... ....+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 99999999999642 34678888899999999999999999999999999999999999999999998532100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
....
T Consensus 222 ----------------------------------------------------------------------------~~~~ 225 (353)
T PLN00034 222 ----------------------------------------------------------------------------MDPC 225 (353)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0001
Q ss_pred cccccCCCCccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHH---HHHHhCCCCCCCCCCCCCHHH
Q 010603 348 MSFVGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET---LFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~-----~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~p~~~~~s~~~ 419 (506)
...+||..|+|||++.. ..++.++|||||||+||||++|+.||......+. ...+. ..........++.++
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 304 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASREF 304 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCHHH
Confidence 12369999999999853 2346789999999999999999999974332221 12221 111122223688999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
++||.+||..||++||+ +.|+++||||...
T Consensus 305 ~~li~~~l~~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 305 RHFISCCLQREPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHccCChhhCcC----HHHHhcCcccccC
Confidence 99999999999999997 9999999999763
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=391.40 Aligned_cols=259 Identities=31% Similarity=0.510 Sum_probs=233.8
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
...+.|.+++.||+|.|++|.+|++..|+..||||+++|..+..... ..+.+|+++|+.|+|||||+|+.+.++...+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 44566999999999999999999999999999999999987765443 44889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.+|+|++++.++ +++.+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+...
T Consensus 132 lV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 999999999999999987 67888999999999999999999999999999999999999999999999998543211
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 209 -----------------------------------------------------------------------------~~l 211 (596)
T KOG0586|consen 209 -----------------------------------------------------------------------------LML 211 (596)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 112
Q ss_pred cccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
.+++|++.|.|||++.+..| ++.+|+||+|++||-|+.|.+||++.+-.+.-..++.+.+.+|. .++-++.+||+++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~--~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF--YMSCDCEDLLRKF 289 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc--eeechhHHHHHHh
Confidence 34689999999999999987 78999999999999999999999999988888888888888887 6899999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
|.++|.+|++ .++++.|.|....
T Consensus 290 lvl~Pskr~~----~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 290 LVLNPSKRGP----CDQIMKDRWRNDL 312 (596)
T ss_pred hccCccccCC----HHHhhhhcccchh
Confidence 9999999987 8999999999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=382.78 Aligned_cols=259 Identities=21% Similarity=0.328 Sum_probs=206.4
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
++..++|++.++||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+|+.+ +|||||++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 455678999999999999999999853 3457899999875421 23345678899999999 899999999988
Q ss_pred EeC-CeEEEEEeecCCCChHHHHhhCC-----------------------------------------------------
Q 010603 181 ETD-KFSCLLMEFCSGGDLHTLRQRQP----------------------------------------------------- 206 (506)
Q Consensus 181 ~~~-~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 206 (506)
... +.+|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 46899999999999999887532
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccc
Q 010603 207 -------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACR 279 (506)
Q Consensus 207 -------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~ 279 (506)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---------- 230 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 230 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch----------
Confidence 134778889999999999999999999999999999999999999999999998542110000
Q ss_pred cCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccc
Q 010603 280 ISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAP 359 (506)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 359 (506)
.......+++.||||
T Consensus 231 -----------------------------------------------------------------~~~~~~~~~~~y~aP 245 (338)
T cd05102 231 -----------------------------------------------------------------VRKGSARLPLKWMAP 245 (338)
T ss_pred -----------------------------------------------------------------hcccCCCCCccccCc
Confidence 001112467889999
Q ss_pred hhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCC
Q 010603 360 EIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 360 E~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~ 438 (506)
|++.+..|+.++|||||||+||||++ |..||.+....+.+...+...........+++++.+||.+||..||.+||+
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-- 323 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT-- 323 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC--
Confidence 99999999999999999999999996 999998766544444443332223333468899999999999999999998
Q ss_pred CChHHhhc
Q 010603 439 RGATEIKQ 446 (506)
Q Consensus 439 ~~a~ell~ 446 (506)
+.++++
T Consensus 324 --~~el~~ 329 (338)
T cd05102 324 --FSALVE 329 (338)
T ss_pred --HHHHHH
Confidence 677765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=397.81 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=220.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccC-CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDM-GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
..|.+.+.||+|+||.||+|....+ ++.||+|.+.... ......+..|+.+|+.++|||||++++++...+.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998877 7889999875432 33445677899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
|||++||+|.+++... ....+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999877542 23568999999999999999999999999999999999999999999999999985421100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.....
T Consensus 224 ---------------------------------------------------------------------------~~~~~ 228 (478)
T PTZ00267 224 ---------------------------------------------------------------------------SLDVA 228 (478)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...... +....++.++++||.+||
T Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L 307 (478)
T PTZ00267 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLL 307 (478)
T ss_pred cccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHh
Confidence 2347999999999999999999999999999999999999999988877777777654332 222368899999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..||++||+ +.+++.|+|++.+
T Consensus 308 ~~dP~~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 308 SKNPALRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred ccChhhCcC----HHHHHhCHHHHHH
Confidence 999999998 8999999999643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=375.39 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=211.4
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||.||+|+++.+++.||||+++..... .....+.+|+++++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 46799999999999999999999999999999999764322 2233456799999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+. ++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 99996 5888877654 3468999999999999999999999999999999999999999999999999984311000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (309)
T cd07872 159 ---------------------------------------------------------------------------KTYSN 163 (309)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC----------------CCC
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP----------------LKF 409 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~----------------~~~ 409 (506)
..||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+. ..+ ..+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 258899999999876 458999999999999999999999998876654443332 111 011
Q ss_pred CC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 410 PE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 410 p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+. ...++.++++||.+||..||.+||| +.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 292 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSL 292 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhc
Confidence 11 1247889999999999999999997 9999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=382.37 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=206.9
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD----- 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 183 (506)
.+++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45789999999999999999999999999999999976432 233445677899999999999999999998644
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 184 -KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 184 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
...|+||||+. ++|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 35799999995 467666643 488999999999999999999999999999999999999999999999999843
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 169 ~~~~---------------------------------------------------------------------------- 172 (355)
T cd07874 169 AGTS---------------------------------------------------------------------------- 172 (355)
T ss_pred CCCc----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-----------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ----------------- 405 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 405 (506)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++..
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred --cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 0011236899999999999999999999999999999999999999877654433322110
Q ss_pred -----CC-----CCC-------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 406 -----PL-----KFP-------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 406 -----~~-----~~p-------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.. .++ .....+.++++||.+||..||++||+ +.|+|+||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~ 316 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINV 316 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhc
Confidence 00 000 01124567899999999999999997 999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=398.15 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=221.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 35799999999999999999999999999999999765433 344566788999999999999999998875432
Q ss_pred ---eEEEEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 185 ---FSCLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 185 ---~~~lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
.+++||||+.+|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 478999999999999988653 235799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
++.+....
T Consensus 190 s~~~~~~~------------------------------------------------------------------------ 197 (496)
T PTZ00283 190 SKMYAATV------------------------------------------------------------------------ 197 (496)
T ss_pred Ceeccccc------------------------------------------------------------------------
Confidence 85421100
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+...... +....+++++
T Consensus 198 ---~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 273 (496)
T PTZ00283 198 ---SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSISPEM 273 (496)
T ss_pred ---cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHH
Confidence 000012347999999999999999999999999999999999999999988877777766654332 2234689999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+||.+||..||.+||+ +.++++|||++..
T Consensus 274 ~~li~~~L~~dP~~RPs----~~ell~~p~~~~~ 303 (496)
T PTZ00283 274 QEIVTALLSSDPKRRPS----SSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHcccChhhCcC----HHHHHhCHHHHHh
Confidence 99999999999999998 8999999998753
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=367.88 Aligned_cols=262 Identities=35% Similarity=0.628 Sum_probs=220.0
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||+|+||+||+|.++.+|+.||+|++.+...........+..|+++|+.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999875544344455567899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCccc
Q 010603 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278 (506)
Q Consensus 199 ~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 278 (506)
.+++.......+++..++.++.||+.||.|||++||+||||+|+|||++.++.+||+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99988765557999999999999999999999999999999999999999999999999987432100
Q ss_pred ccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCcc
Q 010603 279 RISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLA 358 (506)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 358 (506)
.......|+..|+|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~~~y~~ 162 (277)
T cd05577 149 ------------------------------------------------------------------KKIKGRAGTPGYMA 162 (277)
T ss_pred ------------------------------------------------------------------CccccccCCCCcCC
Confidence 00011257889999
Q ss_pred chhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH---H-HHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 359 PEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---E-TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 359 PE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~---~-~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
||++.+..++.++|||||||++|+|++|+.||...... + ....+......++ ..+++.+.+||.+||+.||.+|
T Consensus 163 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R 240 (277)
T cd05577 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQKDPEKR 240 (277)
T ss_pred HHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC--ccCCHHHHHHHHHHccCChhHc
Confidence 99999888999999999999999999999999765442 1 2222222233333 3579999999999999999999
Q ss_pred cCCCC-ChHHhhcCCCCCCCCcchhcc
Q 010603 435 LGFKR-GATEIKQHPFFESVNWALIRS 460 (506)
Q Consensus 435 ~s~~~-~a~ell~hp~f~~~~~~~~~~ 460 (506)
|++++ ++.+++.||||...+|.....
T Consensus 241 ~~~~~~~~~~ll~h~~~~~~~~~~~~~ 267 (277)
T cd05577 241 LGCRGGSADEVREHPLFKDLNWRRLEA 267 (277)
T ss_pred cCCCcccHHHHHhChhhhcCChhhhhc
Confidence 98877 899999999999999977643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=385.31 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=215.9
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+++....+++++.||+|-||.||+|.++. ...||+|.++...+. ...+.+|++||++|+|+|||+|++++..++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 344455568889999999999999999984 348999999876433 234568999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||+.|+|.++++...+..+...+...++.||+.|++||+++++|||||...||||+++..+||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999998667889999999999999999999999999999999999999999999999999997321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
....... .+.
T Consensus 355 d~~Y~~~--------------------~~~-------------------------------------------------- 364 (468)
T KOG0197|consen 355 DDEYTAS--------------------EGG-------------------------------------------------- 364 (468)
T ss_pred CCceeec--------------------CCC--------------------------------------------------
Confidence 1111000 000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.-...|.|||.+....|+.++|||||||+||||+| |+.||.+.+..+.+..+. +..++|.+..+++.+.+++
T Consensus 365 ------kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 365 ------KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred ------CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHHHHHHH
Confidence 11237999999999999999999999999999997 999999999998887776 4567888889999999999
Q ss_pred HHHhhcCCCCccCCC
Q 010603 424 RGLLVKDPQKRLGFK 438 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~ 438 (506)
..||..+|++||||.
T Consensus 438 ~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFE 452 (468)
T ss_pred HHHhhCCcccCCCHH
Confidence 999999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=403.52 Aligned_cols=152 Identities=37% Similarity=0.638 Sum_probs=140.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|+++++||+|+||+||+|.+..+++.||||++.+...........+..|+.+++.++||||+++++++...+++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 56799999999999999999999999999999999876554455567788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
|||+.|++|.+++... ..+++..++.|+.||+.||+|||.+|||||||||+||||+.++.+||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999998765 57899999999999999999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=361.38 Aligned_cols=260 Identities=28% Similarity=0.435 Sum_probs=219.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh--chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA--GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+++++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 3589999999999999999999999999999998764322 12334567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999988765 5689999999999999999999999999999999999999999999999999853210000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
......
T Consensus 160 --------------------------------------------------------------------------~~~~~~ 165 (263)
T cd06625 160 --------------------------------------------------------------------------SGTGMK 165 (263)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000001
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...........+............++..+.+||.+||.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 245 (263)
T cd06625 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245 (263)
T ss_pred CCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhh
Confidence 23588899999999999999999999999999999999999987766666655554433333334689999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f 450 (506)
.+|.+||+ +.++++||||
T Consensus 246 ~~p~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 246 ENAKKRPS----AEELLRHFFV 263 (263)
T ss_pred cCcccCCC----HHHHhhCCCC
Confidence 99999997 8999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=360.26 Aligned_cols=259 Identities=31% Similarity=0.503 Sum_probs=218.3
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||+|+|+.|--|....+|+.||||+|.|.. .-...++.+|++++... .|+||++|+++|+++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 57999999999999999999999999999863 23345677899999888 699999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC---EEEeecCCccccccCCccccC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH---IMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFGla~~~~~~~~~~~~ 272 (506)
|.|...|+.+ +.|+|..+..+.++|+.||+|||.+||.||||||+|||.....+ ||||||.|+..+.....
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~---- 234 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND---- 234 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC----
Confidence 9999988876 78999999999999999999999999999999999999987664 79999999844221110
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
|. ........+.+|
T Consensus 235 ----------------~s--------------------------------------------------pastP~L~tPvG 248 (463)
T KOG0607|consen 235 ----------------CS--------------------------------------------------PASTPELLTPVG 248 (463)
T ss_pred ----------------CC--------------------------------------------------CCCCccccCccc
Confidence 10 001111335589
Q ss_pred CCCCccchhhc---C--CCCCcchhHHHHHHHHHHHhcCCCCCCCCC---------------cHHHHHHHhCCCCCCCC-
Q 010603 353 THEYLAPEIIR---G--DGHGSAVDWWTFGIFFYELLLGRTPFKGNG---------------NRETLFNVVGQPLKFPE- 411 (506)
Q Consensus 353 T~~Y~APE~l~---~--~~~~~~~DiWSlGvil~elltG~~Pf~~~~---------------~~~~~~~i~~~~~~~p~- 411 (506)
+..|||||+.. + ..|+.++|.||||||||-||.|++||.+.- ....+..|..+.+.||+
T Consensus 249 SAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdk 328 (463)
T KOG0607|consen 249 SAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDK 328 (463)
T ss_pred chhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChh
Confidence 99999999863 3 358999999999999999999999997641 12445677788899986
Q ss_pred -CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 412 -GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 412 -~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
|..+|.+++|||..+|..|+.+|++ |.++++|||++.+.
T Consensus 329 dWahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 329 DWAHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCA 368 (463)
T ss_pred hhHHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccc
Confidence 4579999999999999999999997 99999999998764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=381.33 Aligned_cols=254 Identities=29% Similarity=0.443 Sum_probs=208.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC------C
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD------K 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 184 (506)
++|++++.||.|+||+||+|.+..+++.||||++.+.... ......+.+|+++|+.++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 5699999999999999999999999999999999764322 23345567899999999999999999988643 3
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..|++||++ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 579999998 8899887754 469999999999999999999999999999999999999999999999999984310
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.
T Consensus 170 ~------------------------------------------------------------------------------- 170 (343)
T cd07878 170 D------------------------------------------------------------------------------- 170 (343)
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C--------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P-------------- 406 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~-------------- 406 (506)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+... .
T Consensus 171 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 0122468999999999987 46899999999999999999999999876655444333210 0
Q ss_pred ------CCCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 ------LKFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 ------~~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...+. ....++.+.+||.+||..||.+||+ +.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~ 304 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQY 304 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhcc
Confidence 00110 0235677899999999999999997 9999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=370.48 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=226.8
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|.++.+||+|+||.||+|.++.+|..+|||.+.. ...++++..|+.||+.++.|+||++|+.|-....++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 7888999999999999999999999999998865 45677888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
|..|++.++++.+ ++.+.|+.+..+++..+.||+|||...-||||||..||||+.+|+.||+|||.|-++.
T Consensus 110 CGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT-------- 180 (502)
T KOG0574|consen 110 CGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT-------- 180 (502)
T ss_pred cCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh--------
Confidence 9999999988765 5889999999999999999999999999999999999999999999999999984321
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.+..+..+.+|
T Consensus 181 ---------------------------------------------------------------------DTMAKRNTVIG 191 (502)
T KOG0574|consen 181 ---------------------------------------------------------------------DTMAKRNTVIG 191 (502)
T ss_pred ---------------------------------------------------------------------hhHHhhCcccc
Confidence 12233456789
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
||.|||||++..-+|+.++||||||+...||..|++||.+......++.|-.. +..|..+..++.++.|||++||.++|
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~P 271 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKP 271 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCH
Confidence 99999999999999999999999999999999999999988877666666443 44565666899999999999999999
Q ss_pred CCccCCCCChHHhhcCCCCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f~~~ 453 (506)
++|-| |.++++|||++..
T Consensus 272 E~R~T----A~~L~~H~FiknA 289 (502)
T KOG0574|consen 272 EERKT----ALRLCEHTFIKNA 289 (502)
T ss_pred HHHHH----HHHHhhhhhhcCC
Confidence 99976 9999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=407.08 Aligned_cols=269 Identities=27% Similarity=0.398 Sum_probs=222.1
Q ss_pred cCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 103 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
...++..+++|++++.||+|+||+||+|+++.+++.||+|++...... ......+..|+.+|+.|+|||||+++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 456777888999999999999999999999999999999999765433 2345667889999999999999999999854
Q ss_pred --CCeEEEEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-------CeEEccCCCCcEEEec---
Q 010603 183 --DKFSCLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMM-------GVVYRDLKPENVLVRE--- 248 (506)
Q Consensus 183 --~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~-------giiHrDLKp~NILl~~--- 248 (506)
...+|||||||.+|+|.+++... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 45799999999999999988753 235799999999999999999999985 4999999999999964
Q ss_pred --------------CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcc
Q 010603 249 --------------DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRF 314 (506)
Q Consensus 249 --------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (506)
.+.+||+|||++..+...
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~------------------------------------------------ 195 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE------------------------------------------------ 195 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccc------------------------------------------------
Confidence 235899999998432100
Q ss_pred ccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 010603 315 LNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKG 392 (506)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~ 392 (506)
......+||+.|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 196 ------------------------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 196 ------------------------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ------------------------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 00112369999999999965 3588999999999999999999999987
Q ss_pred CCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 393 NGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 393 ~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
......+...+.....++. ...+.++.+||.+||..+|.+||+ +.|+|.||||..+..
T Consensus 246 ~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 246 ANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGP 303 (1021)
T ss_pred CCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCC
Confidence 7766666555544444433 257899999999999999999998 899999999986653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=375.86 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=209.9
Q ss_pred EEeEEeec--CceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 115 LLKKLGCG--DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 115 i~~~LG~G--~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
++++||+| +||+||++.++.+|+.||||.++..... ......+++|+++++.++|||||++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56889999 7899999999999999999999765332 23445677899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~- 159 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR- 159 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc-
Confidence 9999999998765556799999999999999999999999999999999999999999999999986532110000000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
..........+
T Consensus 160 ---------------------------------------------------------------------~~~~~~~~~~~ 170 (327)
T cd08227 160 ---------------------------------------------------------------------VVHDFPKYSVK 170 (327)
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00000011257
Q ss_pred CCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC----------------------
Q 010603 353 THEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK---------------------- 408 (506)
Q Consensus 353 T~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------- 408 (506)
+..|+|||++.+ ..|+.++|||||||++|||++|+.||..................
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T cd08227 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGA 250 (327)
T ss_pred eecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCC
Confidence 788999999986 46899999999999999999999999865544433332221110
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 409 ----------------------FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 409 ----------------------~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
.+....+++++.+||.+||+.||++||| ++++++||||+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 251 NSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred cCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 0011235678999999999999999998 89999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=360.50 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=217.6
Q ss_pred ccCCeEEE-eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHH-HhcCCCCccceeEEEEe----
Q 010603 109 GLGHFRLL-KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPTLYSHFET---- 182 (506)
Q Consensus 109 ~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~---- 182 (506)
..++|+|- ++||-|-.|+|..|.++.||+.||+|++.. ..++++|+++. ..-.|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 34567775 479999999999999999999999998753 23457799884 44589999999999864
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC---CCEEEeecCC
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED---GHIMLSDFDL 259 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFGl 259 (506)
...+.+|||.|+||+|+..++.++...|+|.++..|++||..||.|||+.+|.||||||||+|.... ..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 4578899999999999999999988899999999999999999999999999999999999999864 4699999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
|+.-..
T Consensus 211 AK~t~~-------------------------------------------------------------------------- 216 (400)
T KOG0604|consen 211 AKETQE-------------------------------------------------------------------------- 216 (400)
T ss_pred ccccCC--------------------------------------------------------------------------
Confidence 954110
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCCCCC--CC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLKFPE--GS 413 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~ 413 (506)
.....+.+-||+|.|||++..+.|+..+|+||+|||+|-||+|.+||..+.. ..+-.+|..+.+.||. |.
T Consensus 217 ----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs 292 (400)
T KOG0604|consen 217 ----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS 292 (400)
T ss_pred ----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence 0112344789999999999999999999999999999999999999987654 2445677777777764 57
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+|.+++|+|++||..+|.+|+| +++++.|||+...
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhhee----HHHhhcCchhccc
Confidence 89999999999999999999998 8999999999753
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=363.49 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=211.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeC------
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETD------ 183 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~------ 183 (506)
+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45899999999999999999999999999999987542 2234567899999988 799999999998753
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..+|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999988765567999999999999999999999999999999999999999999999999998532
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 162 ~~~----------------------------------------------------------------------------- 164 (272)
T cd06637 162 DRT----------------------------------------------------------------------------- 164 (272)
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CCCccccccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 344 SARSMSFVGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
........|++.|+|||++. +..|+.++|||||||++|||++|+.||...........+............++.+
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHH
Confidence 00012246899999999986 3458889999999999999999999998766555444444333222233467899
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+.+||.+||..||.+||+ +.++++||||
T Consensus 245 ~~~li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 245 FQSFIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 999999999999999998 8999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=355.53 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=216.9
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-CCeEEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-DKFSCLLM 190 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 190 (506)
+|++++.||.|+||.||++.++.+++.||+|.+...... ......+.+|+++++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 499999999999999999999999999999999764332 2344567889999999999999999998875 44789999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999887655679999999999999999999999999999999999999999999999999984321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (257)
T cd08223 157 --------------------------------------------------------------------------DMASTL 162 (257)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....... ....++..+.+||.+||..|
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~ 241 (257)
T cd08223 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP-MPKDYSPELGELIATMLSKR 241 (257)
T ss_pred cCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC-CccccCHHHHHHHHHHhccC
Confidence 68899999999999999999999999999999999999998777666655655443321 22368899999999999999
Q ss_pred CCCccCCCCChHHhhcCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f 450 (506)
|++||+ +.++++||||
T Consensus 242 p~~Rp~----~~~~l~~~~~ 257 (257)
T cd08223 242 PEKRPS----VKSILRQPYI 257 (257)
T ss_pred cccCCC----HHHHhcCCCC
Confidence 999997 8999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.93 Aligned_cols=259 Identities=37% Similarity=0.663 Sum_probs=207.5
Q ss_pred EEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHH---hcCCCCccceeEEEEeCCeEEEEEeecC
Q 010603 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS---LLDHPFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
.||+|+||.||+|.+..+++.||+|++.+.............+|..+++ ..+||||+.+++++...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998754432322233344544444 4579999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCC
Q 010603 195 GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274 (506)
Q Consensus 195 gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 274 (506)
+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999988765 57999999999999999999999999999999999999999999999999997421000
Q ss_pred CcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCC
Q 010603 275 DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTH 354 (506)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 354 (506)
......||+
T Consensus 151 -----------------------------------------------------------------------~~~~~~~~~ 159 (279)
T cd05633 151 -----------------------------------------------------------------------KPHASVGTH 159 (279)
T ss_pred -----------------------------------------------------------------------CccCcCCCc
Confidence 001125899
Q ss_pred CCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCc--HHHHHHH-hCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 355 EYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGN--RETLFNV-VGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 355 ~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~--~~~~~~i-~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
.|+|||++.+ ..++.++|||||||++|||++|..||..... ...+... ......++ ..++.++.+||.+||..|
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~ 237 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP--DSFSPELKSLLEGLLQRD 237 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCc--cccCHHHHHHHHHHhcCC
Confidence 9999999874 5689999999999999999999999975432 2222222 22222333 358899999999999999
Q ss_pred CCCccCC-CCChHHhhcCCCCCCCCcchhc
Q 010603 431 PQKRLGF-KRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 431 P~~R~s~-~~~a~ell~hp~f~~~~~~~~~ 459 (506)
|.+|++. ..+++++++||||+.++|....
T Consensus 238 p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 238 VSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred HHHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 9999952 2359999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=366.86 Aligned_cols=263 Identities=29% Similarity=0.484 Sum_probs=220.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+.|++++.||.|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 45999999999999999999999999999999987642 344566778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---- 163 (292)
T cd06644 89 EFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---- 163 (292)
T ss_pred ecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc----
Confidence 999999998876553 256899999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 164 -------------------------------------------------------------------------~~~~~~~ 170 (292)
T cd06644 164 -------------------------------------------------------------------------LQRRDSF 170 (292)
T ss_pred -------------------------------------------------------------------------cccccee
Confidence 0001123
Q ss_pred ccCCCCccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC-CCCCCCCCCHHHHHHHH
Q 010603 351 VGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL-KFPEGSSISFAAKDLIR 424 (506)
Q Consensus 351 ~GT~~Y~APE~l~~-----~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~s~~~~~li~ 424 (506)
.|++.|+|||++.+ ..++.++|||||||++|||++|..||...+....+.++..... ..+....++.++.+||.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLK 250 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHH
Confidence 58889999999853 4468899999999999999999999987766555555543322 22333467889999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCCcchh
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
+||..||++||+ ++++++||||..++|...
T Consensus 251 ~~l~~~p~~Rp~----~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 251 TALDKHPETRPS----AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHhcCCcccCcC----HHHHhcCccccccccchh
Confidence 999999999997 899999999999887653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=354.43 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=220.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||+|+||.||+|.++.+++.|++|.+...... ......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 489999999999999999999999999999998764433 3445667889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 9999999999887656789999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd08529 156 -------------------------------------------------------------------------NFANTIV 162 (256)
T ss_pred -------------------------------------------------------------------------chhhccc
Confidence 0011235
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....... ....++..+.++|.+||+.+|
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p 241 (256)
T cd08529 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDY 241 (256)
T ss_pred cCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCc
Confidence 8889999999999989999999999999999999999998887666666665443221 122688999999999999999
Q ss_pred CCccCCCCChHHhhcCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f 450 (506)
++||+ +.++++|||+
T Consensus 242 ~~Rp~----~~~ll~~~~~ 256 (256)
T cd08529 242 RQRPD----TFQLLRNPSL 256 (256)
T ss_pred ccCcC----HHHHhhCCCC
Confidence 99998 8999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=360.90 Aligned_cols=254 Identities=37% Similarity=0.652 Sum_probs=211.3
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.+++.++||||+++++++......|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999886543322 22334599999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999843 6789999999999999999999999999999999999999999999999999843200
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.........|
T Consensus 151 ----------------------------------------------------------------------~~~~~~~~~~ 160 (260)
T PF00069_consen 151 ----------------------------------------------------------------------NNENFNPFVG 160 (260)
T ss_dssp ----------------------------------------------------------------------TTSEBSSSSS
T ss_pred ----------------------------------------------------------------------cccccccccc
Confidence 0001123368
Q ss_pred CCCCccchhhc-CCCCCcchhHHHHHHHHHHHhcCCCCCCCCC---cHHHHHHHhCCCCCCCC--CCCCCHHHHHHHHHH
Q 010603 353 THEYLAPEIIR-GDGHGSAVDWWTFGIFFYELLLGRTPFKGNG---NRETLFNVVGQPLKFPE--GSSISFAAKDLIRGL 426 (506)
Q Consensus 353 T~~Y~APE~l~-~~~~~~~~DiWSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~~~ 426 (506)
|..|+|||++. +..++.++||||||+++|+|++|..||.... ....+............ .......+.+||.+|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM 240 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence 99999999998 7788999999999999999999999999873 22333333332222111 112348999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
|..||++||+ +.++++||||
T Consensus 241 l~~~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 241 LSKDPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp SSSSGGGSTT----HHHHHTSGGG
T ss_pred ccCChhHCcC----HHHHhcCCCC
Confidence 9999999998 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=365.55 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=212.6
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.+++|++++.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35779999999999999999999999999999999875432 1223345679999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+. ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 999996 6898887654 3568999999999999999999999999999999999999999999999999984311000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 159 ----------------------------------------------------------------------------~~~~ 162 (301)
T cd07873 159 ----------------------------------------------------------------------------KTYS 162 (301)
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0001
Q ss_pred ccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC----------------CC
Q 010603 349 SFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP----------------LK 408 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~----------------~~ 408 (506)
...+++.|+|||++.+. .++.++|||||||++|||++|++||...+..+.+..+. ..+ ..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 12578899999998764 47889999999999999999999998877655443322 110 01
Q ss_pred CCC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 409 FPE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 409 ~p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
++. ...+++.+++||.+||..||.+||+ ++|+|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~ 293 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLG 293 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccc
Confidence 111 1247889999999999999999997 99999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.79 Aligned_cols=251 Identities=29% Similarity=0.402 Sum_probs=192.4
Q ss_pred EeEEeecCceEEEEEEEc--cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCeEEEEEe
Q 010603 116 LKKLGCGDIGSVYLAELR--DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKFSCLLME 191 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 191 (506)
.++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+++|+.++||||+++++++.. +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 467899999987542 22345679999999999999999999854 457899999
Q ss_pred ecCCCChHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE----ecCCCEEEeecCCc
Q 010603 192 FCSGGDLHTLRQRQ-------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV----REDGHIMLSDFDLS 260 (506)
Q Consensus 192 ~~~gg~L~~~l~~~-------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFGla 260 (506)
|+ +++|..++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 56888876532 12358999999999999999999999999999999999999 45678999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+.......
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (317)
T cd07868 160 RLFNSPLK------------------------------------------------------------------------ 167 (317)
T ss_pred eccCCCCc------------------------------------------------------------------------
Confidence 53211000
Q ss_pred CCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCc---------HHHHHHHh---CCCC
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGN---------RETLFNVV---GQPL 407 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~---------~~~~~~i~---~~~~ 407 (506)
........+||+.|||||++.+. .|+.++|||||||++|||++|++||..... ...+..+. +.+.
T Consensus 168 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (317)
T cd07868 168 --PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 245 (317)
T ss_pred --cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCC
Confidence 00001234789999999999874 589999999999999999999999965432 11111111 1000
Q ss_pred --------CCC-------------------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 408 --------KFP-------------------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 408 --------~~p-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
.++ .....+..+.+||.+||+.||.+||| |+|+|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 246 DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred hHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 000 00123567899999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=361.64 Aligned_cols=261 Identities=36% Similarity=0.646 Sum_probs=209.5
Q ss_pred EEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHH---HHHHhcCCCCccceeEEEEeCCeEEEEEeecC
Q 010603 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTER---EILSLLDHPFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
.||+|+||+||+|.+..+++.||||++.+..............|. .+++..+||||+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999875433222222233343 34555689999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCC
Q 010603 195 GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274 (506)
Q Consensus 195 gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 274 (506)
||+|..++... ..+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999988764 57999999999999999999999999999999999999999999999999987421000
Q ss_pred CcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCC
Q 010603 275 DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTH 354 (506)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 354 (506)
.....+|+.
T Consensus 151 -----------------------------------------------------------------------~~~~~~~~~ 159 (278)
T cd05606 151 -----------------------------------------------------------------------KPHASVGTH 159 (278)
T ss_pred -----------------------------------------------------------------------CCcCcCCCc
Confidence 001226899
Q ss_pred CCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCc---HHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 355 EYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGN---RETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 355 ~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+......+|. .++.++.++|.+||..+
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l~~~ 237 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRD 237 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCC--cCCHHHHHHHHHHhhcC
Confidence 99999999754 689999999999999999999999986632 2222223333334443 57899999999999999
Q ss_pred CCCccCCC-CChHHhhcCCCCCCCCcchhccC
Q 010603 431 PQKRLGFK-RGATEIKQHPFFESVNWALIRST 461 (506)
Q Consensus 431 P~~R~s~~-~~a~ell~hp~f~~~~~~~~~~~ 461 (506)
|.+|+... .++.++++||||+..+|+.+...
T Consensus 238 p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 238 VNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred HHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 99999321 24999999999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=358.14 Aligned_cols=256 Identities=40% Similarity=0.752 Sum_probs=219.5
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876554445567788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCccc
Q 010603 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278 (506)
Q Consensus 199 ~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 278 (506)
.+++.+. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------
Confidence 9998765 568999999999999999999999999999999999999999999999999984321000
Q ss_pred ccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCcc
Q 010603 279 RISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLA 358 (506)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 358 (506)
......|++.|+|
T Consensus 148 -------------------------------------------------------------------~~~~~~~~~~~~~ 160 (262)
T cd05572 148 -------------------------------------------------------------------KTWTFCGTPEYVA 160 (262)
T ss_pred -------------------------------------------------------------------ccccccCCcCccC
Confidence 0112368889999
Q ss_pred chhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC--cHHHHHHHhC--CCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 359 PEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--NRETLFNVVG--QPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 359 PE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~--~~~~~~~i~~--~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
||++.+..++.++|+|||||++|+|++|..||.... ..+.+..+.. ....+|. .++.++.+||.+||..||.+|
T Consensus 161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhC
Confidence 999998889999999999999999999999998766 4555556653 3334443 468999999999999999999
Q ss_pred cCC-CCChHHhhcCCCCCCCCcc
Q 010603 435 LGF-KRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 435 ~s~-~~~a~ell~hp~f~~~~~~ 456 (506)
+++ +..++|+++||||++.+|+
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred cCCcccCHHHHhcChhhhCCCCC
Confidence 984 3348999999999998885
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=360.95 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=209.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||+|+||.||+|.+..+++.||||++.+... ......+.+|+++|+.++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 68999999999999999999999999999999876421 2334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++++|..+ ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~------ 147 (279)
T cd06619 80 FMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------ 147 (279)
T ss_pred cCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc------
Confidence 9999999654 3578999999999999999999999999999999999999999999999999843110
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
......+
T Consensus 148 -------------------------------------------------------------------------~~~~~~~ 154 (279)
T cd06619 148 -------------------------------------------------------------------------SIAKTYV 154 (279)
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0011236
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-------HHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-------ETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
||..|+|||++.+..++.++|||||||++|+|++|+.||...... +....+.............+.++++||.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 899999999999999999999999999999999999999653221 1122222221111112357889999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+||+.||++||+ ++++++||||...+
T Consensus 235 ~~l~~~P~~Rp~----~~eil~~~~~~~~~ 260 (279)
T cd06619 235 QCMRKQPKERPA----PENLMDHPFIVQYN 260 (279)
T ss_pred HHhhCChhhCCC----HHHHhcCccccccc
Confidence 999999999997 89999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=357.79 Aligned_cols=256 Identities=39% Similarity=0.716 Sum_probs=216.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHH-HhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
+.||.|+||.||+|.+..+++.||||++.+...........+..|..++ ..++|+||+++++++...+.+|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999875443333444445565554 455899999999999999999999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999998765 5789999999999999999999999999999999999999999999999998742100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.....|++.
T Consensus 150 -----------------------------------------------------------------------~~~~~~~~~ 158 (260)
T cd05611 150 -----------------------------------------------------------------------NKKFVGTPD 158 (260)
T ss_pred -----------------------------------------------------------------------cccCCCCcC
Confidence 012358889
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC--CCCCHHHHHHHHHHhhcCCCC
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAAKDLIRGLLVKDPQK 433 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~s~~~~~li~~~L~~dP~~ 433 (506)
|+|||.+.+..++.++|||||||++|+|++|..||...+....+..+......++.. ..++..+.+||.+||..||++
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 238 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence 999999998889999999999999999999999998887776666665554444322 257899999999999999999
Q ss_pred ccCCCCChHHhhcCCCCCCCCcc
Q 010603 434 RLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 434 R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
||+. .+++|++.||||..++|+
T Consensus 239 R~~~-~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 239 RLGA-NGYQEIKSHPFFKSINWD 260 (260)
T ss_pred ccCC-CcHHHHHcChHhhcCCCC
Confidence 9973 247899999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=382.40 Aligned_cols=250 Identities=32% Similarity=0.501 Sum_probs=213.3
Q ss_pred EEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCC
Q 010603 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGD 197 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 197 (506)
+||+|+||+||.|+++.|....|||.|.... ....+.+..|+.+.+.|+|.|||+++|.+..++++-|+||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999987543 3455667889999999999999999999999999999999999999
Q ss_pred hHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCccccccCCccccCCC
Q 010603 198 LHTLRQRQPGKHF--SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLSLRCFVSPKLVQSSD 274 (506)
Q Consensus 198 L~~~l~~~~~~~~--~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~ 274 (506)
|.++++..- +++ .|...-+|.+||+.||.|||++.|||||||-+|+||+. .|.+||+|||-++++.....
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP------ 731 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP------ 731 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc------
Confidence 999988754 455 89999999999999999999999999999999999985 78999999998866432110
Q ss_pred CcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCC
Q 010603 275 DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTH 354 (506)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 354 (506)
| +.++.||.
T Consensus 732 --------------~---------------------------------------------------------TETFTGTL 740 (1226)
T KOG4279|consen 732 --------------C---------------------------------------------------------TETFTGTL 740 (1226)
T ss_pred --------------c---------------------------------------------------------ccccccch
Confidence 1 23467999
Q ss_pred CCccchhhcCC--CCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHh--CCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 355 EYLAPEIIRGD--GHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVV--GQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 355 ~Y~APE~l~~~--~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~--~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|||||++..+ +|+.++|||||||.+.||.||++||...... ..++++- .....+| ..++.+++.||.+|+.+
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP--eelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP--EELSAEAKNFILRCFEP 818 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc--HHHHHHHHHHHHHHcCC
Confidence 99999999865 5999999999999999999999999765544 3334432 2333444 47999999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
||.+||+ |.++|+.||++.-+
T Consensus 819 d~~~R~s----A~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 819 DPCDRPS----AKDLLQDPFLQHNN 839 (1226)
T ss_pred CcccCcc----HHHhccCcccccCC
Confidence 9999998 99999999998653
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=365.02 Aligned_cols=253 Identities=29% Similarity=0.475 Sum_probs=211.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.+..++..||+|.+.... ......++.+|+++++.++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999987542 1234456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 999999999998765 679999999999999999999997 59999999999999999999999999987421000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
....
T Consensus 154 ----------------------------------------------------------------------------~~~~ 157 (308)
T cd06615 154 ----------------------------------------------------------------------------MANS 157 (308)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-----------------------
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP----------------------- 406 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------------- 406 (506)
.+|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ..+....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCCccch
Confidence 3689999999999888899999999999999999999999975543222 2111110
Q ss_pred ---------------CCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 407 ---------------LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 407 ---------------~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
...|. ..++.++++||.+||..||++||+ +.++++||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~ 292 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKR 292 (308)
T ss_pred hhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhh
Confidence 11111 136788999999999999999997 899999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=375.25 Aligned_cols=250 Identities=23% Similarity=0.412 Sum_probs=200.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
..+|++++.||+|+||+||+|++..+++.||+|+..+.. ...|+.+|+.++|||||++++++...+..|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 346999999999999999999999999999999865431 23589999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+ .++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 9999 56888887654 357999999999999999999999999999999999999999999999999988421000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 211 ---------------------------------------------------------------------------~~~~~ 215 (357)
T PHA03209 211 ---------------------------------------------------------------------------PAFLG 215 (357)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC-CCCCCcH---------HHHHHHhC----CCCCCC-----
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTP-FKGNGNR---------ETLFNVVG----QPLKFP----- 410 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~P-f~~~~~~---------~~~~~i~~----~~~~~p----- 410 (506)
..||+.|+|||++.+..|+.++|||||||+||||+++..| |...... ..+..++. .+..++
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 4699999999999999999999999999999999985444 4432111 11111111 011111
Q ss_pred -----------------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 411 -----------------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 411 -----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
....++.++.+||.+||+.||.+||| |.|+|+||||+.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~ 356 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhcc
Confidence 01245677888999999999999998 999999999975
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=360.42 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=208.9
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 599999999999999999999999999999998764322 2334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 192 FCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|+. ++|.+++.... +..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 996 68888876543 3678999999999999999999999999999999999999999999999999974321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (285)
T cd07861 156 --------------------------------------------------------------------------RVYTHE 161 (285)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 000112
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC---------------CCC-
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL---------------KFP- 410 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~---------------~~p- 410 (506)
.|++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+....+.. ... .++
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (285)
T cd07861 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK 241 (285)
T ss_pred cccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccc
Confidence 578899999998764 478999999999999999999999987765444332211 000 000
Q ss_pred --------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 --------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 --------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
....+++++++||.+||..||.+||+ +.+|+.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 242 WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 11247889999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=382.52 Aligned_cols=253 Identities=27% Similarity=0.376 Sum_probs=224.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|.-++.||.|+||.||.|++..+.+.||||.|.-..-+..+....+..|+..|+.++|||+|.+.++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 77889999999999999999999999999999876656667778889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
| -|+-.+++.-+. +++.|..+..|+.+.+.||.|||+++.||||||..||||++.|.|||+|||.|...
T Consensus 108 C-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--------- 176 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--------- 176 (948)
T ss_pred H-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---------
Confidence 9 677777776653 68999999999999999999999999999999999999999999999999987321
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
....+++|
T Consensus 177 ------------------------------------------------------------------------~PAnsFvG 184 (948)
T KOG0577|consen 177 ------------------------------------------------------------------------APANSFVG 184 (948)
T ss_pred ------------------------------------------------------------------------CchhcccC
Confidence 11346799
Q ss_pred CCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 353 THEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 353 T~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
||+|||||+|. .+.|+-++||||||++..||.-.++|+...+....++.|.....+.-....+++.+++||..||++
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqK 264 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK 264 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhh
Confidence 99999999986 456999999999999999999999999888888888887755433333447999999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
-|.+||| .+++|+|+|+..
T Consensus 265 ipqeRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 265 IPQERPT----SEELLKHRFVLR 283 (948)
T ss_pred CcccCCc----HHHHhhcchhcc
Confidence 9999997 899999999963
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=329.28 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=215.6
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|.-+++||+|.||+||+|+.+.+++.||+|.++.+.... ..-..+.+|+.+|+.|+|.|||+++++...+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4777889999999999999999999999999998754332 223456789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|| ..+|..+.... ++.++.+.++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+|+.+..
T Consensus 82 ~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi------ 153 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI------ 153 (292)
T ss_pred Hh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC------
Confidence 99 67898887654 47899999999999999999999999999999999999999999999999999975321
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
|+ .|+ ...+
T Consensus 154 -------------------------pv---------rcy-------------------------------------saev 162 (292)
T KOG0662|consen 154 -------------------------PV---------RCY-------------------------------------SAEV 162 (292)
T ss_pred -------------------------ce---------Eee-------------------------------------ecee
Confidence 11 010 1126
Q ss_pred cCCCCccchhhcCCC-CCcchhHHHHHHHHHHHh-cCCCCCCCCCcHHHHHHHh---CCCC--CCCCC------------
Q 010603 352 GTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVV---GQPL--KFPEG------------ 412 (506)
Q Consensus 352 GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~ell-tG~~Pf~~~~~~~~~~~i~---~~~~--~~p~~------------ 412 (506)
.|.+|++|.++.+.. |+...|+||.|||+.||. .|++.|.+.+..+++.+|. +.+. .+|..
T Consensus 163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~y 242 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIY 242 (292)
T ss_pred eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCc
Confidence 899999999999876 899999999999999999 5999999999888877664 2221 11111
Q ss_pred ----------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 413 ----------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 413 ----------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..++...+||++++|.-+|..|++ |+++++||||.+.
T Consensus 243 pattswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 243 PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSDF 289 (292)
T ss_pred cccchHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccccc
Confidence 123445789999999999999998 9999999999753
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=361.27 Aligned_cols=256 Identities=30% Similarity=0.450 Sum_probs=211.7
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEe------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFET------ 182 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~------ 182 (506)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 356999999999999999999999999999999986542 2334567789998888 79999999999853
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
...+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46889999999999999998876666789999999999999999999999999999999999999999999999999743
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 171 ~~~~---------------------------------------------------------------------------- 174 (282)
T cd06636 171 LDRT---------------------------------------------------------------------------- 174 (282)
T ss_pred hhcc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCCCccccccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCH
Q 010603 343 TSARSMSFVGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISF 417 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~ 417 (506)
.......+|++.|+|||++. ...++.++|||||||++|||++|..||........+..+............++.
T Consensus 175 -~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd06636 175 -VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253 (282)
T ss_pred -ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCH
Confidence 00011236899999999986 345788999999999999999999999876655544444333222222235889
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
++.+||.+||..||.+||+ +.|+++||||
T Consensus 254 ~~~~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 254 KFIDFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 9999999999999999997 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=382.96 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=203.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
...|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++|+.|+|+|||++++++...+..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2345799999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||++ .++|..++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 239 ~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 9999 578888876542 479999999999999999999999999999999999999999999999999985321000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.......
T Consensus 315 -------------------------------------------------------------------------~~~~~~~ 321 (461)
T PHA03211 315 -------------------------------------------------------------------------STPFHYG 321 (461)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0000113
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC-------cHHHHHHHhCC-C---CCCC--------
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-------NRETLFNVVGQ-P---LKFP-------- 410 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~-~---~~~p-------- 410 (506)
.+||+.|||||++.+..++.++|||||||+||||++|..|+.... ....+.+++.. . ..++
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 479999999999999999999999999999999999876653221 11222222211 0 0011
Q ss_pred ---------------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 411 ---------------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 411 ---------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
....++.++.+||.+||+.||.+||+ +.|||+||||+.
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 01135668999999999999999998 999999999974
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.32 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=218.9
Q ss_pred cccCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC--C----Ccc
Q 010603 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH--P----FLP 174 (506)
Q Consensus 101 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--p----nIv 174 (506)
.....+++...+|.|++.||+|+||+|-.+.++.++..||||+|+.- .+..+.+.-|+++|+++.+ | -+|
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 34556777889999999999999999999999999999999999743 3445566789999999942 2 488
Q ss_pred ceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-----
Q 010603 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED----- 249 (506)
Q Consensus 175 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----- 249 (506)
++.+||+-.+++|||+|.+ |-++++++..+.-.+++...++.+++||+.+|+|||+++++|.||||||||+.+.
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 9999999999999999999 8899999999877899999999999999999999999999999999999999632
Q ss_pred ---------------CCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcc
Q 010603 250 ---------------GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRF 314 (506)
Q Consensus 250 ---------------~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (506)
-.|+|+|||-|..
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf---------------------------------------------------- 261 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATF---------------------------------------------------- 261 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcce----------------------------------------------------
Confidence 2588999997732
Q ss_pred ccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC
Q 010603 315 LNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG 394 (506)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~ 394 (506)
.......++.|..|+|||++++.+++.++||||+||||+||++|...|+..+
T Consensus 262 ----------------------------~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 262 ----------------------------DHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ----------------------------eccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 1112345789999999999999999999999999999999999999999988
Q ss_pred cHHHH---HHHhCCC------------------CCCCCCC-----------------------CCCHHHHHHHHHHhhcC
Q 010603 395 NRETL---FNVVGQP------------------LKFPEGS-----------------------SISFAAKDLIRGLLVKD 430 (506)
Q Consensus 395 ~~~~~---~~i~~~~------------------~~~p~~~-----------------------~~s~~~~~li~~~L~~d 430 (506)
+.|.+ +.|++.. +.+++.. ..-.++.|||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 77743 4444311 1222210 00114779999999999
Q ss_pred CCCccCCCCChHHhhcCCCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.+|+| +.|+|.||||+.
T Consensus 394 P~~RiT----l~EAL~HpFF~~ 411 (415)
T KOG0671|consen 394 PARRIT----LREALSHPFFAR 411 (415)
T ss_pred cccccc----HHHHhcCHHhhc
Confidence 999998 899999999975
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=375.78 Aligned_cols=261 Identities=32% Similarity=0.510 Sum_probs=222.1
Q ss_pred eEEE--eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 113 FRLL--KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 113 y~i~--~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
|+|. ++||+|.||+||-|+++++|+.||||+|.|..+..+ +...+++|+.||+.++||.||.|...|++.+.+++||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 5553 689999999999999999999999999999877643 4477899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CEEEeecCCccccccCC
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFGla~~~~~~~ 267 (506)
|-+ .||..+.|-....++++|...++++.||+.||.|||-+||+|+|||||||||.... ++||||||+|+.+.
T Consensus 643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--- 718 (888)
T KOG4236|consen 643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--- 718 (888)
T ss_pred hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc---
Confidence 999 66766666666668999999999999999999999999999999999999998653 79999999996431
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.....
T Consensus 719 ---------------------------------------------------------------------------EksFR 723 (888)
T KOG4236|consen 719 ---------------------------------------------------------------------------EKSFR 723 (888)
T ss_pred ---------------------------------------------------------------------------hhhhh
Confidence 01113
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~li~~ 425 (506)
.+.+|||.|+|||+|+..+|+..-|+||+|||+|--|.|..||....+. -.+|.+..+-+| .|..+++++.|||..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 3569999999999999999999999999999999999999999754432 233333433343 456799999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCCC-cchhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESVN-WALIR 459 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~~-~~~~~ 459 (506)
+|+..-.+|.+ ++..|.|||+++.. |..++
T Consensus 802 LLqVkm~kRys----vdk~lsh~Wlq~yq~w~DLR 832 (888)
T KOG4236|consen 802 LLQVKMRKRYS----VDKSLSHPWLQDYQTWLDLR 832 (888)
T ss_pred HHHHHHHHhcc----hHhhccchhhhcchHHHHHH
Confidence 99999999998 89999999999865 65443
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=354.82 Aligned_cols=265 Identities=40% Similarity=0.757 Sum_probs=225.3
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||.|+||.||+|++..+|+.||+|++.+...........+.+|+++++.++||||+++++.+......|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999876554456667788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCccc
Q 010603 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278 (506)
Q Consensus 199 ~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 278 (506)
.+++.+. ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++...........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 9998875 4789999999999999999999999999999999999999999999999999853211100000
Q ss_pred ccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCcc
Q 010603 279 RISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLA 358 (506)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 358 (506)
...........++..|+|
T Consensus 152 --------------------------------------------------------------~~~~~~~~~~~~~~~~~~ 169 (265)
T cd05579 152 --------------------------------------------------------------NDDEKEDKRIVGTPDYIA 169 (265)
T ss_pred --------------------------------------------------------------ccccccccCcccCccccC
Confidence 000001122468889999
Q ss_pred chhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCC
Q 010603 359 PEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 359 PE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~ 438 (506)
||++.+..++.++|||||||++|+|++|..||......+.+..+......++....++..+.+||.+||+.+|.+||++.
T Consensus 170 Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 249 (265)
T cd05579 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAK 249 (265)
T ss_pred HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCc
Confidence 99999888999999999999999999999999988877777777766666666545699999999999999999999842
Q ss_pred CChHHhhcCCCCCCCCc
Q 010603 439 RGATEIKQHPFFESVNW 455 (506)
Q Consensus 439 ~~a~ell~hp~f~~~~~ 455 (506)
.+.++|+||||+.++|
T Consensus 250 -~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 250 -SIEEIKNHPFFKGIDW 265 (265)
T ss_pred -cHHHHhcCccccCCCC
Confidence 3599999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=358.78 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=212.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ......+++|+.+++.++||||+++++.+...+..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 356999999999999999999999999999999987543 23345567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999999988765 579999999999999999999999999999999999999999999999999985321000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (267)
T cd06645 161 ---------------------------------------------------------------------------AKRKS 165 (267)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred cccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC---CCCCCCHHHHHHH
Q 010603 350 FVGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP---EGSSISFAAKDLI 423 (506)
Q Consensus 350 ~~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~~~s~~~~~li 423 (506)
..|++.|+|||++. ...++.++|||||||++|+|++|..||........+..........+ ....++..+.+||
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHH
Confidence 36899999999985 45588999999999999999999999976655444444333322222 2235788999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhcCCC
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQHPF 449 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~hp~ 449 (506)
.+||..+|++||+ ++++++|||
T Consensus 246 ~~~l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 246 KMALTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred HHHccCCchhCcC----HHHHhcCCC
Confidence 9999999999997 899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=360.00 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=218.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||.|+||.||+|.+..+++.||+|++.... ......+..|+++++.++||||+++++++..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 45999999999999999999999899999999987542 334556778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---- 156 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---- 156 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence 999999999988764 257999999999999999999999999999999999999999999999999987431100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (280)
T cd06611 157 -------------------------------------------------------------------------LQKRDTF 163 (280)
T ss_pred -------------------------------------------------------------------------cccccee
Confidence 0001123
Q ss_pred ccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHHHH
Q 010603 351 VGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 351 ~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~li~ 424 (506)
.||+.|+|||++. ...++.++|||||||++|||++|+.||........+..+.... ..+.....++.++.+||.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (280)
T cd06611 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243 (280)
T ss_pred ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHH
Confidence 6899999999985 3446789999999999999999999998877666666665442 223333468899999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+||..+|.+||+ +.++++||||....
T Consensus 244 ~~l~~~p~~Rps----~~~il~~~~~~~~~ 269 (280)
T cd06611 244 SCLVKDPDDRPT----AAELLKHPFVSDQS 269 (280)
T ss_pred HHhccChhhCcC----HHHHhcChhhcccc
Confidence 999999999997 89999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=360.30 Aligned_cols=242 Identities=16% Similarity=0.191 Sum_probs=205.2
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe----CCeEEEEEee
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----DKFSCLLMEF 192 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 192 (506)
..||+|++|.||+|.+ +|+.||||++++...........+.+|+.+|+.++|||||++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999988 489999999987644444445677899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
+.+|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 9999999998765 578999999999999999999998 49999999999999999999999999998432100
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
....+
T Consensus 177 ---------------------------------------------------------------------------~~~~~ 181 (283)
T PHA02988 177 ---------------------------------------------------------------------------PFKNV 181 (283)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01126
Q ss_pred cCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 352 GTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 352 GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
||..|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+......++....++..+++||.+||+.
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~ 261 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH 261 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence 8899999999976 67999999999999999999999999988877777776554444443346899999999999999
Q ss_pred CCCCccCCCCChHHhhc
Q 010603 430 DPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~ 446 (506)
||++||+ +.++++
T Consensus 262 dp~~Rps----~~ell~ 274 (283)
T PHA02988 262 DSIKRPN----IKEILY 274 (283)
T ss_pred CcccCcC----HHHHHH
Confidence 9999998 677764
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=356.05 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=211.1
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
..++|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3457999999999999999999999999999999987542 2334457789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-- 159 (267)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--
Confidence 99999999999988754 57899999999999999999999999999999999999999999999999998542100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
.....
T Consensus 160 ---------------------------------------------------------------------------~~~~~ 164 (267)
T cd06646 160 ---------------------------------------------------------------------------IAKRK 164 (267)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 00011
Q ss_pred ccccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC---CCCCCCCHHHHHH
Q 010603 349 SFVGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF---PEGSSISFAAKDL 422 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~~~s~~~~~l 422 (506)
...|++.|+|||++. ...++.++|||||||++|||++|+.||......+....+....... +....++..+.+|
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 236889999999985 3447889999999999999999999997655444333332222222 2223578899999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPF 449 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~ 449 (506)
|.+||..||++||+ ++++++|+|
T Consensus 245 i~~~l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 245 VKISLTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred HHHHhhCChhhCcC----HHHHhcCCC
Confidence 99999999999997 899999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.02 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=216.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc------hhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG------RKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
+|.+.+.||.|+||.||+|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999999889999999987643321 2234567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999998765 5789999999999999999999999999999999999999999999999999854321
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
..... ....
T Consensus 159 ~~~~~-----------------------------------------------------------------------~~~~ 167 (267)
T cd06628 159 NSLST-----------------------------------------------------------------------KTNG 167 (267)
T ss_pred ccccC-----------------------------------------------------------------------Cccc
Confidence 00000 0000
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~ 424 (506)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+... ...++ ..++..+.++|.
T Consensus 168 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~ 245 (267)
T cd06628 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP--SNISSEAIDFLE 245 (267)
T ss_pred cccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCC--cccCHHHHHHHH
Confidence 011235889999999999888999999999999999999999999877665555554432 22233 358899999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+||+.||.+||+ +.++++||||
T Consensus 246 ~~l~~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 246 KTFEIDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred HHccCCchhCcC----HHHHhhCCCC
Confidence 999999999997 8999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=359.83 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=216.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|++++.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+......|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 569999999999999999999999999999999876432 23455778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred cccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 99999999998865 358999999999999999999999999999999999999999999999999874311000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 171 --------------------------------------------------------------------------~~~~~~ 176 (296)
T cd06654 171 --------------------------------------------------------------------------SKRSTM 176 (296)
T ss_pred --------------------------------------------------------------------------cccCcc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|++.|+|||.+.+..++.++|||||||++|+|++|+.||........+..+... ....+....++..+.+||.+||..
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcC
Confidence 6889999999999888999999999999999999999999877665544443322 222223346888999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||++||+ +.++++||||...
T Consensus 257 ~p~~Rpt----~~eil~~~~~~~~ 276 (296)
T cd06654 257 DVEKRGS----AKELLQHQFLKIA 276 (296)
T ss_pred CcccCcC----HHHHhhChhhhcc
Confidence 9999997 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=357.50 Aligned_cols=255 Identities=30% Similarity=0.473 Sum_probs=215.1
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++++.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999987543 23455678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+++++|..++... ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 9999998877653 357999999999999999999999999999999999999999999999999998432100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
........|
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (282)
T cd06643 157 -----------------------------------------------------------------------IQRRDSFIG 165 (282)
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 000112368
Q ss_pred CCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHHHHHH
Q 010603 353 THEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 353 T~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~li~~~ 426 (506)
|+.|+|||++. +..++.++|||||||++|||++|++||...+..+.+..+.... ...+....++..+++||.+|
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHH
Confidence 89999999984 3457889999999999999999999998877766666654332 22333346889999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|..||.+||+ ++++++||||..
T Consensus 246 l~~~p~~Rp~----~~~il~~~~~~~ 267 (282)
T cd06643 246 LEKNVDARWT----TTQLLQHPFVTV 267 (282)
T ss_pred ccCChhhCcC----HHHHhcCCCEec
Confidence 9999999998 899999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=352.57 Aligned_cols=261 Identities=27% Similarity=0.386 Sum_probs=214.1
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh---hchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML---AGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
+|++.+.||.|+||.||+|... +++.+|||.+..... ........+.+|+++|+.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4889999999999999999864 688999999875421 123344568889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+++++|.+++.+. ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998765 5689999999999999999999999999999999999999999999999999854211000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
... ......
T Consensus 158 ~~~-----------------------------------------------------------------------~~~~~~ 166 (265)
T cd06631 158 HGT-----------------------------------------------------------------------HSNMLK 166 (265)
T ss_pred ccc-----------------------------------------------------------------------cccccc
Confidence 000 000011
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC-CCCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF-PEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~~~s~~~~~li~~~L 427 (506)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....... +....++.++.+||.+||
T Consensus 167 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06631 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCL 246 (265)
T ss_pred ccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHh
Confidence 2368999999999999889999999999999999999999998766555544443321111 222368899999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f 450 (506)
..+|.+||+ +.+++.||||
T Consensus 247 ~~~p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 247 TRDQHERPS----ALQLLRHDFL 265 (265)
T ss_pred cCCcccCCC----HHHHhcCCCC
Confidence 999999997 8999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=350.97 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=213.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh--hchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML--AGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 186 (506)
.+|++.+.||+|+||.||+|.+..+++.||||.+..... ........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999999864321 1223456778899999999999999999998764 578
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
++||||+++++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998765 46899999999999999999999999999999999999999999999999988532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ....
T Consensus 160 ~~--------------------------------------------------------------------------~~~~ 165 (265)
T cd06652 160 CL--------------------------------------------------------------------------SGTG 165 (265)
T ss_pred cc--------------------------------------------------------------------------cccc
Confidence 00 0000
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........+..+............++..+.++|.+|
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 245 (265)
T cd06652 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRI 245 (265)
T ss_pred cccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence 11235889999999999888999999999999999999999999877666555555543322222335788899999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
|. +|++||+ ++++++|||+.
T Consensus 246 l~-~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 246 FV-EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred hc-ChhhCCC----HHHHhcCcccC
Confidence 95 9999997 89999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=355.66 Aligned_cols=257 Identities=31% Similarity=0.501 Sum_probs=218.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||.|+||.||+|++..+++.||+|++.... .......+.+|+++++.++|+||+++++++..+..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36999999999999999999999999999999987643 1334456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++... .+++..++.++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||+++......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999988753 78999999999999999999999999999999999999999999999999985431100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 153 --------------------------------------------------------------------------~~~~~~ 158 (274)
T cd06609 153 --------------------------------------------------------------------------SKRNTF 158 (274)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC-CCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL-KFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .++. ..++.++.++|.+||..
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-NKFSKPFKDFVSLCLNK 237 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc-cccCHHHHHHHHHHhhC
Confidence 688899999999998899999999999999999999999987766555544443322 2222 22788999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+|++||+ ++++++||||....
T Consensus 238 ~p~~Rpt----~~~il~~~~~~~~~ 258 (274)
T cd06609 238 DPKERPS----AKELLKHKFIKKAK 258 (274)
T ss_pred ChhhCcC----HHHHhhChhhcCCC
Confidence 9999997 89999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=351.11 Aligned_cols=261 Identities=29% Similarity=0.412 Sum_probs=218.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||.|+||+||+|....++..+|+|++.+..... ....+.+|+++|+.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 36999999999999999999999889999999997654322 5567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 191 EFCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999999987642 257899999999999999999999999999999999999999999999999998542211000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.......
T Consensus 159 -------------------------------------------------------------------------~~~~~~~ 165 (267)
T cd06610 159 -------------------------------------------------------------------------TRKVRKT 165 (267)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0000122
Q ss_pred cccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCC---CCCCHHHHHHHH
Q 010603 350 FVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEG---SSISFAAKDLIR 424 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~---~~~s~~~~~li~ 424 (506)
.+|+..|+|||++... .++.++|+|||||++|||++|+.||...+....+....... ..++.. ..++..+.+||.
T Consensus 166 ~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (267)
T cd06610 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245 (267)
T ss_pred ccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHH
Confidence 3689999999999877 78999999999999999999999998777666555554432 222221 257889999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+||..||++||+ +.++++||||
T Consensus 246 ~~l~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 246 LCLQKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred HHcCCChhhCcC----HHHHhhCCCC
Confidence 999999999997 8999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=349.16 Aligned_cols=256 Identities=24% Similarity=0.455 Sum_probs=219.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...++.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 599999999999999999999999999999998764332 2334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence 9999999998877655578999999999999999999999999999999999999999999999999884321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd08218 156 -------------------------------------------------------------------------ELARTCI 162 (256)
T ss_pred -------------------------------------------------------------------------hhhhhcc
Confidence 0001235
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
|++.|+|||++.+..++.++|+|||||++|+|++|+.||......+.+..++.+... +....++.++.++|.+||..+|
T Consensus 163 ~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p 241 (256)
T cd08218 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNP 241 (256)
T ss_pred CCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCCh
Confidence 888999999999888999999999999999999999999887777777666544322 2234688999999999999999
Q ss_pred CCccCCCCChHHhhcCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f 450 (506)
.+||+ +.++++||||
T Consensus 242 ~~Rp~----~~~vl~~~~~ 256 (256)
T cd08218 242 RDRPS----VNSILEKNFI 256 (256)
T ss_pred hhCcC----HHHHhhCcCC
Confidence 99998 8999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=355.45 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=210.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.++.+|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 3699999999999999999999999999999998754321 122345678999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++++.|..++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--- 154 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc---
Confidence 999999888776543 468999999999999999999999999999999999999999999999999985321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (286)
T cd07847 155 --------------------------------------------------------------------------DDYTDY 160 (286)
T ss_pred --------------------------------------------------------------------------ccccCc
Confidence 001123
Q ss_pred ccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---C----------------CCCCC
Q 010603 351 VGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---Q----------------PLKFP 410 (506)
Q Consensus 351 ~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~----------------~~~~p 410 (506)
.++..|+|||++.+ ..++.++|||||||++|||++|++||.+....+....+.. . ....+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 57889999999876 4578999999999999999999999988776555443321 0 00111
Q ss_pred C----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 E----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 ~----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
. ...++..+.+||.+||..||++||+ +.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 1 1246788999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=358.39 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=217.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|++++.||.|+||.||+|.+..+++.||||.+.... ......+.+|+++++.++||||+++++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 45999999999999999999999999999999987543 233456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+.+++|..++.. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 99999999998865 368999999999999999999999999999999999999999999999999874311000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (296)
T cd06655 170 --------------------------------------------------------------------------SKRSTM 175 (296)
T ss_pred --------------------------------------------------------------------------ccCCCc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....+..+... ...+.....+++.+.+||.+||..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhc
Confidence 5889999999999888999999999999999999999999887766555544322 222233346889999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||.+||+ +.++++||||+..
T Consensus 256 dp~~Rpt----~~~il~~~~~~~~ 275 (296)
T cd06655 256 DVEKRGS----AKELLQHPFLKLA 275 (296)
T ss_pred ChhhCCC----HHHHhhChHhhhc
Confidence 9999997 8999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.30 Aligned_cols=255 Identities=37% Similarity=0.702 Sum_probs=218.1
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||.|+||.||+|.+..+++.||+|++.+...........+.+|+++++.++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 49999999999999999999999999999999987655544566788899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+.|++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999998765 579999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (258)
T cd05578 155 --------------------------------------------------------------------------LTTSTS 160 (258)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 011235
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc--HHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN--RETLFNVVG-QPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~--~~~~~~i~~-~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... .+.+..... ....+|. .++.++.++|.+||.
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~ 238 (258)
T cd05578 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA--TWSTEAIDAINKLLE 238 (258)
T ss_pred CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcc--cCcHHHHHHHHHHcc
Confidence 88899999999988899999999999999999999999987664 333333333 3333333 588999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f 450 (506)
.||.+|+++. ..|+++||||
T Consensus 239 ~~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred CChhHcCCcc--HHHHhcCCCC
Confidence 9999999832 4999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=347.85 Aligned_cols=256 Identities=30% Similarity=0.447 Sum_probs=221.2
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||.|+||.||.++...+++.+++|.+...... ......+.+|+++|+.++|+||+++++++...+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 599999999999999999999999999999998765433 2345567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999998876556789999999999999999999999999999999999999999999999999853211000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (256)
T cd08221 157 --------------------------------------------------------------------------MAETVV 162 (256)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 011236
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
|++.|+|||++.+..++.++|||||||++|||++|..||......+....+....... ....++.++.++|.+||..+|
T Consensus 163 ~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p 241 (256)
T cd08221 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDP 241 (256)
T ss_pred CCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCc
Confidence 8999999999998888999999999999999999999999887777777766544332 224688999999999999999
Q ss_pred CCccCCCCChHHhhcCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f 450 (506)
.+||+ +.++++|||+
T Consensus 242 ~~R~s----~~~ll~~~~l 256 (256)
T cd08221 242 EKRPT----ADEVLDQPLL 256 (256)
T ss_pred ccCCC----HHHHhhCcCC
Confidence 99997 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=375.70 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=211.0
Q ss_pred cCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 103 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
..++++..++..+...||+|.||+||+|++.. .||||+++...... .+++.|+.|+.+|++-+|.||+-+.|++..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 36778888999999999999999999999974 59999999876554 488899999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
+.. .||+-+|+|.+|+.+++... ..|.....+.|++||+.|+.|||.++|||||||..||+|.+++.|||+||||+..
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 888 99999999999999887653 6799999999999999999999999999999999999999999999999999832
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
...- . |
T Consensus 538 k~~w-----~----------------g----------------------------------------------------- 543 (678)
T KOG0193|consen 538 KTRW-----S----------------G----------------------------------------------------- 543 (678)
T ss_pred eeee-----c----------------c-----------------------------------------------------
Confidence 1000 0 0
Q ss_pred CCCCccccccCCCCccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC----CCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE----GSSI 415 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~---~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~ 415 (506)
........|...|||||++..+ +|++.+||||||||+|||+||..||... ..+++.-.+++.+-.|. ....
T Consensus 544 -~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 544 -EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred -ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEecccccCccchhhhccC
Confidence 0001112588899999999754 6899999999999999999999999944 44444333444322222 2457
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKR 439 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~ 439 (506)
+.++++|+..||.+++++||.|.+
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~ 645 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQ 645 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHH
Confidence 779999999999999999998643
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=359.89 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=214.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 569999999999999999999999999999999875432 23355678999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999998865 358999999999999999999999999999999999999999999999999874311000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (297)
T cd06656 170 --------------------------------------------------------------------------SKRSTM 175 (297)
T ss_pred --------------------------------------------------------------------------cCcCcc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG-QPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. ..........++..+++||.+||..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccC
Confidence 588899999999998899999999999999999999999987665443333222 2222222346788999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||++||+ +.++++||||+..
T Consensus 256 ~p~~Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 256 DVDRRGS----AKELLQHPFLKLA 275 (297)
T ss_pred ChhhCcC----HHHHhcCchhccc
Confidence 9999997 8999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=351.37 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=212.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh--chhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCeEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA--GRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKFSC 187 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~ 187 (506)
+|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 589999999999999999999999999999998754321 22345667889999999999999999999875 36789
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
++|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999988765 468999999999999999999999999999999999999999999999999985421000
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. .....
T Consensus 161 ~--------------------------------------------------------------------------~~~~~ 166 (266)
T cd06651 161 M--------------------------------------------------------------------------SGTGI 166 (266)
T ss_pred c--------------------------------------------------------------------------cCCcc
Confidence 0 00000
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
....|+..|+|||++.+..++.++|||||||++|||++|+.||........+...............+++.+++|| +||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~ 245 (266)
T cd06651 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCI 245 (266)
T ss_pred ccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHh
Confidence 1235888999999999988999999999999999999999999877665555544433222111235788899999 577
Q ss_pred hcCCCCccCCCCChHHhhcCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
..+|++||+ ++|+++||||+
T Consensus 246 ~~~p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 246 FVEARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred cCChhhCcC----HHHHhcCcccc
Confidence 789999997 89999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.67 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=204.6
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||+|+||.||+|.++.+|+.||+|.+...... ......+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 489999999999999999999999999999999764322 2233456679999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---- 153 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---- 153 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC----
Confidence 995 5888877653 2569999999999999999999999999999999999999999999999999984321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (284)
T cd07839 154 -------------------------------------------------------------------------RCYSAEV 160 (284)
T ss_pred -------------------------------------------------------------------------CCcCCCc
Confidence 0001125
Q ss_pred cCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCC-CCCcHHHHHHHhC---CC--------------CCCC--
Q 010603 352 GTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFK-GNGNRETLFNVVG---QP--------------LKFP-- 410 (506)
Q Consensus 352 GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~-~~~~~~~~~~i~~---~~--------------~~~p-- 410 (506)
+++.|+|||++.+.. ++.++|||||||++|||++|..||. +.+..+.+..+.. .. ..++
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence 788999999987754 7899999999999999999988854 4433333322211 00 0000
Q ss_pred --------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 --------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 --------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
....++.++++||.+||..||.+||| ++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 01246889999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=374.05 Aligned_cols=259 Identities=19% Similarity=0.287 Sum_probs=208.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccC-----CceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
.+..++|++.+.||+|+||.||+|++..+ ++.||||++..... ......+.+|+++|+.+ +|+|||++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34556799999999999999999986543 35799999976432 23345678899999999 899999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCC------------------------------------------------------
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQP------------------------------------------------------ 206 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------ 206 (506)
...+.+|+|||||++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999876421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 207 --------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 207 --------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~---- 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---- 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----
Confidence 12478889999999999999999999999999999999999999999999999853211000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
........+
T Consensus 268 -----------------------------------------------------------------------~~~~~~~~~ 276 (374)
T cd05106 268 -----------------------------------------------------------------------YVVKGNARL 276 (374)
T ss_pred -----------------------------------------------------------------------eeeccCCCC
Confidence 000011235
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
++.|||||++.+..++.++|||||||++|||++ |+.||........+..........+....+++++.+||.+||+.||
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCCh
Confidence 678999999999899999999999999999997 9999987665555555554433333334578999999999999999
Q ss_pred CCccCCCCChHHhhc
Q 010603 432 QKRLGFKRGATEIKQ 446 (506)
Q Consensus 432 ~~R~s~~~~a~ell~ 446 (506)
.+||+ +.++++
T Consensus 357 ~~RPs----~~~l~~ 367 (374)
T cd05106 357 TERPT----FSQISQ 367 (374)
T ss_pred hhCcC----HHHHHH
Confidence 99998 666654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=386.89 Aligned_cols=272 Identities=24% Similarity=0.348 Sum_probs=201.8
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCC-ceEEEEE--------------eccchhhchhHHHHHHHHHHHHHhcC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMG-CLFAMKV--------------MDKGMLAGRKKLMRAQTEREILSLLD 169 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~--------------i~~~~~~~~~~~~~~~~E~~il~~l~ 169 (506)
.++..+++|++++.||+|+||+||+|..+... ..+++|. +.+...........+.+|+++|+.++
T Consensus 142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence 34445688999999999999999999875432 2222221 11111112233456788999999999
Q ss_pred CCCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE
Q 010603 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQP---GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV 246 (506)
Q Consensus 170 hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl 246 (506)
|||||++++++...+..|+|||++ +++|..++.... ........++.|+.||+.||+|||++|||||||||+||||
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 999999999999999999999999 567777665421 1234467788899999999999999999999999999999
Q ss_pred ecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccc
Q 010603 247 REDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEK 326 (506)
Q Consensus 247 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (506)
+.++.+||+|||+++.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~------------------------------------------------------------ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE------------------------------------------------------------ 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc------------------------------------------------------------
Confidence 99999999999998542100
Q ss_pred ccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC-CCCC--cHHHHHHHh
Q 010603 327 TSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF-KGNG--NRETLFNVV 403 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf-~~~~--~~~~~~~i~ 403 (506)
........+||+.|+|||++.+..|+.++|||||||+||||++|..++ .... ....+..++
T Consensus 321 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 321 ----------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred ----------------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 000112347999999999999999999999999999999999987654 3221 222222222
Q ss_pred CC----CCCCC--------------------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 404 GQ----PLKFP--------------------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 404 ~~----~~~~p--------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.. ...+| ....++.++.++|.+||..||.+||+ |.|+|.||||...
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~ 460 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAE 460 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcC
Confidence 10 00011 01135677889999999999999997 9999999999887
Q ss_pred Ccch
Q 010603 454 NWAL 457 (506)
Q Consensus 454 ~~~~ 457 (506)
.+..
T Consensus 461 ~~~~ 464 (501)
T PHA03210 461 EEEE 464 (501)
T ss_pred CchH
Confidence 6543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=349.98 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=209.6
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
+...+|++.+.||+|+||.||+|.++ ..+..||+|.++.... ......+.+|+.+|+.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34567999999999999999999875 3467899999876422 233456788999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999987642 478999999999999999999999999999999999999999999999999763210
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
....
T Consensus 159 ~~~~---------------------------------------------------------------------------- 162 (266)
T cd05064 159 SEAI---------------------------------------------------------------------------- 162 (266)
T ss_pred ccch----------------------------------------------------------------------------
Confidence 0000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+... ...+....++..+.+++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 241 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPRNCPNLLHQLM 241 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHH
Confidence 00001235678999999999999999999999999999775 99999888777666655433 33444457889999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..+|.+||+ +.++++
T Consensus 242 ~~c~~~~p~~RP~----~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPR----FSQIHS 260 (266)
T ss_pred HHHcCCCchhCCC----HHHHHH
Confidence 9999999999998 566654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=353.84 Aligned_cols=267 Identities=21% Similarity=0.333 Sum_probs=214.1
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
++..++|++.+.||+|+||.||+|..+. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4556789999999999999999997653 355799999865421 223345678999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEE
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQP--------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 253 (506)
..+..|+||||+++|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999987532 13346778889999999999999999999999999999999999999
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||+++........
T Consensus 160 L~Dfg~~~~~~~~~~~---------------------------------------------------------------- 175 (288)
T cd05061 160 IGDFGMTRDIYETDYY---------------------------------------------------------------- 175 (288)
T ss_pred ECcCCccccccccccc----------------------------------------------------------------
Confidence 9999998542110000
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCC
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEG 412 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 412 (506)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..... .+..
T Consensus 176 -----------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~ 243 (288)
T cd05061 176 -----------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQP 243 (288)
T ss_pred -----------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCC
Confidence 00011245678999999999889999999999999999998 8999988776665555543321 2222
Q ss_pred CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc------CCCCCCCCc
Q 010603 413 SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ------HPFFESVNW 455 (506)
Q Consensus 413 ~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~------hp~f~~~~~ 455 (506)
..++..+.+||.+||+.||.+||+ +.++++ ||||.+++|
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps----~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPT----FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcC----HHHHHHHHHhhcCCCCCCCCC
Confidence 357899999999999999999998 555554 999999988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=351.22 Aligned_cols=256 Identities=31% Similarity=0.492 Sum_probs=212.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK---- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~---- 184 (506)
.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+++++.+ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 367999999999999999999999889999999987643 2335678899999998 7999999999997644
Q ss_pred --eEEEEEeecCCCChHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 185 --FSCLLMEFCSGGDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 185 --~~~lV~E~~~gg~L~~~l~~~~--~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
.+|+||||+++++|.+++.... +..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999887643 467999999999999999999999999999999999999999999999999987
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
.......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (275)
T cd06608 161 AQLDSTL------------------------------------------------------------------------- 167 (275)
T ss_pred eecccch-------------------------------------------------------------------------
Confidence 4321000
Q ss_pred CCCCCCccccccCCCCccchhhcCC-----CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC-CCCCCCC
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGD-----GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL-KFPEGSS 414 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~ 414 (506)
.......|+..|+|||++... .++.++|||||||+||+|++|+.||........+..+..... .+.....
T Consensus 168 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd06608 168 ----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPEN 243 (275)
T ss_pred ----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhh
Confidence 001123689999999998643 467899999999999999999999987666666666554432 2222234
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
++.++++||.+||..||++||+ +.++++|||+
T Consensus 244 ~~~~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 244 WSKKFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred cCHHHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 7889999999999999999998 8999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=373.18 Aligned_cols=246 Identities=27% Similarity=0.471 Sum_probs=214.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
+++-++...-++-||.|+.|.||+|+.+ ++.||||.++. .-..+|.-|++|+||||+.+.|++.....
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCce
Confidence 3444444445677999999999999998 78999997642 11347888999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||..|-|..+++.. +.+.......|.++|+.|+.|||.++|||||||.-||||..+..|||+|||-++...
T Consensus 187 yCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~- 263 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS- 263 (904)
T ss_pred eEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh-
Confidence 99999999999999999875 789999999999999999999999999999999999999999999999999875321
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
...
T Consensus 264 -----------------------------------------------------------------------------~~S 266 (904)
T KOG4721|consen 264 -----------------------------------------------------------------------------DKS 266 (904)
T ss_pred -----------------------------------------------------------------------------hhh
Confidence 012
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
..++++||..|||||+|...+.+.|+|||||||||||||||..||++-+...++.-+-...+.+|-+..+++.++=||+.
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 24578999999999999999999999999999999999999999998877776666666667777777899999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~h 447 (506)
||.-.|.+||+ ..++|.|
T Consensus 347 cw~sKpRNRPS----Frqil~H 364 (904)
T KOG4721|consen 347 CWNSKPRNRPS----FRQILLH 364 (904)
T ss_pred HHhcCCCCCcc----HHHHHHH
Confidence 99999999998 5688887
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=348.24 Aligned_cols=265 Identities=31% Similarity=0.432 Sum_probs=208.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCC----ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-CC
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-DK 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 184 (506)
+..|++++.||+|+||.||+|..++++ +.||||.++.... .......+-+|+.+++.|+||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 345999999999999999999776553 3689999875432 12333456789999999999999999999987 88
Q ss_pred eEEEEEeecCCCChHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC----CCEEEeec
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQ---PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED----GHIMLSDF 257 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~---~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----~~vkl~DF 257 (506)
.++|++||.+ -||..+|+-+ ..+.++...++.|+.||+.||.|||++.|+||||||.||||..+ |.|||+||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999995 4888877653 23578999999999999999999999999999999999999988 89999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|+|+.+...-+-..
T Consensus 181 GlaR~~~~plkpl~------------------------------------------------------------------ 194 (438)
T KOG0666|consen 181 GLARLFNNPLKPLA------------------------------------------------------------------ 194 (438)
T ss_pred cHHHHhhccccccc------------------------------------------------------------------
Confidence 99976432111000
Q ss_pred cccCCCCCCccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCc------------HHHHHHHhC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGN------------RETLFNVVG 404 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~------------~~~~~~i~~ 404 (506)
.....+.|.+|+|||+|.|.. |+.++|||++|||+.||+|-++.|.+... .+.++.+++
T Consensus 195 --------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG 266 (438)
T KOG0666|consen 195 --------SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLG 266 (438)
T ss_pred --------cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcC
Confidence 012347899999999999875 89999999999999999999999976422 122344444
Q ss_pred CCC--C------CCCC------------------------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 405 QPL--K------FPEG------------------------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 405 ~~~--~------~p~~------------------------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.+- . +|+. ..-++.+.+|+.+||..||.+|++ |+++|+|+||..
T Consensus 267 ~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~ 342 (438)
T KOG0666|consen 267 TPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTE 342 (438)
T ss_pred CCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhccccccc
Confidence 331 1 1111 012345889999999999999998 999999999986
Q ss_pred CC
Q 010603 453 VN 454 (506)
Q Consensus 453 ~~ 454 (506)
.+
T Consensus 343 d~ 344 (438)
T KOG0666|consen 343 DP 344 (438)
T ss_pred CC
Confidence 53
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=337.49 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=216.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 186 (506)
..+++.+++..||.|+.|+|++++.+.+|...|||.|.+... .+..+++...+.++.+. +.|+||+.+|+|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 456678889999999999999999999999999999987543 34556666677775554 599999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|.||.| +.-+..++++. .++++|..+-++..-++.||.||.. +||||||+||+|||+|+.|++||||||++-++..
T Consensus 167 ~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999998 55566666554 3679999999999999999999986 5899999999999999999999999999854321
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
+.
T Consensus 245 Sk------------------------------------------------------------------------------ 246 (391)
T KOG0983|consen 245 SK------------------------------------------------------------------------------ 246 (391)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CccccccCCCCccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCCC-CcHHHHHHHhCC-CCCCCCCCCCCHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFNVVGQ-PLKFPEGSSISFAAK 420 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~---~~~~~~~DiWSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~p~~~~~s~~~~ 420 (506)
..+.-.|-+.|||||-+.- ..|+.++||||||+.|+||.||+.||.+. ++.+.+..+++. +..+|....+|+++.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 0112258899999999864 36999999999999999999999999974 566777777754 445566667999999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+|+..||.+|+.+||. -.++|+|||+...+
T Consensus 327 ~fv~~CL~kd~r~RP~----Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPK----YNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHhhcCcccCcc----hHHHhcCcceeecc
Confidence 9999999999999997 67999999997543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=370.89 Aligned_cols=260 Identities=20% Similarity=0.295 Sum_probs=209.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEE-----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAEL-----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 179 (506)
..+..++|++.+.||+|+||+||+|.+ ..++..||||+++.... ......+.+|+.+|+.+ +|||||+++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 344556799999999999999999974 34577899999975432 22345677899999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCC-----------------------------------------------------
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQP----------------------------------------------------- 206 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 206 (506)
+...+..|+|||||++|+|.+++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 999999999999999999999886532
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 207 --------------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 207 --------------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124788899999999999999999999999999999999999999999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
... ..
T Consensus 268 ~~~---------------------------------------------------------------------------~~ 272 (375)
T cd05104 268 SNY---------------------------------------------------------------------------VV 272 (375)
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 000 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|||||||+||||++ |..||........+.+.+............+.++.+||.+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 352 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS 352 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence 001235678999999999999999999999999999997 9999987765555555554433333334578899999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..||++||+ +.++++
T Consensus 353 cl~~dP~~RPs----~~eil~ 369 (375)
T cd05104 353 CWDADPLKRPT----FKQIVQ 369 (375)
T ss_pred HccCChhHCcC----HHHHHH
Confidence 99999999998 777775
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.11 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=218.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||+|+||.||+|.+..+++.||||.+...... ......+.+|+++|+.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 499999999999999999999999999999999865433 2345678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCccccccCCccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~~~~~~~ 270 (506)
|+++++|.+++....+..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 99999999999876556789999999999999999999999999999999999998654 5799999998532100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (256)
T cd08220 156 --------------------------------------------------------------------------SKAYTV 161 (256)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
.|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...... +....++.++.+||.+||..|
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~ 240 (256)
T cd08220 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLD 240 (256)
T ss_pred ccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHccCC
Confidence 6888999999999888899999999999999999999999887776666665543321 222368999999999999999
Q ss_pred CCCccCCCCChHHhhcCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f 450 (506)
|.+||+ +.|+++||||
T Consensus 241 p~~Rpt----~~~ll~~p~~ 256 (256)
T cd08220 241 PSKRPQ----LSQIMAQPIC 256 (256)
T ss_pred hhhCCC----HHHHhhCCCC
Confidence 999998 8999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=352.01 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=211.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETD----- 183 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~----- 183 (506)
.++|++.+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 467999999999999999999999999999999987532 2234566789999988 899999999998754
Q ss_pred CeEEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+..|+||||+++++|.+++.. .....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 368999999999999998764 223578999999999999999999999999999999999999999999999999874
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
......
T Consensus 177 ~~~~~~-------------------------------------------------------------------------- 182 (291)
T cd06639 177 QLTSTR-------------------------------------------------------------------------- 182 (291)
T ss_pred hccccc--------------------------------------------------------------------------
Confidence 321000
Q ss_pred CCCCCccccccCCCCccchhhcCC-----CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCC
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-----GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSI 415 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~ 415 (506)
.......|+..|+|||++... .++.++|||||||++|||++|++||........+..+.... ..+.....+
T Consensus 183 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (291)
T cd06639 183 ---LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKW 259 (291)
T ss_pred ---ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccccc
Confidence 001123588999999998654 36889999999999999999999998777666665554332 222223357
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
+..+.+||.+||..+|++||+ +.++++||||+
T Consensus 260 ~~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 260 CRSFNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred CHHHHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 788999999999999999998 89999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=354.22 Aligned_cols=256 Identities=31% Similarity=0.466 Sum_probs=210.9
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||.|+||.||+|+++.+|+.||||.+...... ......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999998754322 2333567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+. ++|..++.......+++..++.++.||+.||+|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 995 689988877666789999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (284)
T cd07860 155 -------------------------------------------------------------------------RTYTHEV 161 (284)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001124
Q ss_pred cCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC---------------CCCC-
Q 010603 352 GTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL---------------KFPE- 411 (506)
Q Consensus 352 GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~---------------~~p~- 411 (506)
+++.|+|||++.+.. ++.++|||||||++|||+||+.||.+.+..+.+.++... +. .++.
T Consensus 162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07860 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW 241 (284)
T ss_pred ccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccc
Confidence 788999999987654 688999999999999999999999887765554443311 00 0111
Q ss_pred --------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 --------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 --------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
...++.++++||.+||..||.+||+ ++++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred cccCHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 1246788999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.75 Aligned_cols=254 Identities=31% Similarity=0.476 Sum_probs=215.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+++++.++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999976532 24567788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+.+++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 999999999987664 257999999999999999999999999999999999999999999999999988432100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (262)
T cd06613 155 -------------------------------------------------------------------------IAKRKSF 161 (262)
T ss_pred -------------------------------------------------------------------------hhccccc
Confidence 0001123
Q ss_pred ccCCCCccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC---CCCCCCCHHHHHHHH
Q 010603 351 VGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF---PEGSSISFAAKDLIR 424 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~---~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~~~s~~~~~li~ 424 (506)
.|+..|+|||++.+. .++.++|||||||++|||++|+.||...+.......+....+.. .....++.++.+||.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK 241 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHH
Confidence 688899999999877 78999999999999999999999998877666555544332221 122346788999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPF 449 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~ 449 (506)
+||..+|.+||+ +.+++.|+|
T Consensus 242 ~~l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 242 KCLTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred HHcCCChhhCCC----HHHHhcCCC
Confidence 999999999998 899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=349.34 Aligned_cols=261 Identities=23% Similarity=0.398 Sum_probs=212.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh---chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA---GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
+|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+|+.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999999754321 12245678889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCccccccCC
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~~~~ 267 (506)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998765 5789999999999999999999999999999999999998776 59999999985431100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.. .....
T Consensus 159 ~~-------------------------------------------------------------------------~~~~~ 165 (268)
T cd06630 159 TG-------------------------------------------------------------------------AGEFQ 165 (268)
T ss_pred cc-------------------------------------------------------------------------CCccc
Confidence 00 00001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHH---HHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET---LFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
....||..|+|||++.+..++.++|||||||++|+|++|..||........ ..++............++.++.++|.
T Consensus 166 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 245 (268)
T cd06630 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTL 245 (268)
T ss_pred cccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHH
Confidence 123689999999999988899999999999999999999999975443222 22222111111222357899999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
+||..+|.+||+ +.++++||||+
T Consensus 246 ~~l~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 246 RCLELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred HHcCCCcccCcC----HHHHhcCcccC
Confidence 999999999997 89999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.33 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=213.6
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||.|+||.||++.+..+++.||+|.++.... ......+..|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865422 2345667789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++|+|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence 9999999998876555678999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (255)
T cd08219 155 -------------------------------------------------------------------------AYACTYV 161 (255)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011236
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...... +....++..+.+||.+||..||
T Consensus 162 ~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P 240 (255)
T cd08219 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNP 240 (255)
T ss_pred CCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCc
Confidence 889999999999888999999999999999999999999887766666665544322 2223688999999999999999
Q ss_pred CCccCCCCChHHhhc
Q 010603 432 QKRLGFKRGATEIKQ 446 (506)
Q Consensus 432 ~~R~s~~~~a~ell~ 446 (506)
++||+ +.+++.
T Consensus 241 ~~Rp~----~~~il~ 251 (255)
T cd08219 241 RSRPS----ATTILS 251 (255)
T ss_pred ccCCC----HHHHhh
Confidence 99998 788875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=352.20 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=208.7
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEE-----e
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFE-----T 182 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~ 182 (506)
..++|++++.||+|+||+||+|.+..+++.||+|++.... .....+..|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3467999999999999999999999999999999986532 2224567799999998 7999999999873 4
Q ss_pred CCeEEEEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
.+.+|+||||++|++|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 56799999999999999887632 2356899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+......
T Consensus 172 ~~~~~~~------------------------------------------------------------------------- 178 (286)
T cd06638 172 AQLTSTR------------------------------------------------------------------------- 178 (286)
T ss_pred eecccCC-------------------------------------------------------------------------
Confidence 5421000
Q ss_pred CCCCCCccccccCCCCccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCC
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSS 414 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~ 414 (506)
.......|++.|+|||++.. ..++.++|||||||++|||++|+.||........+..+.... ........
T Consensus 179 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd06638 179 ----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254 (286)
T ss_pred ----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCC
Confidence 00112258999999999853 457889999999999999999999998776555444433221 12222234
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
++..+.+||.+||..||++||+ +.+|++|+||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 6788999999999999999997 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.17 Aligned_cols=261 Identities=28% Similarity=0.394 Sum_probs=211.1
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFS 186 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 186 (506)
.+++|++++.||.|+||.||+|.++.+|+.||+|++...... ........+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 456799999999999999999999999999999998754322 12223456799999999999999999999765 578
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 58888877542 57899999999999999999999999999999999999999999999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. ..
T Consensus 162 ~-----------------------------------------------------------------------------~~ 164 (309)
T cd07845 162 A-----------------------------------------------------------------------------KP 164 (309)
T ss_pred c-----------------------------------------------------------------------------CC
Confidence 0 00
Q ss_pred ccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-------------------
Q 010603 347 SMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP------------------- 406 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------- 406 (506)
.....+++.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 011246789999999876 457999999999999999999999999888776665544210
Q ss_pred CCCCCC---------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 LKFPEG---------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 ~~~p~~---------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..++.. ..+++.+.+||.+||..||++||+ +.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~~ 296 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKEK 296 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhccC
Confidence 011100 125788999999999999999997 9999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=387.18 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=210.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeE-EEEe---
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYS-HFET--- 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~-~~~~--- 182 (506)
+.-.+++|.+.|.+|||+.||+|++...|..||+|.+-.. ....++.+.+||++|+.|. |+|||.+++ ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3345589999999999999999999998899999998654 3567788899999999995 999999999 3321
Q ss_pred C---CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCCEEEeec
Q 010603 183 D---KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 183 ~---~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DF 257 (506)
. -.++|+||||.||.|-+++..+-...|+|..+..||.|+++||.+||..+ |||||||-|||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1 25779999999999999998766677999999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|-|......+.. ...+.--+
T Consensus 191 GSatt~~~~~~~-------------------------------------------------~~e~~~ve----------- 210 (738)
T KOG1989|consen 191 GSATTKILSPTS-------------------------------------------------AQEVNYVE----------- 210 (738)
T ss_pred cccccccCCCcc-------------------------------------------------HHHHHHHH-----------
Confidence 987432111100 00000000
Q ss_pred cccCCCCCCccccccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSS 414 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 414 (506)
......-|+.|+|||++. +.+.+.|+|||+|||+||-|++...||..... ..|+...+.+|....
T Consensus 211 --------~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ 278 (738)
T KOG1989|consen 211 --------EEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPN 278 (738)
T ss_pred --------HHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCcc
Confidence 001124799999999974 66789999999999999999999999987643 457788899999889
Q ss_pred CCHHHHHHHHHHhhcCCCCccCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~ 437 (506)
++..+++||+.||+.||.+||++
T Consensus 279 ys~~l~~LI~~mL~~nP~~RPnI 301 (738)
T KOG1989|consen 279 YSDRLKDLIRTMLQPNPDERPNI 301 (738)
T ss_pred HHHHHHHHHHHHhccCcccCCCH
Confidence 99999999999999999999984
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=354.79 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=214.7
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+...+|++++.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++...+.+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 44567999999999999999999999999999999987542 1334567788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
+||||+++++|.+++... +.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999999988764 578999999999999999999997 69999999999999999999999999987421000
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.
T Consensus 158 -------------------------------------------------------------------------------~ 158 (284)
T cd06620 158 -------------------------------------------------------------------------------I 158 (284)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-----------HHHHHHhCCC-CCCCCCCC
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-----------ETLFNVVGQP-LKFPEGSS 414 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~~~ 414 (506)
....+|+..|+|||++.+..++.++|||||||++|+|++|+.||...... +.+..+.... ..++. ..
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS-SD 237 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc-hh
Confidence 01236899999999998888999999999999999999999999865432 2223333222 22222 23
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
++..+.+||.+||..||.+||+ +.|+++|+||..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccc
Confidence 7788999999999999999998 899999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=346.13 Aligned_cols=253 Identities=30% Similarity=0.501 Sum_probs=215.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||+|+||.||+|..+.+++.||+|.+.... ....+.+|+++++.++||||+++++++......|++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 46999999999999999999999989999999987542 1567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+.+++|.+++... ...+++..++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 999999999998654 3578999999999999999999999999999999999999999999999999984321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (256)
T cd06612 154 --------------------------------------------------------------------------AKRNTV 159 (256)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..+.....++..+.+||.+||..
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVK 239 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhc
Confidence 58889999999999999999999999999999999999998776655444433221 12222335788999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f 450 (506)
||.+||+ +.|+|+||||
T Consensus 240 ~P~~Rps----~~~il~~~~~ 256 (256)
T cd06612 240 DPEERPS----AIQLLQHPFI 256 (256)
T ss_pred ChhhCcC----HHHHhcCCCC
Confidence 9999998 8999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=352.47 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=213.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCC-----ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
+.+++|++++.||+|+||.||+|.+...+ +.||+|.+..... ......+.+|+++++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45668999999999999999999987554 6799999875421 2334567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPG--------------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE 248 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~--------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~ 248 (506)
.+..|++|||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999876421 45788999999999999999999999999999999999999
Q ss_pred CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccccc
Q 010603 249 DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTS 328 (506)
Q Consensus 249 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (506)
++.+||+|||+++.......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY------------------------------------------------------------ 179 (283)
T ss_pred CCcEEECCCcceeecccccc------------------------------------------------------------
Confidence 99999999999853211000
Q ss_pred CCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCC
Q 010603 329 LTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPL 407 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 407 (506)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 180 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05048 180 ---------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244 (283)
T ss_pred ---------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 000112257889999999998899999999999999999998 9999998877776666654432
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 408 ~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.+....++.++.+|+.+||..||.+||+ +.+++++
T Consensus 245 -~~~~~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 245 -LPCPEDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred -CCCcccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 2333478999999999999999999998 7888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.55 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=205.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||.|+||.||+|.++.+++.||||.+...... .....+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 46799999999999999999999989999999998764321 1223456799999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 99996 59999887653 478999999999999999999999999999999999999999999999999874311000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (291)
T cd07844 158 ---------------------------------------------------------------------------KTYSN 162 (291)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHh---CCC----------------CC
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVV---GQP----------------LK 408 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~---~~~----------------~~ 408 (506)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+... .+.+..+. ..+ ..
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 246889999999876 4589999999999999999999999976652 22222111 110 00
Q ss_pred CCC---------CCCCC--HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 409 FPE---------GSSIS--FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 409 ~p~---------~~~~s--~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
++. ...++ .++.+||.+||..||.+||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 000 01234 78899999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=354.51 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=210.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.++.+++.||+|++.+..... .....+.+|+++|+.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 36999999999999999999999999999999987644322 33455678999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++++.|..+.... ..+++..++.++.||+.||.|||+.||+||||+|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999999998876543 458999999999999999999999999999999999999999999999999984321100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (286)
T cd07846 155 --------------------------------------------------------------------------EVYTDY 160 (286)
T ss_pred --------------------------------------------------------------------------cccCcc
Confidence 001123
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-------------------CCCCC
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-------------------PLKFP 410 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~p 410 (506)
.|+..|+|||++.+. .++.++|||||||++|||++|++||......+.+..+... ....+
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 688899999998764 4788999999999999999999999876654443332210 00111
Q ss_pred C----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 E----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 ~----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
. ...++..+.+||.+||..+|++||+ +.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 1 1246888999999999999999998 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=357.49 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=190.7
Q ss_pred eEEeecCceEEEEEEEcc--CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE--eCCeEEEEEee
Q 010603 117 KKLGCGDIGSVYLAELRD--MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE--TDKFSCLLMEF 192 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~ 192 (506)
++||+|+||+||+|+++. +++.||+|.+.... ....+.+|+++|+.++||||+++++++. .+..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 689999999999999764 56889999987542 2234667999999999999999999985 35688999999
Q ss_pred cCCCChHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE----ecCCCEEEeecCCcc
Q 010603 193 CSGGDLHTLRQRQ-------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV----REDGHIMLSDFDLSL 261 (506)
Q Consensus 193 ~~gg~L~~~l~~~-------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFGla~ 261 (506)
+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5787776432 12358999999999999999999999999999999999999 456799999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (317)
T cd07867 161 LFNSPLK------------------------------------------------------------------------- 167 (317)
T ss_pred ccCCCcc-------------------------------------------------------------------------
Confidence 4211000
Q ss_pred CCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcH---------HHHHHHh---CCC--
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---------ETLFNVV---GQP-- 406 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~---------~~~~~i~---~~~-- 406 (506)
........+||+.|+|||++.+. .++.++|||||||++|||+||++||...... ..+..+. +.+
T Consensus 168 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (317)
T cd07867 168 -PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPAD 246 (317)
T ss_pred -cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCCh
Confidence 00001234689999999999874 5899999999999999999999999654321 1111111 100
Q ss_pred ---------CCC----------------------CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 407 ---------LKF----------------------PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 407 ---------~~~----------------------p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
..+ ......+..+.+||.+||+.||.+||| |+|+|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 247 KDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 000 001124567889999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.49 Aligned_cols=257 Identities=33% Similarity=0.516 Sum_probs=212.2
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||.|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 599999999999999999999999999999999765432 2334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 999999887643 6799999999999999999999999999999999999999999999999998843211000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (286)
T cd07832 155 -------------------------------------------------------------------------RLYSHQV 161 (286)
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0011236
Q ss_pred cCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C----------------CCCCC
Q 010603 352 GTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P----------------LKFPE 411 (506)
Q Consensus 352 GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~----------------~~~p~ 411 (506)
|+..|+|||++.+.. ++.++|||||||++|||++|.+||.+....+.+..+... + ..++.
T Consensus 162 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07832 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE 241 (286)
T ss_pred CcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCC
Confidence 899999999987654 689999999999999999999999877766555443321 0 01111
Q ss_pred C---------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 412 G---------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 412 ~---------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
. ...+.++.+||.+||..||.+||+ ++++++||||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 242 SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred CCcchHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 0 245788999999999999999997 89999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.04 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=202.9
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEcc----------------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRD----------------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn 172 (506)
..++|++.++||+|+||.||+|.+.. ++..||||++..... ......+.+|+++|+.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCC
Confidence 34679999999999999999998643 344799999876432 234456788999999999999
Q ss_pred ccceeEEEEeCCeEEEEEeecCCCChHHHHhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Q 010603 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQP-----------------GKHFSEQATRFYASEVLLALEYLHMMGVV 235 (506)
Q Consensus 173 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------~~~~~e~~~~~i~~qil~aL~yLH~~gii 235 (506)
|+++++++...+..|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886531 12467788999999999999999999999
Q ss_pred EccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccc
Q 010603 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFL 315 (506)
Q Consensus 236 HrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (506)
||||||+|||++.++.+||+|||+++.......
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----------------------------------------------- 193 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----------------------------------------------- 193 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----------------------------------------------
Confidence 999999999999999999999999853211000
Q ss_pred cccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc--CCCCCCCC
Q 010603 316 NSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL--GRTPFKGN 393 (506)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt--G~~Pf~~~ 393 (506)
........++..|||||++.+..++.++|||||||++|||++ +..||...
T Consensus 194 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 194 ----------------------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred ----------------------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 000112246789999999998899999999999999999986 67888876
Q ss_pred CcHHHHHHHhC------CCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhh
Q 010603 394 GNRETLFNVVG------QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIK 445 (506)
Q Consensus 394 ~~~~~~~~i~~------~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell 445 (506)
+..+.+..+.. ..........++..+.+||.+||..||++||+ +.+|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~ 299 (304)
T cd05096 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS----FSDIH 299 (304)
T ss_pred CHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC----HHHHH
Confidence 65554433221 11111122357889999999999999999998 67774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.52 Aligned_cols=258 Identities=28% Similarity=0.472 Sum_probs=212.6
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc-------hhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-------RKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
+|.+.+.||.|+||.||+|.+..+|+.||||.++...... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4889999999999999999999999999999986432111 122345778999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998775 579999999999999999999999999999999999999999999999999974311
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
... ..
T Consensus 160 ~~~---------------------------------------------------------------------------~~ 164 (272)
T cd06629 160 DIY---------------------------------------------------------------------------DN 164 (272)
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 000 00
Q ss_pred CCccccccCCCCccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC--CCCCCC--CCCCHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP--LKFPEG--SSISFA 418 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~--~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~--~~~s~~ 418 (506)
.......|+..|+|||++.... ++.++|+|||||++|||++|..||......+.+..+.... ..++.. ..++..
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (272)
T cd06629 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244 (272)
T ss_pred cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHH
Confidence 0011235889999999998754 7899999999999999999999998766655554443322 222221 256889
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+.+||.+||..+|.+||+ ++++++||||
T Consensus 245 ~~~li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 245 ALDFLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred HHHHHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 999999999999999998 8999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.51 Aligned_cols=259 Identities=28% Similarity=0.409 Sum_probs=208.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHH-HHhcCCCCccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-LSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
++|++++.||+|+||.||+|.++.+|+.||||++++.... .....+..|+.+ ++.++||||+++++++..++..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3699999999999999999999999999999999765322 122334446554 6778999999999999999999999
Q ss_pred EeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||++ |+|.+++... ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 7888776542 335789999999999999999999997 9999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 158 ------------------------------------------------------------------------------~~ 159 (283)
T cd06617 158 ------------------------------------------------------------------------------VA 159 (283)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred ccccccCCCCccchhhcC----CCCCcchhHHHHHHHHHHHhcCCCCCCCC-CcHHHHHHHhCC-CCCCCCCCCCCHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRG----DGHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFNVVGQ-PLKFPEGSSISFAAK 420 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~----~~~~~~~DiWSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~p~~~~~s~~~~ 420 (506)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+... ...++. ..++.++.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 238 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA-EKFSPEFQ 238 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc-cccCHHHH
Confidence 011258889999999865 45788999999999999999999999753 333444444433 222332 35789999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
+||.+||..+|.+||+ +.++++||||....+
T Consensus 239 ~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~ 269 (283)
T cd06617 239 DFVNKCLKKNYKERPN----YPELLQHPFFELHLS 269 (283)
T ss_pred HHHHHHccCChhhCcC----HHHHhcCchhhhccc
Confidence 9999999999999998 899999999987654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=344.97 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=212.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+...+|++.+.||.|+||.||+|.++.+++.||+|++.+.. .....+.+|+++|+.++||||+++++++..++.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 44567999999999999999999999999999999987542 23456778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||+++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999877655678999999999999999999999999999999999999999999999999985321000
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. ...
T Consensus 159 ~----------------------------------------------------------------------------~~~ 162 (263)
T cd05052 159 Y----------------------------------------------------------------------------TAH 162 (263)
T ss_pred e----------------------------------------------------------------------------ecc
Confidence 0 000
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. ....+....++.++.+||.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-GYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHH
Confidence 01134668999999999999999999999999999998 9999988766655555443 233333346889999999999
Q ss_pred hhcCCCCccCCCCChHHhhc
Q 010603 427 LVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~ 446 (506)
|..||++||+ +.++++
T Consensus 242 l~~~p~~Rp~----~~~l~~ 257 (263)
T cd05052 242 WQWNPSDRPS----FAEIHQ 257 (263)
T ss_pred ccCCcccCCC----HHHHHH
Confidence 9999999998 666654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=350.05 Aligned_cols=279 Identities=36% Similarity=0.610 Sum_probs=225.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 189 (506)
++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+..|+++++.++ ||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36999999999999999999999999999999998765544455567788999999998 99999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999998875 47999999999999999999999999999999999999999999999999998543211100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
..... ++. ...............
T Consensus 159 ~~~~~----------------------------------~~~-----------------------~~~~~~~~~~~~~~~ 181 (280)
T cd05581 159 ESNKG----------------------------------DAT-----------------------NIDSQIEKNRRRFAS 181 (280)
T ss_pred ccCCC----------------------------------CCc-----------------------ccccccccccccccc
Confidence 00000 000 000000011122334
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+......++. .++..+.+||.+||..
T Consensus 182 ~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 259 (280)
T cd05581 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP--NFPPDAKDLIEKLLVL 259 (280)
T ss_pred ccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCC--ccCHHHHHHHHHHhcC
Confidence 57899999999999888999999999999999999999999988766666666655555554 6789999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f 450 (506)
||.+||++....+++|+||||
T Consensus 260 ~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 260 DPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CHhhCCCcccCHHHHhcCCCC
Confidence 999999822122999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=388.31 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=208.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|+++++||+|+||.||+|.+..+|+.||||++.+..........++.+|+++++.++|||||++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 46899999999999999999999999999999999865443344456788899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 190 MEFCSGGDLHTLRQRQP---------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~---------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
|||++||+|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999999886421 123556678889999999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+.............. . ... . .
T Consensus 161 k~i~~~~~~~~~l~~-~-------~~~---------------s------------------------------------~ 181 (932)
T PRK13184 161 IFKKLEEEDLLDIDV-D-------ERN---------------I------------------------------------C 181 (932)
T ss_pred eeccccccccccccc-c-------ccc---------------c------------------------------------c
Confidence 653111100000000 0 000 0 0
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHH-HhCCCCCCCCCCCCCHHH
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN-VVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~-i~~~~~~~p~~~~~s~~~ 419 (506)
..........+||+.|||||++.+..++.++|||||||++|||++|+.||........... ....+........+++.+
T Consensus 182 ~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L 261 (932)
T PRK13184 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFL 261 (932)
T ss_pred ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHH
Confidence 0000111235799999999999999999999999999999999999999987554433322 222222333334688999
Q ss_pred HHHHHHHhhcCCCCccC
Q 010603 420 KDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s 436 (506)
.+++.+||..||++|++
T Consensus 262 ~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 262 SQIAMKALAVDPAERYS 278 (932)
T ss_pred HHHHHHHccCChhhCcC
Confidence 99999999999999987
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=342.29 Aligned_cols=255 Identities=31% Similarity=0.486 Sum_probs=214.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh--hchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML--AGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+|+..+.||+|+||+||+|....+++.||+|++..... ........+.+|+++++.++|+||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999998899999999876432 1234556788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999998765 468999999999999999999999999999999999999999999999999874321000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
....
T Consensus 157 ----------------------------------------------------------------------------~~~~ 160 (258)
T cd06632 157 ----------------------------------------------------------------------------FAKS 160 (258)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred cccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..|++.|+|||.+.... ++.++|+|||||++|+|++|+.||...........+............++.++.+||.+||.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence 35889999999998776 89999999999999999999999987765555555443121111223578999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f 450 (506)
.+|.+||+ +.+++.|||+
T Consensus 241 ~~p~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 241 RDPSLRPT----AAELLEHPFV 258 (258)
T ss_pred cCcccCcC----HHHHhcCCCC
Confidence 99999997 8999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=362.03 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=207.9
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
.+..++|++.+.||.|+||.||+|.+.. +++.||+|+++.... ......+..|+++++.+ +|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3445679999999999999999997543 457899999875322 23345677899999999 899999999988
Q ss_pred Ee-CCeEEEEEeecCCCChHHHHhhCCC----------------------------------------------------
Q 010603 181 ET-DKFSCLLMEFCSGGDLHTLRQRQPG---------------------------------------------------- 207 (506)
Q Consensus 181 ~~-~~~~~lV~E~~~gg~L~~~l~~~~~---------------------------------------------------- 207 (506)
.. +..+++||||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 4578999999999999998864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCccccc
Q 010603 208 -------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRI 280 (506)
Q Consensus 208 -------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~ 280 (506)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----------- 229 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------- 229 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-----------
Confidence 26789999999999999999999999999999999999999999999999998543211100
Q ss_pred CcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccch
Q 010603 281 SSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPE 360 (506)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 360 (506)
.+.....++..|||||
T Consensus 230 ----------------------------------------------------------------~~~~~~~~~~~y~aPE 245 (337)
T cd05054 230 ----------------------------------------------------------------VRKGDARLPLKWMAPE 245 (337)
T ss_pred ----------------------------------------------------------------hhccCCCCCccccCcH
Confidence 0011235677899999
Q ss_pred hhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCC
Q 010603 361 IIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR 439 (506)
Q Consensus 361 ~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~ 439 (506)
++.+..++.++|||||||+||||++ |..||.+....+.+...+...........+++++.+|+.+||+.+|++||+
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs--- 322 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT--- 322 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC---
Confidence 9999999999999999999999997 999998765545454444333333333467899999999999999999998
Q ss_pred ChHHhhcC
Q 010603 440 GATEIKQH 447 (506)
Q Consensus 440 ~a~ell~h 447 (506)
+.++++|
T Consensus 323 -~~ell~~ 329 (337)
T cd05054 323 -FSELVEI 329 (337)
T ss_pred -HHHHHHH
Confidence 7888774
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=344.76 Aligned_cols=254 Identities=20% Similarity=0.331 Sum_probs=212.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|+++++||+|+||.||+|.+. ++..||+|.+.... .....+.+|+.+++.++|+||+++++.+...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456678999999999999999999875 46789999987542 2345678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
++||||+++++|.+++.......+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999999998766677899999999999999999999999999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 157 ~~----------------------------------------------------------------------------~~ 160 (261)
T cd05072 157 EY----------------------------------------------------------------------------TA 160 (261)
T ss_pred ce----------------------------------------------------------------------------ec
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+... ...+....++.++.+||.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 011246678999999998889999999999999999998 99999887776666555533 3445445688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|++||+ ++++++
T Consensus 240 ~l~~~p~~Rp~----~~~i~~ 256 (261)
T cd05072 240 CWKEKAEERPT----FDYLQS 256 (261)
T ss_pred HccCCcccCcC----HHHHHH
Confidence 99999999998 666654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=361.43 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=206.6
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD----- 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 183 (506)
..++|++++.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35779999999999999999999999999999999875422 223445567899999999999999999998644
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 184 -KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 184 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
...|+||||+ .++|.+++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 93 FQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 3579999999 46888877542 89999999999999999999999999999999999999999999999999853
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 168 ~~~~---------------------------------------------------------------------------- 171 (353)
T cd07850 168 AGTS---------------------------------------------------------------------------- 171 (353)
T ss_pred CCCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC-------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP------------- 406 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~------------- 406 (506)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+.. .+
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred --CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 001123588999999999999999999999999999999999999987665443332221 00
Q ss_pred ------C--------------CCCC-----CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 407 ------L--------------KFPE-----GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 407 ------~--------------~~p~-----~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
. .++. ....+..+++||.+||..||.+||+ +.|+|+||||+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~ 315 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYIN 315 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHh
Confidence 0 0000 1124567899999999999999997 99999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=348.66 Aligned_cols=268 Identities=43% Similarity=0.798 Sum_probs=218.2
Q ss_pred CeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhhc-hhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAG-RKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 186 (506)
+|++.+.||.|+||.||+|.+. .+|+.||+|++.+..... ......+.+|+.+|+.+ +|+||+.++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 478999999997643322 23345677899999999 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999998765 57899999999999999999999999999999999999999999999999998432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. ...
T Consensus 159 ~----------------------------------------------------------------------------~~~ 162 (290)
T cd05613 159 E----------------------------------------------------------------------------VER 162 (290)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 000
Q ss_pred ccccccCCCCccchhhcCC--CCCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGD--GHGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~--~~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
.....|+..|+|||++.+. .++.++|||||||++|+|++|..||..... .+....+......++ ..++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 240 (290)
T cd05613 163 AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAK 240 (290)
T ss_pred cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCCHHHH
Confidence 1123689999999998753 478899999999999999999999975432 222233333333333 35889999
Q ss_pred HHHHHHhhcCCCCccCC-CCChHHhhcCCCCCCCCcchhc
Q 010603 421 DLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~ 459 (506)
+||.+||..||++|++. +..+++++.||||+..+|..+.
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 99999999999999853 3469999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=351.20 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=212.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++.+.||.|+||.||+|.++.+|+.||||.+...... ......+.+|+++++.++||||+++++++......|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36799999999999999999999999999999998764322 23345567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCccccccCCc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla~~~~~~~~ 268 (506)
|||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 99995 68888776655555789999999999999999999999999999999999985 5579999999984321100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (294)
T PLN00009 158 ----------------------------------------------------------------------------RTFT 161 (294)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC-----------------
Q 010603 349 SFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL----------------- 407 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~----------------- 407 (506)
...|++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+.++.. .+.
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T PLN00009 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241 (294)
T ss_pred cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence 23578899999998764 578999999999999999999999988776655544321 110
Q ss_pred -CCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 408 -KFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 408 -~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
.++. ...++..+.++|.+||..||++||+ +.++++||||..++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~ 291 (294)
T PLN00009 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLG 291 (294)
T ss_pred ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHh
Confidence 0000 1246888999999999999999997 89999999998654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=350.97 Aligned_cols=259 Identities=31% Similarity=0.431 Sum_probs=211.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh--chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA--GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+|++++.||.|+||.||+|.+..+++.||||.+...... .......+..|+++++.++|+||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 489999999999999999999999999999999865433 122334567799999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+ +|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 999999987653 379999999999999999999999999999999999999999999999999985421100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (298)
T cd07841 157 ---------------------------------------------------------------------------RKMTH 161 (298)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC--CC--------------
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL--KF-------------- 409 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~--~~-------------- 409 (506)
..+++.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..+... +. .+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T cd07841 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKP 241 (298)
T ss_pred cccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccc
Confidence 246789999999865 45789999999999999999999999877765544443211 00 00
Q ss_pred ----C---CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 410 ----P---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 410 ----p---~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+ .....+..+.+||.+||..||.+||+ +.|+++||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~~ 288 (298)
T cd07841 242 FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSND 288 (298)
T ss_pred cCCcchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccCC
Confidence 0 01235788999999999999999997 9999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=348.26 Aligned_cols=255 Identities=30% Similarity=0.494 Sum_probs=214.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++.+...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 358899999999999999999999999999999987532 234456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||+.+++|.+++.... ..+++..+..++.||+.||+|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999987653 678999999999999999999999 99999999999999999999999999987432100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
....
T Consensus 155 ----------------------------------------------------------------------------~~~~ 158 (265)
T cd06605 155 ----------------------------------------------------------------------------LAKT 158 (265)
T ss_pred ----------------------------------------------------------------------------Hhhc
Confidence 0001
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC-----cHHHHHHHhCCC-CCCCCCCCCCHHHHHHH
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-----NRETLFNVVGQP-LKFPEGSSISFAAKDLI 423 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~-~~~p~~~~~s~~~~~li 423 (506)
..|+..|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+.... ...+. ..++.++++||
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li 237 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQDFV 237 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHHHH
Confidence 368889999999999999999999999999999999999997542 223333444332 22222 12789999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.+||..||.+||+ +.+++.||||+.
T Consensus 238 ~~~l~~~p~~Rpt----~~~ll~~~~~~~ 262 (265)
T cd06605 238 NLCLIKDPRERPS----YKELLEHPFIKK 262 (265)
T ss_pred HHHcCCCchhCcC----HHHHhhCchhhc
Confidence 9999999999998 899999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=350.88 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=211.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+++++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36999999999999999999999999999999987532 2234466788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 191 EFCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||+++++|..++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999998877531 2478999999999999999999996 59999999999999999999999999987431000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
...
T Consensus 157 -----------------------------------------------------------------------------~~~ 159 (286)
T cd06622 157 -----------------------------------------------------------------------------LAK 159 (286)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred ccccCCCCccchhhcCC------CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHH---HHhCC-CCCCCCCCCCCHH
Q 010603 349 SFVGTHEYLAPEIIRGD------GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF---NVVGQ-PLKFPEGSSISFA 418 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~------~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~-~~~~p~~~~~s~~ 418 (506)
...|++.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .+... ...++. .++.+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 237 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS--GYSDD 237 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc--ccCHH
Confidence 12588899999998654 35789999999999999999999997655443332 22222 223333 58999
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+.+||.+||..+|.+||+ +++++.||||...
T Consensus 238 ~~~li~~~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHcccCcccCCC----HHHHhcChhhhhc
Confidence 999999999999999998 8999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=342.77 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=218.1
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||.|+||.||+|.+..+++.||||++...... .....+..|+++++.++|+||+++++++...+..++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 699999999999999999999999999999999875432 345677889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|+++++|.+++... ..+++..++.++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--- 154 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--- 154 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC---
Confidence 99999999998865 679999999999999999999999 999999999999999999999999999874321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (264)
T cd06623 155 --------------------------------------------------------------------------DQCNTF 160 (264)
T ss_pred --------------------------------------------------------------------------Ccccce
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC---cHHHHHHHhCCCCCCCCCCC-CCHHHHHHHHHH
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG---NRETLFNVVGQPLKFPEGSS-ISFAAKDLIRGL 426 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~-~s~~~~~li~~~ 426 (506)
.|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....+..... .+.... ++..+.++|.+|
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP-PSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC-CCCCcccCCHHHHHHHHHH
Confidence 68889999999999889999999999999999999999998764 3333444443322 222234 889999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
|..+|.+||+ +.++++||||+..+
T Consensus 240 l~~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 240 LQKDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred ccCChhhCCC----HHHHHhCHHHHhcc
Confidence 9999999997 89999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=349.69 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=207.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCe----
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKF---- 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~---- 185 (506)
++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 3699999999999999999999999999999998764322 223345677999999995 6999999999987665
Q ss_pred -EEEEEeecCCCChHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCc
Q 010603 186 -SCLLMEFCSGGDLHTLRQRQP---GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLS 260 (506)
Q Consensus 186 -~~lV~E~~~gg~L~~~l~~~~---~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla 260 (506)
.|+||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 8888776532 246899999999999999999999999999999999999998 889999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+......
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (295)
T cd07837 159 RAFSIPV------------------------------------------------------------------------- 165 (295)
T ss_pred eecCCCc-------------------------------------------------------------------------
Confidence 5321100
Q ss_pred CCCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC--C------
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL--K------ 408 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~--~------ 408 (506)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+... +. .
T Consensus 166 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T cd07837 166 ----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241 (295)
T ss_pred ----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh
Confidence 00011257889999999875 45789999999999999999999999887766555443211 00 0
Q ss_pred ------CCC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 409 ------FPE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 409 ------~p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
++. ...++.++.+||.+||..||.+||+ +.|++.||||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 242 LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred ccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 010 0247888999999999999999997 89999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=342.01 Aligned_cols=256 Identities=28% Similarity=0.489 Sum_probs=216.7
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||.|+||.||+|.++.+|..||+|.+....... .....+.+|+++++.++|+||+++++.+......|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4899999999999999999999999999999997653322 234566789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC-EEEeecCCccccccCCccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH-IMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-vkl~DFGla~~~~~~~~~~ 270 (506)
|+++++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++.++. +||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999988765557899999999999999999999999999999999999998864 6999999874321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (257)
T cd08225 157 --------------------------------------------------------------------------ELAYTC 162 (257)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
.|++.|+|||++.+..++.++|+|||||++|||++|..||...+..+.+..+...... +....++.++.++|.+||..+
T Consensus 163 ~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~ 241 (257)
T cd08225 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVS 241 (257)
T ss_pred CCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccC
Confidence 5889999999999888999999999999999999999999877766666655544322 222357889999999999999
Q ss_pred CCCccCCCCChHHhhcCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f 450 (506)
|++||+ +.++++||||
T Consensus 242 p~~Rpt----~~~ll~~~~~ 257 (257)
T cd08225 242 PRDRPS----ITSILKRPFL 257 (257)
T ss_pred hhhCcC----HHHHhhCCCC
Confidence 999997 8999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=341.50 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=214.7
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccch--hhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGM--LAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFSC 187 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 187 (506)
+|++.+.||+|+||.||+|.+..+++.||+|++.... .........+.+|+++++.++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 5999999999999999999999999999999986432 11234456788999999999999999999998764 4688
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 83 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999988765 468999999999999999999999999999999999999999999999999985421000
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. .....
T Consensus 161 ~--------------------------------------------------------------------------~~~~~ 166 (264)
T cd06653 161 M--------------------------------------------------------------------------SGTGI 166 (264)
T ss_pred c--------------------------------------------------------------------------cCccc
Confidence 0 00001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+.+.++...+........+++.+.++|.+||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l 246 (264)
T cd06653 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246 (264)
T ss_pred cccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHh
Confidence 12468999999999998889999999999999999999999998877766666665444332233468999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f 450 (506)
. +|..||+ +.+++.|||.
T Consensus 247 ~-~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 247 V-EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred c-CcccCcc----HHHHhcCCCC
Confidence 9 5799997 8999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=347.89 Aligned_cols=267 Identities=43% Similarity=0.801 Sum_probs=217.6
Q ss_pred CeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhhc-hhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAG-RKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 186 (506)
+|++.+.||+|+||.||+|++. .+++.||||++.+..... ......+..|+++++.+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 457889999997643322 23345677899999999 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.+|+|.+++... ..+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999988754 57899999999999999999999999999999999999999999999999987432110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. ...
T Consensus 159 ~----------------------------------------------------------------------------~~~ 162 (288)
T cd05583 159 E----------------------------------------------------------------------------EER 162 (288)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 000
Q ss_pred ccccccCCCCccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~--~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
.....|+..|+|||.+.+.. ++.++||||||+++|||++|..||..... .+....+.......+ ..++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 240 (288)
T cd05583 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--KTMSAEAR 240 (288)
T ss_pred cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC--cccCHHHH
Confidence 11235889999999997765 78899999999999999999999964332 222233333333333 35889999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhc
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
+||.+||+.||++||++. .+.++|+||||+.++|+.+.
T Consensus 241 ~li~~~l~~~p~~R~t~~-~~~~~l~~~~~~~~~~~~~~ 278 (288)
T cd05583 241 DFIQKLLEKDPKKRLGAN-GADEIKNHPFFQGIDWDDLA 278 (288)
T ss_pred HHHHHHhcCCHhhccCcc-hHHHHhcCcccccCCHHHHh
Confidence 999999999999999864 58899999999999997663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=348.34 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=210.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||+|+||.||+|.++.+++.||||+++..... ......+.+|+++++.++|+||+++++++..++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 3699999999999999999999999999999998764322 334466788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++++.|..++... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999887777665543 5689999999999999999999999999999999999999999999999999853211000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (288)
T cd07833 156 --------------------------------------------------------------------------SPLTDY 161 (288)
T ss_pred --------------------------------------------------------------------------ccccCc
Confidence 001224
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---C----------------CCCCC
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---Q----------------PLKFP 410 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~----------------~~~~p 410 (506)
.|+..|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+.. . ...++
T Consensus 162 ~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07833 162 VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241 (288)
T ss_pred ccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccC
Confidence 688999999999988 789999999999999999999999987665544433211 0 00010
Q ss_pred C-----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 E-----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 ~-----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
. ...++.++++||.+||..+|++||+ ++++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 242 EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred CCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 0 1134788999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=346.29 Aligned_cols=245 Identities=30% Similarity=0.500 Sum_probs=201.0
Q ss_pred CCeEEEeEE--eecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEE
Q 010603 111 GHFRLLKKL--GCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 111 ~~y~i~~~L--G~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 187 (506)
++|++.+.+ |.|+||.||++.++.+++.||+|++.+..... .|+.+...+ +||||+++++.|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 346776666 99999999999999999999999987643211 133333323 7999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCccccccC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCFVS 266 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~~~ 266 (506)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999998765 4899999999999999999999999999999999999999998 999999998743100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
T Consensus 163 -------------------------------------------------------------------------------- 162 (267)
T PHA03390 163 -------------------------------------------------------------------------------- 162 (267)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHH----HHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE----TLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+..........+ ..++..+.+|
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 240 (267)
T PHA03390 163 PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI--KNVSKNANDF 240 (267)
T ss_pred CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc--cccCHHHHHH
Confidence 011258889999999999899999999999999999999999998554332 1222222222222 3689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
|.+||+.||.+|++ .++++|+||||+
T Consensus 241 i~~~l~~~p~~R~~---~~~~~l~h~~~~ 266 (267)
T PHA03390 241 VQSMLKYNINYRLT---NYNEIIKHPFLK 266 (267)
T ss_pred HHHHhccChhhCCc---hHHHHhcCCccc
Confidence 99999999999995 269999999996
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=343.76 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=209.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+++++.++||||+++++++...+..++|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 35799999999999999999999999999999998764444445556678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
|||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999999999887642 23468999999999999999999999999999999999999999999999999875321000
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 161 -----------------------------------------------------------------------------~~~ 163 (267)
T cd08228 161 -----------------------------------------------------------------------------TAA 163 (267)
T ss_pred -----------------------------------------------------------------------------HHH
Confidence 000
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHhCCCCCCCC-CCCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVVGQPLKFPE-GSSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~-~~~~s~~~~~li~~ 425 (506)
....|++.|+|||.+.+..++.++|+|||||++|||++|+.||..... ...+...+......+. ...++..+.+||.+
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T cd08228 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243 (267)
T ss_pred hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHH
Confidence 123588899999999988899999999999999999999999965432 2222222222111111 12577889999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|++||+ +.++++
T Consensus 244 cl~~~p~~Rp~----~~~vl~ 260 (267)
T cd08228 244 CIYPDPDQRPD----IGYVHQ 260 (267)
T ss_pred HCCCCcccCcC----HHHHHH
Confidence 99999999998 778876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=340.46 Aligned_cols=259 Identities=33% Similarity=0.564 Sum_probs=216.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+..|+++++.++|+||+++++.+...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 589999999999999999999989999999999876433 3567788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~-- 155 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-- 155 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc--
Confidence 99999999998764 46899999999999999999999999999999999999999999999999998542110000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.........
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (264)
T cd06626 156 -----------------------------------------------------------------------MGEEVQSLA 164 (264)
T ss_pred -----------------------------------------------------------------------ccccccCCc
Confidence 000011235
Q ss_pred cCCCCccchhhcCCC---CCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHh-CCCCCCCCCCCCCHHHHHHHHHH
Q 010603 352 GTHEYLAPEIIRGDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVV-GQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 352 GT~~Y~APE~l~~~~---~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~-~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .....+. .....+|....++..+.+||.+|
T Consensus 165 ~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 244 (264)
T cd06626 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRC 244 (264)
T ss_pred CCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHH
Confidence 888999999998776 889999999999999999999999765333 2223332 23344555555689999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
|+.+|.+||+ +.+++.|||+
T Consensus 245 l~~~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 245 LESDPKKRPT----ASELLQHPFV 264 (264)
T ss_pred ccCCcccCCC----HHHHhcCCCC
Confidence 9999999997 8999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=353.00 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=213.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|.....||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 455678999999999999999999999999986543 23445678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 999999998754 468999999999999999999999999999999999999999999999999874311000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......|
T Consensus 173 ------------------------------------------------------------------------~~~~~~~~ 180 (292)
T cd06658 173 ------------------------------------------------------------------------PKRKSLVG 180 (292)
T ss_pred ------------------------------------------------------------------------ccCceeec
Confidence 00112368
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
++.|+|||++.+..++.++|||||||++|||++|+.||........+..+... ...++....++..+.+||.+||..||
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCCh
Confidence 99999999999888999999999999999999999999877665555444322 22223334578899999999999999
Q ss_pred CCccCCCCChHHhhcCCCCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+||+ ++++++||||...
T Consensus 261 ~~Rpt----~~~il~~~~~~~~ 278 (292)
T cd06658 261 SQRAT----AQELLQHPFLKLA 278 (292)
T ss_pred hHCcC----HHHHhhChhhhcc
Confidence 99997 8999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=340.41 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=214.2
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCeEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKFSCLL 189 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV 189 (506)
+|++++.||.|+||.||+|.+..+++.||+|++...... .....++..|+++++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 489999999999999999999999999999998765432 3445667889999999999999999998754 4578999
Q ss_pred EeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 190 MEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLH-----MMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH-----~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
|||+++++|.+++... ....+++..++.++.||+.||+||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999988753 2357899999999999999999999 89999999999999999999999999999843
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 160 ~~~~~--------------------------------------------------------------------------- 164 (265)
T cd08217 160 LGHDS--------------------------------------------------------------------------- 164 (265)
T ss_pred ccCCc---------------------------------------------------------------------------
Confidence 21000
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||......+....+...... +....++..+.+|
T Consensus 165 --~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 241 (265)
T cd08217 165 --SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-RIPYRYSSELNEV 241 (265)
T ss_pred --ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC-CCccccCHHHHHH
Confidence 0011236899999999999888999999999999999999999999887755555554433321 2223688999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+.+||..+|.+||+ +.++++|||+
T Consensus 242 ~~~~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 242 IKSMLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred HHHHccCCcccCCC----HHHHhhCCCC
Confidence 99999999999997 8999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=356.53 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=205.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----Ce
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-----KF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 185 (506)
++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 57999999999999999999999999999999986422 123445667899999999999999999987644 36
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999995 588877654 4799999999999999999999999999999999999999999999999999853211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
... ...
T Consensus 159 ~~~--------------------------------------------------------------------------~~~ 164 (336)
T cd07849 159 EHD--------------------------------------------------------------------------HTG 164 (336)
T ss_pred ccc--------------------------------------------------------------------------ccC
Confidence 000 000
Q ss_pred CccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC---------------
Q 010603 346 RSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP--------------- 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~--------------- 406 (506)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+. ..+
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (336)
T cd07849 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARN 244 (336)
T ss_pred CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhh
Confidence 0112468999999998765 468999999999999999999999997765433322211 110
Q ss_pred ----C----CCC---CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 ----L----KFP---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 ----~----~~p---~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
. ..+ .....+.++.+||.+||+.||++||+ +.++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~ 298 (336)
T cd07849 245 YIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQY 298 (336)
T ss_pred HHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHHhcCcccccc
Confidence 0 000 01235788999999999999999997 8999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=348.48 Aligned_cols=255 Identities=29% Similarity=0.418 Sum_probs=202.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||.||+|.++.+|+.||||++...... .....+.+|+++|+.++|+||+++++++..++..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 5699999999999999999999999999999998754321 22234567999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--- 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC---
Confidence 9995 77777665432 467888999999999999999999999999999999999999999999999984310000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (291)
T cd07870 158 --------------------------------------------------------------------------QTYSSE 163 (291)
T ss_pred --------------------------------------------------------------------------CCCCCc
Confidence 000112
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhC---CCC-----------C-----C
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVG---QPL-----------K-----F 409 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~---~~~-----------~-----~ 409 (506)
.+++.|+|||++.+. .++.++|||||||+||||++|+.||...... +.+..+.. .+. . +
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 578899999998764 5788999999999999999999999765432 22222210 000 0 0
Q ss_pred ----C-------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 410 ----P-------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 410 ----p-------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+ .....+.++.+||.+||..||.+||+ +.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 0 00123578899999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=364.72 Aligned_cols=254 Identities=20% Similarity=0.313 Sum_probs=205.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccC-----CceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~ 180 (506)
.+..++|+++++||+|+||.||+|.+... +..||||++..... ......+.+|+++|+.++ |||||++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34456799999999999999999987533 34699999975422 233456788999999996 99999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCC------------------------------------------------------
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQP------------------------------------------------------ 206 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------ 206 (506)
...+.+|||||||++|+|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999998876421
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE
Q 010603 207 ----------------------------------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV 246 (506)
Q Consensus 207 ----------------------------------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl 246 (506)
...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 1347888899999999999999999999999999999999
Q ss_pred ecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccc
Q 010603 247 REDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEK 326 (506)
Q Consensus 247 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (506)
+.++.+||+|||+++........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~--------------------------------------------------------- 293 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNY--------------------------------------------------------- 293 (400)
T ss_pred eCCCEEEEEeCCcceeccccccc---------------------------------------------------------
Confidence 99999999999998542110000
Q ss_pred ccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCC
Q 010603 327 TSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQ 405 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 405 (506)
.......+++.|||||++.+..++.++|||||||+||||++ |..||........+...+..
T Consensus 294 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~ 355 (400)
T cd05105 294 ------------------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355 (400)
T ss_pred ------------------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence 00112257789999999999899999999999999999996 99999876555555444444
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCccCC
Q 010603 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 406 ~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~ 437 (506)
....+....++.++.+||.+||..||++||++
T Consensus 356 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred CCCCCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence 44444445789999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=346.18 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=210.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEc----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELR----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+.+.+|++.+.||+|+||+||+|... .+++.||+|.+.... .......+.+|+++++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 45678999999999999999999863 356789999987532 233446678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQP---------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE 248 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~---------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~ 248 (506)
+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 99999999999999999885431 134788999999999999999999999999999999999999
Q ss_pred CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccccc
Q 010603 249 DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTS 328 (506)
Q Consensus 249 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (506)
++.+||+|||+++.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05090 160 QLHVKISDLGLSREIYSADY------------------------------------------------------------ 179 (283)
T ss_pred CCcEEeccccccccccCCcc------------------------------------------------------------
Confidence 99999999999854211000
Q ss_pred CCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCC
Q 010603 329 LTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPL 407 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 407 (506)
........++..|+|||++.+..++.++|||||||+||||++ |..||.+....+....+....
T Consensus 180 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 243 (283)
T cd05090 180 ---------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ- 243 (283)
T ss_pred ---------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 000112246778999999998889999999999999999998 999998876655555544332
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 408 ~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
..+....++..+.++|.+||+.||++||+ +.+|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 33334468999999999999999999998 6677653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=351.69 Aligned_cols=260 Identities=28% Similarity=0.380 Sum_probs=205.0
Q ss_pred CeEEEeEEeecCceEEEEEEEcc--CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRD--MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFSC 187 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 187 (506)
+|++++.||+|+||.||+|.+.. +++.||||++.+...........+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8999999999875433334445667899999999999999999999988 8899
Q ss_pred EEEeecCCCChHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec----CCCEEEeecCCc
Q 010603 188 LLMEFCSGGDLHTLRQRQP---GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE----DGHIMLSDFDLS 260 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~---~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~----~~~vkl~DFGla 260 (506)
+||||++ ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 57777664321 236899999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
.........
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------- 168 (316)
T cd07842 160 RLFNAPLKP----------------------------------------------------------------------- 168 (316)
T ss_pred cccCCCccc-----------------------------------------------------------------------
Confidence 532110000
Q ss_pred CCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHH---------HHHHH---hC---
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE---------TLFNV---VG--- 404 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~---------~~~~i---~~--- 404 (506)
........+|+.|+|||++.+. .++.++|||||||+||+|++|++||.+..... .+..+ +.
T Consensus 169 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 245 (316)
T cd07842 169 ---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPT 245 (316)
T ss_pred ---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCc
Confidence 0001123689999999998764 58999999999999999999999997654321 11111 10
Q ss_pred --------------------CCCCCC---------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 405 --------------------QPLKFP---------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 405 --------------------~~~~~p---------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
....++ .....+.++.++|.+||..||++||+ +.|+++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 246 EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred hhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 001111 00146778999999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=345.21 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=208.4
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
+..++|++.+.||+|+||+||+|.++. ++..||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455679999999999999999998752 356799999865321 2234457789999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEE
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPG--------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIML 254 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~--------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 254 (506)
....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999875321 23577888999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
+|||+++........
T Consensus 161 ~dfg~~~~~~~~~~~----------------------------------------------------------------- 175 (277)
T cd05062 161 GDFGMTRDIYETDYY----------------------------------------------------------------- 175 (277)
T ss_pred CCCCCccccCCccee-----------------------------------------------------------------
Confidence 999998532110000
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCC
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGS 413 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 413 (506)
.......+++.|||||++.+..++.++|||||||++|||++ |..||.+....+.+..+...... +...
T Consensus 176 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~ 244 (277)
T cd05062 176 ----------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-DKPD 244 (277)
T ss_pred ----------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCC
Confidence 00001146788999999999889999999999999999998 79999887776666655544322 2224
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.++..+.+||.+||+.||++||+ +.|++++
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 245 NCPDMLFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 68889999999999999999998 7787753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=340.43 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=207.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
..+|++++.||+|+||.||+|..+. +..+|+|.+.+... ....+.+|+++|+.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 3569999999999999999998865 56899998875432 234567799999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 99999999999887543 4689999999999999999999999999999999999999999999999998853210000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 156 ---------------------------------------------------------------------------~~~~~ 160 (256)
T cd05114 156 ---------------------------------------------------------------------------TSSSG 160 (256)
T ss_pred ---------------------------------------------------------------------------eccCC
Confidence 00011
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+..... .......+..+.+||.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~c~~ 239 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-LYRPKLASMTVYEVMYSCWH 239 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHcc
Confidence 135668999999998889999999999999999999 9999988877777766664432 22223578899999999999
Q ss_pred cCCCCccCCCCChHHhhc
Q 010603 429 KDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~ 446 (506)
.||.+||+ ++++++
T Consensus 240 ~~p~~Rps----~~~l~~ 253 (256)
T cd05114 240 EKPEGRPT----FAELLR 253 (256)
T ss_pred CCcccCcC----HHHHHH
Confidence 99999998 777765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=352.74 Aligned_cols=256 Identities=21% Similarity=0.271 Sum_probs=208.1
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCce----EEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCL----FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+...+|++++.||+|+||+||+|.+..++.. ||||+++... ......++..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4456799999999999999999998766654 8999986532 133455678899999999999999999998765
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..++|+||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999987653 46889999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (316)
T cd05108 160 GADEKE-------------------------------------------------------------------------- 165 (316)
T ss_pred cCCCcc--------------------------------------------------------------------------
Confidence 110000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+ +..++.....++....++.++.++
T Consensus 166 -~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 166 -YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred -eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHH
Confidence 00001135678999999999999999999999999999997 999998766544 344554544555555788999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+.+||..||.+||+ +.+++.+
T Consensus 244 i~~cl~~~p~~Rps----~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPK----FRELIIE 264 (316)
T ss_pred HHHHccCChhhCcC----HHHHHHH
Confidence 99999999999998 6677664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.41 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=216.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||++.+..+++.||+|.+.... ......+..|+.+++.++||||+++++.+...+..|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 57999999999999999999999889999999986532 233456778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred ecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 99999999998875 358899999999999999999999999999999999999999999999999874311000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (293)
T cd06647 170 --------------------------------------------------------------------------SKRSTM 175 (293)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+. .....++....++..+++||.+||..
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 255 (293)
T ss_pred cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccC
Confidence 58899999999998889999999999999999999999998776654443332 22333334445788999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+|++||+ +.+++.|+||+...
T Consensus 256 ~p~~Rp~----~~~il~h~~~~~~~ 276 (293)
T cd06647 256 DVEKRGS----AKELLQHPFLKIAK 276 (293)
T ss_pred ChhhCcC----HHHHhcCHHHhcCc
Confidence 9999997 89999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.73 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=213.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-----
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----- 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----- 182 (506)
+..++|+|.+.||+|||+.||+++...+++.||+|.+.... .+..+.+++|++..++++||||++++++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 34467999999999999999999999999999999997654 4667778899999999999999999987643
Q ss_pred CCeEEEEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCCEEEeecC
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLSDFD 258 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DFG 258 (506)
....||++.|...|+|.+.+++. .+..++|.++..|+.+|++||++||+.. +.||||||.|||+.+++.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 33599999999999999988763 3457999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccc
Q 010603 259 LSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVL 338 (506)
Q Consensus 259 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (506)
.+......- ..+ .....-.
T Consensus 175 S~~~a~i~i---~~~---------------------------------------------~~a~~lQ------------- 193 (302)
T KOG2345|consen 175 SATQAPIQI---EGS---------------------------------------------RQALRLQ------------- 193 (302)
T ss_pred CccccceEe---ech---------------------------------------------HHHHHHH-------------
Confidence 874321100 000 0000000
Q ss_pred ccCCCCCCccccccCCCCccchhhcCCC---CCcchhHHHHHHHHHHHhcCCCCCCCCCc--HHHHHHHhCCCCCCCCCC
Q 010603 339 IAEPTSARSMSFVGTHEYLAPEIIRGDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGN--RETLFNVVGQPLKFPEGS 413 (506)
Q Consensus 339 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~~ 413 (506)
+ -..-..|..|+|||++.-.. .+.++|||||||+||+|++|..||+..-. ......+....+.+|...
T Consensus 194 --e-----~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~ 266 (302)
T KOG2345|consen 194 --E-----WAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS 266 (302)
T ss_pred --H-----HHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC
Confidence 0 01124688999999997554 58899999999999999999999963221 112234556678899888
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.++..+.+||+.||+.||.+||+ +.+++.+
T Consensus 267 ~yse~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 267 RYSEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred CccHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 89999999999999999999998 7787753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=346.10 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=211.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..++|.+++.||+|+||.||+|.+.. +++.||||++..... ......+.+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34669999999999999999998753 367899999876432 22446778899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQP------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999987542 245789999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCC
Q 010603 252 IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331 (506)
Q Consensus 252 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (506)
+||+|||++........
T Consensus 161 ~kl~d~g~~~~~~~~~~--------------------------------------------------------------- 177 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY--------------------------------------------------------------- 177 (280)
T ss_pred EEECCcccceecccCcc---------------------------------------------------------------
Confidence 99999999843210000
Q ss_pred CCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCC
Q 010603 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFP 410 (506)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 410 (506)
........+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+.......+
T Consensus 178 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (280)
T cd05049 178 ------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245 (280)
T ss_pred ------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 000011246789999999999999999999999999999998 9999988777776666664443322
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
...++..+.+||.+||..||.+||+ +.|+++
T Consensus 246 -~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 246 -PRTCPSEVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 2368899999999999999999998 777765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.88 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=215.1
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|+.++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 48899999999999999999999999999999875422 2345677889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|++||+|.+++.. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06640 83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc----
Confidence 9999999998865 468999999999999999999999999999999999999999999999999984321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (277)
T cd06640 156 -------------------------------------------------------------------------IKRNTFV 162 (277)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011235
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
++..|+|||++.+..++.++|+|||||++|||++|..||...........+.... .......++..+.+||.+||..+|
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHcccCc
Confidence 8889999999998889999999999999999999999998776655544433221 111122577889999999999999
Q ss_pred CCccCCCCChHHhhcCCCCCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
++||+ +.++++|+||....
T Consensus 242 ~~Rp~----~~~il~~~~~~~~~ 260 (277)
T cd06640 242 SFRPT----AKELLKHKFIVKNA 260 (277)
T ss_pred ccCcC----HHHHHhChHhhhcc
Confidence 99997 89999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=351.03 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=213.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
..|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+++++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45999999999999999999999999999999987554333455567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+. |+|.+++.... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9995 67777665432 4689999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....
T Consensus 168 ----------------------------------------------------------------------------~~~~ 171 (307)
T cd06607 168 ----------------------------------------------------------------------------ANSF 171 (307)
T ss_pred ----------------------------------------------------------------------------CCCc
Confidence 0113
Q ss_pred ccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 351 VGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 351 ~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
.|++.|+|||++. ...++.++|||||||++|||++|+.||...+.......+............++..+.+||.+||
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 251 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCL 251 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence 5788999999985 3458899999999999999999999998777665555544332221112347889999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
..||.+||+ +.+++.||||..
T Consensus 252 ~~~p~~Rp~----~~~il~~~~~~~ 272 (307)
T cd06607 252 QKIPQDRPS----SEELLKHRFVLR 272 (307)
T ss_pred cCChhhCcC----HHHHhcChhhcc
Confidence 999999997 899999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=350.48 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=209.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 188 (506)
..+|+.++.||+|+||.||++.+..+++.||||.+.+.... .....+..|+.++.++. ||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 34678889999999999999999999999999998765332 33456778999999885 9999999999999999999
Q ss_pred EEeecCCCChHHHH---hhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 189 LMEFCSGGDLHTLR---QRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 189 V~E~~~gg~L~~~l---~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
+|||+. ++|.++. .......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999984 5655543 223346799999999999999999999975 99999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 160 ~~------------------------------------------------------------------------------ 161 (288)
T cd06616 160 DS------------------------------------------------------------------------------ 161 (288)
T ss_pred cC------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCccccccCCCCccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHhCC-CCCCCC--CCCCCH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVVGQ-PLKFPE--GSSISF 417 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~---~~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~-~~~~p~--~~~~s~ 417 (506)
.......|++.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+.++... ...++. ...++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 000122588899999999876 689999999999999999999999976542 2233333322 122221 135889
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
++.+||.+||..||++||+ ++++++||||+...|.
T Consensus 242 ~l~~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 242 SFVNFINLCLIKDESKRPK----YKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHHHHHHccCChhhCcC----HHHHhcChhhhchhhc
Confidence 9999999999999999998 8999999999876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=350.99 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=213.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|.....||.|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4555689999999999999998999999999875432 2334567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~------ 170 (297)
T cd06659 100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------ 170 (297)
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc------
Confidence 999999987754 46899999999999999999999999999999999999999999999999987431100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
........|
T Consensus 171 -----------------------------------------------------------------------~~~~~~~~~ 179 (297)
T cd06659 171 -----------------------------------------------------------------------VPKRKSLVG 179 (297)
T ss_pred -----------------------------------------------------------------------cccccceec
Confidence 000112368
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC-CCCCCCCCHHHHHHHHHHhhcCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK-FPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~s~~~~~li~~~L~~dP 431 (506)
++.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+...... +.....++..+.++|.+||..+|
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCc
Confidence 99999999999888999999999999999999999999877766666555433221 22234578899999999999999
Q ss_pred CCccCCCCChHHhhcCCCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f~~ 452 (506)
.+||+ +.++++||||..
T Consensus 260 ~~Rps----~~~ll~~~~~~~ 276 (297)
T cd06659 260 QERAT----AQELLDHPFLLQ 276 (297)
T ss_pred ccCcC----HHHHhhChhhcc
Confidence 99997 899999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=359.17 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=204.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 189 (506)
..|+++++||+||-++||++..-. .+.||+|.+.... .....+.-+.+|+++|.+| +|.+||+|++|-.+++++|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 459999999999999999998765 4566666554332 2245567788999999999 699999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||= ..||..+++... ..++...+++|..|+|.||.++|+.||||.||||.|+|+- .|.+||+|||+|..+......
T Consensus 439 mE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred eecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 9975 679999988763 4455568999999999999999999999999999999997 579999999999654322111
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
+ ...+
T Consensus 516 I---------------------------------------------------------------------------~kds 520 (677)
T KOG0596|consen 516 I---------------------------------------------------------------------------VKDS 520 (677)
T ss_pred e---------------------------------------------------------------------------eecc
Confidence 1 1124
Q ss_pred cccCCCCccchhhcCCC-----------CCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhC--CCCCCCCCCCC
Q 010603 350 FVGTHEYLAPEIIRGDG-----------HGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVG--QPLKFPEGSSI 415 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~-----------~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~--~~~~~p~~~~~ 415 (506)
.+||+.||+||.+.... .+.++||||||||||+|+.|++||....+. ..+..|.. ..+.||... -
T Consensus 521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~-~ 599 (677)
T KOG0596|consen 521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIP-E 599 (677)
T ss_pred ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCC-C
Confidence 58999999999997433 357999999999999999999999765432 23333332 234566532 2
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..++.++++.||.+||.+||+ +.++|+|||++.+
T Consensus 600 ~~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 600 NDELIDVMKCCLARDPKKRWS----IPELLQHPFLQIQ 633 (677)
T ss_pred chHHHHHHHHHHhcCcccCCC----cHHHhcCcccccc
Confidence 234999999999999999998 8999999999753
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.37 Aligned_cols=261 Identities=29% Similarity=0.415 Sum_probs=203.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
+++|++++.||+|+||.||+|.++.+++.||||++...... ......+.+|+++++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 46799999999999999999999999999999998654322 222334567999999999999999999987654
Q ss_pred ---eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 185 ---FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 185 ---~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999995 6888877654 2468999999999999999999999999999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
........
T Consensus 168 ~~~~~~~~------------------------------------------------------------------------ 175 (310)
T cd07865 168 AFSLSKNS------------------------------------------------------------------------ 175 (310)
T ss_pred cccCCccc------------------------------------------------------------------------
Confidence 32110000
Q ss_pred CCCCCccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC-----------
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP----------- 406 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~----------- 406 (506)
.........++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+. +..
T Consensus 176 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (310)
T cd07865 176 -KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254 (310)
T ss_pred -CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccch
Confidence 000011235788999999987654 7889999999999999999999998776544332211 110
Q ss_pred -----CCCCCC-----------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 407 -----LKFPEG-----------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 407 -----~~~p~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
..++.. ...+..+.+||.+||..||.+||+ ++++|+||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 001110 013567889999999999999998 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.13 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=213.6
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEE-----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAEL-----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 179 (506)
+.+..++|++.+.||+|+||.||+|.+ ..++..||||++++... ......+.+|+++++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 445667899999999999999999986 33456899999876432 23345678899999999 79999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
+...+..|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999998765445589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
++........
T Consensus 188 ~~~~~~~~~~---------------------------------------------------------------------- 197 (302)
T cd05055 188 ARDIMNDSNY---------------------------------------------------------------------- 197 (302)
T ss_pred cccccCCCce----------------------------------------------------------------------
Confidence 8532110000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||......+.+..........+.....+.+
T Consensus 198 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (302)
T cd05055 198 -----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272 (302)
T ss_pred -----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHH
Confidence 00011246789999999999999999999999999999998 999998877766665555444443334467899
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+|+.+||..+|++||+ +.|+++
T Consensus 273 ~~~li~~cl~~~p~~Rpt----~~ell~ 296 (302)
T cd05055 273 IYDIMKTCWDADPLKRPT----FKQIVQ 296 (302)
T ss_pred HHHHHHHHcCCCchhCcC----HHHHHH
Confidence 999999999999999998 677764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.40 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=210.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCeEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKFSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 188 (506)
++|++++.||.|++|.||+|.+..+++.||+|.+..... .....++.+|+++++.++||||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 369999999999999999999999999999999876432 2345667889999999999999999998865 347899
Q ss_pred EEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 189 LMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999987654 22356899999999999999999999999999999999999999999999999997431100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.
T Consensus 159 -------------------------------------------------------------------------------~ 159 (287)
T cd06621 159 -------------------------------------------------------------------------------L 159 (287)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC-----cHHHHHHHhCCC-CCCCC----CCCCC
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-----NRETLFNVVGQP-LKFPE----GSSIS 416 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~-----~~~~~~~i~~~~-~~~p~----~~~~s 416 (506)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+....+.... ..++. ...++
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchH
Confidence 001247789999999999999999999999999999999999998652 223333333211 11111 12356
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+.+.+||.+||..||.+||+ +.|+++||||...
T Consensus 240 ~~~~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 272 (287)
T cd06621 240 EEFKDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHHHcCCCcccCCC----HHHHHhCcccccc
Confidence 78999999999999999998 8999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=400.13 Aligned_cols=259 Identities=31% Similarity=0.531 Sum_probs=220.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+++-...||.|.||+||-|....+|...|+|.++-.... ...+....+|..+|..|+|||+|+++++=.+.+.++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 466677899999999999999999999999998765443 5566677889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
||.||+|.++++.. +..+|...+.|..|++.||.|||++|||||||||+||+|+.+|.+|++|||.|+.+...-..
T Consensus 1315 yC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~-- 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT-- 1390 (1509)
T ss_pred HhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc--
Confidence 99999999998874 67888899999999999999999999999999999999999999999999999754221000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.+......+
T Consensus 1391 -----------------------------------------------------------------------~~~el~~~~ 1399 (1509)
T KOG4645|consen 1391 -----------------------------------------------------------------------MPGELQSMM 1399 (1509)
T ss_pred -----------------------------------------------------------------------CCHHHHhhc
Confidence 001123568
Q ss_pred cCCCCccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHh-CCCCCCCCCCCCCHHHHHHHHHH
Q 010603 352 GTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVV-GQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 352 GT~~Y~APE~l~~~---~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~-~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
||+.|||||++.+. +.+.+.||||||||+.||+||+.||...+.. ..++.+- +..+++|+ .++.+.+|||.+|
T Consensus 1400 GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~--~ls~~g~dFle~C 1477 (1509)
T KOG4645|consen 1400 GTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE--RLSSEGRDFLEHC 1477 (1509)
T ss_pred CCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch--hhhHhHHHHHHHH
Confidence 99999999999864 5678999999999999999999999876554 4444443 44566676 5999999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|+.||++|++ |.|+|+|.|-+.
T Consensus 1478 l~~dP~~Rw~----~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1478 LEQDPKMRWT----ASQLLEHAFGKS 1499 (1509)
T ss_pred HhcCchhhhH----HHHHHHhhcccc
Confidence 9999999986 889999998764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=355.01 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=209.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+++|+.++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 356999999999999999999999999999999986542 22233456778999999999999999999997654
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.+|+||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899888764 46999999999999999999999999999999999999999999999999998431
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07880 169 DS------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC--------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK-------------- 408 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 408 (506)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 171 --EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred --CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 0012357889999999976 35889999999999999999999999877655444433221100
Q ss_pred ------CC---------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 409 ------FP---------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 409 ------~p---------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+ ....++..+.++|.+||..||.+||+ +.+++.||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~ 304 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEF 304 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhh
Confidence 00 01257888999999999999999998 8999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=350.25 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=207.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCce--EEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCL--FAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
+.+++|++.+.||+|+||+||+|.++.++.. +|+|.+... ........+.+|++++..+ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 5567899999999999999999999877764 577766532 1233445678899999999 8999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG 250 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 250 (506)
.+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999987542 23588999999999999999999999999999999999999999
Q ss_pred CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCC
Q 010603 251 HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLT 330 (506)
Q Consensus 251 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (506)
.+||+|||++......
T Consensus 162 ~~kl~dfg~~~~~~~~---------------------------------------------------------------- 177 (303)
T cd05088 162 VAKIADFGLSRGQEVY---------------------------------------------------------------- 177 (303)
T ss_pred cEEeCccccCcccchh----------------------------------------------------------------
Confidence 9999999987321000
Q ss_pred CCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCC
Q 010603 331 NSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKF 409 (506)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~ 409 (506)
.......++..|+|||++.+..++.++|||||||+||||+| |..||...+..+....+.. ....
T Consensus 178 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~ 242 (303)
T cd05088 178 --------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRL 242 (303)
T ss_pred --------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCcC
Confidence 00001124668999999988889999999999999999998 9999987776665554433 2233
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 410 p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+....++.++.+||.+||..+|++||+ +++++++
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 333457899999999999999999998 7777764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.39 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=222.4
Q ss_pred ccCCCCcccCCeEEEeEEeecCceEEEEEEEccCCc---e-EEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCcccee
Q 010603 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGC---L-FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLY 177 (506)
Q Consensus 102 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 177 (506)
....+++..++-.+.++||+|+||.||+|..+..+. . ||+|.++......+....++.+|+++|+.++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 345677778888889999999999999999986432 3 899998865545577888999999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeec
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 257 (506)
|+......+|||||+|.||+|.++++..+. .++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999999998743 6999999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
||++... ... + ....|++
T Consensus 307 GLs~~~~---~~~--------------~----~~~~~kl----------------------------------------- 324 (474)
T KOG0194|consen 307 GLSRAGS---QYV--------------M----KKFLKKL----------------------------------------- 324 (474)
T ss_pred ccccCCc---cee--------------e----ccccccC-----------------------------------------
Confidence 9985421 000 0 0001122
Q ss_pred cccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s 416 (506)
...|+|||.+...-|+.++|||||||++||+++ |..||.+....+....++....+.+.....+
T Consensus 325 ---------------PirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 325 ---------------PIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred ---------------cceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence 248999999999999999999999999999998 8999999999988888876666666666788
Q ss_pred HHHHHHHHHHhhcCCCCccCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~ 438 (506)
.++..++.+|+..||++|++|.
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~ 411 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMS 411 (474)
T ss_pred HHHHHHHHHhccCChhhccCHH
Confidence 9999999999999999999963
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=344.44 Aligned_cols=255 Identities=25% Similarity=0.473 Sum_probs=211.7
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC---CCCccceeEEEEeCCeEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD---HPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l 188 (506)
.|++++.||.|+||.||+|.+..+++.||+|+++.... ......+.+|+.+++.++ ||||+++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 48889999999999999999999999999999875421 234556778999999886 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 9999999999998865 378999999999999999999999999999999999999999999999999985421100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 156 ----------------------------------------------------------------------------~~~~ 159 (277)
T cd06917 156 ----------------------------------------------------------------------------SKRS 159 (277)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHHHHHH
Q 010603 349 SFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~li~~~ 426 (506)
...|+..|+|||++.+. .++.++|+|||||++|+|++|+.||...........+.... ..++. ..++.++.+||.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~ 238 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED-NGYSKLLREFVAAC 238 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCc-ccCCHHHHHHHHHH
Confidence 23688999999998754 46899999999999999999999998766554443332221 12222 23788999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
|..||.+||+ +.+++.|+||+..
T Consensus 239 l~~~p~~R~~----~~~il~~~~~~~~ 261 (277)
T cd06917 239 LDEEPKERLS----AEELLKSKWIKAH 261 (277)
T ss_pred cCCCcccCcC----HHHHhhChHhhcc
Confidence 9999999997 8999999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.10 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=211.0
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|++.+.||+|+||.||+|.+.. ++.||||.++.... ....+.+|+++++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 3455679999999999999999999764 57899999876432 234567899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.+++|.+++....+..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999988765567999999999999999999999999999999999999999999999999998543200
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 157 ~~----------------------------------------------------------------------------~~ 160 (261)
T cd05068 157 IY----------------------------------------------------------------------------EA 160 (261)
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+....+..+... ...+....++..+.+|+.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence 001123458999999999899999999999999999999 99999888776666665443 2333344688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|.+||+ +.++++
T Consensus 240 ~l~~~P~~Rp~----~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPT----FETLQW 256 (261)
T ss_pred HhhcCcccCCC----HHHHHH
Confidence 99999999998 666653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=355.15 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=206.9
Q ss_pred eEEeec--CceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecC
Q 010603 117 KKLGCG--DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 117 ~~LG~G--~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
..||.| +||+||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||++++++|...+..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 9999999999999999999998764322 2345678889999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCC
Q 010603 195 GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274 (506)
Q Consensus 195 gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 274 (506)
+++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~--- 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK--- 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence 99999998876556799999999999999999999999999999999999999999999999986532110000000
Q ss_pred CcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCC
Q 010603 275 DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTH 354 (506)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 354 (506)
. .........++.
T Consensus 160 --------------------------------------------------------------~-----~~~~~~~~~~~~ 172 (328)
T cd08226 160 --------------------------------------------------------------V-----VYDFPQFSTSVL 172 (328)
T ss_pred --------------------------------------------------------------c-----cccccccccCcc
Confidence 0 000000113567
Q ss_pred CCccchhhcCC--CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC------------------------
Q 010603 355 EYLAPEIIRGD--GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK------------------------ 408 (506)
Q Consensus 355 ~Y~APE~l~~~--~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------------ 408 (506)
.|||||++.+. .++.++|||||||++|||++|+.||........+...+.....
T Consensus 173 ~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (328)
T cd08226 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS 252 (328)
T ss_pred CccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhc
Confidence 89999999874 4789999999999999999999999877655544443322111
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 409 ---------------------FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 409 ---------------------~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+....+++.+.+||.+||+.||++||+ +.|+|+||||..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~ 314 (328)
T cd08226 253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQV 314 (328)
T ss_pred ccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHH
Confidence 1111235678999999999999999997 9999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.89 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=214.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 37788899999999999999999999999999875432 2344567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++++|.+++.. ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc----
Confidence 9999999998764 468999999999999999999999999999999999999999999999999984321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (277)
T cd06642 156 -------------------------------------------------------------------------IKRNTFV 162 (277)
T ss_pred -------------------------------------------------------------------------hhhhccc
Confidence 0011235
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
|+..|+|||++.+..++.++|||||||++|||++|+.||...........+...... .....++..+.+||.+||..+|
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP-TLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC-CCCcccCHHHHHHHHHHccCCc
Confidence 888999999999988999999999999999999999999766555444433322111 1123578889999999999999
Q ss_pred CCccCCCCChHHhhcCCCCCCCCc
Q 010603 432 QKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
.+||+ +.++++||||....+
T Consensus 242 ~~Rp~----~~~il~~~~~~~~~~ 261 (277)
T cd06642 242 RFRPT----AKELLKHKFITRYTK 261 (277)
T ss_pred ccCcC----HHHHHHhHHHHHHhh
Confidence 99997 899999999976443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=354.68 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=208.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----Ce
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-----KF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 185 (506)
.+|++++.||+|+||+||+|++..+++.||||.+.+.... ......+.+|+.+|+.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4699999999999999999999999999999998764322 23345667899999999999999999988654 35
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888754 5799999999999999999999999999999999999999999999999999843210
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.. .
T Consensus 161 ~~-----------------------------------------------------------------------------~ 163 (337)
T cd07858 161 KG-----------------------------------------------------------------------------D 163 (337)
T ss_pred Cc-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred CccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCC---------------
Q 010603 346 RSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQP--------------- 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~--------------- 406 (506)
......|+..|+|||++.. ..++.++|||||||++|+|++|++||.+.+....+..+. +.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 0112368889999999875 458999999999999999999999998765433222111 100
Q ss_pred -----CCCC------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 -----LKFP------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 -----~~~p------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...+ ....++.++.+||.+||+.||++||+ ++++++||||+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~ 297 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASL 297 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhh
Confidence 0000 01257889999999999999999997 8999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.91 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=210.3
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccC-----CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
++..++|++++.||+|+||.||+|.++.. +..||+|.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45567899999999999999999998754 37899999875431 233445678999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEE
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQP--------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 253 (506)
.....|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999987532 12468889999999999999999999999999999999999999999
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||+++.+......
T Consensus 160 l~dfg~~~~~~~~~~~---------------------------------------------------------------- 175 (277)
T cd05032 160 IGDFGMTRDIYETDYY---------------------------------------------------------------- 175 (277)
T ss_pred ECCcccchhhccCccc----------------------------------------------------------------
Confidence 9999998532110000
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCC
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEG 412 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 412 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... ...+..
T Consensus 176 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 243 (277)
T cd05032 176 -----------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GHLDLP 243 (277)
T ss_pred -----------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CCCCCC
Confidence 00111246789999999998889999999999999999998 99999887766665555532 222233
Q ss_pred CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 413 SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 413 ~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
..++.++.+||.+||..+|++||+ +.+++.
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 244 ENCPDKLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 457899999999999999999998 777765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=338.93 Aligned_cols=252 Identities=30% Similarity=0.439 Sum_probs=204.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.+.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3444568999999999999999999999999987643 2344567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCccccccCCc
Q 010603 192 FCSGGDLHTLRQRQPGKHF--SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~--~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla~~~~~~~~ 268 (506)
|+++++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 163 (268)
T cd06624 86 QVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN- 163 (268)
T ss_pred cCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-
Confidence 999999999887642 334 88889999999999999999999999999999999986 6799999999874321000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 164 ----------------------------------------------------------------------------~~~~ 167 (268)
T cd06624 164 ----------------------------------------------------------------------------PCTE 167 (268)
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0011
Q ss_pred ccccCCCCccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCCCCcHH-HHHHH--hCCCCCCCCCCCCCHHHHHHH
Q 010603 349 SFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGNRE-TLFNV--VGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~--~~~~~DiWSlGvil~elltG~~Pf~~~~~~~-~~~~i--~~~~~~~p~~~~~s~~~~~li 423 (506)
...|++.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ..... ......+| ..+++++++|+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li 245 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP--ESLSAEAKNFI 245 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCC--cccCHHHHHHH
Confidence 125888999999987643 7899999999999999999999997644322 12221 12222233 35889999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
.+||..+|.+||+ +.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCC----HHHHHhCCCC
Confidence 9999999999997 8999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=347.64 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=208.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFSC 187 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 187 (506)
+++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.+++.++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35699999999999999999999999999999999765432 22334566799999999999999999999877 8999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 59998887643 468999999999999999999999999999999999999999999999999885421100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 161 -----------------------------------------------------------------------------~~~ 163 (293)
T cd07843 161 -----------------------------------------------------------------------------KPY 163 (293)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 000
Q ss_pred cccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C-----------------
Q 010603 348 MSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P----------------- 406 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~----------------- 406 (506)
....+++.|+|||++.+.. ++.++|||||||++|||++|.+||......+.+..+... +
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 1125788999999987654 689999999999999999999999877665544333210 0
Q ss_pred -----------CCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 407 -----------LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 407 -----------~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
..++. ..+++.+.+||.+||+.||++||+ +.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 00111 015888999999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=343.31 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=208.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++++.||.|++|+||+|++..+|+.||||++..... ......+.+|+++++.++||||+++++++...+..|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 49999999999999999999999999999999976532 2233456679999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 192 FCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|+. ++|.+++.... ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 997 58888776542 3468999999999999999999999999999999999999999999999999884321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (284)
T cd07836 155 --------------------------------------------------------------------------NTFSNE 160 (284)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C---------------CCCCC
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P---------------LKFPE 411 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~---------------~~~p~ 411 (506)
.+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... + ..++.
T Consensus 161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07836 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR 240 (284)
T ss_pred cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccC
Confidence 578899999998764 5789999999999999999999999887765554433211 0 00010
Q ss_pred ---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 ---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 ---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
...++..++++|.+||+.||.+||+ +.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred CChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 0135778999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.17 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=213.7
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|...+.||.|++|.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 555689999999999999999899999999986432 23344567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+.+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~------ 168 (285)
T cd06648 98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------ 168 (285)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC------
Confidence 999999998876 46899999999999999999999999999999999999999999999999987421000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
........|
T Consensus 169 -----------------------------------------------------------------------~~~~~~~~~ 177 (285)
T cd06648 169 -----------------------------------------------------------------------VPRRKSLVG 177 (285)
T ss_pred -----------------------------------------------------------------------CcccccccC
Confidence 000112368
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC-CCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL-KFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
++.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+..... .......++..+.+||.+||..+|
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccCh
Confidence 9999999999988899999999999999999999999988776666665554422 222223478899999999999999
Q ss_pred CCccCCCCChHHhhcCCCCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f~~~ 453 (506)
++||+ +.++++||||+..
T Consensus 258 ~~Rpt----~~~il~~~~~~~~ 275 (285)
T cd06648 258 AQRAT----AAELLNHPFLAKA 275 (285)
T ss_pred hhCcC----HHHHccCcccccC
Confidence 99997 8999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=341.39 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=208.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||.|+||.||+|.++.+++.||||.+.+...........+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999987654444445567788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 191 EFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 191 E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988642 23568999999999999999999999999999999999999999999999999874321000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 161 ----------------------------------------------------------------------------~~~~ 164 (267)
T cd08229 161 ----------------------------------------------------------------------------TAAH 164 (267)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0001
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH--HHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR--ETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
...|+..|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+............++..+.+||.+|
T Consensus 165 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 244 (267)
T cd08229 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244 (267)
T ss_pred cccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHh
Confidence 236889999999999988999999999999999999999999755432 222233222211111235788999999999
Q ss_pred hhcCCCCccCCCCChHHhhc
Q 010603 427 LVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~ 446 (506)
|..||.+||+ +.+|++
T Consensus 245 l~~~p~~Rpt----~~~i~~ 260 (267)
T cd08229 245 INPDPEKRPD----ITYVYD 260 (267)
T ss_pred cCCCcccCCC----HHHHHH
Confidence 9999999998 565543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=339.12 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=206.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++.++||+|+||.||+|++..+ ..||||++.+... ....+.+|+++++.++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4456799999999999999999998765 4699999976432 2245678999999999999999999875 45689
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999987655678999999999999999999999999999999999999999999999999985321100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. ...
T Consensus 157 ~----------------------------------------------------------------------------~~~ 160 (262)
T cd05071 157 Y----------------------------------------------------------------------------TAR 160 (262)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 000
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... ...+....++..+.+||.+|
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 239 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQC 239 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCCccccCHHHHHHHHHH
Confidence 01246778999999998889999999999999999999 89999887776666655433 22333346889999999999
Q ss_pred hhcCCCCccCCCCChHHhhc
Q 010603 427 LVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~ 446 (506)
|+.||++||+ ++++++
T Consensus 240 l~~~p~~Rp~----~~~~~~ 255 (262)
T cd05071 240 WRKEPEERPT----FEYLQA 255 (262)
T ss_pred ccCCcccCCC----HHHHHH
Confidence 9999999998 555553
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=341.19 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=212.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
..+|++++.||.|+||.||+|.++. ++.+|+|++..... .....+..|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3469999999999999999999988 88999999876532 2344577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+++++|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999999876667799999999999999999999999999999999999999999999999999853210000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
....
T Consensus 160 ----------------------------------------------------------------------------~~~~ 163 (261)
T cd05148 160 ----------------------------------------------------------------------------LSSD 163 (261)
T ss_pred ----------------------------------------------------------------------------cccC
Confidence 0001
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||......+.+..+... ...+....++..+.++|.+||.
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIMLECWA 242 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCCCCCCCCHHHHHHHHHHcC
Confidence 235678999999998889999999999999999998 89999888777766666533 3344445789999999999999
Q ss_pred cCCCCccCCCCChHHhhc
Q 010603 429 KDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~ 446 (506)
.||.+||+ +.++++
T Consensus 243 ~~p~~Rpt----~~~l~~ 256 (261)
T cd05148 243 AEPEDRPS----FKALRE 256 (261)
T ss_pred CCchhCcC----HHHHHH
Confidence 99999998 566654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.48 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=208.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
.+|.+.+.||+|+||+||++.+. .++..||+|.+.... ......+.+|+++++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 46999999999999999999863 345679999987542 2345567889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEE
Q 010603 186 SCLLMEFCSGGDLHTLRQRQP-----------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIML 254 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~-----------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 254 (506)
+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999987542 135899999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
+|||+++.+.....
T Consensus 162 ~dfg~~~~~~~~~~------------------------------------------------------------------ 175 (288)
T cd05093 162 GDFGMSRDVYSTDY------------------------------------------------------------------ 175 (288)
T ss_pred ccCCccccccCCce------------------------------------------------------------------
Confidence 99999853211000
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCC
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGS 413 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 413 (506)
........+++.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+..... .+...
T Consensus 176 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~~ 245 (288)
T cd05093 176 ---------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRPR 245 (288)
T ss_pred ---------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-CCCCC
Confidence 000011246788999999999889999999999999999998 9999988777766666665432 22234
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.++.++.+|+.+||+.||.+||+ +.+++.
T Consensus 246 ~~~~~l~~li~~~l~~~p~~Rpt----~~~v~~ 274 (288)
T cd05093 246 TCPKEVYDLMLGCWQREPHMRLN----IKEIHS 274 (288)
T ss_pred CCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 68899999999999999999998 566643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=342.30 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=202.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeC--CeEEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETD--KFSCLL 189 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~lV 189 (506)
|++++.||+|+||.||+|.++.+++.||+|++.+.... ... .....|+.+++.+ +|+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 78899999999999999999999999999998764321 122 2334688888888 499999999999988 899999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+. |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 99996 57877776542 57899999999999999999999999999999999999999 999999999985321000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
....
T Consensus 154 ----------------------------------------------------------------------------~~~~ 157 (282)
T cd07831 154 ----------------------------------------------------------------------------PYTE 157 (282)
T ss_pred ----------------------------------------------------------------------------CcCC
Confidence 0112
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---C---------------CCCCC
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---Q---------------PLKFP 410 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~---------------~~~~p 410 (506)
..+++.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..+.. . ...++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 357889999998754 4568899999999999999999999988766554433321 1 11111
Q ss_pred C---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 E---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 ~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
. ...++..+++||.+||..||++||+ ++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 1 1246789999999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=376.00 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=223.5
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH 179 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 179 (506)
..++...+-+..+.||+|+||+||+|+.-. ....||||.++.... .+..+.|++|+++|..|+|||||+|+|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345666778899999999999999998752 346799999987542 3466789999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCC--------C----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQP--------G----KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR 247 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--------~----~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~ 247 (506)
+..++.+|||+|||..|||.+++..+. + .+++..+...|+.||+.|++||-++.+|||||..+|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 999999999999999999999988642 1 2378889999999999999999999999999999999999
Q ss_pred cCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccc
Q 010603 248 EDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKT 327 (506)
Q Consensus 248 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (506)
++-.|||+||||++.+.......-..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~------------------------------------------------------ 663 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRG------------------------------------------------------ 663 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccC------------------------------------------------------
Confidence 99999999999997654322111000
Q ss_pred cCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCC
Q 010603 328 SLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQP 406 (506)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 406 (506)
.-.-...|||||.|..+.|+.++||||+||+|||+++ |+.||.+.++.+.+..+..+.
T Consensus 664 ---------------------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 664 ---------------------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ---------------------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 0023458999999999999999999999999999995 999999999999999998887
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 407 ~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+ ++.+..++.++.+|+..||+.+|.+||+|++ +..+|+
T Consensus 723 l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e-I~~~L~ 760 (774)
T KOG1026|consen 723 L-LSCPENCPTEVYSLMLECWNENPKRRPSFKE-IHSRLQ 760 (774)
T ss_pred c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHH-HHHHHH
Confidence 6 7777899999999999999999999999764 333343
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.55 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=207.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|.+.. +..+|||.+..... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4569999999999999999998764 45699999875432 234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 99999999999987643 3789999999999999999999999999999999999999999999999998753211000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 156 ---------------------------------------------------------------------------~~~~~ 160 (256)
T cd05113 156 ---------------------------------------------------------------------------TSSVG 160 (256)
T ss_pred ---------------------------------------------------------------------------eecCC
Confidence 00001
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..++..|+|||++.+..++.++|||||||++|||++ |..||......+....+..... .+.....+..+++++.+||.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYRPHLASEKVYAIMYSCWH 239 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcC
Confidence 135678999999998889999999999999999998 9999987776666666654432 22233578999999999999
Q ss_pred cCCCCccCCCCChHHhhcC
Q 010603 429 KDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~h 447 (506)
.||.+||+ +.+++.+
T Consensus 240 ~~p~~Rp~----~~~ll~~ 254 (256)
T cd05113 240 EKAEERPT----FQQLLSS 254 (256)
T ss_pred CCcccCCC----HHHHHHh
Confidence 99999998 7888763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=341.42 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=213.7
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++++.||.|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 8889999999999999999998999999999865432 23445678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+.+++|..++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~----- 155 (277)
T cd06641 84 LGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----- 155 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-----
Confidence 999999998864 468999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (277)
T cd06641 156 ------------------------------------------------------------------------IKRNTFVG 163 (277)
T ss_pred ------------------------------------------------------------------------hhhccccC
Confidence 00112358
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQ 432 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~ 432 (506)
+..|+|||++.+..++.++|+|||||++|+|++|..||...........+...... .....++.++.++|.+||..+|.
T Consensus 164 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~ 242 (277)
T cd06641 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEACLNKEPS 242 (277)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHccCChh
Confidence 88999999998888899999999999999999999999876665555554333211 11235788999999999999999
Q ss_pred CccCCCCChHHhhcCCCCCC
Q 010603 433 KRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 433 ~R~s~~~~a~ell~hp~f~~ 452 (506)
+||+ +.++++||||..
T Consensus 243 ~Rp~----~~~~l~~~~~~~ 258 (277)
T cd06641 243 FRPT----AKELLKHKFIVR 258 (277)
T ss_pred hCcC----HHHHHhCHHHhh
Confidence 9997 899999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=340.83 Aligned_cols=257 Identities=20% Similarity=0.311 Sum_probs=208.7
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+..|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34569999999999999999999987 778999998865321 22334577899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CEEEe
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPG-----KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIMLS 255 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~-----~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~ 255 (506)
+..|+||||+.|++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999999876421 2589999999999999999999999999999999999998765 59999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||+++.+......
T Consensus 162 dfg~~~~~~~~~~~------------------------------------------------------------------ 175 (277)
T cd05036 162 DFGMARDIYRASYY------------------------------------------------------------------ 175 (277)
T ss_pred cCccccccCCccce------------------------------------------------------------------
Confidence 99998542100000
Q ss_pred cccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCC
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSS 414 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 414 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ........
T Consensus 176 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 245 (277)
T cd05036 176 ---------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPPKG 245 (277)
T ss_pred ---------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCC
Confidence 00001134568999999998899999999999999999996 99999987776655554432 22222346
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
++..+.+|+.+||+.+|++||+ +.++++|
T Consensus 246 ~~~~~~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 246 CPGPVYRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 8899999999999999999998 7888875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.64 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=209.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++++.||.|++|.||+|.++.+|+.||||++...... ......+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999998765322 22334567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+ +++|.+++.......+++..++.++.||+.||+|||+++++||||+|+|||++.++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 9 5799999887654579999999999999999999999999999999999999999999999999984321000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......+
T Consensus 154 ------------------------------------------------------------------------~~~~~~~~ 161 (283)
T cd07835 154 ------------------------------------------------------------------------RTYTHEVV 161 (283)
T ss_pred ------------------------------------------------------------------------cccCcccc
Confidence 00011257
Q ss_pred CCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC---------------CCC---
Q 010603 353 THEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL---------------KFP--- 410 (506)
Q Consensus 353 T~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~---------------~~p--- 410 (506)
++.|+|||++.+. .++.++|||||||++|+|++|++||...+....+..+... +. .++
T Consensus 162 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd07835 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWA 241 (283)
T ss_pred ccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccccc
Confidence 8899999988764 4789999999999999999999999877665444433211 00 000
Q ss_pred ------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 ------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 ------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
....++..+.+||.+||+.||.+||+ ++|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 242 RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred ccchhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 11356788999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=345.52 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=213.9
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|..++.||+|+||+||+|++..+++.||||++.............+..|+++++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 77788999999999999999999999999999765444445556778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-------- 172 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-------- 172 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--------
Confidence 95 6777776554 3568999999999999999999999999999999999999999999999999873100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
......|
T Consensus 173 -------------------------------------------------------------------------~~~~~~~ 179 (313)
T cd06633 173 -------------------------------------------------------------------------PANSFVG 179 (313)
T ss_pred -------------------------------------------------------------------------CCCCccc
Confidence 0012368
Q ss_pred CCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 353 THEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 353 T~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
+..|+|||++. ...++.++|||||||++|+|++|..||........+..+............++..+++||.+||+.
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 259 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQK 259 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccC
Confidence 88999999985 355888999999999999999999999887766666555433322222235778899999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+|.+||+ +.+++.||||...+
T Consensus 260 ~P~~Rp~----~~~~l~~~~~~~~~ 280 (313)
T cd06633 260 IPQERPA----SAELLRHDFVRRDR 280 (313)
T ss_pred ChhhCcC----HHHHhcCcccCCCc
Confidence 9999998 89999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=332.99 Aligned_cols=256 Identities=32% Similarity=0.555 Sum_probs=218.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+..|+++++.++|||++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999765432 2445567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 192 FCSGGDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~--~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|+++++|.+++.... +..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999887753 4679999999999999999999999999999999999999999999999999884321000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (258)
T cd08215 158 ---------------------------------------------------------------------------DLAKT 162 (258)
T ss_pred ---------------------------------------------------------------------------ceecc
Confidence 00112
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
..|++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+........... +....++..+.++|.+||..
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~ 241 (258)
T cd08215 163 VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQK 241 (258)
T ss_pred eeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCC
Confidence 36889999999999888999999999999999999999999877766655555544322 22236889999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f 450 (506)
+|.+||+ +.++|+||||
T Consensus 242 ~p~~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 242 DPEERPS----IAQILQSPFI 258 (258)
T ss_pred ChhhCcC----HHHHhcCCCC
Confidence 9999998 8999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=353.82 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=209.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe----CCeE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----DKFS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~ 186 (506)
++|++.+.||.|+||.||+|.++.+|+.||+|++.+.... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 5699999999999999999999999999999999764322 2344566789999999999999999998863 3578
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 56898888654 56999999999999999999999999999999999999999999999999998532110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
... ....
T Consensus 161 ~~~-------------------------------------------------------------------------~~~~ 167 (334)
T cd07855 161 PTE-------------------------------------------------------------------------HKYF 167 (334)
T ss_pred CcC-------------------------------------------------------------------------CCcc
Confidence 000 0000
Q ss_pred ccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC----------------
Q 010603 347 SMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP---------------- 406 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~---------------- 406 (506)
....+|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+.. .+
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 247 (334)
T cd07855 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKY 247 (334)
T ss_pred cccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHH
Confidence 123478999999999876 4589999999999999999999999987665433322111 00
Q ss_pred -------CCCCC---CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 -------LKFPE---GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 -------~~~p~---~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...+. ....+.++.+||.+||+.+|.+||+ +++++.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~ 300 (334)
T cd07855 248 IQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQY 300 (334)
T ss_pred HhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhc
Confidence 00000 1246889999999999999999997 8999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=335.99 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=208.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999987644444455667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 191 EFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 191 E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||+++|+|..++... ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999999988652 23568999999999999999999999999999999999999999999999999874321000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 161 ----------------------------------------------------------------------------~~~~ 164 (267)
T cd08224 161 ----------------------------------------------------------------------------TAAH 164 (267)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0001
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc--HHHHHHHhCCCC-CCCCCCCCCHHHHHHHHH
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN--RETLFNVVGQPL-KFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~-~~p~~~~~s~~~~~li~~ 425 (506)
...|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... .+....+..... ..+ ...++..+.++|.+
T Consensus 165 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~ 243 (267)
T cd08224 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP-ADHYSEELRDLVSR 243 (267)
T ss_pred eecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC-hhhcCHHHHHHHHH
Confidence 23588899999999988899999999999999999999999965432 222223322221 122 12578899999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|.+||+ +.+|++
T Consensus 244 cl~~~p~~Rp~----~~~il~ 260 (267)
T cd08224 244 CINPDPEKRPD----ISYVLQ 260 (267)
T ss_pred HcCCCcccCCC----HHHHHH
Confidence 99999999998 666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.85 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=206.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.+... ....+.+|+++++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 45899999999999999999886 467899999875432 2235667999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence 9999999999987653 4789999999999999999999999999999999999999999999999999853210000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (256)
T cd05059 156 --------------------------------------------------------------------------TSSQGT 161 (256)
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 000001
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+... ...+....++.++.+|+.+||..
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRPKLAPTEVYTIMYSCWHE 240 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhcC
Confidence 24568999999999899999999999999999999 89999887776666555433 23333346899999999999999
Q ss_pred CCCCccCCCCChHHhhc
Q 010603 430 DPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~ 446 (506)
+|++||+ +.++++
T Consensus 241 ~p~~Rpt----~~~~l~ 253 (256)
T cd05059 241 KPEDRPA----FKKLLS 253 (256)
T ss_pred ChhhCcC----HHHHHH
Confidence 9999998 778876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=336.58 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=209.1
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|+++++||+|+||.||+|..+. ++.||+|.+.+... ....+.+|+.+++.++|+||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 3455679999999999999999998664 78899999876532 2345678999999999999999999874 5678
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.+++|.+++....+..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999999988766678999999999999999999999999999999999999999999999999997432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 156 ~~----------------------------------------------------------------------------~~ 159 (260)
T cd05067 156 EY----------------------------------------------------------------------------TA 159 (260)
T ss_pred Cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+.. ....+.....+.++.+||.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence 011246678999999998889999999999999999998 9999988776666555543 33344445688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|++||+ +++++.
T Consensus 239 ~l~~~p~~Rp~----~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPT----FEYLRS 255 (260)
T ss_pred HccCChhhCCC----HHHHHH
Confidence 99999999998 677764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=337.08 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=210.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.++|++.+.||+|+||+||+|.++.+ ...||||++..... ......+..|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 45699999999999999999998754 45799999876432 23345677899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987653 47899999999999999999999999999999999999999999999999998543100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
... ..
T Consensus 160 ~~~---------------------------------------------------------------------------~~ 164 (266)
T cd05033 160 EAT---------------------------------------------------------------------------YT 164 (266)
T ss_pred ccc---------------------------------------------------------------------------ee
Confidence 000 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+... ...+....++..+.+|+.+
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 243 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPMDCPSALYQLMLD 243 (266)
T ss_pred ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 001135678999999998889999999999999999997 99999877766655555433 3334445689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~h 447 (506)
||+.+|++||+ +.+++++
T Consensus 244 cl~~~p~~Rp~----~~ei~~~ 261 (266)
T cd05033 244 CWQKDRNERPT----FSQIVST 261 (266)
T ss_pred HcCCCcccCcC----HHHHHHH
Confidence 99999999998 7777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.48 Aligned_cols=259 Identities=21% Similarity=0.330 Sum_probs=211.2
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCC-----ceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
.+..++|++.+.||+|+||.||++..+..+ ..+|+|++..... ......+.+|+++++.+ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455677999999999999999999987443 7899999876422 23445678899999999 899999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQ--------------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV 246 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl 246 (506)
...+.+|+||||+++|+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998652 23578999999999999999999999999999999999999
Q ss_pred ecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccc
Q 010603 247 REDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEK 326 (506)
Q Consensus 247 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (506)
+.++.+||+|||+++.+......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~--------------------------------------------------------- 188 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY--------------------------------------------------------- 188 (293)
T ss_pred cCCCeEEeCccccccccccccce---------------------------------------------------------
Confidence 99999999999998542110000
Q ss_pred ccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCC
Q 010603 327 TSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQ 405 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 405 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+...
T Consensus 189 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 250 (293)
T cd05053 189 ------------------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250 (293)
T ss_pred ------------------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 00001135668999999999899999999999999999997 99999877666555544433
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 406 ~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
...+.....+..+.+|+.+||..||++||+ +.+++++
T Consensus 251 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 251 -YRMEKPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 333334467899999999999999999998 7888763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=336.92 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=208.1
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|+++++||+|+||.||+|.+. .+..||+|.+...... ...+.+|+.+++.++|+||+++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 355678999999999999999999876 4667999998764332 245778999999999999999999885 4568
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999999988765567899999999999999999999999999999999999999999999999998432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 156 ~~----------------------------------------------------------------------------~~ 159 (260)
T cd05070 156 EY----------------------------------------------------------------------------TA 159 (260)
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+... ...+.....+..+.+||.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHH
Confidence 001135668999999998889999999999999999999 99999887777666665533 2333444688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..||.+||+ +.++++
T Consensus 239 ~l~~~p~~Rpt----~~~l~~ 255 (260)
T cd05070 239 CWKKDPEERPT----FEYLQS 255 (260)
T ss_pred HcccCcccCcC----HHHHHH
Confidence 99999999998 666653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=363.70 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=211.9
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEeccch-hhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe--EEEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGM-LAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF--SCLLM 190 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~lV~ 190 (506)
+.-.+||+|+|-+||+|.+..+|..||--.++... .......+++..|+++|+.|+|||||++|+.|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34468999999999999999999998865554332 2345567889999999999999999999999987765 88999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEec-CCCEEEeecCCccccccCC
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVRE-DGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~-~~~vkl~DFGla~~~~~~~ 267 (506)
|++..|+|+.|+++. +.++...++.|++||++||.|||++. |||||||.+||+|+. -|.|||+|+|||....
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r--- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR--- 197 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh---
Confidence 999999999999987 78999999999999999999999997 999999999999986 5899999999995321
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
....
T Consensus 198 ----------------------------------------------------------------------------~s~a 201 (632)
T KOG0584|consen 198 ----------------------------------------------------------------------------KSHA 201 (632)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 1223
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHH-HhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN-VVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~-i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
.+.+|||.|||||++. ..|+..+||||||.+|.||+|+..||..-.+..++++ +..+..+-.-..--.+++++||.+|
T Consensus 202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC 280 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC 280 (632)
T ss_pred ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence 4568999999999997 7799999999999999999999999987766666655 4433221111122368899999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
|.. ..+|++ |.|+|+||||...
T Consensus 281 l~~-~~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 281 LAT-KSERLS----AKELLKDPFFDED 302 (632)
T ss_pred hcC-chhccC----HHHHhhChhhccc
Confidence 999 899998 9999999999864
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=352.93 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=205.6
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
++..++|++++.||+|+||+||+|.+. .+++.||||+++.... ......+.+|+.+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 455678999999999999999999853 4578999999975432 23445678899999999 689999999987
Q ss_pred EeC-CeEEEEEeecCCCChHHHHhhCC-----------------------------------------------------
Q 010603 181 ETD-KFSCLLMEFCSGGDLHTLRQRQP----------------------------------------------------- 206 (506)
Q Consensus 181 ~~~-~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 206 (506)
... ..+++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 57899999999999999886531
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCC
Q 010603 207 ------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274 (506)
Q Consensus 207 ------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 274 (506)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----- 235 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----- 235 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-----
Confidence 124678888899999999999999999999999999999999999999999998542110000
Q ss_pred CcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCC
Q 010603 275 DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTH 354 (506)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 354 (506)
.......+++
T Consensus 236 ----------------------------------------------------------------------~~~~~~~~~~ 245 (343)
T cd05103 236 ----------------------------------------------------------------------VRKGDARLPL 245 (343)
T ss_pred ----------------------------------------------------------------------hhcCCCCCCc
Confidence 0001123567
Q ss_pred CCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCC
Q 010603 355 EYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQK 433 (506)
Q Consensus 355 ~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~ 433 (506)
.|+|||++.+..++.++|||||||++|||++ |..||........+...+......+....+++++.+++.+||+.||++
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~ 325 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 325 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999999899999999999999999996 999998765444444433332233333357889999999999999999
Q ss_pred ccCCCCChHHhhcC
Q 010603 434 RLGFKRGATEIKQH 447 (506)
Q Consensus 434 R~s~~~~a~ell~h 447 (506)
||+ +.++++|
T Consensus 326 Rps----~~eil~~ 335 (343)
T cd05103 326 RPT----FSELVEH 335 (343)
T ss_pred CcC----HHHHHHH
Confidence 998 7888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=333.37 Aligned_cols=250 Identities=48% Similarity=0.867 Sum_probs=216.0
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||.|+||.||++.+..+++.||+|++.+...........+..|+.+++.++||||+++++.++.++..|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999999887655555667788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCccc
Q 010603 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278 (506)
Q Consensus 199 ~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~ 278 (506)
.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9998765 468999999999999999999999999999999999999999999999999874321100
Q ss_pred ccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCcc
Q 010603 279 RISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLA 358 (506)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 358 (506)
.......|+..|+|
T Consensus 148 ------------------------------------------------------------------~~~~~~~~~~~~~~ 161 (250)
T cd05123 148 ------------------------------------------------------------------SRTNTFCGTPEYLA 161 (250)
T ss_pred ------------------------------------------------------------------CcccCCcCCccccC
Confidence 00112368889999
Q ss_pred chhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCC
Q 010603 359 PEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 359 PE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~ 438 (506)
||.+.+..++.++|+||||+++|+|++|..||......+....+......++. .++..+.+||.+||..||++||+.+
T Consensus 162 Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE--FLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred hHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 99999888899999999999999999999999877766666666655445544 5789999999999999999999843
Q ss_pred CChHHhhcCCCC
Q 010603 439 RGATEIKQHPFF 450 (506)
Q Consensus 439 ~~a~ell~hp~f 450 (506)
. ++++++||||
T Consensus 240 ~-~~~l~~~~~f 250 (250)
T cd05123 240 G-AEEIKAHPFF 250 (250)
T ss_pred c-HHHHHhCCCC
Confidence 2 3999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.41 Aligned_cols=253 Identities=30% Similarity=0.493 Sum_probs=217.6
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||+|++|.||+|.+..+++.||+|.+.+.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 489999999999999999999999999999999876432 2455678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999998775 6799999999999999999999999999999999999999999999999999854211000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (254)
T cd06627 155 --------------------------------------------------------------------------DDASVV 160 (254)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011235
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
|+..|+|||.+.+..++.++|||+||+++|+|++|+.||...........+... ...++ ..++..+.++|.+||..+
T Consensus 161 ~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLP--EGISPELKDFLMQCFQKD 238 (254)
T ss_pred cchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHHhCC
Confidence 888999999998888899999999999999999999999877665555554422 22232 368899999999999999
Q ss_pred CCCccCCCCChHHhhcCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f 450 (506)
|++||+ +.+++.||||
T Consensus 239 p~~R~~----~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPT----AKQLLKHPWI 254 (254)
T ss_pred hhhCcC----HHHHhcCCCC
Confidence 999997 8999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=339.07 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=207.4
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc---CCCCccceeEEEEeCCe----
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPTLYSHFETDKF---- 185 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~---- 185 (506)
|++++.||+|+||.||+|+++.+++.||||+++..... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78999999999999999999988999999999754322 22233455677777655 69999999999988776
Q ss_pred -EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 186 -SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 186 -~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
++++|||+. ++|.+++.......+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 589988877554579999999999999999999999999999999999999999999999999874321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
...
T Consensus 159 ~~~----------------------------------------------------------------------------- 161 (287)
T cd07838 159 FEM----------------------------------------------------------------------------- 161 (287)
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-----CCCC---------
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-----LKFP--------- 410 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----~~~p--------- 410 (506)
......++..|+|||++.+..++.++|||||||++|||++|++||.+....+.+..+.... ..++
T Consensus 162 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07838 162 -ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS 240 (287)
T ss_pred -ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhh
Confidence 0011257889999999999899999999999999999999999999888776665554210 0000
Q ss_pred --C---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 --E---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 --~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
. ...++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 241 FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 0 0134677899999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=340.59 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=208.1
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..++|.+.+.||+|+||.||+|++.. ++..+++|.+.... ......+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 34669999999999999999998643 45679999986543 23335577899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED 249 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~ 249 (506)
+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999987542 2358999999999999999999999999999999999999999
Q ss_pred CCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccC
Q 010603 250 GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSL 329 (506)
Q Consensus 250 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (506)
+.+||+|||++........
T Consensus 160 ~~~~l~dfg~a~~~~~~~~------------------------------------------------------------- 178 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY------------------------------------------------------------- 178 (291)
T ss_pred CcEEECCCCcccccCCCce-------------------------------------------------------------
Confidence 9999999999843211000
Q ss_pred CCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCC
Q 010603 330 TNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLK 408 (506)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 408 (506)
........|++.|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+......
T Consensus 179 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd05094 179 --------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 244 (291)
T ss_pred --------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC
Confidence 000112257889999999999999999999999999999998 99999887776666555443322
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 409 ~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.....++..+.+|+.+||+.||.+||+ +.++++
T Consensus 245 -~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~v~~ 277 (291)
T cd05094 245 -ERPRVCPKEVYDIMLGCWQREPQQRLN----IKEIYK 277 (291)
T ss_pred -CCCccCCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 222357889999999999999999998 666654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=345.31 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=214.6
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|+.++.||+|+||.||+|++..++..||||++.+...........+..|+++++.++||||+++++++..+...|+||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 88899999999999999999999999999999765444445556788899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-------
Confidence 96 5777776543 35689999999999999999999999999999999999999999999999998732100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.....|
T Consensus 178 --------------------------------------------------------------------------~~~~~~ 183 (317)
T cd06635 178 --------------------------------------------------------------------------ANSFVG 183 (317)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 011258
Q ss_pred CCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 353 THEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 353 T~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
++.|+|||++. ...++.++|||||||++|||++|+.||........+..+............++..+++||.+||..
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 263 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK 263 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccC
Confidence 88999999984 356889999999999999999999999887766666666554433333346788999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+|.+||+ +.++++|+|+..
T Consensus 264 ~p~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 264 IPQDRPT----SEELLKHMFVLR 282 (317)
T ss_pred CcccCcC----HHHHHhChhhhc
Confidence 9999997 899999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=333.85 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=201.2
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 196 (506)
+.||+|+||.||+|.++.+++.||+|.+.+.. .......+.+|+++|+.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886532 1234456788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCc
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 276 (506)
+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 999998754 24689999999999999999999999999999999999999999999999999743110000
Q ss_pred ccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCC
Q 010603 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356 (506)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 356 (506)
........++..|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~~~~~y 162 (252)
T cd05084 150 -------------------------------------------------------------------ASTGGMKQIPVKW 162 (252)
T ss_pred -------------------------------------------------------------------cccCCCCCCceee
Confidence 0000001234579
Q ss_pred ccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 357 ~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
+|||.+.+..++.++|||||||++|||++ |..||...........+... ...+....++..+.+|+.+||..||++||
T Consensus 163 ~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 241 (252)
T cd05084 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VRLPCPELCPDAVYRLMERCWEYDPGQRP 241 (252)
T ss_pred cCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCcccCCHHHHHHHHHHcCCChhhCc
Confidence 99999999889999999999999999997 99999876665544444332 22333346789999999999999999999
Q ss_pred CCCCChHHhhc
Q 010603 436 GFKRGATEIKQ 446 (506)
Q Consensus 436 s~~~~a~ell~ 446 (506)
+ +.++++
T Consensus 242 s----~~~~~~ 248 (252)
T cd05084 242 S----FSTVHQ 248 (252)
T ss_pred C----HHHHHH
Confidence 8 677654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.01 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=206.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD------ 183 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 183 (506)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+++++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 36799999999999999999999999999999999764321 23345577899999999999999999988643
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
...|++++++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3578999988 8899888764 36899999999999999999999999999999999999999999999999987421
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 171 ~~------------------------------------------------------------------------------ 172 (345)
T cd07877 171 DD------------------------------------------------------------------------------ 172 (345)
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC----------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP---------------- 406 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------- 406 (506)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..++...
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 173 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred --cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 0112368899999999876 468899999999999999999999998766544333222100
Q ss_pred -------CCCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 407 -------LKFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 407 -------~~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
...+. ....++++++||.+||..||.+|++ +.+++.||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~ 305 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQ 305 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhh
Confidence 00110 1135788999999999999999997 899999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.72 Aligned_cols=257 Identities=19% Similarity=0.296 Sum_probs=210.1
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccC-----CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
+.+.+|++++.||+|+||+||+|.+..+ ++.||||+++.... ......+..|+.+++.++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 4456799999999999999999987643 57899999975431 2234567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE 248 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~ 248 (506)
.+..++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 999999999999999999875321 235788899999999999999999999999999999999999
Q ss_pred CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccccc
Q 010603 249 DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTS 328 (506)
Q Consensus 249 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (506)
++.+||+|||+++.......
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY------------------------------------------------------------ 179 (283)
T ss_pred CCceEecccccccccccchh------------------------------------------------------------
Confidence 99999999999853211000
Q ss_pred CCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCC
Q 010603 329 LTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPL 407 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 407 (506)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.....
T Consensus 180 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~ 244 (283)
T cd05091 180 ---------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV 244 (283)
T ss_pred ---------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 000111246789999999998889999999999999999998 8999988877776666665442
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 408 ~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
. +....++..+.+|+.+||+.+|.+||+ +++++.
T Consensus 245 ~-~~~~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 245 L-PCPDDCPAWVYTLMLECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred C-CCCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 2 223468999999999999999999998 677765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=337.32 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=204.7
Q ss_pred eEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe----
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF---- 185 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 185 (506)
|++.+.||+|+||.||+|.+..+ +..||||.+...... ......+.+|+++|+.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999998753 478999998764322 3345678889999999999999999998865543
Q ss_pred --EEEEEeecCCCChHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 186 --SCLLMEFCSGGDLHTLRQRQ----PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 186 --~~lV~E~~~gg~L~~~l~~~----~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
.++||||+++|+|..++... ....+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999887543 224689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
++.........
T Consensus 160 ~~~~~~~~~~~--------------------------------------------------------------------- 170 (273)
T cd05035 160 SKKIYSGDYYR--------------------------------------------------------------------- 170 (273)
T ss_pred eeecccccccc---------------------------------------------------------------------
Confidence 85432110000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....++..
T Consensus 171 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (273)
T cd05035 171 ------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDCLDE 243 (273)
T ss_pred ------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCCHH
Confidence 0001135678999999988889999999999999999999 999998877766665555332 22333468899
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.++|.+||..||.+||+ +.++++
T Consensus 244 ~~~li~~~l~~~p~~Rp~----~~e~~~ 267 (273)
T cd05035 244 LYDLMYSCWRADPKDRPT----FTKLRE 267 (273)
T ss_pred HHHHHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999998 677765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=344.36 Aligned_cols=268 Identities=26% Similarity=0.411 Sum_probs=207.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD------ 183 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 183 (506)
+++|++++.||+|+||.||+|.++.+++.||||++....... .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 678999999999999999999999999999999987643221 1223456799999999999999999987543
Q ss_pred --CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 184 --KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 184 --~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..+|+||||+. ++|...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999995 5777666543 3579999999999999999999999999999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
........... ...
T Consensus 164 ~~~~~~~~~~~------------------------------------------------------------------~~~ 177 (311)
T cd07866 164 PYDGPPPNPKG------------------------------------------------------------------GGG 177 (311)
T ss_pred hccCCCccccc------------------------------------------------------------------CCc
Confidence 42211000000 000
Q ss_pred CCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC--C-------
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL--K------- 408 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~--~------- 408 (506)
......+...|++.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+.. ... .
T Consensus 178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T cd07866 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSL 257 (311)
T ss_pred ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhc
Confidence 001112345789999999998764 578999999999999999999999988776654444321 100 0
Q ss_pred -----------CC-----CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 409 -----------FP-----EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 409 -----------~p-----~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
.+ ....+...+.+||.+||..||.+||+ +.+++.||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 258 PGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred ccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 00 00234567899999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=333.83 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=204.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE-EeCCeE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF-ETDKFS 186 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~ 186 (506)
+.+.+|++.+.||+|+||.||++... |..||+|.+... .....+.+|+.+++.++|+||+++++++ ...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999876 788999998653 2344577899999999999999999975 455689
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999988765556899999999999999999999999999999999999999999999999987431100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
T Consensus 156 -------------------------------------------------------------------------------- 155 (256)
T cd05082 156 -------------------------------------------------------------------------------- 155 (256)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+... ........+++.+.+||.+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHH
Confidence 001134568999999998889999999999999999997 99999877665555554432 2222234688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|++||+ +.++++
T Consensus 235 ~l~~~p~~Rpt----~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPS----FLQLRE 251 (256)
T ss_pred HhcCChhhCcC----HHHHHH
Confidence 99999999998 677764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=349.38 Aligned_cols=273 Identities=27% Similarity=0.356 Sum_probs=211.0
Q ss_pred CCeEE-EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchh-----------HHHHHHHHHHHHHhcCCCCccceeE
Q 010603 111 GHFRL-LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK-----------KLMRAQTEREILSLLDHPFLPTLYS 178 (506)
Q Consensus 111 ~~y~i-~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~ 178 (506)
++|.. .+.||.|+||+||+|.++.+++.||||++......... ....+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34654 57799999999999999999999999998764322110 0124678999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecC
Q 010603 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFD 258 (506)
Q Consensus 179 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG 258 (506)
++...+..|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999995 6999988764 569999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccc
Q 010603 259 LSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVL 338 (506)
Q Consensus 259 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (506)
++...............
T Consensus 165 ~~~~~~~~~~~~~~~~~--------------------------------------------------------------- 181 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKD--------------------------------------------------------------- 181 (335)
T ss_pred ceeeccccccccccccc---------------------------------------------------------------
Confidence 98543211100000000
Q ss_pred ccCCCCCCccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCCC--CCC-
Q 010603 339 IAEPTSARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPLK--FPE- 411 (506)
Q Consensus 339 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~--~p~- 411 (506)
.............+++.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+.. .+.. ++.
T Consensus 182 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (335)
T PTZ00024 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQA 261 (335)
T ss_pred ccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcch
Confidence 0000001112235788999999997654 68999999999999999999999998877665544331 1110 110
Q ss_pred --------------------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 412 --------------------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 412 --------------------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
....+.++.+||.+||..+|++||+ ++|+|.||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~~ 319 (335)
T PTZ00024 262 KKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKSD 319 (335)
T ss_pred hhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCCC
Confidence 1235788999999999999999997 8999999999854
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.69 Aligned_cols=255 Identities=31% Similarity=0.440 Sum_probs=206.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC------
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK------ 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------ 184 (506)
.+|.+.+.||+|+||.||+|.+..+|+.||||++.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 5799999999999999999999999999999998764321 233345678999999999999999999987553
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+||||+. .+|..++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 4699999995 57776542 468999999999999999999999999999999999999999999999999974210
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.
T Consensus 169 ~------------------------------------------------------------------------------- 169 (342)
T cd07879 169 A------------------------------------------------------------------------------- 169 (342)
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC------------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ------------------ 405 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 405 (506)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 0112367889999999876 45889999999999999999999999877654444332210
Q ss_pred -----CCCCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 406 -----PLKFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 406 -----~~~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
....+. ....+.++.+||.+||+.||.+||+ +++++.||||+.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~ 305 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhccc
Confidence 000110 1246788999999999999999997 899999999988653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.36 Aligned_cols=257 Identities=34% Similarity=0.506 Sum_probs=215.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFSCLL 189 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 189 (506)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|+++++.++||||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 488999999999999999999999999999999765432 34567788999999999999999999999988 899999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998876 38999999999999999999999999999999999999999999999999988542111000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (260)
T cd06606 158 ---------------------------------------------------------------------------EGTGS 162 (260)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 00112
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..++..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+............++..+.+||.+||.
T Consensus 163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 242 (260)
T cd06606 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLR 242 (260)
T ss_pred CCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCc
Confidence 3588899999999988899999999999999999999999987662 233333332111122223578999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f 450 (506)
.||.+||+ +.++++||||
T Consensus 243 ~~p~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 243 RDPKKRPT----ADELLQHPFL 260 (260)
T ss_pred CChhhCCC----HHHHhhCCCC
Confidence 99999997 8999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=335.40 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=208.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCc---eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGC---LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.++|++.+.||+|+||.||+|.++.++. .+|+|.++.... ......+..|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4579999999999999999999875443 799999875432 23345678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999987653 46899999999999999999999999999999999999999999999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
... ...
T Consensus 160 ~~~--------------------------------------------------------------------------~~~ 165 (267)
T cd05066 160 PEA--------------------------------------------------------------------------AYT 165 (267)
T ss_pred cce--------------------------------------------------------------------------eee
Confidence 000 000
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|+|||||++|||++ |..||......+....+... ...+....++..+.+|+.+
T Consensus 166 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 244 (267)
T cd05066 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAALHQLMLD 244 (267)
T ss_pred cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHHHHHHHH
Confidence 001134568999999998889999999999999999886 99999877766655555433 3445545688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||+.+|.+||+ +.++++
T Consensus 245 ~l~~~p~~Rp~----~~~i~~ 261 (267)
T cd05066 245 CWQKDRNERPK----FEQIVS 261 (267)
T ss_pred HcccCchhCCC----HHHHHH
Confidence 99999999998 566654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=341.61 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=208.9
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCC----------------ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMG----------------CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn 172 (506)
..++|++++.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+++|+.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 4567999999999999999999887543 5689999886532 234566788999999999999
Q ss_pred ccceeEEEEeCCeEEEEEeecCCCChHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQP---------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 173 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
|+++++++..++..++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987642 1268999999999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
||++.++.++|+|||+++.......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------------- 185 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY------------------------------------------------------- 185 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-------------------------------------------------------
Confidence 9999999999999999853211000
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc--CCCCCCCCCcHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL--GRTPFKGNGNRETLFN 401 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt--G~~Pf~~~~~~~~~~~ 401 (506)
........+++.|||||++.+..++.++|||||||++|||++ |..||...+..+.+..
T Consensus 186 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~ 245 (296)
T cd05051 186 --------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIEN 245 (296)
T ss_pred --------------------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHH
Confidence 000112256789999999998889999999999999999998 7889987766665554
Q ss_pred HhCC------CCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 402 VVGQ------PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 402 i~~~------~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+... ....+....++.++.+||.+||+.||.+||+ +.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 246 AGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred HHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHHH
Confidence 4321 2222333457789999999999999999998 778764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=343.63 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=206.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEcc-------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD-------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYS 178 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~ 178 (506)
++..++|.+.+.||+|+||.||+|++.. +...||+|++.+.. .......+..|+++++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445679999999999999999998753 23579999997642 123445677899999999 7999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcE
Q 010603 179 HFETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244 (506)
Q Consensus 179 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 244 (506)
++...+..|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999987642 13578899999999999999999999999999999999
Q ss_pred EEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 245 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
|++.++.+||+|||++.........
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~------------------------------------------------------- 196 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY------------------------------------------------------- 196 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh-------------------------------------------------------
Confidence 9999999999999998532100000
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHh
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV 403 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 403 (506)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+.
T Consensus 197 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 197 --------------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred --------------------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 00001134568999999999889999999999999999998 899997766554444443
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 404 ~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
. ....+....++.++.+||.+||..+|.+||+ +.++++
T Consensus 257 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~ 294 (307)
T cd05098 257 E-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 294 (307)
T ss_pred c-CCCCCCCCcCCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 3 3233333468899999999999999999998 667665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=350.00 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=205.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-------
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD------- 183 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------- 183 (506)
++|++.+.||.|+||.||+|.++.+|+.||+|++..... .....+.+|+++|+.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 579999999999999999999999999999999865432 3445677899999999999999999877654
Q ss_pred -------CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEe
Q 010603 184 -------KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLS 255 (506)
Q Consensus 184 -------~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~ 255 (506)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35899999995 689887754 46899999999999999999999999999999999999985 5578999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||++........
T Consensus 158 dfg~~~~~~~~~~------------------------------------------------------------------- 170 (342)
T cd07854 158 DFGLARIVDPHYS------------------------------------------------------------------- 170 (342)
T ss_pred CcccceecCCccc-------------------------------------------------------------------
Confidence 9999843210000
Q ss_pred cccccCCCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC--------
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-------- 406 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 406 (506)
.........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..++...
T Consensus 171 -------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07854 171 -------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243 (342)
T ss_pred -------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 0000011257889999998765 457899999999999999999999998776555444333210
Q ss_pred -----------------CCCC---CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 -----------------LKFP---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 -----------------~~~p---~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...+ ....++.++++||.+||..||.+||+ +.+++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~ 306 (342)
T cd07854 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCccccc
Confidence 0000 01247788999999999999999997 9999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=382.19 Aligned_cols=272 Identities=26% Similarity=0.395 Sum_probs=208.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
+.+|+.++.||+||||.||+|+.+-+|+.||||.|.... ......++.+|+.+|.+|+|||||+++..|....
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 456899999999999999999999999999999998654 4566778899999999999999999997652110
Q ss_pred --------------------------------------------------------------------------------
Q 010603 185 -------------------------------------------------------------------------------- 184 (506)
Q Consensus 185 -------------------------------------------------------------------------------- 184 (506)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------------------eEEEEEeecCCCChHHHHhhCCCCCC-CHHHHHHHHHHHHHHHHHH
Q 010603 185 ----------------------------------FSCLLMEFCSGGDLHTLRQRQPGKHF-SEQATRFYASEVLLALEYL 229 (506)
Q Consensus 185 ----------------------------------~~~lV~E~~~gg~L~~~l~~~~~~~~-~e~~~~~i~~qil~aL~yL 229 (506)
.+||-||||+...|++++.++ ... ....++.+|+||+.||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHHHHHH
Confidence 068999999998888888775 222 4788999999999999999
Q ss_pred HhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCC
Q 010603 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSC 309 (506)
Q Consensus 230 H~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (506)
|+.|||||||||.||+|+.++.|||+|||+|...............
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~---------------------------------- 759 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLS---------------------------------- 759 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccC----------------------------------
Confidence 9999999999999999999999999999999542210000000000
Q ss_pred CCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCC---CCcchhHHHHHHHHHHHhcC
Q 010603 310 FKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG---HGSAVDWWTFGIFFYELLLG 386 (506)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSlGvil~elltG 386 (506)
.. ...........++.+||..|+|||++.+.. |+.|+|+||||||||||+
T Consensus 760 ------------------~~-------~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~-- 812 (1351)
T KOG1035|consen 760 ------------------FS-------TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML-- 812 (1351)
T ss_pred ------------------cc-------ccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh--
Confidence 00 000111222456779999999999998765 999999999999999999
Q ss_pred CCCCCCCCcHHHHH-HHhCCCCCCCCC--CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 387 RTPFKGNGNRETLF-NVVGQPLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 387 ~~Pf~~~~~~~~~~-~i~~~~~~~p~~--~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
.||...-+..... ++....++.+.. ..--+....+|+.||++||.+||| |.|+|++.||-
T Consensus 813 -yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 813 -YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred -ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 6786554443333 333333333311 122234678999999999999997 99999999996
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=341.14 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=205.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCc--eEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGC--LFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 187 (506)
++|++.+.||+|+||+||+|.++.++. .+++|.++... .......+.+|+++++++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 569999999999999999999987765 46888876421 223445678899999999 7999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEE
Q 010603 188 LLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 253 (506)
+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999987532 13588999999999999999999999999999999999999999999
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||++......
T Consensus 160 l~dfg~~~~~~~~------------------------------------------------------------------- 172 (297)
T cd05089 160 IADFGLSRGEEVY------------------------------------------------------------------- 172 (297)
T ss_pred ECCcCCCccccce-------------------------------------------------------------------
Confidence 9999987321000
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCC
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEG 412 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 412 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+... ...+..
T Consensus 173 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 240 (297)
T cd05089 173 -----------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKP 240 (297)
T ss_pred -----------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC
Confidence 00000123457999999999899999999999999999997 99999888777666665543 233333
Q ss_pred CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 413 SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 413 ~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
..++..+.+||.+||..+|.+||+ ++++++.
T Consensus 241 ~~~~~~~~~li~~~l~~~p~~Rp~----~~~i~~~ 271 (297)
T cd05089 241 RNCDDEVYELMRQCWRDRPYERPP----FAQISVQ 271 (297)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 468899999999999999999998 6677553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=338.29 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=207.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
..+|++.++||+|+||.||+|... .++..+|+|.+.... ......+.+|+++++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 456899999999999999999753 346789999887543 334456788999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPG-------------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~-------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
..|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999999876431 35889999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCC
Q 010603 252 IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331 (506)
Q Consensus 252 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (506)
+||+|||+++........
T Consensus 161 ~kL~dfg~~~~~~~~~~~-------------------------------------------------------------- 178 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYY-------------------------------------------------------------- 178 (280)
T ss_pred EEECCCCceeEcCCCcee--------------------------------------------------------------
Confidence 999999998532110000
Q ss_pred CCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCC
Q 010603 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFP 410 (506)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 410 (506)
.......+++.|+|||++.+..++.++|||||||++|||++ |.+||......+.+..+.... ...
T Consensus 179 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 244 (280)
T cd05092 179 -------------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELE 244 (280)
T ss_pred -------------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCC
Confidence 00011246788999999999999999999999999999998 999998777766665555432 222
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
....+++.+.+||.+||..||.+||+ +.++++
T Consensus 245 ~~~~~~~~~~~li~~cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 245 RPRTCPPEVYAIMQGCWQREPQQRMV----IKDIHS 276 (280)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 33468899999999999999999998 667654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.17 Aligned_cols=259 Identities=20% Similarity=0.289 Sum_probs=210.1
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-------cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCcccee
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-------DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLY 177 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 177 (506)
.++...+|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3466678999999999999999999853 234579999987542 123456678899999999 899999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
+++......|+||||+.+|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999987642 2357888899999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
||++.++.+||+|||+++.+......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~------------------------------------------------------ 193 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY------------------------------------------------------ 193 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc------------------------------------------------------
Confidence 99999999999999998543110000
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
.......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+
T Consensus 194 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 252 (304)
T cd05101 194 ---------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252 (304)
T ss_pred ---------------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 00011246678999999999889999999999999999998 88999887766665555
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.... .......++..+++||.+||..+|.+||+ +.++++
T Consensus 253 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~l~ 291 (304)
T cd05101 253 KEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPT----FKQLVE 291 (304)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHH
Confidence 4332 23333468899999999999999999998 677765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.78 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=206.8
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+++++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 3456799999999999999999988764 469999887543 22345678999999999999999999885 45689
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.+|+|.+++.......+++..+..++.||+.||.|||+.||+||||||+|||+++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999987655668999999999999999999999999999999999999999999999999985421100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. ...
T Consensus 157 ~----------------------------------------------------------------------------~~~ 160 (260)
T cd05069 157 Y----------------------------------------------------------------------------TAR 160 (260)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 000
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+... ...+....++..+.+||.+|
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMKLC 239 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHH
Confidence 01136678999999998889999999999999999999 99999987777666665543 23333346889999999999
Q ss_pred hhcCCCCccCCCCChHHhhc
Q 010603 427 LVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~ 446 (506)
|..||.+||+ ++++++
T Consensus 240 l~~~p~~Rp~----~~~i~~ 255 (260)
T cd05069 240 WKKDPDERPT----FEYIQS 255 (260)
T ss_pred ccCCcccCcC----HHHHHH
Confidence 9999999998 677764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.68 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=205.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCc----eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGC----LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+...+|++++.||+|+||+||+|.+..+++ .||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 445679999999999999999999877776 489999875422 23345677899999999999999999998754
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..+++|||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++..
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 578999999999999988754 256899999999999999999999999999999999999999999999999998543
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (279)
T cd05109 160 DIDETE-------------------------------------------------------------------------- 165 (279)
T ss_pred ccccce--------------------------------------------------------------------------
Confidence 110000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||...........+. .....+....++.++.++
T Consensus 166 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 243 (279)
T cd05109 166 -YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDVYMI 243 (279)
T ss_pred -eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCHHHHHH
Confidence 00001135678999999999899999999999999999998 999998766554443333 333334445688999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
|.+||..||++||+ +.+++.
T Consensus 244 i~~~l~~dp~~Rp~----~~~l~~ 263 (279)
T cd05109 244 MVKCWMIDSECRPR----FRELVD 263 (279)
T ss_pred HHHHcCCChhhCcC----HHHHHH
Confidence 99999999999998 677774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=327.70 Aligned_cols=252 Identities=32% Similarity=0.532 Sum_probs=215.1
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||+|++|.||++.+..+++.|++|++..... .....+.+|+++++.++|+||+++++++......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48999999999999999999998999999999976542 345677889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999887653 578999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
......
T Consensus 153 --------------------------------------------------------------------------~~~~~~ 158 (253)
T cd05122 153 --------------------------------------------------------------------------ARNTMV 158 (253)
T ss_pred --------------------------------------------------------------------------ccccee
Confidence 011236
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG-QPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......... ....++....++..+.+||.+||..|
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCC
Confidence 88899999999988899999999999999999999999987755555444432 22333333345899999999999999
Q ss_pred CCCccCCCCChHHhhcCCC
Q 010603 431 PQKRLGFKRGATEIKQHPF 449 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~ 449 (506)
|.+||+ +.++++|||
T Consensus 239 p~~R~t----~~~~l~~~~ 253 (253)
T cd05122 239 PEKRPT----AEQLLKHPF 253 (253)
T ss_pred hhhCCC----HHHHhcCCC
Confidence 999997 899999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=346.28 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=201.5
Q ss_pred CceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCChHHHH
Q 010603 123 DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLR 202 (506)
Q Consensus 123 ~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 202 (506)
++|.||+++.+.+++.||||++..... .......+.+|+++++.++||||+++++++...+..|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 456667777777899999999987532 2345677899999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCc
Q 010603 203 QRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISS 282 (506)
Q Consensus 203 ~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 282 (506)
.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+...........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~----------- 159 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR----------- 159 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc-----------
Confidence 876556799999999999999999999999999999999999999999999999998854321110000
Q ss_pred ccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhh
Q 010603 283 YCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEII 362 (506)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 362 (506)
..........++..|+|||++
T Consensus 160 -----------------------------------------------------------~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 160 -----------------------------------------------------------VVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred -----------------------------------------------------------ccccccccccccccccCHHHh
Confidence 000001123578899999999
Q ss_pred cCC--CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC--------------------------------
Q 010603 363 RGD--GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK-------------------------------- 408 (506)
Q Consensus 363 ~~~--~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------------------- 408 (506)
.+. .|+.++|||||||++|||++|+.||........+.........
T Consensus 181 ~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (314)
T cd08216 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVD 260 (314)
T ss_pred cCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhh
Confidence 763 5889999999999999999999999876554433222211100
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 409 ~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+....++.++.+||.+||..||++||+ ++++|+||||+.+
T Consensus 261 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~ 301 (314)
T cd08216 261 HPYTRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQC 301 (314)
T ss_pred cchhhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhh
Confidence 0001123567899999999999999997 9999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=332.01 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=209.7
Q ss_pred eEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeec
Q 010603 117 KKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 193 (506)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+++++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8899999998754322 4567888999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 194 SGGDLHTLRQRQP-------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 194 ~gg~L~~~l~~~~-------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999987642 367999999999999999999999999999999999999999999999999998542111
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ...
T Consensus 159 ~~---------------------------------------------------------------------------~~~ 163 (262)
T cd00192 159 DY---------------------------------------------------------------------------YRK 163 (262)
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 000
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....+++.|+|||++....++.++|||||||++|||++ |..||......+....+... ...+....++.++.++|.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 242 (262)
T cd00192 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPDELYELMLS 242 (262)
T ss_pred ccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCccCChHHHHHHHH
Confidence 112357889999999998889999999999999999999 69999988776666666542 2333334679999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~h 447 (506)
||..||.+||+ +.|+++|
T Consensus 243 ~l~~~p~~Rps----~~~l~~~ 260 (262)
T cd00192 243 CWQLDPEDRPT----FSELVER 260 (262)
T ss_pred HccCCcccCcC----HHHHHHh
Confidence 99999999998 8888874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.58 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=212.2
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|++.+.||.|+||.||+|.+.. ++.||||.+..... ....+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 4567789999999999999999999764 57899999886432 234577899999999999999999999998999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
++||||+++++|.+++....+..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999998766667999999999999999999999999999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 157 ~~----------------------------------------------------------------------------~~ 160 (261)
T cd05034 157 EY----------------------------------------------------------------------------TA 160 (261)
T ss_pred hh----------------------------------------------------------------------------hh
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.+....+..+... ...+.....+.++.+++.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 001124568999999998889999999999999999998 99999887776666666543 3334344678999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|.+||+ ++++++
T Consensus 240 ~l~~~p~~Rp~----~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPT----FEYLQS 256 (261)
T ss_pred HcccCcccCCC----HHHHHH
Confidence 99999999998 667664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=356.56 Aligned_cols=260 Identities=21% Similarity=0.286 Sum_probs=210.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~ 179 (506)
+++..++|.+.++||+|+||.||+|+++ .+++.||||+++.... ......+.+|+++|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4455667999999999999999999964 3456899999976432 223446788999999997 9999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCC----------------------------------------------------
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPG---------------------------------------------------- 207 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------------------------------------- 207 (506)
+...+.+|+|||||.+|+|.+++.....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999865321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 208 --------------------------------------------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 208 --------------------------------------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
..+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 235777888999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
||++.++.+||+|||+++........
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~------------------------------------------------------ 295 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY------------------------------------------------------ 295 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc------------------------------------------------------
Confidence 99999999999999998532110000
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
.......|++.|||||++.+..++.++|||||||+||||++ |..||......+.+...
T Consensus 296 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~ 354 (401)
T cd05107 296 ---------------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA 354 (401)
T ss_pred ---------------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence 00011257889999999998889999999999999999998 89999877666666555
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+......+....++.++.+||.+||..+|.+||+ +.++++
T Consensus 355 ~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~ 394 (401)
T cd05107 355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVH 394 (401)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 5444344444468899999999999999999998 667765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=339.64 Aligned_cols=259 Identities=30% Similarity=0.461 Sum_probs=219.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
..|++.+.||+|+||.||+|.+..++..||+|++..... ....+..|+++++.++|+||+++++.+...+..|+||
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 458999999999999999999998899999999976432 4556778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--- 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--- 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch---
Confidence 9999999999988753 479999999999999999999999999999999999999999999999999873211000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 171 --------------------------------------------------------------------------~~~~~~ 176 (286)
T cd06614 171 --------------------------------------------------------------------------SKRNSV 176 (286)
T ss_pred --------------------------------------------------------------------------hhhccc
Confidence 001123
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+.... ..++....++..+.+||.+||+.
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVK 256 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhcc
Confidence 57889999999998889999999999999999999999998776665555544332 22333334889999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
+|.+||+ +.+++.|+||....|
T Consensus 257 ~p~~Rpt----~~~il~~~~~~~~~~ 278 (286)
T cd06614 257 DPEKRPS----AEELLQHPFLKKACP 278 (286)
T ss_pred ChhhCcC----HHHHhhChHhhccCc
Confidence 9999997 899999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.65 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=215.9
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+|++.+.||.|+||.||++.++.+++.||+|.+.+.... ......+.+|+++++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 489999999999999999999999999999999765433 2344566789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 192 FCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 192 ~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|+++++|..++... ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999987662 2356899999999999999999999999999999999999999999999999998432100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
....
T Consensus 157 ----------------------------------------------------------------------------~~~~ 160 (256)
T cd08530 157 ----------------------------------------------------------------------------MAKT 160 (256)
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0011
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
..|++.|+|||.+.+..++.++|+||||+++|||++|+.||...+..+....+...... +....++.+++++|.+||..
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCC
Confidence 25788999999999988999999999999999999999999888766655555443322 12236889999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f 450 (506)
+|++||+ +.++++||++
T Consensus 240 ~p~~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 240 KPKLRPN----CDKILASPAV 256 (256)
T ss_pred CcccCCC----HHHHhcCCCC
Confidence 9999998 8999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=349.18 Aligned_cols=260 Identities=27% Similarity=0.379 Sum_probs=213.4
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----eE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK-----FS 186 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 186 (506)
+|++.+.||.|+||.||+|++..+++.||||++.+... .......+.+|+++++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 59999999999999999999999999999999876432 1334456788999999999999999999998775 89
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999996 6898888764 48999999999999999999999999999999999999999999999999998542111
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
... ...
T Consensus 157 ~~~--------------------------------------------------------------------------~~~ 162 (330)
T cd07834 157 EDE--------------------------------------------------------------------------KGF 162 (330)
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred ccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC---------------
Q 010603 347 SMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--------------- 410 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--------------- 410 (506)
.....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.......+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 242 (330)
T cd07834 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNY 242 (330)
T ss_pred ccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhH
Confidence 1223689999999999988 789999999999999999999999988776655544332100000
Q ss_pred --------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 411 --------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 411 --------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
....++.++.+||.+||+.+|.+||+ ++++++||||+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~ 295 (330)
T cd07834 243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQL 295 (330)
T ss_pred HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHhh
Confidence 01236788999999999999999997 8999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.77 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=209.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCc---eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGC---LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
+...+|+..+.||+|+||.||+|.+..+++ .+|+|.+..... ......+..|+++++.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345679999999999999999999986654 799999875422 233456778999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999999987642 578999999999999999999999999999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
......
T Consensus 159 ~~~~~~-------------------------------------------------------------------------- 164 (268)
T cd05063 159 DDPEGT-------------------------------------------------------------------------- 164 (268)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 100000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
........++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.. ....|....++.++.+|+
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li 243 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLM 243 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHH
Confidence 00001123567999999998889999999999999999997 9999987776666655553 334455556889999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..+|.+||+ +.++++
T Consensus 244 ~~c~~~~p~~Rp~----~~~i~~ 262 (268)
T cd05063 244 LQCWQQDRARRPR----FVDIVN 262 (268)
T ss_pred HHHcCCCcccCcC----HHHHHH
Confidence 9999999999998 566654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=349.39 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=210.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF---- 185 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 185 (506)
-++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 35699999999999999999999999999999998754222 2344566789999999999999999998876654
Q ss_pred --EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 186 --SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 186 --~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899998875 46999999999999999999999999999999999999999999999999998431
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07851 169 DD------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC--------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK-------------- 408 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 408 (506)
......++..|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+......
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred --cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 01123588899999998764 5789999999999999999999999877665555443321100
Q ss_pred ------CC---------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 409 ------FP---------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 409 ------~p---------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+ ....++.++.+||.+||..||.+||+ +.+|++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~~ 304 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAEY 304 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCcccc
Confidence 00 01236889999999999999999997 8999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.68 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=207.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+++++.++|+||+++++.+.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 4566789999999999999999998664 5679999887542 234567789999999999999999999987 778
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998766667899999999999999999999999999999999999999999999999988432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 156 ~~----------------------------------------------------------------------------~~ 159 (260)
T cd05073 156 EY----------------------------------------------------------------------------TA 159 (260)
T ss_pred Cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++....++.++|+|||||++|+|++ |..||.+.+..+....+... ...+.....+.++.+++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNIMMR 238 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCCCcccCCHHHHHHHHH
Confidence 001135678999999998889999999999999999998 99999887766555554433 3334445788999999999
Q ss_pred HhhcCCCCccCCCCChHHhh
Q 010603 426 LLVKDPQKRLGFKRGATEIK 445 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell 445 (506)
||..+|++||+ +.+++
T Consensus 239 ~l~~~p~~Rp~----~~~l~ 254 (260)
T cd05073 239 CWKNRPEERPT----FEYIQ 254 (260)
T ss_pred HcccCcccCcC----HHHHH
Confidence 99999999998 55554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=342.56 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=213.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
..|...+.||+|+||.||+|+++.+++.||||.+............++.+|+++++.++|+||+++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34888899999999999999999999999999987543333445566778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+. |+|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 9995 6887766543 25689999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....
T Consensus 168 ----------------------------------------------------------------------------~~~~ 171 (308)
T cd06634 168 ----------------------------------------------------------------------------ANXF 171 (308)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0123
Q ss_pred ccCCCCccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 351 VGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 351 ~GT~~Y~APE~l~~---~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+............++..+.+||.+||
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 251 (308)
T cd06634 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (308)
T ss_pred cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHh
Confidence 58889999999853 457889999999999999999999998776666555555443333233468889999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..+|.+||+ ++++++|||+...
T Consensus 252 ~~~P~~Rp~----~~~ll~~~~~~~~ 273 (308)
T cd06634 252 QKIPQDRPT----SEVLLKHRFVLRE 273 (308)
T ss_pred hCCcccCCC----HHHHhhCcccccc
Confidence 999999997 8999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=329.76 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=208.8
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++.+.||.|+||.||+|... |+.||||.+..... ...++.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 44567999999999999999999876 78999999976532 4566788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999998765557999999999999999999999999999999999999999999999999998532000
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.
T Consensus 156 -------------------------------------------------------------------------------~ 156 (256)
T cd05039 156 -------------------------------------------------------------------------------Q 156 (256)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....++..|+|||++....++.++|||||||++|||++ |+.||......+....+... ........+++.+.+||.+|
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCccCCCHHHHHHHHHH
Confidence 00124567999999998889999999999999999997 99999877665554444332 22223346789999999999
Q ss_pred hhcCCCCccCCCCChHHhhc
Q 010603 427 LVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~ 446 (506)
|..+|++||+ +.++++
T Consensus 236 l~~~p~~Rp~----~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPT----FKQLRE 251 (256)
T ss_pred hccChhhCcC----HHHHHH
Confidence 9999999998 777765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.36 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=213.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
..+|++++.||.|+||.||+|+.+. +.+.||+|.+.... .......+.+|+++|+.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3579999999999999999999764 34679999886532 1224566888999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeec
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPG-------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~-------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 257 (506)
..|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999876531 16899999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|++........
T Consensus 162 ~~~~~~~~~~~--------------------------------------------------------------------- 172 (275)
T cd05046 162 SLSKDVYNSEY--------------------------------------------------------------------- 172 (275)
T ss_pred ccccccCcccc---------------------------------------------------------------------
Confidence 98743110000
Q ss_pred cccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s 416 (506)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+......++....++
T Consensus 173 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (275)
T cd05046 173 -------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP 245 (275)
T ss_pred -------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCC
Confidence 00111246778999999998888999999999999999998 8999987777666666666665565556789
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
..+.++|.+||..||.+||+ +.+++.+
T Consensus 246 ~~l~~~i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 246 SRLYKLMTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred HHHHHHHHHHcCCCcccCCC----HHHHHHH
Confidence 99999999999999999997 8888763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.82 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=202.4
Q ss_pred eEEEeEEeecCceEEEEEEEccCCc--eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC------C
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGC--LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD------K 184 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 184 (506)
|.+.+.||+|+||.||+|++..++. .||+|.++.... .......+..|+++++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999987765 699999876432 234456778899999999999999999976432 3
Q ss_pred eEEEEEeecCCCChHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQ----PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~----~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
..++||||+.+|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999876432 2245899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+........
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------- 168 (272)
T cd05075 160 KKIYNGDYY----------------------------------------------------------------------- 168 (272)
T ss_pred cccCcccce-----------------------------------------------------------------------
Confidence 542110000
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
.......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... ..+....++..+
T Consensus 169 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 243 (272)
T cd05075 169 ----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDCLDGL 243 (272)
T ss_pred ----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHH
Confidence 00011246678999999999999999999999999999999 899998877666655555433 223334688999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.++|.+||+.||++||+ +.++++
T Consensus 244 ~~li~~~l~~~p~~Rps----~~~l~~ 266 (272)
T cd05075 244 YSLMSSCWLLNPKDRPS----FETLRC 266 (272)
T ss_pred HHHHHHHcCCCcccCcC----HHHHHH
Confidence 99999999999999998 777765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=360.12 Aligned_cols=245 Identities=33% Similarity=0.472 Sum_probs=205.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh-cCCCCccceeEEEEeCCeEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~~~~~~ 187 (506)
....|.+...+|.|+|+.|-.+.+..+++.+++|++.+.. ....+|+.++.. -+||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3566999999999999999999999999999999998752 122457766554 48999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE-ecCCCEEEeecCCccccccC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV-REDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl-~~~~~vkl~DFGla~~~~~~ 266 (506)
+|||++.|+.|.+-+... +.....+..|++||+.||+|||++|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999988766654 23337888899999999999999999999999999999 68999999999998542100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
T Consensus 470 -------------------------------------------------------------------------------- 469 (612)
T KOG0603|consen 470 -------------------------------------------------------------------------------- 469 (612)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
..+.+-|..|.|||++...+|+.++||||||++||+||+|+.||........+...++. .++. ..+|+++++||.+|
T Consensus 470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~-~~~s--~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM-PKFS--ECVSDEAKDLLQQL 546 (612)
T ss_pred hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC-Cccc--cccCHHHHHHHHHh
Confidence 11225688999999999999999999999999999999999999887766344333322 2222 47999999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
|+.||.+|++ +.+++.||||
T Consensus 547 L~~dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLG----ADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcC----hhhhccCcch
Confidence 9999999998 8999999999
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=334.38 Aligned_cols=251 Identities=30% Similarity=0.464 Sum_probs=202.4
Q ss_pred EEEeEEeecCceEEEEEEEc----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELR----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
++.+.||.|+||.||+|.+. ..+..|+||+++.. ........+.+|+++++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999998 44678999999542 2233467788899999999999999999999988889999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||++|+|.+++.......+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999875578999999999999999999999999999999999999999999999999998542100000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 160 ---------------------------------------------------------------------------~~~~~ 164 (259)
T PF07714_consen 160 ---------------------------------------------------------------------------KNDSS 164 (259)
T ss_dssp ---------------------------------------------------------------------------EESTT
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..+...|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+... ...+....++..+.++|.+||.
T Consensus 165 ~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~C~~ 243 (259)
T PF07714_consen 165 QQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLPIPDNCPKDIYSLIQQCWS 243 (259)
T ss_dssp SESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETTSBTTSBHHHHHHHHHHT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccceeccchhHHHHHHHHHHcC
Confidence 246678999999999889999999999999999999 78999888777766666433 3344445789999999999999
Q ss_pred cCCCCccCCCCChHHhhc
Q 010603 429 KDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~ 446 (506)
.||++||+ +.++++
T Consensus 244 ~~p~~RPs----~~~i~~ 257 (259)
T PF07714_consen 244 HDPEKRPS----FQEILQ 257 (259)
T ss_dssp SSGGGS------HHHHHH
T ss_pred CChhhCcC----HHHHHh
Confidence 99999998 677764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.78 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=206.3
Q ss_pred eEEeecCceEEEEEEEcc-CCc--eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeec
Q 010603 117 KKLGCGDIGSVYLAELRD-MGC--LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 193 (506)
+.||+|+||.||+|.+.. .++ .||||.+...... ...+.+.+|+.+++.++||||+++++.+.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 456678899999999999999999999988 8999999999
Q ss_pred CCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCC
Q 010603 194 SGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273 (506)
Q Consensus 194 ~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 273 (506)
++++|.+++.......+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 99999999887643578999999999999999999999999999999999999999999999999985431100000
Q ss_pred CCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccC
Q 010603 274 DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGT 353 (506)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 353 (506)
.......++
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (257)
T cd05040 155 -----------------------------------------------------------------------VMEEHLKVP 163 (257)
T ss_pred -----------------------------------------------------------------------ecccCCCCC
Confidence 000012577
Q ss_pred CCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 010603 354 HEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQ 432 (506)
Q Consensus 354 ~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~ 432 (506)
..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+......++....++..+.+|+.+||..+|+
T Consensus 164 ~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 243 (257)
T cd05040 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPA 243 (257)
T ss_pred ceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcc
Confidence 89999999999899999999999999999998 99999887777666665544334444446789999999999999999
Q ss_pred CccCCCCChHHhhc
Q 010603 433 KRLGFKRGATEIKQ 446 (506)
Q Consensus 433 ~R~s~~~~a~ell~ 446 (506)
+||+ +.++++
T Consensus 244 ~Rps----~~~~~~ 253 (257)
T cd05040 244 DRPT----FAALRE 253 (257)
T ss_pred cCCC----HHHHHH
Confidence 9998 677764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.04 Aligned_cols=242 Identities=23% Similarity=0.317 Sum_probs=196.6
Q ss_pred EEeecCceEEEEEEE--ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 118 KLGCGDIGSVYLAEL--RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
.||+|+||.||+|.+ ..+++.||+|+++.... .......+..|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 45678999999875432 2334567788999999999999999999886 4567999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~----- 152 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY----- 152 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-----
Confidence 9999998765 579999999999999999999999999999999999999999999999999985421100000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+++.
T Consensus 153 ---------------------------------------------------------------------~~~~~~~~~~~ 163 (257)
T cd05116 153 ---------------------------------------------------------------------KAKTHGKWPVK 163 (257)
T ss_pred ---------------------------------------------------------------------eecCCCCCCcc
Confidence 00011135679
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
|+|||++....++.++|||||||++|||++ |..||......+....+.... ..+....++.++.+||.+||+.||++|
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~~~~~p~~R 242 (257)
T cd05116 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RMECPQRCPPEMYDLMKLCWTYGVDER 242 (257)
T ss_pred ccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHhccCchhC
Confidence 999999988889999999999999999997 999998877666655554332 223334689999999999999999999
Q ss_pred cCCC
Q 010603 435 LGFK 438 (506)
Q Consensus 435 ~s~~ 438 (506)
|++.
T Consensus 243 p~~~ 246 (257)
T cd05116 243 PGFA 246 (257)
T ss_pred cCHH
Confidence 9853
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.15 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=205.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
+|++.+.||+|+||.||+|.... ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 48899999999999999998753 235799998875432 23346678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcE
Q 010603 187 CLLMEFCSGGDLHTLRQRQP----------------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~----------------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 244 (506)
|+||||+.+|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999876421 23578999999999999999999999999999999999
Q ss_pred EEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 245 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
|+++++.+||+|||+++.........
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~------------------------------------------------------ 184 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV------------------------------------------------------ 184 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh------------------------------------------------------
Confidence 99999999999999985321110000
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHh
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV 403 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 403 (506)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+... .+
T Consensus 185 ---------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~ 242 (290)
T cd05045 185 ---------------------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN-LL 242 (290)
T ss_pred ---------------------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HH
Confidence 0011235678999999998889999999999999999998 999998776555443 44
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 404 ~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
......+....++.++.+||.+||+.||.+||+ +.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 243 KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCC----HHHHHH
Confidence 344444444578899999999999999999998 666654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=340.52 Aligned_cols=261 Identities=29% Similarity=0.401 Sum_probs=208.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC--
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK-- 184 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-- 184 (506)
+...++|++.+.||+|+||.||+|.++.+|+.||||+++..... ......+.+|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 44567899999999999999999999999999999999764321 223345667999999999999999999987655
Q ss_pred --------eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEee
Q 010603 185 --------FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSD 256 (506)
Q Consensus 185 --------~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~D 256 (506)
.+|+||||+++ +|..++... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999965 777766654 35789999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCc
Q 010603 257 FDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336 (506)
Q Consensus 257 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (506)
||++........
T Consensus 160 fg~~~~~~~~~~-------------------------------------------------------------------- 171 (302)
T cd07864 160 FGLARLYNSEES-------------------------------------------------------------------- 171 (302)
T ss_pred ccccccccCCcc--------------------------------------------------------------------
Confidence 999853211000
Q ss_pred ccccCCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCCCC--CC
Q 010603 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQPLK--FP 410 (506)
Q Consensus 337 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~--~p 410 (506)
.......++..|+|||++.+. .++.++|||||||++|||++|++||......+.+..+. ..+.. +|
T Consensus 172 --------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 172 --------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred --------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 000112467789999998754 57899999999999999999999998776655443332 11110 00
Q ss_pred -----------------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 411 -----------------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 411 -----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
....++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 11246889999999999999999998 8999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.05 Aligned_cols=255 Identities=30% Similarity=0.473 Sum_probs=207.7
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeEEEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFSCLLM 190 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 190 (506)
|++++.||.|+||.||+|.+..+++.||+|++.... ........+.+|+++++.++||||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998754 2233445577899999999999999999999988 8999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||++ ++|..++.... ..+++..++.++.||+.||+|||+.|++|+||||+|||+++++.+||+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9996 58988876542 5799999999999999999999999999999999999999999999999999853211000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (287)
T cd07840 156 --------------------------------------------------------------------------ADYTNR 161 (287)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001112
Q ss_pred ccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C--CCCCCC------------
Q 010603 351 VGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P--LKFPEG------------ 412 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~--~~~p~~------------ 412 (506)
.++..|+|||.+.+. .++.++|||||||++|||++|+.||...+....+..+... + ..++..
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07840 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPK 241 (287)
T ss_pred ccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcccc
Confidence 577899999987754 5789999999999999999999999887765554443321 0 001100
Q ss_pred -----------CC-CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 413 -----------SS-ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 413 -----------~~-~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
.. ++.++.++|.+||..||.+||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 242 KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 01 3788999999999999999998 8999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=340.09 Aligned_cols=253 Identities=29% Similarity=0.464 Sum_probs=211.0
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeec
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 193 (506)
....+||+|+||.||++..+.+++.||||.+.... ......+.+|+.+++.++|+||+++++.+...++.|+||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33468999999999999999999999999986432 234456788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCC
Q 010603 194 SGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273 (506)
Q Consensus 194 ~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 273 (506)
++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------ 170 (292)
T cd06657 100 EGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------ 170 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc------
Confidence 99999998754 468999999999999999999999999999999999999999999999999874321000
Q ss_pred CCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccC
Q 010603 274 DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGT 353 (506)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 353 (506)
.......|+
T Consensus 171 -----------------------------------------------------------------------~~~~~~~~~ 179 (292)
T cd06657 171 -----------------------------------------------------------------------PRRKSLVGT 179 (292)
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 001123688
Q ss_pred CCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 010603 354 HEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLLVKDPQ 432 (506)
Q Consensus 354 ~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L~~dP~ 432 (506)
+.|+|||++.+..++.++|+|||||++|+|++|..||.+....+.+..+... +..+.....++..+.++|.+||..||.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 9999999998888999999999999999999999999877665554443322 222333346789999999999999999
Q ss_pred CccCCCCChHHhhcCCCCCCC
Q 010603 433 KRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 433 ~R~s~~~~a~ell~hp~f~~~ 453 (506)
+||+ +.+++.||||...
T Consensus 260 ~R~~----~~~ll~~~~~~~~ 276 (292)
T cd06657 260 QRAT----AAELLKHPFLAKA 276 (292)
T ss_pred cCcC----HHHHhcChHHhcc
Confidence 9997 8999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.50 Aligned_cols=261 Identities=28% Similarity=0.399 Sum_probs=210.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
..+..++|++.+.||+|+||.||+|.+..+++.||||.+++.... .....+..|+.++..+ +||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 356678899999999999999999999999999999999764321 2234455677766666 5999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..|+||||+ ++.|.+++.... ..+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++...
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999998 567887766543 478999999999999999999997 59999999999999999999999999987432
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
....
T Consensus 166 ~~~~---------------------------------------------------------------------------- 169 (296)
T cd06618 166 VDSK---------------------------------------------------------------------------- 169 (296)
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 1000
Q ss_pred CCCccccccCCCCccchhhcCCC----CCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHhCCC-CCCCCCCCCCH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDG----HGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVVGQP-LKFPEGSSISF 417 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~-~~~p~~~~~s~ 417 (506)
......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+..+.... ..++....++.
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 001124788999999997654 78899999999999999999999976433 34444444332 23343335789
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
++.+||.+||..||.+||+ +.++++||||..
T Consensus 248 ~l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~ 278 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPK----YRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHHccCChhhCCC----HHHHhcChhhhc
Confidence 9999999999999999998 899999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.72 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=210.7
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh--chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA--GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+|.+.+.||+|+||+||++.+..++..+++|+++..... .......+..|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999999988777888887653321 122334567799999999999999999999999999999
Q ss_pred EeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988764 23457999999999999999999999999999999999999975 679999999874321100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. ..
T Consensus 160 ~-----------------------------------------------------------------------------~~ 162 (260)
T cd08222 160 D-----------------------------------------------------------------------------LA 162 (260)
T ss_pred c-----------------------------------------------------------------------------cc
Confidence 0 00
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+....... ....++.++.++|.+||
T Consensus 163 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l 241 (260)
T cd08222 163 TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS-LPETYSRQLNSIMQSML 241 (260)
T ss_pred cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC-CcchhcHHHHHHHHHHh
Confidence 12357889999999988889999999999999999999999998776666665655432211 12367889999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f 450 (506)
..||++||+ +.++++||||
T Consensus 242 ~~~p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 242 NKDPSLRPS----AAEILRNPFI 260 (260)
T ss_pred cCChhhCcC----HHHHhhCCCC
Confidence 999999998 8999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.66 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=203.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCce----EEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCL----FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+..++|++++.||+|+||+||+|.+..++.. +|+|.+... .......++..|+.+++.++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4456799999999999999999999877764 667766432 12334456777888899999999999999875 4
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
...++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 56789999999999999987642 57899999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.....
T Consensus 160 ~~~~~--------------------------------------------------------------------------- 164 (279)
T cd05111 160 YPDDK--------------------------------------------------------------------------- 164 (279)
T ss_pred cCCCc---------------------------------------------------------------------------
Confidence 11000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
........|+..|+|||++.+..++.++|||||||++|||++ |..||.+......... +......+....++.++.++
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEKGERLAQPQICTIDVYMV 243 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcCCCCCCCCHHHHHH
Confidence 000112247778999999998899999999999999999998 9999987765543333 33322333334577889999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+||..||++||+ +.|+++
T Consensus 244 i~~c~~~~p~~Rps----~~el~~ 263 (279)
T cd05111 244 MVKCWMIDENVRPT----FKELAN 263 (279)
T ss_pred HHHHcCCCcccCcC----HHHHHH
Confidence 99999999999998 666655
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.76 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=207.2
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEcc-------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD-------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYS 178 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~ 178 (506)
.+..++|.+.+.||+|+||.||+|++.. ....||+|+++.... ......+..|+++++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3445679999999999999999998642 345799999875421 33455678899999999 6999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcE
Q 010603 179 HFETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244 (506)
Q Consensus 179 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 244 (506)
++...+.+|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999999999999999999999987642 23588899999999999999999999999999999999
Q ss_pred EEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 245 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
|++.++.+||+|||+++........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------------------- 190 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY------------------------------------------------------- 190 (314)
T ss_pred EEcCCCcEEEccccccccccccccc-------------------------------------------------------
Confidence 9999999999999998542110000
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHh
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV 403 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 403 (506)
.......++..|||||++.+..++.++|||||||++|||++ |..||.+....+.+..+.
T Consensus 191 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 191 --------------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred --------------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 00001124568999999999889999999999999999999 899998877666555554
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 404 ~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
... .......++.++++||.+||..||++||+ +.++++
T Consensus 251 ~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 251 EGH-RMDKPSNCTHELYMLMRECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 332 22223467889999999999999999998 667765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.86 Aligned_cols=253 Identities=19% Similarity=0.266 Sum_probs=197.5
Q ss_pred CCe-EEEeEEeecCceEEEEEEE----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--
Q 010603 111 GHF-RLLKKLGCGDIGSVYLAEL----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-- 183 (506)
Q Consensus 111 ~~y-~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 183 (506)
++| ++++.||+|+||+||++.. ..+++.||+|++..... ......+.+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 9999999999999988763 35678999999876422 22345667899999999999999999987653
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..+|+||||+.+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999998763 5999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.......
T Consensus 158 ~~~~~~~------------------------------------------------------------------------- 164 (283)
T cd05080 158 PEGHEYY------------------------------------------------------------------------- 164 (283)
T ss_pred CCcchhh-------------------------------------------------------------------------
Confidence 1100000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH--------------HHHHHHhCCCCCC
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR--------------ETLFNVVGQPLKF 409 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~--------------~~~~~i~~~~~~~ 409 (506)
.......++..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......
T Consensus 165 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05080 165 -RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243 (283)
T ss_pred -ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence 0000113566799999999888999999999999999999999998643221 0111111122223
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 410 p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+....++..+.+|+.+||..||++||+ +++++.
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPT----FRSLIP 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 333467899999999999999999998 667764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=331.59 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=209.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCc---eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGC---LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.++|++.+.||+|+||.||+|.++.+++ .||||++.+.. .......+..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999987665 59999987642 233456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999988764 356899999999999999999999999999999999999999999999999987432110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.... ....
T Consensus 160 ~~~~------------------------------------------------------------------------~~~~ 167 (269)
T cd05065 160 TSDP------------------------------------------------------------------------TYTS 167 (269)
T ss_pred cccc------------------------------------------------------------------------cccc
Confidence 0000 0000
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+. .....+....++..+.+++.+
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~ 246 (269)
T cd05065 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLMLD 246 (269)
T ss_pred ccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHH
Confidence 000123457999999999899999999999999999886 999998777666555554 334444445688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..+|.+||+ +.+++.
T Consensus 247 ~l~~~p~~Rp~----~~~i~~ 263 (269)
T cd05065 247 CWQKDRNARPK----FGQIVS 263 (269)
T ss_pred HcCCChhhCcC----HHHHHH
Confidence 99999999998 677764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=328.81 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=200.1
Q ss_pred eEEeecCceEEEEEEEccCC---ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeec
Q 010603 117 KKLGCGDIGSVYLAELRDMG---CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 193 (506)
++||+|+||.||+|.+..++ ..||+|.+...... .....+..|+.+++.++|||||++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999886655 78999999866433 34456788999999999999999999876 44689999999
Q ss_pred CCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCC
Q 010603 194 SGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273 (506)
Q Consensus 194 ~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 273 (506)
.+|+|.+++... ..+++..+..++.|++.||+|||..||+||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~--- 152 (257)
T cd05060 78 PLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY--- 152 (257)
T ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc---
Confidence 999999999875 478999999999999999999999999999999999999999999999999985431110000
Q ss_pred CCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccC
Q 010603 274 DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGT 353 (506)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 353 (506)
.......++
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (257)
T cd05060 153 -----------------------------------------------------------------------RATTAGRWP 161 (257)
T ss_pred -----------------------------------------------------------------------ccccCcccc
Confidence 000001245
Q ss_pred CCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCC
Q 010603 354 HEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQ 432 (506)
Q Consensus 354 ~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~ 432 (506)
..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+... ...+....++..+++||.+||..+|.
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~ 240 (257)
T cd05060 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEECPQEIYSIMLSCWKYRPE 240 (257)
T ss_pred ccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHhcCChh
Confidence 68999999998889999999999999999998 99999877766555444433 23344456889999999999999999
Q ss_pred CccCCCCChHHhhc
Q 010603 433 KRLGFKRGATEIKQ 446 (506)
Q Consensus 433 ~R~s~~~~a~ell~ 446 (506)
+||+ +.++++
T Consensus 241 ~Rp~----~~~l~~ 250 (257)
T cd05060 241 DRPT----FSELES 250 (257)
T ss_pred hCcC----HHHHHH
Confidence 9998 666654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.45 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=209.9
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccC-------CceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccce
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDM-------GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTL 176 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l 176 (506)
.+++...+|++++.||+|+||.||+|++... +..||+|+++... .......+.+|+++++.+ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3455666799999999999999999987532 2368999887532 123456778899999999 89999999
Q ss_pred eEEEEeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCC
Q 010603 177 YSHFETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPE 242 (506)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 242 (506)
++++...+.+|+||||+++|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999987532 234778888999999999999999999999999999
Q ss_pred cEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccc
Q 010603 243 NVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKV 322 (506)
Q Consensus 243 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (506)
|||++.++.+||+|||+++........
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~----------------------------------------------------- 190 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYY----------------------------------------------------- 190 (334)
T ss_pred eEEEcCCCcEEECCcccceeccccccc-----------------------------------------------------
Confidence 999999999999999998542110000
Q ss_pred ccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHH
Q 010603 323 KSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFN 401 (506)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~ 401 (506)
.......++..|||||++.+..++.++|||||||+||||++ |..||.+.+..+.+..
T Consensus 191 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 191 ----------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred ----------------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 00011135568999999999999999999999999999998 8999988776665555
Q ss_pred HhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 402 i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+... ...+....++.++.+||.+||..+|.+||+ +.+++++
T Consensus 249 ~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 249 LKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred HHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 5433 233333467889999999999999999998 7777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.41 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=207.7
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..++|++++.||+|+||.||+|.+.. ++..||||++..... ......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45679999999999999999999753 578999999875432 23345678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQP--------------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~--------------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
+..|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999987531 1347888999999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
||++.++.+||+|||++..+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~------------------------------------------------------ 186 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY------------------------------------------------------ 186 (288)
T ss_pred eEecCCCceEECccccceecccCccc------------------------------------------------------
Confidence 99999999999999987532110000
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 187 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~ 245 (288)
T cd05050 187 ---------------------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV 245 (288)
T ss_pred ---------------------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 00001134567999999998899999999999999999997 88999887776666665
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
..... ++....++.++.+||.+||+.||.+||+ +.|+++
T Consensus 246 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~el~~ 284 (288)
T cd05050 246 RDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPS----FASINR 284 (288)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 54432 2223367899999999999999999998 666654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.49 Aligned_cols=260 Identities=27% Similarity=0.387 Sum_probs=204.7
Q ss_pred CeEEEeEEeecCceEEEEEEEccC--CceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEe----CC
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDM--GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFET----DK 184 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~ 184 (506)
+|++.+.||+|+||.||+|++..+ ++.||||++.... ........+.+|+++++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 489999999999999999999988 8999999987532 1223345667899999998 69999999987543 24
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|++|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 688999999 57899888654 679999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..... ..
T Consensus 157 ~~~~~-------------------------------------------------------------------------~~ 163 (332)
T cd07857 157 ENPGE-------------------------------------------------------------------------NA 163 (332)
T ss_pred ccccc-------------------------------------------------------------------------cc
Confidence 10000 00
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC------------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ------------------ 405 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------ 405 (506)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..++..
T Consensus 164 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (332)
T cd07857 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ 243 (332)
T ss_pred ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHH
Confidence 01123479999999998876 46899999999999999999999999876543333222110
Q ss_pred ----------CCCCC-CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 406 ----------PLKFP-EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 406 ----------~~~~p-~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
...++ .....+..+.+||.+||+.||.+||+ +.++++||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~~ 297 (332)
T cd07857 244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLAI 297 (332)
T ss_pred HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhhh
Confidence 00111 01235788999999999999999997 899999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=342.10 Aligned_cols=255 Identities=29% Similarity=0.423 Sum_probs=206.4
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-CCeEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-DKFSC 187 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~ 187 (506)
..++|++++.||.|+||.||+|.+..+++.||||++.+.... ......+..|+++++.++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 346799999999999999999999999999999998764322 2334566789999999999999999999876 56789
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 999999 6789888764 4689999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
..
T Consensus 161 ------------------------------------------------------------------------------~~ 162 (328)
T cd07856 161 ------------------------------------------------------------------------------QM 162 (328)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 01
Q ss_pred cccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHH---HHhCC------------------
Q 010603 348 MSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF---NVVGQ------------------ 405 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~------------------ 405 (506)
....+++.|+|||++.+ ..++.++|||||||++|+|++|++||........+. +.++.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 12357889999999876 568999999999999999999999998765432211 11110
Q ss_pred -----CCCCCC---CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 406 -----PLKFPE---GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 406 -----~~~~p~---~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
....|. ...++..+.++|.+||+.+|++||+ +++++.||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~~ 293 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLAP 293 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCcccc
Confidence 001110 1246789999999999999999997 899999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.69 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=203.9
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCC--------------ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCcc
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMG--------------CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP 174 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv 174 (506)
..++|++.+.||+|+||.||+|.+..++ ..||||.++.... ......+.+|+++|+.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcC
Confidence 3457999999999999999999876432 3599999876422 23345678899999999999999
Q ss_pred ceeEEEEeCCeEEEEEeecCCCChHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcE
Q 010603 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQP----------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244 (506)
Q Consensus 175 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 244 (506)
++++++...+..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886531 12368889999999999999999999999999999999
Q ss_pred EEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 245 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
|++.++.+||+|||++........
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------------------------------------- 184 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-------------------------------------------------------- 184 (295)
T ss_pred EEcCCCcEEecccccccccccCcc--------------------------------------------------------
Confidence 999999999999999853211000
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc--CCCCCCCCCcHHHHHHH
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL--GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt--G~~Pf~~~~~~~~~~~i 402 (506)
........++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+
T Consensus 185 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~ 245 (295)
T cd05097 185 -------------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT 245 (295)
T ss_pred -------------------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH
Confidence 000011246779999999998889999999999999999987 77899877665544433
Q ss_pred hC------CCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 VG------QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ~~------~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.. ..........++..+.+||.+||..||++||+ +.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 246 GEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred HHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 21 11122223357899999999999999999998 566654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=328.81 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=203.7
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.+++|++.+.||+|+||.||++.. +++.||+|++.... ....+.+|+.+++.++||||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 456799999999999999999875 58899999986532 234567899999999999999999998765 4799
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+.+++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999998765567899999999999999999999999999999999999999999999999987431000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
..
T Consensus 154 ------------------------------------------------------------------------------~~ 155 (254)
T cd05083 154 ------------------------------------------------------------------------------VD 155 (254)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
....+..|+|||++.+..++.++|||||||++|||++ |++||...+..+....+... ...+....++..+.+||.+||
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHc
Confidence 0123467999999998889999999999999999997 99999887766655554433 333333468899999999999
Q ss_pred hcCCCCccCCCCChHHhhc
Q 010603 428 VKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~ 446 (506)
..+|.+||+ +++++.
T Consensus 235 ~~~p~~Rp~----~~~l~~ 249 (254)
T cd05083 235 ETEPKKRPS----FHKLRE 249 (254)
T ss_pred CCChhhCcC----HHHHHH
Confidence 999999998 666654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=335.53 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=203.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEcc----------------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRD----------------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI 173 (506)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+++|+.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999996542 34579999987542 12344567889999999999999
Q ss_pred cceeEEEEeCCeEEEEEeecCCCChHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcE
Q 010603 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPG---------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244 (506)
Q Consensus 174 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 244 (506)
+++++++...+..|+||||+.+|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999998876421 2467888999999999999999999999999999999
Q ss_pred EEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 245 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
|++.++.++|+|||+++.+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------------- 185 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------------------------------------- 185 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--------------------------------------------------------
Confidence 999999999999999853211000
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc--CCCCCCCCCcHHHHHHH
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL--GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt--G~~Pf~~~~~~~~~~~i 402 (506)
........+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+.+...
T Consensus 186 -------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~ 246 (296)
T cd05095 186 -------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENT 246 (296)
T ss_pred -------------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 000011235678999999988889999999999999999998 78999776655544322
Q ss_pred h------CCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 V------GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ~------~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
. .....++....++..+.+|+.+||..||.+||+ +.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 292 (296)
T cd05095 247 GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS----FQEIHA 292 (296)
T ss_pred HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 1 122233444467899999999999999999998 566643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=345.01 Aligned_cols=264 Identities=30% Similarity=0.438 Sum_probs=209.0
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeC--Ce
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETD--KF 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~ 185 (506)
..++|++.+.||+|+||.||+|.+..+|+.||||.+.+... .......+.+|+.+++.+ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45679999999999999999999999999999999865321 123344567799999999 999999999998654 36
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 899999996 6998887653 788999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.... ....
T Consensus 160 ~~~~------------------------------------------------------------------------~~~~ 167 (337)
T cd07852 160 LEEN------------------------------------------------------------------------PENP 167 (337)
T ss_pred cccc------------------------------------------------------------------------ccCc
Confidence 0000 0000
Q ss_pred CccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC------------------
Q 010603 346 RSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP------------------ 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 406 (506)
....++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (337)
T cd07852 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAAT 247 (337)
T ss_pred chhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHH
Confidence 1123468999999998865 457899999999999999999999998766554433221110
Q ss_pred ----------CCCC-CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 ----------LKFP-EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 ----------~~~p-~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..+. ....++.++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~ 301 (337)
T cd07852 248 MLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQF 301 (337)
T ss_pred hhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhh
Confidence 0000 01236889999999999999999998 8999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=330.24 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=207.8
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCc----eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGC----LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+..++|++++.||+|+||+||+|.++.+|+ .||+|.+.+... ......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345679999999999999999999887665 589998876532 3345667889999999999999999999987
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
...++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 78999999999999999987643 45899999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (279)
T cd05057 160 DVDEKEY------------------------------------------------------------------------- 166 (279)
T ss_pred cCcccce-------------------------------------------------------------------------
Confidence 1100000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
......++..|+|||.+....++.++|||||||++|||++ |+.||.+....+....+.. ...++.....+.++.++
T Consensus 167 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 243 (279)
T cd05057 167 --HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTIDVYMV 243 (279)
T ss_pred --ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCHHHHHH
Confidence 0000124568999999988889999999999999999998 9999988776655544443 33344444678899999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+||..||.+||+ +.++++
T Consensus 244 ~~~~l~~~p~~Rp~----~~~l~~ 263 (279)
T cd05057 244 LVKCWMIDAESRPT----FKELIN 263 (279)
T ss_pred HHHHcCCChhhCCC----HHHHHH
Confidence 99999999999998 566554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=334.17 Aligned_cols=254 Identities=23% Similarity=0.302 Sum_probs=201.8
Q ss_pred CeEEEeEEeecCceEEEEEEE----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--Ce
Q 010603 112 HFRLLKKLGCGDIGSVYLAEL----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KF 185 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~ 185 (506)
-|++++.||+|+||.||+|+. ..+++.||+|.++... .......+.+|+++|+.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 389999999999999999985 4568899999987542 233456688999999999999999999998875 57
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.++||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 899999999999999987642 4689999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.... ..
T Consensus 162 ~~~~--------------------------------------------------------------------------~~ 167 (284)
T cd05079 162 DKEY--------------------------------------------------------------------------YT 167 (284)
T ss_pred Cccc--------------------------------------------------------------------------ee
Confidence 0000 00
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC--------------cHHHHHHHhCCCCCCCC
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--------------NRETLFNVVGQPLKFPE 411 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~--------------~~~~~~~i~~~~~~~p~ 411 (506)
......|+..|+|||++.+..++.++|||||||++|||++++.|+.... ........+......+.
T Consensus 168 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05079 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247 (284)
T ss_pred ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCC
Confidence 0012357778999999998889999999999999999999877653211 11112222223333444
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 412 ~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
...++..+.+||.+||+.||.+||+ +.++++
T Consensus 248 ~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 278 (284)
T cd05079 248 PPNCPEEVYQLMRKCWEFQPSKRTT----FQNLIE 278 (284)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 4568999999999999999999998 788876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=333.94 Aligned_cols=254 Identities=32% Similarity=0.509 Sum_probs=209.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+.+|+++|+.++|+||+++++++...+..|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765432 23445677899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+. ++|..++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 96 58888776642 579999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......+
T Consensus 153 ------------------------------------------------------------------------~~~~~~~~ 160 (283)
T cd05118 153 ------------------------------------------------------------------------RPYTHYVV 160 (283)
T ss_pred ------------------------------------------------------------------------ccccCccC
Confidence 00011257
Q ss_pred CCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C----------------CCCCC-
Q 010603 353 THEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P----------------LKFPE- 411 (506)
Q Consensus 353 T~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~----------------~~~p~- 411 (506)
+..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+.+..+... + ..++.
T Consensus 161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 8899999999877 6899999999999999999999999887765554443211 0 00000
Q ss_pred --------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 --------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 --------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
...++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 1236788999999999999999998 8999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=359.14 Aligned_cols=258 Identities=31% Similarity=0.475 Sum_probs=225.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEE-----eCCe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFE-----TDKF 185 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~~~ 185 (506)
-|+|++.||.|.+|+||+++.+.+++.+|+|++.... ..-.++..|.+||+.+ +|||++.++++|. .++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3899999999999999999999999999999998653 2334556788898877 7999999999985 3568
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||.||+..++++...+..+.|+.+..|++.++.||.+||.+.+||||||-.|||++.+|.|||+|||++.+...
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865311
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
+..
T Consensus 176 -----------------------------------------------------------------------------T~g 178 (953)
T KOG0587|consen 176 -----------------------------------------------------------------------------TVG 178 (953)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 223
Q ss_pred CccccccCCCCccchhhcCC-----CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGD-----GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAA 419 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~ 419 (506)
+..+.+|||.|||||++.+. .|+..+|+||||++..||.-|.+|+-+......++.|-..+ +++..+..++..+
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~F 258 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKF 258 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHH
Confidence 34566899999999999764 37889999999999999999999999998888888876554 4445566899999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
.+||..||.+|-++||+ ..++|+|||+....
T Consensus 259 ndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 259 NDFISTCLVKDYEQRPS----TEELLKHPFITEQP 289 (953)
T ss_pred HHHHHHHHhhccccCcc----hhhhccCCcccccc
Confidence 99999999999999997 88999999998543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=325.19 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=206.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
..+|++.+.||+|+||.||+|.+.. +..+|+|++...... ...+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 3469999999999999999998864 678999998754322 23567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+++|.+++.... ..++++.++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999999999887643 4689999999999999999999999999999999999999999999999998853210000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 156 ---------------------------------------------------------------------------~~~~~ 160 (256)
T cd05112 156 ---------------------------------------------------------------------------TSSTG 160 (256)
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00011
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..++..|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+.... ........+..+.+|+.+||.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~ 239 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-RLYKPRLASQSVYELMQHCWK 239 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-CCCCCCCCCHHHHHHHHHHcc
Confidence 135678999999998889999999999999999998 999998777666565554332 222223578999999999999
Q ss_pred cCCCCccCCCCChHHhhc
Q 010603 429 KDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~ 446 (506)
.+|++||+ +.++++
T Consensus 240 ~~p~~Rp~----~~~~l~ 253 (256)
T cd05112 240 ERPEDRPS----FSLLLH 253 (256)
T ss_pred cChhhCCC----HHHHHH
Confidence 99999998 788876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=330.80 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=200.4
Q ss_pred CCeEEEeEEeecCceEEEEEEE----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CC
Q 010603 111 GHFRLLKKLGCGDIGSVYLAEL----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DK 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 184 (506)
.+|++++.||+|+||.||+|.. ..+++.||||.+.... ......+.+|+++|+.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4699999999999999999984 4568899999987542 3445667889999999999999999998753 34
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 7899999999999999987542 468999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (284)
T cd05081 160 QDKEYY-------------------------------------------------------------------------- 165 (284)
T ss_pred CCCcce--------------------------------------------------------------------------
Confidence 100000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH---------------HHHHHHhCCCCCC
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---------------ETLFNVVGQPLKF 409 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~~~~~~ 409 (506)
.......++..|+|||++.+..++.++|||||||++|||++|..|+...... ..+..++.....+
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
T cd05081 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL 245 (284)
T ss_pred eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcC
Confidence 0000012445699999999888999999999999999999988776432211 1112233333344
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 410 p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+....++.++.+||.+||..+|++||+ +.++++
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 246 PAPPGCPAEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 444578899999999999999999998 777765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=326.40 Aligned_cols=241 Identities=22% Similarity=0.297 Sum_probs=194.3
Q ss_pred EEeecCceEEEEEEEc--cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 118 KLGCGDIGSVYLAELR--DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
.||+|+||.||+|.++ .++..||+|++.... .......+.+|+.+++.++||||++++++++. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999875 445679999987542 23344567889999999999999999998864 578999999999
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 152 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----- 152 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-----
Confidence 9999988753 2578999999999999999999999999999999999999999999999999985321100000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.......+++.
T Consensus 153 ---------------------------------------------------------------------~~~~~~~~~~~ 163 (257)
T cd05115 153 ---------------------------------------------------------------------KARSAGKWPLK 163 (257)
T ss_pred ---------------------------------------------------------------------eccCCCCCCcc
Confidence 00001134678
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
|+|||++.+..++.++|||||||++|||++ |..||......+....+.... ..+.....++++.+||.+||..||++|
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c~~~~~~~R 242 (257)
T cd05115 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RLDCPAECPPEMYALMKDCWIYKWEDR 242 (257)
T ss_pred cCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999998889999999999999999996 999998877766555554332 222233678999999999999999999
Q ss_pred cCC
Q 010603 435 LGF 437 (506)
Q Consensus 435 ~s~ 437 (506)
|++
T Consensus 243 p~~ 245 (257)
T cd05115 243 PNF 245 (257)
T ss_pred cCH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=334.20 Aligned_cols=150 Identities=26% Similarity=0.398 Sum_probs=130.4
Q ss_pred chhhhhcccCCCCccc-CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC----
Q 010603 95 WDAVQCVKSKDGDLGL-GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD---- 169 (506)
Q Consensus 95 ~~~~~~~~~~~~~~~~-~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---- 169 (506)
+....+.....|+... ++|.+.++||+|.|++||+|.+..+.+.||+|+.+.. +...+.+..||.+|+.++
T Consensus 61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDP 136 (590)
T ss_pred hhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCC
Confidence 3445566777888777 9999999999999999999999999999999999764 344556788999998873
Q ss_pred -C---CCccceeEEEEeC----CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCC
Q 010603 170 -H---PFLPTLYSHFETD----KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLK 240 (506)
Q Consensus 170 -h---pnIv~l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLK 240 (506)
| ..||+|+++|... .|+|||+|++ |.+|..+|.....+.++...++.|++|||.||+|||.. ||||-|||
T Consensus 137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK 215 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK 215 (590)
T ss_pred CCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence 3 3799999999754 4999999999 88999999988888999999999999999999999975 99999999
Q ss_pred CCcEEEecC
Q 010603 241 PENVLVRED 249 (506)
Q Consensus 241 p~NILl~~~ 249 (506)
|+||||..+
T Consensus 216 PENvLl~~~ 224 (590)
T KOG1290|consen 216 PENVLLCST 224 (590)
T ss_pred cceeeeecc
Confidence 999999754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=332.19 Aligned_cols=253 Identities=34% Similarity=0.531 Sum_probs=206.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEEEe
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 191 (506)
|++.+.||+|+||+||+|+...+++.||||.+.+.... .......+|+..++.++ ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999999999999998764321 11223356888999998 9999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+ +|+|.+++.......+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 99 8899988877644578999999999999999999999999999999999999999999999999884321000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
......
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (283)
T cd07830 154 --------------------------------------------------------------------------PYTDYV 159 (283)
T ss_pred --------------------------------------------------------------------------CcCCCC
Confidence 011236
Q ss_pred cCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC----------------CCCC
Q 010603 352 GTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL----------------KFPE 411 (506)
Q Consensus 352 GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~----------------~~p~ 411 (506)
|+..|+|||++.+ ..++.++|+|||||++|||++|++||......+.+..+.. .+. .++.
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence 8889999998864 4578999999999999999999999987766555443321 110 0000
Q ss_pred ---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 ---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 ---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
....+.++.+||.+||..||++||+ +.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred cccccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 0123678999999999999999997 8999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.05 Aligned_cols=257 Identities=19% Similarity=0.236 Sum_probs=208.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEcc----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRD----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET- 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 182 (506)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345679999999999999999999886 35789999886432 23445667889999999999999999998765
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEee
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPG------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSD 256 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~D 256 (506)
....++++||+.+|+|.+++..... ..+++..++.++.||+.||+|||++|++||||||+|||+++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5688999999999999999876422 4689999999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCc
Q 010603 257 FDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336 (506)
Q Consensus 257 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (506)
||+++.+.......
T Consensus 161 ~g~~~~~~~~~~~~------------------------------------------------------------------ 174 (280)
T cd05043 161 NALSRDLFPMDYHC------------------------------------------------------------------ 174 (280)
T ss_pred CCCcccccCCceEE------------------------------------------------------------------
Confidence 99985432110000
Q ss_pred ccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCC
Q 010603 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSI 415 (506)
Q Consensus 337 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 415 (506)
......++..|+|||++.+..++.++|||||||++|||++ |++||......+....+. ....++....+
T Consensus 175 ---------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (280)
T cd05043 175 ---------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYRLAQPINC 244 (280)
T ss_pred ---------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCCCCCCCcC
Confidence 0001135678999999998889999999999999999998 999998776655444433 33344444567
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
++++.+++.+||..||++||+ +.++++
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps----~~~~~~ 271 (280)
T cd05043 245 PDELFAVMACCWALDPEERPS----FSQLVQ 271 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 899999999999999999998 677764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.65 Aligned_cols=238 Identities=21% Similarity=0.302 Sum_probs=192.5
Q ss_pred eEEeecCceEEEEEEEccCCce-------EEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 117 KKLGCGDIGSVYLAELRDMGCL-------FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~-------vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+.||.|+||.||+|.++.++.. ||+|.+.+.. ......+..|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 3689999999999998765443 8888876532 33445677899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC--------EEEeecCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH--------IMLSDFDLSL 261 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--------vkl~DFGla~ 261 (506)
|||+.+|+|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999987653 46899999999999999999999999999999999999988765 6899999873
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
....
T Consensus 157 ~~~~---------------------------------------------------------------------------- 160 (258)
T cd05078 157 TVLP---------------------------------------------------------------------------- 160 (258)
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcC-CCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLG-RTPFKGNGNRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
.....|++.|+|||++.+. .++.++|||||||++|||++| .+||........ ..+......+|. ..+.++
T Consensus 161 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~ 232 (258)
T cd05078 161 -----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA--PKWTEL 232 (258)
T ss_pred -----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC--CCcHHH
Confidence 0113578899999999874 579999999999999999998 466665544433 233334444444 466889
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||.+||+.||++||+ ++++++
T Consensus 233 ~~li~~~l~~~p~~Rps----~~~il~ 255 (258)
T cd05078 233 ANLINQCMDYEPDFRPS----FRAIIR 255 (258)
T ss_pred HHHHHHHhccChhhCCC----HHHHHH
Confidence 99999999999999998 778876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.74 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=208.9
Q ss_pred eEEEeEEeecCceEEEEEEEccCC----ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
+++++.||.|+||.||+|++..++ ..||+|++..... ......+..|+++|+.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467789999999999999998766 8999999976532 2245677889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+++++|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998775433399999999999999999999999999999999999999999999999999854211000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 159 ----------------------------------------------------------------------------~~~~ 162 (258)
T smart00219 159 ----------------------------------------------------------------------------YKKK 162 (258)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0000
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+.+..+.... ..+....++.++.+++.+||
T Consensus 163 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 241 (258)
T smart00219 163 GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLMLQCW 241 (258)
T ss_pred cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHC
Confidence 1136789999999988889999999999999999998 899998877666666655433 22333458999999999999
Q ss_pred hcCCCCccCCCCChHHhhc
Q 010603 428 VKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~ 446 (506)
..||++||+ +.|+++
T Consensus 242 ~~~p~~Rpt----~~~ll~ 256 (258)
T smart00219 242 AEDPEDRPT----FSELVE 256 (258)
T ss_pred cCChhhCcC----HHHHHh
Confidence 999999998 888875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=325.85 Aligned_cols=233 Identities=29% Similarity=0.432 Sum_probs=191.4
Q ss_pred cCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCChHHH
Q 010603 122 GDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL 201 (506)
Q Consensus 122 G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 201 (506)
|.||+||+|+++.+++.||+|.+.+.. ....|...+....||||+++++++...+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997642 122344555566799999999999999999999999999999998
Q ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccC
Q 010603 202 RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRIS 281 (506)
Q Consensus 202 l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~ 281 (506)
+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------------- 138 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------------- 138 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------------
Confidence 8765 46999999999999999999999999999999999999999999999999987431100
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchh
Q 010603 282 SYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEI 361 (506)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~ 361 (506)
.....++..|+|||+
T Consensus 139 -----------------------------------------------------------------~~~~~~~~~y~aPE~ 153 (237)
T cd05576 139 -----------------------------------------------------------------CDGEAVENMYCAPEV 153 (237)
T ss_pred -----------------------------------------------------------------cccCCcCccccCCcc
Confidence 001245678999999
Q ss_pred hcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCC-CC
Q 010603 362 IRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK-RG 440 (506)
Q Consensus 362 l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~-~~ 440 (506)
+.+..++.++||||+||++|||++|+.||....... . ......+| ..++..+++||.+||+.||.+|++.. ..
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~--~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 227 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--N--THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAG 227 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c--cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence 988889999999999999999999999986432210 0 01112233 35889999999999999999999842 23
Q ss_pred hHHhhcCCCC
Q 010603 441 ATEIKQHPFF 450 (506)
Q Consensus 441 a~ell~hp~f 450 (506)
++++++||||
T Consensus 228 ~~~~~~h~~~ 237 (237)
T cd05576 228 VEDIKSHPFF 237 (237)
T ss_pred hHHHHcCCCC
Confidence 6999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=330.86 Aligned_cols=254 Identities=30% Similarity=0.484 Sum_probs=209.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|++.+.||+|+||.||+|+...+++.||+|++..... .......+..|+++++.++|+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 6788999999999999999999999999999987542 223345567899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 152 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----- 152 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-----
Confidence 96 69999988753 479999999999999999999999999999999999999999999999999874321000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......+
T Consensus 153 ------------------------------------------------------------------------~~~~~~~~ 160 (282)
T cd07829 153 ------------------------------------------------------------------------RTYTHEVV 160 (282)
T ss_pred ------------------------------------------------------------------------cccCcccc
Confidence 00111246
Q ss_pred CCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC------------------CCCCCC--
Q 010603 353 THEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ------------------PLKFPE-- 411 (506)
Q Consensus 353 T~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------~~~~p~-- 411 (506)
+..|+|||++.+. .++.++|||||||++|||++|++||......+.+.++... ...++.
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd07829 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240 (282)
T ss_pred CcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC
Confidence 7789999999876 7899999999999999999999999887765554433210 001111
Q ss_pred -------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 412 -------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 412 -------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
...++..+.+||.+||..||++||+ +.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred ccchHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 0134778999999999999999997 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.73 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=198.2
Q ss_pred eEEeecCceEEEEEEEccCCc--eEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEEeec
Q 010603 117 KKLGCGDIGSVYLAELRDMGC--LFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 193 (506)
+.||+|+||.||+|++..++. .+|+|.+.... .......+..|+++++.+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988775 46888876432 123345677899999999 8999999999999999999999999
Q ss_pred CCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 194 SGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 194 ~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
++|+|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987532 13578999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+......
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (270)
T cd05047 159 SRGQEVY------------------------------------------------------------------------- 165 (270)
T ss_pred ccccchh-------------------------------------------------------------------------
Confidence 7321000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
........+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+... ...+....++.+
T Consensus 166 -----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (270)
T cd05047 166 -----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDE 239 (270)
T ss_pred -----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCCCcCCHH
Confidence 00000124567999999998889999999999999999996 99999877766655555432 233333457889
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+|+.+||..||.+||+ +.++++
T Consensus 240 ~~~li~~~l~~~p~~Rps----~~~il~ 263 (270)
T cd05047 240 VYDLMRQCWREKPYERPS----FAQILV 263 (270)
T ss_pred HHHHHHHHcccChhhCCC----HHHHHH
Confidence 999999999999999998 666654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=320.98 Aligned_cols=245 Identities=21% Similarity=0.317 Sum_probs=199.8
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 196 (506)
+.||+|+||.||+|... ++..||+|++..... ......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 588999999876432 223345778999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCc
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 276 (506)
+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-------- 148 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc--------
Confidence 9999886542 4688999999999999999999999999999999999999999999999999843110000
Q ss_pred ccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCC
Q 010603 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356 (506)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 356 (506)
.......+++.|
T Consensus 149 --------------------------------------------------------------------~~~~~~~~~~~y 160 (250)
T cd05085 149 --------------------------------------------------------------------SSSGLKQIPIKW 160 (250)
T ss_pred --------------------------------------------------------------------ccCCCCCCcccc
Confidence 000011345689
Q ss_pred ccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 357 ~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
+|||++.+..++.++|||||||++|+|++ |..||.+.........+... ........++.++.+|+.+||..+|++||
T Consensus 161 ~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 239 (250)
T cd05085 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRCWDYKPENRP 239 (250)
T ss_pred cCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCC
Confidence 99999998889999999999999999998 99999887766655555433 22233346889999999999999999999
Q ss_pred CCCCChHHhhc
Q 010603 436 GFKRGATEIKQ 446 (506)
Q Consensus 436 s~~~~a~ell~ 446 (506)
+ +.++++
T Consensus 240 ~----~~~l~~ 246 (250)
T cd05085 240 K----FSELQK 246 (250)
T ss_pred C----HHHHHH
Confidence 8 666654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.59 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=205.4
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
...+|.+.+.||+|+||.||+|.+... ...||||....... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 345699999999999999999998654 35699998875431 2344567889999999999999999998875 45
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999987642 4689999999999999999999999999999999999999999999999999853211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
....
T Consensus 160 ~~~~---------------------------------------------------------------------------- 163 (270)
T cd05056 160 ESYY---------------------------------------------------------------------------- 163 (270)
T ss_pred ccce----------------------------------------------------------------------------
Confidence 0000
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
......++..|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+.... ..+....++..+.+||.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 242 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 242 (270)
T ss_pred ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHH
Confidence 0001135568999999988889999999999999999985 999998887766665554332 22333468899999999
Q ss_pred HHhhcCCCCccCCCCChHHhhc
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+||..+|.+||+ +.+++.
T Consensus 243 ~~l~~~P~~Rpt----~~~~~~ 260 (270)
T cd05056 243 KCWAYDPSKRPR----FTELKA 260 (270)
T ss_pred HHcCCChhhCcC----HHHHHH
Confidence 999999999998 677665
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=365.81 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=213.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCc-----eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGC-----LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
-..-++.+.||+|+||.||.|....-.. .||||.+.+. ........+.+|..+|+.++|||||+++|++.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4567889999999999999999875332 4899988764 33566778899999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQP-----GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~-----~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
..+|++|||+||||..+|++.. ...+.......++.||+.|++||+++++|||||..+|+||+....|||+||||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999999998752 34678889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
|+.+..........
T Consensus 849 ArDiy~~~yyr~~~------------------------------------------------------------------ 862 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHG------------------------------------------------------------------ 862 (1025)
T ss_pred hHhhhhchheeccC------------------------------------------------------------------
Confidence 97543221111000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
.-.-...|||||.+..+.|+.|+|||||||+|||+++ |..||.+.++.+.+..++.+. +++.+..+++.
T Consensus 863 ---------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ 932 (1025)
T KOG1095|consen 863 ---------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEK 932 (1025)
T ss_pred ---------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChH
Confidence 0012248999999999999999999999999999997 999999999999888676555 66666789999
Q ss_pred HHHHHHHHhhcCCCCccCCC
Q 010603 419 AKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~ 438 (506)
+.++|..||..+|++||+|.
T Consensus 933 ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 933 LYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred HHHHHHHHccCChhhCccHH
Confidence 99999999999999999974
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.97 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=202.8
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 196 (506)
++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+++++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999988 999999998765332 34556788999999999999999999999999999999999999
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCc
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 276 (506)
+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~------- 149 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT------- 149 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-------
Confidence 9999987642 46889999999999999999999999999999999999999999999999998432100000
Q ss_pred ccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCC
Q 010603 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEY 356 (506)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 356 (506)
.......++..|
T Consensus 150 --------------------------------------------------------------------~~~~~~~~~~~y 161 (251)
T cd05041 150 --------------------------------------------------------------------VSDGLKQIPIKW 161 (251)
T ss_pred --------------------------------------------------------------------eccccCcceecc
Confidence 000001245679
Q ss_pred ccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 357 ~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
+|||++.+..++.++|||||||++|||++ |..||...........+... ...+....++..+.+||.+||..+|.+||
T Consensus 162 ~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMPAPQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred CChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHhccChhhCc
Confidence 99999998889999999999999999998 89999877665544444332 33333446889999999999999999999
Q ss_pred CCCCChHHhhc
Q 010603 436 GFKRGATEIKQ 446 (506)
Q Consensus 436 s~~~~a~ell~ 446 (506)
+ +.|+++
T Consensus 241 ~----~~ell~ 247 (251)
T cd05041 241 S----FSEIYN 247 (251)
T ss_pred C----HHHHHH
Confidence 7 888875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.34 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=192.8
Q ss_pred eEEeecCceEEEEEEEcc--CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecC
Q 010603 117 KKLGCGDIGSVYLAELRD--MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+++++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34568888776432 12334556789999999999999999999999999999999999
Q ss_pred CCChHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 195 GGDLHTLRQRQPG---KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 195 gg~L~~~l~~~~~---~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
+|+|.+++..... ...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999999876432 33578888999999999999999999999999999999999999999999987431110000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (269)
T cd05042 157 -------------------------------------------------------------------------ITKDCHA 163 (269)
T ss_pred -------------------------------------------------------------------------eccCCCC
Confidence 0001124
Q ss_pred cCCCCccchhhcC-------CCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhC-CCCCCCC---CCCCCHHH
Q 010603 352 GTHEYLAPEIIRG-------DGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVG-QPLKFPE---GSSISFAA 419 (506)
Q Consensus 352 GT~~Y~APE~l~~-------~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~-~~~~~p~---~~~~s~~~ 419 (506)
+++.|+|||++.. ..++.++|||||||++|||++ |..||......+.+..++. ....++. ...++..+
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (269)
T cd05042 164 VPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRW 243 (269)
T ss_pred CcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHH
Confidence 6778999999753 346889999999999999998 8899988776666555443 2223322 23578889
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+++..|+ .||++||+ +++|++
T Consensus 244 ~~~~~~~~-~dp~~Rpt----~~~v~~ 265 (269)
T cd05042 244 YEVMQFCW-LDPETRPT----AEEVHE 265 (269)
T ss_pred HHHHHHHh-cCcccccC----HHHHHH
Confidence 99999998 59999998 667654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=329.09 Aligned_cols=259 Identities=17% Similarity=0.229 Sum_probs=190.7
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhc--hhHH------HHHHHHHHHHHhcCCCCccce
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAG--RKKL------MRAQTEREILSLLDHPFLPTL 176 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~--~~~~------~~~~~E~~il~~l~hpnIv~l 176 (506)
+.-++|++.+.||+|+||+||+|.+..+ +..+|+|+........ .... .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4446799999999999999999999887 6778888654322110 0000 111223334566789999999
Q ss_pred eEEEEeCC----eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCE
Q 010603 177 YSHFETDK----FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHI 252 (506)
Q Consensus 177 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~v 252 (506)
++++.... ..+++||++ ..++.+++... ...++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99766543 457889988 45777766553 346888999999999999999999999999999999999999999
Q ss_pred EEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCC
Q 010603 253 MLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNS 332 (506)
Q Consensus 253 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (506)
+|+|||+|+.+.........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~------------------------------------------------------------ 185 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEY------------------------------------------------------------ 185 (294)
T ss_pred EEEEcCCceeeccCCccccc------------------------------------------------------------
Confidence 99999998653211100000
Q ss_pred CCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HH--------HHHHh
Q 010603 333 DSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ET--------LFNVV 403 (506)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~--------~~~i~ 403 (506)
.........||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.... +. +.++.
T Consensus 186 ----------~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 255 (294)
T PHA02882 186 ----------SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH 255 (294)
T ss_pred ----------ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh
Confidence 000011236999999999999999999999999999999999999999876432 21 12222
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 404 ~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.....++ ..++.+.+++..||..+|++||+ .+++++
T Consensus 256 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 256 EGKIKIK---NANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred hhhhccC---CCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 2222232 46889999999999999999998 567654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=331.38 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=203.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCc----eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGC----LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+..++|++++.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345679999999999999999999987776 468888865422 23334577899999999999999999998754
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..++|+||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 467999999999999998764 246899999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (303)
T cd05110 160 EGDEKE-------------------------------------------------------------------------- 165 (303)
T ss_pred cCcccc--------------------------------------------------------------------------
Confidence 110000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+. ..++.....++.....+.++.++
T Consensus 166 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 243 (303)
T cd05110 166 -YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLPQPPICTIDVYMV 243 (303)
T ss_pred -cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHH
Confidence 00011246778999999999899999999999999999997 9999987654443 33333333444445678899999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+||..+|++||+ +.++++
T Consensus 244 i~~c~~~~p~~Rp~----~~~l~~ 263 (303)
T cd05110 244 MVKCWMIDADSRPK----FKELAA 263 (303)
T ss_pred HHHHcCCChhhCcC----HHHHHH
Confidence 99999999999998 556555
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=342.59 Aligned_cols=248 Identities=27% Similarity=0.334 Sum_probs=194.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-eEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK-FSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lV 189 (506)
++|.--..||+|+||.||+|.... |..||||.+....... ..++.+|+++|..++|||+|+|+|||.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 557777899999999999999886 4899999887643221 455899999999999999999999999988 59999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG---VVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g---iiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
+|||++|+|.+.+.......++|.....|+.+++.||+|||... ||||||||+|||||++.++||+|||||+.....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999988764338899999999999999999999864 999999999999999999999999999431100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
...
T Consensus 231 -----------------------------------------------------------------------------~~~ 233 (361)
T KOG1187|consen 231 -----------------------------------------------------------------------------DTS 233 (361)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 000
Q ss_pred cccc-ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC---c---HHHHHHHhCC-CC---CCCC-C-C
Q 010603 347 SMSF-VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG---N---RETLFNVVGQ-PL---KFPE-G-S 413 (506)
Q Consensus 347 ~~~~-~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~---~---~~~~~~i~~~-~~---~~p~-~-~ 413 (506)
.... .||..|+|||++..+..+.++|||||||+|.||+||+.+.+... . .+.....+.. .+ --|. . .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 0011 59999999999999889999999999999999999998887532 1 1111111111 10 0111 0 1
Q ss_pred CCC--H---HHHHHHHHHhhcCCCCccCCCC
Q 010603 414 SIS--F---AAKDLIRGLLVKDPQKRLGFKR 439 (506)
Q Consensus 414 ~~s--~---~~~~li~~~L~~dP~~R~s~~~ 439 (506)
... . .+..+..+|++.+|.+||+|.+
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~ 344 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQ 344 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence 222 2 2556888999999999999644
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=324.90 Aligned_cols=239 Identities=21% Similarity=0.284 Sum_probs=190.0
Q ss_pred eEEeecCceEEEEEEEcc------------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 117 KKLGCGDIGSVYLAELRD------------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~------------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
+.||+|+||+||+|.... ....+|+|++.... ......+..|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998542 23358899876542 233445677899999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC-------EEEeec
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH-------IMLSDF 257 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-------vkl~DF 257 (506)
..++||||+++|+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +|++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999998887654 256899999999999999999999999999999999999987664 899999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|++.....
T Consensus 157 g~~~~~~~------------------------------------------------------------------------ 164 (262)
T cd05077 157 GIPITVLS------------------------------------------------------------------------ 164 (262)
T ss_pred CCCccccC------------------------------------------------------------------------
Confidence 98742100
Q ss_pred cccCCCCCCccccccCCCCccchhhc-CCCCCcchhHHHHHHHHHHHh-cCCCCCCCCCcHHHHHHHhCCCCCCCCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIR-GDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVVGQPLKFPEGSSI 415 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiWSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 415 (506)
.....|+..|||||++. +..++.++|||||||+||||+ .|..||......+.. ......... ....
T Consensus 165 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~--~~~~ 232 (262)
T cd05077 165 ---------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCML--VTPS 232 (262)
T ss_pred ---------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccC--CCCC
Confidence 01125788999999987 456899999999999999998 589998765543322 222222222 2235
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+.++.+||.+||..||.+||+ ..+|+++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcC----HHHHHHh
Confidence 678999999999999999998 6788764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=322.75 Aligned_cols=264 Identities=28% Similarity=0.393 Sum_probs=209.4
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------- 182 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------- 182 (506)
.+.|+-+.+||+|.||.||+|+.+.+|+.||+|++--+... ...-....+|+.+|..|+|+|++.+++.+.+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34588888999999999999999999999999876432211 1222345789999999999999999987743
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 183 -DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 183 -~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
...+||||.+|+ -||.-++... ..+++...++.++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+|+
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 235899999994 5888877654 3679999999999999999999999999999999999999999999999999996
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.+......
T Consensus 173 ~fs~~~n~------------------------------------------------------------------------ 180 (376)
T KOG0669|consen 173 AFSTSKNV------------------------------------------------------------------------ 180 (376)
T ss_pred ceeccccc------------------------------------------------------------------------
Confidence 43211110
Q ss_pred CCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CC--CCCCCCCC--
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQ--PLKFPEGS-- 413 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~--~~~~p~~~-- 413 (506)
...+.+..+.|.+|++||.+.|. .|+.+.|||..|||+.||+||.+.|.++++..++..|. +. +-.||...
T Consensus 181 -~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~l 259 (376)
T KOG0669|consen 181 -VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNL 259 (376)
T ss_pred -CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccc
Confidence 01112234789999999999986 49999999999999999999999999999887765543 21 11122110
Q ss_pred --------------------------CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 414 --------------------------SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 414 --------------------------~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.-++++.||+.+||..||.+|+. +.++|.|.||..-
T Consensus 260 pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~kd 321 (376)
T KOG0669|consen 260 PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFWKD 321 (376)
T ss_pred hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhhcC
Confidence 12347889999999999999997 9999999999754
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.27 Aligned_cols=238 Identities=23% Similarity=0.299 Sum_probs=190.8
Q ss_pred EEeecCceEEEEEEEccC------------------------CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc
Q 010603 118 KLGCGDIGSVYLAELRDM------------------------GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL 173 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI 173 (506)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999985422 2358999886542 2334556778999999999999
Q ss_pred cceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---
Q 010603 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG--- 250 (506)
Q Consensus 174 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~--- 250 (506)
+++++++......|+||||+++|+|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888653 35789999999999999999999999999999999999998654
Q ss_pred ----CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccc
Q 010603 251 ----HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEK 326 (506)
Q Consensus 251 ----~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (506)
.+||+|||++.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------------------------------------------------------------- 176 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------------------------------------------------------------- 176 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------------------------------------
Confidence 389999998732100
Q ss_pred ccCCCCCCCcccccCCCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHh-cCCCCCCCCCcHHHHHHHhC
Q 010603 327 TSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVVG 404 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~ 404 (506)
.....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||......+.. ....
T Consensus 177 --------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~ 235 (274)
T cd05076 177 --------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYE 235 (274)
T ss_pred --------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HHHH
Confidence 001247788999999876 45899999999999999995 799999876654432 2333
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 405 ~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
....++. .....+.+||.+||..+|++||+ +.+++++
T Consensus 236 ~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 236 KKHRLPE--PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred hccCCCC--CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 3333443 35678999999999999999998 7888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.12 Aligned_cols=273 Identities=27% Similarity=0.411 Sum_probs=224.3
Q ss_pred CCcchhh-hhcccCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-
Q 010603 92 DMKWDAV-QCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD- 169 (506)
Q Consensus 92 ~~~~~~~-~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~- 169 (506)
..+|+.. .+.....|++.-++|.+....|+|-|++|..|.+...|..||||+|.... ...+.-+.|++||++|+
T Consensus 412 ~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~ 487 (752)
T KOG0670|consen 412 QDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLND 487 (752)
T ss_pred ccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhc
Confidence 3457544 47788999999999999999999999999999999999999999998753 33444567999999995
Q ss_pred -----CCCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 170 -----HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 170 -----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
--++++|+-+|...+|+|||+|-+ .-+|+++++..+ +-.+....++.|+.|++.||..|-..||+|.||||+|
T Consensus 488 AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDN 566 (752)
T KOG0670|consen 488 ADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDN 566 (752)
T ss_pred cCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccc
Confidence 248999999999999999999998 779999988753 3468899999999999999999999999999999999
Q ss_pred EEEecCC-CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccc
Q 010603 244 VLVREDG-HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKV 322 (506)
Q Consensus 244 ILl~~~~-~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (506)
||+++.. .+||||||.|....-
T Consensus 567 iLVNE~k~iLKLCDfGSA~~~~e--------------------------------------------------------- 589 (752)
T KOG0670|consen 567 ILVNESKNILKLCDFGSASFASE--------------------------------------------------------- 589 (752)
T ss_pred eEeccCcceeeeccCcccccccc---------------------------------------------------------
Confidence 9999865 579999998843110
Q ss_pred ccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHH
Q 010603 323 KSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402 (506)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i 402 (506)
..-+.+..+..|+|||++.|.+|+...|+||+||+||||+||+..|++.++..++...
T Consensus 590 ----------------------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 590 ----------------------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred ----------------------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 0012345678999999999999999999999999999999999999999887766443
Q ss_pred hCCCCCCCCC---------------------------------------------------CCCC-------HHHHHHHH
Q 010603 403 VGQPLKFPEG---------------------------------------------------SSIS-------FAAKDLIR 424 (506)
Q Consensus 403 ~~~~~~~p~~---------------------------------------------------~~~s-------~~~~~li~ 424 (506)
+.....||.. ..++ .++++||.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 3211111100 0111 24789999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+||..||++|++ +.++|+||||..
T Consensus 728 kml~LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 728 KMLILDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred HHhccChhhcCC----HHHHhcCCcccC
Confidence 999999999998 899999999964
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=323.79 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=192.4
Q ss_pred eEEeecCceEEEEEEEc--cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecC
Q 010603 117 KKLGCGDIGSVYLAELR--DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999865 3456799998876432 2233467789999999999999999999999999999999999
Q ss_pred CCChHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 195 GGDLHTLRQRQP---GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 195 gg~L~~~l~~~~---~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
+|+|.+++.... ....++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999999987532 13467778888999999999999999999999999999999999999999998742110000
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
........
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (269)
T cd05087 156 ------------------------------------------------------------------------YVTPDQLW 163 (269)
T ss_pred ------------------------------------------------------------------------eecCCCcC
Confidence 00011235
Q ss_pred cCCCCccchhhcCC-------CCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHh-CCCCCCCCC---CCCCHHH
Q 010603 352 GTHEYLAPEIIRGD-------GHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV-GQPLKFPEG---SSISFAA 419 (506)
Q Consensus 352 GT~~Y~APE~l~~~-------~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~-~~~~~~p~~---~~~s~~~ 419 (506)
|++.|+|||++.+. .++.++|||||||++|||++ |+.||......+...... .....++.. ...+..+
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (269)
T cd05087 164 VPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRW 243 (269)
T ss_pred CcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHH
Confidence 78899999998643 35789999999999999996 999998766555443322 222222221 2467889
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+++.+|+ .+|++||+ +++|+.
T Consensus 244 ~~l~~~c~-~~P~~Rpt----~~~l~~ 265 (269)
T cd05087 244 YEVMQFCW-LQPEQRPS----AEEVHL 265 (269)
T ss_pred HHHHHHHh-cCcccCCC----HHHHHH
Confidence 99999999 68999998 677763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.57 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=199.9
Q ss_pred eEEeecCceEEEEEEEccCC------ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 117 KKLGCGDIGSVYLAELRDMG------CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+.||+|+||.||+|++.... +.||||.+.+... ......+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999987544 7899998865421 233456778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-----CEEEeecCCc
Q 010603 191 EFCSGGDLHTLRQRQ-----PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-----HIMLSDFDLS 260 (506)
Q Consensus 191 E~~~gg~L~~~l~~~-----~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-----~vkl~DFGla 260 (506)
||+++++|.+++... ....+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998753 223478899999999999999999999999999999999999887 8999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
..+......
T Consensus 159 ~~~~~~~~~----------------------------------------------------------------------- 167 (269)
T cd05044 159 RDIYKSDYY----------------------------------------------------------------------- 167 (269)
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 542110000
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+... ..+.....++..+
T Consensus 168 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (269)
T cd05044 168 ----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPENCPDKI 242 (269)
T ss_pred ----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCcccchHHH
Confidence 00001245678999999999899999999999999999998 99999877766655554332 2233334688999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||.+||..+|.+||+ +.++++
T Consensus 243 ~~li~~~l~~~p~~Rp~----~~~i~~ 265 (269)
T cd05044 243 YQLMTNCWAQDPSERPT----FDRIQE 265 (269)
T ss_pred HHHHHHHcCCCcccCCC----HHHHHH
Confidence 99999999999999998 566654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=323.18 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=206.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcc-CCceEEEEEeccchh-------hchhHHHHHHHHHHHHHh-cCCCCccceeEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRD-MGCLFAMKVMDKGML-------AGRKKLMRAQTEREILSL-LDHPFLPTLYSHFET 182 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~ 182 (506)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... .......++.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999999864321 122344556778888765 799999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
++..|+||||++|++|.+++.. .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988754 223578999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+.......
T Consensus 161 ~~~~~~~~------------------------------------------------------------------------ 168 (269)
T cd08528 161 AKQKQPES------------------------------------------------------------------------ 168 (269)
T ss_pred eeeccccc------------------------------------------------------------------------
Confidence 84311000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+............++..+
T Consensus 169 ------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (269)
T cd08528 169 ------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDV 242 (269)
T ss_pred ------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHH
Confidence 01123688999999999988899999999999999999999999987766655555554433322223678999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||.+||..||++||+ +.|+..
T Consensus 243 ~~li~~cl~~~p~~Rp~----~~e~~~ 265 (269)
T cd08528 243 TDVITSCLTPDAEARPD----IIQVSA 265 (269)
T ss_pred HHHHHHHCCCCCccCCC----HHHHHH
Confidence 99999999999999998 566554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=320.57 Aligned_cols=249 Identities=17% Similarity=0.273 Sum_probs=194.9
Q ss_pred eEEeecCceEEEEEEEcc---CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE-eCCeEEEEEee
Q 010603 117 KKLGCGDIGSVYLAELRD---MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE-TDKFSCLLMEF 192 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 192 (506)
+.||+|+||.||+|.+.. .+..||||.+.... .......+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999886422 1234556778999999999999999999765 45678999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+.+|+|.+++.... ...++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 99999999987643 35677888889999999999999999999999999999999999999999998532110000
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.........+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (262)
T cd05058 155 ----------------------------------------------------------------------SVHNHTGAKL 164 (262)
T ss_pred ----------------------------------------------------------------------eecccccCcC
Confidence 0000011246
Q ss_pred CCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCC
Q 010603 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 353 T~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP 431 (506)
+..|+|||++.+..++.++|||||||++|||++ |.+||......+....+... ...+....++..+.+++.+||..+|
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p 243 (262)
T cd05058 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKP 243 (262)
T ss_pred CccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCCh
Confidence 778999999998889999999999999999999 56777776665555554433 2233334578899999999999999
Q ss_pred CCccCCCCChHHhhc
Q 010603 432 QKRLGFKRGATEIKQ 446 (506)
Q Consensus 432 ~~R~s~~~~a~ell~ 446 (506)
++||+ +.++++
T Consensus 244 ~~Rp~----~~~il~ 254 (262)
T cd05058 244 EMRPT----FSELVS 254 (262)
T ss_pred hhCCC----HHHHHH
Confidence 99998 677765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=324.97 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=205.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcc----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CC
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRD----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DK 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 184 (506)
++|++++.||+|+||.||+|.... +++.||||++...... .....+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 468999999999999999999653 4789999999865432 345678899999999999999999999887 56
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999987653 369999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
......
T Consensus 161 ~~~~~~-------------------------------------------------------------------------- 166 (284)
T cd05038 161 EDKDYY-------------------------------------------------------------------------- 166 (284)
T ss_pred cCCcce--------------------------------------------------------------------------
Confidence 100000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc--------------HHHHHHHhCCCCCCC
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN--------------RETLFNVVGQPLKFP 410 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~--------------~~~~~~i~~~~~~~p 410 (506)
.......++..|+|||.+.+..++.++|||||||++|||++|..||..... ...+...+.....++
T Consensus 167 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd05038 167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP 246 (284)
T ss_pred eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCC
Confidence 000011355679999999988899999999999999999999999865322 122233333444445
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
....++.++.+|+.+||..+|.+||+ +.|+++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 247 RPPSCPDEVYDLMKLCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred CCccCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 44567889999999999999999998 677765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=318.34 Aligned_cols=236 Identities=24% Similarity=0.302 Sum_probs=191.2
Q ss_pred eEEeecCceEEEEEEEccCC----------ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 117 KKLGCGDIGSVYLAELRDMG----------CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 357888776542 115667789999999999999999999988 778
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-------CEEEeecCC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-------HIMLSDFDL 259 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-------~vkl~DFGl 259 (506)
++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999988753 3789999999999999999999999999999999999999888 799999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+.....
T Consensus 155 a~~~~~-------------------------------------------------------------------------- 160 (259)
T cd05037 155 PITVLS-------------------------------------------------------------------------- 160 (259)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 843110
Q ss_pred cCCCCCCccccccCCCCccchhhcCC--CCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGD--GHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s 416 (506)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||...+..+...... .....+. ...
T Consensus 161 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~--~~~ 230 (259)
T cd05037 161 -------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPM--PDC 230 (259)
T ss_pred -------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCC--CCc
Confidence 0012467789999999877 78999999999999999999 688887765433332222 2222222 233
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
..+.+||.+||..+|.+||+ +.++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 231 AELANLINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred hHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 78999999999999999998 777765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.27 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=201.0
Q ss_pred eEEEeEEeecCceEEEEEEEcc---CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 113 FRLLKKLGCGDIGSVYLAELRD---MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
|++.+.||+|+||.||+|.++. +++.||||++...... .....++.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998753 5789999999764322 334566788999999999999999999886532
Q ss_pred -eEEEEEeecCCCChHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQP----GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~----~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
..++++||+.+|+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3478999999999988765321 12578999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
++........
T Consensus 160 ~~~~~~~~~~---------------------------------------------------------------------- 169 (273)
T cd05074 160 SKKIYSGDYY---------------------------------------------------------------------- 169 (273)
T ss_pred cccccCCcce----------------------------------------------------------------------
Confidence 8542110000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
.......+++.|++||.+....++.++|||||||++|||++ |++||.+....+....+.... ..+.....+..
T Consensus 170 -----~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (273)
T cd05074 170 -----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPDCLED 243 (273)
T ss_pred -----ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHH
Confidence 00011235678999999998889999999999999999999 899998777665555554332 22222357889
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+|+.+||..+|.+||+ +.++++
T Consensus 244 ~~~l~~~~l~~~p~~Rps----~~~~~~ 267 (273)
T cd05074 244 VYELMCQCWSPEPKCRPS----FQHLRD 267 (273)
T ss_pred HHHHHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999998 677765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.00 Aligned_cols=243 Identities=31% Similarity=0.508 Sum_probs=195.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC------eE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK------FS 186 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------~~ 186 (506)
+..-+.||+|+||.||+++++.+|+.||||.+++.. .....++.-+|+++|++|+|||||+++++-++.. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 566689999999999999999999999999998754 2344556678999999999999999999876554 45
Q ss_pred EEEEeecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec--CCC--EEEeecCCcc
Q 010603 187 CLLMEFCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE--DGH--IMLSDFDLSL 261 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~--vkl~DFGla~ 261 (506)
.+|||||.||||+.+++.-. ...++|...+.+...++.||.|||++|||||||||.||++-. +|+ -||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 79999999999999988632 357999999999999999999999999999999999999864 343 5999999996
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
....
T Consensus 173 el~d---------------------------------------------------------------------------- 176 (732)
T KOG4250|consen 173 ELDD---------------------------------------------------------------------------- 176 (732)
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 5311
Q ss_pred CCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCC----cHHHHHHHhCCC----------
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNG----NRETLFNVVGQP---------- 406 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~---------- 406 (506)
.....+++||+.|.+||++-. ..|+..+|.|||||++|+.+||..||.... ..+.+..++.++
T Consensus 177 --~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 177 --NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred --CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 112456799999999999985 778999999999999999999999996432 233444444222
Q ss_pred -----C----CCCCCCCCCHH----HHHHHHHHhhcCCCCcc
Q 010603 407 -----L----KFPEGSSISFA----AKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 407 -----~----~~p~~~~~s~~----~~~li~~~L~~dP~~R~ 435 (506)
+ .+|....++.. +-..|..+|..+|.+|.
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 23333344443 44678889999999998
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=317.70 Aligned_cols=247 Identities=18% Similarity=0.265 Sum_probs=191.2
Q ss_pred EEeecCceEEEEEEEccC--CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCC
Q 010603 118 KLGCGDIGSVYLAELRDM--GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
.||+|+||+||+|..... ...+++|.+..... ......+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 699999999999976533 23466776654321 23455678899999999999999999999999999999999999
Q ss_pred CChHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCC
Q 010603 196 GDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273 (506)
Q Consensus 196 g~L~~~l~~~~--~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 273 (506)
|+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~----- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY----- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-----
Confidence 99999887642 23567788889999999999999999999999999999999999999999998732100000
Q ss_pred CCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccC
Q 010603 274 DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGT 353 (506)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 353 (506)
........|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (268)
T cd05086 155 ----------------------------------------------------------------------IETEDDKCVP 164 (268)
T ss_pred ----------------------------------------------------------------------hhcccCCcCc
Confidence 0001123688
Q ss_pred CCCccchhhcC-------CCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCC-CCCC---CCCCCCHHHHH
Q 010603 354 HEYLAPEIIRG-------DGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQP-LKFP---EGSSISFAAKD 421 (506)
Q Consensus 354 ~~Y~APE~l~~-------~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p---~~~~~s~~~~~ 421 (506)
..|+|||++.. ..++.++|||||||++|||++ |..||......+.+..+.... ..++ ....+++.+.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (268)
T cd05086 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYE 244 (268)
T ss_pred ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHH
Confidence 89999999853 235779999999999999996 678998777766666554332 2211 12357889999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
++.+|| .+|.+||+ ++++++
T Consensus 245 l~~~c~-~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 245 VLQFCW-LSPEKRAT----AEEVHR 264 (268)
T ss_pred HHHHHh-hCcccCCC----HHHHHH
Confidence 999999 68999998 777764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=317.51 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=212.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
..+|.-++.+|.|+- .|..|.+.-+++.||+|.+... .......+++++|..++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 356888999999999 8888999999999999998776 444666788999999999999999999999996443
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.+|+||||| ..+|...+.. .++.+.+++++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 689999999 7799888774 4788999999999999999999999999999999999999999999999999541
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
. .
T Consensus 169 ~------------------------------------------------------------------------------~ 170 (369)
T KOG0665|consen 169 D------------------------------------------------------------------------------T 170 (369)
T ss_pred C------------------------------------------------------------------------------c
Confidence 1 1
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C--------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P-------------- 406 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~-------------- 406 (506)
..+.+.++.|..|+|||++.+.+|...+||||+|||+.||++|...|.+.+..+++.++... +
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 12356679999999999999999999999999999999999999999988766655544321 0
Q ss_pred ----------C----CCCCC---------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 407 ----------L----KFPEG---------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 407 ----------~----~~p~~---------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
. .+|.. ..-...+++|+.+||..||++|.+ ++++|+||||+
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~ 314 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK 314 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee
Confidence 0 01111 112345899999999999999998 99999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.48 Aligned_cols=263 Identities=19% Similarity=0.216 Sum_probs=182.6
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccC----CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEE-
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDM----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH- 179 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~- 179 (506)
...+..++|++.++||+|+||+||+|.+..+ +..||||.+..... ......| .++...+.+++.++..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence 3445678999999999999999999999998 89999998864321 1111111 1222223333333222
Q ss_pred -----EEeCCeEEEEEeecCCCChHHHHhhCCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEE
Q 010603 180 -----FETDKFSCLLMEFCSGGDLHTLRQRQPG------------------KHFSEQATRFYASEVLLALEYLHMMGVVY 236 (506)
Q Consensus 180 -----~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------~~~~e~~~~~i~~qil~aL~yLH~~giiH 236 (506)
......++|||||+.+++|.+++..... ....+..++.++.||+.||+|||++||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456689999999999999998875321 11224556789999999999999999999
Q ss_pred ccCCCCcEEEec-CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccc
Q 010603 237 RDLKPENVLVRE-DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFL 315 (506)
Q Consensus 237 rDLKp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (506)
|||||+||||+. ++.+||+|||+|+......
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~------------------------------------------------ 310 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI------------------------------------------------ 310 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccc------------------------------------------------
Confidence 999999999996 5799999999985321100
Q ss_pred cccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCC----------------------CCCcchhH
Q 010603 316 NSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD----------------------GHGSAVDW 373 (506)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----------------------~~~~~~Di 373 (506)
......++||+.|||||++... .++.++||
T Consensus 311 ----------------------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 311 ----------------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred ----------------------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 0011234789999999976432 23456799
Q ss_pred HHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCC-------------------CCCCCCCCHHHHHHHHHHhhcCCCC
Q 010603 374 WTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLK-------------------FPEGSSISFAAKDLIRGLLVKDPQK 433 (506)
Q Consensus 374 WSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~-------------------~p~~~~~s~~~~~li~~~L~~dP~~ 433 (506)
||||||||||+++..++.. ....+...+.. ... +.........+++||.+||+.||++
T Consensus 363 wSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999997766532 22222221110 000 0000112345679999999999999
Q ss_pred ccCCCCChHHhhcCCCCCCCCcc
Q 010603 434 RLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 434 R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
||+ +.++|+||||+...+.
T Consensus 441 R~t----a~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 441 RIS----AKAALAHPYFDREGLL 459 (566)
T ss_pred CCC----HHHHhCCcCcCCCCcc
Confidence 998 9999999999987764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.56 Aligned_cols=268 Identities=28% Similarity=0.405 Sum_probs=217.6
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh----hchhHHHHHHHHHHHHHhcCCCCccceeEEEE-e
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML----AGRKKLMRAQTEREILSLLDHPFLPTLYSHFE-T 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~ 182 (506)
...++|-++.+||+|+|+.||+|.+....++||+|+-..... ......+.+.+|.+|.+.|+||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 445679999999999999999999999899999998543221 12344566789999999999999999999997 4
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEec---CCCEEEeec
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVRE---DGHIMLSDF 257 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~---~~~vkl~DF 257 (506)
.+.+|-|+|||+|.||.-|++.+ +.++|..++.|+.||+.||.||.... |||-||||.||||.. -|.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 56789999999999999998876 78999999999999999999999875 999999999999975 468999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
||++-+.......
T Consensus 618 GLSKIMdddSy~~------------------------------------------------------------------- 630 (775)
T KOG1151|consen 618 GLSKIMDDDSYNS------------------------------------------------------------------- 630 (775)
T ss_pred chhhhccCCccCc-------------------------------------------------------------------
Confidence 9986543211100
Q ss_pred cccCCCCCCccccccCCCCccchhhcCC----CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHH-H--HHh-CCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGD----GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL-F--NVV-GQPLKF 409 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~-~--~i~-~~~~~~ 409 (506)
..+..-+.-..||.||++||.+.-+ ..+.++||||+|||+|..+.|+-||..+.....+ . .|+ .....|
T Consensus 631 ---vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqF 707 (775)
T KOG1151|consen 631 ---VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQF 707 (775)
T ss_pred ---ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccC
Confidence 0011112334799999999998643 3588999999999999999999999755433322 2 122 345778
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 410 p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
|....++.++++||++||++.-++|.. +.++-.||||-
T Consensus 708 P~KPvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyll 745 (775)
T KOG1151|consen 708 PPKPVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLL 745 (775)
T ss_pred CCCCccCHHHHHHHHHHHHhhhhhhhh----HHHHccCcccc
Confidence 888889999999999999999999987 89999999995
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=332.71 Aligned_cols=266 Identities=21% Similarity=0.235 Sum_probs=194.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc----------------cCCceEEEEEeccchhhchhH-----------HHHH
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR----------------DMGCLFAMKVMDKGMLAGRKK-----------LMRA 158 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~----------------~~~~~vAiK~i~~~~~~~~~~-----------~~~~ 158 (506)
..+..++|++.++||+|+||+||+|.+. ..++.||||.+.......... ....
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3466789999999999999999999752 235679999986532111111 1123
Q ss_pred HHHHHHHHhcCCCCc-----cceeEEEEe--------CCeEEEEEeecCCCChHHHHhhCC-------------------
Q 010603 159 QTEREILSLLDHPFL-----PTLYSHFET--------DKFSCLLMEFCSGGDLHTLRQRQP------------------- 206 (506)
Q Consensus 159 ~~E~~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~~------------------- 206 (506)
..|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 346777777766554 677777653 356899999999999999886421
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcc
Q 010603 207 ---GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSY 283 (506)
Q Consensus 207 ---~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 283 (506)
...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--------------- 364 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--------------- 364 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---------------
Confidence 11345678889999999999999999999999999999999999999999999843210000
Q ss_pred cCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhc
Q 010603 284 CIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIR 363 (506)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 363 (506)
.......+|+.|+|||++.
T Consensus 365 -------------------------------------------------------------~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 365 -------------------------------------------------------------FNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred -------------------------------------------------------------cCccccCCCcceeChhhhc
Confidence 0000114588999999986
Q ss_pred CCC--------------------CC--cchhHHHHHHHHHHHhcCCC-CCCCCCc-----------HHHHHHHhCCCCCC
Q 010603 364 GDG--------------------HG--SAVDWWTFGIFFYELLLGRT-PFKGNGN-----------RETLFNVVGQPLKF 409 (506)
Q Consensus 364 ~~~--------------------~~--~~~DiWSlGvil~elltG~~-Pf~~~~~-----------~~~~~~i~~~~~~~ 409 (506)
... |+ .++||||+|||||+|++|.. ||.+... ......+......+
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 432 22 24799999999999999986 7753211 11122233445566
Q ss_pred CCCCCCCHHHHHHHHHHhhcCC---CCccCCCCChHHhhcCCCCC
Q 010603 410 PEGSSISFAAKDLIRGLLVKDP---QKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 410 p~~~~~s~~~~~li~~~L~~dP---~~R~s~~~~a~ell~hp~f~ 451 (506)
+.....++.++|||.+||..+| .+|++ |+|+|+||||.
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~ 504 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLS----VGQALSHRFFL 504 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcC
Confidence 6666789999999999999876 68998 99999999995
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=298.94 Aligned_cols=253 Identities=25% Similarity=0.441 Sum_probs=205.6
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCC--e
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDK--F 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--~ 185 (506)
..++|++++++|+|.|+.||.|....+++.++||+++. -..+.+.+|+.||+.|. ||||++|+++..++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 45789999999999999999999999999999999974 34456788999999995 999999999998764 5
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecCCccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLSLRCF 264 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFGla~~~~ 264 (506)
..||+||+.+.|...+.. .++.-.++.++.|++.||+|||+.||+|||+||.|+||+.. -.++|+|+|||..+-
T Consensus 110 paLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 679999999988877643 47888999999999999999999999999999999999975 469999999996532
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.....
T Consensus 185 p~~eY--------------------------------------------------------------------------- 189 (338)
T KOG0668|consen 185 PGKEY--------------------------------------------------------------------------- 189 (338)
T ss_pred CCcee---------------------------------------------------------------------------
Confidence 21111
Q ss_pred CCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCC-CCCCcHHHHHHHh---C---------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPF-KGNGNRETLFNVV---G--------------- 404 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf-~~~~~~~~~~~i~---~--------------- 404 (506)
.-.+.+..|--||+|..- .|+..-|+|||||+|+.|++.+.|| .+.++.+++.+|. +
T Consensus 190 ---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 190 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 112567788999999764 5899999999999999999999997 4666655554332 1
Q ss_pred ---------CCCCC-------CCC-CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 405 ---------QPLKF-------PEG-SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 405 ---------~~~~~-------p~~-~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+..+- +.. .-.++++.|||.++|..|-.+|+| |.|++.||||..+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~ 329 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVR 329 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHH
Confidence 11000 111 235689999999999999999997 99999999997543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=310.67 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=210.6
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHH-HHhcCCCCccceeEEEEeCCeE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-LSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~ 186 (506)
+...+.+-+..||.|+||+|++-.++.+|+..|||.|+.... .+..+++..|.+. ++.-+.||||++||+.-.++.-
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 344556677899999999999999999999999999987654 3444566677776 5566899999999999999999
Q ss_pred EEEEeecCCCChHHHHh---hCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 187 CLLMEFCSGGDLHTLRQ---RQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~---~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
||.||+| ..+|..+.+ ......++|+.+-.|....+.||+||-. .+||||||||+||||+..|.|||||||++-+
T Consensus 139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence 9999999 566655432 2344689999999999999999999985 5899999999999999999999999998743
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
+..+-
T Consensus 218 Lv~Si--------------------------------------------------------------------------- 222 (361)
T KOG1006|consen 218 LVDSI--------------------------------------------------------------------------- 222 (361)
T ss_pred HHHHH---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCCCccccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCCC-CcHHHHHHHhCCCCC-CCC---CCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFNVVGQPLK-FPE---GSSI 415 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~-~p~---~~~~ 415 (506)
.-+.-+|-..|||||-+.. .+|+.++||||||+.|||+.||..|+..- +..+++.+++.+..+ +.. ...+
T Consensus 223 ---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 223 ---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred ---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 0012268889999999964 46999999999999999999999999754 456777777755433 222 2458
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+..++.||..||.+|-..||. -.+++++||+...
T Consensus 300 s~~~~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPK----YDDLKKFPFYRMY 333 (361)
T ss_pred CHHHHHHHHHHhhcccccCcc----hhhhhcCchhhhh
Confidence 899999999999999999998 6799999999753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=330.23 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=213.1
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccC-C--ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDM-G--CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..++.++.++||+|.||+|++|.+... | ..||||+++.+.+.. ....|.+|+.+|.+|+|||+++|||++.+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 345567778999999999999998753 3 358999998765432 56678999999999999999999999988 77
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+.||||+++.|+|.+.+.......|.......|+.||+.||.||.++++|||||...||||-....|||+||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 89999999999999998886667899999999999999999999999999999999999999999999999999865322
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
....- ...
T Consensus 265 ned~Y--------------------------------------------------------------------vm~---- 272 (1039)
T KOG0199|consen 265 NEDMY--------------------------------------------------------------------VMA---- 272 (1039)
T ss_pred CCcce--------------------------------------------------------------------Eec----
Confidence 11100 000
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
....-...|+|||.|....++.++|||++||.||||++ |+.||.+.....++.+|- ..-.++....++.++.+++.
T Consensus 273 --p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk 349 (1039)
T KOG0199|consen 273 --PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMK 349 (1039)
T ss_pred --CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHH
Confidence 00023457999999999999999999999999999996 899999999888887776 44566666789999999999
Q ss_pred HHhhcCCCCccCCCC
Q 010603 425 GLLVKDPQKRLGFKR 439 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~ 439 (506)
.||.++|++||+|..
T Consensus 350 ~cWah~paDRptFsa 364 (1039)
T KOG0199|consen 350 NCWAHNPADRPTFSA 364 (1039)
T ss_pred HhccCCccccccHHH
Confidence 999999999999753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=306.32 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=208.5
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----eEEEEEe
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK-----FSCLLME 191 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E 191 (506)
+.||-|+||+||-+.+..+|+.||+|.+.. .+......+++.+|+.+|...+|.||+..++..+-.. .+|+|+|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 789999999999999999999999998753 2333445567888999999999999999999887654 5789999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
+| ..||..+|..- ..++.+.++-+.+||++||+|||+.||.||||||.|+|++.+..+||||||||+.....
T Consensus 138 Lm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d----- 209 (449)
T KOG0664|consen 138 LM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR----- 209 (449)
T ss_pred HH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-----
Confidence 99 77999887654 68999999999999999999999999999999999999999999999999999642110
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
....++.-+
T Consensus 210 -----------------------------------------------------------------------~~~hMTqEV 218 (449)
T KOG0664|consen 210 -----------------------------------------------------------------------DRLNMTHEV 218 (449)
T ss_pred -----------------------------------------------------------------------hhhhhHHHH
Confidence 011123347
Q ss_pred cCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CC--------------------CC
Q 010603 352 GTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQ--------------------PL 407 (506)
Q Consensus 352 GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~--------------------~~ 407 (506)
.|.+|+|||++.|.. |+.++||||+|||+.||+-.+..|...+..+++..|. +. ..
T Consensus 219 VTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~ 298 (449)
T KOG0664|consen 219 VTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGL 298 (449)
T ss_pred HHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCC
Confidence 899999999999865 8999999999999999999999999888776655443 11 11
Q ss_pred CCCC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 408 KFPE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 408 ~~p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
+-|. ...-..+..+++.++|..||.+|++ .++++.|+|......
T Consensus 299 k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 299 RAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRL 351 (449)
T ss_pred CCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhcccccccccce
Confidence 1111 1123456889999999999999997 899999999987654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=294.21 Aligned_cols=242 Identities=48% Similarity=0.785 Sum_probs=202.9
Q ss_pred CceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCChHHHH
Q 010603 123 DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLR 202 (506)
Q Consensus 123 ~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 202 (506)
+||.||+|.+..+|+.+|+|++........ ...+.+|+++++.++|+||+++++++......++||||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998899999999986543221 567788999999999999999999999999999999999999999998
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCc
Q 010603 203 QRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISS 282 (506)
Q Consensus 203 ~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 282 (506)
... ..+++..+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred Hhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 765 338999999999999999999999999999999999999999999999999985321100
Q ss_pred ccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhh
Q 010603 283 YCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEII 362 (506)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 362 (506)
......|+..|++||++
T Consensus 142 ---------------------------------------------------------------~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 142 ---------------------------------------------------------------LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ---------------------------------------------------------------ccccccCCcCCCCHHHH
Confidence 01123688899999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC-CCCCCCCCCC-CCHHHHHHHHHHhhcCCCCccCCCCC
Q 010603 363 RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG-QPLKFPEGSS-ISFAAKDLIRGLLVKDPQKRLGFKRG 440 (506)
Q Consensus 363 ~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~-~s~~~~~li~~~L~~dP~~R~s~~~~ 440 (506)
.+..++.++|||+||+++|+|++|..||......+.....+. .......... ++.++.+++.+||..+|.+||+
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---- 234 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT---- 234 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC----
Confidence 988899999999999999999999999987444444444443 3332222212 8899999999999999999997
Q ss_pred hHHhhcCCCC
Q 010603 441 ATEIKQHPFF 450 (506)
Q Consensus 441 a~ell~hp~f 450 (506)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 8999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=319.75 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=207.4
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+......+.++||+|-||.|.+|+... +..||+|.++.+.. ......+..|+++|.+|+|||||+|++++..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 344558899999999999999998874 68999999987643 234567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+|||||+.|||.+++.++....+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+...+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999999998733334555666799999999999999999999999999999999999999999997543222
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.... .
T Consensus 692 yy~v---------------------------------------------------------------------------q 696 (807)
T KOG1094|consen 692 YYRV---------------------------------------------------------------------------Q 696 (807)
T ss_pred ceee---------------------------------------------------------------------------e
Confidence 1100 1
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHh--cCCCCCCCCCcHHHHHHHhC------CCCCCCCCCCCCHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL--LGRTPFKGNGNRETLFNVVG------QPLKFPEGSSISFAA 419 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~------~~~~~p~~~~~s~~~ 419 (506)
...+-...|||+|.+.-+.++.++|+|+|||.|||++ +...||...++.+.+.+... ...-++.+.-++..+
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l 776 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL 776 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence 1235567999999999999999999999999999987 58899988887766654321 112233445688999
Q ss_pred HHHHHHHhhcCCCCccCC
Q 010603 420 KDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~ 437 (506)
.+||.+||..|-++||++
T Consensus 777 yelml~Cw~~es~~RPsF 794 (807)
T KOG1094|consen 777 YELMLRCWRRESEQRPSF 794 (807)
T ss_pred HHHHHHHhchhhhcCCCH
Confidence 999999999999999984
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.88 Aligned_cols=261 Identities=19% Similarity=0.296 Sum_probs=222.3
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..+++...+..+..+||-|.||.||.|.+++-...||||.++.+. ..+.++..|..||+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 556777777888899999999999999999989999999998653 4567788999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..+|||+|||..|+|.+|+++.....++.-....++-||..|++||..+++|||||...|+|+.++..||++||||++.+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999999877778888888999999999999999999999999999999999999999999999764
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...... ...
T Consensus 416 tgDTYT-----------------------------------------------------------AHA------------ 424 (1157)
T KOG4278|consen 416 TGDTYT-----------------------------------------------------------AHA------------ 424 (1157)
T ss_pred cCCcee-----------------------------------------------------------ccc------------
Confidence 221100 000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.-.-..-|.|||-|....++.|+|||+|||+|||+.| |..||.+.+-.+ ++.++...++......+++...+|
T Consensus 425 -----GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgyRM~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 425 -----GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGYRMDGPEGCPPKVYEL 498 (1157)
T ss_pred -----CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccccccCCCCCCHHHHHH
Confidence 0012347999999999999999999999999999996 999999876544 455566667776677899999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
++.||+++|.+||+|++ +.++++
T Consensus 499 MraCW~WsPsDRPsFae-iHqafE 521 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAE-IHQAFE 521 (1157)
T ss_pred HHHHhcCCcccCccHHH-HHHHHH
Confidence 99999999999999753 444444
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.63 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=223.1
Q ss_pred hhcccCCCCcccCCeEEEeEEeecCceEEEEEEEccCC---ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccc
Q 010603 99 QCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMG---CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT 175 (506)
Q Consensus 99 ~~~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 175 (506)
+....+..++....-.|.++||.|.||.|++|+.+..| ..||||.++... ..++...|..|+.||-..+||||++
T Consensus 617 qAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 617 QAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred HHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEE
Confidence 34444556777788899999999999999999998766 459999998654 2456677899999999999999999
Q ss_pred eeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEe
Q 010603 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLS 255 (506)
Q Consensus 176 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~ 255 (506)
|.|+......+.||+|||++|+|..+++.+. +.|+..+..-+++.|+.|+.||-+.|+|||||...|||++.+-..|++
T Consensus 695 LEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVs 773 (996)
T KOG0196|consen 695 LEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVS 773 (996)
T ss_pred EEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEec
Confidence 9999999999999999999999999999875 559999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
||||+|.+...+.. ...+.+.
T Consensus 774 DFGLSRvledd~~~---------------------------------------------------------~ytt~GG-- 794 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEA---------------------------------------------------------AYTTLGG-- 794 (996)
T ss_pred cccceeecccCCCc---------------------------------------------------------cccccCC--
Confidence 99999753221100 0000001
Q ss_pred cccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHh-cCCCCCCCCCcHHHHHHHhCCCCCCCCCCC
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVVGQPLKFPEGSS 414 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 414 (506)
.-...|.|||.|....++.++||||+||+|||.+ +|..||.+.++.+.+..|. +.+++|.+..
T Consensus 795 ---------------KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmD 858 (996)
T KOG0196|consen 795 ---------------KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMD 858 (996)
T ss_pred ---------------ccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCC
Confidence 1134899999999999999999999999999988 6999999999998887776 5578888889
Q ss_pred CCHHHHHHHHHHhhcCCCCccCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~ 437 (506)
++..+..|+..||++|-.+||.|
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F 881 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKF 881 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCH
Confidence 99999999999999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.05 Aligned_cols=246 Identities=25% Similarity=0.349 Sum_probs=204.1
Q ss_pred CeEEEeEEeecCceEEEEEEEccC--C--ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDM--G--CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~--~--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
...+.+.||.|.||.||.|.+..- | -.||||..+.+.. ....+.+..|.-+|+.++|||||+|+|++.+. ..+
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 345567899999999999997643 3 3489998876532 34467788999999999999999999998754 589
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
||||+++-|.|+.|++.+. ..++......|+.||+.||.|||+.++|||||...|||+.....|||+||||++.+....
T Consensus 467 ivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999864 578888899999999999999999999999999999999999999999999997643221
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
....
T Consensus 546 yYka---------------------------------------------------------------------------- 549 (974)
T KOG4257|consen 546 YYKA---------------------------------------------------------------------------- 549 (974)
T ss_pred hhhc----------------------------------------------------------------------------
Confidence 1111
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHh-cCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
+...-..-|||||.+.-..++.++|||-|||++||++ .|.-||.+-.+.+.+..+.++ -++|.+..+++.+..|+.+|
T Consensus 550 S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERLPCPPNCPPALYSLMSKC 628 (974)
T ss_pred cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-CCCCCCCCCChHHHHHHHHH
Confidence 0112345899999999999999999999999999988 599999998887766655433 34555558999999999999
Q ss_pred hhcCCCCccCCC
Q 010603 427 LVKDPQKRLGFK 438 (506)
Q Consensus 427 L~~dP~~R~s~~ 438 (506)
|.++|.+||.+.
T Consensus 629 WayeP~kRPrft 640 (974)
T KOG4257|consen 629 WAYEPSKRPRFT 640 (974)
T ss_pred hccCcccCCcHH
Confidence 999999999974
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.19 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=223.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|+++.++|.|+||.||+|+++.+++..|+|+++... ...+.-+++|+-+++..+|||||.+++.+...+.++++|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46999999999999999999999999999999998654 345566788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||.||+|.+..+.. ++++|.++.+.+++.+.||+|||+.|=+|||||-.|||+++.|.+||+|||.+.++.
T Consensus 92 EycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit------ 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT------ 163 (829)
T ss_pred EecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh------
Confidence 999999999976655 789999999999999999999999999999999999999999999999999874321
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
..-.+..++
T Consensus 164 -----------------------------------------------------------------------ati~Krksf 172 (829)
T KOG0576|consen 164 -----------------------------------------------------------------------ATIAKRKSF 172 (829)
T ss_pred -----------------------------------------------------------------------hhhhhhhcc
Confidence 011234567
Q ss_pred ccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CCCCCCCCCCCHHHHHHHH
Q 010603 351 VGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 351 ~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~~~s~~~~~li~ 424 (506)
.||+.|||||+-. .++|+..+|||++|+...||---++|.........++.+... ++.+.+...+++.+.+|++
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK 252 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVK 252 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHH
Confidence 9999999999863 567999999999999999999999997776666666655543 3444555789999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.+|.++|++||+ |+.+|.|||...
T Consensus 253 ~altknpKkRpt----aeklL~h~fvs~ 276 (829)
T KOG0576|consen 253 GALTKNPKKRPT----AEKLLQHPFVSQ 276 (829)
T ss_pred HHhcCCCccCCC----hhhheeceeecc
Confidence 999999999997 999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.78 Aligned_cols=251 Identities=30% Similarity=0.409 Sum_probs=198.4
Q ss_pred eEEEeEEeecCceE-EEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEE
Q 010603 113 FRLLKKLGCGDIGS-VYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 113 y~i~~~LG~G~fG~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
|.--+.+|.|+-|+ ||+|... |+.||||.+- ......+++|+..|+.- +|||||++|+.-.+..++||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHh------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33446789999985 8999988 8899999875 34455678999999988 6999999999999999999999
Q ss_pred eecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CC--CEEEeecCCcccc
Q 010603 191 EFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DG--HIMLSDFDLSLRC 263 (506)
Q Consensus 191 E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~--~vkl~DFGla~~~ 263 (506)
|+| ..+|.++++.. ..........+.+..|++.||++||+.+||||||||.||||+. ++ .++|+|||+++++
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 78999999874 1111121445778899999999999999999999999999987 34 6899999999765
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...+...
T Consensus 662 ~~~~sS~------------------------------------------------------------------------- 668 (903)
T KOG1027|consen 662 AGGKSSF------------------------------------------------------------------------- 668 (903)
T ss_pred CCCcchh-------------------------------------------------------------------------
Confidence 4332211
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCCCCCcHHHHHHHhCCCCCCCCCC-CCCHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLG-RTPFKGNGNRETLFNVVGQPLKFPEGS-SISFAAKD 421 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~-~~s~~~~~ 421 (506)
.+..+..||-+|+|||++....-..++||+|||||+|..++| ..||.+.- +...+|+.+...+-.-. .-..++.|
T Consensus 669 -~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d~eA~d 745 (903)
T KOG1027|consen 669 -SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPDCEAKD 745 (903)
T ss_pred -hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCchHHHHH
Confidence 112334699999999999998888899999999999999986 99996543 33455665543332111 11128999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||.+||.++|..||+ |.++|.||||..
T Consensus 746 LI~~ml~~dP~~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 746 LISRMLNPDPQLRPS----ATDVLNHPLFWD 772 (903)
T ss_pred HHHHhcCCCcccCCC----HHHHhCCCccCC
Confidence 999999999999997 999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=274.87 Aligned_cols=221 Identities=26% Similarity=0.387 Sum_probs=179.3
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHH-HHhcCCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-LSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~ 185 (506)
++.-++..-+..||+|+||.|-+.++..+|...|+|.+..... .+...+...|+.+ ++...+|++|.+||.+.....
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3444556677899999999999999999999999999976432 2334455667777 555689999999999999999
Q ss_pred EEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 186 SCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
++|.||.| ..+|..+... ..++.++|..+-+|+..|+.||.|||++ .|||||+||.||||+.+|+||+||||++-.
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999999 6677665443 3457899999999999999999999976 899999999999999999999999998732
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
+..+- .
T Consensus 199 L~dSi---A----------------------------------------------------------------------- 204 (282)
T KOG0984|consen 199 LVDSI---A----------------------------------------------------------------------- 204 (282)
T ss_pred ehhhh---H-----------------------------------------------------------------------
Confidence 21100 0
Q ss_pred CCCCccccccCCCCccchhhcC----CCCCcchhHHHHHHHHHHHhcCCCCCC-CCCcHHHHHHHhCCCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRG----DGHGSAVDWWTFGIFFYELLLGRTPFK-GNGNRETLFNVVGQPLK 408 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~----~~~~~~~DiWSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~ 408 (506)
-+...|-..|||||.+.. .+|+.++||||||+.++||.+++.||+ +.++.+++.+++..+.+
T Consensus 205 ----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 205 ----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred ----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 001247789999999864 369999999999999999999999997 46778888888877543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.62 Aligned_cols=202 Identities=29% Similarity=0.480 Sum_probs=176.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch-----hHHHHHHHHHHHHHhcC---CCCccceeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR-----KKLMRAQTEREILSLLD---HPFLPTLYSHFE 181 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~---hpnIv~l~~~~~ 181 (506)
..+|..++.||.|+||+|++|.++.....|+||.|.|...-.. ..+-.+-.|+.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4569999999999999999999999999999999998754322 22223456999999997 999999999999
Q ss_pred eCCeEEEEEeec-CCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 182 TDKFSCLLMEFC-SGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 182 ~~~~~~lV~E~~-~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
+++++||+||-- +|.||+++|..+ ..++|..++.|++||+.|+++||+.||||||||-+|+.++.+|.+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999974 567999999987 67999999999999999999999999999999999999999999999999987
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
.....
T Consensus 718 a~~ks--------------------------------------------------------------------------- 722 (772)
T KOG1152|consen 718 AYTKS--------------------------------------------------------------------------- 722 (772)
T ss_pred hhhcC---------------------------------------------------------------------------
Confidence 43111
Q ss_pred CCCCCCccccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCC
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKG 392 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~ 392 (506)
.....++||..|.|||+|.|..| +..-|||+||++||.++....||..
T Consensus 723 ----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 723 ----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 11235689999999999999998 8889999999999999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.97 Aligned_cols=264 Identities=24% Similarity=0.363 Sum_probs=212.9
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEcc-------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccce
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRD-------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTL 176 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l 176 (506)
.+++...+..+.+.||+|+||+|++|.... ....||||.++..... ...+.+..|+++|+.+ .|+|||.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 445555666788899999999999998541 1456999998876543 5567788999999998 59999999
Q ss_pred eEEEEeCCeEEEEEeecCCCChHHHHhhCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCC
Q 010603 177 YSHFETDKFSCLLMEFCSGGDLHTLRQRQP------------G--KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPE 242 (506)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~--~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 242 (506)
++++...+.+++|+|||..|+|..+++..+ . ..++......++.||+.|++||++.++|||||..+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998764 0 13888899999999999999999999999999999
Q ss_pred cEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccc
Q 010603 243 NVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKV 322 (506)
Q Consensus 243 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (506)
|||+..+..+||+|||+|+...........
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-------------------------------------------------- 477 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-------------------------------------------------- 477 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec--------------------------------------------------
Confidence 999999999999999999753222111100
Q ss_pred ccccccCCCCCCCcccccCCCCCCccccccC--CCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHH
Q 010603 323 KSEKTSLTNSDSLPVLIAEPTSARSMSFVGT--HEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETL 399 (506)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT--~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~ 399 (506)
.-.|+ ..|||||.+....|+.++|||||||+||||++ |..||.+....+.+
T Consensus 478 --------------------------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 478 --------------------------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred --------------------------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 00122 25999999999999999999999999999997 89999986633333
Q ss_pred HHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 400 ~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+.+....+...+..++.++.+|++.||..+|++||++.+..+.+-.
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 44555555655666789999999999999999999997654444444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=297.88 Aligned_cols=299 Identities=24% Similarity=0.337 Sum_probs=206.4
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEcc---CCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRD---MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
....|.++.+||+|+|++||+|.+.. .++.||+|.+... ....++.+|+++|..+ .+.||+.+.+++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34569999999999999999999987 7889999998763 3345678899999988 6999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCcccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla~~~ 263 (506)
..++||||++..+..++... ++-..++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||||...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999999988754 678899999999999999999999999999999999986 467899999999742
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
........ +....-+ +..+..-....|.-.+..+.. ......--...
T Consensus 184 d~~~~~~~-s~~~~~~---~~~~~~g~~~~~~~~~~~~~p-----------------------------~g~~~~~~~~r 230 (418)
T KOG1167|consen 184 DGYQQTEH-SRSYSGR---HATPAMGKDVHCQSVATASKP-----------------------------AGYYRRCNDGR 230 (418)
T ss_pred Hhhhhhhh-hhhhhcc---cCCccccCcccccccccccCC-----------------------------CCceeccCCCc
Confidence 11110000 0000000 000000000000000000000 00000000111
Q ss_pred CCCccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHh---------------CC-
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVV---------------GQ- 405 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~---------------~~- 405 (506)
....-...||++|+|||++...+ -+.++||||.|||+.-+++++.||-...+ .+.+..+. +.
T Consensus 231 ~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~ 310 (418)
T KOG1167|consen 231 PSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRI 310 (418)
T ss_pred cceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCce
Confidence 12223457999999999998654 68899999999999999999999843321 11111110 11
Q ss_pred ------C-------------C-------------CCCC-CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 406 ------P-------------L-------------KFPE-GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 406 ------~-------------~-------------~~p~-~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
. + .... ....+..+.||+++||+.||.+|++ |+++|+||||..
T Consensus 311 ~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~ 386 (418)
T KOG1167|consen 311 LLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcc
Confidence 0 0 0000 0123457899999999999999997 999999999985
Q ss_pred CC
Q 010603 453 VN 454 (506)
Q Consensus 453 ~~ 454 (506)
.+
T Consensus 387 ~~ 388 (418)
T KOG1167|consen 387 AD 388 (418)
T ss_pred hh
Confidence 44
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=343.96 Aligned_cols=238 Identities=20% Similarity=0.252 Sum_probs=185.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
..|...+.||+|+||.||+|+++.+++.||||.+..... ....|+++++.++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 346777899999999999999998999999999864321 1124688999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH---MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH---~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
||+++|+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 763 EYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred eCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 9999999999985 3789999999999999999999 6799999999999999998888775 66542100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
..
T Consensus 834 ------------------------------------------------------------------------------~~ 835 (968)
T PLN00113 834 ------------------------------------------------------------------------------TD 835 (968)
T ss_pred ------------------------------------------------------------------------------cC
Confidence 00
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCC--------CCCCCC---
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQP--------LKFPEG--- 412 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~--------~~~p~~--- 412 (506)
....||+.|||||++.+..|+.++|||||||++|||+||+.||..... ........... ......
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 112588999999999999999999999999999999999999954321 11111110000 000000
Q ss_pred -CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 413 -SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 413 -~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.....++.+++.+||+.||++||+ +.|+++
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt----~~evl~ 946 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPC----ANDVLK 946 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcC----HHHHHH
Confidence 011235678999999999999998 677765
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=281.93 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=184.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHH--hcCCCCccceeEEEEeCC----
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS--LLDHPFLPTLYSHFETDK---- 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~--~l~hpnIv~l~~~~~~~~---- 184 (506)
++.++++.||+|.||.||+|.++ |+.||||++.... ...-.+|.+|.+ .|+|+||+.+++.=..+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 56899999999999999999999 9999999997532 122345666654 579999999998754433
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEccCCCCcEEEecCCCEEEee
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM--------GVVYRDLKPENVLVREDGHIMLSD 256 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~--------giiHrDLKp~NILl~~~~~vkl~D 256 (506)
.++||++|.+.|+|++|+.+. .++.+...+++..++.||+|||.. .|.|||||..|||+..+|..-|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 689999999999999999884 789999999999999999999952 399999999999999999999999
Q ss_pred cCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCc
Q 010603 257 FDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336 (506)
Q Consensus 257 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (506)
+|||.+.......+.
T Consensus 360 LGLAv~h~~~t~~id----------------------------------------------------------------- 374 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTID----------------------------------------------------------------- 374 (513)
T ss_pred ceeeEEecccCCccc-----------------------------------------------------------------
Confidence 999965322111110
Q ss_pred ccccCCCCCCccccccCCCCccchhhcCCC----C--CcchhHHHHHHHHHHHhcC----------CCCCCC----CCcH
Q 010603 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDG----H--GSAVDWWTFGIFFYELLLG----------RTPFKG----NGNR 396 (506)
Q Consensus 337 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~--~~~~DiWSlGvil~elltG----------~~Pf~~----~~~~ 396 (506)
...+..|||..|||||+|...- + -..+||||||.||||++.+ ++||.+ +...
T Consensus 375 --------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 375 --------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred --------CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 0112348999999999997532 2 2368999999999999863 578854 3334
Q ss_pred HHHHHHh-CC--CCCCCCCCCCCH---HHHHHHHHHhhcCCCCccC
Q 010603 397 ETLFNVV-GQ--PLKFPEGSSISF---AAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 397 ~~~~~i~-~~--~~~~p~~~~~s~---~~~~li~~~L~~dP~~R~s 436 (506)
+.+..++ -+ ...+|....-.+ .+..|++.||..||.-|.|
T Consensus 447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 5555544 22 233333222233 3457899999999999997
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.13 Aligned_cols=242 Identities=27% Similarity=0.355 Sum_probs=187.2
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh--cCCCCccceeEEEEeCC--
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL--LDHPFLPTLYSHFETDK-- 184 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~-- 184 (506)
.+...++++.||+|.||.||+|+.. ++.||||++.. ...+.++.|.+|.+. |.|+||++++++-+...
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 4566888899999999999999988 68999999974 344567788888665 58999999999876555
Q ss_pred --eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeEEccCCCCcEEEecCCCEE
Q 010603 185 --FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM---------GVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 185 --~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~---------giiHrDLKp~NILl~~~~~vk 253 (506)
.++||+||.+.|+|.+|+..+ .+++.....++..+++||+|||+- .|+|||||..||||..|++..
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 789999999999999999885 799999999999999999999972 499999999999999999999
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||||.++.....
T Consensus 357 IaDFGLAl~~~p~~~----------------------------------------------------------------- 371 (534)
T KOG3653|consen 357 IADFGLALRLEPGKP----------------------------------------------------------------- 371 (534)
T ss_pred eeccceeEEecCCCC-----------------------------------------------------------------
Confidence 999999976532110
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCCC-CC-----cchhHHHHHHHHHHHhcCCCC------------CCC---
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG-HG-----SAVDWWTFGIFFYELLLGRTP------------FKG--- 392 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~-----~~~DiWSlGvil~elltG~~P------------f~~--- 392 (506)
.......+||..|||||+|.+.- +. .+.||||+|.|||||+++..- |..
T Consensus 372 ----------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 372 ----------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred ----------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 00112358999999999997652 22 368999999999999986433 321
Q ss_pred -CCcHHHH-HHHhC--CCCCCCCC---CCCCHHHHHHHHHHhhcCCCCccC
Q 010603 393 -NGNRETL-FNVVG--QPLKFPEG---SSISFAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 393 -~~~~~~~-~~i~~--~~~~~p~~---~~~s~~~~~li~~~L~~dP~~R~s 436 (506)
....+.+ ..++. .+..+|.. ..--..+++.+..||..||+-|+|
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhh
Confidence 1112222 23332 23344432 122345789999999999999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=303.81 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=208.6
Q ss_pred eEEEeEEeecCceEEEEEEEccCCc----eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGC----LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.+..++||+|+||+||+|.+...|+ +||||++.... ..+...++..|+-+|..|+|||+++|++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 5567899999999999999875554 58999887543 3455677889999999999999999999998777 889
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
|++|+++|.|.++++.++ ..+-.+....|..||++||.|||.+++|||||..+|+|+..-.++||.|||+|+......+
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999988764 5788888889999999999999999999999999999999999999999999965322111
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
- +. ..
T Consensus 854 e-----------------------------------------------------------y~----------------~~ 858 (1177)
T KOG1025|consen 854 E-----------------------------------------------------------YS----------------AP 858 (1177)
T ss_pred c-----------------------------------------------------------cc----------------cc
Confidence 0 00 01
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...-.+.|||=|.+....|++++|||||||.+||||| |..|+.+....++ -..+....+++++..++-++.-++.+||
T Consensus 859 ~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~geRLsqPpiCtiDVy~~mvkCw 937 (1177)
T KOG1025|consen 859 GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKGERLSQPPICTIDVYMVMVKCW 937 (1177)
T ss_pred ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhccccCCCCCCccHHHHHHHHHHh
Confidence 1123458999999999999999999999999999996 9999998876654 4444455567777789999999999999
Q ss_pred hcCCCCccCCCCChHHh
Q 010603 428 VKDPQKRLGFKRGATEI 444 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~el 444 (506)
..|+..||+++.+++++
T Consensus 938 mid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 938 MIDADSRPTFKELAEEF 954 (1177)
T ss_pred ccCcccCccHHHHHHHH
Confidence 99999999976555554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.89 Aligned_cols=254 Identities=43% Similarity=0.734 Sum_probs=218.1
Q ss_pred EEeecCceEEEEEEEc---cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEEEeec
Q 010603 118 KLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 193 (506)
.+|+|+||+|++++.. +.|..||+|++++.....+... ....|..++...+ ||++|+++..|+.+..++++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 3799999999988643 4578899999998766554444 5567889999887 999999999999999999999999
Q ss_pred CCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCC
Q 010603 194 SGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273 (506)
Q Consensus 194 ~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 273 (506)
.||+|...+... ..+.+...+.+..+++.+++++|+.||+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~-------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-------- 149 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh--------
Confidence 999998766554 6789999999999999999999999999999999999999999999999999853210
Q ss_pred CCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccC
Q 010603 274 DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGT 353 (506)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 353 (506)
....|||
T Consensus 150 -------------------------------------------------------------------------~~~~cgt 156 (612)
T KOG0603|consen 150 -------------------------------------------------------------------------EKIACGT 156 (612)
T ss_pred -------------------------------------------------------------------------hhhcccc
Confidence 0111799
Q ss_pred CCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCC
Q 010603 354 HEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQK 433 (506)
Q Consensus 354 ~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~ 433 (506)
..|||||++. ++..++|+||||+++|||+||..||.. +....|+...+.+|. .++..+++++..++..+|.+
T Consensus 157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHH
Confidence 9999999998 678899999999999999999999987 677778776767766 69999999999999999999
Q ss_pred ccCCC-CChHHhhcCCCCCCCCcchhccCCC
Q 010603 434 RLGFK-RGATEIKQHPFFESVNWALIRSTHP 463 (506)
Q Consensus 434 R~s~~-~~a~ell~hp~f~~~~~~~~~~~~~ 463 (506)
|+... ..+.++++|+||+.++|..+.....
T Consensus 229 rLg~~~~~~~eik~h~f~~~i~~~~l~~r~~ 259 (612)
T KOG0603|consen 229 RLGAGPDGVDEIKQHEFFQSIDWNELEARSR 259 (612)
T ss_pred HhccCcchhHHHhccchheeeeHhhHhhcCC
Confidence 99863 4689999999999999996544433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=253.57 Aligned_cols=214 Identities=42% Similarity=0.654 Sum_probs=178.8
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|.+.+.||.|++|.||+|.+..+++.+|||.+...... .....+.+|++.++.++|+||+++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999875432 2456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
+.+++|.+++..... .+++..+..++.+++.+|.|||+++++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999887521 18999999999999999999999999999999999999999999999999885421100
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
........+
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (225)
T smart00221 153 -----------------------------------------------------------------------AALLKTVKG 161 (225)
T ss_pred -----------------------------------------------------------------------cccccceec
Confidence 000112367
Q ss_pred CCCCccchhh-cCCCCCcchhHHHHHHHHHHHhcCCCCCCC-CCcHHHH-HHHhCC
Q 010603 353 THEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKG-NGNRETL-FNVVGQ 405 (506)
Q Consensus 353 T~~Y~APE~l-~~~~~~~~~DiWSlGvil~elltG~~Pf~~-~~~~~~~-~~i~~~ 405 (506)
+..|++||++ ....++.++|||+||+++|||++|+.||.. ......+ ..+..+
T Consensus 162 ~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 162 TPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 8899999999 666788899999999999999999999977 4444344 444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=260.48 Aligned_cols=253 Identities=24% Similarity=0.332 Sum_probs=196.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeE-EEEeCCeEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYS-HFETDKFSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-~~~~~~~~~l 188 (506)
+.|.|.+.||+|-||++.+|+++.++..+++|.+.+.. .....+.+|..---.| .|.||+.-|+ .|++.+.+.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 45999999999999999999999999999999998753 4455667777653334 6899998776 4888899999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec--CCCEEEeecCCccccccC
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE--DGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~vkl~DFGla~~~~~~ 266 (506)
+|||++.|||.+-+.. ..+-|...+.++.|++.||+|||++++||||||.+||||-. ...|||||||+.+.....
T Consensus 100 ~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999886654 46889999999999999999999999999999999999964 347999999987432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
T Consensus 177 -------------------------------------------------------------------------------- 176 (378)
T KOG1345|consen 177 -------------------------------------------------------------------------------- 176 (378)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCCCccchhhcCC---C--CCcchhHHHHHHHHHHHhcCCCCCCCCCcH----HHHHHHhCC-CCCCCCC-CCC
Q 010603 347 SMSFVGTHEYLAPEIIRGD---G--HGSAVDWWTFGIFFYELLLGRTPFKGNGNR----ETLFNVVGQ-PLKFPEG-SSI 415 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~---~--~~~~~DiWSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~-~~~~p~~-~~~ 415 (506)
-...--+..|.|||++... . .++..|+|.||+|+|.+|||++||+..... ..+.++.++ ....|.. ..+
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f 256 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF 256 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence 0001234578999987532 2 377899999999999999999999754322 223344433 2334432 468
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
++.+..+.++-|.++|++|-.+ +++....+..|.+
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki-~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKI-WTAKKMRKCLWKE 291 (378)
T ss_pred CHHHHHHHHHhcCCcccccchh-HHHHHHHHHHHHH
Confidence 9999999999999999999432 2367777777765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-31 Score=247.61 Aligned_cols=213 Identities=39% Similarity=0.625 Sum_probs=184.2
Q ss_pred EeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCCh
Q 010603 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL 198 (506)
Q Consensus 119 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 198 (506)
||+|++|.||++....+++.+++|++....... ....+.+|+++++.+.|++|+++++++......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999999889999999998653321 346678899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCccccccCCccccCCCCcc
Q 010603 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLSLRCFVSPKLVQSSDDPA 277 (506)
Q Consensus 199 ~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 277 (506)
.+++.... ..+++..++.++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 46899999999999999999999999999999999999999 89999999998843211000
Q ss_pred cccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCc
Q 010603 278 CRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYL 357 (506)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 357 (506)
......+...|+
T Consensus 149 --------------------------------------------------------------------~~~~~~~~~~~~ 160 (215)
T cd00180 149 --------------------------------------------------------------------LLKTIVGTPAYM 160 (215)
T ss_pred --------------------------------------------------------------------hhhcccCCCCcc
Confidence 011225778999
Q ss_pred cchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccC
Q 010603 358 APEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 358 APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s 436 (506)
+||.+... .++.+.|+|+||+++++| ..+.+++.+||..||.+||+
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999887 788999999999999999 67889999999999999997
Q ss_pred CCCChHHhhcCC
Q 010603 437 FKRGATEIKQHP 448 (506)
Q Consensus 437 ~~~~a~ell~hp 448 (506)
+.++++|+
T Consensus 208 ----~~~l~~~~ 215 (215)
T cd00180 208 ----AKEILEHL 215 (215)
T ss_pred ----HHHHhhCC
Confidence 88998874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=305.58 Aligned_cols=235 Identities=15% Similarity=0.181 Sum_probs=156.7
Q ss_pred hcCC-CCccceeEEE-------EeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcc
Q 010603 167 LLDH-PFLPTLYSHF-------ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238 (506)
Q Consensus 167 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrD 238 (506)
.+.| +||++++++| .....++++|||+ +++|++++... ...+++..++.|++||+.||+|||++||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3445 5888888887 2334677889988 77999999753 35699999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccc
Q 010603 239 LKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318 (506)
Q Consensus 239 LKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (506)
|||+||||+..|.+|++|||++..............+.+ ...
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG--------------------------------------~a~ 147 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIG--------------------------------------SSR 147 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccc--------------------------------------ccc
Confidence 999999999999999999998743211000000000000 000
Q ss_pred ccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHH
Q 010603 319 TTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398 (506)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~ 398 (506)
....... ...... ......+........+||+.|||||++.+..|+.++|||||||+||||++|.+||..... .
T Consensus 148 ~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~ 221 (793)
T PLN00181 148 REEILSE-RRIEKL---EEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--T 221 (793)
T ss_pred ccccccc-cchhhh---hccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--H
Confidence 0000000 000000 000000011112235799999999999999999999999999999999999998764321 2
Q ss_pred HHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 399 LFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 399 ~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+..+..... .+......+.+.+++.+||.+||.+||+ +.|+++||||..
T Consensus 222 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~ 270 (793)
T PLN00181 222 MSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPS----MSELLQSEFINE 270 (793)
T ss_pred HHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcC----hHHHhhchhhhh
Confidence 222211111 1111123456779999999999999998 899999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=287.99 Aligned_cols=254 Identities=37% Similarity=0.655 Sum_probs=198.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|..+|.|-.|+||.||+++++.+.+.+|+| |+|..+--+ .||.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR----------nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR----------NILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh----------ccccccCCccee----------------
Confidence 46999999999999999999999999999994 554322111 155666677766
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||-..+++.- +.++.+. +.+++|||+.||+|||+||+|+||..-|++|++|||+++........
T Consensus 136 -----gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at- 199 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT- 199 (1205)
T ss_pred -----chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-
Confidence 5666666554 3444443 78999999999999999999999999999999999998542111000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
| .+..... ...........
T Consensus 200 ---------------------------------n-----l~eg~I~-----------------------k~t~Ef~dKqv 218 (1205)
T KOG0606|consen 200 ---------------------------------N-----LKEGHIE-----------------------KDTHEFQDKQV 218 (1205)
T ss_pred ---------------------------------h-----hhhcchH-----------------------HHHHHhhhccc
Confidence 0 0000000 00001112345
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC-CCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG-SSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-~~~s~~~~~li~~~L~~ 429 (506)
+|||.|+|||++..++|+..+|||++|+|+||.+.|+.||.+++..+.+-+++...+.||+. ..+.++++++|.+||+.
T Consensus 219 cgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~q 298 (1205)
T KOG0606|consen 219 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQ 298 (1205)
T ss_pred cCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999999999999888888875 56889999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~ 469 (506)
+|..|..- ..+-++.+|+||+..+|..+..+....+|..
T Consensus 299 np~~Rlgt-~ga~evk~h~ff~~LDw~~llRqkaefvpql 337 (1205)
T KOG0606|consen 299 NPLCRLGT-GGALEVKQHGFFQLLDWKSLLRQKAEFVPQL 337 (1205)
T ss_pred ChHhhccc-chhhhhhhccceeecccchhhhhhccccccc
Confidence 99999874 4799999999999999986666666666653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=248.28 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=204.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCC-----ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
+...++++...+-+|.||.||.|.+++.. +.|-+|.++.. ..+.++..+..|.-+|..+.|||+..+.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 44456888889999999999999877432 34556655432 345667778889889999999999999998754
Q ss_pred -CCeEEEEEeecCCCChHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEe
Q 010603 183 -DKFSCLLMEFCSGGDLHTLRQRQ------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLS 255 (506)
Q Consensus 183 -~~~~~lV~E~~~gg~L~~~l~~~------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~ 255 (506)
....++++.++.-|+|..++... ..+.++..+...++.||+.|++|||++||||.||...|.+|++.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 45778889999999999998832 22457788888999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|=.|++.+++.. -+|.+++-
T Consensus 439 DsaLSRDLFP~D-------------------YhcLGDnE----------------------------------------- 458 (563)
T KOG1024|consen 439 DSALSRDLFPGD-------------------YHCLGDNE----------------------------------------- 458 (563)
T ss_pred cchhccccCccc-------------------ccccCCCC-----------------------------------------
Confidence 999998765421 12222210
Q ss_pred cccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCC
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSS 414 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 414 (506)
.....||+||.+....|+.++|+|||||+||||+| |+.|+...++.|+...+. ...++.++.+
T Consensus 459 ---------------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-dGyRlaQP~N 522 (563)
T KOG1024|consen 459 ---------------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-DGYRLAQPFN 522 (563)
T ss_pred ---------------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-ccceecCCCC
Confidence 12348999999999999999999999999999997 999999888887665555 4456666668
Q ss_pred CCHHHHHHHHHHhhcCCCCccCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~ 437 (506)
+++++..++.-||...|++||++
T Consensus 523 CPDeLf~vMacCWallpeeRPsf 545 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSF 545 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCH
Confidence 99999999999999999999984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=280.22 Aligned_cols=262 Identities=27% Similarity=0.352 Sum_probs=202.7
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEecc---chhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDK---GMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
...+.+|.|++|.|+.+......+.++.|.... .....+.....+..|..+-..|.||||+..+..+......+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999998887777777776542 12222333333667777888899999988888777766666669
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||++ ||+.++... ..+....+..+++||+.||+|||+.||.||||||+|+|+..+|.+||+|||.+.-....
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~---- 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP---- 473 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC----
Confidence 99999 999998875 57899999999999999999999999999999999999999999999999987321000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.+........+
T Consensus 474 ---------------------------------------------------------------------~e~~~~~~~g~ 484 (601)
T KOG0590|consen 474 ---------------------------------------------------------------------WEKNIHESSGI 484 (601)
T ss_pred ---------------------------------------------------------------------cchhhhhhcCc
Confidence 00001123456
Q ss_pred ccCCCCccchhhcCCCCCc-chhHHHHHHHHHHHhcCCCCCCCCCcHHHH-HHHh-CCCCC-----CCCCCCCCHHHHHH
Q 010603 351 VGTHEYLAPEIIRGDGHGS-AVDWWTFGIFFYELLLGRTPFKGNGNRETL-FNVV-GQPLK-----FPEGSSISFAAKDL 422 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~-~~DiWSlGvil~elltG~~Pf~~~~~~~~~-~~i~-~~~~~-----~p~~~~~s~~~~~l 422 (506)
+|+..|+|||++.+..|++ .+||||.|++++.|.+|+.||+.....+.. .... ..... .+....++.+.+.+
T Consensus 485 ~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~ 564 (601)
T KOG0590|consen 485 VGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRII 564 (601)
T ss_pred ccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHH
Confidence 8999999999999999965 699999999999999999999765544332 1111 11111 11123578889999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
|.+||+.||.+|.+ +++|++.+||+.++-
T Consensus 565 ~~~~l~~~P~~R~t----i~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 565 IYRMLQLDPTKRIT----IEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHccCChhheec----HHHHhhChHhhhcce
Confidence 99999999999997 899999999998763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-27 Score=234.75 Aligned_cols=262 Identities=38% Similarity=0.589 Sum_probs=205.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC-CccceeEEEEeCCeEEEEEe
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP-FLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 191 (506)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999998 78999999876554433567788899999999988 79999999988888999999
Q ss_pred ecCCCChHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCccccccCCcc
Q 010603 192 FCSGGDLHTLRQRQPG-KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~-~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 269 (506)
|+.+++|.+++..... ..+++..+..++.|++.++.|+|+.|++||||||+|||++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977665422 2799999999999999999999999999999999999999988 7999999998521110000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.. .......
T Consensus 159 ~~-----------------------------------------------------------------------~~~~~~~ 167 (384)
T COG0515 159 SS-----------------------------------------------------------------------IPALPST 167 (384)
T ss_pred cc-----------------------------------------------------------------------ccccccc
Confidence 00 0011234
Q ss_pred cccCCCCccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCC-CCCCCCC------
Q 010603 350 FVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLK-FPEGSSI------ 415 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~---~~~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~~~~------ 415 (506)
.+||..|+|||++.+ ..+....|+||+|++++++++|..||..... ......+...... .......
T Consensus 168 ~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (384)
T COG0515 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELI 247 (384)
T ss_pred cccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchh
Confidence 589999999999998 5788999999999999999999999887764 3333333333322 2211111
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
...+.+++.+++..+|..|.+ +.+...++|...
T Consensus 248 ~~~~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 248 SKAASDLLKKLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred hHHHHHHHHHHHhcCchhcCC----HHHHhhchHhhC
Confidence 257889999999999999987 566666655543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=230.79 Aligned_cols=161 Identities=22% Similarity=0.207 Sum_probs=128.1
Q ss_pred CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 196 GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 196 g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
|+|.+++..+ +..+++..++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 7899998764 357999999999999999999999999 999999999999999 998743100
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
....||+.
T Consensus 62 ------------------------------------------------------------------------~~~~g~~~ 69 (176)
T smart00750 62 ------------------------------------------------------------------------EQSRVDPY 69 (176)
T ss_pred ------------------------------------------------------------------------ccCCCccc
Confidence 00158899
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCCCCCC-----CCCCCCCH--HHHHHHHHHh
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQPLKF-----PEGSSISF--AAKDLIRGLL 427 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~-----p~~~~~s~--~~~~li~~~L 427 (506)
|||||++.+..|+.++|||||||++|||++|+.||...... ..+..+....... +....++. .+++||.+||
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 99999999999999999999999999999999999765433 2233333222111 11112333 6899999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
..||.+||+ +.++++|+|+.
T Consensus 150 ~~~p~~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 150 SRLPQRREA----ANHYLAHCRAL 169 (176)
T ss_pred hcccccccC----HHHHHHHHHHH
Confidence 999999997 89999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=235.66 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=194.1
Q ss_pred CeEEEeEEeecCceEEEEEEEccCC-ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC----CCccceeEEE-EeCCe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMG-CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH----PFLPTLYSHF-ETDKF 185 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~-~~~~~ 185 (506)
+|++.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.+|..+.. +++..+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 6999999999999999999998764 67999987754222111 45668889888863 6899999999 58889
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-----CCEEEeecCCc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-----GHIMLSDFDLS 260 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-----~~vkl~DFGla 260 (506)
-||||+.+ |.+|.++....+.+.++...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999887777899999999999999999999999999999999999999865 35999999999
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
++.......... .
T Consensus 175 r~~~~~~~~~~~-------------------------------------------------------------------~ 187 (322)
T KOG1164|consen 175 RRFKYVGDSGGN-------------------------------------------------------------------L 187 (322)
T ss_pred ccccccCCCCcc-------------------------------------------------------------------c
Confidence 732211110000 0
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCCCCCCCCCCCCH
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQPLKFPEGSSISF 417 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~~p~~~~~s~ 417 (506)
.+.......+.||..|+++.+..+...+.+.|+||++.++.||+.|..||...........+. ............+.
T Consensus 188 ~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (322)
T KOG1164|consen 188 RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPE 267 (322)
T ss_pred ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChH
Confidence 000000123469999999999999999999999999999999999999997765432222222 11111111123456
Q ss_pred HHHHHHHHHhhcCCCCccCC
Q 010603 418 AAKDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~ 437 (506)
.+.++...+-..+...+|.+
T Consensus 268 ~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 268 EFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred HHHHHHHHhhccCCcCCCCH
Confidence 77778877777899999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=241.22 Aligned_cols=143 Identities=20% Similarity=0.137 Sum_probs=115.8
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEcc-CCceEEEEEeccchh--hchhHHHHHHHHHHHHHhcCCCCccc-eeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRD-MGCLFAMKVMDKGML--AGRKKLMRAQTEREILSLLDHPFLPT-LYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~ 183 (506)
...++|++.+.||+|+||+||+|.++. +++.||||++..... ........+.+|+++|+.++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 456779999999999999999999876 678889998764311 11233456889999999999999985 4432
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccC-CCCcEEEecCCCEEEeecCCccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDL-KPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDL-Kp~NILl~~~~~vkl~DFGla~~ 262 (506)
+..|||||||+|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 458999999999999632 11 11 1467899999999999999999999 99999999999999999999965
Q ss_pred c
Q 010603 263 C 263 (506)
Q Consensus 263 ~ 263 (506)
+
T Consensus 162 ~ 162 (365)
T PRK09188 162 F 162 (365)
T ss_pred c
Confidence 3
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=210.90 Aligned_cols=276 Identities=17% Similarity=0.271 Sum_probs=205.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC-CCccceeEEEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-PFLPTLYSHFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~ 184 (506)
..+..+.|+++++||+|+||.+|+|....+|..||||+-.... ..-++..|..+.+.|++ ..|..+..++.+..
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 3466788999999999999999999999999999999865432 12234568889888864 68888888888999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC---CCEEEeecCCcc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED---GHIMLSDFDLSL 261 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFGla~ 261 (506)
+-.|||+++ |.+|.++..-. .+.|+...+..++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||||+
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 999999999 99999876543 4679999999999999999999999999999999999999753 468999999997
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
++....... +
T Consensus 163 ky~d~~t~~----------------------------------------------------------------------H 172 (341)
T KOG1163|consen 163 KYRDIRTRQ----------------------------------------------------------------------H 172 (341)
T ss_pred hhccccccc----------------------------------------------------------------------c
Confidence 653221100 0
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc---HHHHHHHhCCCCCCCCC---CCC
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN---RETLFNVVGQPLKFPEG---SSI 415 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~---~~~ 415 (506)
..-.......||..|.+--...+...+.+-|+=|+|.+|..+.-|..||++... .+.+.+|.......|.. ..+
T Consensus 173 Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~ 252 (341)
T KOG1163|consen 173 IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGF 252 (341)
T ss_pred CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCC
Confidence 001112345799999998888877788899999999999999999999987543 34455666555444422 356
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHh-------hcCCCCCCCCcchhc
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEI-------KQHPFFESVNWALIR 459 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~el-------l~hp~f~~~~~~~~~ 459 (506)
+.++.-.|.-|-..--++-|.+. -..++ |+|.+=--.||..+.
T Consensus 253 P~EF~myl~Y~R~L~F~E~Pdy~-ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 253 PAEFAMYLNYCRGLGFEEKPDYM-YLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred cHHHHHHHHHHhhcCCCCCCcHH-HHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 77777777766555555555421 02222 344444456787654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=213.34 Aligned_cols=215 Identities=24% Similarity=0.395 Sum_probs=176.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+|++.++||+|+||+.++|....+++.||||.-.. +...-++..|.+..+.| ..++|...|.+.+.+-+-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 49999999999999999999999999999996433 23334566788888877 5799999999989998999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-----CEEEeecCCcccccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-----HIMLSDFDLSLRCFV 265 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-----~vkl~DFGla~~~~~ 265 (506)
|++ |.+|.++..-. ++.|+...+..++.|++.-|+|+|++.+|+|||||+|+||...+ .|.|+|||+|+.+..
T Consensus 104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999 99999887654 57899999999999999999999999999999999999998644 589999999976532
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
..+.. +..-.
T Consensus 182 p~Tkq----------------------------------------------------------------------HIPYr 191 (449)
T KOG1165|consen 182 PKTKQ----------------------------------------------------------------------HIPYR 191 (449)
T ss_pred ccccc----------------------------------------------------------------------cCccc
Confidence 21110 00011
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC---CcHHHHHHHh
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN---GNRETLFNVV 403 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~---~~~~~~~~i~ 403 (506)
...+..||..||+---..|..-+.+-|+=|||-+++.+|-|.+||.+. +..+.+++|-
T Consensus 192 E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 192 EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 234557999999999888988999999999999999999999999864 3444455543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=210.50 Aligned_cols=140 Identities=18% Similarity=0.191 Sum_probs=115.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHH------HHHHHHHHHhcCCCCccceeEEEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMR------AQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
+.-++|++++.||.|+||.||++.. ++..+|||++.......+..... +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4557899999999999999999766 36789999998654443343333 578888999999999999999876
Q ss_pred eC--------CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEE
Q 010603 182 TD--------KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 182 ~~--------~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 253 (506)
.. +..+|||||++|.+|.++.. +++. ...+|+.+|..||..||+||||||.|||++.+| ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 43 35899999999999988632 3332 456999999999999999999999999999998 99
Q ss_pred EeecCCc
Q 010603 254 LSDFDLS 260 (506)
Q Consensus 254 l~DFGla 260 (506)
|+|||..
T Consensus 175 liDfg~~ 181 (232)
T PRK10359 175 IIDLSGK 181 (232)
T ss_pred EEECCCc
Confidence 9999976
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=206.38 Aligned_cols=140 Identities=23% Similarity=0.247 Sum_probs=110.2
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchh---------H--------------HHHHHHHHHHHHhcCCCC
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK---------K--------------LMRAQTEREILSLLDHPF 172 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---------~--------------~~~~~~E~~il~~l~hpn 172 (506)
...||+|+||.||+|.+. +|+.||||+++........ . ......|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999999865321111 0 122345999999998887
Q ss_pred ccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCeEEccCCCCcEEEecCCC
Q 010603 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL-HMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 173 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yL-H~~giiHrDLKp~NILl~~~~~ 251 (506)
|.....+. ... .+|||||++|++|...+... ..+++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~-~~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPIL-LKS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEE-ecC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 75443332 222 38999999988776543332 5789999999999999999999 799999999999999998 578
Q ss_pred EEEeecCCcc
Q 010603 252 IMLSDFDLSL 261 (506)
Q Consensus 252 vkl~DFGla~ 261 (506)
++|+|||+|.
T Consensus 156 v~LiDFG~a~ 165 (190)
T cd05147 156 LYIIDVSQSV 165 (190)
T ss_pred EEEEEccccc
Confidence 9999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=211.06 Aligned_cols=235 Identities=25% Similarity=0.322 Sum_probs=153.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC----------CCCccceeEEEE-
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD----------HPFLPTLYSHFE- 181 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~----------hpnIv~l~~~~~- 181 (506)
+...+.||.|+++.||.+.+..||+.+|||++...........+.+++|.-....+. |-.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 677889999999999999999999999999987665555566666666664444432 223333333322
Q ss_pred --------eCC--------eEEEEEeecCCCChHHHHhh---CCCCCC-CHHHH-HHHHHHHHHHHHHHHhCCeEEccCC
Q 010603 182 --------TDK--------FSCLLMEFCSGGDLHTLRQR---QPGKHF-SEQAT-RFYASEVLLALEYLHMMGVVYRDLK 240 (506)
Q Consensus 182 --------~~~--------~~~lV~E~~~gg~L~~~l~~---~~~~~~-~e~~~-~~i~~qil~aL~yLH~~giiHrDLK 240 (506)
... ..+++|+-+ .+||.+++.. ...... ....+ ..+..|+++.+++||..||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 111 236788887 7788876443 221211 12233 3455899999999999999999999
Q ss_pred CCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccc
Q 010603 241 PENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTT 320 (506)
Q Consensus 241 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (506)
|+|+|++.+|.++|+||+...+....
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~------------------------------------------------------ 198 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR------------------------------------------------------ 198 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE------------------------------------------------------
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce------------------------------------------------------
Confidence 99999999999999999976431100
Q ss_pred ccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCC--------CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 010603 321 KVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD--------GHGSAVDWWTFGIFFYELLLGRTPFKG 392 (506)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~~~~~DiWSlGvil~elltG~~Pf~~ 392 (506)
......+..|.+||..... .++.+.|.|+||+++|.|++|+.||..
T Consensus 199 --------------------------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 199 --------------------------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp --------------------------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred --------------------------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 0001245679999987542 478899999999999999999999976
Q ss_pred CCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 393 NGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 393 ~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
....... ...|.....+++..++||.++|++||.+|
T Consensus 253 ~~~~~~~------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADP------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTS------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCccccc------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 5433111 11344444789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=198.00 Aligned_cols=141 Identities=21% Similarity=0.228 Sum_probs=112.0
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchh-----------------------HHHHHHHHHHHHHhcCCCC
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK-----------------------KLMRAQTEREILSLLDHPF 172 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~E~~il~~l~hpn 172 (506)
.+.||+|+||+||+|.+. +|+.||||+++........ .......|.+.+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999999875321000 0122467899999999998
Q ss_pred ccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCC
Q 010603 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 173 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~ 251 (506)
|.....+.... .||||||++|+++....... ..+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 86554443332 48999999888654432222 467888999999999999999999 9999999999999999 899
Q ss_pred EEEeecCCccc
Q 010603 252 IMLSDFDLSLR 262 (506)
Q Consensus 252 vkl~DFGla~~ 262 (506)
++|+|||+|..
T Consensus 156 ~~liDFG~a~~ 166 (190)
T cd05145 156 PYIIDVSQAVE 166 (190)
T ss_pred EEEEEccccee
Confidence 99999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-25 Score=235.35 Aligned_cols=252 Identities=25% Similarity=0.312 Sum_probs=181.5
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccch-hhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGM-LAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+|...+.||++.|=+|.+|++++ | .|+||++-+.. ........+...|++ ...++|||++.+.-+.+++...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 58888999999999999999986 4 49999987653 222233333344555 67789999999999988999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
+|+ .-+|++.+..+ .-+.+-+.++|+.||+.||.-+|..||+|+|||.|||||+.-+.+.|+||.--
T Consensus 101 qyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsF---------- 167 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASF---------- 167 (1431)
T ss_pred HHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccccc----------
Confidence 999 56899887765 45677888899999999999999999999999999999999999999999742
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
||.+.+.++-... .....+..
T Consensus 168 ----------------------------------------KPtYLPeDNPadf--------------~fFFDTSr----- 188 (1431)
T KOG1240|consen 168 ----------------------------------------KPTYLPEDNPADF--------------TFFFDTSR----- 188 (1431)
T ss_pred ----------------------------------------CCccCCCCCcccc--------------eEEEecCC-----
Confidence 3333322221100 00011111
Q ss_pred ccCCCCccchhhcCC----------C-CCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCC---CCCC
Q 010603 351 VGTHEYLAPEIIRGD----------G-HGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPE---GSSI 415 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~----------~-~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~~~ 415 (506)
.-.+|+|||-+... + ..++.||||+||+++||++ |++||.- .++.....+.-..++ ..--
T Consensus 189 -RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le~Ie 263 (1431)
T KOG1240|consen 189 -RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQLLEKIE 263 (1431)
T ss_pred -ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHHHHHhCc
Confidence 12289999988542 1 4678999999999999997 7999842 111111111000000 0011
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+...++||..|++.||.+|++ |++.|+-
T Consensus 264 d~~~Rnlil~Mi~rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 264 DVSLRNLILSMIQRDPSKRLS----AEDYLQK 291 (1431)
T ss_pred CccHHHHHHHHHccCchhccC----HHHHHHh
Confidence 235889999999999999998 9999885
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=190.95 Aligned_cols=203 Identities=23% Similarity=0.219 Sum_probs=142.5
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchh-HHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEEEe
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK-KLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.+...|++|+||+||++.. .+..++.+.+......... ....+.+|+++|+.|+ |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4568899999999998866 4778887777654322111 1235788999999995 5889999886 44799999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccC-CCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDL-KPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDL-Kp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|+.|.+|...+.. . ...++.|++.+|++||++||||||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~- 148 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW- 148 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH-
Confidence 9999999653211 1 1347889999999999999999999 799999999999999999998532110000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.++.. ..++.+ .. ..-.
T Consensus 149 -----------------------------------------~r~L~---------~rDl~~------ll-------k~~~ 165 (218)
T PRK12274 149 -----------------------------------------MRLLA---------REDLRH------LL-------KHKR 165 (218)
T ss_pred -----------------------------------------HHHHH---------HHHHHH------HH-------HHHH
Confidence 00000 000000 00 0001
Q ss_pred ccCCCCccchhhcCC-CCC-cchhHHHHHHHHHHHhcCCCCCCCCCc
Q 010603 351 VGTHEYLAPEIIRGD-GHG-SAVDWWTFGIFFYELLLGRTPFKGNGN 395 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~-~~~-~~~DiWSlGvil~elltG~~Pf~~~~~ 395 (506)
..++.|+.|+.-.-. ..+ ...+|++.|+.+|.++|+..++.++++
T Consensus 166 ~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 166 MYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 367889999875432 233 578999999999999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=207.11 Aligned_cols=273 Identities=25% Similarity=0.320 Sum_probs=183.9
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCc-----------------------------------eEEEEEeccchh
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGC-----------------------------------LFAMKVMDKGML 149 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----------------------------------~vAiK~i~~~~~ 149 (506)
+.-+.+++|+|...||+|--..||.|.....|. +.|||.|-.-..
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 345778899999999999999999998764210 246665532111
Q ss_pred h-chh-HHHHHHHHH------HH--------HH--------hcCCCCccceeEEEEeC----------------------
Q 010603 150 A-GRK-KLMRAQTER------EI--------LS--------LLDHPFLPTLYSHFETD---------------------- 183 (506)
Q Consensus 150 ~-~~~-~~~~~~~E~------~i--------l~--------~l~hpnIv~l~~~~~~~---------------------- 183 (506)
. +.. .++.+.+|. .. .+ .-.|||||+++.+|.+.
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1 111 111122221 01 11 13699999999987322
Q ss_pred -----CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec--CC--CEEE
Q 010603 184 -----KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE--DG--HIML 254 (506)
Q Consensus 184 -----~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~--~vkl 254 (506)
..+|+||.-. ..+|+.++-.+ ..+....+.++.|+++|+.|||++||.|||||.+||||.- |+ .+.|
T Consensus 311 g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 3589999987 56899888764 5777888889999999999999999999999999999853 33 5789
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
+|||.+........ ++|.
T Consensus 387 aDFGCcLAd~~hGl--------------------------qlpy------------------------------------ 404 (598)
T KOG4158|consen 387 ADFGCCLADDNHGL--------------------------QLPY------------------------------------ 404 (598)
T ss_pred cccceeeecccccc--------------------------cccc------------------------------------
Confidence 99998743221111 1110
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCCC------CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh--CCC
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG------HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV--GQP 406 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~ 406 (506)
....-..-|.-.-||||+....+ --.++|.|+.|.+.||++....||....+...-..-. .+-
T Consensus 405 ---------~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL 475 (598)
T KOG4158|consen 405 ---------ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL 475 (598)
T ss_pred ---------ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC
Confidence 00001124666889999986432 1348999999999999999999998754432111111 111
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 407 ~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
..+| ..+++.+++|+..+|+.||.+|++- ..|+.+++--.|..-+|
T Consensus 476 Palp--~~vpp~~rqlV~~lL~r~pskRvsp-~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 476 PALP--SRVPPVARQLVFDLLKRDPSKRVSP-NIAANVLNLSLWRMGED 521 (598)
T ss_pred CCCc--ccCChHHHHHHHHHhcCCccccCCc-cHHHhHHHHHHhcCchH
Confidence 2233 4799999999999999999999983 45777776544444333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-24 Score=228.95 Aligned_cols=314 Identities=31% Similarity=0.478 Sum_probs=245.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
.....+.+++.+-+|+++.++.+.-..+|...++|+..+.......+.+.+..+..++-...+|.++.....|......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45677899999999999999999999889888888877665544555555566666666667788888777777788999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
|||+|+.+++|...++.. ...+++.++.++..++.+++|||...++|||++|.|+|+..+|+.++.|||+.......+
T Consensus 881 L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 999999999999988876 468888999999999999999999999999999999999999999999999654322111
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCC-CCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSC-FKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.....+. +.+. ...++... ...+..... ...+
T Consensus 959 p~~~~sg-------------------------------~~~~~~~~~~~~~---------------~~~~~l~~~-~~~~ 991 (1205)
T KOG0606|consen 959 PTTDLSG-------------------------------PSSSGTPRRLSRS---------------ERRPQLSAD-EARR 991 (1205)
T ss_pred CcCCccc-------------------------------ccccCcccccccc---------------ccccccccc-hhhc
Confidence 1110000 0000 00000000 000000000 1123
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC-CCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG-SSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-~~~s~~~~~li~~ 425 (506)
....+||+.|.|||.+.+...+..+|||++|++++|.++|.+||........+.++.+....+|.. ...+..+.+++.+
T Consensus 992 ~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ 1071 (1205)
T KOG0606|consen 992 KHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINR 1071 (1205)
T ss_pred cccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhh
Confidence 455689999999999999999999999999999999999999999999999999999998888865 5688999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVD 471 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~~~ 471 (506)
+|..+|.+|.++. .+.++..|+||+.++|..+......++|.+..
T Consensus 1072 ll~~~~~qr~~a~-~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s 1116 (1205)
T KOG0606|consen 1072 LLTEEPTQRLGAK-GAAEVKGHPFFQDVDWENLALQKAEFVPQPES 1116 (1205)
T ss_pred hhccCchhccCcc-cccccccCCccCCCCccccccccCccCCCCCC
Confidence 9999999999864 46799999999999999887777777776653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=190.59 Aligned_cols=134 Identities=20% Similarity=0.219 Sum_probs=107.4
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-----CCCCccceeEEEEeCC---eEE
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-----DHPFLPTLYSHFETDK---FSC 187 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~~~ 187 (506)
.+.||+|+||.||. +..++.. +||++..... .....+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 47899999999995 6666655 6998876432 2345678999999999 6799999999999874 444
Q ss_pred -EEEee--cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCeEEccCCCCcEEEecC----CCEEEeecCC
Q 010603 188 -LLMEF--CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL-EYLHMMGVVYRDLKPENVLVRED----GHIMLSDFDL 259 (506)
Q Consensus 188 -lV~E~--~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL-~yLH~~giiHrDLKp~NILl~~~----~~vkl~DFGl 259 (506)
+|||| +.+|+|.+++... .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5579999999653 46666 35678888888 99999999999999999999843 3799999544
Q ss_pred c
Q 010603 260 S 260 (506)
Q Consensus 260 a 260 (506)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=195.13 Aligned_cols=243 Identities=19% Similarity=0.291 Sum_probs=197.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++..++-+|.+...|..|+|++. |..+++|+++......+ ..+.+..|.-.|+...||||+.+++.+..+.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44566778889999999999999998 55788898877654433 2345677888899999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCCEEEe--ecCCcccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLS--DFDLSLRC 263 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~--DFGla~~~ 263 (506)
++..||+.|+|+.++....+-.++..++..++.+|+.|+.|||+.. |----|....++||++-+.+|. |--++-++
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999999877677889999999999999999999986 3344678889999998776654 32222100
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
T Consensus 344 -------------------------------------------------------------------------------- 343 (448)
T KOG0195|consen 344 -------------------------------------------------------------------------------- 343 (448)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCccccccCCCCccchhhcCCCC---CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGH---GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~---~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
....-.|.||+||.++..+- -.++|+|||.++||||.|...||.+..+.+.-.++.-..++...+..++....
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~ 419 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMN 419 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHH
Confidence 01134679999999988764 34799999999999999999999999998877776655555444457999999
Q ss_pred HHHHHHhhcCCCCccCC
Q 010603 421 DLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~ 437 (506)
.|+.-|+..||.+||.+
T Consensus 420 klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 420 KLMNICMNEDPGKRPKF 436 (448)
T ss_pred HHHHHHhcCCCCcCCCc
Confidence 99999999999999985
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=213.28 Aligned_cols=255 Identities=23% Similarity=0.290 Sum_probs=170.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeE-------EE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS-------HF 180 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-------~~ 180 (506)
.-+.+.+..+.+++|.++..+-... ...++-|..+.+.+ .......+++-.+....|.+..-+.+ .+
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 3466677777778887777655443 33344443332221 22233334444444444444333333 11
Q ss_pred -----EeCCeEEEEEeecCCCChHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEE
Q 010603 181 -----ETDKFSCLLMEFCSGGDLHTLRQRQ-PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIML 254 (506)
Q Consensus 181 -----~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 254 (506)
....++||.|++|...+|.+|+.++ .....+....+.++.|++.|++| +|.+|||+||.||+...+..+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 1123689999999999999999743 34456778888999999999999 99999999999999999999999
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
.|||+.......+
T Consensus 398 gDFgl~ts~~~~~------------------------------------------------------------------- 410 (516)
T KOG1033|consen 398 GDFGLVTSQDKDE------------------------------------------------------------------- 410 (516)
T ss_pred hhhhheeecccCC-------------------------------------------------------------------
Confidence 9999974321111
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC-CC
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE-GS 413 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~ 413 (506)
...+.....+..+||++||+||+|.++.|+.++||||||+|||||+. +|............+.. ..+|. ..
T Consensus 411 ----~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~-g~ip~~~~ 482 (516)
T KOG1033|consen 411 ----TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRD-GIIPPEFL 482 (516)
T ss_pred ----cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhc-CCCChHHh
Confidence 00111223455689999999999999999999999999999999994 45433222222222222 23331 11
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
.-.+...+|+.+||.+.|.+||+ +.+.-.|+|.
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCch----HHHHhhhhhc
Confidence 12234568999999999999996 6666666664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=188.61 Aligned_cols=145 Identities=23% Similarity=0.228 Sum_probs=112.6
Q ss_pred eEEEeEEeecCceEEEEEE-EccCCceEEEEEeccchhhch---------------------hHHHHHHHHHHHHHhcCC
Q 010603 113 FRLLKKLGCGDIGSVYLAE-LRDMGCLFAMKVMDKGMLAGR---------------------KKLMRAQTEREILSLLDH 170 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~-~~~~~~~vAiK~i~~~~~~~~---------------------~~~~~~~~E~~il~~l~h 170 (506)
|++.+.||+|+||.||+|. +..+|+.||||+++....... .....+..|+++++.+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8899999999999999999 667899999999986432100 011235689999999976
Q ss_pred CCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-eEEccCCCCcEEEecC
Q 010603 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG-VVYRDLKPENVLVRED 249 (506)
Q Consensus 171 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g-iiHrDLKp~NILl~~~ 249 (506)
.+ +.+...+... ..+|||||+.|++|..+.... ..+.+..+..++.||+.+|.+||++| |+||||||+|||++ +
T Consensus 110 ~~-i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AG-VPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cC-CCCCeeeEec-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 33 2222333222 358999999998887654332 35667778899999999999999999 99999999999999 8
Q ss_pred CCEEEeecCCccc
Q 010603 250 GHIMLSDFDLSLR 262 (506)
Q Consensus 250 ~~vkl~DFGla~~ 262 (506)
+.++|+|||+|..
T Consensus 185 ~~i~LiDFg~a~~ 197 (237)
T smart00090 185 GKVVIIDVSQSVE 197 (237)
T ss_pred CCEEEEEChhhhc
Confidence 8999999999853
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=213.73 Aligned_cols=200 Identities=25% Similarity=0.347 Sum_probs=160.6
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC---CCCccceeEEEEe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD---HPFLPTLYSHFET 182 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~ 182 (506)
-++....|.|-+.||+|+||+||+|.... |+.||||+=+....-. +.-=.+++.+|+ -+.|+.+..++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34566779999999999999999999988 9999999876543211 111223334443 3456777777777
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-------CCEEEe
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-------GHIMLS 255 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-------~~vkl~ 255 (506)
.+.-+||+||.+.|+|.+++.. .+.+++..+.+++.|++..|+.||..+|||+||||+|.||... --++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 7888999999999999999984 4889999999999999999999999999999999999999642 358999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||.|..+..-
T Consensus 844 DfG~siDm~lf--------------------------------------------------------------------- 854 (974)
T KOG1166|consen 844 DFGRSIDMKLF--------------------------------------------------------------------- 854 (974)
T ss_pred ecccceeeeEc---------------------------------------------------------------------
Confidence 99988543221
Q ss_pred cccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTP 389 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~P 389 (506)
+...+....++|-.+-.+|+..|.+|+..+|.|.|.-+++-||+|+..
T Consensus 855 ------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 855 ------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 122234456788899999999999999999999999999999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.7e-23 Score=219.61 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=206.9
Q ss_pred CeEEEeEEeecCceEEEEEEEc-cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELR-DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 189 (506)
.|.+.+.||+|+|+.|-++... .....+|+|.+.... ...........|..+-+.+. |+|++.+++.....+..+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 3888899999999999998874 345567788776543 22344455666888877776 99999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEccCCCCcEEEecCC-CEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH-~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~~~~ 267 (506)
+||..|+++.+.+........+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 99999999998874222236788889999999999999999 99999999999999999999 99999999995432200
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
. .....
T Consensus 180 g--------------------------------------------------------------------------~~~~~ 185 (601)
T KOG0590|consen 180 G--------------------------------------------------------------------------AERSL 185 (601)
T ss_pred C--------------------------------------------------------------------------cceee
Confidence 0 00112
Q ss_pred ccccc-CCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHH-HHHhCC--CCCCCCCCCCCHHHHHH
Q 010603 348 MSFVG-THEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL-FNVVGQ--PLKFPEGSSISFAAKDL 422 (506)
Q Consensus 348 ~~~~G-T~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~--~~~~p~~~~~s~~~~~l 422 (506)
...+| ++.|+|||...+.. .+...|+||.|+++.-+++|..||......... ..+... ......+..++....++
T Consensus 186 ~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (601)
T KOG0590|consen 186 KDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDL 265 (601)
T ss_pred ecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhc
Confidence 23468 99999999999854 478899999999999999999999765443322 222222 22344455789999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+.++|..+|..|.+ ..++..+||+..
T Consensus 266 l~k~l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 266 LHKILKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccccccCCchhccc----cccccccccccc
Confidence 99999999999997 789999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=174.88 Aligned_cols=136 Identities=22% Similarity=0.265 Sum_probs=114.4
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhh-----chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA-----GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
+.||+|++|.||+|.+ .|..+++|+....... ......++.+|++++..+.|++|+....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 4778999986643221 11123456789999999999999888878777888999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
|++|++|.+++.... . ....++.+|+.+|.+||+.|++|||++|.|||++ ++.++|+|||++.
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999999886531 1 7778999999999999999999999999999999 7899999999985
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=170.20 Aligned_cols=132 Identities=23% Similarity=0.270 Sum_probs=107.4
Q ss_pred EEeecCceEEEEEEEccCCceEEEEEeccchhh-----chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA-----GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
.||+|+||.||+|.. +|..+++|+....... ......++.+|+++++.+.|+++....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 4788999986543221 122335677899999999988766555555667778999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
++|++|.+++.... . .++.|++.+|.+||+.|++|||++|.|||++ ++.++++|||++.
T Consensus 79 ~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred ECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999998875431 1 7889999999999999999999999999999 8899999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=172.62 Aligned_cols=137 Identities=25% Similarity=0.249 Sum_probs=108.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch-------------------hHHHHHHHHHHHHHhcCCCC-
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR-------------------KKLMRAQTEREILSLLDHPF- 172 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~~~~E~~il~~l~hpn- 172 (506)
|.+.+.||+|+||.||+|... +|+.||||++........ ........|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888899999999999999875 699999999775321000 01113567888899888774
Q ss_pred -ccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 173 -LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 173 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
++..++ ....++||||++|++|..+... .....++.+|+.++.++|+.||+||||||+|||++.++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 444443 2456899999999999765321 345678899999999999999999999999999999999
Q ss_pred EEEeecCCccc
Q 010603 252 IMLSDFDLSLR 262 (506)
Q Consensus 252 vkl~DFGla~~ 262 (506)
++|+|||++..
T Consensus 164 ~~liDfg~~~~ 174 (198)
T cd05144 164 IYIIDWPQMVS 174 (198)
T ss_pred EEEEECCcccc
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=192.80 Aligned_cols=139 Identities=22% Similarity=0.183 Sum_probs=112.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh-----hchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML-----AGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..|...+.||+|+||+||++.+.. ..+++|+...... .......++.+|+++++.++|++|+....++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345678999999999999998764 3445554322111 112233567889999999999999988877777778
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.++||||++|++|.+++. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998775 346789999999999999999999999999999 678999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=163.95 Aligned_cols=138 Identities=24% Similarity=0.260 Sum_probs=99.7
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHH---------------------HHHHHHHHHHhcCCCC--
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLM---------------------RAQTEREILSLLDHPF-- 172 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~---------------------~~~~E~~il~~l~hpn-- 172 (506)
.+.||+|+||+||+|.+. +|+.||||+++........... ....|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999987 7899999998764321111111 1135666666664433
Q ss_pred ccceeEEEEeCCeEEEEEeecCCCChHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCC
Q 010603 173 LPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDG 250 (506)
Q Consensus 173 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~ 250 (506)
+.+.+++ ...++||||++|+.+.. .+... .. ...++.++.+++.++.++|. .||+||||||+|||++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444443 24689999999855432 11111 01 16678899999999999999 9999999999999999 89
Q ss_pred CEEEeecCCcccc
Q 010603 251 HIMLSDFDLSLRC 263 (506)
Q Consensus 251 ~vkl~DFGla~~~ 263 (506)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=160.57 Aligned_cols=137 Identities=25% Similarity=0.320 Sum_probs=104.8
Q ss_pred eEEe-ecCceEEEEEEEccCCceEEEEEeccchh-----h-----chhHHHHHHHHHHHHHhcCCCCc--cceeEEEEeC
Q 010603 117 KKLG-CGDIGSVYLAELRDMGCLFAMKVMDKGML-----A-----GRKKLMRAQTEREILSLLDHPFL--PTLYSHFETD 183 (506)
Q Consensus 117 ~~LG-~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-----~-----~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~ 183 (506)
..|| .|+.|+||.+... +..++||.+....+ . ......++.+|++++..|+|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3566 7788888888765 77899998865322 0 01223467889999999998875 6777765433
Q ss_pred C-e---EEEEEeecCC-CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecC
Q 010603 184 K-F---SCLLMEFCSG-GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFD 258 (506)
Q Consensus 184 ~-~---~~lV~E~~~g-g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFG 258 (506)
. . .+|||||++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 2 3599999997 689888764 3455543 5689999999999999999999999999999999999999
Q ss_pred Cccc
Q 010603 259 LSLR 262 (506)
Q Consensus 259 la~~ 262 (506)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8853
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=173.29 Aligned_cols=198 Identities=22% Similarity=0.272 Sum_probs=151.6
Q ss_pred HHhcCCCCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe-EEccCCCCc
Q 010603 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV-VYRDLKPEN 243 (506)
Q Consensus 165 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~gi-iHrDLKp~N 243 (506)
|+.+.|.|+.++++.+..+...++|.+||..|+|.+.+... ...++.--...++++|+.||.|||..-| .|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 46789999999999999999999999999999999998874 3567888888899999999999998765 999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
.+++....+||+|||+...... ..
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~-------~~------------------------------------------------- 103 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEE-------TA------------------------------------------------- 103 (484)
T ss_pred ceeeeeEEEEechhhhcccccc-------cc-------------------------------------------------
Confidence 9999999999999998632100 00
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCC-------CCcchhHHHHHHHHHHHhcCCCCCCCCC--
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG-------HGSAVDWWTFGIFFYELLLGRTPFKGNG-- 394 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~DiWSlGvil~elltG~~Pf~~~~-- 394 (506)
.........-...|.|||++.+.. -+.+.||||||+|++|+++...||....
T Consensus 104 -------------------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~ 164 (484)
T KOG1023|consen 104 -------------------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLV 164 (484)
T ss_pred -------------------cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccccccc
Confidence 000000112335799999998742 3567999999999999999999997532
Q ss_pred --cHHHHHHHhC-CCC-CCCC---CCCCCHHHHHHHHHHhhcCCCCccCCC
Q 010603 395 --NRETLFNVVG-QPL-KFPE---GSSISFAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 395 --~~~~~~~i~~-~~~-~~p~---~~~~s~~~~~li~~~L~~dP~~R~s~~ 438 (506)
..+.+..+.. ... ..|. ...+.+++..++..||..+|.+||++.
T Consensus 165 ~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 165 EDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred CChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 2345555544 221 1121 114556789999999999999999963
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=145.63 Aligned_cols=131 Identities=27% Similarity=0.328 Sum_probs=112.2
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC--CCccceeEEEEeCCeEEEEEee
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH--PFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 192 (506)
+++.||.|.++.||++... +..+++|++..... ...+..|+.+++.+.| .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4688999999999999986 47899999876432 3456789999999976 5999999999888899999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM---GVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~---giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+.|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 988888643 4566677889999999999985 79999999999999998999999999985
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.4e-16 Score=158.97 Aligned_cols=262 Identities=21% Similarity=0.184 Sum_probs=194.2
Q ss_pred ccCCeEEEeEEee--cCceEEEEEEE--ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeC
Q 010603 109 GLGHFRLLKKLGC--GDIGSVYLAEL--RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETD 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~--G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 183 (506)
.-..+.+.+.+|. |.+|.||.+.+ ..++..+|+|.=+... .....-.+-.+|..-.+.+ .|+|.|+.+..|+..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccC
Confidence 3345788899999 99999999999 8889999999733211 1112222334566666666 499999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecC
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL----ALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFD 258 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~----aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFG 258 (506)
+..|+-+|+| +.+|..+.... ...+++..++.++.+... ||.++|+.+++|-|+||+||++..+ ...+++|||
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 9999999999 68888876654 456899999999999999 9999999999999999999999999 789999999
Q ss_pred CccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccc
Q 010603 259 LSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVL 338 (506)
Q Consensus 259 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (506)
+...+....-...
T Consensus 269 ~v~~i~~~~~~~~------------------------------------------------------------------- 281 (524)
T KOG0601|consen 269 LVSKISDGNFSSV------------------------------------------------------------------- 281 (524)
T ss_pred eeEEccCCccccc-------------------------------------------------------------------
Confidence 9754321110000
Q ss_pred ccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC--CcHHHHHHHhCCCCCCCCCCCCC
Q 010603 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN--GNRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 339 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~--~~~~~~~~i~~~~~~~p~~~~~s 416 (506)
.......-|...|++||++.+. ++...|++++|.+..+-.+|..++... .....+.+.. ++.......+
T Consensus 282 -----~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e~~~~~s 352 (524)
T KOG0601|consen 282 -----FKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPLEFCEGGS 352 (524)
T ss_pred -----eeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---CchhhhcCcc
Confidence 0000111366789999998754 788999999999999999988776544 2222221111 1111223456
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.++...+..|+..+|..|++ ++.+++|+++...
T Consensus 353 ~~l~~~~~~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 353 SSLRSVTSQMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred hhhhhHHHHhcCcchhhhhH----HHHHhccccccch
Confidence 66667899999999999987 8899999998743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-16 Score=164.37 Aligned_cols=146 Identities=19% Similarity=0.266 Sum_probs=97.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc---------------------------h----hHHHHH
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG---------------------------R----KKLMRA 158 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~---------------------------~----~~~~~~ 158 (506)
..+|.. +.||+|++|+||+|+.+.+|+.||||++++..... . +....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 89999999999999999889999999998653110 0 111122
Q ss_pred HHHHHHHHh------c----CCCCccceeEEEEe-CCeEEEEEeecCCCChHHHHhhCCCC----CCCHHHHHHHHHHHH
Q 010603 159 QTEREILSL------L----DHPFLPTLYSHFET-DKFSCLLMEFCSGGDLHTLRQRQPGK----HFSEQATRFYASEVL 223 (506)
Q Consensus 159 ~~E~~il~~------l----~hpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~----~~~e~~~~~i~~qil 223 (506)
.+|+.+++. + .+.+.+.+-.++.+ ....+|||||+.|+.|.++......+ .+.+..+..++.||+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 333333322 2 13333333333322 34567999999999998753211111 344555555666664
Q ss_pred HHHHHHHhCCeEEccCCCCcEEEecCC----CEEEeecCCcccc
Q 010603 224 LALEYLHMMGVVYRDLKPENVLVREDG----HIMLSDFDLSLRC 263 (506)
Q Consensus 224 ~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFGla~~~ 263 (506)
..|++|+|+||.||+++.+| .++++|||++..+
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 58999999999999999988 9999999998643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.6e-15 Score=154.79 Aligned_cols=142 Identities=23% Similarity=0.235 Sum_probs=96.4
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhch---------------------------hHHH----------HHH
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---------------------------KKLM----------RAQ 159 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---------------------------~~~~----------~~~ 159 (506)
+.||+|++|+||+|+.+ +|+.||||+.+......- ...+ .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999986 589999999876421100 0000 123
Q ss_pred HHHHHHHhc----CCCCccceeEEE-EeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 010603 160 TEREILSLL----DHPFLPTLYSHF-ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL-ALEYLHMMG 233 (506)
Q Consensus 160 ~E~~il~~l----~hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~-aL~yLH~~g 233 (506)
+|.+.+..+ .|.+-|.+-.++ ......+|||||++|++|.++...... ... ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 344444443 222222322222 234457899999999999887654211 122 2345555555 478899999
Q ss_pred eEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 234 VVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 234 iiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
++|+|+||.||+++.+|.++|+|||++..+
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-15 Score=154.05 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=186.9
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEc-cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELR-DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
...+.+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.......++. ...|+.+...+ .|.+++.++..|....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence 345678999999999999999998876 77899999988776543333322 34566666666 5999999999999888
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecCCcccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLSLRC 263 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFGla~~~ 263 (506)
..|+-.|||.++++...+... ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +.-++.|||.+..+
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 899999999999987655332 568888899999999999999999999999999999999986 67899999987432
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.+..
T Consensus 418 ~~~~---------------------------------------------------------------------------- 421 (524)
T KOG0601|consen 418 AFSS---------------------------------------------------------------------------- 421 (524)
T ss_pred ceec----------------------------------------------------------------------------
Confidence 1110
Q ss_pred CCCccccccCCCCc--cchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 344 SARSMSFVGTHEYL--APEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~--APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
....++-.++ +++.+....+..++|++|||.-+.|.++|...-..... ...+..+. .|.......++..
T Consensus 422 ----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~--~p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 422 ----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD--TPNLPGLKLQLQV 492 (524)
T ss_pred ----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc--ccCCCchHHhhhh
Confidence 0011222344 45555556688999999999999999998665332221 22222222 2222234578889
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
+.+.++..++..|+. +.++..|.=|.
T Consensus 493 ~~kv~~~~~~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPS----AVELSLHSEFY 518 (524)
T ss_pred hhhhhcCCccccchh----hhhhcccchhh
Confidence 999999999999986 67777776553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.3e-14 Score=128.77 Aligned_cols=127 Identities=24% Similarity=0.321 Sum_probs=96.5
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc-cceeEEEEeCCeEEEEEeecC
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL-PTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 194 (506)
++.|+.|.++.||++... ++.|+||+...... .......|+.+++.+.+.++ .+++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 478899999999999876 77899998765421 12234678899988865554 45555433 33579999999
Q ss_pred CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe-----EEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 195 GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV-----VYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 195 gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~gi-----iHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
|.++... ......++.+++.+|..||..++ +|+|++|.|||++ ++.++++|||.+.
T Consensus 75 G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9888642 01123456899999999999985 9999999999999 6789999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.4e-13 Score=141.35 Aligned_cols=138 Identities=17% Similarity=0.168 Sum_probs=108.3
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
|.| ...+-++.+.+-.|..+.++..|.|.+.+.... .....+.+-+.-|+.|+||||+++++.++.++.+|||+|-
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 444 333334444333566777888999988875432 3344566677889999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH-~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+. .|..++++. ....+..-+.||+.||-||| ..+++|++|.-.-|+++..|+.||++|.++.
T Consensus 91 V~--Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 91 VR--PLETVLKEL-----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred cc--cHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 84 466666653 36677778899999999998 5689999999999999999999999999873
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-13 Score=125.95 Aligned_cols=138 Identities=19% Similarity=0.185 Sum_probs=101.2
Q ss_pred eEEeecCceEEEEEEEcc------CCceEEEEEeccchhh--c-----------------hhHHHH----HHHHHHHHHh
Q 010603 117 KKLGCGDIGSVYLAELRD------MGCLFAMKVMDKGMLA--G-----------------RKKLMR----AQTEREILSL 167 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~------~~~~vAiK~i~~~~~~--~-----------------~~~~~~----~~~E~~il~~ 167 (506)
..||.|--+.||.|.... .+..+|||+.+..... . ...... +++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998654 3578999997632110 0 011122 3479999988
Q ss_pred cCC--CCccceeEEEEeCCeEEEEEeecCCCChHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCeEEccCCCCc
Q 010603 168 LDH--PFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL-HMMGVVYRDLKPEN 243 (506)
Q Consensus 168 l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~~~~~e~~~~~i~~qil~aL~yL-H~~giiHrDLKp~N 243 (506)
+.. -++..++++ ..-+|||||+.++.+.. .++. ..++++.+..+..|++.+|..| |..||||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 466677764 45689999997654432 2222 3456667778889999999999 89999999999999
Q ss_pred EEEecCCCEEEeecCCccc
Q 010603 244 VLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~ 262 (506)
||+. ++.+.|+|||.|..
T Consensus 156 IL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEEE-CCcEEEEECCCcee
Confidence 9997 57899999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.1e-15 Score=140.66 Aligned_cols=247 Identities=19% Similarity=0.241 Sum_probs=159.1
Q ss_pred EEEEEEEccCCceEEEEEeccchhhch-hHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----eEEEEEeecCCCChH
Q 010603 126 SVYLAELRDMGCLFAMKVMDKGMLAGR-KKLMRAQTEREILSLLDHPFLPTLYSHFETDK-----FSCLLMEFCSGGDLH 199 (506)
Q Consensus 126 ~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L~ 199 (506)
.||++.++..|..|.--.+........ .+......-..-|-.+.|.|||+++.+|.+.. ...+++|||..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 477777777665554332221110000 00011111122245567999999999986544 578999999999999
Q ss_pred HHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 200 TLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 200 ~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
.++++. ....+....-++|+-||+.||.|||+.. |+|+++..+-|++..+|-+|+.--.... +
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s--------~----- 227 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS--------T----- 227 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc--------c-----
Confidence 998873 3356788888899999999999999986 9999999999999999888875321110 0
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
.+.+ .... +.. ...-.|-++
T Consensus 228 -----------------------------------h~s~-----~~~~-----------------~~E---k~~~~~~~g 247 (458)
T KOG1266|consen 228 -----------------------------------HPSV-----NSTR-----------------EAE---KSVNTSLPG 247 (458)
T ss_pred -----------------------------------chhh-----hhhh-----------------Hhh---hhccccCCc
Confidence 0000 0000 000 011146678
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC-CCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF-KGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
|.|||.=.....+.++|||+||....||..|..-- .+.+..+.-.++....+.+.. ..-++++.+||+..|..|
T Consensus 248 ~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len-----~lqr~~i~kcl~~eP~~r 322 (458)
T KOG1266|consen 248 FSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN-----GLQRGSITKCLEGEPNGR 322 (458)
T ss_pred cccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC-----ccccCcCcccccCCCCCC
Confidence 89998765555677999999999999999876542 222222222222211111111 223468999999999999
Q ss_pred cCCCCChHHhhcCCCCCCCC
Q 010603 435 LGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 435 ~s~~~~a~ell~hp~f~~~~ 454 (506)
|+ |.+++.||.+-.+.
T Consensus 323 p~----ar~llfHpllfeVh 338 (458)
T KOG1266|consen 323 PD----ARLLLFHPLLFEVH 338 (458)
T ss_pred cc----hhhhhcCceeeecc
Confidence 97 88999999886654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.5e-12 Score=113.54 Aligned_cols=145 Identities=21% Similarity=0.192 Sum_probs=113.9
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEec-----cchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMD-----KGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~-----~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.+..|-+|+-+.|+++.+. |+.+.||.=- ...+..+-...+..+|+++|.++.--.|.--.=+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999887 8888888522 22333334456678899999888655665555567777778899
Q ss_pred EeecCC-CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CEEEeecCCcc
Q 010603 190 MEFCSG-GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIMLSDFDLSL 261 (506)
Q Consensus 190 ~E~~~g-g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFGla~ 261 (506)
|||++| -++.+++..........+....++.+|=..|.-||.++|||+||..+||||..+| .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999976 4788888776555555666578899999999999999999999999999998776 35899999983
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.7e-12 Score=113.46 Aligned_cols=133 Identities=21% Similarity=0.213 Sum_probs=99.8
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccc-----hhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKG-----MLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
..+++|+-+.+|++.+. |..+.+|.=-+. .+..+-...+..+|..+|..+.--.|..-.=++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999775 556777753222 22333344566789999988865555444445556677789999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
|++|-.|.+++... . ..++..|=.-+.-||..||||+||.++||++..++ +.++||||+.
T Consensus 80 ~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999999888764 1 34566677777889999999999999999998765 9999999985
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-11 Score=117.77 Aligned_cols=139 Identities=22% Similarity=0.258 Sum_probs=106.5
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC--CCccceeEEEEeC---CeEEEEEe
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH--PFLPTLYSHFETD---KFSCLLME 191 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 191 (506)
+.||.|.++.||++.... |+.|++|+....... .....+..|.++++.+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998764 688999998654321 123456789999999865 4467777776654 36789999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM---------------------------------------- 231 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~---------------------------------------- 231 (506)
|++|.+|...+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988765421 246677777777788888888774
Q ss_pred ----------------CCeEEccCCCCcEEEec--CCCEEEeecCCcc
Q 010603 232 ----------------MGVVYRDLKPENVLVRE--DGHIMLSDFDLSL 261 (506)
Q Consensus 232 ----------------~giiHrDLKp~NILl~~--~~~vkl~DFGla~ 261 (506)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23799999999999998 6678999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.1e-10 Score=113.86 Aligned_cols=135 Identities=19% Similarity=0.164 Sum_probs=108.6
Q ss_pred CceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe----CCeEEEEEeecCC-CC
Q 010603 123 DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----DKFSCLLMEFCSG-GD 197 (506)
Q Consensus 123 ~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~ 197 (506)
--.+.|+|....+|..|++|.++......... ...-+++++++.|+|||.+.++|.+ +..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34678999999999999999996544333222 2346789999999999999999974 3478999999876 57
Q ss_pred hHHHHhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 198 LHTLRQRQ-------------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 198 L~~~l~~~-------------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
|.++.-.. .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|+.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 77753321 2345789999999999999999999999999999999999998888888877754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-10 Score=106.33 Aligned_cols=127 Identities=26% Similarity=0.298 Sum_probs=83.6
Q ss_pred EEEEEEEccCCceEEEEEeccchhhc-----------------------hhHHHHHHHHHHHHHhcCCC--CccceeEEE
Q 010603 126 SVYLAELRDMGCLFAMKVMDKGMLAG-----------------------RKKLMRAQTEREILSLLDHP--FLPTLYSHF 180 (506)
Q Consensus 126 ~Vy~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~il~~l~hp--nIv~l~~~~ 180 (506)
.||.|.... |..+|||+.+.....- .......++|.+.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 389998754 7799999976431110 01123467899999999765 566776543
Q ss_pred EeCCeEEEEEeecC--CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCeEEccCCCCcEEEecCCCEEEeec
Q 010603 181 ETDKFSCLLMEFCS--GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY-LHMMGVVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 181 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~y-LH~~giiHrDLKp~NILl~~~~~vkl~DF 257 (506)
.-+|||||++ |..|..+.... ++.+....++.+++..+.. +|..||||+||.+.|||++++ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 3469999998 66665543322 2245566778888885555 579999999999999999977 9999999
Q ss_pred CCccc
Q 010603 258 DLSLR 262 (506)
Q Consensus 258 Gla~~ 262 (506)
|.|..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98853
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.1e-10 Score=108.16 Aligned_cols=134 Identities=16% Similarity=0.081 Sum_probs=94.9
Q ss_pred EEEEEEEccCCceEEEEEeccchhhc--------hhHHHHHHHHHHHHHhcCCCC--ccceeEEEEe-----CCeEEEEE
Q 010603 126 SVYLAELRDMGCLFAMKVMDKGMLAG--------RKKLMRAQTEREILSLLDHPF--LPTLYSHFET-----DKFSCLLM 190 (506)
Q Consensus 126 ~Vy~a~~~~~~~~vAiK~i~~~~~~~--------~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~-----~~~~~lV~ 190 (506)
.|+++... |+.|.||......... ......+.+|...+..|..-+ ++.++++++. ....+|||
T Consensus 37 rvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 35565443 7789999664322110 011123678888887774333 3344555543 23578999
Q ss_pred eecCCC-ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-------CCCEEEeecCCcc
Q 010603 191 EFCSGG-DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-------DGHIMLSDFDLSL 261 (506)
Q Consensus 191 E~~~gg-~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-------~~~vkl~DFGla~ 261 (506)
|++++. +|.+++........++.....++.+|+..+.-||..||+|+||++.|||++. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999876 7998876432345677788899999999999999999999999999999985 4679999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.3e-11 Score=125.57 Aligned_cols=166 Identities=20% Similarity=0.306 Sum_probs=117.7
Q ss_pred HHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCc
Q 010603 220 SEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPV 298 (506)
Q Consensus 220 ~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (506)
.+++.||.|+|.. ++||++|.|++|.++..|..||+.|+.+........ . .|....-++
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-------~-----------p~~~yd~~l-- 165 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-------Y-----------PFSEYDPPL-- 165 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-------c-----------ccccCCCCC--
Confidence 3455999999965 899999999999999999999999998632111000 0 000000000
Q ss_pred cCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHH
Q 010603 299 CVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGI 378 (506)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGv 378 (506)
.....-...|.|||++.+...+.++|++||||
T Consensus 166 ------------------------------------------------p~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~ 197 (700)
T KOG2137|consen 166 ------------------------------------------------PLLLQPHLNFLAPEYLLGTTNTPASDVFSLGV 197 (700)
T ss_pred ------------------------------------------------ChhhccCcccccchhhccccccccccceeeee
Confidence 01113456899999999987889999999999
Q ss_pred HHHHHh-cCCCCCCCCCcHHHHHHH--hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 379 FFYELL-LGRTPFKGNGNRETLFNV--VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 379 il~ell-tG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
++|.+. .|+..+............ ..+-..+-....++.++++=|.++|..++..||+ +.+++.-|||.+..-
T Consensus 198 li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 198 LIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGL 273 (700)
T ss_pred EEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchh
Confidence 999999 777777665443332221 1122222233578999999999999999999996 889999999987554
Q ss_pred ch
Q 010603 456 AL 457 (506)
Q Consensus 456 ~~ 457 (506)
..
T Consensus 274 ~a 275 (700)
T KOG2137|consen 274 KA 275 (700)
T ss_pred hh
Confidence 33
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.6e-09 Score=100.23 Aligned_cols=136 Identities=26% Similarity=0.286 Sum_probs=101.3
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc-------------------hhHHHHHHHHHHHHHhcCCC--
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-------------------RKKLMRAQTEREILSLLDHP-- 171 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-------------------~~~~~~~~~E~~il~~l~hp-- 171 (506)
+.+...||-|--+.||.|.+.. |..+|||.=+.....- ......+++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 5677899999999999999884 8899999754321110 01123467899999999654
Q ss_pred CccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 172 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
.|.+.+++ +...+||||++|-.|.... +..+.+..++..|+.-+.-+-..||||+|+.+=|||++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666654 3567999999998886542 233444455566666666566899999999999999999999
Q ss_pred EEEeecCCc
Q 010603 252 IMLSDFDLS 260 (506)
Q Consensus 252 vkl~DFGla 260 (506)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.2e-08 Score=94.52 Aligned_cols=105 Identities=29% Similarity=0.277 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcCC--CCccceeEEEEeCC----eEEEEEeecCCC-ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH
Q 010603 156 MRAQTEREILSLLDH--PFLPTLYSHFETDK----FSCLLMEFCSGG-DLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228 (506)
Q Consensus 156 ~~~~~E~~il~~l~h--pnIv~l~~~~~~~~----~~~lV~E~~~gg-~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~y 228 (506)
.++.+|...+..|.. -.++..+++.+... ..+||||++++. +|.+++.... ..+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 356778877766642 23455666655432 458999999884 7999887642 26777788899999999999
Q ss_pred HHhCCeEEccCCCCcEEEecCC---CEEEeecCCccc
Q 010603 229 LHMMGVVYRDLKPENVLVREDG---HIMLSDFDLSLR 262 (506)
Q Consensus 229 LH~~giiHrDLKp~NILl~~~~---~vkl~DFGla~~ 262 (506)
||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999987 899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-07 Score=88.87 Aligned_cols=140 Identities=19% Similarity=0.222 Sum_probs=94.3
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHH------HHHHHHHHHhc---CCCCccceeE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMR------AQTEREILSLL---DHPFLPTLYS 178 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~E~~il~~l---~hpnIv~l~~ 178 (506)
+.-++|.+++.+-......|.+-.-. |+.+.+|..+...-..+..+.. ..+++..+..+ .-..++.++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 44567999999999888888777655 7899999987543222222221 12333333333 2233333333
Q ss_pred EEE-----eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEE
Q 010603 179 HFE-----TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 179 ~~~-----~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 253 (506)
+.+ -....+|||||++|..|.++.. +++. +...|+.+|.-||+.|++|+|..|.|++++.+ .++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEE
Confidence 322 2235568999999998876532 3332 44567788999999999999999999999965 499
Q ss_pred EeecCCc
Q 010603 254 LSDFDLS 260 (506)
Q Consensus 254 l~DFGla 260 (506)
++||+..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999975
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.5e-07 Score=87.97 Aligned_cols=141 Identities=15% Similarity=0.121 Sum_probs=100.5
Q ss_pred eecCceEEEEEEEccCCceEEEEEeccch---hhchhHHHHHHHHHHHHHhcCCCC--ccceeEEEEe--C--CeEEEEE
Q 010603 120 GCGDIGSVYLAELRDMGCLFAMKVMDKGM---LAGRKKLMRAQTEREILSLLDHPF--LPTLYSHFET--D--KFSCLLM 190 (506)
Q Consensus 120 G~G~fG~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~--~--~~~~lV~ 190 (506)
|.||-+-|+..... |+.|=||.-.... +.-..-...+.+|...|..|..-+ +.+....-.. + -..+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888889887765 4567788754211 110122345678888888774322 4444422111 1 2467999
Q ss_pred eecCC-CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC--EEEeecCCccc
Q 010603 191 EFCSG-GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH--IMLSDFDLSLR 262 (506)
Q Consensus 191 E~~~g-g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--vkl~DFGla~~ 262 (506)
|-+.| -+|.+++....-.+.++.....++.+|+..|.-||+.|+.|+|+-+.|||++.+|. |+++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98744 58888887654456678888889999999999999999999999999999987777 99999997754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.2e-07 Score=95.17 Aligned_cols=236 Identities=22% Similarity=0.224 Sum_probs=148.6
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh-cCCCCccceeEEE------EeC-CeE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHPFLPTLYSHF------ETD-KFS 186 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~------~~~-~~~ 186 (506)
..+.||+|+-+.+|-.-... ..+.|+..+...... .+.++.|.. -.||-+-.-+.|= ... ..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 34789999999999764432 235588776432211 112333333 3666443312221 112 236
Q ss_pred EEEEeecCCCC-hHHHH----hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 187 CLLMEFCSGGD-LHTLR----QRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 187 ~lV~E~~~gg~-L~~~l----~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
-++|..+.|.. ...+. +++......+.-+...++.|+.+.+-||..|.+-+|+.++|+|+++++.|.|.|=.--.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78888887652 22221 12223456788889999999999999999999999999999999999999999844210
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.+
T Consensus 166 i~------------------------------------------------------------------------------ 167 (637)
T COG4248 166 IN------------------------------------------------------------------------------ 167 (637)
T ss_pred ec------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCCCCccccccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcC-CCCCCCCC-------cHH-HHH-------
Q 010603 342 PTSARSMSFVGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLG-RTPFKGNG-------NRE-TLF------- 400 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG-~~Pf~~~~-------~~~-~~~------- 400 (506)
..+......+|...|.+||.-. +..-+...|.|.|||++|+||.| +.||.+.. ..| .+.
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 0111122348999999999865 33346789999999999999987 99997632 111 110
Q ss_pred HHhCCCCCC----CCCCCCCHHHHHHHHHHhhc--CCCCccCC
Q 010603 401 NVVGQPLKF----PEGSSISFAAKDLIRGLLVK--DPQKRLGF 437 (506)
Q Consensus 401 ~i~~~~~~~----p~~~~~s~~~~~li~~~L~~--dP~~R~s~ 437 (506)
......+.. +...-+++++..|..+|+.. ++.-||+-
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 000111111 11235778888999999874 35578873
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.3e-08 Score=104.77 Aligned_cols=143 Identities=24% Similarity=0.260 Sum_probs=90.0
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhch---------------------------hHH----HH------HH
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---------------------------KKL----MR------AQ 159 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---------------------------~~~----~~------~~ 159 (506)
..|+.++-|+||+|+.+. |+.||||+.+.+....- ..+ +. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999987 99999999886432100 000 11 12
Q ss_pred HHHHHHHhc-----CCCCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Q 010603 160 TEREILSLL-----DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234 (506)
Q Consensus 160 ~E~~il~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~gi 234 (506)
+|..-+.++ +.++|.--.=+++-.+.-.|+|||++|-.+.+...... ..++...+.....++ -+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 333333333 23433222223344556679999999999988743322 334422222211111 1222334799
Q ss_pred EEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 235 VYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 235 iHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+|.|..|.||+++.+|.+.+.|||+..++
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999998554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.3e-10 Score=115.80 Aligned_cols=243 Identities=16% Similarity=0.155 Sum_probs=161.9
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC-ccceeEEEEeCCeEEEEEe
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF-LPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E 191 (506)
|....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.+.+.+++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 445566789999999999887665444 6666432 33455899999999999 7788888888889999999
Q ss_pred ecCCC-ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 192 FCSGG-DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg-~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
++.++ +-...+... .-.+.+-+...+.+.-+++++|||+.-=+||| |||..+ +..|+.||+.+..+...
T Consensus 315 i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~---- 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT---- 384 (829)
T ss_pred hhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc----
Confidence 99887 222111110 01233334445667778899999998778999 888765 68899999976322100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....+.
T Consensus 385 --------------------------------------------------------------------------~~~~t~ 390 (829)
T KOG0576|consen 385 --------------------------------------------------------------------------MKPRTA 390 (829)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 012345
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC--CCCCCCCCHHHH-HHHHHHh
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK--FPEGSSISFAAK-DLIRGLL 427 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~~~s~~~~-~li~~~L 427 (506)
.+|+.++|||+.....+....|.|++|+--.+|.-|-+|-.. .......+-..+-. +.....+++... ++...|+
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~ 468 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCL 468 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCccccc
Confidence 799999999999999999999999999987888877776432 11111111001100 000001111122 4777788
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
...|..|+. +..++.|.+|+...
T Consensus 469 ~g~P~~pkv----~mgacfsKvfngCp 491 (829)
T KOG0576|consen 469 NGLPPTPKV----HMGACFSKVFNGCP 491 (829)
T ss_pred CCCCCCCcc----hhhHHHHHHhccCc
Confidence 888888765 78889999987643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-06 Score=84.14 Aligned_cols=134 Identities=13% Similarity=0.108 Sum_probs=84.6
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC--ccceeEEEEeCCeEEEEEeecC
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF--LPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ 194 (506)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 67899999999984 25568899876432 2234577999998886433 4677888888888899999998
Q ss_pred CCC-hH--------------HH-------HhhC--CCCCCCHHHHHHHHHH----------HHH-HHHHHHh----CCeE
Q 010603 195 GGD-LH--------------TL-------RQRQ--PGKHFSEQATRFYASE----------VLL-ALEYLHM----MGVV 235 (506)
Q Consensus 195 gg~-L~--------------~~-------l~~~--~~~~~~e~~~~~i~~q----------il~-aL~yLH~----~gii 235 (506)
|.+ +. .. ++.. ....++... ..+..+ +.. ...+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 864 11 10 1111 111111111 111111 111 1222221 2479
Q ss_pred EccCCCCcEEEecCCCEEEeecCCcc
Q 010603 236 YRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 236 HrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
|+|+.|.||++++++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999873
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-06 Score=81.05 Aligned_cols=128 Identities=23% Similarity=0.294 Sum_probs=90.8
Q ss_pred CCeEEEeEEeecCc-eEEEEEEEccCCceEEEEEeccchh----------hch--------hHHHHHHHHHHHH---Hhc
Q 010603 111 GHFRLLKKLGCGDI-GSVYLAELRDMGCLFAMKVMDKGML----------AGR--------KKLMRAQTEREIL---SLL 168 (506)
Q Consensus 111 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~~~vAiK~i~~~~~----------~~~--------~~~~~~~~E~~il---~~l 168 (506)
.+++.++.||.|.- |.||+++.. |+.||||++..-.. ... .....+..|.+.. +.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 56999999999999 999999887 88999999432111 000 1223456677764 445
Q ss_pred CCCCc--cceeEEEEeC------------------CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH
Q 010603 169 DHPFL--PTLYSHFETD------------------KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228 (506)
Q Consensus 169 ~hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~y 228 (506)
++.++ |+.+||+.-. ...-||.||++... .+... -+.+|+.-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 56677 8999987311 12457888875543 12222 35678888899
Q ss_pred HHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 229 LH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999987 3589999964
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.4e-06 Score=82.69 Aligned_cols=137 Identities=22% Similarity=0.214 Sum_probs=92.4
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHH---------------------HHHHHHHHHHHhcC--CCCc
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKL---------------------MRAQTEREILSLLD--HPFL 173 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~---------------------~~~~~E~~il~~l~--hpnI 173 (506)
..|..|--+.||+|... ++..+|+|+.+......+... .-...|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 46777888889999764 478999999875433222110 01234555566652 3444
Q ss_pred cceeEEEEeCCeEEEEEeecCCCChH-HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCC
Q 010603 174 PTLYSHFETDKFSCLLMEFCSGGDLH-TLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 174 v~l~~~~~~~~~~~lV~E~~~gg~L~-~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~ 251 (506)
.+-+++.. -.|||||+...-+. -.+.. -.+..+.+..+..+++..+.-|-. .|+||+||..=|||+. ++.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 45444432 46999999443111 11111 234444788888999999998877 8999999999999999 889
Q ss_pred EEEeecCCccc
Q 010603 252 IMLSDFDLSLR 262 (506)
Q Consensus 252 vkl~DFGla~~ 262 (506)
+.|+|||-|..
T Consensus 205 p~iID~~QaV~ 215 (268)
T COG1718 205 PYIIDVSQAVT 215 (268)
T ss_pred EEEEECccccc
Confidence 99999998853
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.51 E-value=2e-06 Score=81.96 Aligned_cols=139 Identities=24% Similarity=0.309 Sum_probs=83.3
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC--CccceeEEEE---eCCeEEEEE
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP--FLPTLYSHFE---TDKFSCLLM 190 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~---~~~~~~lV~ 190 (506)
++.|+.|..+.||++.... ..+++|+.... .....+..|..+++.|... -+.+++.+.. .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998875 48999997653 2345566788888887433 3566766443 233578999
Q ss_pred eecCCCChHH----------------HHh---hC--CCCCCCHHH---HH---HH---------------HHHHHH-HHH
Q 010603 191 EFCSGGDLHT----------------LRQ---RQ--PGKHFSEQA---TR---FY---------------ASEVLL-ALE 227 (506)
Q Consensus 191 E~~~gg~L~~----------------~l~---~~--~~~~~~e~~---~~---~i---------------~~qil~-aL~ 227 (506)
++++|..+.. .+. .. ....+.... .. .+ ...+.. .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 111111100 00 00 111222 233
Q ss_pred HHH-------hCCeEEccCCCCcEEEe-cCCCEEEeecCCcc
Q 010603 228 YLH-------MMGVVYRDLKPENVLVR-EDGHIMLSDFDLSL 261 (506)
Q Consensus 228 yLH-------~~giiHrDLKp~NILl~-~~~~vkl~DFGla~ 261 (506)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24599999999999999 66667899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.1e-06 Score=94.63 Aligned_cols=203 Identities=23% Similarity=0.282 Sum_probs=136.8
Q ss_pred HHHHHHHHHHHHhcCCCCccceeEEEEeCCe----EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 010603 155 LMRAQTEREILSLLDHPFLPTLYSHFETDKF----SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230 (506)
Q Consensus 155 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH 230 (506)
+.....|.+.+.++.|+|++.++.|-..... ..+..|+|.+-++...++.. ..++.+.++.+..+++.||.|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH
Confidence 3344456666888899999999988754432 33557899999999988876 67899999999999999999999
Q ss_pred hCCeEEccCCCC---cEEEecCCCEEEe--ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCC
Q 010603 231 MMGVVYRDLKPE---NVLVREDGHIMLS--DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCL 305 (506)
Q Consensus 231 ~~giiHrDLKp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (506)
+....|.-|-.. +--.+.++.+.+. ||+..+.....
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~--------------------------------------- 344 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN--------------------------------------- 344 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCc---------------------------------------
Confidence 985544444333 3333344455555 66654321100
Q ss_pred CCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcc--hhHHHHHHHHHHH
Q 010603 306 QPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSA--VDWWTFGIFFYEL 383 (506)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~--~DiWSlGvil~el 383 (506)
.......-+..|.|+|.+....+..+ .|+|.+|..+..+
T Consensus 345 ---------------------------------------~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 345 ---------------------------------------EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ---------------------------------------ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 00111234456778888877666544 6999999999999
Q ss_pred hcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 384 LLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 384 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
..|..+-.... ....++.. .......+++.+|+..++++|++ +.+++.|+|.+.
T Consensus 386 ~~~~~i~~~~~---~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 386 SQGEDISEKSA---VPVSLLDV--------LSTSELLDALPKCLDEDSEERLS----ALELLTHPFLRF 439 (1351)
T ss_pred hhcCccccccc---chhhhhcc--------ccchhhhhhhhhhcchhhhhccc----hhhhhhchhccc
Confidence 98765532111 11111111 11115778999999999999997 899999999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.6e-06 Score=81.47 Aligned_cols=136 Identities=20% Similarity=0.157 Sum_probs=84.3
Q ss_pred EEeecCc-eEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEEEeecCC
Q 010603 118 KLGCGDI-GSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLLMEFCSG 195 (506)
Q Consensus 118 ~LG~G~f-G~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 195 (506)
.|-.|.. ..||++... +..+.||+..... .....+|+++++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4555655 789999654 4678889875432 223566888888873 44466788888777778999999999
Q ss_pred CChHHHH-------------------hhCC--CCCCCHH------HHHHH-------------------HHHHHHHHHHH
Q 010603 196 GDLHTLR-------------------QRQP--GKHFSEQ------ATRFY-------------------ASEVLLALEYL 229 (506)
Q Consensus 196 g~L~~~l-------------------~~~~--~~~~~e~------~~~~i-------------------~~qil~aL~yL 229 (506)
..|.... +..+ ...+... ..... ..+++..|.-.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8775321 1111 0111110 00000 11111111111
Q ss_pred ----HhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 230 ----HMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 230 ----H~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
....++|+|+.|.|||++.++.+.|+||+.|.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12349999999999999998778999999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.4e-06 Score=89.39 Aligned_cols=139 Identities=23% Similarity=0.285 Sum_probs=86.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhc----------------------------hhHHHHH------HHHH
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG----------------------------RKKLMRA------QTER 162 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~----------------------------~~~~~~~------~~E~ 162 (506)
+.||.-+.|+||+|+.+. |+.||||+-+.+.-.. .+..+.+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999998 9999999977542110 0000011 1222
Q ss_pred H----HHHhcCCCC------ccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 010603 163 E----ILSLLDHPF------LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA-LEYLHM 231 (506)
Q Consensus 163 ~----il~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~a-L~yLH~ 231 (506)
+ +.+.+.|-+ |.+++- .-.....|+||||+|..+.++-.-.. ..++...+.. .+..+ ++-|=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~---~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILN---KLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHH---HHHHHHHHHHHh
Confidence 2 223334444 333332 22345679999999988776533221 2455443332 22222 122334
Q ss_pred CCeEEccCCCCcEEEec----CCCEEEeecCCccc
Q 010603 232 MGVVYRDLKPENVLVRE----DGHIMLSDFDLSLR 262 (506)
Q Consensus 232 ~giiHrDLKp~NILl~~----~~~vkl~DFGla~~ 262 (506)
.|++|.|=.|.||+++. ++.+.+-|||+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 68999999999999994 56899999999753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.9e-06 Score=92.48 Aligned_cols=81 Identities=20% Similarity=0.357 Sum_probs=57.5
Q ss_pred EEeEEeecCceEEEEEEEccCC--ceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCc--cceeEEEEeC---CeE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMG--CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFL--PTLYSHFETD---KFS 186 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---~~~ 186 (506)
-++.|+.|.+..+|+......+ ..+++|+....... .....+.+|.++|+.|. |++| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3578899999999998775432 46788876443211 12235678999999995 6665 7777777654 467
Q ss_pred EEEEeecCCCC
Q 010603 187 CLLMEFCSGGD 197 (506)
Q Consensus 187 ~lV~E~~~gg~ 197 (506)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.5e-06 Score=75.13 Aligned_cols=129 Identities=27% Similarity=0.320 Sum_probs=91.5
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccc-eeEEEEeCCeEEEEEe
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT-LYSHFETDKFSCLLME 191 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~~~~lV~E 191 (506)
-+..+.||+|.+|.||++.++ |..+|+|+-+.+ .....++.|+++|..+.-.++-. ++.+-+ .++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 345678999999999999998 779999987653 34456778999999998766654 333322 235599
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCC-CCcEEEecCCCEEEeecCCcc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLK-PENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLK-p~NILl~~~~~vkl~DFGla~ 261 (506)
|+.|-.|.++-.. .+ +.-...++..---|-..||-|..|. |..++|..++.+.|+||.-|.
T Consensus 93 ~i~G~~L~~~~~~-----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 93 YIDGRPLGKLEIG-----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhcCcchhhhhhc-----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9999888765331 11 2223345555445667799999886 666666666799999999885
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.1e-05 Score=72.32 Aligned_cols=132 Identities=20% Similarity=0.255 Sum_probs=92.7
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhh-------------chhHHHHHHHHHHHHHhcC------CCCcccee
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA-------------GRKKLMRAQTEREILSLLD------HPFLPTLY 177 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-------------~~~~~~~~~~E~~il~~l~------hpnIv~l~ 177 (506)
..||+|+.-.||.--+ .....||++...... ......+..+|+.-...+. +..|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5799999999998533 335689998876510 0112344455655544443 78999999
Q ss_pred EEEEeCCeEEEEEeecCC------CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-
Q 010603 178 SHFETDKFSCLLMEFCSG------GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG- 250 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~- 250 (506)
|+.+++-..-+|+|.+.. -+|.+++.. ..+++ .. ...+-.-.+||-.++|+.+||+|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999998754 257777754 34665 32 23344456688999999999999999997643
Q ss_pred ---CEEEee-cC
Q 010603 251 ---HIMLSD-FD 258 (506)
Q Consensus 251 ---~vkl~D-FG 258 (506)
.+.|+| ||
T Consensus 157 ~~~~lvlIDG~G 168 (199)
T PF10707_consen 157 GEFRLVLIDGLG 168 (199)
T ss_pred CceEEEEEeCCC
Confidence 477887 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.5e-05 Score=76.84 Aligned_cols=74 Identities=11% Similarity=0.161 Sum_probs=46.8
Q ss_pred EeEEeecCce-EEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC---CccceeEEEEeC---CeEEE
Q 010603 116 LKKLGCGDIG-SVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP---FLPTLYSHFETD---KFSCL 188 (506)
Q Consensus 116 ~~~LG~G~fG-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~---~~~~l 188 (506)
++.|+.|+.. .||+. +..+++|+.... .....+.+|.++|+.|... -+..+++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567877776 59986 235778875542 1234577899999887532 344445443332 24588
Q ss_pred EEeecCCCChH
Q 010603 189 LMEFCSGGDLH 199 (506)
Q Consensus 189 V~E~~~gg~L~ 199 (506)
|||+++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.1e-05 Score=72.86 Aligned_cols=75 Identities=21% Similarity=0.339 Sum_probs=49.4
Q ss_pred EeEEeecCceEEEEEEEcc-CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC-CCccceeEEEEeCCeEEEEEeec
Q 010603 116 LKKLGCGDIGSVYLAELRD-MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-PFLPTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~ 193 (506)
++.|..|-...||++.... .++.|++|+...... ......+|+.+++.+.. .-++++++.+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4678888899999997553 356899998764321 11123468888888843 33455555433 2 3799999
Q ss_pred CCCCh
Q 010603 194 SGGDL 198 (506)
Q Consensus 194 ~gg~L 198 (506)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.6e-07 Score=101.21 Aligned_cols=253 Identities=11% Similarity=-0.042 Sum_probs=156.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc--hhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCeE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG--RKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKFS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 186 (506)
.+|++.=-+|-|.+++--.-+.+.. .+-+|+-+.-.+.. +...+....|+..++...|++++..+.-... ....
T Consensus 1229 e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee 1306 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEE 1306 (2724)
T ss_pred hhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHH
Confidence 4566555566665554322222221 34555544322111 1122334456666777899998877665543 3467
Q ss_pred EEEEeecCCCChHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEccCCCCcEEEecCCCEEEeecCC
Q 010603 187 CLLMEFCSGGDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMG-----VVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~--~~~~~e~~~~~i~~qil~aL~yLH~~g-----iiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
|.+++||.+|++++.+-+.- ...+.+.-+.....+.+.+..-+|+.. .+|++||+-|.+|..+..+|++++|+
T Consensus 1307 ~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gL 1386 (2724)
T KOG1826|consen 1307 YIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGL 1386 (2724)
T ss_pred HHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccccc
Confidence 89999999999999876532 123344444444455477777777642 89999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
++-.
T Consensus 1387 dKIk---------------------------------------------------------------------------- 1390 (2724)
T KOG1826|consen 1387 DKIK---------------------------------------------------------------------------- 1390 (2724)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 8510
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC----CCCCCCCC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL----KFPEGSSI 415 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----~~p~~~~~ 415 (506)
.+........++++.|++|++...-.++.++|+|..|+-+|++--|..+|-. ..+.++.+.+ .+......
T Consensus 1391 -np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~ 1464 (2724)
T KOG1826|consen 1391 -NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEKLK 1464 (2724)
T ss_pred -CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCcccccccccccccC
Confidence 0001112334788999999999888899889999999999999998888732 2222222221 11111122
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
+.++..+...+|-..-..||. ....+.-+.|.
T Consensus 1465 pgdaNve~~~~Ll~K~~~rp~----q~isls~d~~a 1496 (2724)
T KOG1826|consen 1465 PGDANVEALHRLLWKYMERPG----QYISLSRDHFA 1496 (2724)
T ss_pred CCcccHHHHHHHHHHhhhcch----hhhhccccccc
Confidence 344444455555556677886 45566655553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.6e-05 Score=70.75 Aligned_cols=99 Identities=23% Similarity=0.256 Sum_probs=78.6
Q ss_pred HHHHHHHHhcCC-CCccceeEEEEeCCeEEEEEeecCCCChHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 010603 159 QTEREILSLLDH-PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQR-QPGKHFSEQATRFYASEVLLALEYLHM---MG 233 (506)
Q Consensus 159 ~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~e~~~~~i~~qil~aL~yLH~---~g 233 (506)
..|.-+|+.+.+ +++++++|++- .++|.||+..+++...... ..-...++..+..|+.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 69999999883 3679999987766421000 000246889999999999999999997 45
Q ss_pred eEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 234 VVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 234 iiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+.-.|++|+|+-++++|++|++|...+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 8889999999999999999999999763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00026 Score=70.69 Aligned_cols=78 Identities=18% Similarity=0.085 Sum_probs=55.9
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC---CCccceeEEEEe---CCeEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH---PFLPTLYSHFET---DKFSC 187 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~---~~~~~ 187 (506)
.-++.||.|..+.||+..... + .+.+|..+.. .....+..|.+.|+.|.- -.|.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 345789999999999996543 3 5777874321 122356779999988843 367888887754 36789
Q ss_pred EEEeecCCCCh
Q 010603 188 LLMEFCSGGDL 198 (506)
Q Consensus 188 lV~E~~~gg~L 198 (506)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0002 Score=71.97 Aligned_cols=144 Identities=22% Similarity=0.242 Sum_probs=84.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC--CccceeEE------EEe
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP--FLPTLYSH------FET 182 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~------~~~ 182 (506)
+....++.++.|....||++... +..+++|+.+... ....+..|.+++..|... .|.+++.. ...
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEeC--CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 33555788888888999998653 3468899875421 122344577777776322 23444332 123
Q ss_pred CCeEEEEEeecCCCChH--------H---H---HhhC-CC----C----CCCH-H--HHH----------HHHHHHHHHH
Q 010603 183 DKFSCLLMEFCSGGDLH--------T---L---RQRQ-PG----K----HFSE-Q--ATR----------FYASEVLLAL 226 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~--------~---~---l~~~-~~----~----~~~e-~--~~~----------~i~~qil~aL 226 (506)
.+..++||||++|..+. . . ++.. .+ . .++. . ... .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999885532 0 0 1110 00 0 0000 0 000 0112233455
Q ss_pred HHHHh-------CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 227 EYLHM-------MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 227 ~yLH~-------~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+++.. .++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 55542 689999999999999998877899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00087 Score=69.32 Aligned_cols=81 Identities=20% Similarity=0.242 Sum_probs=55.6
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchh---hc-hhHHHHHHHHHHHHHhcC---CCCccceeEEEEeCCeEE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML---AG-RKKLMRAQTEREILSLLD---HPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~---~~-~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~ 187 (506)
-.+.||.|.+..||++.....++.|.||.-....- .. .....+...|.+.|+.+. -.++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 35789999999999999875446899998542110 00 123456677888888763 2457777766 445678
Q ss_pred EEEeecCCCC
Q 010603 188 LLMEFCSGGD 197 (506)
Q Consensus 188 lV~E~~~gg~ 197 (506)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00024 Score=71.07 Aligned_cols=76 Identities=22% Similarity=0.312 Sum_probs=49.8
Q ss_pred EeEEeecCceEEEEEEEcc------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC-ccceeEEEEeCCeEEE
Q 010603 116 LKKLGCGDIGSVYLAELRD------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF-LPTLYSHFETDKFSCL 188 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~l 188 (506)
++.|..|-...||++.... .++.|++|+..... .......+|.++++.+.... ..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4567777788999987653 25789999976532 12233466888888874333 3456665542 35
Q ss_pred EEeecCCCChH
Q 010603 189 LMEFCSGGDLH 199 (506)
Q Consensus 189 V~E~~~gg~L~ 199 (506)
||||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00041 Score=67.63 Aligned_cols=134 Identities=22% Similarity=0.243 Sum_probs=77.2
Q ss_pred EEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc-cceeEEEEeCCeEEEEEeecCCC
Q 010603 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL-PTLYSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 196 (506)
.+..|-.+.+|+.. .+++.+++|+...... .......+|.++|+.+....+ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 34567788899887 3467888997654311 110123568889888854333 44444432 26899999987
Q ss_pred ChHH--------------HHhh---CC--CCCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCeEEccC
Q 010603 197 DLHT--------------LRQR---QP--GKHFSE-QATRFYASEV---------LLALEYLHM--------MGVVYRDL 239 (506)
Q Consensus 197 ~L~~--------------~l~~---~~--~~~~~e-~~~~~i~~qi---------l~aL~yLH~--------~giiHrDL 239 (506)
.+.. .+.+ .+ ...++. ..+..+..++ ...++.+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 1111 11 111111 1222222122 111222211 25899999
Q ss_pred CCCcEEEecCCCEEEeecCCcc
Q 010603 240 KPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 240 Kp~NILl~~~~~vkl~DFGla~ 261 (506)
.|.|||+++++ +.|+||+.|.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999877 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=4.1e-05 Score=75.24 Aligned_cols=134 Identities=20% Similarity=0.331 Sum_probs=95.5
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc-----------------hhHH--HHHHHHHHHHHhcC-CCC
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-----------------RKKL--MRAQTEREILSLLD-HPF 172 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-----------------~~~~--~~~~~E~~il~~l~-hpn 172 (506)
+.++..||-|.-+-||.+-+.. |..+++|+-+.....- ...+ ..+.+|...|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 7788999999999999998876 8889999654322111 0111 23467888888874 332
Q ss_pred -ccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 173 -LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 173 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
|.+.++ -+..|+|||++.|-.|....+.. .+..+...+..-|--|-.+|+||+|..-=|||+.+++.
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 333333 34678999999998887653221 12234455556666788999999999999999999999
Q ss_pred EEEeecCC
Q 010603 252 IMLSDFDL 259 (506)
Q Consensus 252 vkl~DFGl 259 (506)
++++||--
T Consensus 241 i~vIDFPQ 248 (465)
T KOG2268|consen 241 IVVIDFPQ 248 (465)
T ss_pred EEEeechH
Confidence 99999964
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00072 Score=67.34 Aligned_cols=141 Identities=18% Similarity=0.178 Sum_probs=85.0
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC--CccceeE------EEEeCC
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP--FLPTLYS------HFETDK 184 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~------~~~~~~ 184 (506)
..-++.|..|....+|+.... +..+++|+.... ....+..|++++..|.+. .+++++. +....+
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred hhheecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 334678888888999998654 457999987641 123455678887777432 2444443 223455
Q ss_pred eEEEEEeecCCCChHH--------H------HhhC----CCC----CC-C--HHHHH--------HHHHHHHHHHHHHHh
Q 010603 185 FSCLLMEFCSGGDLHT--------L------RQRQ----PGK----HF-S--EQATR--------FYASEVLLALEYLHM 231 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~--------~------l~~~----~~~----~~-~--e~~~~--------~i~~qil~aL~yLH~ 231 (506)
..++||+|++|..+.. + ++.. ... .. . ..... .....+..++.++..
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999999876521 0 1100 000 00 0 00000 011123334445443
Q ss_pred -------CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 232 -------MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 232 -------~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777999999873
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0022 Score=64.57 Aligned_cols=138 Identities=16% Similarity=0.133 Sum_probs=76.3
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC--CccceeE------EEEeCCeE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP--FLPTLYS------HFETDKFS 186 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~------~~~~~~~~ 186 (506)
-++.|+.|....+|+.... +..+++|++... ....+..|..+++.|... .+.+.+. +....+..
T Consensus 26 ~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~------~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~ 97 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTT--QGEYVLTLFERL------TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKP 97 (319)
T ss_pred ccchhccccccceEEEEeC--CCcEEEEEeccC------ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEE
Confidence 3567888888899998765 336899987521 112233455666555311 1333332 12335667
Q ss_pred EEEEeecCCCChH-----------HHHhh----CCC--------CCCCH--HHHHH-----------HHHH-HHHHHHHH
Q 010603 187 CLLMEFCSGGDLH-----------TLRQR----QPG--------KHFSE--QATRF-----------YASE-VLLALEYL 229 (506)
Q Consensus 187 ~lV~E~~~gg~L~-----------~~l~~----~~~--------~~~~e--~~~~~-----------i~~q-il~aL~yL 229 (506)
+++|||++|..+. ..+.+ ... ..+.. +.... .+.+ +...++.+
T Consensus 98 ~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (319)
T PRK05231 98 AAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFL 177 (319)
T ss_pred EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhh
Confidence 8999999887431 11110 000 00000 00000 1111 11122333
Q ss_pred H-------hCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 230 H-------MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 230 H-------~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
. ..++||+|+.|.|||++.+..+-|+||+.+
T Consensus 178 ~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 178 ASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred hccccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 2 248999999999999996655689999987
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0032 Score=64.31 Aligned_cols=140 Identities=16% Similarity=0.231 Sum_probs=82.8
Q ss_pred EEEeEEeecCceEEEEEEEcc----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc-cceeEEEEeCCeEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRD----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL-PTLYSHFETDKFSCL 188 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~l 188 (506)
.-++.|-.|-.-.+|++.... .++.|++|+..... ...+. ..+|..+++.+..-++ .++++.+... .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 334566568888999987532 24689999886542 12222 2668889888854333 4666766432 5
Q ss_pred EEeecCCCChHHH--------------Hhh---C--CCC--CCCHHHHHHHHHHH-----------------HHHHHHH-
Q 010603 189 LMEFCSGGDLHTL--------------RQR---Q--PGK--HFSEQATRFYASEV-----------------LLALEYL- 229 (506)
Q Consensus 189 V~E~~~gg~L~~~--------------l~~---~--~~~--~~~e~~~~~i~~qi-----------------l~aL~yL- 229 (506)
|+||+++.+|... +.+ . +.. ......+..+..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 8999987776321 111 0 111 11122222332211 1111111
Q ss_pred ---H----hCCeEEccCCCCcEEEec-CCCEEEeecCCcc
Q 010603 230 ---H----MMGVVYRDLKPENVLVRE-DGHIMLSDFDLSL 261 (506)
Q Consensus 230 ---H----~~giiHrDLKp~NILl~~-~~~vkl~DFGla~ 261 (506)
. ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4689999999884
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.004 Score=61.48 Aligned_cols=29 Identities=31% Similarity=0.437 Sum_probs=24.9
Q ss_pred CeEEccCCCCcEEEecCCC-EEEeecCCcc
Q 010603 233 GVVYRDLKPENVLVREDGH-IMLSDFDLSL 261 (506)
Q Consensus 233 giiHrDLKp~NILl~~~~~-vkl~DFGla~ 261 (506)
.++|+|+.|.|||++.++. +-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997565 5699999873
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0049 Score=62.54 Aligned_cols=140 Identities=13% Similarity=0.241 Sum_probs=80.5
Q ss_pred eEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc-cceeEEEEeCCeEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL-PTLYSHFETDKFSCL 188 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~l 188 (506)
.++ +.|..|=...+|++..... +..|.+|+..... ...-...+|..+++.+..-++ .++++++. .+ +
T Consensus 17 i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~ 87 (330)
T PLN02421 17 FSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---M 87 (330)
T ss_pred eEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence 444 4454477888999875432 2378999876532 112223568889888865444 46666663 22 5
Q ss_pred EEeecCCCChHH--------------HHhh-C----CCCC-C-CHHHHHHHHHHH----------------------HHH
Q 010603 189 LMEFCSGGDLHT--------------LRQR-Q----PGKH-F-SEQATRFYASEV----------------------LLA 225 (506)
Q Consensus 189 V~E~~~gg~L~~--------------~l~~-~----~~~~-~-~e~~~~~i~~qi----------------------l~a 225 (506)
|.+|++|..|.. .+++ + +... . ....+..+..++ ..-
T Consensus 88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 167 (330)
T PLN02421 88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE 167 (330)
T ss_pred eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence 899997766521 1111 1 0011 1 122222222221 111
Q ss_pred HH----HHHhCC----eEEccCCCCcEEEec-CCCEEEeecCCcc
Q 010603 226 LE----YLHMMG----VVYRDLKPENVLVRE-DGHIMLSDFDLSL 261 (506)
Q Consensus 226 L~----yLH~~g----iiHrDLKp~NILl~~-~~~vkl~DFGla~ 261 (506)
+. ++...+ ++|.||-+.|||+++ ++.++++||..|.
T Consensus 168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 22 222222 899999999999975 5789999999883
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0046 Score=62.82 Aligned_cols=76 Identities=18% Similarity=0.161 Sum_probs=49.1
Q ss_pred EEeecCceEEEEEEEccCCceEEEEEeccchh----hchhHHHHHHHHHHHHHhcC--CC-CccceeEEEEeCCeEEEEE
Q 010603 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGML----AGRKKLMRAQTEREILSLLD--HP-FLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 118 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 190 (506)
.||.|...-||++.....++-++||.-....- .-.-...+...|.+.|+... -| .+++++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57999999999999864446899997442111 11234456677888887763 34 3444433 3444556999
Q ss_pred eecCC
Q 010603 191 EFCSG 195 (506)
Q Consensus 191 E~~~g 195 (506)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.018 Score=57.66 Aligned_cols=28 Identities=25% Similarity=0.527 Sum_probs=25.3
Q ss_pred CCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 232 ~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
.+++|+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 57999999999999987 67899999976
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0061 Score=61.34 Aligned_cols=139 Identities=24% Similarity=0.278 Sum_probs=93.2
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch----------------------hHH-HHHHHHHHHHHhcCCC
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR----------------------KKL-MRAQTEREILSLLDHP 171 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~----------------------~~~-~~~~~E~~il~~l~hp 171 (506)
|-..|..|--+.||.|.... |..+|||+.+...+..+ +.+ --+..|++-|++|+..
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34567788899999997665 78899999875432111 111 1134566668877654
Q ss_pred CccceeEEEEeCCeEEEEEeecCCCChHH--HHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEccCCCCcEEEec
Q 010603 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT--LRQRQPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVRE 248 (506)
Q Consensus 172 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~--~l~~~~~~~~~e~~~~~i~~qil~aL~yLH-~~giiHrDLKp~NILl~~ 248 (506)
.|.----+.. ....|||+|+. ++=+. .++ ...++...+..+-.|++.-+.-|- ..++||.||.-=|+|+-
T Consensus 227 GIP~PePIlL--k~hVLVM~FlG-rdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLG-RDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCCceee--ecceEeeeecc-CCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence 4432211111 12459999994 44322 222 246778888888888888888775 56899999999999986
Q ss_pred CCCEEEeecCCcc
Q 010603 249 DGHIMLSDFDLSL 261 (506)
Q Consensus 249 ~~~vkl~DFGla~ 261 (506)
+|.+.|+|.+-+.
T Consensus 300 dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 DGKLYIIDVSQSV 312 (520)
T ss_pred CCEEEEEEccccc
Confidence 6799999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.013 Score=58.76 Aligned_cols=145 Identities=13% Similarity=0.201 Sum_probs=82.2
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC--ccceeEEEEeCC--eEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF--LPTLYSHFETDK--FSCL 188 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~--~~~l 188 (506)
..+++.+-.|.--.+|..... ++.++|. ... ............+|.++|+.+.--- +...++.+..+. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 445555544544455665554 7778888 321 1122344555677888888775322 234445554444 6699
Q ss_pred EEeecCCCCh---------H-HHHh--------h---C-------CCC--CCCHHHHHHHHHH--------------HHH
Q 010603 189 LMEFCSGGDL---------H-TLRQ--------R---Q-------PGK--HFSEQATRFYASE--------------VLL 224 (506)
Q Consensus 189 V~E~~~gg~L---------~-~~l~--------~---~-------~~~--~~~e~~~~~i~~q--------------il~ 224 (506)
||+|++|..+ . .+.. . - .+. .+...++..+..+ ...
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999988332 1 1111 1 0 000 0111111111111 122
Q ss_pred HHHHHHhC--------CeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 225 ALEYLHMM--------GVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 225 aL~yLH~~--------giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
-..||+.+ .++|+|+.+.||+++.++-+-+.||+++.
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 34455543 38999999999999999999999999984
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.002 Score=67.22 Aligned_cols=80 Identities=20% Similarity=0.164 Sum_probs=57.1
Q ss_pred cchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC-----------CCCCCHHHHHHHHHHhhcCCCCccCC
Q 010603 369 SAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE-----------GSSISFAAKDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 369 ~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-----------~~~~s~~~~~li~~~L~~dP~~R~s~ 437 (506)
+|+||||+|.++.|+.-|...|......+....+..-. ..+. ...++....+++.+|+-..|..||.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l- 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL- 187 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc-
Confidence 49999999999999999998887766655554433211 1110 0135566778999999999999985
Q ss_pred CCChHHhhcCCCCCCC
Q 010603 438 KRGATEIKQHPFFESV 453 (506)
Q Consensus 438 ~~~a~ell~hp~f~~~ 453 (506)
..++++|+-|.++
T Consensus 188 ---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 ---PMELSKRCSFTEV 200 (725)
T ss_pred ---hhHHhcCccHHHH
Confidence 6778888777543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.045 Score=54.93 Aligned_cols=29 Identities=17% Similarity=0.124 Sum_probs=27.1
Q ss_pred CeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 233 GVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 233 giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
++||+|+.+.|||++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999999873
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0093 Score=56.26 Aligned_cols=29 Identities=34% Similarity=0.614 Sum_probs=21.1
Q ss_pred CeEEccCCCCcEEE-ecCCCEEEeecCCcc
Q 010603 233 GVVYRDLKPENVLV-REDGHIMLSDFDLSL 261 (506)
Q Consensus 233 giiHrDLKp~NILl-~~~~~vkl~DFGla~ 261 (506)
.++|.||.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999999884
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.065 Score=53.20 Aligned_cols=75 Identities=25% Similarity=0.273 Sum_probs=47.6
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc---CCCCccceeEEEEeCCeEEEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+-.+.|+-|....+|+.. .+++.|.||+-... ....+..|.+-|+.| .--.+++.+++....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 445789999999999987 55788999987521 223456677777777 3456888999988888889999
Q ss_pred eecCCC
Q 010603 191 EFCSGG 196 (506)
Q Consensus 191 E~~~gg 196 (506)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.04 Score=57.11 Aligned_cols=77 Identities=19% Similarity=0.229 Sum_probs=52.5
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchh-hch---hHHHHHHHHHHHHHhcC---CCCccceeEEEEeCCeEE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML-AGR---KKLMRAQTEREILSLLD---HPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~ 187 (506)
..+.||.|....||+.... ++.|+||.-..... .+. -...+...|.+.|+.+. -..+.+++.+.+ +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999999874 45688997552211 000 13445566777777664 247778887766 4467
Q ss_pred EEEeecCC
Q 010603 188 LLMEFCSG 195 (506)
Q Consensus 188 lV~E~~~g 195 (506)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.025 Score=58.51 Aligned_cols=77 Identities=22% Similarity=0.292 Sum_probs=46.6
Q ss_pred EEeEEeecCceEEEEEEEccC-Cce-----EEEEEeccchhhchhHHHHHHHHHHHHHhcCCC-CccceeEEEEeCCeEE
Q 010603 115 LLKKLGCGDIGSVYLAELRDM-GCL-----FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP-FLPTLYSHFETDKFSC 187 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~-~~~-----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~ 187 (506)
.++.|..|-...+|++..... +.. |.+++... .....-...+|+++++.|... .-.++++.|.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345665688899999975432 122 33333211 112222235689999998654 44566776643 5
Q ss_pred EEEeecCCCChH
Q 010603 188 LLMEFCSGGDLH 199 (506)
Q Consensus 188 lV~E~~~gg~L~ 199 (506)
+|.||++|..|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999987763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.01 Score=59.61 Aligned_cols=72 Identities=21% Similarity=0.277 Sum_probs=56.2
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..+.|++|++- |+.|... .....+++..++++.+..++-+..+ ..=|||+.-.||||+ +|+|.|+||-++|
T Consensus 298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34778889987 7776432 2234667777888888777777654 689999999999999 9999999999997
Q ss_pred c
Q 010603 262 R 262 (506)
Q Consensus 262 ~ 262 (506)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.031 Score=57.56 Aligned_cols=78 Identities=21% Similarity=0.284 Sum_probs=51.9
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchh---hchhHHHHHHHHHHHHHhcC--CC-CccceeEEEEeCCeEEEE
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML---AGRKKLMRAQTEREILSLLD--HP-FLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~~E~~il~~l~--hp-nIv~l~~~~~~~~~~~lV 189 (506)
++.||.|.-.-||++.+...++-|+||.-..-.- .-.-...+...|.++|+.+. -| .+++++. .++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 6889999999999999854456799996432111 11234567778889988763 34 4555544 344556689
Q ss_pred EeecCC
Q 010603 190 MEFCSG 195 (506)
Q Consensus 190 ~E~~~g 195 (506)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.022 Score=58.11 Aligned_cols=62 Identities=23% Similarity=0.190 Sum_probs=46.4
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEccCCCCcEEEecCC
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVREDG 250 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH-~~giiHrDLKp~NILl~~~~ 250 (506)
..||-+|..|-.+..++... ..+|...+.++.--+.||--|- -.+++|.|+.|.||++.-..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 45677789999998888764 4667777777776666665443 45899999999999997543
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.083 Score=55.73 Aligned_cols=76 Identities=14% Similarity=0.245 Sum_probs=49.7
Q ss_pred EEeEEeecCceEEEEEEEccC--------CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCcc-ceeEEEEeCCe
Q 010603 115 LLKKLGCGDIGSVYLAELRDM--------GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP-TLYSHFETDKF 185 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~ 185 (506)
-++.|..|=.-.+|++..... ++.|.+++..... ..+-....|..+++.+..-+|- ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----cceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 567787788889999976522 5679999876542 1222335688888877544443 5666553
Q ss_pred EEEEEeecCCCCh
Q 010603 186 SCLLMEFCSGGDL 198 (506)
Q Consensus 186 ~~lV~E~~~gg~L 198 (506)
-..|.||++|..|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2357999988744
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.093 Score=53.09 Aligned_cols=137 Identities=24% Similarity=0.359 Sum_probs=80.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC---CC---ccceeE----EEEeCCeE
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH---PF---LPTLYS----HFETDKFS 186 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h---pn---Iv~l~~----~~~~~~~~ 186 (506)
+.|.+ .-..||+....+ ..+++|+.+.. . ....+..|.+.|..|.- += |..+-| .+....+.
T Consensus 32 ~~l~s-~eN~~f~~~~~~--g~~iLki~~~~-~----~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 32 RGLNS-EENSNFRVQTED--GRYILKIYRPG-W----TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccccc-ccCceEEEEecC--CCeEEEEecCC-C----CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 44555 566789988774 34599998875 1 22334557777777632 11 222222 22222378
Q ss_pred EEEEeecCCCChHH------------HHhh-------C----CCC--CCCHH----HH---------HHHHHHHHHHHHH
Q 010603 187 CLLMEFCSGGDLHT------------LRQR-------Q----PGK--HFSEQ----AT---------RFYASEVLLALEY 228 (506)
Q Consensus 187 ~lV~E~~~gg~L~~------------~l~~-------~----~~~--~~~e~----~~---------~~i~~qil~aL~y 228 (506)
+-|++|++|..+.. ++.+ . ++. ...+. .. .....++...++.
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 88999999987762 0100 0 000 11111 00 0123344455555
Q ss_pred HHh--------CC--eEEccCCCCcEEEecCCC-EEEeecCCcc
Q 010603 229 LHM--------MG--VVYRDLKPENVLVREDGH-IMLSDFDLSL 261 (506)
Q Consensus 229 LH~--------~g--iiHrDLKp~NILl~~~~~-vkl~DFGla~ 261 (506)
+.+ .+ +||+|+.|.|||++.+.. +.++|||-+.
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 443 34 999999999999999885 8999999874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.24 Score=50.09 Aligned_cols=70 Identities=17% Similarity=0.065 Sum_probs=42.2
Q ss_pred cCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC---CCCcccee---E--EEEeCCeEEEEEeec
Q 010603 122 GDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD---HPFLPTLY---S--HFETDKFSCLLMEFC 193 (506)
Q Consensus 122 G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~---~--~~~~~~~~~lV~E~~ 193 (506)
+.-..||+..... |..|++|+.+... .....+..|.+++..|. -| |+... + ....++..+.|++++
T Consensus 36 s~eN~vy~v~~~~-~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 36 SYENRVYQFGDED-GRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cccceEEEEecCC-CCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeee
Confidence 3456788887543 6679999886432 12334556777776663 22 22211 1 233456788899999
Q ss_pred CCCC
Q 010603 194 SGGD 197 (506)
Q Consensus 194 ~gg~ 197 (506)
+|..
T Consensus 110 ~G~~ 113 (325)
T PRK11768 110 GGRA 113 (325)
T ss_pred CCCC
Confidence 8764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.23 Score=58.08 Aligned_cols=30 Identities=33% Similarity=0.431 Sum_probs=25.8
Q ss_pred CCeEEccCCCCcEEEecCC--CEE-EeecCCcc
Q 010603 232 MGVVYRDLKPENVLVREDG--HIM-LSDFDLSL 261 (506)
Q Consensus 232 ~giiHrDLKp~NILl~~~~--~vk-l~DFGla~ 261 (506)
.++||.|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 555 99999873
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.054 Score=51.00 Aligned_cols=84 Identities=14% Similarity=0.146 Sum_probs=56.2
Q ss_pred HHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeE
Q 010603 158 AQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM--MGVV 235 (506)
Q Consensus 158 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~--~gii 235 (506)
+..+.+|+.++. .|++|.. ...-.+-++.|+|-.... ..-. ++. -=+.+|.-.|+ .+.+
T Consensus 105 y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-----------~~~N---~i~-agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-----------NFSN---FIT-AGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-----------chhH---HHH-HhHHHHHHhhccCCCee
Confidence 356778877764 5777763 223355689999932111 1111 111 12467788894 3699
Q ss_pred EccCCCCcEEEecCCCEEEeecCCc
Q 010603 236 YRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 236 HrDLKp~NILl~~~~~vkl~DFGla 260 (506)
|+|-.|+|||-|..|.+||.|=+.-
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCCCEEecChhhh
Confidence 9999999999999999999998743
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 506 | ||||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-29 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-28 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-26 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-26 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-26 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-25 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-19 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-19 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-19 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-19 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-19 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-18 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-25 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-20 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-20 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-25 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-20 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-19 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-25 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-19 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-25 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-19 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-19 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-19 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-19 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-19 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-23 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-23 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-23 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-23 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-22 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-22 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-19 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-20 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 8e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 6e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 7e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 8e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-04 |
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-57
Identities = 55/182 (30%), Positives = 103/182 (56%), Gaps = 1/182 (0%)
Query: 81 SACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFA 140
S + + ++W V+ K+ L F +LK +G G V + +++ G ++A
Sbjct: 31 SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 141 MKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT 200
MK+M+K + R ++ + ER++L D ++ L+ F+ + + L+ME+ GGDL T
Sbjct: 91 MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150
Query: 201 LRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L + G+ + RFY +E+++A++ +H +G V+RD+KP+N+L+ GHI L+DF
Sbjct: 151 LLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209
Query: 261 LR 262
L+
Sbjct: 210 LK 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 7e-41
Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 23/183 (12%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDG-------HGSAVDWWTFGIFFYELLLGRTPFKGNGNR 396
+ RS+ VGT +YL+PEI++ G +G DWW G+F YE+ G+TPF +
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
Query: 397 ETLFNVVGQPLKFP---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453
ET +V + A+D I+ LL P+ RLG + GA + + HPFF +
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLG-RGGAGDFRTHPFFFGL 334
Query: 454 NWALIRSTHPPEIPK---PVDLS-----FINHKQKTPIPQNDKGAADSDRSSG---PFLD 502
+W +R + PP P D G PF+
Sbjct: 335 DWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVG 394
Query: 503 FEF 505
+ +
Sbjct: 395 YSY 397
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 3e-56
Identities = 58/182 (31%), Positives = 93/182 (51%), Gaps = 10/182 (5%)
Query: 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTER 162
+ F+ K LG G +V LA +A+K+++K + K+ ER
Sbjct: 22 PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 163 EILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
+++S LDHPF LY F+ D+ + + G+L ++ F E TRFY +E+
Sbjct: 82 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEI 139
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISS 282
+ ALEYLH G+++RDLKPEN+L+ ED HI ++DF + K++ A R +S
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------KVLSPESKQA-RANS 191
Query: 283 YC 284
+
Sbjct: 192 FV 193
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 50/134 (37%), Positives = 69/134 (51%), Gaps = 6/134 (4%)
Query: 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR 396
VL E AR+ SFVGT +Y++PE++ + D W G Y+L+ G PF+ GN
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNE 237
Query: 397 ETLF-NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF--KRGATEIKQHPFFESV 453
+F ++ FPE A+DL+ LLV D KRLG G +K HPFFESV
Sbjct: 238 YLIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 454 NWALIRSTHPPEIP 467
W + PP++
Sbjct: 296 TWENLHQQTPPKLT 309
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-56
Identities = 50/161 (31%), Positives = 91/161 (56%), Gaps = 3/161 (1%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
K +D + + ++K +G G G V L + ++AMK++ K + R E
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASE 221
R+I++ + P++ L+ F+ D++ ++ME+ GGDL L E+ RFY +E
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAE 176
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
V+LAL+ +H MG ++RD+KP+N+L+ + GH+ L+DF ++
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 55/172 (31%), Positives = 88/172 (51%), Gaps = 14/172 (8%)
Query: 346 RSMSFVGTHEYLAPEIIRGDG----HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
R + VGT +Y++PE+++ G +G DWW+ G+F YE+L+G TPF + T
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 284
Query: 402 VVG--QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA--L 457
++ L FP+ + IS AK+LI L D + RLG + G EIK+H FF++ WA
Sbjct: 285 IMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLG-RNGVEEIKRHLFFKNDQWAWET 342
Query: 458 IRSTHPPEIPK---PVDLS-FINHKQKTPIPQNDKGAADSDRSSGPFLDFEF 505
+R T P +P +D S F + ++ + + PF+ F +
Sbjct: 343 LRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTY 394
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-55
Identities = 49/160 (30%), Positives = 94/160 (58%), Gaps = 2/160 (1%)
Query: 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT 160
V ++ D+ HF +L+ +G G G V + + D ++AMK M+K R ++
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 161 EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYAS 220
E +I+ L+HPFL L+ F+ ++ ++++ GGDL Q+ HF E+ + +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
E+++AL+YL +++RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 342 PTSARSMSFVGTHEYLAPEII---RGDGHGSAVDWWTFGIFFYELLLGRTPF--KGNGNR 396
P + + GT Y+APE+ +G G+ AVDWW+ G+ YELL GR P+ + + +
Sbjct: 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 397 ETLF-NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
+ + + +P S+ S L++ LL +P +R ++++ P+ +NW
Sbjct: 226 KEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINW 280
Query: 456 ALI--RSTHPPEIPK 468
+ + P IP
Sbjct: 281 DAVFQKRLIPGFIPN 295
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-54
Identities = 54/161 (33%), Positives = 95/161 (59%), Gaps = 1/161 (0%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
K K L F +LK +G G G V + +L++ +FAMK+++K + R + + E
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASE 221
R++L D ++ TL+ F+ D L+M++ GGDL TL + + E+ RFY +E
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAE 183
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
+++A++ +H + V+RD+KP+N+L+ +GHI L+DF L+
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 16/176 (9%)
Query: 344 SARSMSFVGTHEYLAPEIIRGD-----GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
+ +S VGT +Y++PEI++ +G DWW+ G+ YE+L G TPF ET
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289
Query: 399 LFNVVGQPLKFP---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
++ +F + + +S AKDLIR L+ + RLG + G + K+HPFF ++W
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLG-QNGIEDFKKHPFFSGIDW 347
Query: 456 ALIRSTHPPEIPK---PVDLSFINHKQKTPIPQNDKGAADSDRSSG---PFLDFEF 505
IR+ P IP+ P D S + SG PF+ F +
Sbjct: 348 DNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTY 403
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-54
Identities = 57/153 (37%), Positives = 95/153 (62%), Gaps = 2/153 (1%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
L F++L+ LG G G V+L R G +AMKV+ K ++ K++ ER +LS+
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
+ HPF+ ++ F+ + ++M++ GG+L +L ++ + F +FYA+EV LALE
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALE 120
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH ++YRDLKPEN+L+ ++GHI ++DF +
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-45
Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVVG 404
+ + GT +Y+APE++ + ++DWW+FGI YE+L G TPF + N + ++
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILN 217
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFESVNWALI--RST 461
L+FP + KDL+ L+ +D +RLG + G ++K HP+F+ V W + R+
Sbjct: 218 AELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 275
Query: 462 HPPEIPK----PVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDF 503
P P D S + + I G D + F DF
Sbjct: 276 ETPYEPPIQQGQGDTSQFDKYPEEDIN---YGVQGEDPYADLFRDF 318
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 54/159 (33%), Positives = 91/159 (57%), Gaps = 2/159 (1%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
L F +K LG G G V L + ++ G +AMK++DK + K++ E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASE 221
+ IL ++ PFL L F+ + ++ME+ +GG++ + +R FSE RFYA++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ 149
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L EYLH + ++YRDLKPEN+L+ + G+I ++DF +
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 55/165 (33%), Positives = 79/165 (47%), Gaps = 15/165 (9%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVVG 404
R+ + GT E LAPEII G+ AVDWW G+ YE+ G PF + ++ +V
Sbjct: 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVS 252
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFESVNWALI--RST 461
++FP S S KDL+R LL D KR G K G +IK H +F + +W I R
Sbjct: 253 GKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310
Query: 462 HPPEIPK---PVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDF 503
P IPK P D S + + + + +++ F +F
Sbjct: 311 EAPFIPKFKGPGDTSNFD-----DYEEEEIRVSINEKCGKEFTEF 350
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-52
Identities = 58/153 (37%), Positives = 89/153 (58%), Gaps = 2/153 (1%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
+ + F LK LG G G V L + G +AMK++ K ++ + ++ TE +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
HPFL L F+T C +ME+ +GG+L R+ + F+E+ RFY +E++ ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH VVYRD+K EN+++ +DGHI ++DF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 61/178 (34%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NV 402
A +F GT EYLAPE++ + +G AVDWW G+ YE++ GR PF + E LF +
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELI 217
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--R 459
+ + ++FP ++S AK L+ GLL KDP++RLG A E+ +H FF S+NW + +
Sbjct: 218 LMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275
Query: 460 STHPPEIPK---PVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGP---FLDFEF 505
PP P+ VD F TP + D F DF++
Sbjct: 276 KLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDY 333
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-52
Identities = 68/163 (41%), Positives = 101/163 (61%), Gaps = 6/163 (3%)
Query: 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAE---LRDMGCLFAMKVMDKGMLAGRKKLMR 157
VK F LLK LG G G V+L + D L+AMKV+ K L R + +R
Sbjct: 14 VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-VR 72
Query: 158 AQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRF 217
+ ER+IL ++HPF+ L+ F+T+ L+++F GGDL T ++ F+E+ +F
Sbjct: 73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKF 130
Query: 218 YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
Y +E+ LAL++LH +G++YRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 50/135 (37%), Positives = 75/135 (55%), Gaps = 8/135 (5%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
++ SF GT EY+APE++ GH + DWW+FG+ +E+L G PF+G +ET+ ++
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RST 461
L P +S A+ L+R L ++P RLG G EIK+H FF +++W + R
Sbjct: 241 AKLGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI 298
Query: 462 HPPEIPK---PVDLS 473
HPP P P D
Sbjct: 299 HPPFKPATGRPEDTF 313
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-51
Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 2/155 (1%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
+G F + LG G G V+ +++ G L+A K ++K L RK A E++IL+
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLA 225
+ F+ +L FET CL+M +GGD+ H + F E FY ++++
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LE+LH ++YRDLKPENVL+ +DG++ +SD L+
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-41
Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 9/131 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKG---NGNRETLF-N 401
++ + GT ++APE++ G+ + +VD++ G+ YE++ R PF+ + L
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 404
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALI-- 458
V+ Q + +P+ S A+KD LL KDP+KRLGF+ ++ HP F ++W +
Sbjct: 405 VLEQAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA 462
Query: 459 RSTHPPEIPKP 469
PP +P
Sbjct: 463 GMLTPPFVPDS 473
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 60/154 (38%), Positives = 93/154 (60%), Gaps = 3/154 (1%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
LGL F LL+ +G G V L L+ ++AMKV+ K ++ + + QTE+ +
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 168 -LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
+HPFL L+S F+T+ ++E+ +GGDL QRQ + E+ RFY++E+ LAL
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLAL 123
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH G++YRDLK +NVL+ +GHI L+D+ +
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 28/182 (15%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--------NRE 397
+ +F GT Y+APEI+RG+ +G +VDWW G+ +E++ GR+PF G +
Sbjct: 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225
Query: 398 TLF-NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG--FKRGATEIKQHPFFESVN 454
LF ++ + ++ P S+S A +++ L KDP++RLG + G +I+ HPFF +V+
Sbjct: 226 YLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283
Query: 455 WALI--RSTHPPEIPK---PVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGPFLDF 503
W ++ + PP P L F N Q TP + D F F
Sbjct: 284 WDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQS----EFEGF 339
Query: 504 EF 505
E+
Sbjct: 340 EY 341
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 59/164 (35%), Positives = 87/164 (53%), Gaps = 6/164 (3%)
Query: 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAE---LRDMGCLFAMKVMDKGMLAGRKK-LM 156
V + F LL+ LG G G V+ + G +FAMKV+ K M+ K
Sbjct: 7 VNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA 66
Query: 157 RAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATR 216
+ ER IL + HPF+ L F+T L++E+ SGG+L +R+ F E
Sbjct: 67 HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTAC 124
Query: 217 FYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
FY +E+ +AL +LH G++YRDLKPEN+++ GH+ L+DF L
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-44
Identities = 48/135 (35%), Positives = 72/135 (53%), Gaps = 8/135 (5%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
+ +F GT EY+APEI+ GH AVDWW+ G Y++L G PF G ++T+ ++
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RST 461
L P ++ A+DL++ LL ++ RLG A E++ HPFF +NW + R
Sbjct: 236 CKLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKV 293
Query: 462 HPPEIPK---PVDLS 473
PP P D+S
Sbjct: 294 EPPFKPLLQSEEDVS 308
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-51
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 54 VDCLAHSEEESGKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHF 113
+ H + + + S + N + LGL F
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRE------SGKASSSLGLQDF 54
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHPF 172
LL+ +G G V L L+ ++AM+V+ K ++ + + QTE+ + +HPF
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
L L+S F+T+ ++E+ +GGDL QRQ + E+ RFY++E+ LAL YLH
Sbjct: 115 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER 172
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
G++YRDLK +NVL+ +GHI L+D+ +
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 28/182 (15%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--------NRE 397
+ +F GT Y+APEI+RG+ +G +VDWW G+ +E++ GR+PF G +
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
Query: 398 TLF-NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG--FKRGATEIKQHPFFESVN 454
LF ++ + ++ P S+S A +++ L KDP++RLG + G +I+ HPFF +V+
Sbjct: 269 YLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326
Query: 455 WALI--RSTHPPEIPK---PVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGPFLDF 503
W ++ + PP P L F N Q TP + D F F
Sbjct: 327 WDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQS----EFEGF 382
Query: 504 EF 505
E+
Sbjct: 383 EY 384
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-51
Identities = 59/160 (36%), Positives = 89/160 (55%), Gaps = 3/160 (1%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
S + F LK +G G G V LA + +A+KV+ K + +K+ +E
Sbjct: 29 PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 162 REILSL-LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYAS 220
R +L + HPFL L+ F+T ++++ +GG+L QR+ + F E RFYA+
Sbjct: 89 RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAA 146
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
E+ AL YLH + +VYRDLKPEN+L+ GHI+L+DF L
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 58/176 (32%), Positives = 84/176 (47%), Gaps = 17/176 (9%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NV 402
++ + +F GT EYLAPE++ + VDWW G YE+L G PF N ++ N+
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNI 251
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RS 460
+ +PL+ +I+ +A+ L+ GLL KD KRLG K EIK H FF +NW + +
Sbjct: 252 LNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKK 309
Query: 461 THPPEIPK---PVDLS-----FINHKQKTPI---PQNDKGAADSDRSSGPFLDFEF 505
PP P P DL F I P + A ++ FL F +
Sbjct: 310 ITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSY 365
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-51
Identities = 54/153 (35%), Positives = 81/153 (52%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
+ FR + LG G G V ++R G ++A K ++K + RK A E++IL
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
++ F+ +L +ET CL++ +GGDL F E FYA+E+ LE
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LH +VYRDLKPEN+L+ + GHI +SD L+
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-40
Identities = 42/131 (32%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR----ETLFN 401
VGT Y+APE+++ + + + DWW G YE++ G++PF+ + E
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 400
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALI-- 458
V P ++ E S A+ L LL KDP +RLG + A E+K+HP F+ +N+ +
Sbjct: 401 VKEVPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA 458
Query: 459 RSTHPPEIPKP 469
PP P P
Sbjct: 459 GMLEPPFKPDP 469
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-51
Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 12/207 (5%)
Query: 59 HSEEESGKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKK 118
H EEE G S + G + + L K +G+ +F LLK
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEK-----VGIENFELLKV 61
Query: 119 LGCGDIGSVYLAE---LRDMGCLFAMKVMDKGMLAGRKKLM-RAQTEREILSLLDH-PFL 173
LG G G V+L D G L+AMKV+ K + + K +TER++L + PFL
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG 233
TL+ F+T+ L++++ +GG+L T ++ + F+E + Y E++LALE+LH +G
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 234 VVYRDLKPENVLVREDGHIMLSDFDLS 260
++YRD+K EN+L+ +GH++L+DF LS
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 57/142 (40%), Positives = 83/142 (58%), Gaps = 14/142 (9%)
Query: 344 SARSMSFVGTHEYLAPEIIRGD--GHGSAVDWWTFGIFFYELLLGRTPFKGNG---NRET 398
+ R+ F GT EY+AP+I+RG GH AVDWW+ G+ YELL G +PF +G ++
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 399 LF-NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWA 456
+ ++ +P +S AKDLI+ LL+KDP+KRLG R A EIK+H FF+ +NW
Sbjct: 274 ISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331
Query: 457 LI--RSTHPPEIPK---PVDLS 473
+ + P P +D+S
Sbjct: 332 DLAAKKVPAPFKPVIRDELDVS 353
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 57/154 (37%), Positives = 88/154 (57%), Gaps = 3/154 (1%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
L + F L K LG G G V+LAE + FA+K + K ++ + E+ +LSL
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 168 -LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
+HPFL ++ F+T + +ME+ +GGDL Q F FYA+E++L L
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 131
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++LH G+VYRDLK +N+L+ +DGHI ++DF +
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 58/172 (33%), Positives = 93/172 (54%), Gaps = 22/172 (12%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVVG 404
++ +F GT +Y+APEI+ G + +VDWW+FG+ YE+L+G++PF G + E LF ++
Sbjct: 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSIRM 232
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RSTH 462
+P + AKDL+ L V++P+KRLG +I+QHP F +NW + +
Sbjct: 233 DNPFYP--RWLEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELERKEID 287
Query: 463 PPEIPK---PVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGPFLDFEF 505
PP PK P D S F+N K + + + + D + F +F F
Sbjct: 288 PPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQN----MFRNFSF 335
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 63/161 (39%), Positives = 96/161 (59%), Gaps = 7/161 (4%)
Query: 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTER 162
+ LG+ +F ++ LG G G V LA +++ G L+A+KV+ K ++ + TE+
Sbjct: 15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 163 EILSL-LDHPFLPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYA 219
ILSL +HPFL L+ F+T +MEF +GGDL H + R+ F E RFYA
Sbjct: 75 RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYA 130
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+E++ AL +LH G++YRDLK +NVL+ +GH L+DF +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 54/175 (30%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVV 403
+ +F GT +Y+APEI++ +G AVDWW G+ YE+L G PF+ N + LF ++
Sbjct: 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAIL 237
Query: 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF--KRGATEIKQHPFFESVNWALI--R 459
+ +P + + A +++ + K+P RLG + G I +HPFF+ ++WA + R
Sbjct: 238 NDEVVYP--TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHR 295
Query: 460 STHPPEIPK---PVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGPFLDFEF 505
PP P+ D+S FI + TPI + + D F +FE+
Sbjct: 296 QIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQD----EFRNFEY 346
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-50
Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 3/161 (1%)
Query: 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT 160
+ L F L LG G G V L+E + L+A+K++ K ++ +
Sbjct: 10 NNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV 69
Query: 161 EREILSLLD-HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYA 219
E+ +L+L PFL L+S F+T +ME+ +GGDL Q+ F E FYA
Sbjct: 70 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYA 127
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+E+ + L +L G++YRDLK +NV++ +GHI ++DF +
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 19/172 (11%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVVG 404
+ +F GT +Y+APEII +G +VDWW FG+ YE+L G+ PF+G + + LF +++
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIME 235
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RST 461
+ +P S+S A + +GL+ K P KRLG G +IK+H FF ++W + +
Sbjct: 236 HNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEI 293
Query: 462 HPPEIP--KPVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGPFLDFEF 505
PP P + F H TP Q D F F F
Sbjct: 294 QPPYKPKACGRNAENFDRFFTRHPPVLTPPDQEVIRNIDQS----EFEGFSF 341
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-49
Identities = 58/156 (37%), Positives = 87/156 (55%), Gaps = 5/156 (3%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
L + F + + +G G G VY D G ++AMK +DK + ++ A ER +LSL
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 168 L---DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
+ D PF+ + F T +++ +GGDLH + FSE RFYA+E++L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIIL 303
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LE++H VVYRDLKP N+L+ E GH+ +SD L+
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 43/136 (31%), Positives = 78/136 (57%), Gaps = 9/136 (6%)
Query: 341 EPTSARSMSFVGTHEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--NRE 397
+ + + + VGTH Y+APE++ +G + S+ DW++ G ++LL G +PF+ + ++
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 398 TLF-NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNW 455
+ + ++ P+ S S + L+ GLL +D +RLG RGA E+K+ PFF S++W
Sbjct: 401 EIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458
Query: 456 ALI--RSTHPPEIPKP 469
++ + PP IP
Sbjct: 459 QMVFLQKYPPPLIPPR 474
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 59/154 (38%), Positives = 89/154 (57%), Gaps = 3/154 (1%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
+ + F LK LG G G V L + + G +AMK++ K ++ + ++ TE +L
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
HPFL L F+T C +ME+ +GG+L R+ + FSE RFY +E++ AL+
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 262
Query: 228 YLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH VVYRDLK EN+++ +DGHI ++DF L
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-41
Identities = 52/137 (37%), Positives = 75/137 (54%), Gaps = 10/137 (7%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NV 402
A +F GT EYLAPE++ + +G AVDWW G+ YE++ GR PF + E LF +
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELI 361
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--R 459
+ + ++FP ++ AK L+ GLL KDP++RLG A EI QH FF + W + +
Sbjct: 362 LMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEK 419
Query: 460 STHPPEIPK---PVDLS 473
PP P+ D
Sbjct: 420 KLSPPFKPQVTSETDTR 436
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-48
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 2/159 (1%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
+ + F + + LG G G+VYLA + + A+KV+ K L + + E
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASE 221
EI S L HP + +Y++F K L++EF G+L+ Q+ F EQ + + E
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEE 122
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ AL Y H V++RD+KPEN+L+ G + ++DF S
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 45/131 (34%), Positives = 59/131 (45%), Gaps = 10/131 (7%)
Query: 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
S R + GT +YL PE+I G H VD W G+ YE L+G PF + E
Sbjct: 160 WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
Query: 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457
T +V LKFP +S +KDLI LL P +RL K + +HP+ + A
Sbjct: 220 THRRIVNVDLKFP--PFLSDGSKDLISKLLRYHPPQRLPLK----GVMEHPWVK----AN 269
Query: 458 IRSTHPPEIPK 468
R PP
Sbjct: 270 SRRVLPPVYQS 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-48
Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 2/158 (1%)
Query: 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTER 162
SK L F + + LG G G+VYLA + + A+KV+ K L + + E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 163 EILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
EI S L HP + LY +F L++E+ G ++ Q+ F EQ T Y +E+
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITEL 118
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
AL Y H V++RD+KPEN+L+ G + ++DF S
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 6/113 (5%)
Query: 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
S+R GT +YL PE+I G H VD W+ G+ YE L+G+ PF+ N +E
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
Query: 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
T + FP ++ A+DLI LL +P +R + E+ +HP+
Sbjct: 215 TYKRISRVEFTFP--DFVTEGARDLISRLLKHNPSQRPMLR----EVLEHPWI 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 9e-45
Identities = 52/156 (33%), Positives = 85/156 (54%), Gaps = 7/156 (4%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
+ L F L LG G G V L+E + L+A+K++ K ++ + E+ +L+L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 168 -LDHPFLPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLL 224
PFL L+S F+T +ME+ +GGDL H + + F E FYA+E+ +
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAI 453
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L +L G++YRDLK +NV++ +GHI ++DF +
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-39
Identities = 55/171 (32%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+ +F GT +Y+APEII +G +VDWW FG+ YE+L G+ PF+G E +++
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALI--RSTH 462
+ +P S+S A + +GL+ K P KRLG G +IK+H FF ++W + +
Sbjct: 558 NVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQ 615
Query: 463 PPEIP--KPVDLS-----FINHK-QKTPIPQNDKGAADSDRSSGPFLDFEF 505
PP P + F H TP Q D F F F
Sbjct: 616 PPYKPKASGRNAENFDRFFTRHPPVLTPPDQEVIRNIDQS----EFEGFSF 662
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-42
Identities = 44/150 (29%), Positives = 61/150 (40%), Gaps = 4/150 (2%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDH 170
F+ L +LG G G V+ ++ G L+A+K G K R E + H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHEKVGQH 116
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P L +E L E C G L + G E Y + LLAL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH 174
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+V+ D+KP N+ + G L DF L
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 24/108 (22%), Positives = 44/108 (40%), Gaps = 8/108 (7%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T+ G Y+APE+++G +G+A D ++ G+ E+ G + L
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG 267
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
P +F G +S + ++ +L DP+ R A + P
Sbjct: 268 Y-LPPEFTAG--LSSELRSVLVMMLEPDPKLRA----TAEALLALPVL 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 31/180 (17%), Positives = 69/180 (38%), Gaps = 23/180 (12%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT- 160
K+ D + +R+++ L G + L +A+K +K +L ++ ++
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 161 -------------EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL------HTL 201
E +I++ + + + T ++ E+ + +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 202 RQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ Q + VL + Y+H + +RD+KP N+L+ ++G + LSDF S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 29/141 (20%), Positives = 55/141 (39%), Gaps = 24/141 (17%)
Query: 352 GTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVVGQPLK 408
GT+E++ PE + +G+ VD W+ GI Y + PF + LF N+ + ++
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 409 FP-----------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
+P + +S D ++ L K+P +R+ + + +H +
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE----DALKHEWLA 327
Query: 452 SVNWALIRSTHPPEIPKPVDL 472
N +R K L
Sbjct: 328 DTNIEDLREFSKELYKKRKKL 348
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+ F++ LG G VY AE G A+K++DK + K M + + E+
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQ 67
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLAL 226
L HP + LY++FE + L++E C G++ L+ R K FSE R + +++ +
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGM 125
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH G+++RDL N+L+ + +I ++DF L+
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 39/99 (39%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE 411
GT Y++PEI HG D W+ G FY LL+GR PF + + TL VV + P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP- 232
Query: 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
S +S AKDLI LL ++P RL + HPF
Sbjct: 233 -SFLSIEAKDLIHQLLRRNPADRLSLS----SVLDHPFM 266
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 38/151 (25%), Positives = 79/151 (52%), Gaps = 1/151 (0%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
+ + L+K+G G G L + + G + +K ++ ++ K+ ++ E +L+ +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMK 81
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HP + FE + ++M++C GGDL Q G F E + ++ LAL+++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
H +++RD+K +N+ + +DG + L DF ++
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 31/162 (19%), Positives = 57/162 (35%), Gaps = 10/162 (6%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
+ T + + +GT YL+PEI + + D W G YEL + F+ +
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
Query: 399 LFNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457
+ ++ G S+ + L+ L ++P+ R I + F +
Sbjct: 234 VLKIISGSFPPVSLH--YSYDLRSLVSQLFKRNPRDRP----SVNSILEKGFIAK---RI 284
Query: 458 IRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGAADSDRSSGP 499
+ P I + L + PIP + + S P
Sbjct: 285 EKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMP 326
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F + LG G G V A +A+K + +KL +E +L+ L+H +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQY 63
Query: 173 LPTLYSHF-------------ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYA 219
+ Y+ + + + ME+C G L+ L + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLF 122
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L AL Y+H G+++RDLKP N+ + E ++ + DF L+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 11/106 (10%)
Query: 349 SFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQP 406
S +GT Y+A E++ G GH +D ++ GI F+E++ G R + +
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGM-ERVNILKKLRSVS 245
Query: 407 LKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
++FP + K +IR L+ DP KR GA + +
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP----GARTLLNSGWL 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 9/170 (5%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L +FR+ KK+G G VY A G A+K + L K E ++L L+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLALE 227
HP + Y+ F D +++E GDL + ++ + E+ Y ++ ALE
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPA 277
++H V++RD+KP NV + G + L D L + S A
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLG-------RFFSSKTTAA 193
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 8/104 (7%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFN--VVGQ 405
S VGT Y++PE I +G+ D W+ G YE+ ++PF G+ N +L
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
P S + L+ + DP+KR T +
Sbjct: 255 YPPLPSD-HYSEELRQLVNMCINPDPEKR----PDVTYVYDVAK 293
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 8/154 (5%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+ + LG G + D +FA K++ K +L K R + EI
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRS 71
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLAL 226
L H + + FE + F +++E C L ++R K +E R+Y +++L
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGC 128
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+YLH V++RDLK N+ + ED + + DF L+
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 6/99 (6%)
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE 411
GT Y+APE++ GH VD W+ G Y LL+G+ PF+ + +ET + P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP- 235
Query: 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
I+ A LI+ +L DP R E+ FF
Sbjct: 236 -KHINPVAASLIQKMLQTDPTARPTIN----ELLNDEFF 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+ + LG G + D +FA K++ K +L K R + EI
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRS 97
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
L H + + FE + F +++E C L L +R+ K +E R+Y +++L +
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQ 155
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH V++RDLK N+ + ED + + DF L+
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 6/99 (6%)
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE 411
GT Y+APE++ GH VD W+ G Y LL+G+ PF+ + +ET + P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP- 261
Query: 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
I+ A LI+ +L DP R E+ FF
Sbjct: 262 -KHINPVAASLIQKMLQTDPTARPTIN----ELLNDEFF 295
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 39/160 (24%), Positives = 71/160 (44%), Gaps = 10/160 (6%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
+ +L +G G G + G + K +D G + + +E +L L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK 63
Query: 170 HPFLPTLYSHF--ETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLA 225
HP + Y T+ ++ME+C GGDL ++ + + ++ E+ +++ LA
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 226 LEYLH-----MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L+ H V++RDLKP NV + ++ L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 26/114 (22%), Positives = 46/114 (40%), Gaps = 9/114 (7%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
I ++ + +FVGT Y++PE + + D W+ G YEL PF +++
Sbjct: 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKE 223
Query: 399 LFNVV--GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
L + G+ + P S ++I +L R EI ++P
Sbjct: 224 LAGKIREGKFRRIPYR--YSDELNEIITRMLNLKDYHRP----SVEEILENPLI 271
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 10/208 (4%)
Query: 57 LAHSEEESGKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLL 116
+ S S G + + K Q V+ K G + ++ +L
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKIND---YDKFYEDIWKKYVPQPVEVKQGSVY-DYYDIL 56
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTL 176
++LG G G V+ + G +F K ++ + + E I++ L HP L L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINL 113
Query: 177 YSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVY 236
+ FE L++EF SGG+L R SE Y + L+++H +V+
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 237 RDLKPENVLV--REDGHIMLSDFDLSLR 262
D+KPEN++ ++ + + DF L+ +
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATK 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 40/100 (40%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
T E+ APEI+ + G D W G+ Y LL G +PF G + ETL NV +F
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 411 EG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
E SS+S AKD I+ LL K+P+KRL + +HP
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHP 306
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 9/184 (4%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
+ H+ ++KLG G V L E G +A+K + R++ R E ++
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 167 LLDHPFLPTLYSHFETDKFS----CLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYAS 220
L +HP + L ++ ++ + LL+ F G L R + G +E +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRI 280
+ LE +H G +RDLKP N+L+ ++G +L D + + + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 281 SSYC 284
+ C
Sbjct: 202 AQRC 205
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 22/127 (17%), Positives = 42/127 (33%), Gaps = 15/127 (11%)
Query: 348 MSFVGTHEYLAPEIIRGDGH---GSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVV 403
+ T Y APE+ H D W+ G Y ++ G P+ + +++ V
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHP 463
L P+ S A L+ ++ DP +R + ++ P
Sbjct: 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLSQLEA-------LQPPAP 309
Query: 464 PEIPKPV 470
+ +
Sbjct: 310 GQHTTQI 316
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-35
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 8/163 (4%)
Query: 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTER 162
G + F +KLG G G V+L E R G +K ++K + + E
Sbjct: 15 YFQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEI 71
Query: 163 EILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYAS 220
E+L LDHP + ++ FE ++ME C GG+L + + GK SE
Sbjct: 72 EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
+++ AL Y H VV++DLKPEN+L + I + DF L+
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 6/103 (5%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+ GT Y+APE+ + D D W+ G+ Y LL G PF G E +
Sbjct: 185 NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 409 FPEG-SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ ++ A DL++ +L KDP++R A ++ H +F
Sbjct: 244 YAVECRPLTPQAVDLLKQMLTKDPERRP----SAAQVLHHEWF 282
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 53/251 (21%), Positives = 97/251 (38%), Gaps = 15/251 (5%)
Query: 21 MHSVSFCSSSTVSGSDTSVSSNLSNAT----IEAKKGVDCLAHSEEESGKSSLSTGDANE 76
MH SS + + + ++ + ++ +S+ +A +
Sbjct: 1 MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK 60
Query: 77 ASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMG 136
+ ++ M + + + + +G G V R G
Sbjct: 61 LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY-QKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 137 CLFAMKVMDKGMLAGRKKL---MRAQTEREI---LSLLDHPFLPTLYSHFETDKFSCLLM 190
FA+K+M+ + +R T RE + HP + TL +E+ F L+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 191 EFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED 249
+ G+L L ++ SE+ TR +L A+ +LH +V+RDLKPEN+L+ ++
Sbjct: 180 DLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN 236
Query: 250 GHIMLSDFDLS 260
I LSDF S
Sbjct: 237 MQIRLSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 38/111 (34%), Positives = 51/111 (45%), Gaps = 14/111 (12%)
Query: 350 FVGTHEYLAPEIIRG------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV 403
GT YLAPEI++ G+G VD W G+ + LL G PF + + ++
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-RQILMLRMI 317
Query: 404 GQ-PLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
+ +F S KDLI LL DP+ RL A + QHPFFE
Sbjct: 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL----TAEQALQHPFFE 364
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 33/164 (20%), Positives = 68/164 (41%), Gaps = 23/164 (14%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F+ ++ +G G G V+ A+ R G + +K + +A+ E + L+ LDH
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-------NNEKAEREVKALAKLDHVN 65
Query: 173 LPTLYSHFETDKFS----------------CLLMEFCSGGDLHTLRQRQPGKHFSEQATR 216
+ ++ + + MEFC G L +++ G+ +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 217 FYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ ++Y+H ++ RDLKP N+ + + + + DF L
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 12/104 (11%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVVGQP 406
GT Y++PE I +G VD + G+ ELL + T F+ + L +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL-----RD 233
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
K L++ LL K P+ R +EI +
Sbjct: 234 GIIS--DIFDKKEKTLLQKLLSKKPEDRP----NTSEILRTLTV 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-35
Identities = 36/178 (20%), Positives = 56/178 (31%), Gaps = 22/178 (12%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLM 156
+ LG + LG G VY A D+ F +KV A +
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFY 112
Query: 157 RAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL---RQRQPGKHFSEQ 213
E L YS S L+ E S G L + P K +
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 214 ATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-----------EDGHIMLSDFDLS 260
+A +L +E +H +++ D+KP+N ++ + L D S
Sbjct: 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 18/132 (13%), Positives = 35/132 (26%), Gaps = 19/132 (14%)
Query: 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
+ P + T + E++ +D++ Y +L G N E
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 398 TLF--------------NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATE 443
L P+ + + DL+R L K Q+ K
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP--SLDLLRQKLKKVFQQHYTNKI---R 347
Query: 444 IKQHPFFESVNW 455
++ +
Sbjct: 348 ALRNRLIVLLLE 359
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT 160
V+ ++ + LG G G V L + + G A+KV+ K + +
Sbjct: 17 VQHSTAIFS-DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 161 EREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYA 219
E ++L LDHP + LY FE + L+ E +GG+L + R K FSE
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARII 132
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
+VL + Y+H +V+RDLKPEN+L+ +D +I + DF LS
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 35/134 (26%), Positives = 54/134 (40%), Gaps = 13/134 (9%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+GT Y+APE++ G + D W+ G+ Y LL G PF G + L V
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 409 FPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEI 466
F +S +AKDLIR +L P R+ A + H W + +
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMRI----SARDALDHE------WIQTYTKEQISV 295
Query: 467 PKPVDLSFINHKQK 480
P + I + ++
Sbjct: 296 DVPSLDNAILNIRQ 309
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 9/180 (5%)
Query: 85 SKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM 144
+ D++ + SK G L ++ +KKLG G G V L + A+K++
Sbjct: 12 ENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 145 DKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQ 203
K ++ + E +L LLDHP + LY FE + L+ME GG+L +
Sbjct: 71 RKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 204 RQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
R F+E +VL + YLH +V+RDLKPEN+L+ +D I + DF LS
Sbjct: 130 R---MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 7/122 (5%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+GT Y+APE++R + D W+ G+ + LL G PF G ++E L V
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255
Query: 409 FPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEI 466
F ++S AKDLI+ +L D Q+R+ A + +HP+ + + P +
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRI----SAQQALEHPWIKEMCSKKESGIELPSL 311
Query: 467 PK 468
Sbjct: 312 AN 313
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTER 162
S GD+ ++ L +G G G V +A + A K + K + + + E
Sbjct: 2 STKGDIN-QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EI 57
Query: 163 EILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASE 221
EI+ LDHP + LY FE + L+ME C+GG+L + + + F E +
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKD 114
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
VL A+ Y H + V +RDLKPEN L D + L DF L+
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+ VGT Y++P+++ G +G D W+ G+ Y LL G PF + E + +
Sbjct: 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225
Query: 409 FPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
FPE ++S A+ LIR LL K P++R+ + + +H +F
Sbjct: 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRI----TSLQALEHEWF 265
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F ++ LG G V+L + R G LFA+K + K L E +L + H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHE 66
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ TL +E+ L+M+ SGG+L + +R ++E+ +VL A++YLH
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH 123
Query: 231 MMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
G+V+RDLKPEN+L E+ IM++DF LS
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 6/107 (5%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
+ GT Y+APE++ + AVD W+ G+ Y LL G PF + +
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
Query: 408 KFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
+F IS +AKD I LL KDP +R + HP+ +
Sbjct: 225 EFESPFWDDISESAKDFICHLLEKDPNERY----TCEKALSHPWIDG 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 7/160 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLD 169
+ L + +G G V R+ G FA+K++D L +RE I +L
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLLALE 227
HP + L + +D ++ EF G DL +++ G +SE Y ++L AL
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 228 YLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLSLRCF 264
Y H +++RD+KP VL+ + L F ++++
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
VGT ++APE+++ + +G VD W G+ + LL G PF G ++ K
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKM 251
Query: 410 PEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
S IS +AKDL+R +L+ DP +R+ E HP+
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERI----TVYEALNHPWL 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 11/153 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLD 169
+ + + LG G+ G V+ + K + K + ++E IL++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIAR 59
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
H + L+ FE+ + ++ EF SG D+ R +E+ Y +V AL++L
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 230 HMMGVVYRDLKPENVLV--REDGHIMLSDFDLS 260
H + + D++PEN++ R I + +F +
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 6/100 (6%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
EY APE+ + D +A D W+ G Y LL G PF N++ + N++ F
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 411 EG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
E IS A D + LLVK+ + R+ A+E QHP
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHP 259
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDK----GMLAGRKKLMRAQTEREI--- 164
++ + LG G V + +A+K++D A + +R T +E+
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVL 223
+ HP + L +ET+ F L+ + G+L L ++ SE+ TR +L
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 134
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ LH + +V+RDLKPEN+L+ +D +I L+DF S
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 40/118 (33%), Positives = 49/118 (41%), Gaps = 12/118 (10%)
Query: 350 FVGTHEYLAPEIIRGD------GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV 403
GT YLAPEII G+G VD W+ G+ Y LL G PF L ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 404 GQPLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIR 459
+F S KDL+ LV PQKR A E HPFF+ +R
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQQYVVEEVR 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 7/207 (3%)
Query: 59 HSEEESGKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKK 118
+ G G + + + K Q V+ K + H+ + ++
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEE 164
Query: 119 LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYS 178
LG G G V+ R G FA K + + ++ + + E + +S+L HP L L+
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRHPTLVNLHD 221
Query: 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238
FE D ++ EF SGG+L + SE Y +V L ++H V+ D
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLD 280
Query: 239 LKPENVLV--REDGHIMLSDFDLSLRC 263
LKPEN++ + + L DF L+
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHL 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 6e-21
Identities = 40/125 (32%), Positives = 54/125 (43%), Gaps = 14/125 (11%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
GT E+ APE+ G G D W+ G+ Y LL G +PF G + ETL NV
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 411 EG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
+ S IS KD IR LL+ DP R+ + +HP W + + P
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHP------W--LTPGNAPGRDS 424
Query: 469 PVDLS 473
+ S
Sbjct: 425 QIPSS 429
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 4/162 (2%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-LLDH 170
F L+K+G G+ GSV+ R GC++A+K K LAG A E + L H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNALREVYAHAVLGQH 70
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLALEY 228
+ +S + D + E+C+GG L + +F E + +V L Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270
+H M +V+ D+KP N+ + + + + S K++
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 17/108 (15%), Positives = 40/108 (37%), Gaps = 11/108 (10%)
Query: 348 MSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-GQ 405
G +LA E+++ + H D + + + N + + G+
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQWHEIRQGR 244
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453
+ P+ +S +L++ ++ DP++R A + +H S
Sbjct: 245 LPRIPQV--LSQEFTELLKVMIHPDPERRP----SAMALVKHSVLLSA 286
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-RKKLMRAQTERE--ILSLL 168
H+ + ++LG G V + G +A K + K L+ R+ + R + ERE IL +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALE 227
HP + TL+ FE L++E SGG+L L ++ + +E + ++L +
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVH 122
Query: 228 YLHMMGVVYRDLKPENVLV----REDGHIMLSDFDLS 260
YLH + + DLKPEN+++ + I L DF ++
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 4e-22
Identities = 39/101 (38%), Positives = 54/101 (53%), Gaps = 6/101 (5%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
GT E++APEI+ + G D W+ G+ Y LL G +PF G +ETL N+ F
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 410 PEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
E S+ S AKD IR LLVKDP++R+ + +H
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRM----TIAQSLEHS 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ L LG G +V+ + G LFA+KV + + + E E+L L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKN 68
Query: 173 LPTLYSHFE--TDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL 229
+ L++ E T + L+MEFC G L+T L + E +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 230 HMMGVVYRDLKPENVLVR----EDGHIMLSDFDLS 260
G+V+R++KP N++ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 28/138 (20%), Positives = 50/138 (36%), Gaps = 39/138 (28%)
Query: 348 MSFVGTHEYLAPEIIRGD--------GHGSAVDWWTFGIFFYELLLGRTPFK----GNGN 395
+S GT EYL P++ +G+ VD W+ G+ FY G PF+ N
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 396 RETLFNVV---------------GQPLKF----PEGSSISFAAKD----LIRGLLVKDPQ 432
+E ++ ++ P+ + P S+S + ++ +L D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 433 KRLGFKRGATEIKQHPFF 450
K GF +
Sbjct: 293 KCWGFD----QFFAETSD 306
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 8/153 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ ++ LG G G V + R +A+KV++K + E E+L LDHP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHP 81
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ L+ E ++ E +GG+L + +R K FSE +V + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH 138
Query: 231 MMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
+V+RDLKPEN+L+ +D I + DF LS
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 36/104 (34%), Positives = 50/104 (48%), Gaps = 7/104 (6%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+GT Y+APE++RG + D W+ G+ Y LL G PF G + L V
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 409 FPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
F +IS AKDLIR +L P R+ AT+ +HP+
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWI 280
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-----RKKLMRAQTEREILS 166
+ + K LG G G V LA R A+K++ K A + +TE EIL
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLA 225
L+HP + + + F+ + + +++E GG+L + + E + Y ++LLA
Sbjct: 71 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 126
Query: 226 LEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
++YLH G+++RDLKPENVL+ ED I ++DF S
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 12/108 (11%)
Query: 350 FVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV--G 404
GT YLAPE++ G+ AVD W+ G+ + L G PF + + +L + + G
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 405 QPLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ F + +S A DL++ LLV DP+ R E +HP+
Sbjct: 236 K-YNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEALRHPWL 278
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 8/153 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ ++ LG G G V + R +A+KV++K K E E+L LDHP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ L+ E ++ E +GG+L + +R K FSE +V + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH 138
Query: 231 MMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
+V+RDLKPEN+L+ +D I + DF LS
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 40/134 (29%), Positives = 60/134 (44%), Gaps = 12/134 (8%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+GT Y+APE++RG + D W+ G+ Y LL G PF G + L V
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 409 FPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEI 466
F +IS AKDLIR +L P R+ AT+ +HP+ + + S P
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQKYS-----SETPTIS 291
Query: 467 PKPVDLSFINHKQK 480
P S + + ++
Sbjct: 292 DLPSLESAMTNIRQ 305
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR--KKLMRAQTEREILSLLD 169
++ + ++LG G V + G FA K+++ L+ R +KL R E I L
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQ 63
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEY 228
HP + L+ + + F L+ + +GG+L + R + +SE ++L ++ Y
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAY 120
Query: 229 LHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
H G+V+R+LKPEN+L+ + + L+DF L+
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 6/103 (5%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
F GT YL+PE+++ D + VD W G+ Y LL+G PF + +
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 410 --PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
PE +++ AK LI +L +P+KR+ A + + P+
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWI 265
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ L LG G +V+ + G LFA+KV + + + E E+L L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKN 68
Query: 173 LPTLYSHFE--TDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL 229
+ L++ E T + L+MEFC G L+T L + E +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 230 HMMGVVYRDLKPENVLVR----EDGHIMLSDFDLS 260
G+V+R++KP N++ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 31/147 (21%), Positives = 52/147 (35%), Gaps = 44/147 (29%)
Query: 348 MSFVGTHEYLAPEIIRGD--------GHGSAVDWWTFGIFFYELLLGRTPFKGNG----N 395
+S GT EYL P++ +G+ VD W+ G+ FY G PF+ N
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 396 RETLFNV-------------------VGQPLKFPEGSSISFAAKD----LIRGLLVKDPQ 432
+E ++ + + P S+S + ++ +L D +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 433 KRLGFKRGATEIKQHPFFESVNWALIR 459
K GF + FF + L R
Sbjct: 293 KCWGFDQ---------FFAETSDILHR 310
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 52/235 (22%), Positives = 95/235 (40%), Gaps = 9/235 (3%)
Query: 33 SGSDTSVSSNLSNATIEAKKGVDCLAHSEEESGKSSLSTGDANEASFRSACLSKPHKGND 92
SG D + + + H+E + S+ + +
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 93 MKWDAVQCVKSKDGDLGLGHFRLLKK--LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA 150
+ V +K G + + + K LG G G V+ E G A K++ +
Sbjct: 70 PAPFDHRIVTAKQGAVN-SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128
Query: 151 GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHF 210
++++ E +++ LDH L LY FE+ L+ME+ GG+L R +
Sbjct: 129 DKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD-RIIDESYNL 184
Query: 211 SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV--REDGHIMLSDFDLSLRC 263
+E T + ++ + ++H M +++ DLKPEN+L R+ I + DF L+ R
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
GT E+LAPE++ D D W+ G+ Y LL G +PF G+ + ETL N++
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 411 EG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
+ IS AK+ I LL+K+ R+ A+E +HP
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRI----SASEALKHP 344
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-RKKLMRAQTERE--ILSLL 168
+ + ++LG G V + G +A K + K R+ + R + ERE IL +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALE 227
HP + TL+ +E L++E SGG+L L Q++ SE+ + ++L +
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 228 YLHMMGVVYRDLKPENVLVR----EDGHIMLSDFDLS 260
YLH + + DLKPEN+++ HI L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 45/132 (34%), Positives = 63/132 (47%), Gaps = 12/132 (9%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
GT E++APEI+ + G D W+ G+ Y LL G +PF G+ +ETL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 410 PEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
E S S AKD IR LLVK+ +KRL E +HP W T +
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRL----TIQEALRHP------WITPVDTQQAMVR 287
Query: 468 KPVDLSFINHKQ 479
+ ++ N K+
Sbjct: 288 RESVVNLENFKK 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-33
Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLM-RAQTERE--ILSLL 168
+ + ++LG G V + G +A K + K ++ + R + ERE IL +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALE 227
H + TL+ +E L++E SGG+L L Q++ SE+ + ++L +
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 228 YLHMMGVVYRDLKPENVLVR----EDGHIMLSDFDLSLRC 263
YLH + + DLKPEN+++ HI L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 43/132 (32%), Positives = 62/132 (46%), Gaps = 12/132 (9%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
GT E++APEI+ + G D W+ G+ Y LL G +PF G+ +ETL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 410 PEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
E S S AKD IR LLVK+ +KRL E +HP W +
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRL----TIQEALRHP------WITPVDNQQAMVR 287
Query: 468 KPVDLSFINHKQ 479
+ ++ N ++
Sbjct: 288 RESVVNLENFRK 299
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR-----KKLMRAQTEREILS 166
+ + K LG G G V LA R A++++ K A + +TE EIL
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLA 225
L+HP + + + F+ + + +++E GG+L + K E + Y ++LLA
Sbjct: 196 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLA 251
Query: 226 LEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
++YLH G+++RDLKPENVL+ ED I ++DF S
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 12/108 (11%)
Query: 350 FVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV--G 404
GT YLAPE++ G+ AVD W+ G+ + L G PF + + +L + + G
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 405 QPLKF--PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ F + +S A DL++ LLV DP+ R E +HP+
Sbjct: 361 K-YNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEALRHPWL 403
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-33
Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 18/189 (9%)
Query: 86 KPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD 145
+ + + V+ K+G +G + ++KLG G G V L + ++ A+KV+
Sbjct: 12 ENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70
Query: 146 KGMLAGRKKLMRA----------QTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSG 195
K + E +L LDHP + L+ FE K+ L+ EF G
Sbjct: 71 KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130
Query: 196 GDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR---EDGH 251
G+L + R F E ++L + YLH +V+RD+KPEN+L+ +
Sbjct: 131 GELFEQIINR---HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187
Query: 252 IMLSDFDLS 260
I + DF LS
Sbjct: 188 IKIVDFGLS 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 32/134 (23%), Positives = 56/134 (41%), Gaps = 13/134 (9%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
+GT Y+APE+++ + D W+ G+ Y LL G PF G +++ + V
Sbjct: 207 DRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 409 FPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEI 466
F +IS AK+LI+ +L D KR A E W + + +
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRC----TAEEALNSR------WIKKYANNINKS 315
Query: 467 PKPVDLSFINHKQK 480
+ +++ +K
Sbjct: 316 DQKTLCGALSNMRK 329
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 40/157 (25%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLM-RAQTERE--ILSLL 168
++ ++LG G V + G +A K + K ++ + R ERE IL +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALE 227
HP + TL+ +E L++E +GG+L L ++ + +E+ + ++L +
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVY 128
Query: 228 YLHMMGVVYRDLKPENVLVR----EDGHIMLSDFDLS 260
YLH + + + DLKPEN+++ I + DF L+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 42/101 (41%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
GT E++APEI+ + G D W+ G+ Y LL G +PF G+ +ETL NV +F
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 410 PEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
+ S+ S AKD IR LLVKDP+KR+ + QHP
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHP 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 17/209 (8%)
Query: 59 HSEEESGKSSLSTG--DANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLL 116
H SG +G + A F + P G D D ++ + + +L
Sbjct: 3 HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDD-DKASSSANECISVKGRIYSIL 61
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML--AGRKKLMRAQTEREILSLLDHPFLP 174
K++G G V+ L + ++A+K ++ E L+ L
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQQHSDK 117
Query: 175 --TLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
LY + TD++ ++ME C DL++ L+++ K + Y +L A+ +H
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
G+V+ DLKP N L+ DG + L DF ++
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIA 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 16/120 (13%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDG-----------HGSAVDWWTFGIFFYELLLGRTPFK 391
TS S VG Y+ PE I+ D W+ G Y + G+TPF+
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 392 GNGNR-ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
N+ L ++ + +D+++ L +DP++R+ E+ HP+
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP----ELLAHPYV 324
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 35/164 (21%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L F ++ LG G G V+ A+ + C +A+K + + E + L+ L+
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLE 61
Query: 170 HPFLPTLYSHFETD------------KFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATR 216
HP + ++ + + + M+ C +L + R +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 217 FYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ A+E+LH G+++RDLKP N+ D + + DF L
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 10/130 (7%)
Query: 327 TSLTNSDSL-PVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL 385
T++ + VL P AR VGT Y++PE I G+ + VD ++ G+ +ELL
Sbjct: 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL- 224
Query: 386 GRTPFKGNGNRETLFNVVGQPLKFPEGSS-ISFAAKDLIRGLLVKDPQKRLGFKRGATEI 444
PF R V + LKFP + +++ +L P +R A I
Sbjct: 225 --YPFSTQMERVRTLTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP----EAINI 277
Query: 445 KQHPFFESVN 454
++ FE ++
Sbjct: 278 IENAVFEDLD 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 14/154 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML--AGRKKLMRAQTEREILSLLD 169
+ +LK++G G V+ L + ++A+K ++ E L+ L
Sbjct: 29 IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQ 84
Query: 170 HPFLP--TLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
LY + TD++ ++ME C DL++ L+++ K + Y +L A+
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAV 140
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+H G+V+ DLKP N L+ DG + L DF ++
Sbjct: 141 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 30/122 (24%), Positives = 52/122 (42%), Gaps = 20/122 (16%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDG-----------HGSAVDWWTFGIFFYELLLGRTPFK 391
TS S VGT Y+ PE I+ D W+ G Y + G+TPF+
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 392 GNGNR-ETLFNVV--GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
N+ L ++ ++FP+ +D+++ L +DP++R+ E+ HP
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIP----ELLAHP 294
Query: 449 FF 450
+
Sbjct: 295 YV 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 45/191 (23%), Positives = 71/191 (37%), Gaps = 42/191 (21%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLD 169
+ L +G G G V +A + A+K+M+K + + + E ++ L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDL------------------------------- 198
HP + LY +E +++ CL+ME C GG L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 199 -------HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV--RED 249
+ E+ ++ AL YLH G+ +RD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 250 GHIMLSDFDLS 260
I L DF LS
Sbjct: 207 FEIKLVDFGLS 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 350 FVGTHEYLAPEIIRGDGH--GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
GT ++APE++ G D W+ G+ + LL+G PF G + +T+ V+ + L
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL 293
Query: 408 KF--PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
F P + +S A+DL+ LL ++ +R A QHP+
Sbjct: 294 CFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWI 334
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
++ + ++LG G V + G FA K+++ L+ R + E I L HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ L+ + + F L+ + +GG+L + R + +SE ++L ++ Y H
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCH 145
Query: 231 MMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
G+V+R+LKPEN+L+ + + L+DF L+
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 6/103 (5%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
F GT YL+PE+++ D + VD W G+ Y LL+G PF + +
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 410 --PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
PE +++ AK LI +L +P+KR+ A + + P+
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWI 288
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
++L ++LG G V G +A +++ L+ R + + E I LL HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHP 70
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ L+ + L+ + +GG+L + R +++SE ++L A+ + H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCH 127
Query: 231 MMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
MGVV+R+LKPEN+L+ + + L+DF L+
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 6/103 (5%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
F GT YL+PE++R D +G VD W G+ Y LL+G PF + F
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF 232
Query: 410 PEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
P +++ AKDLI +L +P KR+ A E +HP+
Sbjct: 233 PSPEWDTVTPEAKDLINKMLTINPSKRI----TAAEALKHPWI 271
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+ + L++ LG G G V LA R A+K++D ++EI +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKM 61
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
L+H + Y H L +E+CSGG+L R E + + +++ +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFD-RIEPDIG-MPEPDAQRFFHQLMAGVV 119
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH +G+ +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 349 SFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQP 406
GT Y+APE+++ H VD W+ GI +L G P+ + + + +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
I A L+ +LV++P R+ +IK+ ++
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWY 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 14/154 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML--AGRKKLMRAQTEREILSLLD 169
+ +LK++G G V+ L + ++A+K ++ E L+ L
Sbjct: 10 IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRN---EIAYLNKLQ 65
Query: 170 HPFLP--TLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
LY + TD++ ++ME C DL++ L+++ K + Y +L A+
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAV 121
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+H G+V+ DLKP N L+ DG + L DF ++
Sbjct: 122 HTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 30/122 (24%), Positives = 52/122 (42%), Gaps = 20/122 (16%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDG-----------HGSAVDWWTFGIFFYELLLGRTPFK 391
TS S VGT Y+ PE I+ D W+ G Y + G+TPF+
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
Query: 392 GNGNR-ETLFNVV--GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
N+ L ++ ++FP+ +D+++ L +DP++R+ E+ HP
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIP----ELLAHP 275
Query: 449 FF 450
+
Sbjct: 276 YV 277
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+ + L++ LG G G V LA R A+K++D ++EI +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKM 61
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
L+H + Y H L +E+CSGG+L R E + + +++ +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFD-RIEPDIG-MPEPDAQRFFHQLMAGVV 119
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH +G+ +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 32/149 (21%), Positives = 56/149 (37%), Gaps = 19/149 (12%)
Query: 349 SFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVVGQP 406
GT Y+APE+++ H VD W+ GI +L G P+ + + + +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF-------------ESV 453
I A L+ +LV++P R+ +IK+ ++ S
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWYNKPLKKGAKRPRVTSG 281
Query: 454 NWALIRSTHPPEIPKPVDLSFINHKQKTP 482
+ S I +D S +N +TP
Sbjct: 282 GVSESPSGFSKHIQSNLDFSPVNSASRTP 310
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 43/149 (28%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPT 175
K LG G + FA+K++ K + Q E L L + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 176 LYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
L+ F + L+ME +GG+L ++++ KHFSE + +++ A+ ++H +GV
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 235 VYRDLKPENVLVR---EDGHIMLSDFDLS 260
V+RDLKPEN+L ++ I + DF +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 21/138 (15%)
Query: 330 TNSDSLPVLIA--------EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFY 381
+D+L + I P + + T Y APE++ +G+ + D W+ G+ Y
Sbjct: 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILY 200
Query: 382 ELLLGRTPFKGNGNRET------LFNVVGQ-PLKFPEG--SSISFAAKDLIRGLLVKDPQ 432
+L G+ PF+ + T + + + F ++S AKDLI+GLL DP
Sbjct: 201 TMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260
Query: 433 KRLGFKRGATEIKQHPFF 450
KRL + ++ + +
Sbjct: 261 KRL----KMSGLRYNEWL 274
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 5/148 (3%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-PFLPT 175
K+LG G V + G +A K + K G+ E +L L P +
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVV 235
L+ +E L++E+ +GG++ +L + + SE ++L + YLH +V
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 236 YRDLKPENVLV---REDGHIMLSDFDLS 260
+ DLKP+N+L+ G I + DF +S
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMS 181
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 45/133 (33%), Positives = 62/133 (46%), Gaps = 14/133 (10%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF 409
+GT EYLAPEI+ D +A D W GI Y LL +PF G N+ET N+ + +
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 410 PEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
E SS+S A D I+ LLVK+P+KR A H W ++ +
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRP----TAEICLSHS------W--LQQWDFENLF 300
Query: 468 KPVDLSFINHKQK 480
P + S + Q
Sbjct: 301 HPEETSSSSQTQD 313
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F + +LG G VY + + +A+KV+ K +TE +L L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHP 108
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ L FET L++E +GG+L + ++ ++SE+ ++L A+ YLH
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLH 165
Query: 231 MMGVVYRDLKPENVLVR---EDGHIMLSDFDLS 260
G+V+RDLKPEN+L D + ++DF LS
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 39/104 (37%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV--GQP 406
+ GT Y APEI+RG +G VD W+ GI Y LL G PF + +F + +
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE- 267
Query: 407 LKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
F +S AKDL+R L+V DP+KRL + QHP
Sbjct: 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRL----TTFQALQHP 307
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 6/155 (3%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+G + + LG G G V + C A+K++ K L R A ++EI L
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRR 62
Query: 168 LDHPFLPTLYS--HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
L H + L + E + ++ME+C G + + P K F Y +++
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LEYLH G+V++D+KP N+L+ G + +S ++
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 35/123 (28%), Positives = 52/123 (42%), Gaps = 13/123 (10%)
Query: 352 GTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-NVVGQPLK 408
G+ + PEI G G VD W+ G+ Y + G PF+G+ N LF N+
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-NIYKLFENIGKGSYA 231
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
P DL++G+L +P KR + +I+QH +F + P IP
Sbjct: 232 IP--GDCGPPLSDLLKGMLEYEPAKRFSIR----QIRQHSWFRK---KHPPAEAPVPIPP 282
Query: 469 PVD 471
D
Sbjct: 283 SPD 285
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 28/176 (15%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKL-------------- 155
L + L ++G G G V LA + +AMKV+ K L +
Sbjct: 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 156 -------MRAQTEREI--LSLLDHPFLPTLYSHFE--TDKFSCLLMEFCSGGDLHTLRQR 204
Q +EI L LDHP + L + + ++ E + G + +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 205 QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+P SE RFY +++ +EYLH +++RD+KP N+LV EDGHI ++DF +S
Sbjct: 132 KP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 350 FVGTHEYLAPEIIRGDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406
VGT ++APE + G A+D W G+ Y + G+ PF + Q
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
L+FP+ I+ KDLI +L K+P+ R+ EIK HP+
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVP----EIKLHPWV 296
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 52/160 (32%), Positives = 84/160 (52%), Gaps = 5/160 (3%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
D +G++RLLK +G G+ V LA G A+K++DK L L + E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFRE 64
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYAS 220
I+ +L+HP + L+ ET+K L+ME+ SGG++ L E+ R
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFR 121
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++ A++Y H +V+RDLK EN+L+ D +I ++DF S
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 33/139 (23%), Positives = 55/139 (39%), Gaps = 7/139 (5%)
Query: 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
F G Y APE+ +G G VD W+ G+ Y L+ G PF G N + L V + K
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRG-K 230
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
+ +S ++L++ LV +P KR + +I + + + +
Sbjct: 231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLE----QIMKDRWINAGHEEDELKPFVEPELD 286
Query: 469 PVDLSFINHKQKTPIPQND 487
D I+ Q +
Sbjct: 287 ISDQKRIDIMVGMGYSQEE 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 11/149 (7%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPT 175
LG G V +A+K+++K R ++ R E E+L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 176 LYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
L FE + L+ E GG + + +R +HF+E +V AL++LH G+
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKGI 132
Query: 235 VYRDLKPENVLVR---EDGHIMLSDFDLS 260
+RDLKPEN+L + + + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 34/125 (27%), Positives = 53/125 (42%), Gaps = 26/125 (20%)
Query: 348 MSFVGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
++ G+ EY+APE++ + D W+ G+ Y LL G PF G + ++
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 403 VGQPLKFPEG-----------------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIK 445
+ IS AAKDLI LLV+D ++RL A ++
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL----SAAQVL 294
Query: 446 QHPFF 450
QHP+
Sbjct: 295 QHPWV 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKL---MRAQTEREI-- 164
+ + LG G G V+ A ++ +K + K + + + EI
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEF-CSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
LS ++H + + FE F L+ME SG DL R P E + +++
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLV 140
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A+ YL + +++RD+K EN+++ ED I L DF +
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 34/152 (22%), Positives = 59/152 (38%), Gaps = 15/152 (9%)
Query: 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
F GT EY APE++ G+ G ++ W+ G+ Y L+ PF L V +
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIH 242
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF-ESVNWALIRSTHPPEIP 467
P +S L+ GLL P++R + ++ P+ + VN A +
Sbjct: 243 PP--YLVSKELMSLVSGLLQPVPERRTTLE----KLVTDPWVTQPVNLADYTWEEVFRVN 296
Query: 468 KPVDLSFINHKQKTPIPQNDKGAADSDRSSGP 499
KP + ++ ++ A + G
Sbjct: 297 KP-ESGVLSAASLEMGNRSLSDVAQAQELCGG 327
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 8/161 (4%)
Query: 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTER 162
DG + +GH+ L LG G G V + E + G A+K++++ + + + + E
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 163 EILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLH---TLRQRQPGKHFSEQATRFYA 219
+ L L HP + LY T ++ME+ SGG+L R E R
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-----VEEMEARRLF 117
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L A++Y H VV+RDLKPENVL+ + ++DF LS
Sbjct: 118 QQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 3e-16
Identities = 32/100 (32%), Positives = 47/100 (47%), Gaps = 7/100 (7%)
Query: 352 GTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
G+ Y APE+I G G VD W+ G+ Y LL G PF + TLF + F
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-HVPTLFKKIRGG-VFY 229
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
++ + L+ +L DP KR K +I++H +F
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIK----DIREHEWF 265
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 16/155 (10%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDH 170
+ + + +G G + FA+K++DK + E EIL H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRYGQH 75
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
P + TL ++ K+ ++ E GG+L + ++ K FSE+ + +EYL
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYL 132
Query: 230 HMMGVVYRDLKPENVLVREDGH----IMLSDFDLS 260
H GVV+RDLKP N+L ++ I + DF +
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG--NRETLFNVVGQ 405
M+ T ++APE++ G+ +A D W+ G+ Y +L G TPF E + +G
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237
Query: 406 -PLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
G +S+S AKDL+ +L DP +RL A + +HP+
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL----TAALVLRHPWI 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 1e-29
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 12/161 (7%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
G + + ++LG G G V +D G A+K + + K R E +I+ L+
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLN 70
Query: 170 HPFLPTLY------SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEV 222
HP + + + L ME+C GGDL L Q + E R S++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGH---IMLSDFDLS 260
AL YLH +++RDLKPEN++++ + D +
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 23/128 (17%), Positives = 46/128 (35%), Gaps = 26/128 (20%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
FVGT +YLAPE++ + VD+W+FG +E + G PF N V +
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 409 FPEG----------------------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446
++ + ++ +L+ ++R +
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP----QNPN 297
Query: 447 HPFFESVN 454
F++++
Sbjct: 298 VGCFQALD 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-29
Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 14/180 (7%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL- 165
+LG R+ + L G VY A+ G +A+K + + +++ E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMK 80
Query: 166 SLLDHPFLPTLYSHFETDKFS--------CLLMEFCSGGDLHTLRQRQPGKHFSEQATRF 217
L HP + S K LL E C G + L++ + S
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 218 YASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275
+ A++++H +++RDLK EN+L+ G I L DF + P S+
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 31/155 (20%), Positives = 48/155 (30%), Gaps = 28/155 (18%)
Query: 348 MSFVGTHEYLAPEII---RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
++ T Y PEII G D W G Y L + PF+ +V
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVN 263
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPP 464
P + LIR +L +P++RL E+ I +
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIAEVVHQLQ-------EIAAARNV 312
Query: 465 EIPKPVDLSFINHKQKTPIPQNDKGAADSDRSSGP 499
P+ T + + + G + S GP
Sbjct: 313 NPKSPI----------TELLEQNGGYGSATLSRGP 337
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 12/155 (7%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+ +K +G G+ G L + L A+K +++G + +REI
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------AAIDENVQREIINHRS 72
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
L HP + T ++ME+ SGG+L+ R G+ FSE RF+ ++L +
Sbjct: 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYE-RICNAGR-FSEDEARFFFQQLLSGVS 130
Query: 228 YLHMMGVVYRDLKPENVLVRED--GHIMLSDFDLS 260
Y H M + +RDLK EN L+ + + DF S
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 12/160 (7%)
Query: 349 SFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
S VGT Y+APE++ G D W+ G+ Y +L+G PF+ + Q +
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPRDYRKTIQRI 234
Query: 408 K-----FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF-ESVNWALIRST 461
P+ IS LI + V DP R+ EIK H +F +++ L+ +
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIP----EIKTHSWFLKNLPADLMNES 290
Query: 462 HPPEIPKPVDLSFINHKQKTPIPQNDKGAADSDRSSGPFL 501
+ + + + I A +R F+
Sbjct: 291 NTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFM 330
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 8/162 (4%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
+ DG + +GH+ L LG G G V + + G A+K++++ + + + + E
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLH---TLRQRQPGKHFSEQATRFY 218
+ L L HP + LY T ++ME+ SGG+L R E+ +R
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRL 121
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L ++Y H VV+RDLKPENVL+ + ++DF LS
Sbjct: 122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 7/102 (6%)
Query: 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
G+ Y APE+I G G VD W+ G+ Y LL G PF + + TLF +
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-HVPTLFKKICDG-I 232
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
F ++ + L++ +L DP KR K +I++H +F
Sbjct: 233 FYTPQYLNPSVISLLKHMLQVDPMKRATIK----DIREHEWF 270
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 34/182 (18%), Positives = 53/182 (29%), Gaps = 32/182 (17%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+L++ L GD V+L + FA+KV G R +L R + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 172 FLPTLYSHFETDKFS--------------------------CLLMEFCSGGDLHTL---- 201
S LLM S DL L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLFSTL 181
Query: 202 -RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A ++++ L G+V+ P+N+ + DG +ML D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 261 LR 262
+
Sbjct: 242 WK 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 23/121 (19%), Positives = 35/121 (28%), Gaps = 13/121 (10%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGN- 395
R + Y E + A++ W G+ Y + PF
Sbjct: 240 ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 396 ------RETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
R +L L F + + K LI L D ++RL E + P
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPE 355
Query: 450 F 450
F
Sbjct: 356 F 356
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 25/184 (13%), Positives = 51/184 (27%), Gaps = 35/184 (19%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKL---------------- 155
LG D + A ++ G F + V +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 156 ---------MRAQTEREILSLLDHPFLPTLYSHFETDKFS--CLLMEFCS------GGDL 198
+R +++ + + L G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 199 HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFD 258
+ K A +V+ L LH G+V+ L+P ++++ + G + L+ F+
Sbjct: 194 LSHSSTH--KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 259 LSLR 262
+R
Sbjct: 252 HLVR 255
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 18/133 (13%), Positives = 37/133 (27%), Gaps = 26/133 (19%)
Query: 346 RSMSFVGTHEYLAPEII-----------RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG 394
+ + + PE+ R + D W G+ Y + P +
Sbjct: 258 ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA 317
Query: 395 NRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454
+ P+ + L+ G L + RL + + P +E
Sbjct: 318 ALGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRL----LPLQAMETPEYEQ-- 365
Query: 455 WALIRSTHPPEIP 467
+R+ +P
Sbjct: 366 ---LRTELSAALP 375
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 44/163 (26%), Positives = 66/163 (40%), Gaps = 5/163 (3%)
Query: 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE 161
+ D LG G G VY A+K + + + L E
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE---E 69
Query: 162 REILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGK-HFSEQATRFYAS 220
+ L H + F + F + ME GG L L + + G +EQ FY
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLV-REDGHIMLSDFDLSLR 262
++L L+YLH +V+RD+K +NVL+ G + +SDF S R
Sbjct: 130 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 34/130 (26%), Positives = 53/130 (40%), Gaps = 15/130 (11%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGD--GHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETL 399
+ + +F GT +Y+APEII G+G A D W+ G E+ G+ PF G +
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIR 459
F V + S+S AK I DP KR A ++ F ++
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA----CANDLLVDEF--------LK 283
Query: 460 STHPPEIPKP 469
+ + +P
Sbjct: 284 VSSKKKKTQP 293
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
+G + + + LG G G V LA A+K + + +L M + EREI L L
Sbjct: 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD--MHMRVEREISYLKL 65
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLH---TLRQRQPGKHFSEQATRFYASEVLL 224
L HP + LY T +++E+ GG+L ++R +E R + +++
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR-----MTEDEGRRFFQQIIC 119
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A+EY H +V+RDLKPEN+L+ ++ ++ ++DF LS
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 352 GTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
G+ Y APE+I G G VD W+ GI Y +L+GR PF V P
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP 228
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+S A+ LIR ++V DP +R+ + EI++ P+F
Sbjct: 229 --DFLSPGAQSLIRRMIVADPMQRITIQ----EIRRDPWF 262
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 16/152 (10%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPT 175
+ LG G G V R G A+K++ K + E + P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQ---EVDHHWQASGGPHIVC 86
Query: 176 LYSHFETDKFSC----LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ +E ++ME GG+L + Q + + F+E+ ++ A+++LH
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 232 MGVVYRDLKPENVLV---REDGHIMLSDFDLS 260
+ +RD+KPEN+L +D + L+DF +
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 17/126 (13%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET---LFNVVG 404
+ T Y+APE++ + + + D W+ G+ Y LL G PF N + + +
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 405 Q-PLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRST 461
FP S +S AK LIR LL DP +RL T+ HP W + +S
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL----TITQFMNHP------W-INQSM 295
Query: 462 HPPEIP 467
P+ P
Sbjct: 296 VVPQTP 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 44/218 (20%), Positives = 84/218 (38%), Gaps = 22/218 (10%)
Query: 57 LAHSEEESGKSSLSTGDANEASFRSACLSKPHKGNDM------KWDAVQCVKSKDGDLGL 110
L++S+ +S A P + ++ ++ K +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLD 169
+ + LG G G V + FA+K++ K R E E+
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARR---EVELHWRASQ 113
Query: 170 HPFLPTLYSHFET----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
P + + +E K ++ME GG+L + Q + + F+E+ + A
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 226 LEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLS 260
++YLH + + +RD+KPEN+L R + + L+DF +
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 10/107 (9%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET---LFNVVG 404
+ T Y+APE++ + + + D W+ G+ Y LL G PF N + +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 405 Q-PLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
+FP S +S K LIR LL +P +R+ TE HP
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHP 323
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 15/153 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDH 170
++G G G V+ + + G A+K + + E+ + L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----------LEVFRVEELVACAGLSS 109
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P + LY + + ME GG L L ++ E +Y + L LEYLH
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH 167
Query: 231 MMGVVYRDLKPENVLVREDG-HIMLSDFDLSLR 262
+++ D+K +NVL+ DG L DF +L
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 24/128 (18%), Positives = 43/128 (33%), Gaps = 5/128 (3%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
+ GT ++APE++ G + VD W+ +L G P+ +
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268
Query: 403 V-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRST 461
P S + I+ L K+P R A E+++ ++S
Sbjct: 269 ASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA----SAMELRRKVGKALQEVGGLKSP 324
Query: 462 HPPEIPKP 469
E +P
Sbjct: 325 WKGEYKEP 332
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 22/186 (11%)
Query: 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQT 160
++ K + + + LG G G V + FA+K++ A R
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------- 59
Query: 161 EREIL-SLLDHPFLPTLYSHFET----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAT 215
E E+ P + + +E K ++ME GG+L + Q + + F+E+
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 119
Query: 216 RFYASEVLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLSLRCFVSPKLVQS 272
+ A++YLH + + +RD+KPEN+L + + L+DF + +
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------AKETTGE 173
Query: 273 SDDPAC 278
D +C
Sbjct: 174 KYDKSC 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 28/98 (28%), Positives = 39/98 (39%), Gaps = 11/98 (11%)
Query: 357 LAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET---LFNVVGQ-PLKFPEG 412
A E + + D W+ G+ Y LL G PF N + + +FP
Sbjct: 166 FAKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 413 --SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448
S +S K LIR LL +P +R+ TE HP
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHP 258
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 69 LSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVY 128
+ + + H A + K+ + +++ LG G GSVY
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVY 60
Query: 129 LAELRDMGCLFAMKVMDKGMLAGRKKL-MRAQTEREI--LSLLDHPFLP---TLYSHFET 182
A+K ++K ++ +L + E+ L + F L FE
Sbjct: 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFER 119
Query: 183 DKFSCLLMEFCSG-GDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLK 240
L++E DL + +R E+ R + +VL A+ + H GV++RD+K
Sbjct: 120 PDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIK 176
Query: 241 PENVLV-REDGHIMLSDFDLS 260
EN+L+ G + L DF
Sbjct: 177 DENILIDLNRGELKLIDFGSG 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 13/106 (12%)
Query: 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
F GT Y PE IR HG + W+ GI Y+++ G PF + E ++ +
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEE----IIRGQVF 261
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454
F +S + LIR L P R F+ EI+ HP+ + V
Sbjct: 262 FR--QRVSSECQHLIRWCLALRPSDRPTFE----EIQNHPWMQDVL 301
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/414 (17%), Positives = 134/414 (32%), Gaps = 115/414 (27%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL 165
GDL G + +++KLG G +V+L+ AMKV+ + A E +L
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLL 87
Query: 166 SLL-----DHP---FLPTLYSHFETD----KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQ 213
+ + P + L F+ C++ E G L + +
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLP 146
Query: 214 ATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVR-EDGHIMLSDFDLSLRCFVSPKLVQ 271
+ +VL L+YLH +++ D+KPEN+L+ + +I + +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331
S ++ + ++P N
Sbjct: 207 GSAVSTAPATAGNFLVNPLEP-------------------------------------KN 229
Query: 332 SDSLPVLIAEPTSARSMS-----FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLG 386
++ L V IA+ +A + + T +Y + E++ G G+ + D W+ +EL G
Sbjct: 230 AEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 387 RTPFKGNGNRE------------------------------------------------T 398
F+ + E
Sbjct: 290 DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349
Query: 399 LFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
LF V+ + ++ + + F D + +L P+KR A E +HP+ S
Sbjct: 350 LFEVLVEKYEWSQEEAAGFT--DFLLPMLELIPEKRA----TAAECLRHPWLNS 397
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 7/151 (4%)
Query: 111 GHFRLLKKLGCG--DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LS 166
G + LL +G G D+ +V LA + G ++ ++ L M + E+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN---LEACSNEMVTFLQGELHVSK 81
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
L +HP + + F D ++ F + G L +E A + VL AL
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+Y+H MG V+R +K ++L+ DG + LS
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGL 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 24/148 (16%), Positives = 40/148 (27%), Gaps = 50/148 (33%)
Query: 349 SFVGTHEYLAPEIIRGDGHG--SAVDWWTFGIFFYELLLGRTPF---------------- 390
V +L+PE+++ + G + D ++ GI EL G PF
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253
Query: 391 ----------------------------KGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422
+ T G P + S
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313
Query: 423 IRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ L ++P R A+ + H FF
Sbjct: 314 VEQCLQRNPDARP----SASTLLNHSFF 337
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 17/177 (9%)
Query: 96 DAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKL 155
KD + +RL LG G G+V+ A+KV+ + + G L
Sbjct: 16 TPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL 75
Query: 156 MRAQT-EREI--LSLLD----HPFLPTLYSHFETDKFSCLLMEF-CSGGDLH---TLRQR 204
+ T E+ L + HP + L FET + L++E DL T +
Sbjct: 76 SDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP 135
Query: 205 QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV-REDGHIMLSDFDLS 260
E +R + +V+ A+++ H GVV+RD+K EN+L+ G L DF
Sbjct: 136 -----LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 32/126 (25%), Positives = 46/126 (36%), Gaps = 16/126 (12%)
Query: 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
F GT Y PE I H W+ GI Y+++ G PF ++E ++ L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQE----ILEAELH 251
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPK 468
FP + +S LIR L P R + EI P+ P
Sbjct: 252 FP--AHVSPDCCALIRRCLAPKPSSRPSLE----EILLDPWM---QTPAEDVPLNPSKGG 302
Query: 469 PVDLSF 474
P L++
Sbjct: 303 PAPLAW 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 10/155 (6%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP- 171
+ ++G G +VY + A + L + + R + E E+L L HP
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPN 86
Query: 172 ---FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
F + S + K L+ E + G L T +R K + R + ++L L++
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQF 144
Query: 229 LHMMG--VVYRDLKPENVLV-REDGHIMLSDFDLS 260
LH +++RDLK +N+ + G + + D L+
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 23/111 (20%), Positives = 50/111 (45%), Gaps = 10/111 (9%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
++ + + +GT E++APE+ + + +VD + FG+ E+ P+ N ++
Sbjct: 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241
Query: 403 VGQ---PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
V P F + + K++I G + ++ +R ++ H FF
Sbjct: 242 VTSGVKPASFDKVAIP--EVKEIIEGCIRQNKDERY----SIKDLLNHAFF 286
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 3e-25
Identities = 32/186 (17%), Positives = 59/186 (31%), Gaps = 34/186 (18%)
Query: 111 GHFRLLKK---LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
R L + LG D + A ++ G F + V + + + E L L
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 168 L----------------------DHPFLPTLYSHFETDKFSCLLMEF----CSGGDLHTL 201
L P + ++ +L F +L T
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 202 -----RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSD 256
K A +V+ L LH G+V+ L+P ++++ + G + L+
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 257 FDLSLR 262
F+ +R
Sbjct: 255 FEHLVR 260
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 24/158 (15%), Positives = 43/158 (27%), Gaps = 17/158 (10%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHG-----SAVDWWTFGIFFYELLLGRTPFKGNGN 395
+ E A ++ H A D WT G+ Y + P +
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 396 RETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
+ P+ + L+ G L + RL + + P +E +
Sbjct: 323 LGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRL----LPLQAMETPEYEQLRT 372
Query: 456 ALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGAADS 493
L S P + + + Q D+ A
Sbjct: 373 EL--SAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAE 408
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 45/146 (30%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ ++ +LG G G VY A+ ++ G L A KV++ ++L E EIL+ DHP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHP 76
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
++ L + D +++EFC GG + + +E + ++L AL +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS 135
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
+++RDLK NVL+ +G I L+DF
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 29/119 (24%), Positives = 50/119 (42%), Gaps = 14/119 (11%)
Query: 343 TSARSMSFVGTHEYLAPEII-----RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
T + SF+GT ++APE++ + + D W+ GI E+ P
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229
Query: 398 TLFNVVGQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453
L + L P S+ F +D ++ L K+P+ R A ++ +HPF S+
Sbjct: 230 VLLKIAKSDPPTLLTPSKWSVEF--RDFLKIALDKNPETRP----SAAQLLEHPFVSSI 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 35/154 (22%), Positives = 58/154 (37%), Gaps = 15/154 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HP 171
F LG G G++ + D A+K + + A E ++L D HP
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILP------ECFSFADREVQLLRESDEHP 78
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ + + +F + +E C L + Q + L +LH
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 232 MGVVYRDLKPENVLVREDGH-----IMLSDFDLS 260
+ +V+RDLKP N+L+ M+SDF L
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 7e-19
Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 9/115 (7%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLL-GRTPFKGNGNR 396
+ +R GT ++APE++ D VD ++ G FY ++ G PF + R
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236
Query: 397 ETLFNVVGQPLKFPEG-SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ + L A++LI ++ DPQKR A + +HPFF
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP----SAKHVLKHPFF 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 5/146 (3%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F L+K+G G G V+ + A+K++D + ++ Q E +LS D P
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSP 80
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
++ Y + D ++ME+ GG L + P E E+L L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS 137
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
++RD+K NVL+ E G + L+DF
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 7/109 (6%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T + +FVGT ++APE+I+ + S D W+ GI EL G P + LF +
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231
Query: 403 V-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
P S K+ + L K+P R A E+ +H F
Sbjct: 232 PKNNPPTLEGNYSKPL--KEFVEACLNKEPSFRP----TAKELLKHKFI 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 42/168 (25%), Positives = 66/168 (39%), Gaps = 27/168 (16%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-LLDH 170
K LG G G+V G A+K M A E ++L+ DH
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI------DFCDIALMEIKLLTESDDH 68
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTL-----RQRQPGKHFSEQATRFYASEVLLA 225
P + Y TD+F + +E C +L L + K E ++
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 226 LEYLHMMGVVYRDLKPENVLV-------------REDGHIMLSDFDLS 260
+ +LH + +++RDLKP+N+LV E+ I++SDF L
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 29/118 (24%), Positives = 49/118 (41%), Gaps = 15/118 (12%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGH-------GSAVDWWTFGIFFYELL-LGRTPFKGNGN 395
+ GT + APE++ + ++D ++ G FY +L G+ PF +
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 396 RETLF---NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
RE+ +K S+ A DLI ++ DP KR A ++ +HP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP----TAMKVLRHPLF 299
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 38/152 (25%), Positives = 65/152 (42%), Gaps = 8/152 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ L + +G G V A A+K ++ + + + E + +S HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHHP 73
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTL------RQRQPGKHFSEQATRFYASEVLLA 225
+ + Y+ F L+M+ SGG + + + E EVL
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
LEYLH G ++RD+K N+L+ EDG + ++DF
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 31/111 (27%), Positives = 49/111 (44%), Gaps = 13/111 (11%)
Query: 349 SFVGTHEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP- 406
+FVGT ++APE++ + G+ D W+FGI EL G P+ + L +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244
Query: 407 --LKFPEGSSI-----SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
L+ + + +I L KDP+KR A E+ +H FF
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP----TAAELLRHKFF 291
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 6/145 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
K+G G G V LA + G A+K+MD L +++ E I+ H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFN 103
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ +Y + + +LMEF GG L + + +E+ VL AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ 160
Query: 233 GVVYRDLKPENVLVREDGHIMLSDF 257
GV++RD+K +++L+ DG + LSDF
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 9/114 (7%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
+ S VGT ++APE+I + + VD W+ GI E++ G P+ + + +
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 402 VVGQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
+ P LK S +D + +LV+DPQ+R A E+ HPF
Sbjct: 253 LRDSPPPKLKNSHKVSPVL--RDFLERMLVRDPQERA----TAQELLDHPFLLQ 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 6/145 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ +K+G G G+VY A G A++ M+ L + K E ++ +P
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ + ++ME+ +GG L + E E L ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN 135
Query: 233 GVVYRDLKPENVLVREDGHIMLSDF 257
V++RD+K +N+L+ DG + L+DF
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDF 160
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 9/114 (7%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
P ++ + VGT ++APE++ +G VD W+ GI E++ G P+ L+
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 402 VVGQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
+ L+ PE S F +D + L D +KR A E+ QH F +
Sbjct: 228 IATNGTPELQNPEKLSAIF--RDFLNRCLEMDVEKRG----SAKELLQHQFLKI 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 6/145 (4%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +L+KLG G GSVY A ++ G + A+K + + + + E I+ D P
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEI--IKEISIMQQCDSPH 85
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ Y + + ++ME+C G + + + + +E L LEYLH M
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFM 144
Query: 233 GVVYRDLKPENVLVREDGHIMLSDF 257
++RD+K N+L+ +GH L+DF
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 35/114 (30%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
T A+ + +GT ++APE+I+ G+ D W+ GI E+ G+ P+ +F
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236
Query: 402 VVGQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
+ P + PE S +F D ++ LVK P++R AT++ QHPF S
Sbjct: 237 IPTNPPPTFRKPELWSDNF--TDFVKQCLVKSPEQRA----TATQLLQHPFVRS 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 40/146 (27%), Positives = 60/146 (41%), Gaps = 2/146 (1%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F L+++G G G+VY A + A+K M +K E L L HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ + + L+ME+C G L + K E L L YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS 172
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDF 257
+++RD+K N+L+ E G + L DF
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 27/108 (25%), Positives = 43/108 (39%), Gaps = 13/108 (12%)
Query: 349 SFVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
SFVGT ++APE+I + VD W+ GI EL + P L+++
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 268
Query: 406 P---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
L+ S ++ + L K PQ R + + +H F
Sbjct: 269 ESPALQSGHWSE---YFRNFVDSCLQKIPQDRP----TSEVLLKHRFV 309
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 93 MKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD-KGMLAG 151
+ +A K K G+L F + +LG G+ G V+ + G + A K++ + A
Sbjct: 15 KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI 74
Query: 152 RKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFS 211
R +++R E ++L + P++ Y F +D + ME GG L + ++
Sbjct: 75 RNQIIR---ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIP 129
Query: 212 EQATRFYASEVLLALEYLHMMG-VVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270
EQ + V+ L YL +++RD+KP N+LV G I L DF VS +L+
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG------VSGQLI 183
Query: 271 QS 272
S
Sbjct: 184 DS 185
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 19/89 (21%), Positives = 32/89 (35%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK 408
SFVGT Y++PE ++G + D W+ G+ E+ +GR P +E Q
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGF 437
+ D + +
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLAE-LRDMGCLFAMKVM----DKGMLAGRKKLMRAQT 160
GD+ G + + + G +G +YLA G +K + D A A
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA------MAMA 128
Query: 161 EREILSLLDHPFLPTLYSHFETDKFSC-----LLMEFCSGGDLHTLRQRQPGKHFSEQAT 215
ER+ L+ + HP + +++ E ++ME+ G +L++ + K +A
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG---QSLKRSKGQKLPVAEAI 185
Query: 216 RFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
Y E+L AL YLH +G+VY DLKPEN+++ E+ + L D
Sbjct: 186 A-YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 21/94 (22%), Positives = 32/94 (34%), Gaps = 13/94 (13%)
Query: 345 ARSM----SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
+ GT + APEI+R G A D +T G L L G +
Sbjct: 228 VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG----RYVD 282
Query: 401 NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434
+ S+ L+R + DP++R
Sbjct: 283 GLPEDDPVLKT--YDSYGR--LLRRAIDPDPRQR 312
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-23
Identities = 31/152 (20%), Positives = 51/152 (33%), Gaps = 4/152 (2%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL 165
+ G +RLL G + A + A+ +D + L + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 166 SLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
S +D P + + T ++ E+ GG L + P A R + A
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGAIR-AMQSLAAA 141
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+ H GV P V V DG ++L+
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 15/89 (16%), Positives = 20/89 (22%), Gaps = 12/89 (13%)
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQPL 407
+ + D G Y LL+ R P G R L
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 408 KFPE--GSSISFAAKDLIRGLLVKDPQKR 434
P I F + + D R
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-LLD 169
G F L++ +G G G VY G L A+KVMD + ++ + + E +L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEI--KQEINMLKKYSH 79
Query: 170 HPFLPTLYSHFETDKFSC------LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
H + T Y F L+MEFC G + L + G E+ + E+L
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L +LH V++RD+K +NVL+ E+ + L DF +S
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 29/116 (25%), Positives = 45/116 (38%), Gaps = 9/116 (7%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGD-----GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
T R +F+GT ++APE+I D + D W+ GI E+ G P
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453
LF + P + S + I LVK+ +R ++ +HPF
Sbjct: 242 ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP----ATEQLMKHPFIRDQ 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 12/185 (6%)
Query: 90 GNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML 149
G+ K + + + L ++G G G V+ R G + A+K M
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RS 61
Query: 150 AGRKKLMRAQTEREIL-SLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGK 208
+++ R + +++ D P++ + F T+ + ME L++R G
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGP 120
Query: 209 HFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
E+ ++ AL YL GV++RD+KP N+L+ E G I L DF +S
Sbjct: 121 -IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG------ISG 173
Query: 268 KLVQS 272
+LV
Sbjct: 174 RLVDD 178
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 28/109 (25%), Positives = 42/109 (38%), Gaps = 11/109 (10%)
Query: 349 SFVGTHEYLAPEII-----RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNV 402
G Y+APE I + D W+ GI EL G+ P+K E L V
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 403 V-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ +P P S + ++ L KD +KR ++ +H F
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP----KYNKLLEHSFI 287
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 4/149 (2%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
G +RL + +G G +G VY AE + A+K+M + + + R Q E L
Sbjct: 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ 92
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEY 228
P + ++ E D + M +G DL LR++ P + ++ AL+
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDA 149
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDF 257
H G +RD+KPEN+LV D L DF
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDF 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 17/59 (28%), Positives = 25/59 (42%), Gaps = 4/59 (6%)
Query: 339 IAEPTSARSM----SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN 393
IA T+ + + VGT Y+APE D + YE L G P++G+
Sbjct: 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 36/175 (20%), Positives = 68/175 (38%), Gaps = 16/175 (9%)
Query: 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE 163
+ D + L ++G G GSV + G + A+K + + + + Q +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMD 70
Query: 164 I---LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFY 218
+ + D P++ Y + + ME S + E+
Sbjct: 71 LDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 219 ASEVLLALEYLH-MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272
+ AL +L + +++RD+KP N+L+ G+I L DF +S +LV S
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG------ISGQLVDS 179
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 32/116 (27%), Positives = 45/116 (38%), Gaps = 13/116 (11%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSA----VDWWTFGIFFYELLLGRTPFKGNGN-RE 397
+ A++ G Y+APE I D W+ GI YEL GR P+ + +
Sbjct: 179 SIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
Query: 398 TLFNVVGQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
L VV L E S + + + L KD KR E+ +HPF
Sbjct: 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP----KYKELLKHPFI 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 15/171 (8%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-- 164
++ + +LG G G V G + A+K + A + + ++
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDI 58
Query: 165 -LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQ-RQPGKHFSEQATRFYASEV 222
+ +D PF T Y + + ME +Q G+ E A +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 223 LLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272
+ ALE+LH + V++RD+KP NVL+ G + + DF +S LV
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG------ISGYLVDD 163
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 31/114 (27%), Positives = 44/114 (38%), Gaps = 12/114 (10%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSA----VDWWTFGIFFYELLLGRTPFKGNGN-RE 397
A+ G Y+APE I + + D W+ GI EL + R P+ G +
Sbjct: 163 DVAKD-IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 398 TLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
L VV + P S D L K+ ++R E+ QHPFF
Sbjct: 222 QLKQVVEEPSPQLPAD-KFSAEFVDFTSQCLKKNSKER----PTYPELMQHPFF 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 22/152 (14%), Positives = 48/152 (31%), Gaps = 2/152 (1%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L H +++ + + D + + + +
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPM-DAPSVKIRRMDPFS 119
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEY 228
+ + M+ C +L + +R + ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LH G+++RDLKP N+ D + + DF L
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 9/129 (6%)
Query: 326 KTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL 385
+ + VL P A VGT Y++PE I G+ + VD ++ G+ +ELL
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL- 270
Query: 386 GRTPFKGNGNRETLFNVVGQPLKFPEGSSISF-AAKDLIRGLLVKDPQKRLGFKRGATEI 444
F R + V KFP + + +++ +L P +R AT+I
Sbjct: 271 --YSFSTQMERVRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDI 323
Query: 445 KQHPFFESV 453
++ FE++
Sbjct: 324 IENAIFENL 332
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 4/148 (2%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
++++ KLG G + +VYLAE + A+K + + L R + E S L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL 229
+ ++ E D L+ME+ G L + P S + +++L +++
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHA 127
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDF 257
H M +V+RD+KP+N+L+ + + + DF
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 25/103 (24%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
++E + ++ +GT +Y +PE +G+ D ++ GI YE+L+G PF G ET
Sbjct: 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG----ET 216
Query: 399 LFNVVGQPL--KFPEGSS-----ISFAAKDLIRGLLVKDPQKR 434
++ + + P ++ I + ++I KD R
Sbjct: 217 AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLDH 170
+ + +G G G V A+ R A+K + + R E LS ++H
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAKDV--AIKQI-------ESESERKAFIVELRQLSRVNH 60
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL 229
P + LY + CL+ME+ GG L+ L +P +++ + + + YL
Sbjct: 61 PNIVKLYG-ACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 230 HMM---GVVYRDLKPENVLVREDGHIM-LSDFDLS 260
H M +++RDLKP N+L+ G ++ + DF +
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 20/96 (20%), Positives = 40/96 (41%), Gaps = 1/96 (1%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKG-NGNRETLFNV 402
+ G+ ++APE+ G + D +++GI +E++ R PF G +
Sbjct: 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
V + P ++ + L+ KDP +R +
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSME 252
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 11/156 (7%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
+RL +K+G G G +YL G A+K+ + K + E +I ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 63
Query: 171 -PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
+PT+ ++ ++ME G L L + FS + A +++ +EY+
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYI 121
Query: 230 HMMGVVYRDLKPENVLVREDGH---IMLSDFDLSLR 262
H ++RD+KP+N L+ + + DF L+ +
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 93/498 (18%), Positives = 152/498 (30%), Gaps = 149/498 (29%)
Query: 60 SEEESGKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKL 119
S E + ++G + S + + + K A D + + + +
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHLI 61
Query: 120 GCGDIGSVYLAELRDMGCLFAMK----VMDKGMLAGRKKLMRAQTEREI--LSLLDHP-- 171
G G G V A + + A+K V + + R REI L+ L+H
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-------ILREIAILNRLNHDHV 114
Query: 172 ------FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLL 224
+P F+ + + +++E D R +E + +L+
Sbjct: 115 VKVLDIVIPKDVEKFD-ELY--VVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLV 167
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYC 284
++Y+H G+++RDLKP N LV +D + + DF L+ R P+
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA-RTVDYPE---------------- 210
Query: 285 IQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344
S L S + K+ K LT
Sbjct: 211 ---------------NGNSQLPISPREDDMNLVTFPHTKNLKRQLTG------------- 242
Query: 345 ARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLF-- 400
V T Y APE+I + A+D W+ G F ELL +R LF
Sbjct: 243 -----HVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297
Query: 401 -------------------------------NVVGQP-----------------LKFPEG 412
N++G P FP+
Sbjct: 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357
Query: 413 SSISFA---------AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHP 463
A A L++ +LV +P KR+ E HPFF+ V +
Sbjct: 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRI----TINECLAHPFFKEVR----IAEVE 409
Query: 464 PEIPKPVDLSFINHKQKT 481
+ V L F +
Sbjct: 410 TNATEKVRLPFNDWMNMD 427
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 77/443 (17%), Positives = 134/443 (30%), Gaps = 150/443 (33%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK----VMDKGMLAGRKKLMRAQTEREI--L 165
++ + +G G G VYLA ++ A+K + + + R REI L
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-------ILREITIL 79
Query: 166 SLLDHP--------FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATR 216
+ L +P F+ + + +++E DL + +E+ +
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFD-ELY--IVLEIA-DSDLKKLFKTPIF---LTEEHIK 132
Query: 217 FYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDP 276
+LL ++H G+++RDLKP N L+ +D + + DF L+ R
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA-R-------------- 177
Query: 277 ACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336
+ K+ K LT+
Sbjct: 178 ----------------------TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS----- 210
Query: 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLG--------- 386
V T Y APE+I + ++D W+ G F ELL
Sbjct: 211 -------------HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 387 -RTP-FKGNGNRETL--------------------FNVVGQP-----------------L 407
R P F G+ FN++G P
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 408 KFPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458
FP I+ +L+ +L +P KR+ + HP+ + V
Sbjct: 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI----TIDQALDHPYLKDVR---- 369
Query: 459 RSTHPPEIPKPVDLSFINHKQKT 481
+ K + L F + +
Sbjct: 370 KKKLENFSTKKIILPFDDWMVLS 392
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 14/159 (8%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA----QTEREILSLL 168
K++G G G V+ L + A+K + G G +++ Q E I+S L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+HP + LY + ++MEF GDL+ + R ++ L +EY
Sbjct: 81 NHPNIVKLYG-LMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIALGIEY 137
Query: 229 LHMMG--VVYRDLKPENVLVREDG-----HIMLSDFDLS 260
+ +V+RDL+ N+ ++ ++DF LS
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 21/98 (21%), Positives = 39/98 (39%), Gaps = 8/98 (8%)
Query: 347 SMSFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKG-NGNRETLFNVV 403
+G +++APE I + + D ++F + Y +L G PF + + N++
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 404 GQP---LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
+ PE ++I DP+KR F
Sbjct: 243 REEGLRPTIPEDCPPRLR--NVIELCWSGDPKKRPHFS 278
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 34/148 (22%), Positives = 67/148 (45%), Gaps = 4/148 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ LG G G R+ G + MK + + ++ ++ E +++ L+HP
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPN 68
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ DK + E+ GG L + + + +A ++ + YLH M
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGI-IKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RDL N LVRE+ +++++DF L+
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLA 155
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 24/100 (24%), Positives = 37/100 (37%), Gaps = 5/100 (5%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
P + + VG ++APE+I G + VD ++FGI E++ R F
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 402 VV---GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
+ P SF + DP+KR F
Sbjct: 234 LNVRGFLDRYCPPNCPPSFF--PITVRCCDLDPEKRPSFV 271
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 34/174 (19%), Positives = 63/174 (36%), Gaps = 19/174 (10%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCL--------FAMKV--MDKGMLAGRKKLM 156
D ++L + G +Y A F++K+ D + +
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 157 RAQTEREI-----LSLLDHPFLPTLYSH-FETDKFSCLLMEFCSGGDLHTLRQRQPGKHF 210
RA ++ L +PT DK+ L++ G L + P
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL 156
Query: 211 SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV--REDGHIMLSDFDLSLR 262
SE++ A +L ALE+LH V+ ++ EN+ V + + L+ + + R
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP 174
+ +K+G G G+V+ AE G A+K++ + +++ E I+ L HP +
Sbjct: 41 IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIV 97
Query: 175 TLY------SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
+ ++ E+ S G L+ L + + E+ A +V +
Sbjct: 98 LFMGAVTQPPNL------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 228 YLHMMG--VVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH +V+R+LK N+LV + + + DF LS
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
T S S GT E++APE++R + D ++FG+ +EL + P+ + + V
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
Query: 403 V--GQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434
+ L+ P + A +I G +P KR
Sbjct: 252 GFKCKRLEIPRNLNPQVA--AIIEGCWTNEPWKR 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 28/152 (18%), Positives = 53/152 (34%), Gaps = 9/152 (5%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP 174
L KL G ++ + G +KV+ + RK E L + HP +
Sbjct: 14 FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFSHPNVL 70
Query: 175 TLY--SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFS-EQATRFYASEVLLALEYLHM 231
+ L+ + G L+ + QA +F A ++ + +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDMARGMAFLHT 129
Query: 232 MG--VVYRDLKPENVLVREDGHIMLSDFDLSL 261
+ + L +V++ ED +S D+
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 25/97 (25%), Positives = 42/97 (43%), Gaps = 7/97 (7%)
Query: 343 TSARSMSFVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
S +S + ++APE ++ D + + D W+F + +EL+ PF N E
Sbjct: 161 FSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG 220
Query: 400 FNVV--GQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434
V G P G S + L++ + +DP KR
Sbjct: 221 MKVALEGLRPTIPPGISPHVS--KLMKICMNEDPAKR 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 33/158 (20%), Positives = 65/158 (41%), Gaps = 13/158 (8%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
H+++ +++G G G ++ A+K + R + + E LL
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAG 64
Query: 171 -PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
+P +Y + + L+++ G L L G+ FS + A ++L ++ +
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSI 122
Query: 230 HMMGVVYRDLKPENVLVREDGH-----IMLSDFDLSLR 262
H +VYRD+KP+N L+ I + DF +
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 85/428 (19%), Positives = 144/428 (33%), Gaps = 136/428 (31%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK----VMDKGMLAGRKKLMRAQTEREIL-- 165
+ L+KKLG G G V+ + R G + A+K A R T REI+
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR-------TFREIMIL 62
Query: 166 -SLLDHPFLPTLYSHFETDKFSCL-----LMEFCSGGDLHTLRQRQPGKHFSEQATRFYA 219
L H + L + D + ME DLH + + ++
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANI---LEPVHKQYVV 115
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACR 279
+++ ++YLH G+++RD+KP N+L+ + H+ ++DF LS R FV+ + V ++
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS-RSFVNIRRVTNN------ 168
Query: 280 ISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339
P +N T ++ LT+
Sbjct: 169 -------------------------------IPLSINENTENFDDDQPILTD-------- 189
Query: 340 AEPTSARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNR-- 396
+V T Y APEI+ G +D W+ G E+L G+ F G+
Sbjct: 190 ----------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 397 -ETLFNVVGQP-----------------LKFPEGSSISFA-------------------- 418
E + V+ P E I +
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 419 -----AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLS 473
A DL+ LL +P KR+ A + +HPF + P + +
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRI----SANDALKHPFVSIFH----NPNEEPNCDHIITIP 351
Query: 474 FINHKQKT 481
++ + +
Sbjct: 352 INDNVKHS 359
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 33/152 (21%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
+ L + LG G + V+LA A+KV+ + +R + E + + L+H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 171 PFLPTLYSHFETDKFSC----LLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLA 225
P + +Y E + + ++ME+ G L + P + + ++ A
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
L + H G+++RD+KP N+++ + + DF
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 26/101 (25%), Positives = 47/101 (46%), Gaps = 10/101 (9%)
Query: 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
+ + ++ + +GT +YL+PE RGD + D ++ G YE+L G PF G ++
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSP 224
Query: 400 FNV----VGQPLKFP--EGSSISFAAKDLIRGLLVKDPQKR 434
+V V + P +S ++ L K+P+ R
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDM----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
H + L++LG G+ GSV + + G + A+K + + R E EIL
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILKS 98
Query: 168 LDHPFLPTLY--SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLL 224
L H + + + L+ME+ G L L++ + Y S++
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICK 156
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+EYL ++RDL N+LV + + + DF L+
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 40/151 (26%), Positives = 62/151 (41%), Gaps = 7/151 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKG-MLAGRKKLMRAQTEREILSLLDH 170
L +++G G+ G V+ LR L A+K + + K ++ E IL H
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ---EARILKQYSH 171
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL 229
P + L + ++ME GGD T LR G + + +EYL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYL 229
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV E + +SDF +S
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 37/156 (23%), Positives = 65/156 (41%), Gaps = 12/156 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGC----LFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
H + L++LG G+ GSV + + + A+K + + R E EIL
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILKS 67
Query: 168 LDHPFLPTLY--SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLL 224
L H + + + L+ME+ G L L++ + Y S++
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICK 125
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+EYL ++RDL N+LV + + + DF L+
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 2e-16
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------REI- 164
F+ ++K+G G G VY A + G + A+K K + +TE REI
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALK----------KIRLDTETEGVPSTAIREIS 54
Query: 165 -LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
L L+HP + L T+ L+ EF DL + Y ++L
Sbjct: 55 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
L + H V++RDLKP+N+L+ +G I L+DF L+ R F P
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVP 156
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 12/156 (7%)
Query: 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPFL 173
+ K+G G G V+ RD G + A+K K + + +++ REI L L HP L
Sbjct: 8 IGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASEVLLALEYLHM 231
L F + L+ E+C HT+ + + E + + L A+ + H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
++RD+KPEN+L+ + I L DF + R P
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGP 155
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 35/152 (23%), Positives = 54/152 (35%), Gaps = 43/152 (28%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
E Y +PE++ GD G VD W G F ELL G + G + + L +
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 404 GQP----------------LKFPEGSS----------ISFAAKDLIRGLLVKDPQKRLGF 437
G +K P+ IS+ A L++G L DP +RL
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-- 277
Query: 438 KRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469
++ HP+FE++ +
Sbjct: 278 --TCEQLLHHPYFENIR----EIEDLAKEHDK 303
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL--- 168
++L++KLG G V+ A +K++ K + + + +REI +L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKKKIKREI-KILENL 87
Query: 169 -DHPFLPTLYS--HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
P + TL + L+ E + D L Q ++ RFY E+L A
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 226 LEYLHMMGVVYRDLKPENVLV-REDGHIMLSDFDL 259
L+Y H MG+++RD+KP NV++ E + L D+ L
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 28/140 (20%), Positives = 46/140 (32%), Gaps = 41/140 (29%)
Query: 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTP-FKGNGNRETL---FNVVGQ 405
V + + PE++ ++D W+ G ++ + P F G+ N + L V+G
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 406 P------------------LKFPEGSSISFA--------------AKDLIRGLLVKDPQK 433
S + A D + LL D Q
Sbjct: 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 434 RLGFKRGATEIKQHPFFESV 453
RL A E +HP+F +V
Sbjct: 311 RL----TAREAMEHPYFYTV 326
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 36/175 (20%), Positives = 69/175 (39%), Gaps = 21/175 (12%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVM---DKGMLAGRKKLMRA 158
D+ +++ +G G G +YLA++ +KV + + K RA
Sbjct: 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 159 QTEREI-----LSLLDHPFLPTLY----SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKH 209
+I L + +P + + ++M+ G DL + + K
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKR 148
Query: 210 FSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV--REDGHIMLSDFDLSLR 262
FS + + +L LEY+H V+ D+K N+L+ + + L D+ L+ R
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 34/156 (21%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-D 169
FRL +K+G G G +YL A+K+ + + K + E +I +L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQG 61
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
+P + ++ L+M+ G L L + S + A +++ +E++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFV 119
Query: 230 HMMGVVYRDLKPENVLVREDGH---IMLSDFDLSLR 262
H ++RD+KP+N L+ + + DF L+ +
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 35/162 (21%), Positives = 62/162 (38%), Gaps = 25/162 (15%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPF 172
L + +G G G V+ + R G A+K+ E EI +L H
Sbjct: 46 LQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS------WFREAEIYQTVMLRHEN 97
Query: 173 LPTLYSHFETDKFS----CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+ + D + L+ ++ G L R + + A L +
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 154
Query: 229 LHM--------MGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
LHM + +RDLK +N+LV+++G ++D L++R
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 7e-16
Identities = 43/169 (25%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE--------REI 164
F+ L+KLG G +VY + G A+K + + +E REI
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV------------KLDSEEGTPSTAIREI 54
Query: 165 --LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL----RQRQPGKHFSEQATRFY 218
+ L H + LY T+ L+ EF DL + +++
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
++L L + H +++RDLKP+N+L+ + G + L DF L+ R F P
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIP 161
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 31/165 (18%), Positives = 53/165 (32%), Gaps = 51/165 (30%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
+ E Y AP+++ G +++D W+ G E++ G+ F G + E L F+++
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 404 GQP-----------------------------LKFPEGSSISFAAKDLIRGLLVKDPQKR 434
G P L+ + D + GLL +P R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 435 LGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQ 479
L A + HP+F S +H
Sbjct: 286 L----SAKQALHHPWFAEY---------YHHASMGGSRSHHHHHH 317
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 7e-16
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 12/159 (7%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDH 170
+ L +G G G V +D G + A+K K + + K+++ REI L L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQ--RQPGKHFSEQATRFYASEVLLALEY 228
L L + K L+ EF HT+ Q + Y +++ + +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
H +++RD+KPEN+LV + G + L DF + R +P
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAP 177
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 35/153 (22%), Positives = 50/153 (32%), Gaps = 42/153 (27%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
E Y APE++ GD G AVD W G E+ +G F G+ + + L +
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241
Query: 404 GQP----------------LKFPEGS----------SISFAAKDLIRGLLVKDPQKRLGF 437
G ++ PE +S DL + L DP KR
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP-- 299
Query: 438 KRGATEIKQHPFFESVNWALIRSTHPPEIPKPV 470
E+ H FF+ E+ V
Sbjct: 300 --FCAELLHHDFFQMDG---FAERFSQELQLKV 327
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
+FR+ KK+GCG+ G + L + A+K+ + + + E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-----KSRAPQLHLEYRFYKQLGS 63
Query: 171 -PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
+P +Y K++ +++E G L L + FS + A +++ +EY+
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYV 121
Query: 230 HMMGVVYRDLKPENVLVREDGH-----IMLSDFDLS 260
H ++YRD+KPEN L+ G+ I + DF L+
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 19/171 (11%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
H + + +LG G+ GSV L +G L A+K + ++ R E +IL
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILKA 80
Query: 168 LDHPFLPTLY--SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLL 224
L F+ S+ + L+ME+ G L L++ + Y+S++
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICK 138
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275
+EYL V+RDL N+LV + H+ ++DF L+ KL+ D
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA-------KLLPLDKD 182
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 32/162 (19%), Positives = 61/162 (37%), Gaps = 25/162 (15%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPF 172
LL+ +G G G V+ + G A+K+ E E+ +L H
Sbjct: 12 LLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEK------SWFRETELYNTVMLRHEN 63
Query: 173 LPTLYSHFETDKFS----CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+ + T + S L+ + G L+ Q + + L +
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAH 120
Query: 229 LHM--------MGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
LH+ + +RDLK +N+LV+++G ++D L++
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 45/185 (24%), Positives = 69/185 (37%), Gaps = 27/185 (14%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSL 167
L + +LL+ +G G G+VY L A+KV E+ I + L
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQN------FINEKNIYRVPL 63
Query: 168 LDHPFLPTLYSHFETDKFS-----CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
++H + E L+ME+ G L ++ A V
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSV 120
Query: 223 LLALEYLHMM---------GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273
L YLH + +RDL NVLV+ DG ++SDF LS+R + +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 274 DDPAC 278
+D A
Sbjct: 181 EDNAA 185
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 14/72 (19%), Positives = 29/72 (40%), Gaps = 7/72 (9%)
Query: 333 DSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG-------DGHGSAVDWWTFGIFFYELLL 385
++ ++S VGT Y+APE++ G + VD + G+ ++E+ +
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 386 GRTPFKGNGNRE 397
T +
Sbjct: 231 RCTDLFPGESVP 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 31/154 (20%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 114 RLLKKLGCGDIGSVYLAELR-DMGCLFAMKVMDKGMLAGRKKLMRA-QTEREILSLLDHP 171
+ +++G G G+VY + D+ A+K+++ + ++A + E +L H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGDV----AVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHV 80
Query: 172 FLPTLY-----SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
+ ++ ++C G L+ K F + A + +
Sbjct: 81 NILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGM 133
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+YLH +++RDLK N+ + ED + + DF L+
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 7/102 (6%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHG---SAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
S + G+ ++APE+IR D + FGI YEL+ G+ P+ NR+ +
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 401 NVVGQPLKFPEGSSISF----AAKDLIRGLLVKDPQKRLGFK 438
+VG+ P+ S + K L+ L K +R F
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 25/165 (15%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE--------REI 164
+ L KLG G +VY + + L A+K + R + E RE+
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI------------RLEHEEGAPCTAIREV 51
Query: 165 --LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
L L H + TL+ T+K L+ E+ DL G + + + ++
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY-LDDCGNIINMHNVKLFLFQL 109
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
L L Y H V++RDLKP+N+L+ E G + L+DF L+ R P
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-RAKSIP 153
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 34/167 (20%), Positives = 58/167 (34%), Gaps = 44/167 (26%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
+E Y P+I+ G + +D W G FYE+ GR F G+ E L F ++
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 404 GQP----------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFK 438
G P +P+ + + DL+ LL + + R+
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI--- 274
Query: 439 RGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQ 485
A + +HPFF S+ ++P + + Q
Sbjct: 275 -SAEDAMKHPFFLSLG------ERIHKLPDTTSIFALKEIQLQKEAS 314
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 39/169 (23%), Positives = 65/169 (38%), Gaps = 37/169 (21%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA-QTEREILSLLDHP- 171
L + +G G G VY A G A+K + + + E ++ ++L HP
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 172 ---FL------PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
P L CL+MEF GG L+ + GK +A ++
Sbjct: 68 IIALRGVCLKEPNL----------CLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQI 114
Query: 223 LLALEYLHMMG---VVYRDLKPENVLVREDGHIM--------LSDFDLS 260
+ YLH +++RDLK N+L+ + ++DF L+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 28/94 (29%), Positives = 39/94 (41%), Gaps = 4/94 (4%)
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV--G 404
MS G + ++APE+IR D W++G+ +ELL G PF+G + V
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
L P FA L+ DP R F
Sbjct: 231 LALPIPSTCPEPFA--KLMEDCWNPDPHSRPSFT 262
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 20/169 (11%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM-----DKGMLAGRKK-LMRAQTEREI 164
+ L KK+G G G +YLA + A V+ + G L K R + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 165 -----LSLLDHPFLPTLY----SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAT 215
LD+ +P Y + F+ + ++ME G DL + + F +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTV 153
Query: 216 RFYASEVLLALEYLHMMGVVYRDLKPENVLV--REDGHIMLSDFDLSLR 262
+L LEY+H V+ D+K N+L+ + + L+D+ LS R
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 28/157 (17%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA-QTEREILSLLDHP-- 171
+ + +G G G VY A++++D + ++A + E H
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDN--EDQLKAFKREVMAYRQTRHENV 91
Query: 172 --FL------PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
F+ P L ++ C G L+++ R TR A E++
Sbjct: 92 VLFMGACMSPPHL----------AIITSLCKGRTLYSV-VRDAKIVLDVNKTRQIAQEIV 140
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ YLH G++++DLK +NV ++G ++++DF L
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 29/135 (21%), Positives = 47/135 (34%), Gaps = 17/135 (12%)
Query: 348 MSFVGTHEYLAPEIIRGDGHGS---------AVDWWTFGIFFYELLLGRTPFKGNGNRET 398
G +LAPEIIR + D + G +YEL PFK E
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEA 250
Query: 399 LFNVVGQPLKFPE-GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457
+ +G +K + D++ + ++R F T++ E +
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTF----TKLMDM--LEKLPKRN 304
Query: 458 IRSTHPPEIPKPVDL 472
R +HP K +L
Sbjct: 305 RRLSHPGHFWKSAEL 319
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 34/162 (20%), Positives = 67/162 (41%), Gaps = 25/162 (15%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPF 172
++K++G G G V++ + R G A+KV A + E EI L+ H
Sbjct: 41 MVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFR------ETEIYQTVLMRHEN 92
Query: 173 LPTLYSHFETDKFS----CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+ + S L+ ++ G L+ + ++ A + L +
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCH 149
Query: 229 LHM--------MGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
LH + +RDLK +N+LV+++G ++D L+++
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 9/155 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML---AGRKKLMRAQTEREILSLL 168
+ ++ LG G G V L G +V K L +G + + E EIL L
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-SLKPESGGNHIADLKKEIEILRNL 80
Query: 169 DHPFLPTLY--SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLA 225
H + + L+MEF G L L + + + + YA ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKG 138
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++YL V+RDL NVLV + + + DF L+
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF----AMKVMDKG-MLAGRKKLMRAQTEREILS 166
F+ +K LG G G+VY G A+K + + K+++ E +++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVMA 72
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLA 225
+D+P + L T L+ + G L +R+ + + Q + ++
Sbjct: 73 SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 129
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 22/164 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------REI- 164
+ L+K+G G G+V+ A+ R+ + A+K + + E REI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALK----------RVRLDDDDEGVPSSALREIC 53
Query: 165 -LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
L L H + L+ +DK L+ EFC DL G + + + ++L
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLL 111
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
L + H V++RDLKP+N+L+ +G + L++F L+ R F P
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIP 154
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 2e-08
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 38/136 (27%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTP-FKGNGNRETL---FNV 402
+ E Y P+++ G +++D W+ G F EL P F GN + L F +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 403 VGQP-----------------LKFPEGSS-------ISFAAKDLIRGLLVKDPQKRLGFK 438
+G P +P +S ++ +DL++ LL +P +R+
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI--- 275
Query: 439 RGATEIKQHPFFESVN 454
A E QHP+F
Sbjct: 276 -SAEEALQHPYFSDFC 290
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 36/150 (24%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ KLG G G VY + A+K + + + ++ ++ E ++ + HP
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK---EAAVMKEIKHP 69
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L L + ++ EF + G+L LR+ + + A+++ A+EYL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSAMEYLE 128
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV E+ + ++DF LS
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 8e-15
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 12/166 (7%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-----LSL 167
+ + ++G G G+VY A G A+K + G + T RE+ L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 168 LDHPFLPTLYSHFETDKFSC-----LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
+HP + L T + L+ E DL T + P + + +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268
L L++LH +V+RDLKPEN+LV G + L+DF L+ R +
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-RIYSYQM 174
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 8e-10
Identities = 28/131 (21%), Positives = 45/131 (34%), Gaps = 34/131 (25%)
Query: 353 THE-----YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVG 404
T Y APE++ + + VD W+ G F E+ + F GN + L F+++G
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 405 QP-------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFKRGAT 442
P FP + L+ +L +P KR+ A
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI----SAF 292
Query: 443 EIKQHPFFESV 453
QH +
Sbjct: 293 RALQHSYLHKD 303
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ KLG G G VY + A+K + + + ++ ++ E ++ + HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK---EAAVMKEIKHP 276
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L L + ++ EF + G+L LR+ + S + A+++ A+EYL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 335
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++R+L N LV E+ + ++DF LS
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 34/157 (21%), Positives = 57/157 (36%), Gaps = 15/157 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKG-MLAGRKKLMRAQTEREILS 166
+ + ++ LG G G V L + A+K + R + E +IL
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILR 88
Query: 167 LLDHPFLPTLY--SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVL 223
L H + L+ME+ G L L + +A ++
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQIC 144
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ YLH ++RDL NVL+ D + + DF L+
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 5/157 (3%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL--LDH 170
+ L LG G +VY A ++ + A+K + G + K + REI L L H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P + L F L+ +F DL + + + + Y L LEYLH
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
+++RDLKP N+L+ E+G + L+DF L+ + F SP
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLA-KSFGSP 165
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 41/185 (22%), Positives = 64/185 (34%), Gaps = 42/185 (22%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
TH+ Y APE++ G G VD W G ELLL G+ + + L F +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 404 GQP--------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFKRG 440
G P + F I DLI+GL + +P R+
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI----T 285
Query: 441 ATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDKGAADSDRSSGPF 500
AT+ + +F + T ++P+P +Q P + ++ G
Sbjct: 286 ATQALKMKYFSN----RPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLP 341
Query: 501 --LDF 503
L F
Sbjct: 342 KKLIF 346
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 44/168 (26%), Positives = 66/168 (39%), Gaps = 14/168 (8%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKGMLAGRKKLMRAQTEREILSLL 168
RLL+KLG G G V E A+K + +L+ + + E + L
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
DH L LY T ++ E G L LR+ Q HF YA +V +
Sbjct: 79 DHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMG 135
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275
YL ++RDL N+L+ + + DF L + + +DD
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------RALPQNDD 176
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 2e-14
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDM-GCLFAMKVMDKGMLAGRKKLMRAQTE-------REI 164
+ L+K+G G G VY A ++ G FA+K K + + E REI
Sbjct: 4 YHGLEKIGEGTYGVVYKA--QNNYGETFALK----------KIRLEKEDEGIPSTTIREI 51
Query: 165 --LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
L L H + LY T K L+ E DL L G + + ++
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQL 109
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
L + Y H V++RDLKP+N+L+ +G + ++DF L+ R F P
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA-RAFGIP 153
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 8e-10
Identities = 30/135 (22%), Positives = 52/135 (38%), Gaps = 37/135 (27%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
THE Y AP+++ G + +D W+ G F E++ G F G + L F ++
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 404 GQP---------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFKR 439
G P F + + + DL+ +L DP +R+
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---- 273
Query: 440 GATEIKQHPFFESVN 454
A + +H +F+ N
Sbjct: 274 TAKQALEHAYFKENN 288
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 30/174 (17%)
Query: 113 FRLLKKLGCGDIGSVYLA-ELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------REI 164
+ + ++G G G V+ A +L++ G A+K + ++ E RE+
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALK----------RVRVQTGEEGMPLSTIREV 62
Query: 165 -----LSLLDHPFLPTLY-----SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQA 214
L +HP + L+ S + + L+ E DL T + P +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 215 TRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268
+ ++L L++LH VV+RDLKP+N+LV G I L+DF L+ R +
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-RIYSFQM 174
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 31/147 (21%), Positives = 53/147 (36%), Gaps = 36/147 (24%)
Query: 353 THE-----YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVG 404
T Y APE++ + + VD W+ G F E+ + F+G+ + + L +V+G
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 405 QP-------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFKRGAT 442
P F S+ KDL+ L +P KR+ A
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI----SAY 292
Query: 443 EIKQHPFFESVNWALIRSTHPPEIPKP 469
HP+F+ + + +P
Sbjct: 293 SALSHPYFQDLE--RCKENLDSHLPPS 317
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 8/150 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
RL KLG G G V++ +V K + G E +++ L H
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L LY+ +++ ++ E+ S G L L+ GK+ A+++ + Y+
Sbjct: 240 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE 297
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
M V+RDL+ N+LV E+ ++DF L+
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 11/154 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSL 167
L + +G G G V+ A+K + R+K ++ E +
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTMRQ 72
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
DHP + L + ++ME C+ G+L + L+ R+ + YA ++ AL
Sbjct: 73 FDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTAL 129
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL V+RD+ NVLV + + L DF LS
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 10/151 (6%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+LL+ +G G+ G V L + R G A+K + + + E +++ L H
Sbjct: 22 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT--AQAFLA---EASVMTQLRHS 74
Query: 172 FLPTLYS-HFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYL 229
L L E ++ E+ + G L LR R ++ +V A+EYL
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYL 133
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL NVLV ED +SDF L+
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 42/153 (27%), Positives = 62/153 (40%), Gaps = 8/153 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSL 167
+ K +G GD G V LR G A+K + G R+ + E I+
Sbjct: 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS---EASIMGQ 106
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
DHP + L + + ++ E+ G L T + G+ Q V +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMR 165
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL +G V+RDL NVLV + +SDF LS
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 7e-14
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDM-GCLFAMKVMDKGMLAGRKKLMRAQTE-------REI 164
++ L+K+G G G VY A +D G + A+K + + A+ E REI
Sbjct: 23 YQKLEKVGEGTYGVVYKA--KDSQGRIVALK----------RIRLDAEDEGIPSTAIREI 70
Query: 165 --LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
L L HP + +L +++ L+ EF DL + + + Y ++
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQL 128
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267
L + + H +++RDLKP+N+L+ DG + L+DF L+ R F P
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA-RAFGIP 172
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 38/136 (27%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
THE Y AP+++ G ++VD W+ G F E++ G+ F G + + L F+++
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 404 GQP----------------LKFPEGSSISF---------AAKDLIRGLLVKDPQKRLGFK 438
G P F + DL+ +L DP KR+
Sbjct: 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI--- 293
Query: 439 RGATEIKQHPFFESVN 454
A + HP+F+ ++
Sbjct: 294 -SARDAMNHPYFKDLD 308
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 35/150 (23%), Positives = 69/150 (46%), Gaps = 8/150 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+L KKLG G G V++A + A+K M G ++ + + E ++ L H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMS-VEAFLA---EANVMKTLQHD 243
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L L++ T + ++ EF + G L L+ + K + F ++++ + ++
Sbjct: 244 KLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFIE 301
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL+ N+LV ++DF L+
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 14/160 (8%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
L + LG G+ GSV A+L+ F A+K++ K + + E + DH
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 171 PFLPTLY------SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATR---FYAS 220
P + L +++ F GDLH L + G++ + +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 221 EVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ +EYL ++RDL N ++ ED + ++DF LS
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLF--AMKVMDKGML--AGRKKLMRAQTEREILSLLDHPF 172
K+LG G+ G+V + + A+K++ A + +L+ E ++ LD+P+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPY 79
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ + E + + L+ME G L+ L+Q +H ++ +V + ++YL
Sbjct: 80 IVRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+RDL NVL+ + +SDF LS
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 30/153 (19%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSLLD 169
+ +G G G VY L D A+K +++ + + + E I+
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT---EGIIMKDFS 84
Query: 170 HPFLPTLY-SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
HP + +L ++ +++ + GDL +R + + + + +V ++
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMK 142
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL V+RDL N ++ E + ++DF L+
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 23/165 (13%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+LL+ G G V+ A+L A+K+ + + E L + H
Sbjct: 25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS----WQNEYEVYSLPGMKHE 78
Query: 172 ----FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
F+ D L+ F G L + S A + L
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLA 135
Query: 228 YLHMM----------GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262
YLH + +RD+K +NVL++ + ++DF L+L+
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 13/159 (8%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
L K LG G+ GSV L+ A+K M K + ++++ +E + H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 171 PFLPTLY-----SHFETDKFSCLLMEFCSGGDLHT-LRQRQP---GKHFSEQATRFYASE 221
P + L + +++ F GDLHT L + KH Q + +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ L +EYL ++RDL N ++R+D + ++DF LS
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF----AMKVMDKG-MLAGRKKLMRAQTEREILS 166
F+ +K LG G G+VY G A+K + + K+++ E +++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVMA 72
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLA 225
+D+P + L T L+ + G L +R+ + + Q + ++
Sbjct: 73 SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKG 129
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 8/150 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
RL KLG G G V++ +V K + G E +++ L H
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L LY+ +++ ++ E+ S G L L+ GK+ A+++ + Y+
Sbjct: 323 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE 380
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
M V+RDL+ N+LV E+ ++DF L+
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 11/154 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSL 167
L + +G G G V+ A+K + R+K ++ E +
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ---EALTMRQ 447
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
DHP + L + ++ME C+ G+L + L+ R+ + YA ++ AL
Sbjct: 448 FDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTAL 504
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL V+RD+ NVLV + + L DF LS
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 36/157 (22%), Positives = 59/157 (37%), Gaps = 15/157 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF----AMKVMDKG-MLAGRKKLMRAQTEREILS 166
K +G G+ G VY L+ A+K + G R + E I+
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG---EAGIMG 101
Query: 167 LLDHPFLPTLY---SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
H + L S ++ ++ E+ G L + + G+ Q +
Sbjct: 102 QFSHHNIIRLEGVISKYKP---MMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGIA 157
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++YL M V+RDL N+LV + +SDF LS
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 23/167 (13%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGC-----LFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
R +++LG G VY L A+K + R++ E + +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRAR 68
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
L HP + L D+ ++ +CS GDLH L R P L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 227 EYLHM-------------MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++H+ VV++DL NVLV + ++ +SD L
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 33/161 (20%), Positives = 66/161 (40%), Gaps = 17/161 (10%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
+ ++LG G G VY + + A+K +++ + R + + E ++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASVMKE 84
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF-------YA 219
+ + L + + ++ME + GDL + LR +P + A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
E+ + YL+ V+RDL N +V ED + + DF ++
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 8/153 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSL 167
+ + K +G G+ G V L+ A+K + G R+ + E I+
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EASIMGQ 102
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
DHP + L K ++ E+ G L + ++ + Q + ++
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIASGMK 161
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL MG V+RDL N+L+ + +SDF L
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 40/169 (23%), Positives = 68/169 (40%), Gaps = 28/169 (16%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------REI- 164
+R + KLG G G VY A A+K + + + E RE+
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIK----------RIRLEHEEEGVPGTAIREVS 85
Query: 165 -LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
L L H + L S + L+ E+ DL + P S + + + +++
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLI 142
Query: 224 LALEYLHMMGVVYRDLKPENVLV-----REDGHIMLSDFDLSLRCFVSP 267
+ + H ++RDLKP+N+L+ E + + DF L+ R F P
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-RAFGIP 190
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 34/135 (25%), Positives = 51/135 (37%), Gaps = 38/135 (28%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
THE Y PEI+ G H ++VD W+ + E+L+ F G+ + L F V+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 404 GQP---------------LKFPEGSSISF----------AAKDLIRGLLVKDPQKRLGFK 438
G P FP+ + DL+ +L DP KR+
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI--- 311
Query: 439 RGATEIKQHPFFESV 453
A +HP+F
Sbjct: 312 -SAKNALEHPYFSHN 325
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 27/162 (16%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK---VMDKGMLAGRKKLMRAQTEREI--LS 166
F+L LG G G V A + G + A+K DK + A R T REI L
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-------TLREIKILK 64
Query: 167 LLDHP--------FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFY 218
H P + +F LM+ DLH + Q S+ +++
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQM---LSDDHIQYF 117
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ L A++ LH V++RDLKP N+L+ + + + DF L+
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 35/159 (22%), Positives = 53/159 (33%), Gaps = 35/159 (22%)
Query: 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNR---ETLFNVVGQP 406
V T Y APE++ A+D W+ G EL L R F G R +F ++G P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 407 ------------------LKFPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKR 439
P + DL++ +LV DP KR+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI---- 298
Query: 440 GATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHK 478
A E +HP+ ++ + P P +
Sbjct: 299 TAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEA 337
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+LL+ +G G+ G V L + R G A+K + + + E +++ L H
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT--AQAFLA---EASVMTQLRHS 246
Query: 172 FLPTLY---SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
L L + ++ E+ + G L LR R ++ +V A+E
Sbjct: 247 NLVQLLGVIVEEKGGL--YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAME 303
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL V+RDL NVLV ED +SDF L+
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 42/171 (24%), Positives = 63/171 (36%), Gaps = 43/171 (25%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK----VMDKGMLAGRKKLMRAQTEREI--L 165
+R L+ +G G G+V A G A+K + A R RE+ L
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-------AYRELRLL 78
Query: 166 SLLDHP--------FLPT--------LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKH 209
+ H F P Y M DL L + +
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMP-------FMG----TDLGKLMKHEK--- 124
Query: 210 FSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
E +F ++L L Y+H G+++RDLKP N+ V ED + + DF L+
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 45/168 (26%), Positives = 63/168 (37%), Gaps = 50/168 (29%)
Query: 345 ARSMS-----FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
AR +V T Y APE+I VD W+ G E++ G+T FKG+ + +
Sbjct: 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 399 L---FNVVGQP-----------------LKFPEGSSISFA---------AKDLIRGLLVK 429
L V G P PE FA A +L+ +LV
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294
Query: 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPE---IPKPVDLSF 474
D ++R+ A E HP+FES+ H E + D SF
Sbjct: 295 DAEQRV----TAGEALAHPYFESL--------HDTEDEPQVQKYDDSF 330
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 38/162 (23%), Positives = 58/162 (35%), Gaps = 27/162 (16%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK---VMDKGMLAGRKKLMRAQTEREI--LS 166
+ L +G G G V A A+K + R T REI L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-------TLREIKILL 80
Query: 167 LLDHP--------FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFY 218
H + LME DL+ L + Q S ++
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQH---LSNDHICYF 133
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L L+Y+H V++RDLKP N+L+ + + DF L+
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 32/154 (20%), Positives = 50/154 (32%), Gaps = 38/154 (24%)
Query: 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP 406
V T Y APEI+ ++D W+ G E+L R F G + L ++G P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 407 -----------------LKFPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKRG 440
L P + + + A DL+ +L +P KR+
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI----E 307
Query: 441 ATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSF 474
+ HP+ E + P P
Sbjct: 308 VEQALAHPYLEQ----YYDPSDEPIAEAPFKFDM 337
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 21/165 (12%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
L +LG G G V+LAE ++ L A+K + + + R+ R E E+L++L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTML 100
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF---------- 217
H + + + ++ E+ GDL+ LR P
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 218 --YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
AS+V + YL + V+RDL N LV + + + DF +S
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 29/153 (18%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSLLD 169
+ +G G G VY L D A+K +++ + + + E I+
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT---EGIIMKDFS 148
Query: 170 HPFLPTLY-SHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
HP + +L ++ +++ + GDL +R + + + + +V ++
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMK 206
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+L V+RDL N ++ E + ++DF L+
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 112 HFRLLK-KLGCGDIGSVYLAELRDMGCLF--AMKVMDKG-MLAGRKKLMRAQTEREILSL 167
+ + +LGCG+ GSV R A+KV+ +G A +++MR E +I+
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQ 66
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
LD+P++ L + + L+ME GG LH L + + +V + +
Sbjct: 67 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGM 123
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+YL V+RDL NVL+ + +SDF LS
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 18/163 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ K +G G G VY A+L D G L A+K K + R K R E +I+ LDH
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQDKRFKN-R---ELQIMRKLDHCN 108
Query: 173 LPTLYSHF------ETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLL 224
+ L F + + + L++++ ++ + + + + Y ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIM-LSDFDLSLRCFVS 266
+L Y+H G+ +RD+KP+N+L+ D ++ L DF + + V
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-KQLVR 209
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 41/166 (24%), Positives = 59/166 (35%), Gaps = 41/166 (24%)
Query: 344 SARSM-------SFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGN 395
SA+ + S++ + Y APE+I G S++D W+ G ELLLG+ F G+
Sbjct: 203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262
Query: 396 RETL---FNVVGQP--------------LKFPEGSSISFA----------AKDLIRGLLV 428
+ L V+G P KFP+ + + A L LL
Sbjct: 263 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 322
Query: 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSF 474
P RL E H FF+ P P +F
Sbjct: 323 YTPTARL----TPLEACAHSFFDE--LRDPNVKLPNGRDTPALFNF 362
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 19/159 (11%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLD 169
++ L +G G GSV A G A+K K + + +T RE+ L +
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 170 HP--------FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASE 221
H F P E L+ G DL+ + + Q ++ +F +
Sbjct: 87 HENVIGLLDVFTPA--RSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQ 140
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+L L+Y+H +++RDLKP N+ V ED + + DF L+
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 44/168 (26%), Positives = 61/168 (36%), Gaps = 50/168 (29%)
Query: 345 ARSMS-----FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
AR + +V T Y APEI+ H VD W+ G ELL GRT F G + +
Sbjct: 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
Query: 399 L---FNVVGQP-----------------LKFPEGSSISFA---------AKDLIRGLLVK 429
L +VG P + ++FA A DL+ +LV
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 298
Query: 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPE---IPKPVDLSF 474
D KR+ A + H +F H P+ + P D S
Sbjct: 299 DSDKRI----TAAQALAHAYFAQY--------HDPDDEPVADPYDQSL 334
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 8/150 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
LLK+LG G G V L + + + A+K++ +G ++ + AQ + L HP
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQEAQ----TMMKLSHP 63
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L Y + ++ E+ S G L LR GK +V + +L
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV D + +SDF ++
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMR--AQTERE 163
D + +LK +G G G V A + A+K++ +K A E
Sbjct: 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN------EKRFHRQAAEEIR 145
Query: 164 ILSLL-------DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATR 216
IL L + + +F C+ E S +L+ L ++ + FS R
Sbjct: 146 ILEHLRKQDKDNTMNVI-HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR 203
Query: 217 FYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH--IMLSDFDLSLRCFVSPKL---VQ 271
+A +L L+ LH +++ DLKPEN+L+++ G I + DF S C+ ++ +Q
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQ 261
Query: 272 S 272
S
Sbjct: 262 S 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 26/152 (17%), Positives = 41/152 (26%), Gaps = 61/152 (40%)
Query: 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---------------- 399
Y APE+I G +G +D W+ G ELL G G + L
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 400 --------FNVVGQPL-----KFPEGSSISFAAKDL------------------------ 422
+ G P +GS + +
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 423 ----IRGLLVKDPQKRLGFKRGATEIKQHPFF 450
++ L DP R+ + +HP+
Sbjct: 385 FLDFLKQCLEWDPAVRM----TPGQALRHPWL 412
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 41/154 (26%), Positives = 63/154 (40%), Gaps = 11/154 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSL 167
L + LG G G VY + A+K K L ++K M E I+
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKN 69
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
LDHP + L E + ++ME G+L L + + Y+ ++ A+
Sbjct: 70 LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAM 126
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL + V+RD+ N+LV + L DF LS
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 32/155 (20%), Positives = 59/155 (38%), Gaps = 12/155 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-----RKKLMRAQTEREILS 166
R LK LG G G+V+ G + V K + + + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAIG 70
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLA 225
LDH + L L+ ++ G L +RQ + Q + ++
Sbjct: 71 SLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKG 127
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ YL G+V+R+L NVL++ + ++DF ++
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 10/148 (6%)
Query: 117 KKLGCGDIGSVYLAELRDMGCLF--AMKVMDKG-MLAGRKKLMRAQTEREILSLLDHPFL 173
+LGCG+ GSV R A+KV+ +G A +++MR E +I+ LD+P++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYI 398
Query: 174 PTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
L + + L+ME GG LH L + + +V + ++YL
Sbjct: 399 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLS 260
V+R+L NVL+ + +SDF LS
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 30/165 (18%), Positives = 60/165 (36%), Gaps = 21/165 (12%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLF-------AMKVMDKGMLAGRKKLMRAQTEREI 164
+ LG G ++ R++G +KV+DK + +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE---AASM 65
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVL 223
+S L H L Y + L+ EF G L T L++ + + A ++
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLA 123
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIM--------LSDFDLS 260
A+ +L +++ ++ +N+L+ + LSD +S
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 52/173 (30%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE-------REI- 164
+ L K+G G G V+ A R G A+K K LM + E REI
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALK----------KVLMENEKEGFPITALREIK 68
Query: 165 -LSLLDHPFLPTLY-------SHFETDKFSC-LLMEFCSGGDLHTLRQRQPGKHFSEQAT 215
L LL H + L S + K S L+ +FC DL L F+
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGL-LSNVLVKFTLSEI 126
Query: 216 RFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268
+ +L L Y+H +++RD+K NVL+ DG + L+DF L+ R F K
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-RAFSLAK 178
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 33/157 (21%), Positives = 48/157 (30%), Gaps = 53/157 (33%)
Query: 353 THE-----YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVV 403
T+ Y PE++ G+ G +D W G E+ +GN + L +
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 404 GQP----------------LKFPEGS-----------SISFAAKDLIRGLLVKDPQKRLG 436
G L+ +G A DLI LLV DP +R+
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI- 304
Query: 437 FKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLS 473
+ + H FF P P DL
Sbjct: 305 ---DSDDALNHDFFW-------------SDPMPSDLK 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 45/164 (27%), Positives = 67/164 (40%), Gaps = 30/164 (18%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK----VMDKGMLAGRKKLMRAQTEREI--L 165
+ +G G GSV A + G A+K + A R RE+ L
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR-------AYRELLLL 77
Query: 166 SLLDHP--------FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATR 216
+ H F P S L+M F DL + + FSE+ +
Sbjct: 78 KHMQHENVIGLLDVFTPA--SSLRNFYDFYLVMPFM-QTDLQKIMGLK-----FSEEKIQ 129
Query: 217 FYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ ++L L+Y+H GVV+RDLKP N+ V ED + + DF L+
Sbjct: 130 YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 45/165 (27%), Positives = 56/165 (33%), Gaps = 43/165 (26%)
Query: 345 ARSMS-----FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
AR +V T Y APE+I H VD W+ G E+L G+T FKG +
Sbjct: 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 399 L---FNVVGQP-----------------LKFPEGSSISFA---------AKDLIRGLLVK 429
L V G P P+ F A DL+ +L
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292
Query: 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSF 474
D KRL A + HPFFE E +P D S
Sbjct: 293 DVDKRL----TAAQALTHPFFEP----FRDPEEETEAQQPFDDSL 329
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 44/166 (26%), Positives = 65/166 (39%), Gaps = 22/166 (13%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
L ++LG G G V+LAE ++ L A+K + LA RK R E E+L+ L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNL 74
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
H + Y ++ E+ GDL+ LR P A L +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 228 YLHM-------------MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
LH+ V+RDL N LV + + + DF +S
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 24/161 (14%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK----VMDKGMLAGRKKLMRAQTEREI--L 165
++ LK +G G G V A + A+K A R RE+ +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-------AYRELVLM 115
Query: 166 SLLDHPFLPTLY------SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYA 219
++H + +L E + L+ME +L + Q + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ----MELDHERMSYLL 170
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++L +++LH G+++RDLKP N++V+ D + + DF L+
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 37/181 (20%), Positives = 60/181 (33%), Gaps = 54/181 (29%)
Query: 345 ARSMS-------FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
AR+ +V T Y APE+I G G+ VD W+ G E++ + F G +
Sbjct: 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
Query: 398 TL---FNVVGQP----------------LKFPEGSSISFA-------------------- 418
+G P P+ + ++F
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 330
Query: 419 -AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINH 477
A+DL+ +LV DP KR+ + QHP+ W + P+ D
Sbjct: 331 QARDLLSKMLVIDPAKRI----SVDDALQHPYINV--WYDP-AEVEAPPPQIYDKQLDER 383
Query: 478 K 478
+
Sbjct: 384 E 384
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 8/150 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
++++G G G V+L + + A+K + +G ++ + A+ ++ L HP
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIEEAE----VMMKLSHP 63
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L LY CL+ EF G L LR ++ F+ + +V + YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE 121
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
V++RDL N LV E+ I +SDF ++
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 34/153 (22%), Positives = 63/153 (41%), Gaps = 11/153 (7%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF---AMKVMDKG-MLAGRKKLMRAQTEREILSLLD 169
+ +G G G VY E D A+K + + + + +R E ++ L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR---EGLLMRGLN 80
Query: 170 HPFLPTLYSH-FETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALE 227
HP + L + +L+ + GDL +R Q + + + +V +E
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS--FGLQVARGME 138
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YL V+RDL N ++ E + ++DF L+
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 18/177 (10%)
Query: 90 GNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML 149
+ K V K G+ + K +G G G V+ A+L + A+K K +
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIK---KVLQ 74
Query: 150 AGRKKLMRAQTEREILSLLDHPFLPTL----YSHFETDKFSC--LLMEFCSGGDLHTL-- 201
R K R E +I+ ++ HP + L YS+ + L++E+ ++
Sbjct: 75 DKRFKN-R---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASR 129
Query: 202 RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV-REDGHIMLSDF 257
+ + + Y ++L +L Y+H +G+ +RD+KP+N+L+ G + L DF
Sbjct: 130 HYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 40/147 (27%), Positives = 57/147 (38%), Gaps = 32/147 (21%)
Query: 356 YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP----- 406
Y APE+I G + + +D W+ G EL+ G+ F G + L V+G P
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 407 ---------LKFPEGSSISFA----------AKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
KFP+ F+ A DLI LL P RL A E H
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL----TAIEALCH 322
Query: 448 PFFESVNWALIRSTHPPEIPKPVDLSF 474
PFF+ + R + E+P + +
Sbjct: 323 PFFDELRTGEARMPNGRELPPLFNWTK 349
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 8/150 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
LK+LG G G V + R A+K++ +G ++ + + A+ ++ L H
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAK----VMMNLSHE 79
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L LY + ++ E+ + G L LR+ + F Q +V A+EYL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 137
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV + G + +SDF LS
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 31/150 (20%), Positives = 66/150 (44%), Gaps = 8/150 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+L+++LG G G V++ + A+K + +G ++ L A ++ L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLAEAN----LMKQLQHQ 68
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLALEYLH 230
L LY+ + ++ E+ G L L+ G + A+++ + ++
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL+ N+LV + ++DF L+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 31/175 (17%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
++ +G G G V+ A + + A+K++ + + R E +++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAE 106
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF--------- 217
D+P + L K CLL E+ + GDL+ LR P S +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 218 ------------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A +V + YL V+RDL N LV E+ + ++DF LS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 25/162 (15%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK-VMDKGMLAGRKKLMRAQTEREI--LSLL 168
F++ + G G G+V L + + G A+K V+ R + + L++L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------ELQIMQDLAVL 76
Query: 169 DHP--------FLPTLYSHFETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFY 218
HP F D + ++ME+ LH + + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRR-DIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 219 ASEVLLALEYLHM--MGVVYRDLKPENVLV-REDGHIMLSDF 257
+++ ++ LH+ + V +RD+KP NVLV DG + L DF
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 42/146 (28%)
Query: 344 SARSM-------SFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGN 395
SA+ + +++ + Y APE+I G+ H +AVD W+ G F E++LG F+G+ +
Sbjct: 178 SAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237
Query: 396 RETL---FNVVGQP--------------LKFPEGSSISFA-------------AKDLIRG 425
L V+G P + I ++ A DL+
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 426 LLVKDPQKRLGFKRGATEIKQHPFFE 451
LL P++R+ E HP+F+
Sbjct: 298 LLQYLPEERM----KPYEALCHPYFD 319
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 24/182 (13%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMR--AQTERE 163
G+ + + + +G G G V A R A+K++ KK AQ E
Sbjct: 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN------KKAFLNQAQIEVR 102
Query: 164 ILSLL------DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRF 217
+L L+ ++ L HF CL+ E S +L+ L + + S TR
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK 161
Query: 218 YASEVLLALEYLHM--MGVVYRDLKPENVLVREDGH--IMLSDFDLSLRCFVSPKL---V 270
+A ++ AL +L + +++ DLKPEN+L+ I + DF S C + ++ +
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYI 219
Query: 271 QS 272
QS
Sbjct: 220 QS 221
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 12/44 (27%), Positives = 21/44 (47%)
Query: 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
Y +PE++ G + A+D W+ G E+ G F G + +
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
+L K LG G G V A+ + A+K++ +G + + LM E +IL
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIH 86
Query: 168 LD-HPFLPTLYSH-FETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF------- 217
+ H + L + +++EFC G+L T LR ++ + A
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 218 ------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
Y+ +V +E+L ++RDL N+L+ E + + DF L+
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 40/193 (20%), Positives = 76/193 (39%), Gaps = 36/193 (18%)
Query: 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMR--AQTEREI 164
+ L++KLG G +V+LA+ AMK++ K+ A+ E ++
Sbjct: 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKL 68
Query: 165 LSLL--------DHPFLP---TLYSHFE----TDKFSCLLMEFCSGGDLHTLRQRQPGKH 209
L + D L HF ++ E G +L L ++ +
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG 127
Query: 210 FSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVRE------DGHIMLSDFDLSLR 262
+ + ++LL L+Y+H G+++ D+KPENVL+ I ++D +
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-- 185
Query: 263 CFVSPKL---VQS 272
C+ +Q+
Sbjct: 186 CWYDEHYTNSIQT 198
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 25/150 (16%), Positives = 46/150 (30%), Gaps = 54/150 (36%)
Query: 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN------- 401
+ + T EY +PE++ G G D W+ +EL+ G F+ + +
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 402 --VVGQP---------------------------------------LKFPEGSSISFAAK 420
++G+ KF + +
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI--S 311
Query: 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
D + +L DP+KR A + HP+
Sbjct: 312 DFLSPMLQLDPRKRA----DAGGLVNHPWL 337
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 38/165 (23%), Positives = 64/165 (38%), Gaps = 21/165 (12%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGC--LFAMKVMDKG-MLAGRKKLMRAQTEREILS-LLD 169
+ +G G+ G V A ++ G A+K M + + E E+L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCKLGH 84
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL-- 226
HP + L E + L +E+ G+L LR+ + + A + L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 227 -----------EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+YL ++RDL N+LV E+ ++DF LS
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 24/166 (14%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK-----KLMRAQ-TEREI- 164
+ + + + G G+V + G A+K + + GR + REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 165 -LSLLDHP--------FLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQA 214
L+ HP F+ LM DL + ++ S Q
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQR--IVISPQH 135
Query: 215 TRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++ +LL L LH GVV+RDL P N+L+ ++ I + DF+L+
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 31/163 (19%), Positives = 51/163 (31%), Gaps = 46/163 (28%)
Query: 350 FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNR---ETLFNVVGQ 405
+V Y APE++ VD W+ G E+ + F+G+ + VVG
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 406 P------------------LKFPEGSSISFA---------AKDLIRGLLVKDPQKRLGFK 438
P + ++ A DLI +L +PQ+R+
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI--- 309
Query: 439 RGATEIKQHPFFESVNWALIRSTHPPE---IPKPVDLSFINHK 478
+ +HP+FES+ P F
Sbjct: 310 -STEQALRHPYFESL--------FDPLDLTEGLSERFHFDESV 343
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 31/175 (17%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
L K LG G+ G V A + A+K++ + + + L+ E +L
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS---EFNVLKQ 82
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF--------- 217
++HP + LY D L++E+ G L LR+ + +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 218 ------------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+A ++ ++YL M +V+RDL N+LV E + +SDF LS
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 40/170 (23%), Positives = 67/170 (39%), Gaps = 26/170 (15%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF-------AMKVM-DKGMLAGRKKLMRAQTEREIL 165
L K LG G G V +AE + A+K++ D L+ E E++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---EMEMM 94
Query: 166 SLL-DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF------ 217
++ H + L D +++E+ S G+L LR R+P
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 218 -------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ +EYL ++RDL NVLV E+ + ++DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 14/155 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F LG G G VY L D G L A+K + + G + + QTE E++S+ H
Sbjct: 32 FSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRN 88
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLL----ALE 227
L L T L+ + + G + LR+R + + R + L L
Sbjct: 89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ---RIALGSARGLA 145
Query: 228 YLH---MMGVVYRDLKPENVLVREDGHIMLSDFDL 259
YLH +++RD+K N+L+ E+ ++ DF L
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 36/172 (20%), Positives = 66/172 (38%), Gaps = 46/172 (26%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK----VMDKGMLAGRKKLMRAQTEREI--L 165
++ LK +G G G V A + A+K A R RE+ +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR-------AYRELVLM 78
Query: 166 SLLDHP--------FLPT--------LYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGK 208
++H F P +Y E LM+ +L ++
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-------LMDA----NLCQVIQM----- 122
Query: 209 HFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ + ++L +++LH G+++RDLKP N++V+ D + + DF L+
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 39/169 (23%), Positives = 56/169 (33%), Gaps = 47/169 (27%)
Query: 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP 406
+V T Y APE+I G G+ VD W+ G E++ G F G + + +G P
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 407 ----------------LKFPEGSSISFA---------------------AKDLIRGLLVK 429
P+ + SF A+DL+ +LV
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHK 478
D KR+ E QHP+ W S PK D +
Sbjct: 306 DASKRI----SVDEALQHPYINV--WYDP-SEAEAPPPKIPDKQLDERE 347
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 17/161 (10%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
L++ LG G G VY ++ M A+K + + + E I+S
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISK 89
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQP----GKHFSEQATRFYASEV 222
+H + +LME +GGDL + LR+ +P + A ++
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIML---SDFDLS 260
+YL ++RD+ N L+ G + DF ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 33/161 (20%), Positives = 61/161 (37%), Gaps = 17/161 (10%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
L++ LG G G VY ++ M A+K + + + E I+S
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISK 130
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQP----GKHFSEQATRFYASEV 222
+H + +L+E +GGDL + LR+ +P + A ++
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIML---SDFDLS 260
+YL ++RD+ N L+ G + DF ++
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 43/171 (25%), Positives = 67/171 (39%), Gaps = 36/171 (21%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMK--VMDKGMLAGRKKLMRAQTEREI--LSL 167
+ LK LGCG G V+ A D A+K V+ REI +
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-------ALREIKIIRR 64
Query: 168 LDHP--------FLP----TLYSHFETDKFSCL-----LMEFCSGGDLHTLRQRQPGKHF 210
LDH P + + + ME DL + ++ P
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGP---L 117
Query: 211 SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV-REDGHIMLSDFDLS 260
E+ R + ++L L+Y+H V++RDLKP N+ + ED + + DF L+
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 25/131 (19%), Positives = 38/131 (29%), Gaps = 33/131 (25%)
Query: 351 VGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP 406
+ T Y +P ++ + A+D W G F E+L G+T F G E + +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 407 ----------------LKFPEGSSISFA---------AKDLIRGLLVKDPQKRLGFKRGA 441
A D + +L P RL A
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL----TA 300
Query: 442 TEIKQHPFFES 452
E HP+
Sbjct: 301 EEALSHPYMSI 311
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 26/170 (15%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF-------AMKVMDKG-MLAGRKKLMRAQTEREIL 165
L K LG G G V +AE + A+K++ L+ E E++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---EMEMM 140
Query: 166 SLL-DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF------ 217
++ H + L D +++E+ S G+L LR R+P
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 218 -------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ +EYL ++RDL NVLV E+ + ++DF L+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 28/181 (15%)
Query: 114 RLLKKLGCGDIGSVYLAELRDM--GCLFAMKVMDK-GMLAGRKKLMRAQTEREILSLLDH 170
K+G G G VY A+ +D +A+K ++ G+ M A E +L L H
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------MSACREIALLRELKH 77
Query: 171 PFLPTLY----SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV---- 222
P + +L SH + + LL ++ DL + + +++ + V
Sbjct: 78 PNVISLQKVFLSHADRKVW--LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 223 ---LLALEYLHMMGVVYRDLKPENVLVRED----GHIMLSDFDLSLRCFVSPKLVQSSDD 275
L + YLH V++RDLKP N+LV + G + ++D + R F SP + D
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLD 193
Query: 276 P 276
P
Sbjct: 194 P 194
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 40/173 (23%), Positives = 53/173 (30%), Gaps = 63/173 (36%)
Query: 356 YLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGN---------GNRETL---FNV 402
Y APE++ G H A+D W G F ELL F + + L FNV
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260
Query: 403 VGQP--------LKFPE-------------------------GSSISFAAKDLIRGLLVK 429
+G P K PE A L++ LL
Sbjct: 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320
Query: 430 DPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTP 482
DP KR+ + + Q P+F E P P F + P
Sbjct: 321 DPIKRI----TSEQAMQDPYFL-------------EDPLPTSDVFAGCQIPYP 356
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 26/170 (15%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLF-------AMKVMDKG-MLAGRKKLMRAQTEREIL 165
L K LG G G V LAE + A+K++ L+ E E++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS---EMEMM 128
Query: 166 SLL-DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF------ 217
++ H + L D +++E+ S G+L L+ R+P
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 218 -------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
A +V +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 37/170 (21%), Positives = 66/170 (38%), Gaps = 26/170 (15%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
K LG G G V A + A+K++ L R+ LM E ++LS
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELKVLSY 82
Query: 168 L-DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF-------- 217
L +H + L + ++ E+C GDL LR+++ S+ +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 218 -------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++ +V + +L ++RDL N+L+ + DF L+
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
F +G G G VY LRD G A+K G ++ +TE E LS HP
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEF---ETEIETLSFCRHPH 96
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDL--HTLRQRQPGKHFSEQATRFYASEVLL----AL 226
L +L + L+ ++ G+L H P S R E+ + L
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS-WEQRL---EICIGAARGL 152
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
YLH +++RD+K N+L+ E+ ++DF +S
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 36/166 (21%), Positives = 62/166 (37%), Gaps = 22/166 (13%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
+ K LG G G V A +G A+K++ ++ LM E +I+S
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSH 105
Query: 168 LD-HPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF-------- 217
L H + L ++ E+C GDL LR++
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 218 ---YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++S+V + +L ++RD+ NVL+ + DF L+
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 40/180 (22%), Positives = 71/180 (39%), Gaps = 22/180 (12%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR-KKLMR--AQTER 162
G L F +++K+G G G V L + D +A+KV+ R K A+ E
Sbjct: 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-------RNIKKYTRSAKIEA 82
Query: 163 EILSLL------DHPFLPTLYSHFETDKFSCLLMEFCSGG--DLHTLRQRQPGKHFSEQA 214
+IL + ++ + + F CL+ E ++ T F +
Sbjct: 83 DILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG---FHIED 138
Query: 215 TRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274
+ Y E+L AL YL M + + DLKPEN+L+ + + ++ ++
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 31/140 (22%), Positives = 44/140 (31%), Gaps = 48/140 (34%)
Query: 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---------------- 399
Y APE+I G + D W+FG EL G F+ + + E L
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 400 ----------FNVVGQPLKFPEGSSISFAAK------------------DLIRGLLVKDP 431
N L +PE +S + K D + +L DP
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 432 QKRLGFKRGATEIKQHPFFE 451
R E+ +H F E
Sbjct: 345 TLRP----SPAELLKHKFLE 360
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 40/175 (22%), Positives = 64/175 (36%), Gaps = 31/175 (17%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKG-MLAGRKKLMRAQTEREILSL 167
K LG G G V A + A+K++ + + R+ LM E ++++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELKMMTQ 104
Query: 168 L-DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRF-------- 217
L H + L L+ E+C GDL LR ++ E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 218 ------------YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+A +V +E+L V+RDL NVLV + + DF L+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 43/187 (22%), Positives = 71/187 (37%), Gaps = 49/187 (26%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ L K LG G G V + G FA+K K + R K R E +I+ +LDH
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRYKN-R---ELDIMKVLDHV 60
Query: 172 FLPTLYSHFETDKFSC--------------------------------------LLMEFC 193
+ L +F T ++ME+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 194 SGGDLHTL--RQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV-REDG 250
LH + + G+ Y ++ A+ ++H +G+ +RD+KP+N+LV +D
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 251 HIMLSDF 257
+ L DF
Sbjct: 180 TLKLCDF 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 38/198 (19%), Positives = 69/198 (34%), Gaps = 61/198 (30%)
Query: 344 SARSM-------SFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGN 395
SA+ + +++ + Y APE++ G ++D W+ G F EL+LG+ F G +
Sbjct: 188 SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 396 RETL---FNVVGQP--------------LKFPEGSSISFA----------AKDLIRGLLV 428
+ L ++G P ++FP + + A DL+ +L
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 429 KDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIPQNDK 488
+P R+ E HPFF+ + + + S H IP
Sbjct: 308 YEPDLRI----NPYEAMAHPFFDHL--------RNSYESEVKNNSNFPHGVNQNIP---- 351
Query: 489 GAADSDRSSGPFLDFEFF 506
+F +
Sbjct: 352 ----------QLFNFSPY 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 32/162 (19%), Positives = 56/162 (34%), Gaps = 20/162 (12%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLA-ELRDMGCLFAMKVMDKGMLAGR-KKLMR--AQTE 161
GD + ++ LG G G V + A+K++ R R A+ E
Sbjct: 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLE 66
Query: 162 REILSLL-------DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQA 214
+L + + + F C+ E G + + + +
Sbjct: 67 INVLKKIKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPH 124
Query: 215 TRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSD 256
R A ++ AL +LH + + DLKPEN+L L +
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 38/154 (24%), Positives = 51/154 (33%), Gaps = 47/154 (30%)
Query: 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP------ 406
Y PE+I G D W+ G +E G T F+ + NRE L ++G
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264
Query: 407 ------------LKFPEGSSISFAAK---------------------DLIRGLLVKDPQK 433
L + E SS K DL+R +L DP +
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 434 RLGFKRGATEIKQHPFFESVNWALIRSTHPPEIP 467
R+ E HPFF + RS H P
Sbjct: 325 RI----TLAEALLHPFFAGL-TPEERSFHTSRNP 353
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 32/164 (19%), Positives = 61/164 (37%), Gaps = 24/164 (14%)
Query: 106 GDLGLGHFRLLKKLGCGDIGSVYLA-ELRDMGCLFAMKVMDKGMLAGR-KKLMR--AQTE 161
GD+ + ++ LG G G V + + G A+K++ + A++E
Sbjct: 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-------KNVDRYCEAARSE 61
Query: 162 REILSLL-------DHPFLPTLYSHFETDKFSCLLMEFCSGG--DLHTLRQRQPGKHFSE 212
++L L + + FE C++ E D P F
Sbjct: 62 IQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP---FRL 117
Query: 213 QATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSD 256
R A ++ ++ +LH + + DLKPEN+L + + +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 34/137 (24%), Positives = 46/137 (33%), Gaps = 46/137 (33%)
Query: 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL---FNVVGQP------ 406
Y APE+I G D W+ G E LG T F + ++E L ++G
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 407 ------------LKFPEGSSISF---------------------AAKDLIRGLLVKDPQK 433
L + E SS DLI+ +L DP K
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 434 RLGFKRGATEIKQHPFF 450
R+ E +HPFF
Sbjct: 320 RI----TLREALKHPFF 332
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 4e-07
Identities = 80/492 (16%), Positives = 145/492 (29%), Gaps = 137/492 (27%)
Query: 42 NLSNATIEAKKGVDCLAHSEEESGKSSLSTGDANEASFRSACLSKP---HKGNDMKWDAV 98
L A +E + + L SGK+ + A + CLS + W +
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWV----ALD-----VCLSYKVQCKMDFKIFWLNL 189
Query: 99 QCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA 158
+ S + L +L+KL I + + + + L ++L+++
Sbjct: 190 KNCNSPETVL-----EMLQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQAEL---RRLLKS 240
Query: 159 QTEREILSLLDHPFLPTLYSHFETDKFSC-LLMEFCSGGDLHTLRQRQ--------PGKH 209
+ L +L + ++ F SC +L+ T R +Q H
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFN---LSCKILL---------TTRFKQVTDFLSAATTTH 288
Query: 210 FS--EQATRFYASEVL-LALEYLHMMGVVYRDLKPENVLVREDGH-IMLSDFDLSLRCFV 265
S + EV L L+YL +DL E + + LS S+R
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCR---PQDLPREVL----TTNPRRLSIIAESIR--- 338
Query: 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFL-------NSK 318
D ++ +C + + L+P+ ++ F ++
Sbjct: 339 ---------DGLATWDNW-KHVNCDKLTTIIESSLN--VLEPAEYRKMFDRLSVFPPSAH 386
Query: 319 -TTKV------------------KSEKTSLTNSD------SLPVLIAEPTSARSMSFVGT 353
T + K K SL S+P + E + +
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLE-LKVKLENEYAL 445
Query: 354 HEYLAPEIIRGDGHGSAVDWWTFG-------IFFYELLLGR-TPFKGNGNRETLFNVVGQ 405
H I+ D + + +G + R TLF +V
Sbjct: 446 HR----SIVDHYNIPKTFDSDDLIPPYLDQYFYSH---IGHHLKNIEHPERMTLFRMVFL 498
Query: 406 PLKFPEG----SSISFAAKDLIRGLLV-----------KDPQKRLGFKRGATEIKQHPFF 450
+F E S ++ A I L DP+ ++R I F
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPK----YERLVNAILD--FL 552
Query: 451 ESVNWALIRSTH 462
+ LI S +
Sbjct: 553 PKIEENLICSKY 564
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 5e-07
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 12/148 (8%)
Query: 118 KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA-QTEREILSLLDHPFLPTL 176
K+G G G VY + + A+K + + ++L + E ++++ H L L
Sbjct: 38 KMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 177 YSHFETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLL----ALEYLHM 231
CL+ + G L L S R ++ + +LH
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS-WHMRC---KIAQGAANGINFLHE 151
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDL 259
++RD+K N+L+ E +SDF L
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 3e-06
Identities = 27/198 (13%), Positives = 54/198 (27%), Gaps = 50/198 (25%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVM---DKGMLAGRKKLMRAQTEREILSLL- 168
+ +K+G G G V+ A+K++ ++ G + + EI+
Sbjct: 22 LQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 169 ----------DHPFLPTLYSHF------------------------------ETDKFSCL 188
L S D +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVR 247
++EF GG ++ K S + ++ +L + +RDL NVL++
Sbjct: 140 VLEFEFGG---IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 248 EDGHIMLSDFDLSLRCFV 265
+ L +
Sbjct: 197 KTSLKKLHYTLNGKSSTI 214
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 8e-05
Identities = 32/159 (20%), Positives = 54/159 (33%), Gaps = 30/159 (18%)
Query: 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK-------------KLMRAQT 160
+ K +G G +V+ +K G + +K L
Sbjct: 93 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 161 ERE--ILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFY 218
E L L +P +Y+ +LME +L+ +R P +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDEVLDM------ 201
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
+L + + G+V+ DL NVLV E+ I + DF
Sbjct: 202 ---ILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 56/321 (17%), Positives = 107/321 (33%), Gaps = 41/321 (12%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML---AGRKKLMRAQTEREILSLLD 169
+L K LG G G V A+ + + + ML A + +E +IL +
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 170 -HPFLPTLYSH-FETDKFSCLLMEFCSGGDLHT-LRQRQPGKHFSEQATRFYASEVLLAL 226
H + L + +++EFC G+L T LR ++ Y ++
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV-------PYKTKGARFR 136
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQ 286
+ +G + DLK + S F + D ++ +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 287 PSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346
A + C+ R L ++ + + V I + AR
Sbjct: 197 CYSFQVAKGMEFLASRKCIH------RDLAARNILLSEKNV---------VKICDFGLAR 241
Query: 347 SMSFVGTHE----------YLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGN 395
+ + ++APE I + D W+FG+ +E+ LG +P+ G
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301
Query: 396 RETLFNVV--GQPLKFPEGSS 414
E + G ++ P+ ++
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTT 322
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.01 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.84 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.48 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.99 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.83 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.58 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.3 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.29 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.21 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.34 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.15 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.23 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 80.28 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-71 Score=553.34 Aligned_cols=278 Identities=35% Similarity=0.631 Sum_probs=248.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.|+|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35699999999999999999999999999999999987766666778899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||+||+|.+++.+. +.++|..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~-- 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 186 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT--
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC--
Confidence 9999999999999876 679999999999999999999999999999999999999999999999999996431110
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......+
T Consensus 187 -------------------------------------------------------------------------~~~~~~~ 193 (311)
T 4aw0_A 187 -------------------------------------------------------------------------KQARANS 193 (311)
T ss_dssp -------------------------------------------------------------------------TCCCBCC
T ss_pred -------------------------------------------------------------------------CcccccC
Confidence 1112345
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+++...+.+|. .+++++++||.+||+.
T Consensus 194 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~ 271 (311)
T 4aw0_A 194 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLLVL 271 (311)
T ss_dssp CCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TCCHHHHHHHHHHSCS
T ss_pred cccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--ccCHHHHHHHHHHccC
Confidence 68999999999999999999999999999999999999999999999999999988888876 6999999999999999
Q ss_pred CCCCccCCCC--ChHHhhcCCCCCCCCcchhccCCCCCC
Q 010603 430 DPQKRLGFKR--GATEIKQHPFFESVNWALIRSTHPPEI 466 (506)
Q Consensus 430 dP~~R~s~~~--~a~ell~hp~f~~~~~~~~~~~~~~~~ 466 (506)
||++|||..+ ...++++||||++++|+.+....||.+
T Consensus 272 dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp SGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred CHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 9999998421 123479999999999998877666543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-69 Score=534.54 Aligned_cols=276 Identities=41% Similarity=0.777 Sum_probs=235.7
Q ss_pred cCCeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.++|++++.||+|+||+||+|++. .+++.||||++++....... ..++.+|+++|+.++|||||+++++|++++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 457999999999999999999984 46889999999876543322 23567899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||||||+||+|.+++.+. +.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999999876 67999999999999999999999999999999999999999999999999999532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
...
T Consensus 180 -----------------------------------------------------------------------------~~~ 182 (304)
T 3ubd_A 180 -----------------------------------------------------------------------------EKK 182 (304)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 011
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
..+.+||+.|||||++.+..|+.++|||||||+||||+||++||.+.+..+.+.++....+.+|. .+++++++||.+|
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~ 260 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRML 260 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHH
Confidence 23458999999999999999999999999999999999999999999999999999888877775 6999999999999
Q ss_pred hhcCCCCccCCC-CChHHhhcCCCCCCCCcchhc--cCCCCCCC
Q 010603 427 LVKDPQKRLGFK-RGATEIKQHPFFESVNWALIR--STHPPEIP 467 (506)
Q Consensus 427 L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~--~~~~~~~p 467 (506)
|+.||++|||.. ..++|+++||||++++|+.+. ...||.+|
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred cccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 999999999842 246899999999999998763 33455544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-67 Score=531.92 Aligned_cols=260 Identities=23% Similarity=0.448 Sum_probs=227.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++++.... .....++.+|+++|+.|+|||||+++++|++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 56899999999999999999999999999999999876544 34466788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||+||+|.+++....+..++|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--- 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH---
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC---
Confidence 99999999999998776678899999999999999999999999999999999999999999999999999542100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
....++
T Consensus 179 --------------------------------------------------------------------------~~~~~~ 184 (350)
T 4b9d_A 179 --------------------------------------------------------------------------VELARA 184 (350)
T ss_dssp --------------------------------------------------------------------------HHHHHH
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001234
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
.+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+.+.+++..... +....+++++++||.+||+.
T Consensus 185 ~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~ 263 (350)
T 4b9d_A 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKR 263 (350)
T ss_dssp HHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCS
T ss_pred cCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccC
Confidence 58999999999999999999999999999999999999999999998888888866543 23347999999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||++||+ ++|+|+||||+.
T Consensus 264 dP~~R~s----~~e~l~hp~~~~ 282 (350)
T 4b9d_A 264 NPRDRPS----VNSILEKGFIAK 282 (350)
T ss_dssp SGGGSCC----HHHHHTSHHHHT
T ss_pred ChhHCcC----HHHHhcCHHhhc
Confidence 9999997 999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-67 Score=511.87 Aligned_cols=256 Identities=31% Similarity=0.511 Sum_probs=217.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+++|+.++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999987666556667889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||| +|+|.+++... +.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC----
Confidence 9999 78999998876 6799999999999999999999999999999999999999999999999999853210
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....+
T Consensus 165 --------------------------------------------------------------------------~~~~~~ 170 (275)
T 3hyh_A 165 --------------------------------------------------------------------------GNFLKT 170 (275)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------CCccCC
Confidence 001224
Q ss_pred cccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
.+||+.|||||++.+..| +.++|||||||+||||+||++||.+.+..+.+..+......+|. .+++++++||.+||+
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRMLI 248 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSC
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 589999999999999886 68999999999999999999999998888888888888777775 699999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.||++||| ++|+|+||||+.
T Consensus 249 ~dP~~R~s----~~eil~hpw~k~ 268 (275)
T 3hyh_A 249 VNPLNRIS----IHEIMQDDWFKV 268 (275)
T ss_dssp SSGGGSCC----HHHHHHCHHHHT
T ss_pred CChhHCcC----HHHHHcCccccc
Confidence 99999997 999999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-66 Score=524.68 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=226.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.+|+++++||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+++|+.++|||||+++++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998654332 344678999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++.+ ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 151 Ey~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---- 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 223 (346)
T ss_dssp CCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred eCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC----
Confidence 99999999999876 46999999999999999999999999999999999999999999999999998642110
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.....++
T Consensus 224 -------------------------------------------------------------------------~~~~~~~ 230 (346)
T 4fih_A 224 -------------------------------------------------------------------------VPRRKSL 230 (346)
T ss_dssp -------------------------------------------------------------------------SCCBCCC
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 1112356
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+.+..+.... ..++....+++++++||.+||+.
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 310 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence 89999999999999999999999999999999999999999998888887776542 33444457999999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||++||| ++|+|+||||+.
T Consensus 311 dP~~R~t----a~e~l~Hp~~~~ 329 (346)
T 4fih_A 311 DPAQRAT----AAELLKHPFLAK 329 (346)
T ss_dssp STTTSCC----HHHHTTCGGGGG
T ss_pred ChhHCcC----HHHHhcCHhhcC
Confidence 9999997 999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-65 Score=526.80 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=227.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|+++++||+|+||+||+|+++.+|+.||||++++..... .+.+.+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 356999999999999999999999999999999998754332 34567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||+||+|.+++.. ..+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 227 mEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--- 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 300 (423)
T ss_dssp EECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence 999999999999876 46999999999999999999999999999999999999999999999999999642110
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....+
T Consensus 301 --------------------------------------------------------------------------~~~~~~ 306 (423)
T 4fie_A 301 --------------------------------------------------------------------------VPRRKS 306 (423)
T ss_dssp --------------------------------------------------------------------------CCCBCC
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 111335
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
++||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+.+..+... ...++....+++++++||.+||+
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence 68999999999999999999999999999999999999999999888888877654 33445556799999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.||++||| |+|+|+||||+.
T Consensus 387 ~dP~~R~t----a~ell~Hp~~~~ 406 (423)
T 4fie_A 387 RDPAQRAT----AAELLKHPFLAK 406 (423)
T ss_dssp SSTTTSCC----HHHHTTCGGGGG
T ss_pred CChhHCcC----HHHHhcCHHhcC
Confidence 99999997 999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-65 Score=547.93 Aligned_cols=283 Identities=35% Similarity=0.616 Sum_probs=242.0
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHH---HHHHHhcCCCCccceeEEEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTE---REILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E---~~il~~l~hpnIv~l~~~~~ 181 (506)
...+.+++|++++.||+|+||+||+|+++.+|+.||||+|++..+........+.+| +.+++.++|||||+++++|+
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 346789999999999999999999999999999999999998765544444444444 55667779999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+.+.+|||||||.||+|.+++.+. +.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999999999876 679999999999999999999999999999999999999999999999999995
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.+..
T Consensus 341 ~~~~---------------------------------------------------------------------------- 344 (689)
T 3v5w_A 341 DFSK---------------------------------------------------------------------------- 344 (689)
T ss_dssp ECSS----------------------------------------------------------------------------
T ss_pred ecCC----------------------------------------------------------------------------
Confidence 4210
Q ss_pred CCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCC---cHHHHHHHhCCCCCCCCCCCCCH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNG---NRETLFNVVGQPLKFPEGSSISF 417 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~s~ 417 (506)
....+.+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+ ..+....+....+.+|. .+++
T Consensus 345 ---~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--~~S~ 419 (689)
T 3v5w_A 345 ---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSP 419 (689)
T ss_dssp ---CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT--TSCH
T ss_pred ---CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc--cCCH
Confidence 11234589999999999974 579999999999999999999999997643 23445566667777765 6999
Q ss_pred HHHHHHHHHhhcCCCCccCC-CCChHHhhcCCCCCCCCcchhc--cCCCCCCCCCC
Q 010603 418 AAKDLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALIR--STHPPEIPKPV 470 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~~ 470 (506)
++++||.+||+.||.+|++. ...|+||++||||++++|+.+. ...||.+|...
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~ 475 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 475 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCC
Confidence 99999999999999999985 3468999999999999998763 44677777543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-63 Score=494.28 Aligned_cols=255 Identities=23% Similarity=0.407 Sum_probs=217.0
Q ss_pred CCe-EEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe----CCe
Q 010603 111 GHF-RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----DKF 185 (506)
Q Consensus 111 ~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~ 185 (506)
++| ++.++||+|+||+||+|.++.+++.||||++.+.... .....++.+|+++|+.|+|||||+++++|++ ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 345 7888999999999999999999999999999876543 3445678899999999999999999999975 357
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEec-CCCEEEeecCCccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVRE-DGHIMLSDFDLSLR 262 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~-~~~vkl~DFGla~~ 262 (506)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999875 67999999999999999999999999 999999999999985 79999999999842
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
..
T Consensus 182 ~~------------------------------------------------------------------------------ 183 (290)
T 3fpq_A 182 KR------------------------------------------------------------------------------ 183 (290)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~ 421 (506)
.....+.+||+.|||||++.+ .|+.++|||||||+||||+||++||.+......+.+.+... ........+++++++
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred -CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 011234589999999999875 69999999999999999999999998776666555544332 222223468899999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||.+||+.||++||| ++|+|+||||+.
T Consensus 262 li~~~L~~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 262 IIEGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHHHccCChhHCcC----HHHHhcCccccC
Confidence 999999999999997 999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-64 Score=503.75 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=221.4
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++.++||+|+||+||+|+++.+|+.||||++++.... .+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 45699999999999999999999999999999999865321 3599999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCccccccCCc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~~~~~ 268 (506)
||||+||+|.++++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999876 6799999999999999999999999999999999999999988 699999999964321100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
. .......
T Consensus 207 ~------------------------------------------------------------------------~~~~~~~ 214 (336)
T 4g3f_A 207 G------------------------------------------------------------------------KSLLTGD 214 (336)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred c------------------------------------------------------------------------cceecCC
Confidence 0 0000122
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC-CCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP-EGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-~~~~~s~~~~~li~~~L 427 (506)
.++||+.|||||++.+..|+.++|||||||+||||+||++||.+.+..+.+.++......++ .+..+++++++||.+||
T Consensus 215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L 294 (336)
T 4g3f_A 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGL 294 (336)
T ss_dssp CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHT
T ss_pred ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHc
Confidence 45899999999999999999999999999999999999999998888777888876654432 23479999999999999
Q ss_pred hcCCCCccCCCCChHHh-------------hcCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEI-------------KQHPFFESV 453 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~el-------------l~hp~f~~~ 453 (506)
+.||.+||| +.|+ |+|||+...
T Consensus 295 ~~dP~~R~s----a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 295 RKEPVHRAS----AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CSSGGGSCC----HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred cCCHhHCcC----HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999999997 7886 679998753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-62 Score=488.95 Aligned_cols=271 Identities=25% Similarity=0.404 Sum_probs=204.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
+++|++++.||+|+||+||+|+++.+|+.||||+++... .....+++.+|+++|+.|+|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 356999999999999999999999999999999997643 2334567889999999999999999999997544
Q ss_pred -------eEEEEEeecCCCChHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEee
Q 010603 185 -------FSCLLMEFCSGGDLHTLRQRQPG-KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSD 256 (506)
Q Consensus 185 -------~~~lV~E~~~gg~L~~~l~~~~~-~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~D 256 (506)
++|||||||.||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999986522 2345677899999999999999999999999999999999999999999
Q ss_pred cCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCc
Q 010603 257 FDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336 (506)
Q Consensus 257 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (506)
||+|+.+.........
T Consensus 162 FGla~~~~~~~~~~~~---------------------------------------------------------------- 177 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTV---------------------------------------------------------------- 177 (299)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred CccceecCCCcccccc----------------------------------------------------------------
Confidence 9999653221100000
Q ss_pred ccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCCCCCCCC-CCC
Q 010603 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQPLKFPE-GSS 414 (506)
Q Consensus 337 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~-~~~ 414 (506)
........+.++.+||+.|||||++.+..|+.++|||||||+||||++ ||.+..+. ..+..+... .+|. ...
T Consensus 178 -~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~--~~p~~~~~ 251 (299)
T 4g31_A 178 -LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL--KFPPLFTQ 251 (299)
T ss_dssp ---------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT--CCCHHHHH
T ss_pred -ccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC--CCCCCCcc
Confidence 000011123445689999999999999999999999999999999996 88654332 223333332 2221 123
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.++.+.+||.+||+.||.+||+ +.|+|+||||++++|.
T Consensus 252 ~~~~~~~li~~~L~~dP~~Rps----~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 252 KYPCEYVMVQDMLSPSPMERPE----AINIIENAVFEDLDFP 289 (299)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGCCC---
T ss_pred cCHHHHHHHHHHcCCChhHCcC----HHHHhcCHhhCCCCCC
Confidence 5677899999999999999997 9999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=499.73 Aligned_cols=264 Identities=24% Similarity=0.375 Sum_probs=221.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe------CC
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------DK 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 184 (506)
++|++++.||+|+||+||+|+++.+|+.||||+|++.... ....+++.+|+++|+.|+|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4699999999999999999999999999999999765432 3445677899999999999999999999764 36
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+||||||| +|+|.+++... +.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999999 57899998765 689999999999999999999999999999999999999999999999999996432
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.... ...
T Consensus 210 ~~~~-------------------------------------------------------------------------~~~ 216 (398)
T 4b99_A 210 TSPA-------------------------------------------------------------------------EHQ 216 (398)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred cCcc-------------------------------------------------------------------------ccc
Confidence 1100 001
Q ss_pred CCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC---------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK--------------- 408 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 408 (506)
....+++||+.|||||++.+. .|+.++||||||||||||++|++||.+.+..+++..|......
T Consensus 217 ~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~ 296 (398)
T 4b99_A 217 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVR 296 (398)
T ss_dssp CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHH
T ss_pred cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhh
Confidence 123456899999999999876 4699999999999999999999999999988887766521110
Q ss_pred -----CCC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 409 -----FPE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 409 -----~p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
++. ...++++++|||.+||+.||.+||| |+|+|+||||+....
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 297 AYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYHD 353 (398)
T ss_dssp HHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTCC
T ss_pred hhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCCC
Confidence 111 1247899999999999999999997 999999999987653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=485.40 Aligned_cols=281 Identities=25% Similarity=0.373 Sum_probs=210.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 186 (506)
++|+++++||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+++|+.+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 56999999999999999999986 467899999987642 334567899999988 699999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecCCcccccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLSLRCFV 265 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFGla~~~~~ 265 (506)
|||||||+||+|.+++. .+++..++.|++||+.||+|||++|||||||||+||||+.+ +++||+|||+|+....
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999883 48999999999999999999999999999999999999977 7999999999975432
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
............ .....|....| ........
T Consensus 171 ~~~~~~~~~~~~------~~~~~~~~~~~-------------------------------------------~~~~~~~~ 201 (361)
T 4f9c_A 171 TKIELLKFVQSE------AQQERCSQNKC-------------------------------------------SICLSRRQ 201 (361)
T ss_dssp CSCGGGGGC-----------------------------------------------------------------------
T ss_pred cccccccccccc------ccccccccccc-------------------------------------------cccccccc
Confidence 111000000000 00000000000 00001112
Q ss_pred CccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC-CcHHHHHHHhC---C---------------
Q 010603 346 RSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFNVVG---Q--------------- 405 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~-~~~~~~~~i~~---~--------------- 405 (506)
..++.+||+.|||||++.+. .|+.++||||+|||||||++|++||... ++.+++..+.. .
T Consensus 202 ~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~ 281 (361)
T 4f9c_A 202 QVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSIL 281 (361)
T ss_dssp ----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEE
T ss_pred cccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccc
Confidence 23456899999999999876 4899999999999999999999999644 44444433321 0
Q ss_pred ----------------------------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 406 ----------------------------------PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 406 ----------------------------------~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
....+.+..++++++|||.+||+.||.+|+| |+|+|+||||+
T Consensus 282 ~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~ 357 (361)
T 4f9c_A 282 CSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFK 357 (361)
T ss_dssp ESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGT
T ss_pred ccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccC
Confidence 0011223468999999999999999999997 99999999999
Q ss_pred CCC
Q 010603 452 SVN 454 (506)
Q Consensus 452 ~~~ 454 (506)
+++
T Consensus 358 ~i~ 360 (361)
T 4f9c_A 358 DMS 360 (361)
T ss_dssp TC-
T ss_pred CCC
Confidence 865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-60 Score=509.53 Aligned_cols=264 Identities=31% Similarity=0.438 Sum_probs=234.7
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
-.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+|+++|+.|+|||||+|+++|++++.+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 346789999999999999999999999999999999987542 33456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC--CCEEEeecCCcccccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED--GHIMLSDFDLSLRCFV 265 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~--~~vkl~DFGla~~~~~ 265 (506)
||||||.||+|.+++... ...+++..++.|++||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+..
T Consensus 231 iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999999988654 3579999999999999999999999999999999999999864 8999999999964311
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. .
T Consensus 310 ~------------------------------------------------------------------------------~ 311 (573)
T 3uto_A 310 K------------------------------------------------------------------------------Q 311 (573)
T ss_dssp T------------------------------------------------------------------------------S
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 1
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLI 423 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li 423 (506)
.....+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+.+.++......++. ...+++++++||
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 123458999999999999999999999999999999999999999999999999999877666553 257999999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
.+||+.||.+||+ ++|+|+||||+..+|..
T Consensus 392 ~~~L~~dp~~R~t----~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 392 RKLLLADPNTRMT----IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HTTSCSSGGGSCC----HHHHHHSTTTSCCCCTT
T ss_pred HHHccCChhHCcC----HHHHhcCcCcCCCCCCC
Confidence 9999999999997 99999999999888753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=466.24 Aligned_cols=260 Identities=21% Similarity=0.348 Sum_probs=219.1
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
.+..++|.+.+.||+|+||+||+|++. .+++.||||+++... ....+++.+|+++|+.|+|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 455678999999999999999999975 357899999997643 344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQ-----------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG 250 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~-----------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 250 (506)
+++.+|||||||++|+|.+++... ....+++..+..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 235799999999999999999999999999999999999999999
Q ss_pred CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCC
Q 010603 251 HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLT 330 (506)
Q Consensus 251 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (506)
++||+|||+|+.......
T Consensus 166 ~~Ki~DFGla~~~~~~~~-------------------------------------------------------------- 183 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------- 183 (299)
T ss_dssp CEEECCCSCHHHHTGGGC--------------------------------------------------------------
T ss_pred cEEECCcccceecCCCCc--------------------------------------------------------------
Confidence 999999999964311100
Q ss_pred CCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCC-CC
Q 010603 331 NSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQP-LK 408 (506)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~ 408 (506)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+. +.
T Consensus 184 -------------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 250 (299)
T 4asz_A 184 -------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 250 (299)
T ss_dssp -------------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred -------------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 000122469999999999999999999999999999999998 999999998888887776543 33
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 409 ~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.| ..+++++.+||.+||+.||++||+ +++++ +|++.
T Consensus 251 ~p--~~~~~~~~~li~~cl~~dP~~RPs----~~~i~--~~L~~ 286 (299)
T 4asz_A 251 RP--RTCPQEVYELMLGCWQREPHMRKN----IKGIH--TLLQN 286 (299)
T ss_dssp CC--TTCCHHHHHHHHHHTCSSGGGSCC----HHHHH--HHHHH
T ss_pred CC--ccchHHHHHHHHHHcCCChhHCcC----HHHHH--HHHHH
Confidence 33 479999999999999999999998 77874 46653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-59 Score=475.62 Aligned_cols=281 Identities=36% Similarity=0.736 Sum_probs=242.5
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 185 (506)
.+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.+ +|||||+++++|++.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 46678899999999999999999999999999999999987655556677788999999988 79999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999998876 6799999999999999999999999999999999999999999999999999853110
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
...
T Consensus 177 -----------------------------------------------------------------------------~~~ 179 (353)
T 3txo_A 177 -----------------------------------------------------------------------------NGV 179 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------CCc
Confidence 001
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+......+|. .++.++.+||.+
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~ 257 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLHEDATGILKS 257 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHH
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHH
Confidence 123458999999999999999999999999999999999999999999999999999888877776 599999999999
Q ss_pred HhhcCCCCccCC--CCChHHhhcCCCCCCCCcchhc--cCCCCCCCC
Q 010603 426 LLVKDPQKRLGF--KRGATEIKQHPFFESVNWALIR--STHPPEIPK 468 (506)
Q Consensus 426 ~L~~dP~~R~s~--~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~ 468 (506)
||..||.+||+. ...++|+++||||+.++|..+. ...||..|.
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~ 304 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCC
Confidence 999999999984 1234899999999999998763 345666664
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=469.36 Aligned_cols=281 Identities=38% Similarity=0.711 Sum_probs=246.3
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||+++++++++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45778999999999999999999999999999999998865545556677889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||++||+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 999999999999998775 5799999999999999999999999999999999999999999999999999853110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (337)
T 1o6l_A 158 ---------------------------------------------------------------------------DGATM 162 (337)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00112
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+......+|. .+++++++||.+||
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL 240 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLL 240 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHT
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 3458999999999999999999999999999999999999999998888888888877777775 68999999999999
Q ss_pred hcCCCCccCCC-CChHHhhcCCCCCCCCcchhc--cCCCCCCCCC
Q 010603 428 VKDPQKRLGFK-RGATEIKQHPFFESVNWALIR--STHPPEIPKP 469 (506)
Q Consensus 428 ~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~ 469 (506)
..||.+||+.. .+++|+++||||..++|..+. ...||..|..
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~ 285 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCC
Confidence 99999999431 259999999999999998663 3455665543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-59 Score=462.97 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=210.6
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+++..++|++.++||+|+||+||+|+++. .||||+++.... .....+.+.+|+++|+.++|||||++++++. ++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence 456777889999999999999999998753 599999975432 2455678899999999999999999999875 45
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 689999999999999998765 3579999999999999999999999999999999999999999999999999995321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
... ..
T Consensus 184 ~~~---------------------------------------------------------------------------~~ 188 (307)
T 3omv_A 184 RWS---------------------------------------------------------------------------GS 188 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCC---------------------------------------------------------------------------cc
Confidence 000 00
Q ss_pred CCccccccCCCCccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC----CCCCCCH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP----EGSSISF 417 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~---~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~s~ 417 (506)
......+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++......| ....+++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 112345899999999999753 589999999999999999999999998877776666654433332 2346899
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhh
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIK 445 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell 445 (506)
++.+||.+||+.||++||+ +.|++
T Consensus 269 ~l~~li~~cl~~dP~~RPs----~~ei~ 292 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPL----FPQIL 292 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCC----HHHHH
T ss_pred HHHHHHHHHcCCCHhHCcC----HHHHH
Confidence 9999999999999999998 55554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-59 Score=468.33 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=213.3
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
+...+|.+.++||+|+||+||+|+++ .+++.||||+++... ....+.+.+|+++|+.|+|||||++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 44567999999999999999999875 368899999997643 3445678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQP-------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED 249 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~-------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~ 249 (506)
.+.+|||||||++|+|.++++... ...+++..+..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 999999999999999999987642 2468999999999999999999999999999999999999999
Q ss_pred CCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccC
Q 010603 250 GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSL 329 (506)
Q Consensus 250 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (506)
+++||+|||+|+.......
T Consensus 195 ~~~Ki~DFGla~~~~~~~~------------------------------------------------------------- 213 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDY------------------------------------------------------------- 213 (329)
T ss_dssp TEEEECCCC-----------------------------------------------------------------------
T ss_pred CcEEEcccccceeccCCCc-------------------------------------------------------------
Confidence 9999999999964211100
Q ss_pred CCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCC
Q 010603 330 TNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLK 408 (506)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 408 (506)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+.... .
T Consensus 214 --------------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~ 278 (329)
T 4aoj_A 214 --------------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-E 278 (329)
T ss_dssp --------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-C
T ss_pred --------------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-C
Confidence 001123479999999999999999999999999999999998 999999988888777776432 2
Q ss_pred CCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 409 FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 409 ~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+.+..+++++.+||.+||+.||++||+ ++||++
T Consensus 279 ~~~p~~~~~~~~~li~~cl~~dP~~RPs----~~ei~~ 312 (329)
T 4aoj_A 279 LERPRACPPEVYAIMRGCWQREPQQRHS----IKDVHA 312 (329)
T ss_dssp CCCCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCcChhHCcC----HHHHHH
Confidence 3333479999999999999999999998 778876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=461.34 Aligned_cols=277 Identities=35% Similarity=0.715 Sum_probs=245.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45678999999999999999999999999999999998866554556677889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999875 5799999999999999999999999999999999999999999999999999853110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
..
T Consensus 159 ------------------------------------------------------------------------------~~ 160 (318)
T 1fot_A 159 ------------------------------------------------------------------------------VT 160 (318)
T ss_dssp ------------------------------------------------------------------------------CB
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..++.....+|. .++.++++||.+||
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL 238 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLI 238 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHT
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHh
Confidence 2347999999999999999999999999999999999999999998888888888888777775 68999999999999
Q ss_pred hcCCCCccCCC-CChHHhhcCCCCCCCCcchhcc--CCCCCCCC
Q 010603 428 VKDPQKRLGFK-RGATEIKQHPFFESVNWALIRS--THPPEIPK 468 (506)
Q Consensus 428 ~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~--~~~~~~p~ 468 (506)
..||.+||+.. .+++++++||||+.++|..+.. ..+|..|.
T Consensus 239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~ 282 (318)
T 1fot_A 239 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282 (318)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred ccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCC
Confidence 99999999532 2599999999999999987633 34555554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=463.01 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=219.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF 180 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 180 (506)
.++...+++++++||+|+||+||+|++. .+++.||||+++... .....+++.+|+.+|+.|+|||||++++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 4567788999999999999999999864 457899999997543 223456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV 246 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl 246 (506)
.+++.+|||||||++|+|.+++..+. ...+++..+..|+.||+.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 99999999999999999999986532 2468999999999999999999999999999999999999
Q ss_pred ecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccc
Q 010603 247 REDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEK 326 (506)
Q Consensus 247 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (506)
++++++||+|||+|+.......
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~---------------------------------------------------------- 200 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADY---------------------------------------------------------- 200 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGC----------------------------------------------------------
T ss_pred CCCCCEEECCcccceeccCCCc----------------------------------------------------------
Confidence 9999999999999964321100
Q ss_pred ccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCC
Q 010603 327 TSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQ 405 (506)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 405 (506)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+
T Consensus 201 -----------------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 201 -----------------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp -----------------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred -----------------eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 001223479999999999999999999999999999999998 89999999888887777654
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 406 ~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
. ..|.+..+++++.+||.+||+.||++||+ +.||+++
T Consensus 264 ~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs----~~ei~~~ 300 (308)
T 4gt4_A 264 Q-VLPCPDDCPAWVYALMIECWNEFPSRRPR----FKDIHSR 300 (308)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred C-CCCCcccchHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 3 33444579999999999999999999998 6777653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=466.73 Aligned_cols=277 Identities=38% Similarity=0.755 Sum_probs=238.8
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 185 (506)
.+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|+.+ +||||+++++++++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678899999999999999999999999999999999886554455566778899999876 99999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999998875 5799999999999999999999999999999999999999999999999999853110
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. ..
T Consensus 171 ~-----------------------------------------------------------------------------~~ 173 (345)
T 1xjd_A 171 G-----------------------------------------------------------------------------DA 173 (345)
T ss_dssp T-----------------------------------------------------------------------------TC
T ss_pred C-----------------------------------------------------------------------------CC
Confidence 0 01
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++++||.+
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~ 251 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVK 251 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHH
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--ccCHHHHHHHHH
Confidence 123458999999999999999999999999999999999999999998888888888877777765 589999999999
Q ss_pred HhhcCCCCccCCCCChH-HhhcCCCCCCCCcchhc--cCCCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGAT-EIKQHPFFESVNWALIR--STHPPEIPK 468 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~-ell~hp~f~~~~~~~~~--~~~~~~~p~ 468 (506)
||..||.+||+ +. ++++||||+.++|..+. ...||..|.
T Consensus 252 lL~~dp~~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~ 293 (345)
T 1xjd_A 252 LFVREPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPK 293 (345)
T ss_dssp HSCSSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC-----
T ss_pred HhcCCHhHcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcCCC
Confidence 99999999998 44 99999999999998763 345555554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=461.41 Aligned_cols=278 Identities=37% Similarity=0.685 Sum_probs=247.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
...+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678899999999999999999999999999999999887655556677788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
||||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999999875 5799999999999999999999999999999999999999999999999999854210
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.
T Consensus 194 -------------------------------------------------------------------------------~ 194 (350)
T 1rdq_E 194 -------------------------------------------------------------------------------R 194 (350)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||.+|
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~l 272 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNL 272 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHH
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHH
Confidence 12347999999999999999999999999999999999999999998888888888887777775 6899999999999
Q ss_pred hhcCCCCccCC-CCChHHhhcCCCCCCCCcchhc--cCCCCCCCC
Q 010603 427 LVKDPQKRLGF-KRGATEIKQHPFFESVNWALIR--STHPPEIPK 468 (506)
Q Consensus 427 L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~ 468 (506)
|+.||.+||+. ..+++++++||||+.++|..+. ...||.+|.
T Consensus 273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~ 317 (350)
T 1rdq_E 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCC
Confidence 99999999973 3458999999999999998653 345666665
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=474.30 Aligned_cols=282 Identities=37% Similarity=0.741 Sum_probs=238.6
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 185 (506)
.+.+++|+++++||+|+||+||+|+++.+++.||||++++...........+..|+.+|+.+ +|||||+++++|++.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 35677899999999999999999999999999999999987665555566678899999876 89999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||.||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999998875 5799999999999999999999999999999999999999999999999999853100
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
...
T Consensus 206 -----------------------------------------------------------------------------~~~ 208 (396)
T 4dc2_A 206 -----------------------------------------------------------------------------PGD 208 (396)
T ss_dssp -----------------------------------------------------------------------------TTC
T ss_pred -----------------------------------------------------------------------------CCC
Confidence 001
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC---------cHHHHHHHhCCCCCCCCCCCCC
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG---------NRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~---------~~~~~~~i~~~~~~~p~~~~~s 416 (506)
.....+||+.|+|||++.+..|+.++|||||||+||||++|++||.... .......+....+.+|. .++
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 286 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 286 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSC
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCC
Confidence 1234589999999999999999999999999999999999999996432 22344566667777776 699
Q ss_pred HHHHHHHHHHhhcCCCCccCCC--CChHHhhcCCCCCCCCcchhc--cCCCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFK--RGATEIKQHPFFESVNWALIR--STHPPEIPKP 469 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~--~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~ 469 (506)
.++++||.+||+.||.+||+.. ..++||++||||+.++|..+. ...||..|..
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~ 343 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 343 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCC
Confidence 9999999999999999999842 236899999999999998764 3356666653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-58 Score=467.45 Aligned_cols=282 Identities=35% Similarity=0.690 Sum_probs=246.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 185 (506)
.+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..+ +||||++++++|++.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 46678899999999999999999999999999999999887655555667788899999987 89999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999998875 5799999999999999999999999999999999999999999999999999853110
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. ..
T Consensus 174 ~-----------------------------------------------------------------------------~~ 176 (353)
T 2i0e_A 174 D-----------------------------------------------------------------------------GV 176 (353)
T ss_dssp T-----------------------------------------------------------------------------TC
T ss_pred C-----------------------------------------------------------------------------Cc
Confidence 0 01
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+....+.+|. .++.++++||.+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~ 254 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKG 254 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHH
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHH
Confidence 123457999999999999999999999999999999999999999999888888888888777775 699999999999
Q ss_pred HhhcCCCCccCCC-CChHHhhcCCCCCCCCcchh--ccCCCCCCCCC
Q 010603 426 LLVKDPQKRLGFK-RGATEIKQHPFFESVNWALI--RSTHPPEIPKP 469 (506)
Q Consensus 426 ~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~--~~~~~~~~p~~ 469 (506)
||..||.+||+.. .+++++++||||+.++|..+ +...||..|..
T Consensus 255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 255 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp HTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCC
Confidence 9999999999752 35899999999999999876 34456666654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=473.48 Aligned_cols=281 Identities=33% Similarity=0.652 Sum_probs=242.5
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34567889999999999999999999999999999999987554444444557789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999998763 699999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.. ..
T Consensus 221 ~~----------------------------------------------------------------------------~~ 224 (410)
T 3v8s_A 221 EG----------------------------------------------------------------------------MV 224 (410)
T ss_dssp TS----------------------------------------------------------------------------EE
T ss_pred CC----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred CccccccCCCCccchhhcCCC----CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCCCCCCHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDG----HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEGSSISFAA 419 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~s~~~ 419 (506)
.....+||+.|||||++.+.. |+.++|||||||+||||++|++||.+.+..+.+.+++.. .+.+|....++.++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 122357999999999998765 789999999999999999999999999988888888764 35667666899999
Q ss_pred HHHHHHHhhcCCCC--ccCCCCChHHhhcCCCCCCCCcch--hccCCCCCCCCC
Q 010603 420 KDLIRGLLVKDPQK--RLGFKRGATEIKQHPFFESVNWAL--IRSTHPPEIPKP 469 (506)
Q Consensus 420 ~~li~~~L~~dP~~--R~s~~~~a~ell~hp~f~~~~~~~--~~~~~~~~~p~~ 469 (506)
++||.+||..+|.+ |++ ++||++||||+.++|.. .+...||.+|..
T Consensus 305 ~~li~~lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~ 354 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 354 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCC
T ss_pred HHHHHHHccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcC
Confidence 99999999988888 876 99999999999999864 455667777753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=468.10 Aligned_cols=280 Identities=38% Similarity=0.682 Sum_probs=237.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHH-HHhcCCCCccceeEEEEeCCeE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI-LSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~ 186 (506)
+..++|++++.||+|+||+||+|+++.+++.||||++++...........+..|+.+ ++.++|||||+++++|++.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 556789999999999999999999999999999999998765555555666778777 5778999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||||||.||+|.+++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++.....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999998875 57999999999999999999999999999999999999999999999999998531100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
...
T Consensus 193 -----------------------------------------------------------------------------~~~ 195 (373)
T 2r5t_A 193 -----------------------------------------------------------------------------NST 195 (373)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred -----------------------------------------------------------------------------CCc
Confidence 011
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..++.....++. .++.++++||.+|
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~l 273 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGL 273 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--SSCHHHHHHHHHH
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHHHH
Confidence 23458999999999999999999999999999999999999999998888888888888777765 6999999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCCCcchh--ccCCCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESVNWALI--RSTHPPEIPK 468 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~--~~~~~~~~p~ 468 (506)
|+.||.+||+....+.++++||||+.++|..+ +...||..|.
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~ 317 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPN 317 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred cccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCC
Confidence 99999999997767899999999999999866 3345666664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=460.20 Aligned_cols=281 Identities=37% Similarity=0.737 Sum_probs=240.6
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 185 (506)
.+.+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|+.+ +|||||+++++|.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35678899999999999999999999999999999999987666566677788999999987 89999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+||||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++....
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999998875 5799999999999999999999999999999999999999999999999999853110
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. ..
T Consensus 163 ~-----------------------------------------------------------------------------~~ 165 (345)
T 3a8x_A 163 P-----------------------------------------------------------------------------GD 165 (345)
T ss_dssp T-----------------------------------------------------------------------------TC
T ss_pred C-----------------------------------------------------------------------------CC
Confidence 0 01
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC---------CcHHHHHHHhCCCCCCCCCCCCC
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN---------GNRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~~~s 416 (506)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||... ........+......+|. .++
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 243 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 243 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSC
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCC
Confidence 122457999999999999999999999999999999999999999752 223344556666666665 689
Q ss_pred HHHHHHHHHHhhcCCCCccCCC--CChHHhhcCCCCCCCCcchhc--cCCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFK--RGATEIKQHPFFESVNWALIR--STHPPEIPK 468 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~--~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~ 468 (506)
.++++||.+||..||.+||+.. ..++|+++||||+.++|..+. ...||..|.
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~ 299 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 299 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999999999842 235899999999999998763 334555554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=477.17 Aligned_cols=283 Identities=34% Similarity=0.633 Sum_probs=243.5
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 34567889999999999999999999999999999999987554444444457889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||+||+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 99999999999999999763 35799999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.. ..
T Consensus 228 ~~----------------------------------------------------------------------------~~ 231 (437)
T 4aw2_A 228 DG----------------------------------------------------------------------------TV 231 (437)
T ss_dssp TS----------------------------------------------------------------------------CE
T ss_pred CC----------------------------------------------------------------------------Cc
Confidence 00 00
Q ss_pred CccccccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCCC-CCCCH
Q 010603 346 RSMSFVGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPEG-SSISF 417 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~-~~~s~ 417 (506)
.....+||+.|||||++. ...|+.++|||||||+||||++|++||.+.+..+.+.+++.. .+.+|.. ..+++
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 311 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCH
Confidence 112347999999999997 456899999999999999999999999999888888888753 2445543 46899
Q ss_pred HHHHHHHHHhhcCCCC--ccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCC
Q 010603 418 AAKDLIRGLLVKDPQK--RLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~--R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~ 469 (506)
++++||.+||..+|++ |++ ++|+++||||++++|..++...||.+|..
T Consensus 312 ~~~dLi~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~ 361 (437)
T 4aw2_A 312 NAKDLIRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEV 361 (437)
T ss_dssp HHHHHHHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCC
T ss_pred HHHHHHHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcC
Confidence 9999999999988877 776 89999999999999998887777777753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-58 Score=465.92 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=218.2
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccC-----CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC-CCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-PFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~ 179 (506)
+++..++|++++.||+|+||+||+|.+..+ ++.||||+++.... ....+.+.+|+++|+.++| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 466778899999999999999999998754 36799999976532 2345678899999999965 899999999
Q ss_pred EEe-CCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcE
Q 010603 180 FET-DKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244 (506)
Q Consensus 180 ~~~-~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 244 (506)
+.. .+.+|||||||++|+|.++++... ...+++..+..|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 866 457999999999999999997642 24589999999999999999999999999999999999
Q ss_pred EEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 245 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
||+.++++||+|||+|+.+.....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~-------------------------------------------------------- 240 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPD-------------------------------------------------------- 240 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT--------------------------------------------------------
T ss_pred eeCCCCCEEECcchhhhhcccCCC--------------------------------------------------------
Confidence 999999999999999964321110
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHh
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV 403 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 403 (506)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+.+...+
T Consensus 241 -------------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 241 -------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp -------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred -------------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 011223579999999999999999999999999999999998 999999877666565555
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 404 ~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.....++.+..+++++.+||.+||+.||++||| +.||++|
T Consensus 302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 443344444579999999999999999999998 8899886
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=469.89 Aligned_cols=286 Identities=34% Similarity=0.661 Sum_probs=243.7
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
...+..++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++|||||+++++|++.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 34566788999999999999999999999999999999998765444445556788999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||+||+|.+++.+. +..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++...
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 999999999999999998764 2479999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
... .
T Consensus 214 ~~~----------------------------------------------------------------------------~ 217 (412)
T 2vd5_A 214 ADG----------------------------------------------------------------------------T 217 (412)
T ss_dssp TTS----------------------------------------------------------------------------C
T ss_pred CCC----------------------------------------------------------------------------c
Confidence 100 0
Q ss_pred CCccccccCCCCccchhhc-------CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC--CCCCCC-CCC
Q 010603 345 ARSMSFVGTHEYLAPEIIR-------GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ--PLKFPE-GSS 414 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~-------~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~-~~~ 414 (506)
......+||+.|||||++. +..|+.++|||||||+||||++|+.||.+.+..+.+.+++.. .+.+|. ...
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 297 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence 0112347999999999998 356899999999999999999999999998888888877753 234443 246
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhccCCCCCCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~~~~~~~~p~~ 469 (506)
+++++++||.+||. +|.+|++ +++++|+++||||+.++|+.++...||.+|..
T Consensus 298 ~s~~~~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~ 350 (412)
T 2vd5_A 298 VPEEARDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350 (412)
T ss_dssp CCHHHHHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-
T ss_pred CCHHHHHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcC
Confidence 99999999999999 9999975 24699999999999999998887778877754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=452.57 Aligned_cols=281 Identities=29% Similarity=0.617 Sum_probs=242.1
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..+++.+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|||||+++++|.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 35677889999999999999999999999999999999999887665566677888999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+.+|+|||||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|..+
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999998865 67999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 166 ~~------------------------------------------------------------------------------ 167 (384)
T 4fr4_A 166 PR------------------------------------------------------------------------------ 167 (384)
T ss_dssp CT------------------------------------------------------------------------------
T ss_pred cC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCCccccccCCCCccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCCCC---cHHHHHHHhCCCCCCCCCCCCCH
Q 010603 344 SARSMSFVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNG---NRETLFNVVGQPLKFPEGSSISF 417 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DiWSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~s~ 417 (506)
.......+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.... ..+.+..+......+|. .++.
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~--~~s~ 245 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--AWSQ 245 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT--TSCH
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC--cCCH
Confidence 011224579999999999974 458999999999999999999999997533 33444555555556665 6899
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhc--cCCCCCCCCC
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIR--STHPPEIPKP 469 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~ 469 (506)
++.+||.+||..||.+||+ .++++++||||+.++|..+. ...|+.+|..
T Consensus 246 ~~~~li~~lL~~dP~~R~s---~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~ 296 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK 296 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCC---SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred HHHHHHHHHhcCCHhHhcc---cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence 9999999999999999997 48999999999999998653 3456666653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=487.93 Aligned_cols=284 Identities=35% Similarity=0.682 Sum_probs=248.7
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
..+.+++|++++.||+|+||+||+|+++.+++.||||++++...........+..|+.+|..+ +||||+.++++|++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 456788999999999999999999999999999999999987655556667788899999987 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+||||||+.||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999876 579999999999999999999999999999999999999999999999999985311
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.. .
T Consensus 494 ~~-----------------------------------------------------------------------------~ 496 (674)
T 3pfq_A 494 WD-----------------------------------------------------------------------------G 496 (674)
T ss_dssp CT-----------------------------------------------------------------------------T
T ss_pred cC-----------------------------------------------------------------------------C
Confidence 00 0
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
.....++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..++...+.+|. .+++++++||.
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~ 574 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICK 574 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT--TSCHHHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHH
Confidence 1123458999999999999999999999999999999999999999999999999999988888876 69999999999
Q ss_pred HHhhcCCCCccCC-CCChHHhhcCCCCCCCCcchhc--cCCCCCCCCCC
Q 010603 425 GLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALIR--STHPPEIPKPV 470 (506)
Q Consensus 425 ~~L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~~ 470 (506)
+||..||.+||+. ...++||++||||+.++|..+. ...||..|...
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 9999999999985 2346999999999999998764 34566666543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-55 Score=441.00 Aligned_cols=262 Identities=30% Similarity=0.505 Sum_probs=232.8
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
....+++|++++.||+|+||+||+|++..+|+.||||++.+.... .....++.+|+++|+.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 345678899999999999999999999999999999999875433 3455678899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999998776 5799999999999999999999999999999999999999999999999999853211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. .
T Consensus 167 ~------------------------------------------------------------------------------~ 168 (328)
T 3fe3_A 167 G------------------------------------------------------------------------------G 168 (328)
T ss_dssp S------------------------------------------------------------------------------C
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred CccccccCCCCccchhhcCCCCC-cchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHG-SAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~-~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
.....+||+.|+|||++.+..+. .++|||||||+||||++|+.||.+.+..+....+......+|. .+++++.+||.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~ 246 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLK 246 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 12234799999999999988874 7999999999999999999999999888888888877777765 58999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+||..||.+||| ++|+++||||+...
T Consensus 247 ~~L~~dP~~R~t----~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 247 RFLVLNPIKRGT----LEQIMKDRWINAGH 272 (328)
T ss_dssp HHCCSSTTTSCC----HHHHTTCTTTTTTC
T ss_pred HHCCCChhHCcC----HHHHhcCHhhcCCC
Confidence 999999999997 99999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=468.09 Aligned_cols=285 Identities=33% Similarity=0.644 Sum_probs=246.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||+++++|++.+.
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 34677899999999999999999999999999999999988766555666778899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~--~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+|||||||+||+|..++.... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999999999987643 357999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 340 ~~~----------------------------------------------------------------------------- 342 (543)
T 3c4z_A 340 KAG----------------------------------------------------------------------------- 342 (543)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC----cHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG----NRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.. ..+....+......+|. .++..+
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~ 420 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPAS 420 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHHH
Confidence 001123479999999999999999999999999999999999999998753 34555666666666664 699999
Q ss_pred HHHHHHHhhcCCCCccCCCC-ChHHhhcCCCCCCCCcchhcc--CCCCCCCCC
Q 010603 420 KDLIRGLLVKDPQKRLGFKR-GATEIKQHPFFESVNWALIRS--THPPEIPKP 469 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~-~a~ell~hp~f~~~~~~~~~~--~~~~~~p~~ 469 (506)
++||.+||..||.+||++.. +++++++||||+.++|..+.. ..||.+|.+
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence 99999999999999998743 589999999999999987643 456666654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=462.15 Aligned_cols=282 Identities=38% Similarity=0.716 Sum_probs=234.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++||||+++++++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 45667889999999999999999999999999999999987655555566677889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++.+||+|||+|+...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999998775 579999999999999999999998 999999999999999999999999999984311
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.. .
T Consensus 301 ~~-----------------------------------------------------------------------------~ 303 (446)
T 4ejn_A 301 KD-----------------------------------------------------------------------------G 303 (446)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CC-----------------------------------------------------------------------------C
Confidence 00 0
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|. .+++++.+||.
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~ 381 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLS 381 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHH
Confidence 0122357999999999999999999999999999999999999999998888888888877777775 68999999999
Q ss_pred HHhhcCCCCccCC-CCChHHhhcCCCCCCCCcchhcc--CCCCCCCC
Q 010603 425 GLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALIRS--THPPEIPK 468 (506)
Q Consensus 425 ~~L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~~--~~~~~~p~ 468 (506)
+||..||.+||+. .++++|+++||||+.++|..+.. ..||..|.
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~ 428 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQ 428 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCC
Confidence 9999999999932 23499999999999999986533 34444443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-55 Score=439.12 Aligned_cols=280 Identities=37% Similarity=0.711 Sum_probs=232.6
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhh-chhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLA-GRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
.+..++|++++.||+|+||+||+|++. .+|+.||||++++.... .......+.+|+.+|+.++|||||++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 455678999999999999999999985 67999999999875432 22344557789999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.+.+|||||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999998875 5799999999999999999999999999999999999999999999999999843
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 171 ~~~~---------------------------------------------------------------------------- 174 (327)
T 3a62_A 171 SIHD---------------------------------------------------------------------------- 174 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccC----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++++|
T Consensus 175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l 251 (327)
T 3a62_A 175 -GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP--YLTQEARDL 251 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHH
T ss_pred -CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHH
Confidence 00112347999999999999999999999999999999999999999998888888888877777665 689999999
Q ss_pred HHHHhhcCCCCccCCC-CChHHhhcCCCCCCCCcchhcc--CCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIRS--THPPEIP 467 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~--~~~~~~p 467 (506)
|.+||..||.+||+.. +++.|+++||||+.++|..+.. ..||..|
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p 299 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKP 299 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCC
Confidence 9999999999999754 3699999999999999986533 3344444
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-55 Score=467.22 Aligned_cols=285 Identities=34% Similarity=0.587 Sum_probs=244.7
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
...+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||++++++++.+
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 34577788999999999999999999999999999999998876555556677889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987655669999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 338 ~~------------------------------------------------------------------------------ 339 (576)
T 2acx_A 338 EG------------------------------------------------------------------------------ 339 (576)
T ss_dssp TT------------------------------------------------------------------------------
T ss_pred cC------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+... .+....+...+..++. .++++++
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~--~~s~~~~ 417 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE--RFSPQAR 417 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc--cCCHHHH
Confidence 011234799999999999999999999999999999999999999987542 3344455555555654 6999999
Q ss_pred HHHHHHhhcCCCCccCCC-CChHHhhcCCCCCCCCcchhcc--CCCCCCCCC
Q 010603 421 DLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIRS--THPPEIPKP 469 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~--~~~~~~p~~ 469 (506)
+||.+||..||.+||+.. .+++|+++||||+.++|..+.. ..||..|.+
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~ 469 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence 999999999999999643 2589999999999999987643 456666654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=441.69 Aligned_cols=265 Identities=31% Similarity=0.466 Sum_probs=233.4
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---KKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..++|++++.||+|+||+||+|+++.+|+.||||++.+...... .....+.+|+.+|+.++|||||+++++|++.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 44679999999999999999999999999999999987643321 134667889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC----CEEEeecCCcc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG----HIMLSDFDLSL 261 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFGla~ 261 (506)
+|||||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999998764 6799999999999999999999999999999999999998877 79999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 168 ~~~~~--------------------------------------------------------------------------- 172 (361)
T 2yab_A 168 EIEDG--------------------------------------------------------------------------- 172 (361)
T ss_dssp ECCTT---------------------------------------------------------------------------
T ss_pred EcCCC---------------------------------------------------------------------------
Confidence 42110
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAA 419 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~ 419 (506)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......++. +..++..+
T Consensus 173 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 249 (361)
T 2yab_A 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249 (361)
T ss_dssp ---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHH
T ss_pred ---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 0012347999999999999999999999999999999999999999999988888888877666653 24689999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
++||.+||..||.+||+ +.|+|+||||+.++|..
T Consensus 250 ~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 250 KDFIRKLLVKETRKRLT----IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHHHHHSCSSTTTSCC----HHHHHTSTTTSCSSHHH
T ss_pred HHHHHHHCCCChhHCcC----HHHHhcCcCcCCCchhh
Confidence 99999999999999997 99999999999988853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=430.58 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=191.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC----eE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----FS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~ 186 (506)
++|.+.++||+|+||+||+|+++ |+.||||+++... ......+.|+.++..++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 46999999999999999999884 8999999997642 11122234555567889999999999998654 68
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEccCCCCcEEEecCCCEEEeecC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM--------GVVYRDLKPENVLVREDGHIMLSDFD 258 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~--------giiHrDLKp~NILl~~~~~vkl~DFG 258 (506)
|||||||++|+|.++++.. .++++.+..++.||+.||+|||++ +||||||||+||||+.++++||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999999864 689999999999999999999987 99999999999999999999999999
Q ss_pred CccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccc
Q 010603 259 LSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVL 338 (506)
Q Consensus 259 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (506)
+|+.........
T Consensus 154 la~~~~~~~~~~-------------------------------------------------------------------- 165 (303)
T 3hmm_A 154 LAVRHDSATDTI-------------------------------------------------------------------- 165 (303)
T ss_dssp TCEEEETTTTEE--------------------------------------------------------------------
T ss_pred CCccccCCCCce--------------------------------------------------------------------
Confidence 996532111000
Q ss_pred ccCCCCCCccccccCCCCccchhhcCC------CCCcchhHHHHHHHHHHHhcCCCCCCCCC--------------cHHH
Q 010603 339 IAEPTSARSMSFVGTHEYLAPEIIRGD------GHGSAVDWWTFGIFFYELLLGRTPFKGNG--------------NRET 398 (506)
Q Consensus 339 ~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~~~~~DiWSlGvil~elltG~~Pf~~~~--------------~~~~ 398 (506)
.......+||+.|||||++.+. .|+.++|||||||+||||+||.+||.... ..+.
T Consensus 166 -----~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 166 -----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp -----SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred -----eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 0012235899999999999765 36789999999999999999987663221 1233
Q ss_pred HHH-HhCCCCC--CCCC---CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 399 LFN-VVGQPLK--FPEG---SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 399 ~~~-i~~~~~~--~p~~---~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.. +...... +|.. ......+.+||.+||+.||++||| +.||++
T Consensus 241 ~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~ 290 (303)
T 3hmm_A 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred HHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 333 3333322 2221 112346889999999999999998 777765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=438.42 Aligned_cols=273 Identities=23% Similarity=0.352 Sum_probs=223.1
Q ss_pred ccCCeEEEeEEeec--CceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 109 GLGHFRLLKKLGCG--DIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 109 ~~~~y~i~~~LG~G--~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
..++|++++.||+| +||+||+|+++.+|+.||||++.+.... ......+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34679999999999 9999999999999999999999876433 34566788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||||||++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999999998876678999999999999999999999999999999999999999999999999998543211
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..... .....
T Consensus 182 ~~~~~----------------------------------------------------------------------~~~~~ 191 (389)
T 3gni_B 182 GQRQR----------------------------------------------------------------------VVHDF 191 (389)
T ss_dssp TEECS----------------------------------------------------------------------CBCCC
T ss_pred ccccc----------------------------------------------------------------------ccccc
Confidence 10000 00001
Q ss_pred ccccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC----------------
Q 010603 347 SMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK---------------- 408 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 408 (506)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..++.....
T Consensus 192 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (389)
T 3gni_B 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMS 271 (389)
T ss_dssp CTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------
T ss_pred cccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccc
Confidence 122379999999999988 57999999999999999999999999887665555443322110
Q ss_pred ----------------------------CCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 409 ----------------------------FPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 409 ----------------------------~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.+....+++++++||.+||+.||.+||+ ++|+|+||||+.+.|.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 272 PSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRR 343 (389)
T ss_dssp ----------------------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---
T ss_pred ccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhc
Confidence 1122357889999999999999999998 9999999999988764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=421.05 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=223.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4679999999999999999999999999999999976542 2345577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc---
Confidence 9999999999998874 6999999999999999999999999999999999999999999999999998542110
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (297)
T 3fxz_A 170 --------------------------------------------------------------------------QSKRST 175 (297)
T ss_dssp --------------------------------------------------------------------------TCCBCC
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 001123
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG-QPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......+..+.. ....+.....++..+.+||.+||.
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 255 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSC
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHcc
Confidence 4799999999999999999999999999999999999999998887766655542 233333345789999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.||.+||+ ++|+++||||+..
T Consensus 256 ~dp~~Rps----~~ell~h~~~~~~ 276 (297)
T 3fxz_A 256 MDVEKRGS----AKELLQHQFLKIA 276 (297)
T ss_dssp SSTTTSCC----HHHHTTCGGGGGC
T ss_pred CChhHCcC----HHHHhhChhhccc
Confidence 99999997 9999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=440.57 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=226.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|.++.+|+.||+|++.+.... ......+.+|+++|+.++|||||++++++.+.+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45699999999999999999999999999999999876543 23456678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe---cCCCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~---~~~~vkl~DFGla~~~~~~ 266 (506)
||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999988876 6799999999999999999999999999999999999998 4578999999998532110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
...
T Consensus 167 -----------------------------------------------------------------------------~~~ 169 (444)
T 3soa_A 167 -----------------------------------------------------------------------------QQA 169 (444)
T ss_dssp -----------------------------------------------------------------------------CCB
T ss_pred -----------------------------------------------------------------------------Cce
Confidence 001
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~ 424 (506)
....+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+.+..+......++. +..+++++++||.
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 249 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 12347999999999999999999999999999999999999999999888888888777665543 3578999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+||..||.+||+ +.|+|+||||+.
T Consensus 250 ~~L~~dP~~Rpt----a~e~L~hp~~~~ 273 (444)
T 3soa_A 250 KMLTINPSKRIT----AAEALKHPWISH 273 (444)
T ss_dssp HHSCSSTTTSCC----HHHHHHSCTTHH
T ss_pred HHcCCChhHCCC----HHHHhcCccccC
Confidence 999999999997 999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=423.15 Aligned_cols=264 Identities=30% Similarity=0.469 Sum_probs=229.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---KKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.++|++++.||+|+||+||+|.++.+|+.||||++.+...... .....+.+|+.+|+.++|||||++++++...+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3569999999999999999999999999999999987543221 2356678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC----CEEEeecCCccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG----HIMLSDFDLSLR 262 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFGla~~ 262 (506)
|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999998764 6799999999999999999999999999999999999999887 899999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 168 ~~~~~--------------------------------------------------------------------------- 172 (326)
T 2y0a_A 168 IDFGN--------------------------------------------------------------------------- 172 (326)
T ss_dssp CCTTS---------------------------------------------------------------------------
T ss_pred CCCCC---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAK 420 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~ 420 (506)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....+.+..+......++. ...++..++
T Consensus 173 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (326)
T 2y0a_A 173 ---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249 (326)
T ss_dssp ---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred ---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence 011236999999999999999999999999999999999999999998888877777655544442 146899999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
+||.+||..||.+||+ +.|+|+||||+..+|..
T Consensus 250 ~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 250 DFIRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp HHHHHHSCSSGGGSCC----HHHHHHSTTTSCCSHHH
T ss_pred HHHHHHccCChhhCCC----HHHHhcCCCccCCcchh
Confidence 9999999999999997 99999999999888754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=430.84 Aligned_cols=258 Identities=31% Similarity=0.514 Sum_probs=222.4
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
..+++|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999998765544444567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+ +|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 999999 88999988765 57999999999999999999999999999999999999999999999999998432100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 162 -----------------------------------------------------------------------------~~~ 164 (336)
T 3h4j_B 162 -----------------------------------------------------------------------------NFL 164 (336)
T ss_dssp -----------------------------------------------------------------------------BTT
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
...+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+....+.+..+......+|. .+++++.+||.+|
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~ 242 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD--FLSPGAQSLIRRM 242 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCT--TSCHHHHHHHHTT
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcc--cCCHHHHHHHHHH
Confidence 23479999999999998876 78999999999999999999999876655443333333334443 6899999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|..||.+||| ++|+++||||+.
T Consensus 243 L~~dP~~Rpt----~~eil~hp~~~~ 264 (336)
T 3h4j_B 243 IVADPMQRIT----IQEIRRDPWFNV 264 (336)
T ss_dssp SCSSGGGSCC----HHHHTTCHHHHT
T ss_pred cCCChhHCcC----HHHHHhChhhcc
Confidence 9999999997 999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=424.43 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=226.7
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|.++.+++.||+|++.... .....+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 467999999999999999999999999999999997542 3345578899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec--CCCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE--DGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~vkl~DFGla~~~~~~~ 267 (506)
||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999998754 347999999999999999999999999999999999999997 789999999998542110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 158 -----------------------------------------------------------------------------~~~ 160 (321)
T 1tki_A 158 -----------------------------------------------------------------------------DNF 160 (321)
T ss_dssp -----------------------------------------------------------------------------CEE
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~~ 425 (506)
...+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+..+.+..+......++. ...++.++++||.+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 240 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHH
Confidence 2347999999999999988999999999999999999999999999888888888877665543 24689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||..||.+||+ +.|+|+||||+..
T Consensus 241 ~L~~dp~~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 241 LLVKERKSRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp TSCSSGGGSCC----HHHHHHSHHHHSC
T ss_pred HcCCChhHCcC----HHHHhcChhhccC
Confidence 99999999997 9999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=416.98 Aligned_cols=260 Identities=33% Similarity=0.537 Sum_probs=219.6
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc-----------------------hhHHHHHHHHHHH
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-----------------------RKKLMRAQTEREI 164 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~i 164 (506)
+.+++|++++.||+|+||+||+|+++.+++.||||++.+..... ......+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45678999999999999999999999999999999998654321 1123567889999
Q ss_pred HHhcCCCCccceeEEEEe--CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCC
Q 010603 165 LSLLDHPFLPTLYSHFET--DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPE 242 (506)
Q Consensus 165 l~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~ 242 (506)
|+.++||||+++++++.+ .+.+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999987 5689999999999999886543 57999999999999999999999999999999999
Q ss_pred cEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccc
Q 010603 243 NVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKV 322 (506)
Q Consensus 243 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (506)
|||++.++.+||+|||+++......
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------------- 191 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD------------------------------------------------------- 191 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-------------------------------------------------------
T ss_pred HEEECCCCCEEEecCCCcccccccc-------------------------------------------------------
Confidence 9999999999999999985421100
Q ss_pred ccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCC---CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHH
Q 010603 323 KSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399 (506)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~ 399 (506)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.......
T Consensus 192 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 192 ----------------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ----------------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 0011236999999999998765 378899999999999999999999988877777
Q ss_pred HHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 400 ~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
..+......++....+++++.+||.+||..||.+||+ +.|+++||||+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHH
T ss_pred HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhcCcccc
Confidence 7777677777766689999999999999999999997 99999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=441.17 Aligned_cols=263 Identities=29% Similarity=0.477 Sum_probs=234.4
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..+.+.+++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35667889999999999999999999999999999999999876555445567788999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999999998764 67999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 167 ~~~----------------------------------------------------------------------------- 169 (476)
T 2y94_A 167 SDG----------------------------------------------------------------------------- 169 (476)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CCCccccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
......+||+.|+|||++.+..| +.++|||||||+||||++|+.||.+.+..+.+..+.......|. .+++++.+|
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~L 246 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ--YLNPSVISL 246 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT--TCCHHHHHH
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc--cCCHHHHHH
Confidence 00123479999999999998876 78999999999999999999999998888888888877666654 689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.+||..||.+||+ +.|+++||||+.
T Consensus 247 i~~~L~~dP~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 247 LKHMLQVDPMKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHTCSSTTTSCC----HHHHHTCHHHHT
T ss_pred HHHHcCCCchhCcC----HHHHHhCHHhhh
Confidence 99999999999997 999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=411.29 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=213.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|+++.+++.||||++..... .......+.+|+.+|+.++||||+++++++.+++.+|||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4679999999999999999999999999999999986543 234456678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 154 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--- 154 (292)
T ss_dssp EECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC---
T ss_pred EecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc---
Confidence 999965 665555443 367999999999999999999999999999999999999999999999999998542100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (292)
T 3o0g_A 155 --------------------------------------------------------------------------VRCYSA 160 (292)
T ss_dssp --------------------------------------------------------------------------CSCCCS
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000122
Q ss_pred cccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCC-CCCCCcHHHHHHHhC---CCCC--C-------------
Q 010603 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTP-FKGNGNRETLFNVVG---QPLK--F------------- 409 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~P-f~~~~~~~~~~~i~~---~~~~--~------------- 409 (506)
.+||+.|+|||++.+.. |+.++|||||||++|||++|..| |.+.+..+.+..+.. .+.. +
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 36899999999998766 89999999999999999988877 455555555544432 1100 0
Q ss_pred ---------CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 410 ---------PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 410 ---------p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.....++.++++||.+||+.||++||| ++|+|+||||+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTC
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCcccccC
Confidence 001247899999999999999999997 9999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=428.05 Aligned_cols=258 Identities=26% Similarity=0.496 Sum_probs=226.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.... ......+.+|+++|+.++|||||++++++.+.+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45699999999999999999999999999999999875443 34456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFGla~~~~~~ 266 (506)
||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999988765 5799999999999999999999999999999999999998654 5999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 185 ------------------------------------------------------------------------------~~ 186 (362)
T 2bdw_A 185 ------------------------------------------------------------------------------EA 186 (362)
T ss_dssp ------------------------------------------------------------------------------CS
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC--CCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~s~~~~~li~ 424 (506)
....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+......++.. ..+++++++||.
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 266 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 123479999999999999999999999999999999999999999988888888887766655542 468999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+||..||.+||+ +.++|+||||..
T Consensus 267 ~~L~~dP~~R~t----~~e~l~hp~~~~ 290 (362)
T 2bdw_A 267 SMLTVNPKKRIT----ADQALKVPWICN 290 (362)
T ss_dssp HHSCSSGGGSCC----HHHHTTSHHHHT
T ss_pred HHcCCChhhCcC----HHHHhcCcccCC
Confidence 999999999997 999999999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=417.44 Aligned_cols=266 Identities=26% Similarity=0.430 Sum_probs=217.0
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
++-..++|++++.||+|+||+||+|++.. |+.||||++...... ......+.+|+++|+.++|||||++++++.+.+.
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 34556789999999999999999999864 899999999765322 3345667889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+|||||. |+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999999996 5888877654 35699999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.. .
T Consensus 172 ~~-----------------------------------------------------------------------------~ 174 (311)
T 3niz_A 172 PV-----------------------------------------------------------------------------R 174 (311)
T ss_dssp CC-----------------------------------------------------------------------------C
T ss_pred Cc-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred CccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCCCC--CC---------
Q 010603 346 RSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQPLK--FP--------- 410 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~--~p--------- 410 (506)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+....+.+..+. +.+.. ++
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 0112368999999999987 468999999999999999999999998877766555443 22110 00
Q ss_pred --------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 411 --------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 411 --------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
....+++++++||.+||+.||.+||| ++|+|+||||++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCTT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCcc
Confidence 01246789999999999999999997 9999999999988753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=411.53 Aligned_cols=260 Identities=33% Similarity=0.565 Sum_probs=230.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+.+++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+++++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35678899999999999999999999999999999999987655545556678899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999999998875 5799999999999999999999999999999999999999999999999998732100
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.
T Consensus 162 -------------------------------------------------------------------------------~ 162 (279)
T 3fdn_A 162 -------------------------------------------------------------------------------S 162 (279)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|. .++..+.+||.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~ 240 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISR 240 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--cCCHHHHHHHHH
Confidence 011236999999999999999999999999999999999999999998888877777766666665 689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||..||.+||+ +.|+++||||+.
T Consensus 241 ~l~~~p~~Rps----~~e~l~h~~~~~ 263 (279)
T 3fdn_A 241 LLKHNPSQRPM----LREVLEHPWITA 263 (279)
T ss_dssp HCCSSGGGSCC----HHHHHHCHHHHH
T ss_pred HhccChhhCCC----HHHHhhCccccC
Confidence 99999999997 999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=430.30 Aligned_cols=281 Identities=26% Similarity=0.438 Sum_probs=212.7
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCC--
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDK-- 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-- 184 (506)
..+++|++++.||+|+||+||+|.++.+|+.||||++.+.. .......++.+|+.+|+.+. |||||++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34678999999999999999999999999999999997542 22445567788999999997 999999999998654
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||. |+|..++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 7999999996 699998876 479999999999999999999999999999999999999999999999999997542
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
........ . +. ..... ........
T Consensus 161 ~~~~~~~~--~---------------------~~------------------------~~~~~---------~~~~~~~~ 184 (388)
T 3oz6_A 161 NIRRVTNN--I---------------------PL------------------------SINEN---------TENFDDDQ 184 (388)
T ss_dssp SCCCCCCC--G---------------------GG------------------------CCC-------------------
T ss_pred cccccccc--c---------------------cc------------------------ccccc---------cccccccc
Confidence 21110000 0 00 00000 00000011
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC-------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP------------- 410 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------------- 410 (506)
...+..+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+++..++.. +..|
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~ 263 (388)
T 3oz6_A 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV-IDFPSNEDVESIQSPFA 263 (388)
T ss_dssp -----CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHHTSCCSSH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCHHHHHhccCHHH
Confidence 22345689999999999987 57899999999999999999999999998887777665421 1111
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 411 ---------------------------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 411 ---------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
....+++++.+||.+||..||.+||| ++|+|+||||+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 264 KTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTC
T ss_pred HHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhc
Confidence 11257899999999999999999997 99999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=419.63 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=219.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+.+++.++|||||++++++.+.+..|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 57899999999999999999999999999999999754322 2234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 160 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc-
Confidence 9999999999988754 5799999999999999999999999999999999999999999999999999854211100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 161 --------------------------------------------------------------------------~~~~~~ 166 (323)
T 3tki_A 161 --------------------------------------------------------------------------ERLLNK 166 (323)
T ss_dssp --------------------------------------------------------------------------ECCBCS
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 001123
Q ss_pred cccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 350 FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
.+||+.|+|||++.+..+ +.++|||||||+||||++|+.||...... ..+..+.......+....++..+.+||.+||
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 246 (323)
T 3tki_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246 (323)
T ss_dssp CCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred CccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHc
Confidence 479999999999988775 77999999999999999999999876554 3334444444444444578999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..||.+||+ ++|+++||||+..
T Consensus 247 ~~dP~~R~t----~~eil~h~~~~~~ 268 (323)
T 3tki_A 247 VENPSARIT----IPDIKKDRWYNKP 268 (323)
T ss_dssp CSSTTTSCC----HHHHTTCTTTTCC
T ss_pred cCChhhCcC----HHHHhhChhhccc
Confidence 999999997 9999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=426.47 Aligned_cols=265 Identities=28% Similarity=0.450 Sum_probs=222.4
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch--hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR--KKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
..++|++++.||+|+||+||+|.++.+|+.||||++.+...... .....+.+|+.+|+.++|||||++++++...+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34569999999999999999999999999999999976543221 2356678999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC---EEEeecCCcc
Q 010603 187 CLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH---IMLSDFDLSL 261 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFGla~ 261 (506)
|||||||+||+|.+++... .+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999998877543 2346899999999999999999999999999999999999987655 9999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
......
T Consensus 182 ~~~~~~-------------------------------------------------------------------------- 187 (351)
T 3c0i_A 182 QLGESG-------------------------------------------------------------------------- 187 (351)
T ss_dssp ECCTTS--------------------------------------------------------------------------
T ss_pred EecCCC--------------------------------------------------------------------------
Confidence 421100
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAA 419 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~ 419 (506)
......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.. .+.+..+......++. +..++.++
T Consensus 188 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~ 263 (351)
T 3c0i_A 188 ---LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESA 263 (351)
T ss_dssp ---CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred ---eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHH
Confidence 00123479999999999999999999999999999999999999998753 4455555555444332 24689999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
++||.+||..||.+||+ +.|+|+||||+..++
T Consensus 264 ~~li~~~L~~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 264 KDLVRRMLMLDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHHHTCSSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred HHHHHHHCCCChhHCcC----HHHHhcChhhcCCcc
Confidence 99999999999999997 999999999987553
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=423.17 Aligned_cols=262 Identities=29% Similarity=0.391 Sum_probs=221.9
Q ss_pred cccCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-----CCCccc
Q 010603 101 VKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-----HPFLPT 175 (506)
Q Consensus 101 ~~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~ 175 (506)
.....+.+..++|+++++||+|+||+||+|++..+++.||||++... .........|+++|+.+. |||||+
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34566778888999999999999999999999999999999999753 234455677999999986 999999
Q ss_pred eeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-------
Q 010603 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE------- 248 (506)
Q Consensus 176 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~------- 248 (506)
+++++...+..||||||+ +++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 999999998876667999999999999999999999999999999999999975
Q ss_pred ------------------CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCC
Q 010603 249 ------------------DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCF 310 (506)
Q Consensus 249 ------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (506)
++.+||+|||+|.....
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--------------------------------------------- 214 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--------------------------------------------- 214 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---------------------------------------------
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC---------------------------------------------
Confidence 78999999999843100
Q ss_pred CCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 010603 311 KPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF 390 (506)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf 390 (506)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||
T Consensus 215 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 215 -----------------------------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp -----------------------------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred -----------------------------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 011247999999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHHhCCCCCC--------------------------CCCC------------------CCCHHHHHHHHHH
Q 010603 391 KGNGNRETLFNVVGQPLKF--------------------------PEGS------------------SISFAAKDLIRGL 426 (506)
Q Consensus 391 ~~~~~~~~~~~i~~~~~~~--------------------------p~~~------------------~~s~~~~~li~~~ 426 (506)
.+.+..+.+..+......+ |... ..++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 9887766655443211111 1110 1236788999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCC
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
|+.||.+||+ ++|+|+||||+
T Consensus 340 L~~dP~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCC----HHHHTTSGGGC
T ss_pred hcCChhhCCC----HHHHhcCcccC
Confidence 9999999997 99999999995
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=408.11 Aligned_cols=260 Identities=34% Similarity=0.559 Sum_probs=231.0
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 34667889999999999999999999999999999999987655444455678899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999999998875 5799999999999999999999999999999999999999999999999998743110
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.
T Consensus 167 -------------------------------------------------------------------------------~ 167 (284)
T 2vgo_A 167 -------------------------------------------------------------------------------L 167 (284)
T ss_dssp -------------------------------------------------------------------------------S
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......+|. .++.++++||.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~ 245 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--FLSDGSKDLISK 245 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC--cCCHHHHHHHHH
Confidence 011236999999999999999999999999999999999999999988888877778777666664 689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||..||.+||+ +.++++||||+.
T Consensus 246 ~l~~~p~~Rps----~~~ll~h~~~~~ 268 (284)
T 2vgo_A 246 LLRYHPPQRLP----LKGVMEHPWVKA 268 (284)
T ss_dssp HSCSSGGGSCC----HHHHHTCHHHHH
T ss_pred HhhcCHhhCCC----HHHHhhCHHHHh
Confidence 99999999997 999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=420.43 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=214.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
..+++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+++|+.++||||+++++++.+.+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3456799999999999999999999999999999999765322 233455678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe-----cCCCEEEeecCCccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-----EDGHIMLSDFDLSLR 262 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-----~~~~vkl~DFGla~~ 262 (506)
|||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 110 lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999996 5999998876 5699999999999999999999999999999999999995 445599999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 187 ~~~~~--------------------------------------------------------------------------- 191 (329)
T 3gbz_A 187 FGIPI--------------------------------------------------------------------------- 191 (329)
T ss_dssp HC------------------------------------------------------------------------------
T ss_pred cCCcc---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC--CCC------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL--KFP------ 410 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~--~~p------ 410 (506)
......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+....+.+..+... +. .++
T Consensus 192 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
T 3gbz_A 192 --RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence 001223689999999999875 4899999999999999999999999998887777665421 10 000
Q ss_pred CC-----------------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 411 EG-----------------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 411 ~~-----------------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.+ ..+++++++||.+||..||.+||+ ++|+|+||||+..+|+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 00 016789999999999999999997 9999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=437.59 Aligned_cols=293 Identities=26% Similarity=0.390 Sum_probs=205.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-----CC
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-----DK 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~ 184 (506)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. .......++.+|+++|+.++|||||++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 367999999999999999999999999999999997642 234456778899999999999999999999943 35
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+||||||+ +|+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 68999988765 679999999999999999999999999999999999999999999999999996542
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
........ ++. .++ ..... ...........
T Consensus 208 ~~~~~~~~-----------------------~~~------------~~~------------~~~~~---~~~~~~~~~~~ 237 (458)
T 3rp9_A 208 YPENGNSQ-----------------------LPI------------SPR------------EDDMN---LVTFPHTKNLK 237 (458)
T ss_dssp SCTTCCCC-----------------------CC-----------------------------------------------
T ss_pred Cccccccc-----------------------ccc------------Ccc------------ccccc---ccccccccccc
Confidence 21100000 000 000 00000 00000000011
Q ss_pred CCccccccCCCCccchhhc-CCCCCcchhHHHHHHHHHHHhc-----------CCCCCCCCCc-----------------
Q 010603 345 ARSMSFVGTHEYLAPEIIR-GDGHGSAVDWWTFGIFFYELLL-----------GRTPFKGNGN----------------- 395 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiWSlGvil~ellt-----------G~~Pf~~~~~----------------- 395 (506)
...+..+||+.|||||++. +..|+.++||||||||||||++ |+++|.+.+.
T Consensus 238 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~ 317 (458)
T 3rp9_A 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHT 317 (458)
T ss_dssp -------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------C
T ss_pred ccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccc
Confidence 2345678999999999874 5669999999999999999999 7888876541
Q ss_pred ---HHHH---HHHhCCCC-----------------CCC---------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHH
Q 010603 396 ---RETL---FNVVGQPL-----------------KFP---------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATE 443 (506)
Q Consensus 396 ---~~~~---~~i~~~~~-----------------~~p---------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~e 443 (506)
.+++ ..+++.+. .++ ....+++++++||.+||..||.+||| ++|
T Consensus 318 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----~~e 393 (458)
T 3rp9_A 318 RGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INE 393 (458)
T ss_dssp HHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC----HHH
T ss_pred cCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC----HHH
Confidence 1122 12222110 000 11246899999999999999999997 999
Q ss_pred hhcCCCCCCCCcchhcc
Q 010603 444 IKQHPFFESVNWALIRS 460 (506)
Q Consensus 444 ll~hp~f~~~~~~~~~~ 460 (506)
+|+||||+.++|.....
T Consensus 394 ~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 394 CLAHPFFKEVRIAEVET 410 (458)
T ss_dssp HHHSGGGTTTCCGGGCC
T ss_pred HhcCHhhhhcCCCccCC
Confidence 99999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=412.53 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=213.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc--hhHHHHHHHHHHHHHhc---CCCCccceeEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG--RKKLMRAQTEREILSLL---DHPFLPTLYSHF 180 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l---~hpnIv~l~~~~ 180 (506)
+++..++|++++.||+|+||+||+|+++.+++.||||++....... ......+.+|+++++.+ +||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4566788999999999999999999999999999999997543211 11123445677776665 599999999999
Q ss_pred EeCC-----eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEe
Q 010603 181 ETDK-----FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLS 255 (506)
Q Consensus 181 ~~~~-----~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~ 255 (506)
.... .+++||||+. |+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 5899999995 699999988766669999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||+++....
T Consensus 163 Dfg~a~~~~~---------------------------------------------------------------------- 172 (308)
T 3g33_A 163 DFGLARIYSY---------------------------------------------------------------------- 172 (308)
T ss_dssp SCSCTTTSTT----------------------------------------------------------------------
T ss_pred eCccccccCC----------------------------------------------------------------------
Confidence 9999843210
Q ss_pred cccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC--CCC
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL--KFP 410 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~--~~p 410 (506)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+... +. .++
T Consensus 173 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 173 --------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp --------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred --------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 00112347999999999999999999999999999999999999999998887777665421 10 011
Q ss_pred C--------------------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 411 E--------------------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 411 ~--------------------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
. ...+++++.+||.+||+.||.+||+ +.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC---
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCC
Confidence 0 1247899999999999999999997 9999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=424.21 Aligned_cols=256 Identities=28% Similarity=0.461 Sum_probs=214.3
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
..++|++++.||+|+||+||+|+++.+++.||||++.+... ....+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 34679999999999999999999999999999999976532 22456789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC--EEEeecCCccccccC
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH--IMLSDFDLSLRCFVS 266 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--vkl~DFGla~~~~~~ 266 (506)
|||||.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+|+.....
T Consensus 94 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999998765 57999999999999999999999999999999999999987765 999999998421000
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 172 ------------------------------------------------------------------------------~~ 173 (361)
T 3uc3_A 172 ------------------------------------------------------------------------------SQ 173 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred ccccccCCCCccchhhcCCCCCcc-hhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSA-VDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~-~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
....+||+.|+|||++.+..++.+ +|||||||+||+|++|+.||.+... ...+..+......+|....+++++++
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 123479999999999998888655 8999999999999999999987543 34455666677777777789999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||.+||..||.+||+ +.|+++||||..
T Consensus 254 li~~~L~~dP~~Rps----~~ell~hp~f~~ 280 (361)
T 3uc3_A 254 LISRIFVADPATRIS----IPEIKTHSWFLK 280 (361)
T ss_dssp HHHHHSCSCTTTSCC----HHHHHTSHHHHT
T ss_pred HHHHHccCChhHCcC----HHHHHhCcchhc
Confidence 999999999999997 999999999953
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=424.37 Aligned_cols=260 Identities=30% Similarity=0.453 Sum_probs=226.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|.++.+|+.||+|++..... .....+.+|+++|+.++|||||++++++.+...+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999976532 2334678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec--CCCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE--DGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~vkl~DFGla~~~~~~~ 267 (506)
||||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999988754 347999999999999999999999999999999999999974 478999999998542110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 205 -----------------------------------------------------------------------------~~~ 207 (387)
T 1kob_A 205 -----------------------------------------------------------------------------EIV 207 (387)
T ss_dssp -----------------------------------------------------------------------------SCE
T ss_pred -----------------------------------------------------------------------------cce
Confidence 001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~~ 425 (506)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++. ...+++++++||.+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 287 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHH
Confidence 1236999999999999999999999999999999999999999998888888777765544432 24689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
||..||.+||+ +.|+|+||||+...+
T Consensus 288 ~L~~dP~~Rpt----~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 288 LLQKEPRKRLT----VHDALEHPWLKGDHS 313 (387)
T ss_dssp TSCSSGGGSCC----HHHHHTSTTTSSCCT
T ss_pred HcCCChhHCcC----HHHHhhCccccCCcc
Confidence 99999999997 999999999987554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=416.98 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=205.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ......+.+|+++|+.++|||||++++++..++.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 4579999999999999999999999999999999976532 22335567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 190 MEFCSGGDLHTLRQRQP----GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~----~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
|||+. |+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 69998876532 24689999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.. .
T Consensus 161 ~~-----------------------------------------------------------------------------~ 163 (317)
T 2pmi_A 161 PV-----------------------------------------------------------------------------N 163 (317)
T ss_dssp CC-----------------------------------------------------------------------------C
T ss_pred Cc-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred CccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCCC-------------
Q 010603 346 RSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPLK------------- 408 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~------------- 408 (506)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+.. .+..
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence 01123689999999999874 689999999999999999999999998887776655532 1100
Q ss_pred --C--------------CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 409 --F--------------PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 409 --~--------------p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+ .....++.++++||.+||+.||.+||+ ++|+|+||||+...|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHH 303 (317)
T ss_dssp TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC-
T ss_pred cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccch
Confidence 0 011257889999999999999999997 9999999999976654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=408.56 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=213.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|++ .+|+.||||++...... ......+.+|+++|+.++||||+++++++...+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 46799999999999999999998 56899999999765422 22335667899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 79 FEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp EECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 99996 5999888764 3579999999999999999999999999999999999999999999999999985421000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 155 ---------------------------------------------------------------------------~~~~~ 159 (288)
T 1ob3_A 155 ---------------------------------------------------------------------------RKYTH 159 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred cccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC--CCC-------------
Q 010603 350 FVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL--KFP------------- 410 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~--~~p------------- 410 (506)
.+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.. .+. .++
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 3689999999999864 589999999999999999999999998887776655532 110 000
Q ss_pred ---------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 411 ---------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 411 ---------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
....+++++.+||.+||..||.+||+ ++|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC-
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhc
Confidence 01247899999999999999999997 9999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=420.17 Aligned_cols=258 Identities=29% Similarity=0.484 Sum_probs=217.9
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 187 (506)
..++|++++.||+|+||+||+|.++.+|+.||||++.+.... ..+|+++|..+ +|||||++++++++.+.+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 345699999999999999999999999999999999765321 24588888777 7999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC----CCEEEeecCCcccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED----GHIMLSDFDLSLRC 263 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----~~vkl~DFGla~~~ 263 (506)
+|||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||++...
T Consensus 93 lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999999998765 679999999999999999999999999999999999998543 35999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
....
T Consensus 171 ~~~~---------------------------------------------------------------------------- 174 (342)
T 2qr7_A 171 RAEN---------------------------------------------------------------------------- 174 (342)
T ss_dssp BCTT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC---CCcHHHHHHHhCCCCCCCC--CCCCCHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKG---NGNRETLFNVVGQPLKFPE--GSSISFA 418 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~---~~~~~~~~~i~~~~~~~p~--~~~~s~~ 418 (506)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+ .+..+.+..+......++. +..++++
T Consensus 175 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 253 (342)
T 2qr7_A 175 -GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253 (342)
T ss_dssp -CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred -CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence 011234799999999999988899999999999999999999999986 3444556666666555543 3568999
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchh
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
+++||.+||..||.+||+ +.++++||||. +|..+
T Consensus 254 ~~~li~~~L~~dP~~R~t----~~~il~hp~~~--~~~~~ 287 (342)
T 2qr7_A 254 AKDLVSKMLHVDPHQRLT----AALVLRHPWIV--HWDQL 287 (342)
T ss_dssp HHHHHHHHTCSSTTTSCC----HHHHTTSHHHH--TGGGS
T ss_pred HHHHHHHHCCCChhHCcC----HHHHhcCCeec--Ccccc
Confidence 999999999999999997 99999999995 46544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=399.38 Aligned_cols=262 Identities=26% Similarity=0.484 Sum_probs=228.4
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||.||+|.++.+++.||+|++...... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 46799999999999999999999999999999999875433 34456778999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC---EEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH---IMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFGla~~~~~~ 266 (506)
|||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999888765 57999999999999999999999999999999999999987665 999999998532110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 162 ------------------------------------------------------------------------------~~ 163 (284)
T 3kk8_A 162 ------------------------------------------------------------------------------EA 163 (284)
T ss_dssp ------------------------------------------------------------------------------CB
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~ 424 (506)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+......++. ...+++++.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence 11246999999999999999999999999999999999999999998888777777666555443 3478999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+||..||.+||+ ++|+++||||+...+.
T Consensus 244 ~~l~~dp~~Rps----~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 244 SMLTVNPKKRIT----ADQALKVPWICNRERV 271 (284)
T ss_dssp HHSCSSTTTSCC----HHHHTTSHHHHSCCCG
T ss_pred HHcccChhhCCC----HHHHhcCccccCChhH
Confidence 999999999997 9999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=411.67 Aligned_cols=265 Identities=31% Similarity=0.462 Sum_probs=231.0
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---KKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..++|++++.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34569999999999999999999999999999999987543221 135667889999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC----CEEEeecCCcc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG----HIMLSDFDLSL 261 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFGla~ 261 (506)
.|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999998764 5799999999999999999999999999999999999999888 79999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 168 ~~~~~--------------------------------------------------------------------------- 172 (321)
T 2a2a_A 168 EIEDG--------------------------------------------------------------------------- 172 (321)
T ss_dssp ECCTT---------------------------------------------------------------------------
T ss_pred ecCcc---------------------------------------------------------------------------
Confidence 42110
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC--CCCCHHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAA 419 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~s~~~ 419 (506)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++.. ..++..+
T Consensus 173 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (321)
T 2a2a_A 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249 (321)
T ss_dssp ---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHH
T ss_pred ---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHH
Confidence 00112369999999999999999999999999999999999999999988888888877665554421 3689999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
.+||.+||..||.+||+ +.|+++||||+.++|..
T Consensus 250 ~~li~~~l~~dp~~Rps----~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 250 KDFIRKLLVKETRKRLT----IQEALRHPWITPVDNQQ 283 (321)
T ss_dssp HHHHHTTSCSSTTTSCC----HHHHHHSTTTSCSSHHH
T ss_pred HHHHHHHcCCChhhCcC----HHHHhcCccccCCCccc
Confidence 99999999999999997 99999999999988764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=419.39 Aligned_cols=275 Identities=42% Similarity=0.790 Sum_probs=225.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhh-chhHHHHHHHHHHHHHhc-CCCCccceeEEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLA-GRKKLMRAQTEREILSLL-DHPFLPTLYSHFE 181 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 181 (506)
.+.+++|++++.||+|+||+||+|++. .+++.||||++++.... .......+.+|+++|+.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 455678999999999999999999984 57999999999865321 122234456799999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..+.+|||||||.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999998875 579999999999999999999999999999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
......
T Consensus 208 ~~~~~~-------------------------------------------------------------------------- 213 (355)
T 1vzo_A 208 EFVADE-------------------------------------------------------------------------- 213 (355)
T ss_dssp ECCGGG--------------------------------------------------------------------------
T ss_pred ecccCC--------------------------------------------------------------------------
Confidence 421100
Q ss_pred CCCCCccccccCCCCccchhhcCC--CCCcchhHHHHHHHHHHHhcCCCCCCCCCc----HHHHHHHhCCCCCCCCCCCC
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD--GHGSAVDWWTFGIFFYELLLGRTPFKGNGN----RETLFNVVGQPLKFPEGSSI 415 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiWSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~~~ 415 (506)
.......+||+.|+|||++.+. .++.++|||||||+||||++|+.||..... .+....+......++. .+
T Consensus 214 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 289 (355)
T 1vzo_A 214 --TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 289 (355)
T ss_dssp --GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TS
T ss_pred --CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--cc
Confidence 0012234799999999999863 478999999999999999999999975432 2333444444444444 68
Q ss_pred CHHHHHHHHHHhhcCCCCccCCC-CChHHhhcCCCCCCCCcchhccC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIRST 461 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~~ 461 (506)
+..+.+||.+||..||.+||+.. ++++|+++||||+.++|..+...
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~ 336 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 336 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhc
Confidence 99999999999999999999542 25999999999999999876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=424.73 Aligned_cols=287 Identities=25% Similarity=0.369 Sum_probs=214.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----C
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-----K 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~ 184 (506)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. .......++.+|+.+|+.++|||||++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 467999999999999999999999999999999997642 2345566788999999999999999999999876 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+||||||+ +|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 799999999 46999998765 679999999999999999999999999999999999999999999999999996532
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
........... .. ...+........
T Consensus 181 ~~~~~~~~~~~------------------------------------------------------~~-~~~~~~~~~~~~ 205 (432)
T 3n9x_A 181 SEKDTNIVNDL------------------------------------------------------EE-NEEPGPHNKNLK 205 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccccccc------------------------------------------------------cc-cccccccccchh
Confidence 21100000000 00 000000000011
Q ss_pred CCccccccCCCCccchhhc-CCCCCcchhHHHHHHHHHHHhc-----------CCCCCCCCCc-----------------
Q 010603 345 ARSMSFVGTHEYLAPEIIR-GDGHGSAVDWWTFGIFFYELLL-----------GRTPFKGNGN----------------- 395 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiWSlGvil~ellt-----------G~~Pf~~~~~----------------- 395 (506)
...+..+||+.|+|||++. +..|+.++||||||||||||++ |+++|.+.+.
T Consensus 206 ~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~ 285 (432)
T 3n9x_A 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN 285 (432)
T ss_dssp -----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHH
T ss_pred ccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccch
Confidence 2235678999999999974 5569999999999999999998 4555544331
Q ss_pred HHHHH---HHhCCC---------------------CCCCC-----CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 396 RETLF---NVVGQP---------------------LKFPE-----GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 396 ~~~~~---~i~~~~---------------------~~~p~-----~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+++. .+++.+ ...+. ...+++++++||.+||..||.+||| ++|+|+
T Consensus 286 ~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~ 361 (432)
T 3n9x_A 286 RDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALD 361 (432)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHT
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhc
Confidence 11221 122211 01110 1258999999999999999999997 999999
Q ss_pred CCCCCCCCcchhc
Q 010603 447 HPFFESVNWALIR 459 (506)
Q Consensus 447 hp~f~~~~~~~~~ 459 (506)
||||+.+.|....
T Consensus 362 Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 362 HPYLKDVRKKKLE 374 (432)
T ss_dssp CGGGTTTCCTTTC
T ss_pred ChhhhhccCcccC
Confidence 9999999987554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=401.56 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=230.3
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
..++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34679999999999999999999999999999999987655555566778899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp EEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 99999999999988775 579999999999999999999999999999999999999999999999999985421100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 170 ----------------------------------------------------------------------------~~~~ 173 (294)
T 2rku_A 170 ----------------------------------------------------------------------------ERKK 173 (294)
T ss_dssp ----------------------------------------------------------------------------CCBC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+......+|. .++..+.+||.+||.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~ 251 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQ 251 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTC
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc--ccCHHHHHHHHHHcc
Confidence 236999999999999999999999999999999999999999998888877777776666655 689999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.||.+||+ ++|+++||||...
T Consensus 252 ~~p~~Rps----~~~ll~~~~~~~~ 272 (294)
T 2rku_A 252 TDPTARPT----INELLNDEFFTSG 272 (294)
T ss_dssp SSGGGSCC----GGGGGGSHHHHTS
T ss_pred cChhhCcC----HHHHhhChheecC
Confidence 99999997 8999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=415.95 Aligned_cols=259 Identities=33% Similarity=0.465 Sum_probs=211.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
...++|++.+.||+|+||+||+|+++.+++.||||++.+.. ....+.+|+++|+.++||||+++++++...+.+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999998642 2345678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CCCEEEeecCCccccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DGHIMLSDFDLSLRCF 264 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFGla~~~~ 264 (506)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 125 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999999988765 57999999999999999999999999999999999999975 8899999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 203 ~~------------------------------------------------------------------------------ 204 (349)
T 2w4o_A 203 HQ------------------------------------------------------------------------------ 204 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHH-HHHHHhCCCCCCC--CCCCCCHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE-TLFNVVGQPLKFP--EGSSISFAAKD 421 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p--~~~~~s~~~~~ 421 (506)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||......+ .+..+......++ ....++.++.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 284 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHH
Confidence 00123479999999999999999999999999999999999999998776655 4555665544433 23578999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
||.+||..||++||+ +.|+|+||||....+
T Consensus 285 li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 285 LVRKLIVLDPKKRLT----TFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHTTSCSSGGGSCC----HHHHHHSTTTTSTTC
T ss_pred HHHHHccCChhhCcC----HHHHhcCcccCCCcc
Confidence 999999999999998 999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=435.38 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=210.4
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD----- 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 183 (506)
..++|++++.||+|+||+||+|.+..+|+.||||++.+.. .......++.+|+.+|+.++|||||+++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4578999999999999999999999999999999998653 2345566788999999999999999999999654
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 184 -KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 184 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
..+|||||||.+ +|.+.+.. .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 467999999965 56666543 499999999999999999999999999999999999999999999999999853
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
...
T Consensus 214 ~~~----------------------------------------------------------------------------- 216 (464)
T 3ttj_A 214 AGT----------------------------------------------------------------------------- 216 (464)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL------------ 407 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~------------ 407 (506)
....+..+||+.|+|||++.+..|+.++||||||||||||++|++||.+.+..+++..++.. +.
T Consensus 217 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 217 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred -CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 00122358999999999999999999999999999999999999999998877776655421 10
Q ss_pred ----CCCCCCC---------------------CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 408 ----KFPEGSS---------------------ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 408 ----~~p~~~~---------------------~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
..+.... .++++++||.+||..||.+||| ++|+|+||||+.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGG
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhh
Confidence 0000000 1567999999999999999997 999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=402.34 Aligned_cols=260 Identities=32% Similarity=0.590 Sum_probs=202.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999999999999999999876544445567788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 9999999999998764 3579999999999999999999999999999999999999999999999999985421000
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 167 ---------------------------------------------------------------------------~~~~~ 171 (278)
T 3cok_A 167 ---------------------------------------------------------------------------EKHYT 171 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------Cccee
Confidence 00112
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+......+|. .++.++.+||.+||..
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 249 (278)
T 3cok_A 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS--FLSIEAKDLIHQLLRR 249 (278)
T ss_dssp --------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCT--TSCHHHHHHHHHHSCS
T ss_pred ccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCcc--ccCHHHHHHHHHHccc
Confidence 36999999999999989999999999999999999999999887766555555444444443 6899999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||.+||+ ++++++||||...
T Consensus 250 dp~~Rps----~~~~l~h~~~~~~ 269 (278)
T 3cok_A 250 NPADRLS----LSSVLDHPFMSRN 269 (278)
T ss_dssp SGGGSCC----HHHHTTSTTTC--
T ss_pred CHhhCCC----HHHHhcCccccCC
Confidence 9999997 9999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=407.90 Aligned_cols=263 Identities=29% Similarity=0.455 Sum_probs=216.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+++++.++||||+++++++...+..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 5689999999999999999999999999999999876532 233455678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-- 156 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence 9999999999987765 579999999999999999999999999999999999999999999999999985421100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (311)
T 4agu_A 157 ---------------------------------------------------------------------------DYYDD 161 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00112
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---C----------------CCCC
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---Q----------------PLKF 409 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~----------------~~~~ 409 (506)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.. . ....
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 368999999999986 5689999999999999999999999998877666544321 1 0111
Q ss_pred CC----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 410 PE----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 410 p~----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+. ...++.++.+||.+||..||.+||| ++|+++||||+.+.|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREI 294 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC--
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCH
Confidence 11 1257889999999999999999997 9999999999988764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=411.85 Aligned_cols=266 Identities=30% Similarity=0.437 Sum_probs=228.2
Q ss_pred cCCeEEE-eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEE
Q 010603 110 LGHFRLL-KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 110 ~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 187 (506)
.++|.+. +.||+|+||+||+|+++.+++.||||++.+.... ......+.+|+.+++.+ +||||+++++++...+.+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3458888 8999999999999999999999999999875433 23355678899999998 5699999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CCCEEEeecCCccccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DGHIMLSDFDLSLRCF 264 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFGla~~~~ 264 (506)
+||||+.+|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999999987665678999999999999999999999999999999999999998 7899999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 186 ~~------------------------------------------------------------------------------ 187 (327)
T 3lm5_A 186 HA------------------------------------------------------------------------------ 187 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKDL 422 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~l 422 (506)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++ ....++..+.+|
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 001124799999999999999999999999999999999999999999888877777665444433 235689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchh
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
|.+||..||.+||+ ++++|+||||+..+|..+
T Consensus 268 i~~~L~~dP~~Rpt----~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 268 IQSLLVKNPEKRPT----AEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHHHSCSSGGGSCC----HHHHTTCGGGCCCCTTCC
T ss_pred HHHHcCCChhhCcC----HHHHhCCHhhcccccccc
Confidence 99999999999997 999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=417.27 Aligned_cols=269 Identities=29% Similarity=0.482 Sum_probs=224.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh--chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA--GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
++|++++.||+|+||+||+|.+..+++.||||++.+.... .......+.+|+++|+.++|||||++++++.+.+..||
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5599999999999999999999999999999999875432 23456678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 010603 189 LMEFCSGGDLHTLRQRQ--------------------------------------PGKHFSEQATRFYASEVLLALEYLH 230 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~--------------------------------------~~~~~~e~~~~~i~~qil~aL~yLH 230 (506)
|||||+||+|.+++... ....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999987521 0123468889999999999999999
Q ss_pred hCCeEEccCCCCcEEEecCC--CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCC
Q 010603 231 MMGVVYRDLKPENVLVREDG--HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPS 308 (506)
Q Consensus 231 ~~giiHrDLKp~NILl~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (506)
++||+||||||+||||+.++ .+||+|||++..+......
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------------------------- 226 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG--------------------------------------- 226 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc---------------------------------------
Confidence 99999999999999998776 8999999998643211000
Q ss_pred CCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcC
Q 010603 309 CFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLG 386 (506)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG 386 (506)
.........||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 227 ----------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 272 (345)
T 3hko_A 227 ----------------------------------EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272 (345)
T ss_dssp ------------------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 0001123479999999999976 6789999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhCCCCCCCCC--CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 387 RTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 387 ~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+.||.+....+.+..+......++.. ..+++++.+||.+||..||.+||+ +.++|+||||+...|.
T Consensus 273 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 273 AVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDK 340 (345)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSC
T ss_pred CCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHh
Confidence 99999998888888887666554432 358999999999999999999997 9999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=409.90 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=229.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45699999999999999999999999999999999876555555667788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence 9999999999998775 579999999999999999999999999999999999999999999999999985421100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 196 ---------------------------------------------------------------------------~~~~~ 200 (335)
T 2owb_A 196 ---------------------------------------------------------------------------ERKKV 200 (335)
T ss_dssp ---------------------------------------------------------------------------CCBCC
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
..||+.|+|||++.+..++.++|||||||+||||++|+.||......+.+..+......++. .++..+.+||.+||..
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 278 (335)
T 2owb_A 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQT 278 (335)
T ss_dssp CCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred cCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHccC
Confidence 36999999999999999999999999999999999999999988877777777766666655 6899999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||.+||+ +.|+++||||...
T Consensus 279 dp~~Rps----~~ell~~~~~~~~ 298 (335)
T 2owb_A 279 DPTARPT----INELLNDEFFTSG 298 (335)
T ss_dssp SGGGSCC----GGGGGGSHHHHTS
T ss_pred ChhHCcC----HHHHhcCccccCC
Confidence 9999998 8999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=438.43 Aligned_cols=264 Identities=31% Similarity=0.483 Sum_probs=231.6
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||++++++.+.+.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34456799999999999999999999999999999999876655455667788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE---ecCCCEEEeecCCcccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRC 263 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFGla~~~ 263 (506)
|+|||||.+|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|...
T Consensus 102 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999988765 679999999999999999999999999999999999999 56789999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 180 ~~~----------------------------------------------------------------------------- 182 (484)
T 3nyv_A 180 EAS----------------------------------------------------------------------------- 182 (484)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC--CCCCCCCHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF--PEGSSISFAAKD 421 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~s~~~~~ 421 (506)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+......+ +.+..+++++++
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 -KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp -CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred -cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 01123479999999999976 69999999999999999999999999999888888887665544 334578999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
||.+||..||.+||+ +.|+|+||||+...+
T Consensus 261 li~~~L~~dp~~R~s----~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 261 LIRKMLTYVPSMRIS----ARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHTSHHHHHHTC
T ss_pred HHHHHCCCChhHCcC----HHHHhhChhhccccc
Confidence 999999999999997 999999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=414.02 Aligned_cols=262 Identities=28% Similarity=0.426 Sum_probs=212.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+++|+.++||||+++++++...+..|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 46799999999999999999999999999999999754321 1111234699999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+. |+|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 153 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 153 (324)
T ss_dssp EECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence 99996 6998888765 357999999999999999999999999999999999999999999999999998531100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (324)
T 3mtl_A 154 --------------------------------------------------------------------------TKTYDN 159 (324)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred cccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCCC--CC-------------
Q 010603 350 FVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPLK--FP------------- 410 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~~--~p------------- 410 (506)
.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+.. .+.. ++
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 368999999999987 5689999999999999999999999999887776655432 2110 11
Q ss_pred ----------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 411 ----------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 411 ----------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
....+++++.+||.+||+.||.+||+ ++|+|+||||..+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCST
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhcccc
Confidence 01247889999999999999999997 9999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=424.00 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=208.8
Q ss_pred ccCCeEEE-eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHH-HhcCCCCccceeEEEEe----
Q 010603 109 GLGHFRLL-KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPTLYSHFET---- 182 (506)
Q Consensus 109 ~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~---- 182 (506)
.+++|.++ +.||+|+||+||+|.++.+|+.||||++... ..+.+|++++ +.++||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 45678887 7899999999999999999999999999642 2345688886 55689999999999976
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CCCEEEeecCC
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DGHIMLSDFDL 259 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFGl 259 (506)
..++|||||||.||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 668999999999999999998765567999999999999999999999999999999999999998 78999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
++.....
T Consensus 211 a~~~~~~------------------------------------------------------------------------- 217 (400)
T 1nxk_A 211 AKETTSH------------------------------------------------------------------------- 217 (400)
T ss_dssp CEECC---------------------------------------------------------------------------
T ss_pred ccccCCC-------------------------------------------------------------------------
Confidence 8532100
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHH----HHHHHhCCCCCCC--CCC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE----TLFNVVGQPLKFP--EGS 413 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~ 413 (506)
......+||+.|+|||++.+..|+.++||||||||||||++|+.||.+..... ....+......++ .+.
T Consensus 218 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 292 (400)
T 1nxk_A 218 -----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292 (400)
T ss_dssp --------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTT
T ss_pred -----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccc
Confidence 00123479999999999999999999999999999999999999998654322 3344444444444 335
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.++.++++||.+||..||.+||+ +.|+++||||..
T Consensus 293 ~~s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 327 (400)
T 1nxk_A 293 EVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 327 (400)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcC----HHHHhcCccccC
Confidence 78999999999999999999997 999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=418.42 Aligned_cols=258 Identities=30% Similarity=0.448 Sum_probs=212.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
.++|++++.||+|+||+||+|.+..+|+.||||++.... .......++.+|+++|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 367999999999999999999999999999999997643 22345567889999999999999999999998763
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8999999876 46999999999999999999999999999999999999999999999999998531
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 179 ~~------------------------------------------------------------------------------ 180 (367)
T 1cm8_A 179 DS------------------------------------------------------------------------------ 180 (367)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL------------ 407 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~------------ 407 (506)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+.. .+.
T Consensus 181 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred --ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 0123479999999999987 6799999999999999999999999999887766655432 110
Q ss_pred -------------CCC-CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 408 -------------KFP-EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 408 -------------~~p-~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.+. ....+++++.+||.+||..||.+||| ++|+|+||||+...+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC--
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCC
Confidence 000 11357899999999999999999997 9999999999987643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=411.46 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=198.7
Q ss_pred CCeEEE---eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeE
Q 010603 111 GHFRLL---KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFS 186 (506)
Q Consensus 111 ~~y~i~---~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 186 (506)
.+|++. +.||+|+||+||+|.++.+++.||||++.+. ......+|+.+|+.+. |||||++++++.+....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 447775 7899999999999999999999999999753 2345678999999996 99999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CEEEeecCCcccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIMLSDFDLSLRC 263 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFGla~~~ 263 (506)
|||||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999875 6799999999999999999999999999999999999998766 7999999998532
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 160 ~~~----------------------------------------------------------------------------- 162 (325)
T 3kn6_A 160 PPD----------------------------------------------------------------------------- 162 (325)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc-------HHHHHHHhCCCCCCCCC--CC
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN-------RETLFNVVGQPLKFPEG--SS 414 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~p~~--~~ 414 (506)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... .+.+..+......++.. ..
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence 0011234789999999999999999999999999999999999999976433 34555666555544432 35
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+++++++||.+||..||.+||+ +.|+++||||+..
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt----~~ell~h~w~~~~ 277 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQDG 277 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCC----TTTSTTCGGGCTT
T ss_pred CCHHHHHHHHHHCCCChhHCCC----HHHHhcChhhccC
Confidence 8999999999999999999998 8899999999853
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=405.77 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=221.4
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|...+.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3888899999999999999999999999999997643 2334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
|+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 194 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-----
Confidence 9999999998865 46999999999999999999999999999999999999999999999999998542110
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.......+
T Consensus 195 ------------------------------------------------------------------------~~~~~~~~ 202 (321)
T 2c30_A 195 ------------------------------------------------------------------------VPKRKSLV 202 (321)
T ss_dssp ------------------------------------------------------------------------SCCBCCCC
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00012347
Q ss_pred cCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC-CCCCCCCCCHHHHHHHHHHhhcC
Q 010603 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL-KFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 352 GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~s~~~~~li~~~L~~d 430 (506)
||+.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+..... .+.....+++.+.+||.+||..|
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSS
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999998887777666654432 23333468999999999999999
Q ss_pred CCCccCCCCChHHhhcCCCCCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
|.+||+ +.++++||||....
T Consensus 283 p~~Rps----~~ell~hp~~~~~~ 302 (321)
T 2c30_A 283 PQERAT----AQELLDHPFLLQTG 302 (321)
T ss_dssp TTTSCC----HHHHHTSGGGGGCC
T ss_pred hhhCcC----HHHHhcChhhccCC
Confidence 999997 99999999997543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=397.91 Aligned_cols=254 Identities=33% Similarity=0.530 Sum_probs=223.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||+|+||.||+|.++.++..||+|++.+... .....+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 569999999999999999999999999999999986543 33556788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE---ecCCCEEEeecCCccccccCC
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFGla~~~~~~~ 267 (506)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 999999999988775 579999999999999999999999999999999999999 78889999999998542110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 163 -----------------------------------------------------------------------------~~~ 165 (277)
T 3f3z_A 163 -----------------------------------------------------------------------------KMM 165 (277)
T ss_dssp -----------------------------------------------------------------------------SCB
T ss_pred -----------------------------------------------------------------------------cch
Confidence 001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC--CCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~s~~~~~li~~ 425 (506)
....||+.|+|||++.+. ++.++|||||||++|||++|+.||......+....+......++.. ..+++.+.+||.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence 123699999999998765 8999999999999999999999999988888888887766655532 3689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||..||.+||+ +.++|+||||+.
T Consensus 245 ~l~~dp~~R~s----~~~~l~h~~~~~ 267 (277)
T 3f3z_A 245 LLTKSPKQRIT----SLQALEHEWFEK 267 (277)
T ss_dssp HTCSSTTTSCC----HHHHTTSHHHHH
T ss_pred HccCChhhCcC----HHHHhcCHHHhc
Confidence 99999999997 999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=420.32 Aligned_cols=258 Identities=30% Similarity=0.471 Sum_probs=218.8
Q ss_pred eEE--EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 113 FRL--LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 113 y~i--~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
|++ .+.||+|+||+||+|.+..+|+.||||+++.... .....+.+|+++|+.++|||||++++++...+.+||||
T Consensus 89 ~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 554 6789999999999999999999999999987542 34456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE--ecCCCEEEeecCCccccccCCc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV--REDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl--~~~~~vkl~DFGla~~~~~~~~ 268 (506)
|||++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 166 E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp ECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 999999999988654 2469999999999999999999999999999999999999 456789999999985421100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
...
T Consensus 244 -----------------------------------------------------------------------------~~~ 246 (373)
T 2x4f_A 244 -----------------------------------------------------------------------------KLK 246 (373)
T ss_dssp -----------------------------------------------------------------------------BCC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHHHHH
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIRGL 426 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~~~ 426 (506)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+.++......++. ...+++++++||.+|
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 236999999999999999999999999999999999999999999888888888766554443 246899999999999
Q ss_pred hhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 427 LVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
|..||.+||+ +.|+|+||||+...|.
T Consensus 327 L~~dp~~Rps----~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 327 LIKEKSWRIS----ASEALKHPWLSDHKLH 352 (373)
T ss_dssp SCSSGGGSCC----HHHHHHSHHHHCHHHH
T ss_pred cCCChhhCCC----HHHHhcCcCcCCCchh
Confidence 9999999997 9999999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=397.89 Aligned_cols=262 Identities=30% Similarity=0.489 Sum_probs=222.6
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+.+..++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 46677889999999999999999999999999999999998765544455677889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999998775 579999999999999999999999999999999999999999999999999984321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 163 ~~------------------------------------------------------------------------------ 164 (276)
T 2h6d_A 163 DG------------------------------------------------------------------------------ 164 (276)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCccccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+.+..+......+|. .++..+.+||
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li 242 (276)
T 2h6d_A 165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--YLNRSVATLL 242 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch--hcCHHHHHHH
Confidence 00112368999999999998776 68999999999999999999999988777777777666555554 6899999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.+||..||.+||+ +.++++||||+.
T Consensus 243 ~~~l~~~p~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 243 MHMLQVDPLKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp HHHTCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHccCChhhCCC----HHHHHhChhhcc
Confidence 9999999999998 999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=421.63 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=217.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc------CCCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL------DHPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~ 179 (506)
.+....+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+++|+.+ +|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 345567899999999999999999999999999999999764 23345567788888776 67899999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC--EEEeec
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH--IMLSDF 257 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~--vkl~DF 257 (506)
+...+.+||||||+ +++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999999999 579999998876667999999999999999999999999999999999999999987 999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|+|....
T Consensus 247 G~a~~~~------------------------------------------------------------------------- 253 (429)
T 3kvw_A 247 GSSCYEH------------------------------------------------------------------------- 253 (429)
T ss_dssp TTCEETT-------------------------------------------------------------------------
T ss_pred ccceecC-------------------------------------------------------------------------
Confidence 9984310
Q ss_pred cccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---CC-------
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---PL------- 407 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~------- 407 (506)
......+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..++.. +.
T Consensus 254 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 254 -------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp -------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred -------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 0012347999999999999999999999999999999999999999998887766554421 00
Q ss_pred ----------CCC-----------------------------C--------CCCCCHHHHHHHHHHhhcCCCCccCCCCC
Q 010603 408 ----------KFP-----------------------------E--------GSSISFAAKDLIRGLLVKDPQKRLGFKRG 440 (506)
Q Consensus 408 ----------~~p-----------------------------~--------~~~~s~~~~~li~~~L~~dP~~R~s~~~~ 440 (506)
.+| . ....++++.+||.+||+.||.+|||
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt---- 402 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT---- 402 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----
Confidence 000 0 0123788999999999999999997
Q ss_pred hHHhhcCCCCCC
Q 010603 441 ATEIKQHPFFES 452 (506)
Q Consensus 441 a~ell~hp~f~~ 452 (506)
|+|||+||||+.
T Consensus 403 a~e~L~Hpw~~~ 414 (429)
T 3kvw_A 403 PGQALRHPWLRR 414 (429)
T ss_dssp HHHHHTSTTTC-
T ss_pred HHHHhCChhhcc
Confidence 999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=409.21 Aligned_cols=265 Identities=22% Similarity=0.368 Sum_probs=221.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC---
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK--- 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--- 184 (506)
...++|++++.||+|+||.||+|++..+++.||||++.............+.+|+++++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 44577999999999999999999999999999999998766555566677889999999999999999999987655
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 349999999999999999875 57999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..... .
T Consensus 167 ~~~~~--------------------------------------------------------------------------~ 172 (311)
T 3ork_A 167 ADSGN--------------------------------------------------------------------------S 172 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc--------------------------------------------------------------------------c
Confidence 11100 0
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKD 421 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~ 421 (506)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...++.......+ ....++.++.+
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252 (311)
T ss_dssp ---------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHH
T ss_pred cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHH
Confidence 0011234799999999999999999999999999999999999999999888777766654433322 12468999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||.+||..||.+||+ +.+++.|+|++.
T Consensus 253 li~~~l~~dP~~R~~----~~~~l~~~l~~~ 279 (311)
T 3ork_A 253 VVLKALAKNPENRYQ----TAAEMRADLVRV 279 (311)
T ss_dssp HHHHHTCSSGGGSCS----SHHHHHHHHHHH
T ss_pred HHHHHHhcCHhhChh----hHHHHHHHHHHH
Confidence 999999999999997 789999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=403.34 Aligned_cols=260 Identities=24% Similarity=0.334 Sum_probs=209.6
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHH-HhcCCCCccceeEEEEe
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPTLYSHFET 182 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~ 182 (506)
..+++..++|+++++||+|+||+||+|+++.+|+.||||++......... ..+...|+..+ +.++|||||++++++..
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 34555667899999999999999999999999999999998764333222 33334455554 44599999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.+.+||||||+ +++|.+++... +..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++..
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred CCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 99999999999 78998887765 35799999999999999999999999999999999999999999999999999853
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 207 ~~~~---------------------------------------------------------------------------- 210 (311)
T 3p1a_A 207 LGTA---------------------------------------------------------------------------- 210 (311)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......||+.|+|||++.+ .++.++|||||||+||||++|..||.+... ...+............+++++.+|
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHH
Confidence 00112369999999999886 699999999999999999999777754322 333333322211223689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.+||+.||++||+ ++|+|+||||+.
T Consensus 285 i~~~L~~dP~~Rpt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRAT----AEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCC----HHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcC----HHHHHhCccccC
Confidence 99999999999997 999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=407.63 Aligned_cols=267 Identities=29% Similarity=0.454 Sum_probs=213.7
Q ss_pred CCeEEE-eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEE
Q 010603 111 GHFRLL-KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 111 ~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 188 (506)
++|++. +.||+|+||+||+|++..+++.||||++.+.. ......+.+|+++|+.+ +||||+++++++.+.+.+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 569996 78999999999999999999999999997653 23345678899999884 79999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC---EEEeecCCcccccc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH---IMLSDFDLSLRCFV 265 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFGla~~~~~ 265 (506)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999998875 57999999999999999999999999999999999999998776 99999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
...... ....
T Consensus 167 ~~~~~~----------------------------------------------------------------------~~~~ 176 (316)
T 2ac3_A 167 NGDCSP----------------------------------------------------------------------ISTP 176 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCcccc----------------------------------------------------------------------cccc
Confidence 100000 0000
Q ss_pred CccccccCCCCccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCCCCc---------------HHHHHHHhCC
Q 010603 346 RSMSFVGTHEYLAPEIIRG-----DGHGSAVDWWTFGIFFYELLLGRTPFKGNGN---------------RETLFNVVGQ 405 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiWSlGvil~elltG~~Pf~~~~~---------------~~~~~~i~~~ 405 (506)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+... ...+..+...
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 256 (316)
T 2ac3_A 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256 (316)
T ss_dssp -----CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC
T ss_pred ccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhcc
Confidence 1123469999999999975 4588999999999999999999999987542 2234455555
Q ss_pred CCCCCCC--CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 406 PLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 406 ~~~~p~~--~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
...++.. ..++.++++||.+||..||.+||+ ++|+|+||||+...|.
T Consensus 257 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-----
T ss_pred CcccCchhcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCCc
Confidence 5555532 368999999999999999999997 9999999999976543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=431.91 Aligned_cols=258 Identities=32% Similarity=0.505 Sum_probs=224.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+++.||||++.+.... ......+.+|+++|+.++|||||++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 5699999999999999999999999999999999765432 234567789999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe---cCCCEEEeecCCccccccCC
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~---~~~~vkl~DFGla~~~~~~~ 267 (506)
|||.||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+.....
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999988765 5799999999999999999999999999999999999995 4567999999998532100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 178 -----------------------------------------------------------------------------~~~ 180 (486)
T 3mwu_A 178 -----------------------------------------------------------------------------TKM 180 (486)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC--CCCCCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF--PEGSSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~s~~~~~li~~ 425 (506)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+......+ +.+..+++++++||.+
T Consensus 181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 259 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (486)
T ss_dssp -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence 22379999999999986 59999999999999999999999999998888888887665444 3445789999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
||..||.+||+ +.++|+||||+...
T Consensus 260 ~L~~dp~~R~t----~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 260 MLTFHPSLRIT----ATQCLEHPWIQKYS 284 (486)
T ss_dssp HTCSSTTTSCC----HHHHHHCHHHHHTC
T ss_pred HcCCChhhCcC----HHHHhcCHhhccCc
Confidence 99999999997 99999999997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=430.67 Aligned_cols=260 Identities=30% Similarity=0.439 Sum_probs=222.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch----------hHHHHHHHHHHHHHhcCCCCccceeE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR----------KKLMRAQTEREILSLLDHPFLPTLYS 178 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~l~~ 178 (506)
..++|+++++||+|+||+||+|+++.+++.||||++.+...... .....+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45779999999999999999999999999999999987543321 33567889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CEEEe
Q 010603 179 HFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIMLS 255 (506)
Q Consensus 179 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~ 255 (506)
++.+...+|||||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999988765 5799999999999999999999999999999999999999876 69999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||+|......
T Consensus 192 Dfg~a~~~~~~--------------------------------------------------------------------- 202 (504)
T 3q5i_A 192 DFGLSSFFSKD--------------------------------------------------------------------- 202 (504)
T ss_dssp CCTTCEECCTT---------------------------------------------------------------------
T ss_pred ECCCCEEcCCC---------------------------------------------------------------------
Confidence 99998542110
Q ss_pred cccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCC
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGS 413 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~ 413 (506)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++ .+.
T Consensus 203 ---------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (504)
T 3q5i_A 203 ---------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWK 272 (504)
T ss_dssp ---------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred ---------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence 01123479999999999874 699999999999999999999999999998888888877665544 235
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+++++++||.+||..||.+||+ ++|+|+||||+..
T Consensus 273 ~~s~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 273 NISDEAKELIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred CCCHHHHHHHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 78999999999999999999997 9999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=399.54 Aligned_cols=264 Identities=22% Similarity=0.353 Sum_probs=220.8
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+++..++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 35667788999999999999999999999999999999997655555566778899999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999999999876 579999999999999999999999999999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.. ..
T Consensus 163 ~~----------------------------------------------------------------------------~~ 166 (294)
T 4eqm_A 163 ET----------------------------------------------------------------------------SL 166 (294)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC---CCCCCCCHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF---PEGSSISFAAKD 421 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~~~s~~~~~ 421 (506)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.....+...... .....+++.+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 01123479999999999999999999999999999999999999999988877666665443221 122468999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+|.+||..||.+||+ ..+.+.+.|.
T Consensus 247 li~~~l~~dp~~R~~----~~~~l~~~l~ 271 (294)
T 4eqm_A 247 VILRATEKDKANRYK----TIQEMKDDLS 271 (294)
T ss_dssp HHHHHSCSSGGGSCS----SHHHHHHHHH
T ss_pred HHHHHhcCCHhHccc----cHHHHHHHHH
Confidence 999999999999996 3344444444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=396.31 Aligned_cols=266 Identities=30% Similarity=0.414 Sum_probs=225.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh------hchhHHHHHHHHHHHHHhcC-CCCccceeEEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML------AGRKKLMRAQTEREILSLLD-HPFLPTLYSHFE 181 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~ 181 (506)
..++|++++.||+|+||.||+|.++.+|+.||||++..... ........+.+|+++|+.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35679999999999999999999999999999999976431 11233456788999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999998875 579999999999999999999999999999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 173 ~~~~~--------------------------------------------------------------------------- 177 (298)
T 1phk_A 173 QLDPG--------------------------------------------------------------------------- 177 (298)
T ss_dssp ECCTT---------------------------------------------------------------------------
T ss_pred hcCCC---------------------------------------------------------------------------
Confidence 42110
Q ss_pred CCCCCccccccCCCCccchhhc------CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CC
Q 010603 342 PTSARSMSFVGTHEYLAPEIIR------GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GS 413 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~------~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~ 413 (506)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+......++. ..
T Consensus 178 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 1phk_A 178 ---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 254 (298)
T ss_dssp ---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred ---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence 0011236899999999986 456889999999999999999999999988877777777665554433 24
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchh
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
.++..+.+||.+||..||.+||+ +.|+++||||+...|+.+
T Consensus 255 ~~~~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~ 295 (298)
T 1phk_A 255 DYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEV 295 (298)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTTC----
T ss_pred ccCHHHHHHHHHHccCCcccCCC----HHHHHhChHhhhccchhh
Confidence 68999999999999999999997 999999999998876544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=396.79 Aligned_cols=257 Identities=31% Similarity=0.483 Sum_probs=216.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++.+.||+|+||+||+|.++.+++.||+|++.+... ......+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 459999999999999999999999999999999987542 234567788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE---ecCCCEEEeecCCcccccc
Q 010603 191 EFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 191 E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFGla~~~~~ 265 (506)
||+.+|+|.+++... .+..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999987542 23679999999999999999999999999999999999999 4567899999999843210
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. .
T Consensus 180 ~------------------------------------------------------------------------------~ 181 (285)
T 3is5_A 180 D------------------------------------------------------------------------------E 181 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c------------------------------------------------------------------------------c
Confidence 0 0
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC-CCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP-EGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p-~~~~~s~~~~~li~ 424 (506)
......||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+....+......++ ....+++++.+||.
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 260 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLK 260 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHH
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHH
Confidence 012236999999999986 4689999999999999999999999998887776666554433332 22458999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+||..||.+||+ +.|+|+||||+.
T Consensus 261 ~~L~~dP~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 261 QMLTKDPERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp HHTCSCTTTSCC----HHHHHTSGGGGC
T ss_pred HHccCChhhCcC----HHHHhcCHHhhc
Confidence 999999999997 999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=409.29 Aligned_cols=256 Identities=26% Similarity=0.353 Sum_probs=221.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
..|++++.||+|+||+||+|++..+|+.||||++.............+.+|+++|+.++|||||++++++...+..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998654444555677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+. |+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 9996 6888877543 25799999999999999999999999999999999999999999999999999843100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
....
T Consensus 207 ----------------------------------------------------------------------------~~~~ 210 (348)
T 1u5q_A 207 ----------------------------------------------------------------------------ANSF 210 (348)
T ss_dssp ----------------------------------------------------------------------------BCCC
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 1123
Q ss_pred ccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 351 VGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 351 ~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
+||+.|+|||++. +..|+.++|||||||+||||++|+.||.+.+..+.+..+............++..+.+||.+||
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 290 (348)
T 1u5q_A 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 290 (348)
T ss_dssp CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHT
T ss_pred cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 6999999999985 4678999999999999999999999999888777776666544333334578999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..||.+||+ ++++++||||...
T Consensus 291 ~~dP~~Rps----~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 291 QKIPQDRPT----SEVLLKHRFVLRE 312 (348)
T ss_dssp CSSGGGSCC----HHHHTTCHHHHSC
T ss_pred ccChhhCcC----HHHHhhChhhhcc
Confidence 999999997 9999999999653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=418.58 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=209.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC------C
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD------K 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 184 (506)
.+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++|||||+++++|... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 459999999999999999999999999999999875421 123699999999999999999998542 2
Q ss_pred eEEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecCCcc
Q 010603 185 FSCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLSL 261 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFGla~ 261 (506)
++++||||+++ +|..++.. .....+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 57899999965 66665543 234679999999999999999999999999999999999999965 568999999986
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 206 ~~~~~--------------------------------------------------------------------------- 210 (420)
T 1j1b_A 206 QLVRG--------------------------------------------------------------------------- 210 (420)
T ss_dssp ECCTT---------------------------------------------------------------------------
T ss_pred hcccC---------------------------------------------------------------------------
Confidence 42110
Q ss_pred CCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---C------------
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---Q------------ 405 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~------------ 405 (506)
......+||+.|+|||++.+. .|+.++||||||||||||++|++||.+.+..+.+..++. .
T Consensus 211 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 211 ---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp ---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred ---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 001234799999999999875 699999999999999999999999999887776665542 1
Q ss_pred --CCCCCC----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 406 --PLKFPE----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 406 --~~~~p~----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
.+.+|. ...+++++++||.+||..||.+||+ +.|+++||||+.+.+..
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPN 347 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTT
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhccccccc
Confidence 112221 1246899999999999999999997 99999999998776543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=429.16 Aligned_cols=259 Identities=32% Similarity=0.499 Sum_probs=220.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|+++.++..||||++.+..... .....+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356999999999999999999999999999999998764332 2345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC---CCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED---GHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFGla~~~~~~ 266 (506)
||||.||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.. +.+||+|||+|......
T Consensus 115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999988765 579999999999999999999999999999999999999764 45999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 193 ------------------------------------------------------------------------------~~ 194 (494)
T 3lij_A 193 ------------------------------------------------------------------------------KK 194 (494)
T ss_dssp ------------------------------------------------------------------------------BC
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~li~ 424 (506)
....+||+.|+|||++. ..|+.++|||||||++|+|++|++||.+.+..+.+..+......++ .+..+++.+++||.
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 273 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence 12347999999999986 4699999999999999999999999999998888888877665554 33578999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+||+.||.+||+ +.|+|+||||+...
T Consensus 274 ~~L~~dp~~R~s----~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 274 QMLQFDSQRRIS----AQQALEHPWIKEMC 299 (494)
T ss_dssp HHTCSSTTTSCC----HHHHHTCHHHHHHH
T ss_pred HHCCCChhhCcc----HHHHhcCcccccCc
Confidence 999999999997 99999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=413.49 Aligned_cols=268 Identities=26% Similarity=0.441 Sum_probs=225.7
Q ss_pred ccCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 102 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
....+++..++|++++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred hhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 34567788899999999999999999999999999999999998653 2344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
.++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999999999999999999999875 5799999999999999999999996 9999999999999999999999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
......
T Consensus 180 ~~~~~~-------------------------------------------------------------------------- 185 (360)
T 3eqc_A 180 GQLIDS-------------------------------------------------------------------------- 185 (360)
T ss_dssp HHHHHH--------------------------------------------------------------------------
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 532100
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHH--------------------
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF-------------------- 400 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~-------------------- 400 (506)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp -----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred -----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 0112479999999999999999999999999999999999999998765443221
Q ss_pred ----------------------HHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 401 ----------------------NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 401 ----------------------~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.+............++.++.+||.+||..||.+||+ ++|+|+||||+..+|.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAE 334 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHHS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchHh
Confidence 111111111122357899999999999999999997 9999999999876654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=410.19 Aligned_cols=265 Identities=28% Similarity=0.392 Sum_probs=213.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch--hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR--KKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
.++|++++.||+|+||+||+|.+..+|+.||||++........ .....+.+|+++|+.++||||+++++++...+..|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 4679999999999999999999999999999999976432211 11235678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.+ +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 99999965 888887654 357899999999999999999999999999999999999999999999999998532100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
....
T Consensus 166 ----------------------------------------------------------------------------~~~~ 169 (346)
T 1ua2_A 166 ----------------------------------------------------------------------------NRAY 169 (346)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred ----------------------------------------------------------------------------cccC
Confidence 0011
Q ss_pred cccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C--CCCCC----------
Q 010603 348 MSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P--LKFPE---------- 411 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~--~~~p~---------- 411 (506)
...+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+... + ..++.
T Consensus 170 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T 1ua2_A 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 249 (346)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccc
Confidence 234799999999999765 5899999999999999999999999998887777665421 1 01110
Q ss_pred -----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 412 -----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 412 -----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
...++.++++||.+||..||.+||+ ++|+|+||||....|..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 250 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGPT 302 (346)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCCC
T ss_pred cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCCC
Confidence 0346789999999999999999997 99999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=408.84 Aligned_cols=269 Identities=23% Similarity=0.366 Sum_probs=209.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+|+++|+.++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467999999999999999999999999999999997643 2344567889999999999999999999986543
Q ss_pred ----------------------------------------------------eEEEEEeecCCCChHHHHhhCCC-CCCC
Q 010603 185 ----------------------------------------------------FSCLLMEFCSGGDLHTLRQRQPG-KHFS 211 (506)
Q Consensus 185 ----------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~-~~~~ 211 (506)
++|+|||||++|+|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999887532 2356
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCC
Q 010603 212 EQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291 (506)
Q Consensus 212 e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (506)
+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...........
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~------------------- 223 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV------------------- 223 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc-------------------
Confidence 6778999999999999999999999999999999999999999999998653211100000
Q ss_pred CCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcch
Q 010603 292 PACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAV 371 (506)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~ 371 (506)
....+........+||+.|+|||++.+..++.++
T Consensus 224 ----------------------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 257 (332)
T 3qd2_B 224 ----------------------------------------------LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257 (332)
T ss_dssp ------------------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHH
T ss_pred ----------------------------------------------cccccccccccccCCCcCccChHHhcCCCCcchh
Confidence 0000001112345799999999999999999999
Q ss_pred hHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC-CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 372 DWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE-GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 372 DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
|||||||++|||++|..|+.. .......+.... ++. ....++++.+||.+||..||.+||+ +.|+++||||
T Consensus 258 Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f 329 (332)
T 3qd2_B 258 DIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--FPLLFTQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIF 329 (332)
T ss_dssp HHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--CCHHHHHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTC
T ss_pred hHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--CCcccccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhh
Confidence 999999999999998777532 112222232222 221 1245678899999999999999997 9999999999
Q ss_pred CCC
Q 010603 451 ESV 453 (506)
Q Consensus 451 ~~~ 453 (506)
+++
T Consensus 330 ~~~ 332 (332)
T 3qd2_B 330 ENL 332 (332)
T ss_dssp CCC
T ss_pred hcC
Confidence 863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=409.58 Aligned_cols=270 Identities=21% Similarity=0.380 Sum_probs=231.5
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchh--------------HHHHHHHHHHHHHhcC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK--------------KLMRAQTEREILSLLD 169 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~E~~il~~l~ 169 (506)
..+++..++|++++.||+|+||.||+|.+ +|+.||||++......... ....+.+|+++++.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34556778999999999999999999999 7999999999875443221 1267889999999999
Q ss_pred CCCccceeEEEEeCCeEEEEEeecCCCChHHH------HhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCC
Q 010603 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL------RQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPE 242 (506)
Q Consensus 170 hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~ 242 (506)
||||+++++++...+..|+||||+++|+|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 665445789999999999999999999999 99999999999
Q ss_pred cEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccc
Q 010603 243 NVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKV 322 (506)
Q Consensus 243 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (506)
|||++.++.+||+|||++......
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------------------------------------------------------- 205 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------------------------------------------------------- 205 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT--------------------------------------------------------
T ss_pred hEEEcCCCcEEEeccccccccccc--------------------------------------------------------
Confidence 999999999999999998532100
Q ss_pred ccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCC-CCCc-chhHHHHHHHHHHHhcCCCCCCCCCc-HHHH
Q 010603 323 KSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD-GHGS-AVDWWTFGIFFYELLLGRTPFKGNGN-RETL 399 (506)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~-~~DiWSlGvil~elltG~~Pf~~~~~-~~~~ 399 (506)
......||+.|+|||++.+. .++. ++|||||||++|||++|+.||..... .+.+
T Consensus 206 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 206 -----------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp -----------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred -----------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 01123699999999999987 6666 99999999999999999999998777 6666
Q ss_pred HHHhCCCCCCCCC-----------------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchh
Q 010603 400 FNVVGQPLKFPEG-----------------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 400 ~~i~~~~~~~p~~-----------------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
..+......+|.. ..++.++.+||.+||..||.+||+ +.|+++||||+..+|..+
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~ 334 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDL 334 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHH
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHH
Confidence 6776666666532 468999999999999999999997 999999999999988754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=399.13 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=221.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc-hhHHHHHHHHHHHHHhcCCCCccceeEEEE--eCCeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-RKKLMRAQTEREILSLLDHPFLPTLYSHFE--TDKFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~ 186 (506)
+++|++++.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+++++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 578999999999999999999999999999999998754332 244567889999999999999999999984 45689
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.++ |.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999776 878877766678999999999999999999999999999999999999999999999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ...
T Consensus 163 ~~---------------------------------------------------------------------------~~~ 167 (305)
T 2wtk_C 163 AA---------------------------------------------------------------------------DDT 167 (305)
T ss_dssp CS---------------------------------------------------------------------------SCE
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 000
Q ss_pred ccccccCCCCccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~--~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+.+..+......++. .+++.+.+||.
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--~~~~~l~~li~ 245 (305)
T 2wtk_C 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--DCGPPLSDLLK 245 (305)
T ss_dssp ECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS--SSCHHHHHHHH
T ss_pred cccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC--ccCHHHHHHHH
Confidence 11236999999999998754 378999999999999999999999988877777777766655554 68999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+||..||.+||+ +.|+++||||+...
T Consensus 246 ~~l~~dp~~Rps----~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 246 GMLEYEPAKRFS----IRQIRQHSWFRKKH 271 (305)
T ss_dssp HHTCSSTTTSCC----HHHHHHSHHHHSCC
T ss_pred HHccCChhhCCC----HHHHhcCcccccCC
Confidence 999999999997 99999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=410.74 Aligned_cols=258 Identities=27% Similarity=0.385 Sum_probs=209.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK---- 184 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 184 (506)
.+++|++++.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.+|+.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 45789999999999999999999999999999999976432 2345567789999999999999999999998665
Q ss_pred --eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 185 --FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 185 --~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.+|+|||||. |+|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999995 57888775 3589999999999999999999999999999999999999999999999999853
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 177 ~~~~---------------------------------------------------------------------------- 180 (371)
T 2xrw_A 177 AGTS---------------------------------------------------------------------------- 180 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC--------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK-------------- 408 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 408 (506)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..++.....
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred --cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 0012347999999999999999999999999999999999999999998887777666542110
Q ss_pred -----CCCCC---------------------CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 409 -----FPEGS---------------------SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 409 -----~p~~~---------------------~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
.+... ..+.++++||.+||..||.+||| ++|+|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWY 326 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTC
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhc
Confidence 00000 01567899999999999999997 99999999998543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=397.39 Aligned_cols=263 Identities=30% Similarity=0.494 Sum_probs=226.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---KKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.++|++++.||+|+||.||+|+++.+++.||||++.+...... .....+.+|+.+|+.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3569999999999999999999999999999999987543321 2356778899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC----CEEEeecCCccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG----HIMLSDFDLSLR 262 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFGla~~ 262 (506)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999998765 5799999999999999999999999999999999999999877 899999999853
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 162 ~~~~---------------------------------------------------------------------------- 165 (283)
T 3bhy_A 162 IEAG---------------------------------------------------------------------------- 165 (283)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAK 420 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~ 420 (506)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++. ...++..+.
T Consensus 166 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T 3bhy_A 166 --NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAK 243 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred --CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHH
Confidence 0011236899999999999999999999999999999999999999998888777777655544432 136889999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+||.+||..||.+||+ +.++++||||+.+.+.
T Consensus 244 ~li~~~l~~dp~~Rps----~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 244 DFIRRLLVKDPKRRMT----IAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHTTSCSSGGGSCC----HHHHHHCHHHHHHHHC
T ss_pred HHHHHHccCCHhHCcC----HHHHHhCHHHHHHHHH
Confidence 9999999999999997 9999999999876554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=399.60 Aligned_cols=256 Identities=32% Similarity=0.484 Sum_probs=221.7
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+|+.+|+.++||||+++++++...+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4569999999999999999999999999999999986432 2234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE---ecCCCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFGla~~~~~~ 266 (506)
|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 85 MQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp ECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999999999988765 579999999999999999999999999999999999999 7788999999998742100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 162 ------------------------------------------------------------------------------~~ 163 (304)
T 2jam_A 162 ------------------------------------------------------------------------------GI 163 (304)
T ss_dssp ------------------------------------------------------------------------------BT
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~ 424 (506)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+......++. ...++.++.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC 243 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence 12236999999999999999999999999999999999999999988887777777766544432 3568999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
+||..||.+||+ ++|+++||||+..
T Consensus 244 ~~l~~dp~~Rps----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 244 HLLEKDPNERYT----CEKALSHPWIDGN 268 (304)
T ss_dssp HHHCSSTTTSCC----HHHHHTSHHHHSS
T ss_pred HHcCCChhHCcC----HHHHhcCccccCC
Confidence 999999999997 9999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=390.86 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=220.4
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3569999999999999999999999999999999975432 23456678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 160 (276)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-
Confidence 9999999999988654 5799999999999999999999999999999999999999999999999999854211100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 161 --------------------------------------------------------------------------~~~~~~ 166 (276)
T 2yex_A 161 --------------------------------------------------------------------------ERLLNK 166 (276)
T ss_dssp --------------------------------------------------------------------------ECCBCC
T ss_pred --------------------------------------------------------------------------hhcccC
Confidence 000123
Q ss_pred cccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 350 FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
..||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ..+..+.......+....++..+.+||.+||
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 246 (276)
T 2yex_A 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246 (276)
T ss_dssp CCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred CccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHC
Confidence 469999999999988775 77999999999999999999999876543 2334444444344444568999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..||.+||+ ++|+++||||+..
T Consensus 247 ~~~p~~Rps----~~~il~~~~~~~~ 268 (276)
T 2yex_A 247 VENPSARIT----IPDIKKDRWYNKP 268 (276)
T ss_dssp CSSTTTSCC----HHHHTTCTTTTCC
T ss_pred CCCchhCCC----HHHHhcCccccCh
Confidence 999999997 9999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=415.32 Aligned_cols=264 Identities=27% Similarity=0.457 Sum_probs=211.5
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK- 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 184 (506)
++....+|++++.||+|+||+||+|++..+++ ||+|++.+.... ..+|+++|+.++|||||+++++|...+
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 33445679999999999999999999988666 888877543211 135999999999999999999996543
Q ss_pred -----eEEEEEeecCCCChHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe-cCCCEEEeec
Q 010603 185 -----FSCLLMEFCSGGDLHTLRQR-QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-EDGHIMLSDF 257 (506)
Q Consensus 185 -----~~~lV~E~~~gg~L~~~l~~-~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~DF 257 (506)
.+|+|||||.++.+..+... .....+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 48899999976544443321 2236799999999999999999999999999999999999999 7999999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|+|+.....
T Consensus 187 G~a~~~~~~----------------------------------------------------------------------- 195 (394)
T 4e7w_A 187 GSAKILIAG----------------------------------------------------------------------- 195 (394)
T ss_dssp TTCEECCTT-----------------------------------------------------------------------
T ss_pred CCcccccCC-----------------------------------------------------------------------
Confidence 998542110
Q ss_pred cccCCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC-------
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP------- 406 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~------- 406 (506)
......+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+..+.+..++. .+
T Consensus 196 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 196 -------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp -------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred -------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 001234789999999999875 589999999999999999999999999887776665542 11
Q ss_pred -------CCCCC----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchhc
Q 010603 407 -------LKFPE----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIR 459 (506)
Q Consensus 407 -------~~~p~----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~~ 459 (506)
..++. ...+++++++||.+||+.||.+||+ +.|+++||||+.+.|....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCC
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhcccccc
Confidence 11111 1247899999999999999999997 9999999999998876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=409.15 Aligned_cols=251 Identities=26% Similarity=0.432 Sum_probs=213.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch-----hHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR-----KKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+.+|+++|+.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3569999999999999999999999999999999987543221 13334567999999999999999999999999
Q ss_pred eEEEEEeecCCC-ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 185 FSCLLMEFCSGG-DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 ~~~lV~E~~~gg-~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.+++||||+.+| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999998777 999998875 57999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 181 ~~~----------------------------------------------------------------------------- 183 (335)
T 3dls_A 181 ERG----------------------------------------------------------------------------- 183 (335)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CCCccccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ........| ..+++++.+|
T Consensus 184 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~--~~~~~~l~~l 254 (335)
T 3dls_A 184 -KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPP--YLVSKELMSL 254 (335)
T ss_dssp -CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCS--SCCCHHHHHH
T ss_pred -CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCC--cccCHHHHHH
Confidence 01123479999999999998886 8899999999999999999999976322 122222222 3689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.+||..||.+||+ +.++++||||+.
T Consensus 255 i~~~L~~dP~~Rps----~~ell~hp~~~~ 280 (335)
T 3dls_A 255 VSGLLQPVPERRTT----LEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHTCSSGGGSCC----HHHHHHCTTTTC
T ss_pred HHHHccCChhhCcC----HHHHhcCccccC
Confidence 99999999999997 999999999965
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=421.90 Aligned_cols=263 Identities=30% Similarity=0.477 Sum_probs=211.2
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc-----hhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-----RKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..++|++++.||+|+||+||+|.++.+++.||||++.+..... ......+.+|+++|+.++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3467999999999999999999999999999999998754321 1222346789999999999999999999865
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CEEEeecCCc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HIMLSDFDLS 260 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~vkl~DFGla 260 (506)
+..|+|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4579999999999999987664 6799999999999999999999999999999999999997654 5999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+....
T Consensus 290 ~~~~~--------------------------------------------------------------------------- 294 (419)
T 3i6u_A 290 KILGE--------------------------------------------------------------------------- 294 (419)
T ss_dssp TSCC----------------------------------------------------------------------------
T ss_pred eecCC---------------------------------------------------------------------------
Confidence 53210
Q ss_pred CCCCCCccccccCCCCccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHH-HHHHHhCCCCCCCC--CCC
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE-TLFNVVGQPLKFPE--GSS 414 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~--~~~ 414 (506)
.......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||....... ....+......++. ...
T Consensus 295 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 295 ---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp -------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred ---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 001123479999999999864 568899999999999999999999998755433 33344444433321 246
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+++.+.+||.+||+.||.+||+ ++|+|+||||+..+|.
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 409 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGCCHHHH
T ss_pred cCHHHHHHHHHHccCChhHCcC----HHHHhCCcccCChhHH
Confidence 8999999999999999999997 9999999999987764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=407.94 Aligned_cols=266 Identities=27% Similarity=0.358 Sum_probs=215.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------- 182 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------- 182 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+++|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 56799999999999999999999999999999999765432 2233456789999999999999999999987
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 183 -DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 183 -~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.+.+|||||||. |+|...+... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999996 5777766554 2569999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.+......
T Consensus 173 ~~~~~~~~------------------------------------------------------------------------ 180 (351)
T 3mi9_A 173 AFSLAKNS------------------------------------------------------------------------ 180 (351)
T ss_dssp ECCCCSSS------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred CCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC-----CCCC--
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF-----PEGS-- 413 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~-- 413 (506)
........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+......+ +...
T Consensus 181 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 259 (351)
T 3mi9_A 181 -QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259 (351)
T ss_dssp -SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence 00112234799999999999874 58999999999999999999999999988777665554211111 1100
Q ss_pred -----------------------CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 414 -----------------------SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 414 -----------------------~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
..++.+++||.+||..||.+||+ ++|+|+||||+...+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSDPM 320 (351)
T ss_dssp GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSSSC
T ss_pred hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCCCC
Confidence 02678999999999999999997 999999999986543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=408.06 Aligned_cols=257 Identities=33% Similarity=0.489 Sum_probs=221.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh-----hchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML-----AGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
++|++.+.||+|+||+||+|.++.+|+.||||++..... ........+.+|+.+++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 569999999999999999999999999999999976431 1122345678899999999 8999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..||||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999998865 579999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 252 ~~------------------------------------------------------------------------------ 253 (365)
T 2y7j_A 252 PG------------------------------------------------------------------------------ 253 (365)
T ss_dssp TT------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCccccccCCCCccchhhcC------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCC
Q 010603 345 ARSMSFVGTHEYLAPEIIRG------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSIS 416 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s 416 (506)
......+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||........+..+......++ .+..++
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 333 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 00123479999999999974 3588999999999999999999999998887777777766554443 234688
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
..+.+||.+||..||.+||+ +.++|+||||+
T Consensus 334 ~~~~~li~~~L~~dP~~Rps----~~ell~hp~f~ 364 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLT----AEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGC
T ss_pred HHHHHHHHHHcCCChhHCcC----HHHHhcCcccC
Confidence 99999999999999999997 99999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=405.59 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=213.3
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC--CCccceeEEEEeCCeE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH--PFLPTLYSHFETDKFS 186 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~ 186 (506)
.-++|++++.||+|+||+||+|.+. +++.||||++...... ......+.+|+++|+.++| |||+++++++..++.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3456999999999999999999885 5889999999765432 3455678899999999976 9999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||||+ .+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+ ++.+||+|||+++.....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999995 589999999876 6799999999999999999999999999999999999997 678999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. ....
T Consensus 161 ~---------------------------------------------------------------------------~~~~ 165 (343)
T 3dbq_A 161 T---------------------------------------------------------------------------TSVV 165 (343)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0001
Q ss_pred ccccccCCCCccchhhcC-----------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCCCCCCCCCCC
Q 010603 347 SMSFVGTHEYLAPEIIRG-----------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQPLKFPEGSS 414 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~-----------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~ 414 (506)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||...... ..+..++...........
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCC
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCccc
Confidence 123479999999999975 67899999999999999999999999875443 445555554444444446
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+.++.+||.+||..||.+||+ +.|+|+||||+..
T Consensus 246 ~~~~l~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 246 PEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 280 (343)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSC
T ss_pred CCHHHHHHHHHHcCCChhHCCC----HHHHHhCcccccc
Confidence 7889999999999999999997 9999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=412.27 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=202.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC------C
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD------K 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 184 (506)
++|++++.||+|+||.||+|.+..+|+.||||++.... .......++.+|+++|+.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 67999999999999999999999999999999997643 2234556778999999999999999999999754 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 689999999 8999998865 479999999999999999999999999999999999999999999999999985310
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.
T Consensus 184 ~------------------------------------------------------------------------------- 184 (367)
T 2fst_X 184 D------------------------------------------------------------------------------- 184 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC--------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP-------------- 406 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~-------------- 406 (506)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+.. .+
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 0123479999999999987 6789999999999999999999999999887766655432 11
Q ss_pred ------CCCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 407 ------LKFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 407 ------~~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
...+. ...+++.+.+||.+||..||.+||+ +.|+|+||||+....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCC
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccC
Confidence 00010 1246889999999999999999997 999999999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=397.96 Aligned_cols=255 Identities=26% Similarity=0.409 Sum_probs=209.3
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEe--CCe
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFET--DKF 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~ 185 (506)
..++|++++.||+|+||+||+|++..+++.||||++... ....+.+|+++|+.++ ||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 346799999999999999999999999999999999753 2345778999999997 9999999999998 668
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCF 264 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~ 264 (506)
.++||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 108 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999999998875 389999999999999999999999999999999999999777 89999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
...
T Consensus 183 ~~~----------------------------------------------------------------------------- 185 (330)
T 3nsz_A 183 PGQ----------------------------------------------------------------------------- 185 (330)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCC-cHHHHHHHh-------------CCCCCC
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNG-NRETLFNVV-------------GQPLKF 409 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~-~~~~~~~i~-------------~~~~~~ 409 (506)
.....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ..+.+..+. .....+
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 0112368999999999987 668999999999999999999999995433 322222211 001000
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 410 ----------------------PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 410 ----------------------p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.....+++++++||.+||..||.+||| ++|+|+||||+.+.|+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 329 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC--
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhccC
Confidence 011237999999999999999999997 9999999999988764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=407.53 Aligned_cols=264 Identities=27% Similarity=0.393 Sum_probs=219.7
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.+++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+++|+.++||||+++++++...+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45679999999999999999999999999999999876432 23344567789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+.+++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp EEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 99999999998876654 579999999999999999999999999999999999999999999999999985321100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 179 ----------------------------------------------------------------------------~~~~ 182 (331)
T 4aaa_A 179 ----------------------------------------------------------------------------EVYD 182 (331)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------cccC
Confidence 0011
Q ss_pred ccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-------------------CCC
Q 010603 349 SFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-------------------PLK 408 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------------------~~~ 408 (506)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+... ...
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 23689999999999876 6899999999999999999999999988877666544311 011
Q ss_pred CCC----------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 409 FPE----------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 409 ~p~----------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
++. ...+++.+.+||.+||..||.+||+ ++|+|+||||+..+|.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFA 316 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHH
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChh
Confidence 111 1257899999999999999999998 8999999999877654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=415.62 Aligned_cols=262 Identities=23% Similarity=0.362 Sum_probs=212.8
Q ss_pred ccCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC--------CCCc
Q 010603 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--------HPFL 173 (506)
Q Consensus 102 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--------hpnI 173 (506)
....+++..++|++++.||+|+||+||+|++..+++.||||++.+. ......+.+|+++|+.++ |+||
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 4456677788999999999999999999999999999999999764 234556788999998885 7889
Q ss_pred cceeEEEE----eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEec
Q 010603 174 PTLYSHFE----TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVRE 248 (506)
Q Consensus 174 v~l~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~ 248 (506)
++++++|. ....+||||||+ +++|.+++.......+++..++.++.||+.||+|||++ |||||||||+||||+.
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 99999998 556899999999 77777776665556799999999999999999999998 9999999999999997
Q ss_pred CC-------------------------------------------------CEEEeecCCccccccCCccccCCCCcccc
Q 010603 249 DG-------------------------------------------------HIMLSDFDLSLRCFVSPKLVQSSDDPACR 279 (506)
Q Consensus 249 ~~-------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~ 279 (506)
++ .+||+|||+|.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------------- 248 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------------- 248 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--------------
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--------------
Confidence 75 799999999853210
Q ss_pred cCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccc
Q 010603 280 ISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAP 359 (506)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 359 (506)
.....+||+.|+||
T Consensus 249 ------------------------------------------------------------------~~~~~~gt~~y~aP 262 (397)
T 1wak_A 249 ------------------------------------------------------------------HFTEDIQTRQYRSL 262 (397)
T ss_dssp ------------------------------------------------------------------CSCSCCSCGGGCCH
T ss_pred ------------------------------------------------------------------cCccCCCCCcccCC
Confidence 01123699999999
Q ss_pred hhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc------HHHHH---HHhCCCCC---------------------C
Q 010603 360 EIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN------RETLF---NVVGQPLK---------------------F 409 (506)
Q Consensus 360 E~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~------~~~~~---~i~~~~~~---------------------~ 409 (506)
|++.+..|+.++|||||||+||||++|+.||...+. .+.+. .+.+.... +
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 999999999999999999999999999999986542 22222 22221100 0
Q ss_pred ----------------CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 410 ----------------PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 410 ----------------p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
......+..+.+||.+||+.||.+||+ ++|||+||||++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 001123457889999999999999997 999999999963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=401.72 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=218.1
Q ss_pred cCCCCcccCCeEEEeEEeecCceEEEEEEE-ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC------Cccc
Q 010603 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAEL-RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP------FLPT 175 (506)
Q Consensus 103 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp------nIv~ 175 (506)
...+++..++|++++.||+|+||+||+|.+ +.+++.||||+++.. ......+.+|+++++.++|+ +|++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 345677778999999999999999999998 567899999999754 23455677899999888665 4999
Q ss_pred eeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-------
Q 010603 176 LYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE------- 248 (506)
Q Consensus 176 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~------- 248 (506)
+++++...+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 999999998876568999999999999999999999999999999999999987
Q ss_pred ------------CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccc
Q 010603 249 ------------DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLN 316 (506)
Q Consensus 249 ------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (506)
++.+||+|||++.....
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--------------------------------------------------- 189 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDE--------------------------------------------------- 189 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTS---------------------------------------------------
T ss_pred CCccccccccccCCCceEeeCcccccCcc---------------------------------------------------
Confidence 66899999999843100
Q ss_pred ccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH
Q 010603 317 SKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR 396 (506)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~ 396 (506)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 190 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 190 -----------------------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -----------------------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred -----------------------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 011236999999999999999999999999999999999999999988776
Q ss_pred HHHHHHhCCCCCCC------------------------------------------CCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 397 ETLFNVVGQPLKFP------------------------------------------EGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 397 ~~~~~i~~~~~~~p------------------------------------------~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
+.+..+......+| .....++++.+||.+||..||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 55443321100000 011234678899999999999999
Q ss_pred cCCCCChHHhhcCCCCCCCC
Q 010603 435 LGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 435 ~s~~~~a~ell~hp~f~~~~ 454 (506)
|+ +.|+++||||+.+.
T Consensus 321 pt----~~ell~hp~f~~~~ 336 (339)
T 1z57_A 321 IT----LREALKHPFFDLLK 336 (339)
T ss_dssp CC----HHHHTTSGGGGGGG
T ss_pred cC----HHHHhcCHHHHHHh
Confidence 97 99999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=401.42 Aligned_cols=263 Identities=29% Similarity=0.431 Sum_probs=219.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEe-----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFET----- 182 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----- 182 (506)
..++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3467999999999999999999999999999999997542 2335677899999998 89999999999987
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 183 -DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 183 -~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.+.+|+||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 5689999999999999999987655689999999999999999999999999999999999999999999999999984
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 178 ~~~~~--------------------------------------------------------------------------- 182 (326)
T 2x7f_A 178 QLDRT--------------------------------------------------------------------------- 182 (326)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ecCcC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred CCCCCccccccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCC
Q 010603 342 PTSARSMSFVGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s 416 (506)
........||+.|+|||++. +..++.++|||||||++|+|++|..||.+......+..+............++
T Consensus 183 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 2x7f_A 183 --VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSC
T ss_pred --ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccC
Confidence 00012246999999999997 55689999999999999999999999998887776666654443333335689
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
..+.+||.+||..||.+||+ +.++++||||+...+.
T Consensus 261 ~~l~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 261 KKFQSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HHHHHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTTH
T ss_pred HHHHHHHHHHhccChhhCCC----HHHHhhChHHhhCccc
Confidence 99999999999999999997 9999999999876653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=391.06 Aligned_cols=255 Identities=22% Similarity=0.389 Sum_probs=215.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe----CCeE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----DKFS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~ 186 (506)
..|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3499999999999999999999999999999999865433 3445678899999999999999999999875 4578
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEe-cCCCEEEeecCCcccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVR-EDGHIMLSDFDLSLRC 263 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~-~~~~vkl~DFGla~~~ 263 (506)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999875 57999999999999999999999999 99999999999998 7899999999998421
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 183 ~~------------------------------------------------------------------------------ 184 (290)
T 1t4h_A 183 RA------------------------------------------------------------------------------ 184 (290)
T ss_dssp CT------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~l 422 (506)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||............+... .........++++.+|
T Consensus 185 -~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 262 (290)
T 1t4h_A 185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred -cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence 00123469999999998874 58999999999999999999999998866655555444332 2222233578899999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.+||..||.+||+ ++|+++||||++
T Consensus 263 i~~~l~~dp~~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 263 IEGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHHccCChhhCCC----HHHHhhCccccc
Confidence 99999999999997 999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=403.97 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=215.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----Ce
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-----KF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 185 (506)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+++|+.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 57999999999999999999999999999999997532 234456778999999999999999999999765 47
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.|+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 899999995 699998876 3699999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
... ...
T Consensus 181 ~~~--------------------------------------------------------------------------~~~ 186 (364)
T 3qyz_A 181 DHD--------------------------------------------------------------------------HTG 186 (364)
T ss_dssp GGC--------------------------------------------------------------------------BCC
T ss_pred CCC--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred CccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC--------------
Q 010603 346 RSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL-------------- 407 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~-------------- 407 (506)
.....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.. .+.
T Consensus 187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T 3qyz_A 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266 (364)
T ss_dssp TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence 11234799999999987654 589999999999999999999999998887766655532 110
Q ss_pred ---CCCC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 408 ---KFPE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 408 ---~~p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.++. ...++.++.+||.+||..||.+||+ +.|+|+||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 320 (364)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhc
Confidence 0000 1257899999999999999999997 9999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=411.09 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=214.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC--CCCccceeEEEEeCCeEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--HPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~l 188 (506)
.+|++++.||+|+||+||+|.+.. ++.||||++.+... .......+.+|+++|+.++ |||||++++++...+.+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 459999999999999999999876 89999999986543 2345667889999999996 5999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||| +.+++|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+ ++.+||+|||+++.+.....
T Consensus 134 v~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 999 5589999999876 5789999999999999999999999999999999999995 68999999999854211000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
.....
T Consensus 210 ---------------------------------------------------------------------------~~~~~ 214 (390)
T 2zmd_A 210 ---------------------------------------------------------------------------SVVKD 214 (390)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00012
Q ss_pred ccccCCCCccchhhcC-----------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHhCCCCCCCCCCCCC
Q 010603 349 SFVGTHEYLAPEIIRG-----------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~-----------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~s 416 (506)
..+||+.|+|||++.+ ..|+.++||||||||||||++|+.||..... ...+..++.....++.....+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (390)
T 2zmd_A 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294 (390)
T ss_dssp CSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSC
T ss_pred CCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccch
Confidence 3479999999999975 3689999999999999999999999987644 345566665554444444678
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
.++.+||.+||..||.+||+ +.|+|+||||+...
T Consensus 295 ~~~~~li~~~L~~dP~~Rps----~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSCC
T ss_pred HHHHHHHHHHcccChhhCCC----HHHHhhCcCccccC
Confidence 99999999999999999997 99999999997543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=405.55 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=217.7
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-------cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCcccee
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-------DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLY 177 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 177 (506)
..+..++|++++.||+|+||+||+|++. .++..||||+++... .......+.+|+++|+.+ +|||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3456678999999999999999999975 345679999997652 234566788999999999 899999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
+++...+.+|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999988753 2358999999999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
|||+.+|.+||+|||+++.......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~------------------------------------------------------- 258 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDY------------------------------------------------------- 258 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCT-------------------------------------------------------
T ss_pred EEECCCCCEEEccccCCcccCcccc-------------------------------------------------------
Confidence 9999999999999999864211100
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+....+.+..+
T Consensus 259 --------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 259 --------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp --------------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred --------------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 000112357889999999999999999999999999999999 99999988877766665
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.... ..+....++.++.+||.+||..||.+||+ +.|++++
T Consensus 319 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~ 358 (370)
T 2psq_A 319 KEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 358 (370)
T ss_dssp HTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 5432 23333478999999999999999999997 7888763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=410.17 Aligned_cols=258 Identities=28% Similarity=0.506 Sum_probs=211.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-----
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----- 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----- 182 (506)
...++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+++|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456799999999999999999999999999999998754211 2369999999999999999999844
Q ss_pred ---------------------------------CCeEEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHH
Q 010603 183 ---------------------------------DKFSCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALE 227 (506)
Q Consensus 183 ---------------------------------~~~~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~ 227 (506)
..++++||||++ |+|.+++.. ..+..+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999996 688776653 23468999999999999999999
Q ss_pred HHHhCCeEEccCCCCcEEEe-cCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCC
Q 010603 228 YLHMMGVVYRDLKPENVLVR-EDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQ 306 (506)
Q Consensus 228 yLH~~giiHrDLKp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (506)
|||++||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---------------------------------------- 195 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---------------------------------------- 195 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT----------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC----------------------------------------
Confidence 99999999999999999998 6889999999998542110
Q ss_pred CCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhc
Q 010603 307 PSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLL 385 (506)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~ellt 385 (506)
......+||+.|+|||++.+.. |+.++|||||||++|||++
T Consensus 196 --------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 196 --------------------------------------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp --------------------------------------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred --------------------------------------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 0012346899999999998754 8999999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHhC---CC--------------CCCCC----------CCCCCHHHHHHHHHHhhcCCCCccCCC
Q 010603 386 GRTPFKGNGNRETLFNVVG---QP--------------LKFPE----------GSSISFAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 386 G~~Pf~~~~~~~~~~~i~~---~~--------------~~~p~----------~~~~s~~~~~li~~~L~~dP~~R~s~~ 438 (506)
|++||.+.+..+.+..++. .+ ..+|. ...+++++.+||.+||..||.+|||
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 315 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN-- 315 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC--
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC--
Confidence 9999999888777766542 11 11111 1247899999999999999999997
Q ss_pred CChHHhhcCCCCCCCCc
Q 010603 439 RGATEIKQHPFFESVNW 455 (506)
Q Consensus 439 ~~a~ell~hp~f~~~~~ 455 (506)
+.|+|+||||+.+.+
T Consensus 316 --~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 316 --PYEAMAHPFFDHLRN 330 (383)
T ss_dssp --HHHHHTSGGGHHHHH
T ss_pred --HHHHhcCHHHHHHHh
Confidence 999999999986543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=393.06 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=206.0
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|++++.||+|+||+||+|++..+|+.||||++...... ......+..+..+++.++||||+++++++...+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 45667899999999999999999999999999999999765322 22333344555568889999999999999999999
Q ss_pred EEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 187 CLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
|+||||++ |+|.+++.. ..+..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 588777654 2346799999999999999999999998 9999999999999999999999999998532
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 161 ~~~----------------------------------------------------------------------------- 163 (290)
T 3fme_A 161 VDD----------------------------------------------------------------------------- 163 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CCCccccccCCCCccchhh----cCCCCCcchhHHHHHHHHHHHhcCCCCCCCC-CcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 344 SARSMSFVGTHEYLAPEII----RGDGHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l----~~~~~~~~~DiWSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
.......||+.|+|||++ .+..++.++|||||||++|||++|+.||... .....+...............++++
T Consensus 164 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (290)
T 3fme_A 164 -VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHH
T ss_pred -ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHH
Confidence 001122699999999997 4567899999999999999999999999864 3344444444333333333468999
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+.+||.+||..||.+||+ +.|+++||||+.
T Consensus 243 ~~~li~~~l~~~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 243 FVDFTSQCLKKNSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHTTSHHHHH
T ss_pred HHHHHHHHhhcChhhCcC----HHHHHhCccccc
Confidence 999999999999999997 999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=402.85 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=220.5
Q ss_pred ccCCCCcccCCeEEEeEEeecCceEEEEEEEccCC-ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC------cc
Q 010603 102 KSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMG-CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF------LP 174 (506)
Q Consensus 102 ~~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv 174 (506)
....+++..++|++++.||+|+||+||+|.+..++ +.||||+++.. ......+.+|+++|+.++|++ |+
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 34556777789999999999999999999998777 68999999754 234456678999999887665 99
Q ss_pred ceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE--------
Q 010603 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV-------- 246 (506)
Q Consensus 175 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl-------- 246 (506)
.+++++...+.+||||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 7778777777655679999999999999999999999999999999999999
Q ss_pred -----------ecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccc
Q 010603 247 -----------REDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFL 315 (506)
Q Consensus 247 -----------~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (506)
+.++.+||+|||+++....
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-------------------------------------------------- 194 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE-------------------------------------------------- 194 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS--------------------------------------------------
T ss_pred ccccccccccccCCCcEEEeecCccccccc--------------------------------------------------
Confidence 6788999999999843100
Q ss_pred cccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc
Q 010603 316 NSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN 395 (506)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~ 395 (506)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 195 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 195 ------------------------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp ------------------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ------------------------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 01123799999999999999999999999999999999999999998877
Q ss_pred HHHHHHHhCCCCCCC------------------------------------------CCCCCCHHHHHHHHHHhhcCCCC
Q 010603 396 RETLFNVVGQPLKFP------------------------------------------EGSSISFAAKDLIRGLLVKDPQK 433 (506)
Q Consensus 396 ~~~~~~i~~~~~~~p------------------------------------------~~~~~s~~~~~li~~~L~~dP~~ 433 (506)
.+.+..+......+| .....+.++.+||.+||..||.+
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 655443321100100 01112457889999999999999
Q ss_pred ccCCCCChHHhhcCCCCCCCCcchh
Q 010603 434 RLGFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 434 R~s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
||+ +.|+|+||||+.++|...
T Consensus 325 Rpt----~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 325 RIT----LAEALLHPFFAGLTPEER 345 (355)
T ss_dssp SCC----HHHHTTSGGGGGCCHHHH
T ss_pred CcC----HHHHhcChhhcCCChhhc
Confidence 997 999999999999887643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=418.65 Aligned_cols=261 Identities=21% Similarity=0.223 Sum_probs=201.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc--CCCCcccee-------EEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL--DHPFLPTLY-------SHFE 181 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~-------~~~~ 181 (506)
.+|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3499999999999999999999999999999999987654455666778886655555 699988755 5554
Q ss_pred eC-----------------CeEEEEEeecCCCChHHHHhhCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCeEEcc
Q 010603 182 TD-----------------KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQAT------RFYASEVLLALEYLHMMGVVYRD 238 (506)
Q Consensus 182 ~~-----------------~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~------~~i~~qil~aL~yLH~~giiHrD 238 (506)
.. ..+|||||||. |+|.+++.... ..+++... ..++.||+.||+|||++||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 43 34899999997 89999988642 23454545 56779999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccc
Q 010603 239 LKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318 (506)
Q Consensus 239 LKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (506)
|||+||||+.+|.+||+|||+|+....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----------------------------------------------------- 246 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----------------------------------------------------- 246 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----------------------------------------------------
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----------------------------------------------------
Confidence 999999999999999999999853210
Q ss_pred ccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH
Q 010603 319 TTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR 396 (506)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~ 396 (506)
......||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+....
T Consensus 247 ---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 299 (371)
T 3q60_A 247 ---------------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299 (371)
T ss_dssp ---------------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred ---------------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence 0012357799999999987 67999999999999999999999999876432
Q ss_pred HH--H-----HHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 397 ET--L-----FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 397 ~~--~-----~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
.. + .........++....+++.+.+||.+||..||++||+ +.++|+||||+.+.|..
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp CTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHH
T ss_pred cccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHH
Confidence 10 0 0111223344544578999999999999999999997 99999999999888764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=394.79 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=212.6
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
..++..++|++++.||+|+||+||+|++. |+.||||++.+.... ......+.+|+++|+.++||||+++++++...+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34566778999999999999999999874 889999999865432 344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPG-KHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~-~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.+|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999876421 23999999999999999999999999 9999999999999999999999999984
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 188 ~~~~~--------------------------------------------------------------------------- 192 (309)
T 3p86_A 188 LKAST--------------------------------------------------------------------------- 192 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 31100
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......+....+++++.+
T Consensus 193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 193 --FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred --ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 000123479999999999999999999999999999999999999999888877776664333333334479999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
||.+||..||.+||+ ++++++
T Consensus 271 li~~~l~~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 271 IIEGCWTNEPWKRPS----FATIMD 291 (309)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHccCChhhCcC----HHHHHH
Confidence 999999999999998 788876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=421.05 Aligned_cols=251 Identities=18% Similarity=0.190 Sum_probs=204.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHH---HHhcCCCCcccee-------EE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI---LSLLDHPFLPTLY-------SH 179 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i---l~~l~hpnIv~l~-------~~ 179 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++ |+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4679999999999999999999999999999999987655555666778899955 5555899999998 77
Q ss_pred EEeCC-----------------eEEEEEeecCCCChHHHHhhCCCCCCC-------HHHHHHHHHHHHHHHHHHHhCCeE
Q 010603 180 FETDK-----------------FSCLLMEFCSGGDLHTLRQRQPGKHFS-------EQATRFYASEVLLALEYLHMMGVV 235 (506)
Q Consensus 180 ~~~~~-----------------~~~lV~E~~~gg~L~~~l~~~~~~~~~-------e~~~~~i~~qil~aL~yLH~~gii 235 (506)
++..+ ..||||||+ +|+|.+++... ..++ +..++.|+.||+.||+|||++|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 76654 389999999 78999998864 2344 488888999999999999999999
Q ss_pred EccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccc
Q 010603 236 YRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFL 315 (506)
Q Consensus 236 HrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (506)
||||||+||||+.+|.+||+|||+|+...
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~--------------------------------------------------- 257 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG--------------------------------------------------- 257 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT---------------------------------------------------
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC---------------------------------------------------
Confidence 99999999999999999999999985310
Q ss_pred cccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCC-----------CCCcchhHHHHHHHHHHHh
Q 010603 316 NSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD-----------GHGSAVDWWTFGIFFYELL 384 (506)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~~~~~DiWSlGvil~ell 384 (506)
......+| +.|+|||++.+. .|+.++|||||||+||||+
T Consensus 258 -----------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 258 -----------------------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp -----------------------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 01123368 999999999987 8999999999999999999
Q ss_pred cCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 385 LGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 385 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+|+.||.+....+.+..+.. ....+++++.+||.+||..||.+||+ +.|+++||||+.+.
T Consensus 308 tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 308 CADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLR 367 (377)
T ss_dssp HSSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHHH
T ss_pred HCCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHHH
Confidence 99999987654433322221 22468999999999999999999997 99999999997643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=408.20 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=215.9
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CC-----Ccccee
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HP-----FLPTLY 177 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~ 177 (506)
..++...++|++++.||+|+||+||+|.++.+++.||||+++.. ......+..|+++++.++ |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 45566778999999999999999999999999999999999754 234456677888888875 54 499999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeEEccCCCCcEEEe--cCCCEE
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH--MMGVVYRDLKPENVLVR--EDGHIM 253 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH--~~giiHrDLKp~NILl~--~~~~vk 253 (506)
+++...+.+||||||+. |+|.+++.......+++..++.++.||+.||.||| +.|||||||||+||||+ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999999995 69999998876567999999999999999999999 57999999999999995 477899
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||+|+....
T Consensus 202 L~DFG~a~~~~~-------------------------------------------------------------------- 213 (382)
T 2vx3_A 202 IVDFGSSCQLGQ-------------------------------------------------------------------- 213 (382)
T ss_dssp ECCCTTCEETTC--------------------------------------------------------------------
T ss_pred EEeccCceeccc--------------------------------------------------------------------
Confidence 999999853210
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC-----
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK----- 408 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----- 408 (506)
.....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+......
T Consensus 214 ------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 214 ------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp ------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 011247999999999999999999999999999999999999999998877766655421000
Q ss_pred -------------CCC-------------------CCC-------------------------CCHHHHHHHHHHhhcCC
Q 010603 409 -------------FPE-------------------GSS-------------------------ISFAAKDLIRGLLVKDP 431 (506)
Q Consensus 409 -------------~p~-------------------~~~-------------------------~s~~~~~li~~~L~~dP 431 (506)
++. ... .++++++||.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 000 000 01378999999999999
Q ss_pred CCccCCCCChHHhhcCCCCCCCC
Q 010603 432 QKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 432 ~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
++||| ++|+|+||||+...
T Consensus 362 ~~Rpt----a~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 362 KTRIQ----PYYALQHSFFKKTA 380 (382)
T ss_dssp TTSCC----HHHHTTSGGGCC--
T ss_pred hhCCC----HHHHhcCcccccCC
Confidence 99998 99999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=405.22 Aligned_cols=256 Identities=31% Similarity=0.425 Sum_probs=214.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE----
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS---- 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~---- 186 (506)
++|++++.||+|+||+||+|.++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 579999999999999999999999999999999976432 234456778999999999999999999999887755
Q ss_pred --EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 187 --CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 187 --~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
|+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999995 78887763 359999999999999999999999999999999999999999999999999984310
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.
T Consensus 196 ~------------------------------------------------------------------------------- 196 (371)
T 4exu_A 196 A------------------------------------------------------------------------------- 196 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C--------------
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P-------------- 406 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~-------------- 406 (506)
.....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..++.. +
T Consensus 197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 0122478999999999987 67899999999999999999999999988877666555321 0
Q ss_pred ------CCCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 407 ------LKFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 407 ------~~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
...+. ...+++++.+||.+||+.||.+||+ ++|+|+||||+.+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCG
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCc
Confidence 00000 1257899999999999999999997 9999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=387.53 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=209.5
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 188 (506)
.++|++++.||+|+||+||+|.++.+++.||||++.+.... ......+.+|+.++..+ +||||+++++++...+..|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35699999999999999999999999999999999865332 23445677899999988 99999999999999999999
Q ss_pred EEeecCCCChHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-----------------
Q 010603 189 LMEFCSGGDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED----------------- 249 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~--~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~----------------- 249 (506)
||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999987642 2568999999999999999999999999999999999999844
Q ss_pred --CCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccc
Q 010603 250 --GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKT 327 (506)
Q Consensus 250 --~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (506)
..+||+|||++.....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~-------------------------------------------------------------- 186 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISS-------------------------------------------------------------- 186 (289)
T ss_dssp -CCCEEECCCTTCEETTC--------------------------------------------------------------
T ss_pred CceEEEEcccccccccCC--------------------------------------------------------------
Confidence 4799999999853210
Q ss_pred cCCCCCCCcccccCCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC
Q 010603 328 SLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406 (506)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 406 (506)
.....||+.|+|||++.+. .++.++|||||||++|||++|.+|+.... ....+....
T Consensus 187 -------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~ 244 (289)
T 1x8b_A 187 -------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGR 244 (289)
T ss_dssp -------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTC
T ss_pred -------------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCC
Confidence 0112589999999999876 56789999999999999999998875443 233343332
Q ss_pred C-CCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 L-KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 ~-~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
. .++ ..+++++.+||.+||..||.+||+ +.|+++||||...
T Consensus 245 ~~~~~--~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 245 LPRIP--QVLSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp CCCCS--SCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred CCCCC--cccCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 2 233 368999999999999999999997 9999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=393.05 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=220.3
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
..++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+++|+.++||||+++++++...+..|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4467999999999999999999999999999999997643 3345667889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999999988764 2569999999999999999999999999999999999999999999999999874211000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 172 ----------------------------------------------------------------------------~~~~ 175 (302)
T 2j7t_A 172 ----------------------------------------------------------------------------QKRD 175 (302)
T ss_dssp ----------------------------------------------------------------------------HC--
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHH
Q 010603 349 SFVGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDL 422 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~l 422 (506)
...||+.|+|||++. +..++.++|||||||++|+|++|+.||...+....+..+.... ........++..+.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHH
Confidence 236999999999984 6678999999999999999999999999888777666665433 2223334689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
|.+||..||.+||+ +.++++||||+.+.|.
T Consensus 256 i~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 256 LKIALDKNPETRPS----AAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHHHSCSCTTTSCC----HHHHTTSTTTTTCCCC
T ss_pred HHHHcccChhhCCC----HHHHhcChHHhhhccc
Confidence 99999999999997 9999999999988764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=398.17 Aligned_cols=272 Identities=27% Similarity=0.394 Sum_probs=217.7
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD----- 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 183 (506)
..++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+++|+.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4567999999999999999999999999999999997532 234455677899999999999999999988754
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
...|+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 68999999995 699998876 46999999999999999999999999999999999999999999999999998653
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
......... ....
T Consensus 163 ~~~~~~~~~-------------------------------------------------------------------~~~~ 175 (353)
T 2b9h_A 163 DESAADNSE-------------------------------------------------------------------PTGQ 175 (353)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccccccC-------------------------------------------------------------------cccc
Confidence 211100000 0000
Q ss_pred CCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh---CCCC------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV---GQPL------------ 407 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~------------ 407 (506)
.......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+. +.+.
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (353)
T 2b9h_A 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255 (353)
T ss_dssp ----CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHH
T ss_pred ccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccch
Confidence 011223579999999999875 678999999999999999999999999887665554432 1111
Q ss_pred ---------CCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 408 ---------KFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 408 ---------~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
..+. ...+++++.+||.+||..||.+||+ ++|+++||||+...+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDPN 316 (353)
T ss_dssp HHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCTT
T ss_pred hhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCcc
Confidence 0010 1257899999999999999999997 99999999999876643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=397.87 Aligned_cols=262 Identities=31% Similarity=0.499 Sum_probs=212.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh-----chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA-----GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.++|++++.||+|+||.||+|.++.+++.||||++.+.... .......+.+|+++|+.++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35699999999999999999999999999999999865432 1122345678999999999999999999997765
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC---EEEeecCCcc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH---IMLSDFDLSL 261 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFGla~ 261 (506)
.|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 89999999999999988754 67999999999999999999999999999999999999987664 9999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 166 ~~~~~--------------------------------------------------------------------------- 170 (322)
T 2ycf_A 166 ILGET--------------------------------------------------------------------------- 170 (322)
T ss_dssp ECCCC---------------------------------------------------------------------------
T ss_pred ecccc---------------------------------------------------------------------------
Confidence 32100
Q ss_pred CCCCCccccccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHH-HHHHHhCCCCCCCC--CCCC
Q 010603 342 PTSARSMSFVGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE-TLFNVVGQPLKFPE--GSSI 415 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~~p~--~~~~ 415 (506)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||....... ....+......+.. ...+
T Consensus 171 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 171 ---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp ---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 0012346999999999984 4568999999999999999999999998655432 23333333333221 1358
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+..+.+||.+||..||.+||+ ++++|+||||+..+|.
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred CHHHHHHHHHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 999999999999999999997 9999999999987764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=393.93 Aligned_cols=273 Identities=25% Similarity=0.366 Sum_probs=201.1
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..+..++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 34566789999999999999999999998999999999876432 2334567789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 186 SCLLMEFCSGGDLHTLRQR------QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~------~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
.|+||||+++++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999998874 1235699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+..........
T Consensus 168 ~~~~~~~~~~~--------------------------------------------------------------------- 178 (303)
T 2vwi_A 168 SAFLATGGDIT--------------------------------------------------------------------- 178 (303)
T ss_dssp HHHCC---------------------------------------------------------------------------
T ss_pred hheeccCCCcc---------------------------------------------------------------------
Confidence 85432110000
Q ss_pred cCCCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC-CC-------
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK-FP------- 410 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~p------- 410 (506)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+......... .+
T Consensus 179 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (303)
T 2vwi_A 179 ---RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKE 255 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----C
T ss_pred ---chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccch
Confidence 0001123479999999999976 56899999999999999999999999987776666555433211 11
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
....++.++.+||.+||..||.+||+ +.++++||||+...+.
T Consensus 256 ~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 256 MLKKYGKSFRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKNK 297 (303)
T ss_dssp CCCCCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSTTC------
T ss_pred hhhhhhHHHHHHHHHHccCChhhCcC----HHHHhhChhhhcCCCC
Confidence 12357899999999999999999997 9999999999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=393.58 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=218.8
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCc---eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGC---LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF 180 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 180 (506)
...++..++|++++.||+|+||+||+|.++.+++ .||||++.... .......+.+|+++|+.++||||+++++++
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4456778899999999999999999999986655 49999997643 234456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
.+.+..||||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 9999999999999999999998754 357999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+.........
T Consensus 199 ~~~~~~~~~~---------------------------------------------------------------------- 208 (325)
T 3kul_A 199 RVLEDDPDAA---------------------------------------------------------------------- 208 (325)
T ss_dssp EECC----CC----------------------------------------------------------------------
T ss_pred cccccCccce----------------------------------------------------------------------
Confidence 6432110000
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
.......||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+....+... ...+....+++++
T Consensus 209 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 283 (325)
T 3kul_A 209 ----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHAL 283 (325)
T ss_dssp ----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHH
T ss_pred ----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHHH
Confidence 00112257889999999999999999999999999999999 99999988888777776644 3444455799999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||.+||..||.+||+ +.++++
T Consensus 284 ~~li~~~l~~dp~~Rps----~~eil~ 306 (325)
T 3kul_A 284 HQLMLDCWHKDRAQRPR----FSQIVS 306 (325)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHccCChhhCcC----HHHHHH
Confidence 99999999999999998 777775
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.78 Aligned_cols=261 Identities=29% Similarity=0.470 Sum_probs=218.0
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4467999999999999999999999999999999997642 33557789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999998743 3679999999999999999999999999999999999999999999999999985421100
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....
T Consensus 180 ----------------------------------------------------------------------------~~~~ 183 (314)
T 3com_A 180 ----------------------------------------------------------------------------AKRN 183 (314)
T ss_dssp ----------------------------------------------------------------------------SCBC
T ss_pred ----------------------------------------------------------------------------cccC
Confidence 0012
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ-PLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~s~~~~~li~~~L 427 (506)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... ...+.....++..+.+||.+||
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 263 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHT
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHc
Confidence 236999999999999999999999999999999999999999887776655554433 2233333467999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
..||.+||+ +.++++||||+...+.
T Consensus 264 ~~dp~~Rpt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 264 VKSPEQRAT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp CSCTTTSCC----HHHHTTSHHHHTCCCG
T ss_pred cCChhhCcC----HHHHHhCHHHhcCCcc
Confidence 999999997 9999999999877653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=395.80 Aligned_cols=257 Identities=31% Similarity=0.417 Sum_probs=213.7
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF---- 185 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 185 (506)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 367999999999999999999999999999999997643 223445677899999999999999999999987654
Q ss_pred --EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 186 --SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 186 --~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+|+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999995 68887764 35999999999999999999999999999999999999999999999999998431
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 177 ~~------------------------------------------------------------------------------ 178 (353)
T 3coi_A 177 DA------------------------------------------------------------------------------ 178 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C-------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P------------- 406 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~------------- 406 (506)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+... +
T Consensus 179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 0112368999999999987 67899999999999999999999999988776655544320 0
Q ss_pred ------------CCCC-CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 407 ------------LKFP-EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 407 ------------~~~p-~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
..++ ....+++++.+||.+||..||.+||+ ++++|+||||+.+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDP 315 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCG
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccCc
Confidence 0111 11357899999999999999999997 9999999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=391.53 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=217.1
Q ss_pred cCCeEEEeEEeecCceEEEEEEEc-cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc---CCCCccceeEEEE----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELR-DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPTLYSHFE---- 181 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~---- 181 (506)
.++|++++.||+|+||+||+|++. .+|+.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 467999999999999999999995 678999999997643221 1122345677776665 8999999999987
Q ss_pred -eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 182 -TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 182 -~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
....+++||||+. |+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678999999996 69999998876667999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
......
T Consensus 168 ~~~~~~-------------------------------------------------------------------------- 173 (326)
T 1blx_A 168 RIYSFQ-------------------------------------------------------------------------- 173 (326)
T ss_dssp CCCCGG--------------------------------------------------------------------------
T ss_pred ccccCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C--CCCC-----
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P--LKFP----- 410 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~--~~~p----- 410 (506)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..++.. + ..++
T Consensus 174 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 174 ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp ----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred ----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 0011236899999999999999999999999999999999999999998877766665421 1 0010
Q ss_pred ---------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 411 ---------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 411 ---------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
....++..+++||.+||..||.+||+ +.|+++||||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERC 306 (326)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCC
T ss_pred chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchh
Confidence 11358899999999999999999997 9999999999987754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=402.51 Aligned_cols=261 Identities=27% Similarity=0.431 Sum_probs=199.6
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC----
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK---- 184 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 184 (506)
.+++|++++.||+|+||+||+|+++.+|+.||||++..... ...+..+|++.++.++||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 45679999999999999999999999999999999866432 2234456788888999999999999997643
Q ss_pred ---eEEEEEeecCCCChHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeEEccCCCCcEEEec-CCCEEEee
Q 010603 185 ---FSCLLMEFCSGGDLHTLRQR--QPGKHFSEQATRFYASEVLLALEYLH--MMGVVYRDLKPENVLVRE-DGHIMLSD 256 (506)
Q Consensus 185 ---~~~lV~E~~~gg~L~~~l~~--~~~~~~~e~~~~~i~~qil~aL~yLH--~~giiHrDLKp~NILl~~-~~~vkl~D 256 (506)
.+|+||||+.+ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 38999999976 54443332 23467899999999999999999999 999999999999999997 89999999
Q ss_pred cCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCc
Q 010603 257 FDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336 (506)
Q Consensus 257 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (506)
||+++.....
T Consensus 176 fg~a~~~~~~---------------------------------------------------------------------- 185 (360)
T 3e3p_A 176 FGSAKKLSPS---------------------------------------------------------------------- 185 (360)
T ss_dssp CTTCBCCCTT----------------------------------------------------------------------
T ss_pred CCCceecCCC----------------------------------------------------------------------
Confidence 9998532110
Q ss_pred ccccCCCCCCccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC---C------
Q 010603 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ---P------ 406 (506)
Q Consensus 337 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~------ 406 (506)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+... +
T Consensus 186 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 186 --------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp --------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred --------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 0012246899999999997655 899999999999999999999999998877666555421 0
Q ss_pred --------CCC-------------CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 407 --------LKF-------------PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 407 --------~~~-------------p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
..+ ......+.++.+||.+||+.||.+||+ +.|+|+||||+.+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDP 324 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCT
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCc
Confidence 000 011125678999999999999999997 9999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=386.41 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=220.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+.|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 459999999999999999999999999999999976532 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 173 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc---
Confidence 99999999999865 479999999999999999999999999999999999999999999999999985421100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......
T Consensus 174 --------------------------------------------------------------------------~~~~~~ 179 (303)
T 3a7i_A 174 --------------------------------------------------------------------------IKRNTF 179 (303)
T ss_dssp --------------------------------------------------------------------------CCBCCC
T ss_pred --------------------------------------------------------------------------cccCcc
Confidence 001224
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... .....++..+.+||.+||..|
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~d 258 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEACLNKE 258 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCCSSCCHHHHHHHHHHCCSS
T ss_pred CCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC-CCccccCHHHHHHHHHHcCCC
Confidence 6999999999999999999999999999999999999999887776666555433211 122368999999999999999
Q ss_pred CCCccCCCCChHHhhcCCCCCC
Q 010603 431 PQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 431 P~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.+||+ +.++++||||..
T Consensus 259 p~~Rps----~~~ll~~~~~~~ 276 (303)
T 3a7i_A 259 PSFRPT----AKELLKHKFILR 276 (303)
T ss_dssp GGGSCC----HHHHTTCHHHHH
T ss_pred hhhCcC----HHHHhhChhhhc
Confidence 999997 999999999964
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=405.56 Aligned_cols=267 Identities=17% Similarity=0.255 Sum_probs=221.0
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEE-----EccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAE-----LRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF 180 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 180 (506)
.++..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+|+.++|||||++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34566789999999999999999999 44568899999997532 233445678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC---CE
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQPG-----KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG---HI 252 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~~-----~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~---~v 252 (506)
......|||||||.||+|.+++..... ..+++..++.++.||+.||+|||++|||||||||+||||+.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999999887432 4589999999999999999999999999999999999999655 59
Q ss_pred EEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCC
Q 010603 253 MLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNS 332 (506)
Q Consensus 253 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (506)
||+|||+|+.......
T Consensus 224 kL~DFG~a~~~~~~~~---------------------------------------------------------------- 239 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGY---------------------------------------------------------------- 239 (367)
T ss_dssp EECCCHHHHHHHHHSS----------------------------------------------------------------
T ss_pred EECCCccccccccccc----------------------------------------------------------------
Confidence 9999999864211100
Q ss_pred CCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCC
Q 010603 333 DSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPE 411 (506)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~ 411 (506)
........||+.|+|||++.+..|+.++|||||||+||||++ |..||.+....+.+..+.... ..+.
T Consensus 240 -----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~ 307 (367)
T 3l9p_A 240 -----------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDP 307 (367)
T ss_dssp -----------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCC
T ss_pred -----------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 001123468999999999999999999999999999999998 999999988887777766543 2233
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 412 ~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
...++..+.+||.+||+.||.+||+ +.++++|.++-..+
T Consensus 308 ~~~~~~~l~~li~~~l~~dP~~Rps----~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 308 PKNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQD 346 (367)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHC
T ss_pred CccCCHHHHHHHHHHcCCCHhHCcC----HHHHHHHHHHHhhC
Confidence 3478999999999999999999998 89999988775433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=391.43 Aligned_cols=256 Identities=24% Similarity=0.406 Sum_probs=209.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC--eE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK--FS 186 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~ 186 (506)
..++|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+++|+.++||||+++++++.... ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 346799999999999999999999999999999999865432 33456678999999999999999999998765 88
Q ss_pred EEEEeecCCCChHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE----ecCCCEEEeecCCcc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPG-KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV----REDGHIMLSDFDLSL 261 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~-~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFGla~ 261 (506)
||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999886432 339999999999999999999999999999999999999 777789999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 165 ~~~~~--------------------------------------------------------------------------- 169 (319)
T 4euu_A 165 ELEDD--------------------------------------------------------------------------- 169 (319)
T ss_dssp ECCTT---------------------------------------------------------------------------
T ss_pred ecCCC---------------------------------------------------------------------------
Confidence 42110
Q ss_pred CCCCCccccccCCCCccchhhc--------CCCCCcchhHHHHHHHHHHHhcCCCCCCCCC----cHHHHHHHhCCCC--
Q 010603 342 PTSARSMSFVGTHEYLAPEIIR--------GDGHGSAVDWWTFGIFFYELLLGRTPFKGNG----NRETLFNVVGQPL-- 407 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~--------~~~~~~~~DiWSlGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~-- 407 (506)
......+||+.|+|||++. +..|+.++|||||||++|||++|+.||.... ..+.+..++....
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 170 ---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp ---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred ---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 0012246999999999987 5678999999999999999999999997533 2344455543221
Q ss_pred -----------------CCCCC----CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCC
Q 010603 408 -----------------KFPEG----SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448 (506)
Q Consensus 408 -----------------~~p~~----~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp 448 (506)
.++.. ..++..+.+||.+||+.||++||+ ++|+|+||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 11211 123457889999999999999998 99999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=400.25 Aligned_cols=260 Identities=21% Similarity=0.321 Sum_probs=215.2
Q ss_pred CcccCCeEEEeEEeecCceEEEEEE-----EccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAE-----LRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
++..++|++++.||+|+||.||+|+ ...+++.||||++++... ......+.+|+++|+.+ +|||||++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4566789999999999999999999 456678999999976432 33456788999999999 799999999999
Q ss_pred EeCC-eEEEEEeecCCCChHHHHhhCCC----------------------------------------------------
Q 010603 181 ETDK-FSCLLMEFCSGGDLHTLRQRQPG---------------------------------------------------- 207 (506)
Q Consensus 181 ~~~~-~~~lV~E~~~gg~L~~~l~~~~~---------------------------------------------------- 207 (506)
...+ .+|+|||||.+|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8765 59999999999999999887532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCCC
Q 010603 208 ------------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDD 275 (506)
Q Consensus 208 ------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 275 (506)
..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++........
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------- 248 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------- 248 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-------
Confidence 1289999999999999999999999999999999999999999999999999853211000
Q ss_pred cccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCC
Q 010603 276 PACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHE 355 (506)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 355 (506)
........||+.
T Consensus 249 --------------------------------------------------------------------~~~~~~~~~t~~ 260 (359)
T 3vhe_A 249 --------------------------------------------------------------------YVRKGDARLPLK 260 (359)
T ss_dssp --------------------------------------------------------------------CEEC--CEECGG
T ss_pred --------------------------------------------------------------------chhccccCCCce
Confidence 001123468999
Q ss_pred CccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCc
Q 010603 356 YLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKR 434 (506)
Q Consensus 356 Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R 434 (506)
|+|||++.+..|+.++|||||||++|||++ |+.||.+....+.+...+......+....+++++.+||.+||..||.+|
T Consensus 261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 340 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999998 9999988776555555443333334445789999999999999999999
Q ss_pred cCCCCChHHhhcC
Q 010603 435 LGFKRGATEIKQH 447 (506)
Q Consensus 435 ~s~~~~a~ell~h 447 (506)
|+ +.|+++|
T Consensus 341 ps----~~ell~~ 349 (359)
T 3vhe_A 341 PT----FSELVEH 349 (359)
T ss_dssp CC----HHHHHHH
T ss_pred CC----HHHHHHH
Confidence 97 8888875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=387.63 Aligned_cols=260 Identities=32% Similarity=0.490 Sum_probs=222.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||.||+|+++.+++.||||++.+.... ......+.+|+++++.++||||+++++++...+..|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 45699999999999999999999999999999999765432 23456778899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC---CCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED---GHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vkl~DFGla~~~~~~ 266 (506)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999988765 579999999999999999999999999999999999999764 47999999998432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 178 ------------------------------------------------------------------------------~~ 179 (287)
T 2wei_A 178 ------------------------------------------------------------------------------TK 179 (287)
T ss_dssp ------------------------------------------------------------------------------SS
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC--CCCCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF--PEGSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--p~~~~~s~~~~~li~ 424 (506)
.....||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+....+......+ +....++.++.+||.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 258 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHH
T ss_pred cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHH
Confidence 1123689999999998764 8999999999999999999999999988877777776554433 333578999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
+||..||.+||+ +.|+++||||+...|
T Consensus 259 ~~l~~dp~~Rps----~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 259 KMLTFHPSLRIT----ATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHTCSSGGGSCC----HHHHHHSHHHHHHCC
T ss_pred HHcccChhhCcC----HHHHhcCHHHhcccc
Confidence 999999999997 999999999986543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=409.77 Aligned_cols=263 Identities=27% Similarity=0.376 Sum_probs=195.9
Q ss_pred CCeEE-EeEEeecCceEEEEEEEc--cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCe
Q 010603 111 GHFRL-LKKLGCGDIGSVYLAELR--DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKF 185 (506)
Q Consensus 111 ~~y~i-~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ 185 (506)
+.|++ .++||+|+||+||+|+++ .+++.||||++..... ...+.+|+++|+.++|||||++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44777 458999999999999976 5688999999976432 2346789999999999999999999954 678
Q ss_pred EEEEEeecCCCChHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE----ecCCCEEE
Q 010603 186 SCLLMEFCSGGDLHTLRQRQ-------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV----REDGHIML 254 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~-------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl 254 (506)
+||||||+. |+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 6888776532 12359999999999999999999999999999999999999 67789999
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
+|||+|+.......
T Consensus 174 ~Dfg~a~~~~~~~~------------------------------------------------------------------ 187 (405)
T 3rgf_A 174 ADMGFARLFNSPLK------------------------------------------------------------------ 187 (405)
T ss_dssp CCTTCCC-------------------------------------------------------------------------
T ss_pred EECCCceecCCCCc------------------------------------------------------------------
Confidence 99999854211000
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCc---------HHHHHHHh-
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGN---------RETLFNVV- 403 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~---------~~~~~~i~- 403 (506)
........+||+.|+|||++.+. .|+.++||||||||||||++|++||.+... .+.+..+.
T Consensus 188 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 188 --------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred --------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 00012234799999999999885 489999999999999999999999976543 23333332
Q ss_pred --CCCCC--CC-------------------------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCC
Q 010603 404 --GQPLK--FP-------------------------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHP 448 (506)
Q Consensus 404 --~~~~~--~p-------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp 448 (506)
+.+.. ++ .....+..+.+||.+||..||.+||| |+|||+||
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp 335 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDP 335 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSG
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcCh
Confidence 21110 00 00123678999999999999999997 99999999
Q ss_pred CCCCCCcch
Q 010603 449 FFESVNWAL 457 (506)
Q Consensus 449 ~f~~~~~~~ 457 (506)
||....|..
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 999876643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=392.51 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=211.4
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE------
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE------ 181 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------ 181 (506)
...++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+|+++++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 34567999999999999999999999999999999987542 345567789999999999999999999884
Q ss_pred --------eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe-cCCCE
Q 010603 182 --------TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-EDGHI 252 (506)
Q Consensus 182 --------~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~v 252 (506)
.....|+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4468899999996 699998864 5799999999999999999999999999999999999998 56799
Q ss_pred EEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCC
Q 010603 253 MLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNS 332 (506)
Q Consensus 253 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (506)
||+|||+++.......
T Consensus 161 kl~Dfg~~~~~~~~~~---------------------------------------------------------------- 176 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYS---------------------------------------------------------------- 176 (320)
T ss_dssp EECCCTTCBCC---------------------------------------------------------------------
T ss_pred EEccCccccccCCCcc----------------------------------------------------------------
Confidence 9999999854211000
Q ss_pred CCCcccccCCCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCC---
Q 010603 333 DSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLK--- 408 (506)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--- 408 (506)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+......
T Consensus 177 ----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 177 ----------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp -------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred ----------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 0001122368999999999876 67899999999999999999999999988877666555432110
Q ss_pred -------------------CC------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 409 -------------------FP------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 409 -------------------~p------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.+ ....++.++++||.+||..||.+||+ ++|+|+||||+..+|.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCc
Confidence 00 01258999999999999999999997 9999999999987764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.44 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=219.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCeEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKFSC 187 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~ 187 (506)
.++|++++.||+|+||.||+|.++.+++.||+|++...... ......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 46799999999999999999999999999999999865432 3445678899999999999999999998854 56899
Q ss_pred EEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 188 LLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMG-----VVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~g-----iiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
+||||+++++|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998763 2345999999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
.......
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (279)
T 2w5a_A 164 RILNHDT------------------------------------------------------------------------- 170 (279)
T ss_dssp HHC---C-------------------------------------------------------------------------
T ss_pred eeecccc-------------------------------------------------------------------------
Confidence 5421000
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC-CCCCCCCCCHHH
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL-KFPEGSSISFAA 419 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~s~~~ 419 (506)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+..... .++ ..++.++
T Consensus 171 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l 244 (279)
T 2w5a_A 171 ----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP--YRYSDEL 244 (279)
T ss_dssp ----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC--TTSCHHH
T ss_pred ----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC--cccCHHH
Confidence 001124699999999999999999999999999999999999999998887766666654433 233 3689999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.+||.+||..||.+||+ +.|+++|+|+..
T Consensus 245 ~~li~~~l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHTSTTCCG
T ss_pred HHHHHHHcCCCcccCCC----HHHHHhChhhhh
Confidence 99999999999999997 999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=389.97 Aligned_cols=275 Identities=23% Similarity=0.328 Sum_probs=205.7
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCc---eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGC---LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
...+..++|++++.||+|+||+||+|+++.++. .||||++...... ......+.+|+++++.++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344566789999999999999999999987765 8999999765433 344677889999999999999999999998
Q ss_pred eCCeE------EEEEeecCCCChHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 182 TDKFS------CLLMEFCSGGDLHTLRQRQP----GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 182 ~~~~~------~lV~E~~~gg~L~~~l~~~~----~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
..... |+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 87655 99999999999999886532 125899999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCC
Q 010603 252 IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331 (506)
Q Consensus 252 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (506)
+||+|||+++........
T Consensus 176 ~kl~Dfg~a~~~~~~~~~-------------------------------------------------------------- 193 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYY-------------------------------------------------------------- 193 (323)
T ss_dssp EEECCCCC------------------------------------------------------------------------
T ss_pred EEEeeccccccccccccc--------------------------------------------------------------
Confidence 999999998542111000
Q ss_pred CCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCC
Q 010603 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFP 410 (506)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 410 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... ..+
T Consensus 194 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~ 259 (323)
T 3qup_A 194 -------------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLK 259 (323)
T ss_dssp --------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCC
T ss_pred -------------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCC
Confidence 00112257889999999999999999999999999999999 999999988888777776543 233
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCC---CChHHhhcCCCCCCCCcc
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFK---RGATEIKQHPFFESVNWA 456 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~---~~a~ell~hp~f~~~~~~ 456 (506)
....+++++.+||.+||..||.+||++. ..+++++.|||+....++
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 3347899999999999999999999732 126788999999765443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=378.45 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=216.4
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+..++|++++.||+|+||.||+|.+.. ++.||||++..... ....+.+|+++|+.++||||+++++++.+.+..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 4556789999999999999999999874 77899999986532 234578899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999998764 357999999999999999999999999999999999999999999999999998532110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 160 ~~----------------------------------------------------------------------------~~ 163 (269)
T 4hcu_A 160 QY----------------------------------------------------------------------------TS 163 (269)
T ss_dssp HH----------------------------------------------------------------------------HS
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....||+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.... .......+++.+.+||.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCCCCCcCCHHHHHHHHH
Confidence 112257889999999999999999999999999999999 999999988887777776542 233334689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~h 447 (506)
||..||.+||+ +.++++|
T Consensus 243 ~l~~~p~~Rps----~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPA----FSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred HccCCcccCcC----HHHHHHH
Confidence 99999999998 8888875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=378.26 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=209.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc-hhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG-RKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
++..++|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+++++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 355678999999999999999999986 8899999997654322 2335678899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEccCCCCcEEEec--------CCCEEE
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG---VVYRDLKPENVLVRE--------DGHIML 254 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g---iiHrDLKp~NILl~~--------~~~vkl 254 (506)
.|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999998864 57999999999999999999999999 999999999999986 778999
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
+|||++......
T Consensus 158 ~Dfg~~~~~~~~-------------------------------------------------------------------- 169 (271)
T 3dtc_A 158 TDFGLAREWHRT-------------------------------------------------------------------- 169 (271)
T ss_dssp CCCCC---------------------------------------------------------------------------
T ss_pred ccCCcccccccc--------------------------------------------------------------------
Confidence 999998432100
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCC
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSS 414 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 414 (506)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+....
T Consensus 170 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 170 -----------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred -----------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 011236899999999999999999999999999999999999999998888777777766666665668
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+++.+.+||.+||..||.+||+ +.|+++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcC----HHHHHHH
Confidence 9999999999999999999998 8888864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=391.86 Aligned_cols=261 Identities=19% Similarity=0.277 Sum_probs=217.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 179 (506)
.++..++|++++.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+|+.+ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4566788999999999999999999973 3567899999986432 23445678899999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcc
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPG---------------------KHFSEQATRFYASEVLLALEYLHMMGVVYRD 238 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrD 238 (506)
+...+.+||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999999999999999999987532 2379999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccc
Q 010603 239 LKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318 (506)
Q Consensus 239 LKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (506)
|||+||||+.++.+||+|||++........
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-------------------------------------------------- 227 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------------------------------- 227 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------------------------------------------
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc--------------------------------------------------
Confidence 999999999999999999999854211100
Q ss_pred ccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHH
Q 010603 319 TTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRE 397 (506)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~ 397 (506)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+.....
T Consensus 228 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 282 (344)
T 1rjb_A 228 -------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282 (344)
T ss_dssp -------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred -------------------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence 000112368899999999999999999999999999999998 999999887766
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 398 ~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.+..++......+....+++++.+||.+||..||.+||+ +.++++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 328 (344)
T 1rjb_A 283 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 328 (344)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 666666555555555578999999999999999999998 8888875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=384.89 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=218.6
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH 179 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 179 (506)
..++..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+++|+.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 44566788999999999999999999984 456889999997643 23455678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPG----------------------KHFSEQATRFYASEVLLALEYLHMMGVVYR 237 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~----------------------~~~~e~~~~~i~~qil~aL~yLH~~giiHr 237 (506)
+...+..|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987532 348999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccc
Q 010603 238 DLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNS 317 (506)
Q Consensus 238 DLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (506)
||||+|||++.++.+||+|||+++........
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------ 206 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------ 206 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCE------------------------------------------------
T ss_pred ccchheEEEcCCCCEEEccccccccccccccc------------------------------------------------
Confidence 99999999999999999999998543111000
Q ss_pred cccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcH
Q 010603 318 KTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNR 396 (506)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~ 396 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 207 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 207 ---------------------------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp ---------------------------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ---------------------------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 00112257889999999999899999999999999999999 99999988877
Q ss_pred HHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 397 ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 397 ~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+....+.... ..+....+++++.+||.+||..||.+||+ +.+++++
T Consensus 260 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 260 RLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp GHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 6665555432 33333478999999999999999999998 7888764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=396.56 Aligned_cols=258 Identities=23% Similarity=0.387 Sum_probs=208.1
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-----------CCCccc
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-----------HPFLPT 175 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~ 175 (506)
.+..++|++++.||+|+||+||+|++..+++.||||++.+.. .....+.+|+.+++.++ ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 355678999999999999999999999999999999998643 33455678999988876 899999
Q ss_pred eeEEEEeCC----eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecC-
Q 010603 176 LYSHFETDK----FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVRED- 249 (506)
Q Consensus 176 l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~- 249 (506)
+++++...+ .+++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.+
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999998654 899999999 99999999887667799999999999999999999998 99999999999999643
Q ss_pred -----CCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 250 -----GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 250 -----~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
+.+||+|||++.....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~----------------------------------------------------------- 190 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE----------------------------------------------------------- 190 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB-----------------------------------------------------------
T ss_pred CCcCcceEEEcccccccccCC-----------------------------------------------------------
Confidence 3799999999853210
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc------HHH
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN------RET 398 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~------~~~ 398 (506)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.
T Consensus 191 ---------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 191 ---------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp ---------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ---------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 01123689999999999999999999999999999999999999986542 222
Q ss_pred HHHHh---CCCCC-------------------------------------CCCCCCCCHHHHHHHHHHhhcCCCCccCCC
Q 010603 399 LFNVV---GQPLK-------------------------------------FPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438 (506)
Q Consensus 399 ~~~i~---~~~~~-------------------------------------~p~~~~~s~~~~~li~~~L~~dP~~R~s~~ 438 (506)
+..+. +.... +.....++.++.+||.+||+.||.+||+
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-- 327 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD-- 327 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC--
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC--
Confidence 22221 11000 0001134567899999999999999998
Q ss_pred CChHHhhcCCCCCCC
Q 010603 439 RGATEIKQHPFFESV 453 (506)
Q Consensus 439 ~~a~ell~hp~f~~~ 453 (506)
++|+|+||||+..
T Consensus 328 --~~ell~hp~f~~~ 340 (373)
T 1q8y_A 328 --AGGLVNHPWLKDT 340 (373)
T ss_dssp --HHHHHTCGGGTTC
T ss_pred --HHHHhhChhhhcc
Confidence 9999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=376.81 Aligned_cols=252 Identities=19% Similarity=0.283 Sum_probs=217.5
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-- 183 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-- 183 (506)
..+..++|++++.||+|+||.||+|++. ++.||||++...... ......+.+|+.+|+.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567788999999999999999999986 889999999875432 34456688999999999999999999999887
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+..++||||+++|+|.+++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998875557999999999999999999999999 9999999999999999999999999863
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
...
T Consensus 162 ~~~----------------------------------------------------------------------------- 164 (271)
T 3kmu_A 162 SFQ----------------------------------------------------------------------------- 164 (271)
T ss_dssp TTS-----------------------------------------------------------------------------
T ss_pred eec-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCc---chhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGS---AVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~---~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
.....||+.|+|||++.+..++. ++|||||||++|||++|+.||.+....+....+.......+....++++
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 01236899999999999876544 8999999999999999999999988887777766554444444579999
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+||.+||..||.+||+ +.++++
T Consensus 240 ~~~li~~~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999998 788875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=375.07 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=215.8
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|++++.||+|+||.||+|.++. +..||||++..... ....+.+|+++++.++||||+++++++...+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 4566789999999999999999998774 67899999986532 234577899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999998765 246999999999999999999999999999999999999999999999999998542111
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 158 ~~----------------------------------------------------------------------------~~ 161 (268)
T 3sxs_A 158 QY----------------------------------------------------------------------------VS 161 (268)
T ss_dssp CE----------------------------------------------------------------------------EE
T ss_pred hh----------------------------------------------------------------------------hc
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+...... .....+++.+.+||.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-YRPHLASDTIYQIMYS 240 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-CCCCcChHHHHHHHHH
Confidence 111247788999999999899999999999999999999 99999988888777776654322 2234689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~h 447 (506)
||..||.+||+ +.++++|
T Consensus 241 ~l~~~p~~Rps----~~~ll~~ 258 (268)
T 3sxs_A 241 CWHELPEKRPT----FQQLLSS 258 (268)
T ss_dssp TTCSSGGGSCC----HHHHHHH
T ss_pred HcCCChhhCcC----HHHHHHH
Confidence 99999999998 8888875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=387.29 Aligned_cols=268 Identities=21% Similarity=0.315 Sum_probs=212.6
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++.+.||+|+||+||+|.++.+++.||+|++.... ......+.+|+++|+.++||||+++++++.+++..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 44577999999999999999999999999999999986532 445567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999874 3579999999999999999999999999999999999999999999999999986532111
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...... .....+.....
T Consensus 163 ~~~~~~---------------------------------------------------------------~~~~~~~~~~~ 179 (310)
T 3s95_A 163 TQPEGL---------------------------------------------------------------RSLKKPDRKKR 179 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccc---------------------------------------------------------------ccccccccccc
Confidence 100000 00000111122
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHH-----HHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE-----TLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
...+||+.|+|||++.+..++.++|||||||+||||++|..||....... ........ ..+ ..+++.+.+|
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~l~~l 255 (310)
T 3s95_A 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--YCP--PNCPPSFFPI 255 (310)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--TCC--TTCCTTHHHH
T ss_pred cccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--cCC--CCCCHHHHHH
Confidence 34589999999999999999999999999999999999999987543211 01111111 112 3578889999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
|.+||..||++||+ +.++++ |++.
T Consensus 256 i~~~l~~dP~~Rps----~~~l~~--~L~~ 279 (310)
T 3s95_A 256 TVRCCDLDPEKRPS----FVKLEH--WLET 279 (310)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH--HHHH
T ss_pred HHHHccCChhhCcC----HHHHHH--HHHH
Confidence 99999999999998 788876 5543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=393.21 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=186.9
Q ss_pred ccCCeEEEe-EEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe----C
Q 010603 109 GLGHFRLLK-KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----D 183 (506)
Q Consensus 109 ~~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~ 183 (506)
..++|++++ .||+|+||+||+|.++.+|+.||||++.... .. .......++.++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KA---RQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 456799976 5999999999999999999999999996532 11 1223334677899999999999986 5
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CCCEEEeecCCc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DGHIMLSDFDLS 260 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFGla 260 (506)
..+|||||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998876668999999999999999999999999999999999999986 455999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
.....
T Consensus 179 ~~~~~--------------------------------------------------------------------------- 183 (336)
T 3fhr_A 179 KETTQ--------------------------------------------------------------------------- 183 (336)
T ss_dssp EEC-----------------------------------------------------------------------------
T ss_pred eeccc---------------------------------------------------------------------------
Confidence 53210
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHH----HHHhCCCC--CCCCCCC
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL----FNVVGQPL--KFPEGSS 414 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~----~~i~~~~~--~~p~~~~ 414 (506)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..+..... ..+....
T Consensus 184 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (336)
T 3fhr_A 184 ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred ----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence 0011236899999999998888999999999999999999999999776544321 12222222 2233357
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
++.++++||.+||..||.+||+ +.|+|+||||+.
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 260 VSEDAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcC----HHHHhcCccccc
Confidence 8999999999999999999997 999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=394.38 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=209.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh--------chhHHHHHHHHHHHHHhcCCCCccceeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA--------GRKKLMRAQTEREILSLLDHPFLPTLYSHF 180 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 180 (506)
..++|++++.||+|+||.||+|.+.. |+.||||++...... .......+.+|+++|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34679999999999999999999876 899999999754321 223346788999999999999999999999
Q ss_pred Ee-----CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEe
Q 010603 181 ET-----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLS 255 (506)
Q Consensus 181 ~~-----~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~ 255 (506)
.. ...+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 54 347899999996 6888877654 3579999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||++......
T Consensus 177 Dfg~~~~~~~~--------------------------------------------------------------------- 187 (362)
T 3pg1_A 177 DFNLAREDTAD--------------------------------------------------------------------- 187 (362)
T ss_dssp CTTC----------------------------------------------------------------------------
T ss_pred ecCcccccccc---------------------------------------------------------------------
Confidence 99998421100
Q ss_pred cccccCCCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC-----
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP----- 406 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~----- 406 (506)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.. .+
T Consensus 188 ---------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (362)
T 3pg1_A 188 ---------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258 (362)
T ss_dssp -----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ---------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence 00122468999999999987 6789999999999999999999999998887666655432 10
Q ss_pred ----------------CCCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 407 ----------------LKFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 407 ----------------~~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
...+. ...+++.+.+||.+||..||.+||+ +.|+|+||||+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESLF 324 (362)
T ss_dssp HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTTC
T ss_pred hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhcc
Confidence 00110 1246889999999999999999997 99999999999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=393.05 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=218.5
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccC-------CceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCcccee
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDM-------GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLY 177 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 177 (506)
+++..++|++++.||+|+||+||+|++..+ +..||||++.... .......+.+|+++++.+ +|||||+++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 456667899999999999999999997643 3579999997653 234556788999999999 999999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
+++...+.+|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998753 2459999999999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
|||+.++.+||+|||+|+.......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~------------------------------------------------------- 246 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY------------------------------------------------------- 246 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT-------------------------------------------------------
T ss_pred EEEcCCCcEEEcccCcccccccccc-------------------------------------------------------
Confidence 9999999999999999853211000
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+....+
T Consensus 247 --------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~ 306 (382)
T 3tt0_A 247 --------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306 (382)
T ss_dssp --------------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred --------------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 000112357889999999999999999999999999999999 99999988877766665
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.... .......+++++.+||.+||..||.+||+ +.|++++
T Consensus 307 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 307 KEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp HTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 5432 33333578999999999999999999998 7888874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=379.79 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=222.1
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..+++..++|++.+.||+|+||+||+|.++.+++.||||++... ......+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34567778899999999999999999999999999999999764 23456678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+..|+||||+.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999999998876678999999999999999999999999999999999999999999999999998532
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
....
T Consensus 162 ~~~~---------------------------------------------------------------------------- 165 (288)
T 3kfa_A 162 TGDT---------------------------------------------------------------------------- 165 (288)
T ss_dssp CSSS----------------------------------------------------------------------------
T ss_pred cCCc----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... ...+....+++.+.+|
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPEKVYEL 244 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHH
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCCHHHHHH
Confidence 000112357889999999999999999999999999999999 99999988776665555433 3344445789999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
|.+||..||.+||+ +.++++
T Consensus 245 i~~~l~~dp~~Rps----~~~~~~ 264 (288)
T 3kfa_A 245 MRACWQWNPSDRPS----FAEIHQ 264 (288)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHhCCChhhCcC----HHHHHH
Confidence 99999999999998 777765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=388.86 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=218.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF 180 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 180 (506)
.++..++|++++.||+|+||.||+|++. .+++.||||++++.. .......+.+|+.+|+.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456678999999999999999999997 345899999998653 234456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcc
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQP----------------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrD 238 (506)
...+..|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999988742 15799999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccc
Q 010603 239 LKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318 (506)
Q Consensus 239 LKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (506)
|||+|||++.++.+||+|||+++.......
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------- 229 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADY-------------------------------------------------- 229 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC--------------------------------------------------
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcc--------------------------------------------------
Confidence 999999999999999999999854311100
Q ss_pred ccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHH
Q 010603 319 TTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRE 397 (506)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~ 397 (506)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 230 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 230 -------------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp -------------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred -------------------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 000112368999999999999999999999999999999999 999999888877
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 398 ~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
....+...... +....++.++.+||.+||..||.+||+ +.++++
T Consensus 285 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~ 328 (343)
T 1luf_A 285 VIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 328 (343)
T ss_dssp HHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 77777654432 223468999999999999999999998 778776
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=379.88 Aligned_cols=271 Identities=25% Similarity=0.415 Sum_probs=209.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--------
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-------- 182 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------- 182 (506)
++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4699999999999999999999999999999999753 3445678889999999999999999998865
Q ss_pred -----CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeec
Q 010603 183 -----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 183 -----~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 257 (506)
.+..|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 45789999999999999999864 356889999999999999999999999999999999999999999999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|++.............. .
T Consensus 161 g~~~~~~~~~~~~~~~~----------------------------------------------------~---------- 178 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDS----------------------------------------------------Q---------- 178 (303)
T ss_dssp CCCSCTTC------------------------------------------------------------------------
T ss_pred cchhhcccccchhcccc----------------------------------------------------c----------
Confidence 99854321100000000 0
Q ss_pred cccCCCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC-CcHHHHHHHhCCCCCCCC--CC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFNVVGQPLKFPE--GS 413 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~p~--~~ 413 (506)
.............||+.|+|||++.+. .++.++|||||||++|||++ ||... ...+.+..+......+|. ..
T Consensus 179 -~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (303)
T 1zy4_A 179 -NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDD 254 (303)
T ss_dssp ----------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCT
T ss_pred -cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccc
Confidence 000001112345799999999999865 68999999999999999998 66533 223344445444444443 23
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
..+..+.+||.+||..||.+||+ +.++++||||+...+.
T Consensus 255 ~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 255 NKMKVEKKIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQD 293 (303)
T ss_dssp TTSHHHHHHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHH
T ss_pred cchHHHHHHHHHHHhcCcccCcC----HHHHhCCCCcCCCChH
Confidence 56788999999999999999997 9999999999876654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=380.37 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=211.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
..+|.....||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 344555669999999999999999999999999997643 33456678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-CCCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-DGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-~~~vkl~DFGla~~~~~~~ 267 (506)
|||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999999988753 235679999999999999999999999999999999999998 8999999999985421100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 178 -----------------------------------------------------------------------------~~~ 180 (295)
T 2clq_A 178 -----------------------------------------------------------------------------PCT 180 (295)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 001
Q ss_pred cccccCCCCccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHH-HHH--HhCCCCCCCCCCCCCHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGNRET-LFN--VVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~--~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~-~~~--i~~~~~~~p~~~~~s~~~~~l 422 (506)
....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ... .......++ ..++.++.+|
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 258 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP--ESMSAEAKAF 258 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC--TTSCHHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccc--ccCCHHHHHH
Confidence 1236999999999998654 88999999999999999999999976544322 222 222233333 3689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
|.+||..||++||+ +.++++||||+..
T Consensus 259 i~~~l~~dp~~Rps----~~~ll~~~~~~~~ 285 (295)
T 2clq_A 259 ILKCFEPDPDKRAC----ANDLLVDEFLKVS 285 (295)
T ss_dssp HHHTTCSSTTTSCC----HHHHHTSGGGCC-
T ss_pred HHHHccCChhhCCC----HHHHhcChhhhhc
Confidence 99999999999997 9999999999854
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=387.74 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=211.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 187 (506)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.+ +||||+++++++...+..|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34679999999999999999999999999999999875422 22466799999999 9999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC-----EEEeecCCccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH-----IMLSDFDLSLR 262 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-----vkl~DFGla~~ 262 (506)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++. +||+|||+|+.
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 999999 99999998865 367999999999999999999999999999999999999998887 99999999964
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
......... .
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------~ 169 (330)
T 2izr_A 160 YIDPETKKH----------------------------------------------------------------------I 169 (330)
T ss_dssp SBCTTTCCB----------------------------------------------------------------------C
T ss_pred eecCCCCcc----------------------------------------------------------------------c
Confidence 321100000 0
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc---HHHHHHHhCCCCCCCC---CCCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN---RETLFNVVGQPLKFPE---GSSIS 416 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~---~~~~s 416 (506)
........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+..+.......+. ...++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 249 (330)
T 2izr_A 170 PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP 249 (330)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH
T ss_pred cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh
Confidence 00112345799999999999999999999999999999999999999987543 2333343322222221 11244
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhc----------CCCCCCCCcc
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQ----------HPFFESVNWA 456 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~----------hp~f~~~~~~ 456 (506)
++.+||.+||..||.+||+ ++++++ ..+...++|.
T Consensus 250 -~~~~li~~~l~~~p~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 250 -EMATYLRYVRRLDFFEKPD----YDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp -HHHHHHHHHHHCCTTCCCC----HHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred -HHHHHHHHHHhCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 8999999999999999998 555544 3444556776
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=387.29 Aligned_cols=271 Identities=19% Similarity=0.287 Sum_probs=224.2
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH 179 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 179 (506)
..++..++|++.+.||+|+||.||+|.++ .+++.||||++..... ......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 44566778999999999999999999987 4578899999975432 2344567889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQP--------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
+...+..|+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 999999999999999999999887531 145799999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCC
Q 010603 252 IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331 (506)
Q Consensus 252 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (506)
+||+|||+++.......
T Consensus 177 ~kl~Dfg~~~~~~~~~~--------------------------------------------------------------- 193 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDY--------------------------------------------------------------- 193 (322)
T ss_dssp EEECCTTCCCGGGGGGC---------------------------------------------------------------
T ss_pred EEECcCccccccccccc---------------------------------------------------------------
Confidence 99999999853211000
Q ss_pred CCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCC
Q 010603 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFP 410 (506)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p 410 (506)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..... .+
T Consensus 194 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~ 260 (322)
T 1p4o_A 194 ------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LD 260 (322)
T ss_dssp ------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CC
T ss_pred ------------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CC
Confidence 000112367899999999999999999999999999999999 8999998887777766665432 22
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC------CCCCCCCcch
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH------PFFESVNWAL 457 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h------p~f~~~~~~~ 457 (506)
....++..+.+||.+||..||.+||+ +.|+++| ++|..++|..
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps----~~e~l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 261 KPDNCPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHCSTT
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHHHHHHhhccCCccccccc
Confidence 33478999999999999999999998 7788776 6776655543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=383.63 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=218.0
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEE-----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAEL-----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
++..++|++++.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.+|+.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 45667899999999999999999985 45678999999986532 23456778999999999 999999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcE
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQPG----------------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~~----------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NI 244 (506)
...+..|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 999999999999999999999887532 2589999999999999999999999999999999999
Q ss_pred EEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccc
Q 010603 245 LVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKS 324 (506)
Q Consensus 245 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (506)
|++.++.+||+|||++.........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------------- 201 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNY------------------------------------------------------- 201 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTS-------------------------------------------------------
T ss_pred EEcCCCCEEEccccccccccccccc-------------------------------------------------------
Confidence 9999999999999998542111000
Q ss_pred ccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHh
Q 010603 325 EKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV 403 (506)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 403 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......+...+
T Consensus 202 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 202 --------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp --------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred --------------------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 00112358889999999999999999999999999999998 999998877666665555
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 404 ~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
......+....++..+.+||.+||..||.+||+ +.+++++
T Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 444444444578999999999999999999998 7888763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=396.66 Aligned_cols=259 Identities=24% Similarity=0.294 Sum_probs=216.9
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+.+..++|++++.||+|+||.||+|.++.+++.||||+++... .......+.+|+++|+.++|||||++++++...+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 44566788999999999999999999999999999999997542 1233456778999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999999998764 2468999999999999999999999999999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.....
T Consensus 265 ~~~~~--------------------------------------------------------------------------- 269 (377)
T 3cbl_A 265 DGVYA--------------------------------------------------------------------------- 269 (377)
T ss_dssp TSEEE---------------------------------------------------------------------------
T ss_pred CCcee---------------------------------------------------------------------------
Confidence 00000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......+++.|+|||++.+..|+.++|||||||+||||++ |..||.+....+....+... ...+....+++++.+||
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHH
Confidence 00001136778999999999899999999999999999998 99999988877665555433 34444457899999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..||.+||+ ++++++
T Consensus 349 ~~cl~~dP~~Rps----~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPS----FSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHcCCCchhCcC----HHHHHH
Confidence 9999999999998 677764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=375.06 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=209.4
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhH----HHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKK----LMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
.+..++|++.+.||+|+||+||+|++..+++.||||++.......... ...+.+|+++++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 455678999999999999999999999999999999997654332222 2577899999999999999999999976
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCC-----EEEe
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGH-----IMLS 255 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~-----vkl~ 255 (506)
.. ++||||+++|+|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 65 6999999999999887654 357999999999999999999999999 999999999999998876 9999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||+++....
T Consensus 172 Dfg~~~~~~~---------------------------------------------------------------------- 181 (287)
T 4f0f_A 172 DFGLSQQSVH---------------------------------------------------------------------- 181 (287)
T ss_dssp CCTTCBCCSS----------------------------------------------------------------------
T ss_pred CCCccccccc----------------------------------------------------------------------
Confidence 9999842100
Q ss_pred cccccCCCCCCccccccCCCCccchhhc--CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHH--HHHHhCCCCCCCC
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIR--GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET--LFNVVGQPLKFPE 411 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~--~~~i~~~~~~~p~ 411 (506)
......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+.........
T Consensus 182 ----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 182 ----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251 (287)
T ss_dssp ----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred ----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence 011246999999999994 44578999999999999999999999987654433 3334434333334
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 412 ~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
...+++.+.+||.+||..||.+||+ +.++++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CcccCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 4578999999999999999999998 788875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=389.40 Aligned_cols=259 Identities=26% Similarity=0.371 Sum_probs=215.6
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---hHHHHHHHHHHHHHhcC--CCCccceeEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---KKLMRAQTEREILSLLD--HPFLPTLYSH 179 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~--hpnIv~l~~~ 179 (506)
.++...++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 345566789999999999999999999999999999999987543321 11234567999999996 5999999999
Q ss_pred EEeCCeEEEEEeecCC-CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe-cCCCEEEeec
Q 010603 180 FETDKFSCLLMEFCSG-GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-EDGHIMLSDF 257 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~g-g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~DF 257 (506)
+...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 9999999999999976 8999998875 5799999999999999999999999999999999999999 7889999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|++......
T Consensus 195 g~~~~~~~~----------------------------------------------------------------------- 203 (320)
T 3a99_A 195 GSGALLKDT----------------------------------------------------------------------- 203 (320)
T ss_dssp TTCEECCSS-----------------------------------------------------------------------
T ss_pred ccccccccc-----------------------------------------------------------------------
Confidence 998542100
Q ss_pred cccCCCCCCccccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSIS 416 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s 416 (506)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+......++ ..++
T Consensus 204 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--~~~~ 267 (320)
T 3a99_A 204 --------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVS 267 (320)
T ss_dssp --------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--SCCC
T ss_pred --------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--ccCC
Confidence 0112369999999999987775 788999999999999999999997532 2222333333 3689
Q ss_pred HHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
+++.+||.+||..||.+||+ ++++++||||+.+.+.
T Consensus 268 ~~~~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPT----FEEIQNHPWMQDVLLP 303 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSCCCH
T ss_pred HHHHHHHHHHccCChhhCcC----HHHHhcCHhhcCccCc
Confidence 99999999999999999997 9999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.58 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=208.6
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEE----EccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAE----LRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
.++..++|++++.||+|+||+||+|+ +..+++.||||++.... ......+.+|+++|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45667889999999999999999999 56789999999997643 344567889999999999999999999986
Q ss_pred eC--CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 182 TD--KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 182 ~~--~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
.. ..+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 54 56899999999999999998752 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+.........
T Consensus 161 ~~~~~~~~~~---------------------------------------------------------------------- 170 (295)
T 3ugc_A 161 TKVLPQDKEF---------------------------------------------------------------------- 170 (295)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccccCCcce----------------------------------------------------------------------
Confidence 8542111000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH---------------HHHHHHhC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---------------ETLFNVVG 404 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~---------------~~~~~i~~ 404 (506)
........||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+...+.
T Consensus 171 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 171 ----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred ----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 00011225788899999999999999999999999999999999998643211 01122222
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 405 ~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.....+....+++++.+||.+||..||.+||+ +.|+++
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 33344445579999999999999999999998 777765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=377.03 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=213.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
.++..++|++++.||+|+||.||+|.+. ++..||||++..... ....+.+|+++|+.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 3456678999999999999999999887 477899999986532 23457789999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999998763 25699999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
... .
T Consensus 173 ~~~----------------------------------------------------------------------------~ 176 (283)
T 3gen_A 173 DEY----------------------------------------------------------------------------T 176 (283)
T ss_dssp HHH----------------------------------------------------------------------------H
T ss_pred ccc----------------------------------------------------------------------------c
Confidence 000 0
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.... .......+++.+.+||.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRPHLASEKVYTIMY 255 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-CCCCCCcCCHHHHHHHH
Confidence 0111257889999999999999999999999999999998 999999888877777766543 23333468999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+||..||.+||+ +.++++|
T Consensus 256 ~~l~~~p~~Rps----~~~ll~~ 274 (283)
T 3gen_A 256 SCWHEKADERPT----FKILLSN 274 (283)
T ss_dssp HTTCSSGGGSCC----HHHHHHH
T ss_pred HHccCChhHCcC----HHHHHHH
Confidence 999999999998 8888875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.33 Aligned_cols=250 Identities=19% Similarity=0.253 Sum_probs=208.8
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCC-------ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMG-------CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH 179 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 179 (506)
++..++|++.+.||+|+||+||+|+++.++ +.||+|++.+.. ......+.+|+++|+.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456678999999999999999999999877 469999997643 3445677889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC--------
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH-------- 251 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-------- 251 (506)
+..++..|+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999999998752 44999999999999999999999999999999999999999887
Q ss_pred EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCC
Q 010603 252 IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331 (506)
Q Consensus 252 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (506)
+||+|||++.....
T Consensus 160 ~kl~Dfg~~~~~~~------------------------------------------------------------------ 173 (289)
T 4fvq_A 160 IKLSDPGISITVLP------------------------------------------------------------------ 173 (289)
T ss_dssp EEECCCCSCTTTSC------------------------------------------------------------------
T ss_pred eeeccCcccccccC------------------------------------------------------------------
Confidence 99999999742100
Q ss_pred CCCCcccccCCCCCCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC
Q 010603 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410 (506)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 410 (506)
.....||+.|+|||++.+ ..++.++|||||||++|||++|..|+..................++
T Consensus 174 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (289)
T 4fvq_A 174 ---------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238 (289)
T ss_dssp ---------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred ---------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence 112358999999999988 6789999999999999999995544444433434444444444444
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
. ..+.++.+||.+||..||.+||+ +.++++|
T Consensus 239 ~--~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 239 A--PKAAELANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp C--CSSCTTHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred C--CCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 4 46788999999999999999997 8888874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=375.18 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=207.2
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
.++..++|++++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 456677899999999999999999998754 4579999987542 2344567789999999999999999999984
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
++..|+||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 56789999999999999998765 34699999999999999999999999999999999999999999999999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
......
T Consensus 166 ~~~~~~-------------------------------------------------------------------------- 171 (281)
T 1mp8_A 166 MEDSTY-------------------------------------------------------------------------- 171 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCcccc--------------------------------------------------------------------------
Confidence 211000
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....+++.+.+
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~ 248 (281)
T 1mp8_A 172 --YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYS 248 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHH
T ss_pred --cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 00112257889999999999999999999999999999996 999999888877777766443 23333478999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
||.+||..||.+||+ +.++++
T Consensus 249 li~~~l~~~p~~Rps----~~~l~~ 269 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPR----FTELKA 269 (281)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHccCChhhCcC----HHHHHH
Confidence 999999999999998 778876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=379.70 Aligned_cols=257 Identities=24% Similarity=0.306 Sum_probs=207.2
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.+++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++..++.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35779999999999999999999999999999999987655555556778899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK- 188 (309)
T ss_dssp EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-
Confidence 99999999999998875 579999999999999999999999999999999999999999999999999984321000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
.....
T Consensus 189 ---------------------------------------------------------------------------~~~~~ 193 (309)
T 2h34_A 189 ---------------------------------------------------------------------------LTQLG 193 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00012
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCC-CCCCCCCHHHHHHHHHHh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKF-PEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-p~~~~~s~~~~~li~~~L 427 (506)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....... .....++.++.+||.+||
T Consensus 194 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 273 (309)
T 2h34_A 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGM 273 (309)
T ss_dssp ---CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHT
T ss_pred ccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhc
Confidence 2369999999999999999999999999999999999999998776553333333222111 122468999999999999
Q ss_pred hcCCCCccCCCCChHHhhc
Q 010603 428 VKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~ 446 (506)
..||.+||+ +++++++
T Consensus 274 ~~dP~~Rp~---s~~~l~~ 289 (309)
T 2h34_A 274 AKNPEDRYV---TCGDLSA 289 (309)
T ss_dssp CSSGGGSCS---SHHHHHH
T ss_pred cCCHHHHHH---hHHHHHH
Confidence 999999994 2666664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=385.02 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=206.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceE----EEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLF----AMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+|+.++|||||++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45567999999999999999999998887765 666665432 223456788899999999999999999999876
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
. .++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 789999999999999988753 57999999999999999999999999999999999999999999999999998643
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.....
T Consensus 168 ~~~~~--------------------------------------------------------------------------- 172 (327)
T 3poz_A 168 GAEEK--------------------------------------------------------------------------- 172 (327)
T ss_dssp TTTCC---------------------------------------------------------------------------
T ss_pred cCCcc---------------------------------------------------------------------------
Confidence 11100
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
........||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+....+....+... ...+....++.++.+|
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 251 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-CCCCCCccCCHHHHHH
Confidence 000112357889999999999999999999999999999999 99999988776655554433 3444445789999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
|.+||+.||.+||+ +.+++++
T Consensus 252 i~~~l~~~p~~Rps----~~ell~~ 272 (327)
T 3poz_A 252 MVKCWMIDADSRPK----FRELIIE 272 (327)
T ss_dssp HHHHTCSCGGGSCC----HHHHHHH
T ss_pred HHHHcCCChhhCCC----HHHHHHH
Confidence 99999999999998 7788765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=407.06 Aligned_cols=258 Identities=20% Similarity=0.295 Sum_probs=220.9
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..+++...+|++.+.||+|+||.||+|.++.++..||||+++... .....+.+|+++|+.++|||||++++++...
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345667788999999999999999999999999999999997653 2356678899999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+.+|||||||.+|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 99999999999999999998766677999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.....
T Consensus 369 ~~~~~--------------------------------------------------------------------------- 373 (495)
T 1opk_A 369 TGDTY--------------------------------------------------------------------------- 373 (495)
T ss_dssp TTCCE---------------------------------------------------------------------------
T ss_pred cCCce---------------------------------------------------------------------------
Confidence 11000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..+....+. .....+....+++.+.+|
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHH
Confidence 00011247789999999999999999999999999999999 999999887776655554 333444445799999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
|.+||..||.+||+ +.++++
T Consensus 452 i~~cl~~dP~~RPs----~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPS----FAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHcCcChhHCcC----HHHHHH
Confidence 99999999999998 667765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=377.37 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=207.6
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
+...+++|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+|+.++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34566789999999999999999999999999999999987544445566778899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
.++||||+.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999988652 2467999999999999999999999999999999999999999999999999998532
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
....
T Consensus 187 ~~~~---------------------------------------------------------------------------- 190 (310)
T 2wqm_A 187 SSKT---------------------------------------------------------------------------- 190 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 1000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc--HHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN--RETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~--~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+............++.++.+
T Consensus 191 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 191 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred -ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 001123689999999999999999999999999999999999999976532 23334444333322223468999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
||.+||..||.+||+ +.++++
T Consensus 270 li~~~l~~dp~~Rps----~~~il~ 290 (310)
T 2wqm_A 270 LVNMCINPDPEKRPD----VTYVYD 290 (310)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHcCCChhhCCC----HHHHHH
Confidence 999999999999998 788876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=374.84 Aligned_cols=260 Identities=17% Similarity=0.224 Sum_probs=209.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
+.+..++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+ +|+||+++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 45566789999999999999999999999999999999875432 23456799999999 8999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC-----EEEeecCC
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH-----IMLSDFDL 259 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-----vkl~DFGl 259 (506)
..|+||||+ +++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 999999999 99999999875 356999999999999999999999999999999999999988776 99999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+...........
T Consensus 158 ~~~~~~~~~~~~-------------------------------------------------------------------- 169 (298)
T 1csn_A 158 VKFYRDPVTKQH-------------------------------------------------------------------- 169 (298)
T ss_dssp CEESBCTTTCCB--------------------------------------------------------------------
T ss_pred cccccccccccc--------------------------------------------------------------------
Confidence 864321100000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC---cHHHHHHHhCCCCCCC---CCC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG---NRETLFNVVGQPLKFP---EGS 413 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~p---~~~ 413 (506)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..+.......+ ...
T Consensus 170 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1csn_A 170 --IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 247 (298)
T ss_dssp --CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTT
T ss_pred --ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHh
Confidence 00011223479999999999999999999999999999999999999998743 2333333332211111 112
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+++++.+||.+||..||.+||+ ++++++
T Consensus 248 ~~~~~l~~li~~~l~~dp~~RP~----~~~l~~ 276 (298)
T 1csn_A 248 GFPEEFYKYMHYARNLAFDATPD----YDYLQG 276 (298)
T ss_dssp TSCHHHHHHHHHHHHCCTTCCCC----HHHHHH
T ss_pred hCcHHHHHHHHHHhcCCcccCCC----HHHHHH
Confidence 58999999999999999999998 566654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=397.43 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=215.1
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
...++..++|++++.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+++|+.++|||||++++++...
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 456778899999999999999999999886 7899999998643 345678899999999999999999998766
Q ss_pred C-eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 184 K-FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 184 ~-~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
. .+|||||||++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 5 899999999999999999887555689999999999999999999999999999999999999999999999999853
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 339 ~~~~---------------------------------------------------------------------------- 342 (450)
T 1k9a_A 339 ASST---------------------------------------------------------------------------- 342 (450)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
.....+|+.|+|||++.+..|+.++|||||||+||||++ |+.||.+.+..+.+..+..+ ...+....+++++.+
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYD 417 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 001247889999999999999999999999999999998 99999988777766666543 334444579999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
||.+||..||.+||+ +.++++
T Consensus 418 li~~cl~~dp~~Rpt----~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPT----FLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHcCCChhHCcC----HHHHHH
Confidence 999999999999998 666654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=383.56 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=204.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---hHHHHHHHHHHHHHhc----CCCCccceeE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---KKLMRAQTEREILSLL----DHPFLPTLYS 178 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l----~hpnIv~l~~ 178 (506)
.+...++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34556779999999999999999999999999999999976543221 1223345689999888 8999999999
Q ss_pred EEEeCCeEEEEEee-cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe-cCCCEEEee
Q 010603 179 HFETDKFSCLLMEF-CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR-EDGHIMLSD 256 (506)
Q Consensus 179 ~~~~~~~~~lV~E~-~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~-~~~~vkl~D 256 (506)
++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 99999999999999 7899999998875 5799999999999999999999999999999999999999 789999999
Q ss_pred cCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCc
Q 010603 257 FDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336 (506)
Q Consensus 257 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (506)
||++......
T Consensus 184 fg~~~~~~~~---------------------------------------------------------------------- 193 (312)
T 2iwi_A 184 FGSGALLHDE---------------------------------------------------------------------- 193 (312)
T ss_dssp CSSCEECCSS----------------------------------------------------------------------
T ss_pred cchhhhcccC----------------------------------------------------------------------
Confidence 9998542110
Q ss_pred ccccCCCCCCccccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCC
Q 010603 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSI 415 (506)
Q Consensus 337 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 415 (506)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+......++. .+
T Consensus 194 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~--~~ 256 (312)
T 2iwi_A 194 ---------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA--HV 256 (312)
T ss_dssp ---------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT--TS
T ss_pred ---------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc--cC
Confidence 0112369999999999987776 458999999999999999999997532 22334444443 68
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+.++.+||.+||..||++||+ ++|+++||||+...
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps----~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPS----LEEILLDPWMQTPA 291 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHHSTTTCC--
T ss_pred CHHHHHHHHHHccCChhhCcC----HHHHhcChhhcCch
Confidence 999999999999999999997 99999999998654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=384.94 Aligned_cols=260 Identities=19% Similarity=0.286 Sum_probs=217.6
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCc-----eEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGC-----LFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 179 (506)
.++..++|++++.||+|+||.||+|.+..+++ .||+|++..... ......+.+|+.+|+.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34566789999999999999999999987654 799999976432 23456678999999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQP------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR 247 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~ 247 (506)
+...+.+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 999999999999999999999987532 34689999999999999999999999999999999999999
Q ss_pred cCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccc
Q 010603 248 EDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKT 327 (506)
Q Consensus 248 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (506)
.++.+||+|||++........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------------------- 219 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN----------------------------------------------------------- 219 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-----------------------------------------------------------
T ss_pred CCCeEEECccccccccccccc-----------------------------------------------------------
Confidence 999999999999853211100
Q ss_pred cCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCC
Q 010603 328 SLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQP 406 (506)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~ 406 (506)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..++...
T Consensus 220 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 283 (333)
T 2i1m_A 220 ----------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283 (333)
T ss_dssp ----------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred ----------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence 000112357889999999999999999999999999999998 999999877666666655444
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 407 ~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
...+....++..+.+||.+||..||.+||+ +.++++
T Consensus 284 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 319 (333)
T 2i1m_A 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPT----FQQICS 319 (333)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 444444568999999999999999999998 788876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=391.48 Aligned_cols=261 Identities=22% Similarity=0.304 Sum_probs=209.2
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEc---cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF 180 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 180 (506)
...++..++|++.+.||+|+||.||+|+++ .++..||||+++... .......+.+|+.+|+.++|||||++++++
T Consensus 38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 344566778999999999999999999987 457789999997643 234456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
...+.+||||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 9999999999999999999998764 357999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+........
T Consensus 195 ~~~~~~~~~----------------------------------------------------------------------- 203 (373)
T 2qol_A 195 RVLEDDPEA----------------------------------------------------------------------- 203 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccCCcc-----------------------------------------------------------------------
Confidence 542111000
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHH
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAA 419 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~ 419 (506)
........+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+....+... ...+....++..+
T Consensus 204 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l 279 (373)
T 2qol_A 204 ---AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-EECCCCTTCBHHH
T ss_pred ---ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCccccHHH
Confidence 000011246789999999999999999999999999999997 99999988877766665543 3444455789999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||.+||..||.+||+ +.++++
T Consensus 280 ~~li~~cl~~dp~~RPs----~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPK----FEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHhCcChhhCcC----HHHHHH
Confidence 99999999999999998 666665
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=385.98 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=194.4
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHH-HHHhcCCCCccceeEEEEeCCe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE-ILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~ 185 (506)
++..++|++++.||+|+||.||+|.++.+|+.||||++..... .....++..|+. +++.++||||+++++++...+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4566789999999999999999999999999999999976532 223334445555 6788899999999999999999
Q ss_pred EEEEEeecCCCChHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 186 SCLLMEFCSGGDLHTLRQR---QPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~---~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.|+||||+. |+|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 999999996 588776653 2346799999999999999999999999 99999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 175 ~~~~~--------------------------------------------------------------------------- 179 (327)
T 3aln_A 175 QLVDS--------------------------------------------------------------------------- 179 (327)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ecccc---------------------------------------------------------------------------
Confidence 32100
Q ss_pred CCCCCccccccCCCCccchhh----cCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCC-CCCCCC--CC
Q 010603 342 PTSARSMSFVGTHEYLAPEII----RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQ-PLKFPE--GS 413 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l----~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~-~~~~p~--~~ 413 (506)
.......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... +.+..+... ...++. ..
T Consensus 180 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 180 ---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred ---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence 001122699999999999 4567899999999999999999999999865432 222222221 112221 23
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
.+++.+.+||.+||..||.+||+ +.++++||||....+
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPK----YKELLKHPFILMYEE 294 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHH
T ss_pred cCCHHHHHHHHHHhhCChhhCcC----HHHHHhChHHHHhHh
Confidence 58999999999999999999997 999999999976544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=381.59 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=213.4
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEE-----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAEL-----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
++..++|++++.||+|+||+||+|.+ ..+++.||||++.+... ......+.+|+.+|+.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 34567899999999999999999985 35678999999986532 33455678899999999 799999999998
Q ss_pred EeCC-eEEEEEeecCCCChHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEE
Q 010603 181 ETDK-FSCLLMEFCSGGDLHTLRQRQPG--------------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVL 245 (506)
Q Consensus 181 ~~~~-~~~lV~E~~~gg~L~~~l~~~~~--------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NIL 245 (506)
...+ .+|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 8755 59999999999999999987532 12899999999999999999999999999999999999
Q ss_pred EecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccc
Q 010603 246 VREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSE 325 (506)
Q Consensus 246 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (506)
++.++.+||+|||+++.......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------------- 203 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD--------------------------------------------------------- 203 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT---------------------------------------------------------
T ss_pred ECCCCCEEECCCccccccccCcc---------------------------------------------------------
Confidence 99999999999999853211100
Q ss_pred cccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhC
Q 010603 326 KTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVG 404 (506)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 404 (506)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+.
T Consensus 204 ------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 265 (316)
T 2xir_A 204 ------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265 (316)
T ss_dssp ------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred ------------------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence 001122368999999999999999999999999999999998 9999988765554444433
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 405 ~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.....+....+++.+.+||.+||..||.+||+ +.++++|
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cCccCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 32233333468999999999999999999997 8888875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=379.03 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=202.0
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+.+++|++++.||+|+||.||+|+++.+|+.||||++...... ......+..+..+++.++||||+++++++...+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 4567899999999999999999999999999999999865322 222333445556788889999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM-GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~-giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999 66666655542 36799999999999999999999995 9999999999999999999999999998432100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 179 ------------------------------------------------------------------------------~~ 180 (318)
T 2dyl_A 179 ------------------------------------------------------------------------------KA 180 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred ccccccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCC-CcHHHHHHHhCC-CCCCCCCCCCCHHH
Q 010603 347 SMSFVGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGN-GNRETLFNVVGQ-PLKFPEGSSISFAA 419 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~-~~~~p~~~~~s~~~ 419 (506)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+.+..+... ...++....++.++
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHH
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHH
Confidence 11236999999999995 456899999999999999999999999874 344445555433 33445545689999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.+||.+||..||.+||+ ++++++||||+..
T Consensus 261 ~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 261 QSFVKDCLTKDHRKRPK----YNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHTCSCTTTSCC----HHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhHCcC----HHHHhhCHHHHhc
Confidence 99999999999999998 9999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=378.47 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=212.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC--CCCccceeEEEEeCCe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--HPFLPTLYSHFETDKF 185 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~ 185 (506)
+..++|++++.||+|+||.||+|.+.. ++.||||++...... ......+.+|+++|+.++ ||||+++++++...+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 344569999999999999999999864 889999999765332 345567889999999997 5999999999999999
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred EEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 999999 5589999999875 5799999999999999999999999999999999999996 58999999999853211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
... ..
T Consensus 179 ~~~---------------------------------------------------------------------------~~ 183 (313)
T 3cek_A 179 DTT---------------------------------------------------------------------------SV 183 (313)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 000 00
Q ss_pred CccccccCCCCccchhhcC-----------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCCCCCCCCCC
Q 010603 346 RSMSFVGTHEYLAPEIIRG-----------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQPLKFPEGS 413 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-----------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~ 413 (506)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+.......+...
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc
Confidence 0112369999999999976 46889999999999999999999999876443 44455554444433334
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..+.++.+||.+||..||.+||+ +.|+++||||+..
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~~~~~ 299 (313)
T 3cek_A 264 IPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 299 (313)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHCC
T ss_pred cchHHHHHHHHHHccCCcccCcC----HHHHhcCccccCC
Confidence 67899999999999999999997 9999999999753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=384.12 Aligned_cols=251 Identities=23% Similarity=0.268 Sum_probs=199.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC---
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK--- 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--- 184 (506)
+..++|++++.||+|+||+||+|++. ++.||||++.... ........|+.+|+.++|||||++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 55677999999999999999999886 7899999997542 23334556888899999999999999998744
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CeEEccCCCCcEEEecCCCEE
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM----------GVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~----------giiHrDLKp~NILl~~~~~vk 253 (506)
.+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred ceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 479999999999999999774 599999999999999999999999 999999999999999999999
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||+|+.......
T Consensus 172 L~DFg~a~~~~~~~~----------------------------------------------------------------- 186 (322)
T 3soc_A 172 IADFGLALKFEAGKS----------------------------------------------------------------- 186 (322)
T ss_dssp ECCCTTCEEECTTSC-----------------------------------------------------------------
T ss_pred EccCCcccccccccC-----------------------------------------------------------------
Confidence 999999864321100
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCC-----CCCcchhHHHHHHHHHHHhcCCCCCCCCCc-------------
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD-----GHGSAVDWWTFGIFFYELLLGRTPFKGNGN------------- 395 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiWSlGvil~elltG~~Pf~~~~~------------- 395 (506)
.......+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+...
T Consensus 187 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 187 ----------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp ----------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred ----------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 0011234799999999999873 456789999999999999999999976432
Q ss_pred --HHHHHHHhCCCCCCCCC------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 396 --RETLFNVVGQPLKFPEG------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 396 --~~~~~~i~~~~~~~p~~------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
...+..........|.. ...+.++.+||.+||..||++||+ +.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 12222222221111111 112355999999999999999998 778775
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=384.39 Aligned_cols=257 Identities=19% Similarity=0.227 Sum_probs=209.2
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCce----EEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCL----FAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
.+..++|++++.||+|+||+||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 45567899999999999999999999988876 6666664332 1222344567999999999999999999986
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.+..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 56689999999999999998764 35789999999999999999999999999999999999999999999999999864
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
......
T Consensus 165 ~~~~~~-------------------------------------------------------------------------- 170 (325)
T 3kex_A 165 LPPDDK-------------------------------------------------------------------------- 170 (325)
T ss_dssp SCCCTT--------------------------------------------------------------------------
T ss_pred cCcccc--------------------------------------------------------------------------
Confidence 311100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... ..+....++.++.+
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 171 -QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQPQICTIDVYM 248 (325)
T ss_dssp -CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-BCCCCTTBCTTTTH
T ss_pred -cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-CCCCCCcCcHHHHH
Confidence 001122368889999999999999999999999999999999 999999887766666555432 23333467888999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
||.+||..||.+||+ +.++++|
T Consensus 249 li~~~l~~dp~~Rps----~~el~~~ 270 (325)
T 3kex_A 249 VMVKCWMIDENIRPT----FKELANE 270 (325)
T ss_dssp HHHHHTCSCTTTSCC----HHHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999998 7888775
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=379.80 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=214.9
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-------cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCcccee
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-------DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLY 177 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 177 (506)
.++..++|++++.||+|+||+||+|.+. .+++.||||++.... .......+.+|+++|+.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 3455678999999999999999999986 457789999997643 234556788999999999 899999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPG--------------KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
+++...+.+|+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 999999999999999999999999886531 348999999999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
||++.++.+||+|||+++........
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------------------ 213 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY------------------------------------------------------ 213 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE------------------------------------------------------
T ss_pred EEEcCCCCEEEccccccccccccccc------------------------------------------------------
Confidence 99999999999999998542111000
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 214 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 272 (334)
T 2pvf_A 214 ---------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272 (334)
T ss_dssp ---------------------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred ---------------------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence 00112257889999999999889999999999999999999 99999988777666555
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.... ..+....++.++.+||.+||..||.+||+ +.+++++
T Consensus 273 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 273 KEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp HHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hcCC-CCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 4332 22333478999999999999999999998 7888764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=381.07 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=208.3
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceE----EEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLF----AMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
+..++|++++.||+|+||+||+|++..+++.| |+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 45577999999999999999999999888776 555544321 234456788899999999999999999999876
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
. .++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 789999999999999988753 57999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.....
T Consensus 168 ~~~~~--------------------------------------------------------------------------- 172 (327)
T 3lzb_A 168 GAEEK--------------------------------------------------------------------------- 172 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCccc---------------------------------------------------------------------------
Confidence 11000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
........||+.|+|||++.+..|+.++|||||||+||||++ |+.||.+....+....+... ...+....++.++.+|
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 251 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVYMI 251 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTBCHHHHHH
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHH
Confidence 000112357889999999999999999999999999999999 99999988777665555433 3444445789999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
|.+||..||.+||+ +.|+++
T Consensus 252 i~~~l~~dp~~Rps----~~ell~ 271 (327)
T 3lzb_A 252 MRKCWMIDADSRPK----FRELII 271 (327)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHcCCChhHCcC----HHHHHH
Confidence 99999999999998 778876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=367.16 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=215.3
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+..++|++++.||+|+||.||+|.+. +++.||||++..... ....+.+|+++++.++||||+++++++...+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 345678999999999999999999987 478899999987532 234678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999999998765 356899999999999999999999999999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ..
T Consensus 158 ~~----------------------------------------------------------------------------~~ 161 (267)
T 3t9t_A 158 QY----------------------------------------------------------------------------TS 161 (267)
T ss_dssp HH----------------------------------------------------------------------------HS
T ss_pred cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.... .......++..+.+||.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCCccCcHHHHHHHHH
Confidence 112257889999999999999999999999999999999 999999888777777766542 222334689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~h 447 (506)
||..||.+||+ +.+++++
T Consensus 241 ~l~~~p~~Rps----~~~ll~~ 258 (267)
T 3t9t_A 241 CWRERPEDRPA----FSRLLRQ 258 (267)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred HccCChhhCcC----HHHHHHH
Confidence 99999999998 7888763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=373.59 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=209.0
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEE----EccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAE----LRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
+.+...+|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+++|+.++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34555669999999999999999999 56789999999998653 2334567789999999999999999999998
Q ss_pred eC--CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 182 TD--KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 182 ~~--~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
.. ..+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 77 67999999999999999986542 5699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+..........
T Consensus 173 ~~~~~~~~~~~--------------------------------------------------------------------- 183 (302)
T 4e5w_A 173 TKAIETDKEYY--------------------------------------------------------------------- 183 (302)
T ss_dssp CEECCTTCCEE---------------------------------------------------------------------
T ss_pred cccccCCCcce---------------------------------------------------------------------
Confidence 85432111000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC--------------CcHHHHHHHhCC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN--------------GNRETLFNVVGQ 405 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~--------------~~~~~~~~i~~~ 405 (506)
.......||..|+|||++.+..++.++|||||||++|||++|..||... .....+...+..
T Consensus 184 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 184 -----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp -----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred -----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 0011236888999999999999999999999999999999999986322 122223333333
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 406 ~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
....+....+++++.+||.+||..||.+||+ +.++++
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 3344445579999999999999999999998 778775
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=383.62 Aligned_cols=263 Identities=17% Similarity=0.252 Sum_probs=214.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEE-----EccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAE-----LRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
++..++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4556779999999999999999999 55678899999997532 2344556788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC---CCEE
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPG-----KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED---GHIM 253 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~-----~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~---~~vk 253 (506)
..+..|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999999987532 358999999999999999999999999999999999999944 4699
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||++........
T Consensus 184 l~Dfg~~~~~~~~~~----------------------------------------------------------------- 198 (327)
T 2yfx_A 184 IGDFGMARDIYRASY----------------------------------------------------------------- 198 (327)
T ss_dssp ECCCHHHHHHHC--------------------------------------------------------------------
T ss_pred ECccccccccccccc-----------------------------------------------------------------
Confidence 999999854211100
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCC
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEG 412 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 412 (506)
........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+.... ..+..
T Consensus 199 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 267 (327)
T 2yfx_A 199 ----------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP 267 (327)
T ss_dssp -------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC
T ss_pred ----------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCC
Confidence 000112368999999999999999999999999999999998 999999887777666665443 22233
Q ss_pred CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 413 SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 413 ~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
..++..+.+||.+||..||.+||+ +.++++|.|+-
T Consensus 268 ~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~l~~~ 302 (327)
T 2yfx_A 268 KNCPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 302 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCChhhCcC----HHHHHHHHHHH
Confidence 468999999999999999999997 89999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=380.32 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=212.8
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceE--EEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLF--AMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
+..++|++.+.||+|+||.||+|+++.++..+ |||.+.... .......+.+|+++|+.+ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55678999999999999999999999988865 999987532 233445678899999999 9999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG 250 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 250 (506)
.+|+||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999987642 24799999999999999999999999999999999999999999
Q ss_pred CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCC
Q 010603 251 HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLT 330 (506)
Q Consensus 251 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (506)
.+||+|||+++.....
T Consensus 180 ~~kL~Dfg~~~~~~~~---------------------------------------------------------------- 195 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---------------------------------------------------------------- 195 (327)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred eEEEcccCcCcccccc----------------------------------------------------------------
Confidence 9999999998421000
Q ss_pred CCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCC
Q 010603 331 NSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKF 409 (506)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~ 409 (506)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+... ...
T Consensus 196 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~ 260 (327)
T 1fvr_A 196 --------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRL 260 (327)
T ss_dssp --------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCC
T ss_pred --------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-CCC
Confidence 00111257889999999999889999999999999999998 99999988877666655433 233
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 410 p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+....+++++.+||.+||..||.+||+ ++++++|
T Consensus 261 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 261 EKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 334478999999999999999999998 8888874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=400.03 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=215.8
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
...++..++|++.+.||+|+||+||+|.++. +..||||+++... .....+.+|+++|+.++|||||++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 3456777889999999999999999999874 6789999998643 33567789999999999999999999986 6
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+.+|||||||.+|+|.+++.......+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 67899999999999999998654457899999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.....
T Consensus 335 ~~~~~--------------------------------------------------------------------------- 339 (454)
T 1qcf_A 335 EDNEY--------------------------------------------------------------------------- 339 (454)
T ss_dssp CCHHH---------------------------------------------------------------------------
T ss_pred CCCce---------------------------------------------------------------------------
Confidence 11000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......+|+.|+|||++....|+.++|||||||+||||++ |+.||.+.+..+.+..+... ...+....+++++.+|
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNI 417 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTSCHHHHHH
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHH
Confidence 00011246789999999999999999999999999999999 99999998887777666533 3444555799999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
|.+||..||.+||+ +.+|+.
T Consensus 418 i~~cl~~dp~~RPt----~~~i~~ 437 (454)
T 1qcf_A 418 MMRCWKNRPEERPT----FEYIQS 437 (454)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHccCChhHCcC----HHHHHH
Confidence 99999999999998 566654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=367.73 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=212.9
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+++..++|++++.||+|+||.||+|.+. +++.||||++.... .....+.+|+++|+.++||||+++++++. .+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 34566688999999999999999999976 46789999997643 23456788999999999999999999986 45
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..|+||||+.+++|.+++....+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 68999999999999999876433479999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
....
T Consensus 161 ~~~~---------------------------------------------------------------------------- 164 (279)
T 1qpc_A 161 DNEY---------------------------------------------------------------------------- 164 (279)
T ss_dssp SSCE----------------------------------------------------------------------------
T ss_pred Cccc----------------------------------------------------------------------------
Confidence 1000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ........++.++.+||
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLM 243 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHHHHHHH
Confidence 00112257889999999998889999999999999999999 99999988877776666543 23333347899999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..||++||+ +.++++
T Consensus 244 ~~~l~~~p~~Rps----~~~l~~ 262 (279)
T 1qpc_A 244 RLCWKERPEDRPT----FDYLRS 262 (279)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHhccChhhCCC----HHHHHH
Confidence 9999999999998 677765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.01 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=203.4
Q ss_pred cCCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 103 SKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 103 ~~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
...+++..++|++.+.||+|+||+||+|++.. .||||+++.... .......+.+|+++|+.++||||++++++. .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 34567888899999999999999999998753 599999976532 234566788999999999999999999954 5
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
....++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 66789999999999999988654 36799999999999999999999999999999999999999999999999999853
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 170 ~~~~~--------------------------------------------------------------------------- 174 (289)
T 3og7_A 170 KSRWS--------------------------------------------------------------------------- 174 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 21000
Q ss_pred CCCCccccccCCCCccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC----CCCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIR---GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP----EGSSI 415 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~ 415 (506)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||.+....+.+...+......+ ....+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 000112346999999999997 56688999999999999999999999998777666655543221111 12368
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
++.+.+||.+||..||.+||+ +.++++
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps----~~ell~ 281 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPS----FPRILA 281 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 899999999999999999998 778775
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=367.46 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=214.0
Q ss_pred CcccCCeEEEe-EEeecCceEEEEEEEc--cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 107 DLGLGHFRLLK-KLGCGDIGSVYLAELR--DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 107 ~~~~~~y~i~~-~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
.+..++|.+++ .||+|+||.||+|.++ .+++.||||++.... .......+.+|+++|+.++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 34556799988 9999999999999864 467889999998642 234566788999999999999999999999 45
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+..|+||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 6799999999999999998654 356999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (287)
T 1u59_A 161 GADDSYY------------------------------------------------------------------------- 167 (287)
T ss_dssp TTCSCEE-------------------------------------------------------------------------
T ss_pred ccCccee-------------------------------------------------------------------------
Confidence 1110000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.... ..+....+++++.+|
T Consensus 168 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l 245 (287)
T 1u59_A 168 -TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYAL 245 (287)
T ss_dssp -CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred -eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCCCCcCHHHHHH
Confidence 00112257899999999998889999999999999999998 999999888777666665432 222234789999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
|.+||..||.+||+ +.++++|
T Consensus 246 i~~~l~~~p~~Rps----~~~l~~~ 266 (287)
T 1u59_A 246 MSDCWIYKWEDRPD----FLTVEQR 266 (287)
T ss_dssp HHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999997 8888876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=373.10 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=208.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEcc-CCc--eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRD-MGC--LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
+..++|++++.||+|+||+||+|++.. +++ .||||+++............+.+|+++++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 345679999999999999999998753 333 69999998765555566778889999999999999999999998765
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred -ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 89999999999999988764 2569999999999999999999999999999999999999999999999999985431
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..... .
T Consensus 173 ~~~~~--------------------------------------------------------------------------~ 178 (291)
T 1u46_A 173 QNDDH--------------------------------------------------------------------------Y 178 (291)
T ss_dssp C-CCE--------------------------------------------------------------------------E
T ss_pred ccccc--------------------------------------------------------------------------h
Confidence 11000 0
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+.+..+......++....++.++.+||
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (291)
T 1u46_A 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 258 (291)
T ss_dssp EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHH
T ss_pred hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHH
Confidence 00112357889999999999889999999999999999999 99999998888888887766656666668999999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..||.+||+ +.++++
T Consensus 259 ~~~l~~~p~~Rps----~~~l~~ 277 (291)
T 1u46_A 259 VQCWAHKPEDRPT----FVALRD 277 (291)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHccCCcccCcC----HHHHHH
Confidence 9999999999998 788886
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=376.27 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=213.3
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCC----ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEE
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH 179 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 179 (506)
...++...+|++.+.||+|+||+||+|.++.++ ..||||++.... .......+.+|+++++.++||||++++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 334567788999999999999999999987653 359999997643 23344567889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
+...+..||||||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999999998764 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
++........
T Consensus 194 ~~~~~~~~~~---------------------------------------------------------------------- 203 (333)
T 1mqb_A 194 SRVLEDDPEA---------------------------------------------------------------------- 203 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred chhhcccccc----------------------------------------------------------------------
Confidence 8542111000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHH
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ...+....++..
T Consensus 204 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 278 (333)
T 1mqb_A 204 ----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCPSA 278 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCBHH
T ss_pred ----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCcccCCHH
Confidence 000111247889999999999999999999999999999998 99999988877766666543 334444578999
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+.+||.+||..||.+||+ +.+++++
T Consensus 279 l~~li~~~l~~~p~~Rps----~~~l~~~ 303 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPK----FADIVSI 303 (333)
T ss_dssp HHHHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999998 6777663
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=379.28 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=210.6
Q ss_pred cccCCeEEEeEEeecCceEEEEEE----EccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE--
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAE----LRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE-- 181 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-- 181 (506)
+..++|++++.||+|+||.||+|+ +..+++.||||++.... ......+.+|+++|+.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 455789999999999999999999 46789999999997653 344566789999999999999999999987
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
....+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 4567999999999999999987642 469999999999999999999999999999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
........
T Consensus 176 ~~~~~~~~------------------------------------------------------------------------ 183 (327)
T 3lxl_A 176 LLPLDKDY------------------------------------------------------------------------ 183 (327)
T ss_dssp ECCTTCSE------------------------------------------------------------------------
T ss_pred ecccCCcc------------------------------------------------------------------------
Confidence 43111000
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH--------------HHHHHHhCCCC
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR--------------ETLFNVVGQPL 407 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~--------------~~~~~i~~~~~ 407 (506)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+...+....
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3lxl_A 184 --YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261 (327)
T ss_dssp --EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred --ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence 00011235889999999999999999999999999999999999998643321 22233333334
Q ss_pred CCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 408 ~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
..+....+++.+.+||.+||..||.+||+ +.++++
T Consensus 262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~ 296 (327)
T 3lxl_A 262 RLPAPPACPAEVHELMKLCWAPSPQDRPS----FSALGP 296 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 44455679999999999999999999998 777754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=367.46 Aligned_cols=257 Identities=21% Similarity=0.280 Sum_probs=210.3
Q ss_pred CcccCCeEEEe-EEeecCceEEEEEEE--ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 107 DLGLGHFRLLK-KLGCGDIGSVYLAEL--RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 107 ~~~~~~y~i~~-~LG~G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
.+..++|++.+ .||+|+||.||+|.+ ..+++.||||++..... .......+.+|+++++.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 34556799999 999999999999954 56678999999986532 234456788999999999999999999999 56
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+..|+||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 7789999999999999999875 57999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.......
T Consensus 168 ~~~~~~~------------------------------------------------------------------------- 174 (291)
T 1xbb_A 168 RADENYY------------------------------------------------------------------------- 174 (291)
T ss_dssp CTTCSEE-------------------------------------------------------------------------
T ss_pred ccCCCcc-------------------------------------------------------------------------
Confidence 1110000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... ..+....+++.+.+|
T Consensus 175 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 175 -KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDL 252 (291)
T ss_dssp -EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred -cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHH
Confidence 00111247889999999998889999999999999999999 999999888776666655432 222334789999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
|.+||..||.+||+ +.++++
T Consensus 253 i~~~l~~dp~~Rps----~~~l~~ 272 (291)
T 1xbb_A 253 MNLCWTYDVENRPG----FAAVEL 272 (291)
T ss_dssp HHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHcCCChhhCcC----HHHHHH
Confidence 99999999999998 777765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=385.15 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=200.4
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccC-----CceEEEEEeccchhhchhHH--------HHHHHHHHHHHhcCCCCcc
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKL--------MRAQTEREILSLLDHPFLP 174 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~--------~~~~~E~~il~~l~hpnIv 174 (506)
+..++|++++.||+|+||+||+|.++.+ ++.||||++........... .....|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3445799999999999999999999765 58899999876532111111 1233466677888999999
Q ss_pred ceeEEEEeC----CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe--c
Q 010603 175 TLYSHFETD----KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR--E 248 (506)
Q Consensus 175 ~l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~--~ 248 (506)
++++++... .+.||||||| |++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998765 5689999999 99999998774 36799999999999999999999999999999999999999 8
Q ss_pred CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccccccccc
Q 010603 249 DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTS 328 (506)
Q Consensus 249 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (506)
++.+||+|||+|+.+........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~--------------------------------------------------------- 212 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKA--------------------------------------------------------- 212 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCC---------------------------------------------------------
T ss_pred CCeEEEEECCcceecccCCcccc---------------------------------------------------------
Confidence 89999999999965321110000
Q ss_pred CCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC----
Q 010603 329 LTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---- 404 (506)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---- 404 (506)
.........+||+.|||||++.+..++.++|||||||+||||++|+.||.+......+.....
T Consensus 213 -------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 279 (364)
T 3op5_A 213 -------------YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYR 279 (364)
T ss_dssp -------------SSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH
T ss_pred -------------cccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhh
Confidence 000111234799999999999999999999999999999999999999986433222211110
Q ss_pred CCC------CCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 405 QPL------KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 405 ~~~------~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
..+ .++ ...++.++.+||.+||..||.+||+ +.++++
T Consensus 280 ~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~----~~~l~~ 322 (364)
T 3op5_A 280 ENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPL----YENLRD 322 (364)
T ss_dssp HCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred hhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCC----HHHHHH
Confidence 000 011 1368899999999999999999998 555543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=367.73 Aligned_cols=255 Identities=18% Similarity=0.253 Sum_probs=200.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE-EeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF-ETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lV 189 (506)
++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|++++..+..+ ...+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 579999999999999999999999999999998765432 22356799999999888777666555 677889999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE---ecCCCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFGla~~~~~~ 266 (506)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999 99999998754 2579999999999999999999999999999999999999 78999999999998643211
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..... .....
T Consensus 162 ~~~~~----------------------------------------------------------------------~~~~~ 171 (296)
T 4hgt_A 162 RTHQH----------------------------------------------------------------------IPYRE 171 (296)
T ss_dssp TTCCB----------------------------------------------------------------------CCCCC
T ss_pred ccCcc----------------------------------------------------------------------CCCCc
Confidence 00000 00001
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH---HHHHHHhCCCCCCCC---CCCCCHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---ETLFNVVGQPLKFPE---GSSISFAAK 420 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~p~---~~~~s~~~~ 420 (506)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+.......+. ...+++++.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (296)
T 4hgt_A 172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFA 251 (296)
T ss_dssp SCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHH
T ss_pred ccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHH
Confidence 22347999999999999999999999999999999999999999864332 233333322222221 135789999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+||.+||..||++||+ ++++++
T Consensus 252 ~li~~~l~~~p~~Rpt----~~~l~~ 273 (296)
T 4hgt_A 252 TYLNFCRSLRFDDKPD----YSYLRQ 273 (296)
T ss_dssp HHHHHHHTSCTTCCCC----HHHHHH
T ss_pred HHHHHHHhcCCCCCCC----HHHHHH
Confidence 9999999999999998 666665
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=369.98 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=197.3
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh--cCCCCccceeEEEEe--
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL--LDHPFLPTLYSHFET-- 182 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~-- 182 (506)
++..++|++++.||+|+||+||+|++ +++.||||++... .......|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999988 4899999999753 22344557777666 799999999998654
Q ss_pred --CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeEEccCCCCcEEEecCCCE
Q 010603 183 --DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH--------MMGVVYRDLKPENVLVREDGHI 252 (506)
Q Consensus 183 --~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH--------~~giiHrDLKp~NILl~~~~~v 252 (506)
...+|+||||+++|+|.++++. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++.+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence 3568999999999999999964 47999999999999999999999 9999999999999999999999
Q ss_pred EEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCC
Q 010603 253 MLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNS 332 (506)
Q Consensus 253 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (506)
||+|||+|+.........
T Consensus 153 kl~Dfg~a~~~~~~~~~~-------------------------------------------------------------- 170 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQL-------------------------------------------------------------- 170 (301)
T ss_dssp EECCCTTCEEEETTTTEE--------------------------------------------------------------
T ss_pred EEeeCCCeeecccccccc--------------------------------------------------------------
Confidence 999999985422111000
Q ss_pred CCCcccccCCCCCCccccccCCCCccchhhcCC------CCCcchhHHHHHHHHHHHhcC----------CCCCCCCC--
Q 010603 333 DSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD------GHGSAVDWWTFGIFFYELLLG----------RTPFKGNG-- 394 (506)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~~~~~DiWSlGvil~elltG----------~~Pf~~~~-- 394 (506)
.......+||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 171 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 171 -----------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp -----------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred -----------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 0001223799999999999877 445799999999999999999 88986532
Q ss_pred --cHHHHHHHhCCCCC---CCCC---CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 395 --NRETLFNVVGQPLK---FPEG---SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 395 --~~~~~~~i~~~~~~---~p~~---~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
....+......... ++.. ..++..+.+||.+||..||.+||+ +.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 23334443322222 2210 124577999999999999999998 788875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.36 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=207.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------- 182 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------- 182 (506)
.++|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 356999999999999999999999999999999997642 234579999999999999999999865
Q ss_pred ---------CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEE
Q 010603 183 ---------DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIM 253 (506)
Q Consensus 183 ---------~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vk 253 (506)
...+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999876557899999999999999999999999999999999999999999999
Q ss_pred EeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCC
Q 010603 254 LSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333 (506)
Q Consensus 254 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (506)
|+|||++.......
T Consensus 163 l~Dfg~~~~~~~~~------------------------------------------------------------------ 176 (284)
T 2a19_B 163 IGDFGLVTSLKNDG------------------------------------------------------------------ 176 (284)
T ss_dssp ECCCTTCEESSCCS------------------------------------------------------------------
T ss_pred ECcchhheeccccc------------------------------------------------------------------
Confidence 99999985421100
Q ss_pred CCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCC
Q 010603 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGS 413 (506)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 413 (506)
......||+.|+|||++.+..++.++|||||||++|||++|..||... ......+.... ++ .
T Consensus 177 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~--~~--~ 238 (284)
T 2a19_B 177 ------------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI--IS--D 238 (284)
T ss_dssp ------------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC--CC--T
T ss_pred ------------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc--cc--c
Confidence 011236999999999999999999999999999999999999998532 22223333222 22 3
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
.++..+.+||.+||..||.+||+ +.|+++|.+.
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rps----~~e~l~~l~~ 271 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRPN----TSEILRTLTV 271 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcC----HHHHHHHHHH
Confidence 58899999999999999999997 8999998765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=364.89 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=210.7
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEcc---CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD---MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
.+..++|++.+.||+|+||+||+|.+.. ++..||||++.+.. .......+.+|+.+|+.++||||+++++++..+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4556789999999999999999999764 34569999998653 233456788999999999999999999998754
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
..|+||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 568999999999999998765 256999999999999999999999999999999999999999999999999998532
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.....
T Consensus 164 ~~~~~--------------------------------------------------------------------------- 168 (281)
T 3cc6_A 164 EDEDY--------------------------------------------------------------------------- 168 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 11000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.... ..+....+++.+.+|
T Consensus 169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 246 (281)
T 3cc6_A 169 -YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCPPVLYTL 246 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCCCCTTCCHHHHHH
T ss_pred -cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCCCCCCCCHHHHHH
Confidence 00112257889999999999999999999999999999998 999998877766665554332 233344689999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
|.+||..||.+||+ +.+++++
T Consensus 247 i~~~l~~~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 247 MTRCWDYDPSDRPR----FTELVCS 267 (281)
T ss_dssp HHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHccCCchhCcC----HHHHHHH
Confidence 99999999999998 7888764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=380.65 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=206.3
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
..++|++.+.||+|+||+||+|+++ +++.||||++.... ......+.+|+++|+.++||||+++++++...+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 4577999999999999999999975 58999999987643 3445678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 189 LMEFCSGGDLHTLRQRQP--GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~--~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999886543 235899999999999999999999999999999999999999999999999998532100
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
. ....
T Consensus 193 ~---------------------------------------------------------------------------~~~~ 197 (321)
T 2qkw_B 193 D---------------------------------------------------------------------------QTHL 197 (321)
T ss_dssp S---------------------------------------------------------------------------CCCC
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0000
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHH------HH-HhCCCCC------CC--C
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL------FN-VVGQPLK------FP--E 411 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~------~~-i~~~~~~------~p--~ 411 (506)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.. .. .....+. .. .
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 12246999999999999999999999999999999999999999765432111 11 1111100 00 1
Q ss_pred CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 412 ~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
....+..+.+||.+||..||++||+ +.|+++|
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 1123467889999999999999998 8888875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=393.50 Aligned_cols=256 Identities=24% Similarity=0.311 Sum_probs=213.5
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..+++..++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+++|+.++|||||++++++..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 3456777889999999999999999999985 46799999986532 23567889999999999999999999876
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+.+|||||||.+|+|.+++....+..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 67899999999999999997654467999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
.....
T Consensus 331 ~~~~~--------------------------------------------------------------------------- 335 (452)
T 1fmk_A 331 EDNEY--------------------------------------------------------------------------- 335 (452)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCce---------------------------------------------------------------------------
Confidence 11000
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
.......||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+... ...+....+++.+.+|
T Consensus 336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHH
T ss_pred -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHH
Confidence 00112257889999999999999999999999999999999 99999998887777766543 3444445799999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
|.+||..||++||+ ++++++
T Consensus 414 i~~cl~~dP~~Rpt----~~~l~~ 433 (452)
T 1fmk_A 414 MCQCWRKEPEERPT----FEYLQA 433 (452)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHccCChhhCcC----HHHHHH
Confidence 99999999999998 677765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=370.41 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=207.8
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEcc---CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD---MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
.+..++|++.+.||+|+||.||+|.+.. +++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 4556779999999999999999998875 4568999999765322 34456788999999999999999999999876
Q ss_pred C-----eEEEEEeecCCCChHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEE
Q 010603 184 K-----FSCLLMEFCSGGDLHTLRQRQ----PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIML 254 (506)
Q Consensus 184 ~-----~~~lV~E~~~gg~L~~~l~~~----~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl 254 (506)
+ ..|+||||+.+|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 5 459999999999999988532 3357999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
+|||++........
T Consensus 189 ~Dfg~~~~~~~~~~------------------------------------------------------------------ 202 (313)
T 3brb_A 189 ADFGLSKKIYSGDY------------------------------------------------------------------ 202 (313)
T ss_dssp CSCSCC--------------------------------------------------------------------------
T ss_pred eecCcceecccccc------------------------------------------------------------------
Confidence 99999854211000
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCC
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGS 413 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 413 (506)
........|++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.... ..+...
T Consensus 203 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 272 (313)
T 3brb_A 203 ---------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQPE 272 (313)
T ss_dssp -----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCBT
T ss_pred ---------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCCc
Confidence 000112257889999999999999999999999999999999 999999888877776666443 223334
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.+++.+.+||.+||..||.+||+ +.+++++
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 78999999999999999999998 7888764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=365.90 Aligned_cols=254 Identities=18% Similarity=0.221 Sum_probs=206.7
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCc---eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE-E
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGC---LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS-C 187 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~ 187 (506)
.|++.+.||+|+||+||+|.+..+++ .||+|++.... .......+.+|+.+|+.++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 37788999999999999999866554 79999987532 234556788999999999999999999999877655 9
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999998763 4678999999999999999999999999999999999999999999999999985321100
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.. .....
T Consensus 179 ~~-------------------------------------------------------------------------~~~~~ 185 (298)
T 3pls_A 179 YY-------------------------------------------------------------------------SVQQH 185 (298)
T ss_dssp GG-------------------------------------------------------------------------CSCCS
T ss_pred cc-------------------------------------------------------------------------ccccC
Confidence 00 00011
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLG-RTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....||+.|+|||++.+..++.++|||||||++|+|++| .+||...+..+....+... ...+....+++.+.+||.+|
T Consensus 186 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 264 (298)
T 3pls_A 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLPQPEYCPDSLYQVMQQC 264 (298)
T ss_dssp SCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-CCCCCCccchHHHHHHHHHH
Confidence 223688999999999999999999999999999999995 5555555555555444433 34444457899999999999
Q ss_pred hhcCCCCccCCCCChHHhhc
Q 010603 427 LVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~ 446 (506)
|..||.+||+ +.++++
T Consensus 265 l~~~p~~Rps----~~~ll~ 280 (298)
T 3pls_A 265 WEADPAVRPT----FRVLVG 280 (298)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred ccCChhhCcC----HHHHHH
Confidence 9999999998 777776
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=367.29 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=206.7
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-C
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-K 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~ 184 (506)
..+..++|++++.||+|+||+||+|.+. |+.||||+++.. ...+.+.+|+++++.++||||+++++++... +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 4566788999999999999999999875 889999999754 2445678899999999999999999997544 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
..|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 79999999999999999887533448999999999999999999999999999999999999999999999999984311
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (278)
T 1byg_A 169 ST------------------------------------------------------------------------------ 170 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 00
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+... ...+....+++.+.+||
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHH
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHH
Confidence 011257889999999999999999999999999999998 99999988776666665433 23333457899999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..||.+||+ +.++++
T Consensus 248 ~~~l~~~p~~Rps----~~~l~~ 266 (278)
T 1byg_A 248 KNCWHLDAAMRPS----FLQLRE 266 (278)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHhcCChhhCCC----HHHHHH
Confidence 9999999999998 777765
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=393.46 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=199.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 189 (506)
.+|++.+.||+|+||+||. ....+|+.||||++.+.... .+.+|+++|+.+ +|||||++++++.+....|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3499999999999999764 34456899999999764322 235699999999 799999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---C--CCEEEeecCCccccc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---D--GHIMLSDFDLSLRCF 264 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~--~~vkl~DFGla~~~~ 264 (506)
||||. |+|.+++.... ..+.+..++.++.||+.||+|||++|||||||||+||||+. + ..+||+|||+|+...
T Consensus 97 ~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99995 69999987653 34556667889999999999999999999999999999953 2 368899999985431
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.... ..
T Consensus 175 ~~~~--------------------------------------------------------------------------~~ 180 (432)
T 3p23_A 175 VGRH--------------------------------------------------------------------------SF 180 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCc--------------------------------------------------------------------------ce
Confidence 1100 00
Q ss_pred CCccccccCCCCccchhhcC---CCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCC-CCCCCCCHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKF-PEGSSISFAA 419 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~---~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~~~s~~~ 419 (506)
......+||+.|+|||++.+ ..++.++|||||||+||||++ |..||...........+....... ......+..+
T Consensus 181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (432)
T 3p23_A 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260 (432)
T ss_dssp -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHH
T ss_pred eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHH
Confidence 11223479999999999984 567889999999999999999 999997655443322222111111 1112345668
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
++||.+||+.||.+||+ +.++++||||..++|.
T Consensus 261 ~~li~~~L~~dP~~Rps----~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 261 RELIEKMIAMDPQKRPS----AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp HHHHHHHSCSSGGGSCC----HHHHHTSTTTCCHHHH
T ss_pred HHHHHHHHhCCHhhCCC----HHHHHhCccccChHHH
Confidence 99999999999999997 9999999999988874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=379.52 Aligned_cols=262 Identities=19% Similarity=0.203 Sum_probs=199.5
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEcc---CCceEEEEEeccchhhchh--------HHHHHHHHHHHHHhcCCCCccce
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRD---MGCLFAMKVMDKGMLAGRK--------KLMRAQTEREILSLLDHPFLPTL 176 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l 176 (506)
+..++|++++.||+|+||+||+|.+.. ++..||||++.+....... ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 344679999999999999999999987 7889999999865321111 11235578888999999999999
Q ss_pred eEEEEe----CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC--
Q 010603 177 YSHFET----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-- 250 (506)
Q Consensus 177 ~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-- 250 (506)
++++.. ....||||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 999988 78999999999 99999998765 4799999999999999999999999999999999999999887
Q ss_pred CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCC
Q 010603 251 HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLT 330 (506)
Q Consensus 251 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (506)
.+||+|||+|+.+........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~----------------------------------------------------------- 211 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQ----------------------------------------------------------- 211 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCC-----------------------------------------------------------
T ss_pred cEEEEeCCCceeccccccccc-----------------------------------------------------------
Confidence 999999999965321100000
Q ss_pred CCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC-cHHHHHHHh-CCCCC
Q 010603 331 NSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-NRETLFNVV-GQPLK 408 (506)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~-~~~~~~~i~-~~~~~ 408 (506)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ......... .....
T Consensus 212 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 280 (345)
T 2v62_A 212 -----------YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE 280 (345)
T ss_dssp -----------CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHT
T ss_pred -----------chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccc
Confidence 00011123479999999999999999999999999999999999999996532 222121111 10111
Q ss_pred CC-------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 409 FP-------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 409 ~p-------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
++ ....++.++.+||.+||..||.+||+ ++++++
T Consensus 281 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 321 (345)
T 2v62_A 281 LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN----YQALKK 321 (345)
T ss_dssp TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC----HHHHHH
Confidence 11 11268899999999999999999998 777776
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=366.73 Aligned_cols=255 Identities=16% Similarity=0.237 Sum_probs=207.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE-EeCCeE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF-ETDKFS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~ 186 (506)
.+|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++++ ..++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4599999999999999999997643 3468999987632 234556788999999999999999999985 556788
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999998764 357899999999999999999999999999999999999999999999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
... ....
T Consensus 182 ~~~-------------------------------------------------------------------------~~~~ 188 (298)
T 3f66_A 182 EYY-------------------------------------------------------------------------SVHN 188 (298)
T ss_dssp GGC-------------------------------------------------------------------------BC--
T ss_pred chh-------------------------------------------------------------------------cccc
Confidence 000 0001
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....||+.|+|||++.+..++.++|||||||++|||++ |.+||......+....+...... .....++..+.+||.+
T Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 267 (298)
T 3f66_A 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLK 267 (298)
T ss_dssp ---CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-CCCTTCCHHHHHHHHH
T ss_pred ccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHH
Confidence 122368899999999999999999999999999999999 77788777776666666544332 2234689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhc
Q 010603 426 LLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~ 446 (506)
||..||.+||+ +.++++
T Consensus 268 ~l~~~p~~Rps----~~ell~ 284 (298)
T 3f66_A 268 CWHPKAEMRPS----FSELVS 284 (298)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCChhhCcC----HHHHHH
Confidence 99999999998 777775
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=373.06 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=207.0
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE----eCC
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE----TDK 184 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~ 184 (506)
..++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+++++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 3456999999999999999999999999999999986532 345567789999999999999999999987 345
Q ss_pred eEEEEEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
..|+||||+.+|+|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 889999999999999988762 346799999999999999999999999999999999999999999999999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
......... . . .
T Consensus 184 ~~~~~~~~~-----------------------------------------------~-~--------------------~ 195 (317)
T 2buj_A 184 ACIHVEGSR-----------------------------------------------Q-A--------------------L 195 (317)
T ss_dssp SCEEEESHH-----------------------------------------------H-H--------------------H
T ss_pred ccccccccc-----------------------------------------------c-c--------------------c
Confidence 211000000 0 0 0
Q ss_pred CCCCccccccCCCCccchhhcCCC---CCcchhHHHHHHHHHHHhcCCCCCCCCCc-HHHHHHHhCCCCCCCCCCCCCHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDG---HGSAVDWWTFGIFFYELLLGRTPFKGNGN-RETLFNVVGQPLKFPEGSSISFA 418 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~~~s~~ 418 (506)
.........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+.........++....++.+
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (317)
T 2buj_A 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSA 275 (317)
T ss_dssp HHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHH
T ss_pred cccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHH
Confidence 000012236899999999998654 68999999999999999999999954211 01122222234455555678999
Q ss_pred HHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+.+||.+||..||.+||+ +.++++|
T Consensus 276 l~~li~~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 276 LWQLLNSMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHhhcChhhCCC----HHHHHHH
Confidence 999999999999999997 8898874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.79 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=199.6
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++.+.||+|+||+||+|++. ++.||||++... .....+.+|+++|+.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999886 789999998653 344567889999999999999999998873 489
Q ss_pred EEEeecCCCChHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEccCCCCcEEEecCCC-EEEeecCCccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPG-KHFSEQATRFYASEVLLALEYLHM---MGVVYRDLKPENVLVREDGH-IMLSDFDLSLR 262 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~-~~~~e~~~~~i~~qil~aL~yLH~---~giiHrDLKp~NILl~~~~~-vkl~DFGla~~ 262 (506)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999886532 247899999999999999999999 89999999999999999887 79999999843
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
...
T Consensus 156 ~~~----------------------------------------------------------------------------- 158 (307)
T 2eva_A 156 IQT----------------------------------------------------------------------------- 158 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH--HHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR--ETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... ...+....++..+.
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 159 ---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCCBTTCCHHHH
T ss_pred ---ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-CCCCcccccCHHHH
Confidence 001225999999999999999999999999999999999999999864432 222233322 22233346899999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+||.+||..||.+||+ ++++++
T Consensus 235 ~li~~~l~~dp~~Rps----~~ell~ 256 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPS----MEEIVK 256 (307)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHhcCChhhCcC----HHHHHH
Confidence 9999999999999998 778876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=386.47 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=204.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC--eE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK--FS 186 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~ 186 (506)
..++|++.+.||+|+||+||+|+++.+|+.||||++...... .....+.+|+++|+.++|||||++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 346799999999999999999999999999999999865432 33456678999999999999999999998765 78
Q ss_pred EEEEeecCCCChHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE----ecCCCEEEeecCCcc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPG-KHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV----REDGHIMLSDFDLSL 261 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~-~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl----~~~~~vkl~DFGla~ 261 (506)
|||||||.+|+|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999999876422 339999999999999999999999999999999999999 677789999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.....
T Consensus 165 ~~~~~--------------------------------------------------------------------------- 169 (396)
T 4eut_A 165 ELEDD--------------------------------------------------------------------------- 169 (396)
T ss_dssp ECCCG---------------------------------------------------------------------------
T ss_pred EccCC---------------------------------------------------------------------------
Confidence 42110
Q ss_pred CCCCCccccccCCCCccchhhcC--------CCCCcchhHHHHHHHHHHHhcCCCCCCC----CCcHHHHHHHhCCCCC-
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRG--------DGHGSAVDWWTFGIFFYELLLGRTPFKG----NGNRETLFNVVGQPLK- 408 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiWSlGvil~elltG~~Pf~~----~~~~~~~~~i~~~~~~- 408 (506)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.. ....+.+..++.....
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 170 ---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp ---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred ---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 00122469999999999875 4678899999999999999999999964 2334555555543211
Q ss_pred ------------------CCCCC----CCCHHHHHHHHHHhhcCCCCccCCCCChHHhh
Q 010603 409 ------------------FPEGS----SISFAAKDLIRGLLVKDPQKRLGFKRGATEIK 445 (506)
Q Consensus 409 ------------------~p~~~----~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell 445 (506)
++... .++..+.+||.+||..||++||+ +.+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s----~~e~l 301 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFF 301 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc----HHHHH
Confidence 11111 23457889999999999999998 66664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=387.37 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=194.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 189 (506)
+.|.+.+.||+|+||+||.+ ...+|+.||||++.... ...+.+|+++|+.+ +|||||++++++.+.+.+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34677789999999999876 44569999999987532 34567899999876 899999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-------------CC
Q 010603 190 MEFCSGGDLHTLRQRQPGKH-----FSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-------------GH 251 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~-----~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-------------~~ 251 (506)
|||| +|+|.+++....... ..+..++.++.||+.||+|||++|||||||||+||||+.+ +.
T Consensus 88 ~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 9999 469999988652211 1233456799999999999999999999999999999764 48
Q ss_pred EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCC
Q 010603 252 IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331 (506)
Q Consensus 252 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (506)
+||+|||+++........
T Consensus 167 ~kL~DFG~a~~~~~~~~~-------------------------------------------------------------- 184 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS-------------------------------------------------------------- 184 (434)
T ss_dssp EEECCCTTCEECCC------------------------------------------------------------------
T ss_pred EEEcccccceecCCCCcc--------------------------------------------------------------
Confidence 999999998643211000
Q ss_pred CCCCcccccCCCCCCccccccCCCCccchhhcC-------CCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHh
Q 010603 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG-------DGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVV 403 (506)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~ 403 (506)
........+||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+ ..++
T Consensus 185 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~ 251 (434)
T 2rio_A 185 -----------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNII 251 (434)
T ss_dssp ---------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHH
T ss_pred -----------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHh
Confidence 0000123479999999999976 568999999999999999999 999997665443 2333
Q ss_pred CCCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 404 GQPLKFPEG-----SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 404 ~~~~~~p~~-----~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.....++.. ..++.++.+||.+||+.||.+||+ +.++++||||...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 333333221 134578999999999999999997 9999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=363.37 Aligned_cols=256 Identities=18% Similarity=0.253 Sum_probs=203.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE-EeCCeEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF-ETDKFSCL 188 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~l 188 (506)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+.++ ...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4679999999999999999999999999999999876432 23467899999999988866655554 66778999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE---ecCCCEEEeecCCcccccc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFGla~~~~~ 265 (506)
||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 99999998754 3579999999999999999999999999999999999999 4889999999999864321
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
...... ....
T Consensus 161 ~~~~~~----------------------------------------------------------------------~~~~ 170 (296)
T 3uzp_A 161 ARTHQH----------------------------------------------------------------------IPYR 170 (296)
T ss_dssp TTTCCB----------------------------------------------------------------------CCCC
T ss_pred cccccc----------------------------------------------------------------------cccc
Confidence 110000 0000
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc---HHHHHHHhCCCCCCC---CCCCCCHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN---RETLFNVVGQPLKFP---EGSSISFAA 419 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p---~~~~~s~~~ 419 (506)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+..+.......+ ....+++++
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (296)
T 3uzp_A 171 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 250 (296)
T ss_dssp CSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHH
T ss_pred cccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHH
Confidence 12234799999999999999999999999999999999999999986432 233333332222222 113689999
Q ss_pred HHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 420 KDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 420 ~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||.+||+.||.+||+ +.++++
T Consensus 251 ~~li~~~l~~dp~~Rps----~~~l~~ 273 (296)
T 3uzp_A 251 ATYLNFCRSLRFDDKPD----YSYLRQ 273 (296)
T ss_dssp HHHHHHHHTSCTTCCCC----HHHHHH
T ss_pred HHHHHHHHhcCcCcCCC----HHHHHH
Confidence 99999999999999998 666665
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=382.84 Aligned_cols=242 Identities=19% Similarity=0.191 Sum_probs=195.4
Q ss_pred cccCCeEEEeEEeecCceEEEEE-----EEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC---CCCccceeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLA-----ELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD---HPFLPTLYSH 179 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~ 179 (506)
+..++|++.+.||+|+||+||+| .+..+++.||||++.... ...+..|+++++.++ |+||+.++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 44567999999999999999999 467789999999997642 334567888887776 9999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec--------
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQ---PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-------- 248 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-------- 248 (506)
+...+..|||||||++|+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999998752 3467999999999999999999999999999999999999998
Q ss_pred ---CCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccc
Q 010603 249 ---DGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSE 325 (506)
Q Consensus 249 ---~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (506)
++.+||+|||+|+.+....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~---------------------------------------------------------- 237 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP---------------------------------------------------------- 237 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC----------------------------------------------------------
T ss_pred ccccCCEEEeeCchhhhhhccC----------------------------------------------------------
Confidence 8999999999995431110
Q ss_pred cccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC
Q 010603 326 KTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405 (506)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 405 (506)
........+||+.|||||++.+..|+.++|||||||+||||++|+.||......... ...
T Consensus 238 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~ 297 (365)
T 3e7e_A 238 -----------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEG 297 (365)
T ss_dssp -----------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECS
T ss_pred -----------------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---ech
Confidence 001122347999999999999999999999999999999999999999644321100 001
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhhcCCCCccC
Q 010603 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 406 ~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s 436 (506)
.++. ...++.+.+|+.+||..+|.+|++
T Consensus 298 --~~~~-~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 298 --LFRR-LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp --CCTT-CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred --hccc-cCcHHHHHHHHHHHcCCCCCCcch
Confidence 1111 135678899999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=398.84 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=214.8
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+++..++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+++|+.++|||||++++++.. +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 345667889999999999999999999986 46799999986532 23567889999999999999999999876 6
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||.+|+|.+++....+..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999976544579999999999999999999999999999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
....
T Consensus 415 ~~~~---------------------------------------------------------------------------- 418 (535)
T 2h8h_A 415 DNEY---------------------------------------------------------------------------- 418 (535)
T ss_dssp CHHH----------------------------------------------------------------------------
T ss_pred CCce----------------------------------------------------------------------------
Confidence 0000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......+|..|+|||++.+..|+.++|||||||+||||++ |+.||.+....+.+..+... ...+....++..+.+||
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li 497 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLM 497 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHH
Confidence 00011247789999999999999999999999999999999 99999998887777766543 34444457899999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..||++||+ +++|++
T Consensus 498 ~~cl~~dP~~RPt----~~~l~~ 516 (535)
T 2h8h_A 498 CQCWRKEPEERPT----FEYLQA 516 (535)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHcCCChhHCcC----HHHHHH
Confidence 9999999999998 667765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=377.12 Aligned_cols=254 Identities=19% Similarity=0.254 Sum_probs=203.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccC--------CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccc------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDM--------GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPT------ 175 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~------ 175 (506)
.++|++++.||+|+||.||+|++..+ ++.||||++.+. ..+.+|+++++.++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 36799999999999999999999874 889999998754 24567999999999999988
Q ss_pred ---------eeEEEEe-CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEE
Q 010603 176 ---------LYSHFET-DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVL 245 (506)
Q Consensus 176 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NIL 245 (506)
+++++.. .+..||||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677766 77899999999 999999998765578999999999999999999999999999999999999
Q ss_pred EecCC--CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 246 VREDG--HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 246 l~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
++.++ .+||+|||+++.+........
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~---------------------------------------------------- 219 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA---------------------------------------------------- 219 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCC----------------------------------------------------
T ss_pred EcCCCCceEEEecCcceeeccCCCcccc----------------------------------------------------
Confidence 99998 899999999864321100000
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCC-cHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG-NRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~-~~~~~~~i 402 (506)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||.... ..+.+...
T Consensus 220 ------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 281 (352)
T 2jii_A 220 ------------------YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQ 281 (352)
T ss_dssp ------------------CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHH
T ss_pred ------------------ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHH
Confidence 00011123479999999999999999999999999999999999999998764 33333222
Q ss_pred ----hCCCCCCCC----CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 ----VGQPLKFPE----GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ----~~~~~~~p~----~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
......++. +..++.++.+||.+||..||.+||+ ++++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 329 (352)
T 2jii_A 282 KQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP----YAMLRN 329 (352)
T ss_dssp HHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred HHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC----HHHHHH
Confidence 222222221 1257899999999999999999998 677765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=390.56 Aligned_cols=276 Identities=17% Similarity=0.235 Sum_probs=214.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC-CCccceeEEEEeCCeEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-PFLPTLYSHFETDKFSC 187 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 187 (506)
..++|+++++||+|+||.||+|++..+++.||||++...... ..+..|+++++.|+| ++|+.+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 346799999999999999999999999999999998764321 235679999999977 56666667777888999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE---ecCCCEEEeecCCccccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl---~~~~~vkl~DFGla~~~~ 264 (506)
|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+.
T Consensus 80 lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999999 99999998754 3579999999999999999999999999999999999999 688999999999996532
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
....... ...
T Consensus 158 ~~~~~~~----------------------------------------------------------------------~~~ 167 (483)
T 3sv0_A 158 DTSTHQH----------------------------------------------------------------------IPY 167 (483)
T ss_dssp CTTTCCB----------------------------------------------------------------------CCC
T ss_pred CCccccc----------------------------------------------------------------------ccc
Confidence 1110000 000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc---HHHHHHHhCCCCCCC---CCCCCCHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN---RETLFNVVGQPLKFP---EGSSISFA 418 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p---~~~~~s~~ 418 (506)
......+||+.|+|||++.+..++.++||||||||||||++|+.||.+... .+.+..+........ ....++.+
T Consensus 168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (483)
T 3sv0_A 168 RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTE 247 (483)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHH
T ss_pred ccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHH
Confidence 012235799999999999999999999999999999999999999987543 233333322211111 01357899
Q ss_pred HHHHHHHHhhcCCCCccCCCCC------hHHhhcCCCCCCCCcchhccC
Q 010603 419 AKDLIRGLLVKDPQKRLGFKRG------ATEIKQHPFFESVNWALIRST 461 (506)
Q Consensus 419 ~~~li~~~L~~dP~~R~s~~~~------a~ell~hp~f~~~~~~~~~~~ 461 (506)
+.+||.+||..||++||++... +.+.+.++|+..++|..+...
T Consensus 248 l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 248 FASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp HHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 9999999999999999984311 111234899999999876443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=374.75 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=204.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+..++|++.+.||+|+||+||+|.+. +|+.||||++....... ....+.+|+++++.++||||+++++++...+..+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 45567999999999999999999855 58999999998654322 1225678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPG--KHFSEQATRFYASEVLLALEYLHMM---GVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~--~~~~e~~~~~i~~qil~aL~yLH~~---giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
+||||+.+|+|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 99999999999999887532 3599999999999999999999999 999999999999999999999999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 184 ~~~~~--------------------------------------------------------------------------- 188 (326)
T 3uim_A 184 MDYKD--------------------------------------------------------------------------- 188 (326)
T ss_dssp CCSSS---------------------------------------------------------------------------
T ss_pred cCccc---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC----CCcHHHHHHHhCCCCC---CC-----
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKG----NGNRETLFNVVGQPLK---FP----- 410 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~----~~~~~~~~~i~~~~~~---~p----- 410 (506)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.. ..........+..... ..
T Consensus 189 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 3uim_A 189 -THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267 (326)
T ss_dssp -SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCT
T ss_pred -ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcCh
Confidence 0011223699999999999998899999999999999999999999952 1111111122211110 00
Q ss_pred -----CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCC
Q 010603 411 -----EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449 (506)
Q Consensus 411 -----~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~ 449 (506)
.....+..+.+||.+||..||.+||+ +.|+++|-.
T Consensus 268 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L~ 307 (326)
T 3uim_A 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRMLE 307 (326)
T ss_dssp TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHhc
Confidence 00122367899999999999999998 889988754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=370.10 Aligned_cols=251 Identities=21% Similarity=0.276 Sum_probs=205.0
Q ss_pred eEEEeEEeecCceEEEEEEE----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC--CeE
Q 010603 113 FRLLKKLGCGDIGSVYLAEL----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD--KFS 186 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 186 (506)
|++++.||+|+||+||+|.+ ..+++.||||++.+.. .......+.+|+++|+.++||||+++++++.+. ..+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 49999999999999988864 3578999999998652 234456788999999999999999999999874 689
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999999998764 5999999999999999999999999999999999999999999999999998543111
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
... ...
T Consensus 188 ~~~--------------------------------------------------------------------------~~~ 193 (318)
T 3lxp_A 188 HEY--------------------------------------------------------------------------YRV 193 (318)
T ss_dssp CSE--------------------------------------------------------------------------EEC
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH--------------HHHHHHhCCCCCCCCC
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR--------------ETLFNVVGQPLKFPEG 412 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~--------------~~~~~i~~~~~~~p~~ 412 (506)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+..
T Consensus 194 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (318)
T 3lxp_A 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRP 273 (318)
T ss_dssp ---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCC
T ss_pred ccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCC
Confidence 11235888999999999999999999999999999999999999653221 1122333334444555
Q ss_pred CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 413 SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 413 ~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
..++.++.+||.+||..||.+||+ +.++++
T Consensus 274 ~~~~~~l~~li~~~l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 274 DKCPAEVYHLMKNCWETEASFRPT----FENLIP 303 (318)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred ccccHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 679999999999999999999998 788875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=367.02 Aligned_cols=233 Identities=27% Similarity=0.441 Sum_probs=192.8
Q ss_pred ccCCeEEE-eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHH-HhcCCCCccceeEEEEe----
Q 010603 109 GLGHFRLL-KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREIL-SLLDHPFLPTLYSHFET---- 182 (506)
Q Consensus 109 ~~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~---- 182 (506)
.+++|.++ +.||+|+||.||+|.++.+++.||||++... ....+|++++ +.++||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 45679888 7899999999999999999999999999642 2345688887 66799999999999987
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CCCEEEeecCC
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DGHIMLSDFDL 259 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFGl 259 (506)
...+||||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 778999999999999999999876668999999999999999999999999999999999999998 78999999998
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+...
T Consensus 167 a~~~---------------------------------------------------------------------------- 170 (299)
T 3m2w_A 167 AKET---------------------------------------------------------------------------- 170 (299)
T ss_dssp CEEC----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 7321
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHh----CCCCCCCC--CC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV----GQPLKFPE--GS 413 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~~~p~--~~ 413 (506)
.+..|+.++|||||||+||||++|+.||.+.........+. .....++. ..
T Consensus 171 -----------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (299)
T 3m2w_A 171 -----------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227 (299)
T ss_dssp -----------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHT
T ss_pred -----------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcc
Confidence 01346789999999999999999999998765443221111 11112221 13
Q ss_pred CCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 414 SISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 414 ~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.+++++.+||.+||..||.+||+ +.|+++||||+.
T Consensus 228 ~~~~~~~~li~~~l~~dP~~Rps----~~e~l~hp~~~~ 262 (299)
T 3m2w_A 228 EVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 262 (299)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHT
T ss_pred cCCHHHHHHHHHHcccChhhCCC----HHHHhcChhhcc
Confidence 68999999999999999999997 999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=372.91 Aligned_cols=261 Identities=24% Similarity=0.315 Sum_probs=189.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEE-------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFE------- 181 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~------- 181 (506)
..+|++++.||+|+||.||+|++..+++.||||++.+.. ......+.+|+.+|+.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 346999999999999999999999999999999986543 344556788999999995 999999999994
Q ss_pred -eCCeEEEEEeecCCCChHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEecCCCEEEeec
Q 010603 182 -TDKFSCLLMEFCSGGDLHTLRQR-QPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 182 -~~~~~~lV~E~~~gg~L~~~l~~-~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~~~~~vkl~DF 257 (506)
....+++||||+ +|+|.+++.. .....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 445689999999 5799888765 23357999999999999999999999999 999999999999999999999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|++..............
T Consensus 183 g~~~~~~~~~~~~~~~~--------------------------------------------------------------- 199 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQ--------------------------------------------------------------- 199 (337)
T ss_dssp TTCBCCSSCC----------------------------------------------------------------------
T ss_pred ccceeccccCccccccc---------------------------------------------------------------
Confidence 99864321111000000
Q ss_pred cccCCCCCCccccccCCCCccchhh---cCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCC
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEII---RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSS 414 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l---~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 414 (506)
............||+.|+|||++ .+..++.++|||||||++|||++|+.||....... +.......+....
T Consensus 200 --~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 273 (337)
T 3ll6_A 200 --RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDT 273 (337)
T ss_dssp --------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCC
T ss_pred --ccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----hhcCcccCCcccc
Confidence 00000111234699999999999 56678999999999999999999999997655433 2333344444556
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.+..+.+||.+||..||.+||+ +.|+++|
T Consensus 274 ~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 274 QYTVFHSLIRAMLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp SSGGGHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred cchHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 7888999999999999999997 8899886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=379.65 Aligned_cols=255 Identities=16% Similarity=0.242 Sum_probs=202.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCC---ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE-eCCeEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMG---CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE-TDKFSC 187 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~ 187 (506)
.|++.+.||+|+||+||+|.+..++ ..||||.++... .......+.+|+.+|+.++|||||++++++. .++..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4899999999999999999986543 468999987532 2345677889999999999999999999864 456889
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 168 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999998764 3568999999999999999999999999999999999999999999999999985431110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.. .....
T Consensus 247 ~~-------------------------------------------------------------------------~~~~~ 253 (373)
T 3c1x_A 247 FD-------------------------------------------------------------------------SVHNK 253 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 00 00001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....||+.|+|||++.+..++.++|||||||+||||++ |.+||.+.+..+....+.... ..+....++..+.+||.+|
T Consensus 254 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~c 332 (373)
T 3c1x_A 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKC 332 (373)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHH
Confidence 12357889999999999999999999999999999999 788898777666666655443 2233346899999999999
Q ss_pred hhcCCCCccCCCCChHHhhcC
Q 010603 427 LVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~h 447 (506)
|..||.+||+ +.+++++
T Consensus 333 l~~dp~~RPs----~~ell~~ 349 (373)
T 3c1x_A 333 WHPKAEMRPS----FSELVSR 349 (373)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCChhhCcC----HHHHHHH
Confidence 9999999998 7777763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=396.30 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=208.5
Q ss_pred cccCCeEEEe-EEeecCceEEEEEEEcc--CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLK-KLGCGDIGSVYLAELRD--MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~-~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
+..++|.+.+ .||+|+||+||+|.++. ++..||||++++.. .......+.+|+++|+.++|||||++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4445677777 89999999999998863 46679999998652 23455678899999999999999999999976 5
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||.+|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 699999999999999998754 3579999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..... .
T Consensus 488 ~~~~~--------------------------------------------------------------------------~ 493 (613)
T 2ozo_A 488 ADDSY--------------------------------------------------------------------------Y 493 (613)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCce--------------------------------------------------------------------------e
Confidence 10000 0
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......+|+.|+|||++.+..|+.++|||||||+||||++ |+.||.+.+..+.+..+.... ..+....+++++.+||
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li 572 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYALM 572 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHHHHH
Confidence 00011246789999999999999999999999999999998 999999988888777766442 3333347999999999
Q ss_pred HHHhhcCCCCccCCCCChHHhh
Q 010603 424 RGLLVKDPQKRLGFKRGATEIK 445 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell 445 (506)
.+||..||.+||+ +.+++
T Consensus 573 ~~cl~~dP~~RPs----~~~l~ 590 (613)
T 2ozo_A 573 SDCWIYKWEDRPD----FLTVE 590 (613)
T ss_dssp HHTTCSSTTTSCC----HHHHH
T ss_pred HHHcCCChhHCcC----HHHHH
Confidence 9999999999998 55553
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=397.52 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=206.7
Q ss_pred CCeEEE-eEEeecCceEEEEEEE--ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 111 GHFRLL-KKLGCGDIGSVYLAEL--RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 111 ~~y~i~-~~LG~G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
..+.+. +.||+|+||+||+|.+ +.+++.||||+++.... .......+.+|+++|+.++|||||++++++.. +.++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 335554 4899999999999965 45678999999986532 23445678899999999999999999999975 4589
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
||||||.+|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 446 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 999999999999999765 679999999999999999999999999999999999999999999999999986432110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
.. ....
T Consensus 524 ~~--------------------------------------------------------------------------~~~~ 529 (635)
T 4fl3_A 524 NY--------------------------------------------------------------------------YKAQ 529 (635)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc--------------------------------------------------------------------------cccc
Confidence 00 0001
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGL 426 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~ 426 (506)
....||+.|+|||++.+..|+.++|||||||+||||++ |+.||.+....+....+.... ..+....++.++.+||.+|
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~c 608 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLC 608 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHH
Confidence 12257889999999999999999999999999999998 999999988877776665443 3333347999999999999
Q ss_pred hhcCCCCccCCCCChHHhhc
Q 010603 427 LVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 427 L~~dP~~R~s~~~~a~ell~ 446 (506)
|..||++||+ +++|++
T Consensus 609 l~~dP~~RPs----~~~l~~ 624 (635)
T 4fl3_A 609 WTYDVENRPG----FAAVEL 624 (635)
T ss_dssp TCSSTTTSCC----HHHHHH
T ss_pred cCCCHhHCcC----HHHHHH
Confidence 9999999998 666654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=367.46 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=208.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEE----ccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAEL----RDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
..+..++|++++.||+|+||.||+|++ ..+++.||||++.... ......+.+|+++|+.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 345667799999999999999999994 5679999999997642 345567889999999999999999999987
Q ss_pred eCC--eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCC
Q 010603 182 TDK--FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDL 259 (506)
Q Consensus 182 ~~~--~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGl 259 (506)
..+ .+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 654 7899999999999999998753 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccc
Q 010603 260 SLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLI 339 (506)
Q Consensus 260 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (506)
+..........
T Consensus 192 ~~~~~~~~~~~--------------------------------------------------------------------- 202 (326)
T 2w1i_A 192 TKVLPQDKEYY--------------------------------------------------------------------- 202 (326)
T ss_dssp CEECCSSCSEE---------------------------------------------------------------------
T ss_pred hhhcccccccc---------------------------------------------------------------------
Confidence 85431110000
Q ss_pred cCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCc------------H---HHHHHHhC
Q 010603 340 AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGN------------R---ETLFNVVG 404 (506)
Q Consensus 340 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~------------~---~~~~~i~~ 404 (506)
.......||..|+|||++.+..++.++|||||||++|||++|..||..... . ..+...+.
T Consensus 203 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 203 -----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp -----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred -----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 000112578889999999998899999999999999999999999864211 0 01122222
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 405 ~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.....+....++.++.+||.+||..||.+||+ +.++++
T Consensus 278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred cCCCCCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 33334444578999999999999999999998 777765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.08 Aligned_cols=251 Identities=21% Similarity=0.331 Sum_probs=195.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh--cCCCCccceeEEEEeC---
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL--LDHPFLPTLYSHFETD--- 183 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~--- 183 (506)
..++|++++.||+|+||.||+|++. ++.||||++.... ......|.+++.. ++||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3456999999999999999999886 8999999986432 2233446666554 4999999999999887
Q ss_pred -CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEccCCCCcEEEecCCCEEE
Q 010603 184 -KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM--------GVVYRDLKPENVLVREDGHIML 254 (506)
Q Consensus 184 -~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~--------giiHrDLKp~NILl~~~~~vkl 254 (506)
..+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++ |||||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999764 699999999999999999999999 9999999999999999999999
Q ss_pred eecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCC
Q 010603 255 SDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDS 334 (506)
Q Consensus 255 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (506)
+|||+|+.........
T Consensus 184 ~Dfg~a~~~~~~~~~~---------------------------------------------------------------- 199 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEV---------------------------------------------------------------- 199 (337)
T ss_dssp CCCTTCEECC----------------------------------------------------------------------
T ss_pred EeCCCceeeccccccc----------------------------------------------------------------
Confidence 9999985432110000
Q ss_pred CcccccCCCCCCccccccCCCCccchhhcCCCCCcc------hhHHHHHHHHHHHhcC----------CCCCCCCC----
Q 010603 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSA------VDWWTFGIFFYELLLG----------RTPFKGNG---- 394 (506)
Q Consensus 335 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~------~DiWSlGvil~elltG----------~~Pf~~~~---- 394 (506)
.......+||+.|+|||++.+..+... +|||||||++|||++| +.||....
T Consensus 200 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 200 ---------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ---------cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 000123479999999999988776655 9999999999999999 77775432
Q ss_pred cHHHHHHHhCC-C--CCCCC---CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 395 NRETLFNVVGQ-P--LKFPE---GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 395 ~~~~~~~i~~~-~--~~~p~---~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
....+...... . ..++. ...++.++.+||.+||..||.+||+ +.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 22233333321 1 12221 1245677999999999999999998 8888874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=368.19 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=193.9
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHH--HHhcCCCCccceeEEEEe-
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI--LSLLDHPFLPTLYSHFET- 182 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i--l~~l~hpnIv~l~~~~~~- 182 (506)
..+.+++|++++.||+|+||+||+|++ +++.||||++.... ...+..|.++ +..++||||+++++++..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 346778899999999999999999976 48999999997542 2223334445 456899999999986542
Q ss_pred ----CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CeEEccCCCCcEEEecC
Q 010603 183 ----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM---------GVVYRDLKPENVLVRED 249 (506)
Q Consensus 183 ----~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~---------giiHrDLKp~NILl~~~ 249 (506)
...+|||||||++|+|.+++... ..++..++.++.||+.||.|||++ |||||||||+||||+.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 33689999999999999999774 458999999999999999999999 99999999999999999
Q ss_pred CCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccC
Q 010603 250 GHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSL 329 (506)
Q Consensus 250 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (506)
+.+||+|||+++.+........
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~---------------------------------------------------------- 178 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRP---------------------------------------------------------- 178 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC------------------------------------------------------------
T ss_pred CcEEEeeccceeecccccccCc----------------------------------------------------------
Confidence 9999999999965321110000
Q ss_pred CCCCCCcccccCCCCCCccccccCCCCccchhhcC-------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCc-------
Q 010603 330 TNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRG-------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGN------- 395 (506)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~------- 395 (506)
..........+||+.|+|||++.+ ..++.++|||||||+||||++|..||.....
T Consensus 179 -----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 179 -----------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp ------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred -----------cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 000011223479999999999987 3567799999999999999999777632211
Q ss_pred ----------HHHHHHHhCC---CCCCCCC----CCCCHHHHHHHHHHhhcCCCCccCCCCChHHh------hcCCCCCC
Q 010603 396 ----------RETLFNVVGQ---PLKFPEG----SSISFAAKDLIRGLLVKDPQKRLGFKRGATEI------KQHPFFES 452 (506)
Q Consensus 396 ----------~~~~~~i~~~---~~~~p~~----~~~s~~~~~li~~~L~~dP~~R~s~~~~a~el------l~hp~f~~ 452 (506)
.+.+...+.. ...+|.. ..+++++.+||.+||..||++||+ +.|+ +.++|-+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAEERMAELMMIWERN 323 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHHHHHHHHCCCC-
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHHHHHHHHHHHHHhc
Confidence 1122222211 1222221 124457999999999999999998 7788 44566543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=381.69 Aligned_cols=247 Identities=19% Similarity=0.137 Sum_probs=192.3
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh-----chhHHHHHHHHHHHHHhcC---------CCCc
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA-----GRKKLMRAQTEREILSLLD---------HPFL 173 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~---------hpnI 173 (506)
+..++|++++.||+|+||+||+|++ +|+.||||++.+.... .......+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3456799999999999999999998 5899999999875421 2334467788999988885 6666
Q ss_pred cceeEEE-----------------Ee-------------CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHH
Q 010603 174 PTLYSHF-----------------ET-------------DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223 (506)
Q Consensus 174 v~l~~~~-----------------~~-------------~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil 223 (506)
|++++++ .+ .+.+|||||||.+|+|.+.+.+ ..+++..++.|+.||+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 6666653 32 6899999999999977666543 4689999999999999
Q ss_pred HHHHHHH-hCCeEEccCCCCcEEEecCC--------------------CEEEeecCCccccccCCccccCCCCcccccCc
Q 010603 224 LALEYLH-MMGVVYRDLKPENVLVREDG--------------------HIMLSDFDLSLRCFVSPKLVQSSDDPACRISS 282 (506)
Q Consensus 224 ~aL~yLH-~~giiHrDLKp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 282 (506)
.||+||| ++|||||||||+||||+.++ .+||+|||+|+....
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----------------- 234 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----------------- 234 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------------
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------------
Confidence 9999999 99999999999999999987 899999999854210
Q ss_pred ccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhh
Q 010603 283 YCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEII 362 (506)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 362 (506)
...+||+.|||||++
T Consensus 235 -----------------------------------------------------------------~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 235 -----------------------------------------------------------------GIVVFCDVSMDEDLF 249 (336)
T ss_dssp -----------------------------------------------------------------TEEECCCCTTCSGGG
T ss_pred -----------------------------------------------------------------CcEEEeecccChhhh
Confidence 123799999999999
Q ss_pred cCCCCCcchhHHHHHHH-HHHHhcCCCCCCCCCcHH-HHHHHhCC-CCCCCC----CCCCCHHHHHHHHHHhhcCCCCcc
Q 010603 363 RGDGHGSAVDWWTFGIF-FYELLLGRTPFKGNGNRE-TLFNVVGQ-PLKFPE----GSSISFAAKDLIRGLLVKDPQKRL 435 (506)
Q Consensus 363 ~~~~~~~~~DiWSlGvi-l~elltG~~Pf~~~~~~~-~~~~i~~~-~~~~p~----~~~~s~~~~~li~~~L~~dP~~R~ 435 (506)
.+.. +.++||||||++ .++++.|..||.+..... ....+... ...... ...+++++++||.+||+.|
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----- 323 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----- 323 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence 9776 899999998777 788899999995421111 12222211 111111 1246788999999999977
Q ss_pred CCCCChHHhh-cCCCCC
Q 010603 436 GFKRGATEIK-QHPFFE 451 (506)
Q Consensus 436 s~~~~a~ell-~hp~f~ 451 (506)
| |+|+| +||||+
T Consensus 324 s----a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 S----ATDLLCQHSLFK 336 (336)
T ss_dssp S----HHHHHHHCGGGC
T ss_pred C----HHHHHhcCCCcC
Confidence 4 99999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=384.73 Aligned_cols=253 Identities=19% Similarity=0.183 Sum_probs=197.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC-CCc---------ccee--
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-PFL---------PTLY-- 177 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnI---------v~l~-- 177 (506)
...|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++| .|+ +..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3458999999999999999999999999999999985544444446678899999999977 221 1111
Q ss_pred ----------EEEEe-----CCeEEEEEeecCCCChHHHHh-----hCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010603 178 ----------SHFET-----DKFSCLLMEFCSGGDLHTLRQ-----RQPGKHFSEQATRFYASEVLLALEYLHMMGVVYR 237 (506)
Q Consensus 178 ----------~~~~~-----~~~~~lV~E~~~gg~L~~~l~-----~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHr 237 (506)
.++.. ...++++|+++ +++|.+++. ...+..+++..+..++.||+.||+|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 11111 22467888877 789999885 2233567888999999999999999999999999
Q ss_pred cCCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccc
Q 010603 238 DLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNS 317 (506)
Q Consensus 238 DLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (506)
||||+||||+.++.+||+|||+++....
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~---------------------------------------------------- 263 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---------------------------------------------------- 263 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTE----------------------------------------------------
T ss_pred CcccceEEEecCCeEEEEeccceeecCC----------------------------------------------------
Confidence 9999999999999999999999853110
Q ss_pred cccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhh----------cCCCCCcchhHHHHHHHHHHHhcCC
Q 010603 318 KTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEII----------RGDGHGSAVDWWTFGIFFYELLLGR 387 (506)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~~~~~DiWSlGvil~elltG~ 387 (506)
.....+| +.|||||++ .+..|+.++|||||||+||||++|+
T Consensus 264 ----------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 264 ----------------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp ----------------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ----------------------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 0122368 999999999 5556888999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 388 TPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 388 ~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
.||......+....+. .....+++++.+||.+||..||.+||+ +.++++||||+.+.
T Consensus 315 ~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 315 LPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLR 371 (413)
T ss_dssp CCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHH
T ss_pred CCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHH
Confidence 9998766544333222 223368899999999999999999997 99999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=367.41 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=210.0
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
..++..++|++++.||+|+||.||+|.+.. .||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 445677889999999999999999999864 4999999764322 222344567999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+++||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999999998764 35799999999999999999999999999999999999998 6899999999974321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
..... ...
T Consensus 181 ~~~~~------------------------------------------------------------------------~~~ 188 (319)
T 2y4i_B 181 VLQAG------------------------------------------------------------------------RRE 188 (319)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ccccc------------------------------------------------------------------------ccc
Confidence 10000 000
Q ss_pred CCccccccCCCCccchhhcC---------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCC
Q 010603 345 ARSMSFVGTHEYLAPEIIRG---------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSI 415 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~---------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 415 (506)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+............+
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGM 268 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCC
Confidence 11122369999999999975 357899999999999999999999999888877777766554333333468
Q ss_pred CHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 416 SFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 416 s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.++.+||.+||..||.+||+ +.++++
T Consensus 269 ~~~l~~li~~~l~~~p~~Rpt----~~~l~~ 295 (319)
T 2y4i_B 269 GKEISDILLFCWAFEQEERPT----FTKLMD 295 (319)
T ss_dssp CTTHHHHHHHHHCSSTTTSCC----HHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 889999999999999999998 788876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=360.23 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=200.5
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchh-hchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML-AGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
|...+.||+|+||+||+|.+ +++.||||++..... ........+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55568999999999999987 488999999976432 223455678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 192 FCSGGDLHTLRQRQ-PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 192 ~~~gg~L~~~l~~~-~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-- 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc--
Confidence 99999999988753 235699999999999999999999999999999999999999999999999999854211000
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 189 -------------------------------------------------------------------------~~~~~~~ 195 (307)
T 2nru_A 189 -------------------------------------------------------------------------TVMTSRI 195 (307)
T ss_dssp -------------------------------------------------------------------------CEECSSC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001124
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHH----HHHhCCCCC--------CC-CCCCCCH
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL----FNVVGQPLK--------FP-EGSSISF 417 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~----~~i~~~~~~--------~p-~~~~~s~ 417 (506)
.||+.|+|||++.+ .++.++|||||||++|+|++|+.||........+ ..+...... ++ .....+.
T Consensus 196 ~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (307)
T 2nru_A 196 VGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE 274 (307)
T ss_dssp CSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHH
T ss_pred CCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHH
Confidence 69999999999875 4889999999999999999999999865443211 111111110 11 1113456
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.+.+||.+||..||.+||+ +.+++++
T Consensus 275 ~l~~li~~cl~~~p~~Rps----~~~l~~~ 300 (307)
T 2nru_A 275 AMYSVASQCLHEKKNKRPD----IKKVQQL 300 (307)
T ss_dssp HHHHHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 7899999999999999998 7888763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=362.60 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=198.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHh--cCCCCccceeEEEEeCC---
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL--LDHPFLPTLYSHFETDK--- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~--- 184 (506)
.++|++++.||+|+||.||+|++. |+.||||++... ....+.+|+++++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 456999999999999999999984 899999999753 23456678888887 79999999999998876
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCeEEccCCCCcEEEecCCCEEEe
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH--------MMGVVYRDLKPENVLVREDGHIMLS 255 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH--------~~giiHrDLKp~NILl~~~~~vkl~ 255 (506)
.+|+||||+++|+|.+++... .+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999999764 6999999999999999999999 8999999999999999999999999
Q ss_pred ecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCC
Q 010603 256 DFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSL 335 (506)
Q Consensus 256 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (506)
|||++..........
T Consensus 190 Dfg~~~~~~~~~~~~----------------------------------------------------------------- 204 (342)
T 1b6c_B 190 DLGLAVRHDSATDTI----------------------------------------------------------------- 204 (342)
T ss_dssp CCTTCEEEETTTTEE-----------------------------------------------------------------
T ss_pred ECCCceecccccccc-----------------------------------------------------------------
Confidence 999985432111000
Q ss_pred cccccCCCCCCccccccCCCCccchhhcCCC------CCcchhHHHHHHHHHHHhcC----------CCCCCCCC----c
Q 010603 336 PVLIAEPTSARSMSFVGTHEYLAPEIIRGDG------HGSAVDWWTFGIFFYELLLG----------RTPFKGNG----N 395 (506)
Q Consensus 336 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~~DiWSlGvil~elltG----------~~Pf~~~~----~ 395 (506)
........||+.|+|||++.+.. ++.++|||||||+||||++| ..||.... .
T Consensus 205 --------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 205 --------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp --------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred --------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 00012337999999999998763 33689999999999999999 88987642 2
Q ss_pred HHHHHH-HhCCCCC--CCC---CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 396 RETLFN-VVGQPLK--FPE---GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 396 ~~~~~~-i~~~~~~--~p~---~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.+.+.. +...... ++. ...++..+.+||.+||..||.+||+ +.++++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 233333 3332222 221 0123457899999999999999998 8888874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=390.17 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=211.7
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccC---CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
.++..++|++++.||+|+||+||+|.+..+ +..||||++.... .......+.+|+.+|+.++|||||++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 455667899999999999999999998754 4679999987532 2344567889999999999999999999984
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
++..|+||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 56789999999999999998865 34689999999999999999999999999999999999999999999999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 541 ~~~~~--------------------------------------------------------------------------- 545 (656)
T 2j0j_A 541 MEDST--------------------------------------------------------------------------- 545 (656)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred cCCCc---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
........||+.|||||++.+..|+.++|||||||+||||++ |..||.+....+.+..+.... ..+....+++.+.+
T Consensus 546 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~ 623 (656)
T 2j0j_A 546 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYS 623 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHHHHH
T ss_pred -ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHHHHH
Confidence 000112357889999999999999999999999999999997 999999988877777665432 22233478999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
||.+||..||.+||+ +.++++
T Consensus 624 li~~~l~~dP~~RPs----~~el~~ 644 (656)
T 2j0j_A 624 LMTKCWAYDPSRRPR----FTELKA 644 (656)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHcCCChhHCcC----HHHHHH
Confidence 999999999999998 777765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=398.49 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=207.6
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe------
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------ 182 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------ 182 (506)
.+++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+++|+.++|||||++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3478999999999999999999999999999999987642 23445678889999999999999999999765
Q ss_pred CCeEEEEEeecCCCChHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC---EEEeecC
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQP-GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH---IMLSDFD 258 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~---vkl~DFG 258 (506)
.+..|+|||||+||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 678899999999999999988743 236999999999999999999999999999999999999998775 9999999
Q ss_pred CccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccc
Q 010603 259 LSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVL 338 (506)
Q Consensus 259 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (506)
++......
T Consensus 170 ~a~~~~~~------------------------------------------------------------------------ 177 (676)
T 3qa8_A 170 YAKELDQG------------------------------------------------------------------------ 177 (676)
T ss_dssp CCCBTTSC------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 98532100
Q ss_pred ccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHH--------------HhC
Q 010603 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN--------------VVG 404 (506)
Q Consensus 339 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~--------------i~~ 404 (506)
.......||+.|+|||++.+..++.++|||||||++|||++|..||........+.. ...
T Consensus 178 ------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 178 ------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251 (676)
T ss_dssp ------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred ------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence 001234799999999999999999999999999999999999999976533221100 001
Q ss_pred CCCCCC----CC----CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 405 QPLKFP----EG----SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 405 ~~~~~p----~~----~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
+...++ .. ..+++.+.+||.+||..||.+||+ +.++++||||+.++
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l~ 305 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQALD 305 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHHH
T ss_pred cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHHH
Confidence 111111 11 135688999999999999999998 88999999997643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=352.75 Aligned_cols=230 Identities=20% Similarity=0.191 Sum_probs=192.1
Q ss_pred CCCC-cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 104 KDGD-LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 104 ~~~~-~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
..|+ +..++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++..
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 3455 666789999999999999999999999999999999987655545566778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.+..||||||++|++|.++++.. ..+..+..++.||+.||+|||++||+||||||+||||+.+|.+||+++|.
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--- 175 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--- 175 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---
T ss_pred CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---
Confidence 99999999999999999998542 35567888999999999999999999999999999999999999985542
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
T Consensus 176 -------------------------------------------------------------------------------- 175 (286)
T 3uqc_A 176 -------------------------------------------------------------------------------- 175 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHH---HHhCCCCCCC--CCCCCCH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF---NVVGQPLKFP--EGSSISF 417 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~~~p--~~~~~s~ 417 (506)
++ .++.++|||||||+||||++|+.||.+.+..+.+. +........+ ....+++
T Consensus 176 --------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T 3uqc_A 176 --------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234 (286)
T ss_dssp --------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCH
T ss_pred --------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCH
Confidence 22 37889999999999999999999998876543221 1111111110 1136899
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
++.+||.+||+.||.+| + +.|+++
T Consensus 235 ~l~~li~~~l~~dP~~R-s----~~el~~ 258 (286)
T 3uqc_A 235 QISAVAARSVQGDGGIR-S----ASTLLN 258 (286)
T ss_dssp HHHHHHHHHHCTTSSCC-C----HHHHHH
T ss_pred HHHHHHHHHcccCCccC-C----HHHHHH
Confidence 99999999999999999 7 788876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=389.24 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=200.8
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEcc-CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRD-MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
..+++..++|++++.||+|+||+||+|.++. +|+.||||++.... .......+.+|+++|+.++|||||++++++..
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 3466777899999999999999999999986 78999999987532 23445567889999999999999999999987
Q ss_pred CCe-----EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeec
Q 010603 183 DKF-----SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 183 ~~~-----~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 257 (506)
.+. .||||||++|++|.+++.. .+++..++.|+.||+.||+|||++|||||||||+||||+.+ .+||+||
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEec
Confidence 665 7999999999999987653 69999999999999999999999999999999999999875 9999999
Q ss_pred CCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcc
Q 010603 258 DLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPV 337 (506)
Q Consensus 258 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (506)
|+++....
T Consensus 226 G~a~~~~~------------------------------------------------------------------------ 233 (681)
T 2pzi_A 226 GAVSRINS------------------------------------------------------------------------ 233 (681)
T ss_dssp TTCEETTC------------------------------------------------------------------------
T ss_pred ccchhccc------------------------------------------------------------------------
Confidence 99853210
Q ss_pred cccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCH
Q 010603 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISF 417 (506)
Q Consensus 338 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~ 417 (506)
....+||+.|+|||++.+. ++.++|||||||+||+|++|.+||.+.... ...........++
T Consensus 234 ---------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~ 295 (681)
T 2pzi_A 234 ---------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYD 295 (681)
T ss_dssp ---------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCH
T ss_pred ---------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCH
Confidence 0123699999999999775 488999999999999999999998753211 0000000012457
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
.+.+||.+||..||.+||+ ..+++.|+|+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~----~~~~l~~~l~~ 325 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFT----TAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCS----SHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCC----HHHHHHHHHHH
Confidence 8999999999999999997 67788888875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.76 Aligned_cols=191 Identities=16% Similarity=0.134 Sum_probs=137.1
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchh-------hchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCCeEEE
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML-------AGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l 188 (506)
..++.|++|.+..++....|+.||+|++.+... ......+++.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456788889888888888899999999987532 1233456789999999999 79999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
|||||+|++|.+++... +++++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--- 391 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--- 391 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC---
Confidence 99999999999999875 567764 4789999999999999999999999999999999999999999854210
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
......
T Consensus 392 --------------------------------------------------------------------------~~~~~~ 397 (569)
T 4azs_A 392 --------------------------------------------------------------------------DCSWPT 397 (569)
T ss_dssp ----------------------------------------------------------------------------CCSH
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 001133
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF 390 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf 390 (506)
+.+||+.|||||++.+. +..++|+||+|+++++|+++..+|
T Consensus 398 t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 398 NLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 56899999999999764 677899999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=277.64 Aligned_cols=194 Identities=16% Similarity=0.121 Sum_probs=145.4
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEeccchhh-----chhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLA-----GRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
...+.||+|+||+||+|... ++.+|+|++...... .....+++.+|+++|+.++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44578999999999999444 788999987553322 22234567899999999999999966666667778899
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
|||||+|++|.+++.. +..++.||+.||+|||++|||||||||+|||++. ++||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999998765 5679999999999999999999999999999998 999999999964211000
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
. . . .......
T Consensus 485 ~---------------------------------------------------~-----~--------------~~~~~~~ 494 (540)
T 3en9_A 485 K---------------------------------------------------A-----V--------------DLIVFKK 494 (540)
T ss_dssp H---------------------------------------------------H-----H--------------HHHHHHH
T ss_pred c---------------------------------------------------c-----c--------------chhhhhh
Confidence 0 0 0 0000012
Q ss_pred ccccCCCCccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCC
Q 010603 349 SFVGTHEYLAPEIIRG--DGHGSAVDWWTFGIFFYELLLGRTPFK 391 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~--~~~~~~~DiWSlGvil~elltG~~Pf~ 391 (506)
.++||+.|||||++.. ..|+..+|+|+..+-..+.+-++.+|.
T Consensus 495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 4689999999999987 668889999999999888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=242.90 Aligned_cols=133 Identities=20% Similarity=0.150 Sum_probs=109.7
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---------------hHHHHHHHHHHHHHhcCCCCcccee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---------------KKLMRAQTEREILSLLDHPFLPTLY 177 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~E~~il~~l~hpnIv~l~ 177 (506)
|++++.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+++|+.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 77789999999999999999 7899999999975432111 13456789999999999 5 6666
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeec
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 257 (506)
+++.. +..|+|||||+||+|.+ +.. ..+..++.||+.||.|||++|||||||||+|||++ +|.+||+||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 66644 55699999999999987 321 23456999999999999999999999999999999 999999999
Q ss_pred CCc
Q 010603 258 DLS 260 (506)
Q Consensus 258 Gla 260 (506)
|+|
T Consensus 237 G~a 239 (282)
T 1zar_A 237 PQS 239 (282)
T ss_dssp TTC
T ss_pred CCC
Confidence 998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=201.90 Aligned_cols=139 Identities=19% Similarity=0.173 Sum_probs=109.1
Q ss_pred eEEEeEEeecCceEEEEEEEccCCce--EEEEEeccchhhch---------------------hHHHHHHHHHHHHHhcC
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCL--FAMKVMDKGMLAGR---------------------KKLMRAQTEREILSLLD 169 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~i~~~~~~~~---------------------~~~~~~~~E~~il~~l~ 169 (506)
|++.+.||+|+||.||+|.+..+|+. ||||+++....... .....+.+|+++|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999778999 99999765421100 11235788999999998
Q ss_pred CCCc--cceeEEEEeCCeEEEEEeecCC-C----ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEccCCC
Q 010603 170 HPFL--PTLYSHFETDKFSCLLMEFCSG-G----DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKP 241 (506)
Q Consensus 170 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH-~~giiHrDLKp 241 (506)
|++| +.++++ +..||||||+.+ | .|.++... .++..+..++.||+.||.||| +.|||||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8864 444432 357899999942 3 67665432 235567889999999999999 99999999999
Q ss_pred CcEEEecCCCEEEeecCCccc
Q 010603 242 ENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 242 ~NILl~~~~~vkl~DFGla~~ 262 (506)
+|||++. .++|+|||+|..
T Consensus 200 ~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS--SEEECCCTTCEE
T ss_pred HHEEEcC--cEEEEECccccc
Confidence 9999998 999999999954
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.1e-20 Score=186.22 Aligned_cols=138 Identities=14% Similarity=0.215 Sum_probs=101.4
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc------------hhH-------HHHHHHHHHHHHhcCCCCc
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG------------RKK-------LMRAQTEREILSLLDHPFL 173 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~------------~~~-------~~~~~~E~~il~~l~hpnI 173 (506)
|++.+.||.|+||.||+|.+. +|+.||||+++...... ... ...+..|...|.+|.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999986 59999999986432110 000 0112456777777755444
Q ss_pred cceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC--
Q 010603 174 PTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH-- 251 (506)
Q Consensus 174 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~-- 251 (506)
... ..+... ..+|||||+.|+.|..+.. ...+..++.||+.+|.|||+.|||||||||.||||+++|.
T Consensus 176 ~vp-~p~~~~-~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVP-EPIAQS-RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCC-CEEEEE-TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCC-eeeecc-CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 222 222222 2379999999999865422 1234568899999999999999999999999999998873
Q ss_pred --------EEEeecCCcc
Q 010603 252 --------IMLSDFDLSL 261 (506)
Q Consensus 252 --------vkl~DFGla~ 261 (506)
+.|+||+-+.
T Consensus 246 d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CTTSEEEEEEECCCTTCE
T ss_pred cccccccceEEEEeCCcc
Confidence 8999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-13 Score=133.47 Aligned_cols=140 Identities=17% Similarity=0.153 Sum_probs=112.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 188 (506)
+..|++...+|.|+.+.||++... ++.+++|+........ ...+.+|+++|+.|. +..+.++++++...+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 356999999999999999999754 6789999987532111 124677999999884 6788899999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM------------------------------------- 231 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~------------------------------------- 231 (506)
||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999976521 112234678899999999998
Q ss_pred ----------------------CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 232 ----------------------MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 232 ----------------------~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 459999999999999876566799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=9.1e-13 Score=126.62 Aligned_cols=134 Identities=18% Similarity=0.071 Sum_probs=99.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC--ccceeEEEEeCCeEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF--LPTLYSHFETDKFSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~l 188 (506)
.+|.+....+.|..+.||++.. .+|..|+||+..... ...+..|+++|+.+.+.+ +.+++++....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4466655445666799999965 457789999976531 134567999998885444 5678999888888999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG----------------------------------- 233 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g----------------------------------- 233 (506)
||||++|.+|. .. .... ..++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SS-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TS-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cC-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999999884 11 1121 246677778888888653
Q ss_pred -----------------------eEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 234 -----------------------VVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 234 -----------------------iiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999974
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=7.5e-12 Score=126.85 Aligned_cols=140 Identities=17% Similarity=0.234 Sum_probs=106.7
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEec--cchhhchhHHHHHHHHHHHHHhcC--CCCccceeEEEEeC---CeE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMD--KGMLAGRKKLMRAQTEREILSLLD--HPFLPTLYSHFETD---KFS 186 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~---~~~ 186 (506)
..++.|+.|.++.||++... +..+++|+.. ..... .....+.+|.++|+.|. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34688999999999999865 4678899876 33211 12235677999999986 45688899988776 458
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM----------------------------------- 231 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~----------------------------------- 231 (506)
|+||||++|..|.+.. -..+++.....++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999998885421 1346788888899999999999997
Q ss_pred -----------------------CCeEEccCCCCcEEEecCCC--EEEeecCCcc
Q 010603 232 -----------------------MGVVYRDLKPENVLVREDGH--IMLSDFDLSL 261 (506)
Q Consensus 232 -----------------------~giiHrDLKp~NILl~~~~~--vkl~DFGla~ 261 (506)
.++||+|++|.|||++.++. +.|+||+.+.
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 36999999999999998763 6999999885
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=3.7e-11 Score=118.89 Aligned_cols=131 Identities=17% Similarity=0.140 Sum_probs=97.9
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCC--ccceeEEEEeCC---eEEEEE
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPF--LPTLYSHFETDK---FSCLLM 190 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpn--Iv~l~~~~~~~~---~~~lV~ 190 (506)
+.++.|....||++. ..+++|+.... .....+.+|.++|+.+ .+.. +.+++......+ ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 569999999999973 56899986532 2345678899999887 3333 445554443333 358999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM--------------------------------------- 231 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~--------------------------------------- 231 (506)
|+++|..|..... ..++.+....++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999999875433 246777788888888888888886
Q ss_pred -------------------CCeEEccCCCCcEEEec--CCCEEEeecCCcc
Q 010603 232 -------------------MGVVYRDLKPENVLVRE--DGHIMLSDFDLSL 261 (506)
Q Consensus 232 -------------------~giiHrDLKp~NILl~~--~~~vkl~DFGla~ 261 (506)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 13799999999999998 4567899999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=5.1e-08 Score=96.40 Aligned_cols=132 Identities=16% Similarity=0.126 Sum_probs=93.8
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC---CccceeEEEE-eCCeEEEEEe
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP---FLPTLYSHFE-TDKFSCLLME 191 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E 191 (506)
++.++.|....||+. |..+++|+-.. ......+.+|.++|+.|.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456899999999998 56789998532 23345678899999999652 3566666664 4566789999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM--------------------------------------- 232 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~--------------------------------------- 232 (506)
|++|..|....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999988876321 1234444455555555555555532
Q ss_pred ---------------------CeEEccCCCCcEEEec---CCCE-EEeecCCcc
Q 010603 233 ---------------------GVVYRDLKPENVLVRE---DGHI-MLSDFDLSL 261 (506)
Q Consensus 233 ---------------------giiHrDLKp~NILl~~---~~~v-kl~DFGla~ 261 (506)
.++|+|++|.|||++. ++.+ .|+||+.+.
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3699999999999997 4564 899999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.1e-07 Score=91.79 Aligned_cols=133 Identities=17% Similarity=0.109 Sum_probs=95.1
Q ss_pred eEEeecCce-EEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEEEeecC
Q 010603 117 KKLGCGDIG-SVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 117 ~~LG~G~fG-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
+.+..|..| .||+......+..+.+|+-... ....+.+|..+|+.|. +--|.+++.+..+.+..|+|||+++
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 345556555 6999888877888999986532 3345678999998884 3347788999999999999999999
Q ss_pred CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 010603 195 GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM------------------------------------------ 232 (506)
Q Consensus 195 gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~------------------------------------------ 232 (506)
|.++.+..... ......+..++...|.-||..
T Consensus 104 G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 104 GKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp SEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 98877654332 111223344444444444431
Q ss_pred ----------------CeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 233 ----------------GVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 233 ----------------giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 27999999999999987777899999884
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=4.8e-07 Score=92.60 Aligned_cols=80 Identities=18% Similarity=0.206 Sum_probs=50.9
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchh-hc---hhHHHHHHHHHHHHHhcCC--C-CccceeEEEEeCCeEE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML-AG---RKKLMRAQTEREILSLLDH--P-FLPTLYSHFETDKFSC 187 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-~~---~~~~~~~~~E~~il~~l~h--p-nIv~l~~~~~~~~~~~ 187 (506)
-++.||.|.++.||++....+++.|+||......- .. .....+...|.++|+.+.. | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999998766678899998653211 00 0123345678899887742 3 34455543 344568
Q ss_pred EEEeecCCC
Q 010603 188 LLMEFCSGG 196 (506)
Q Consensus 188 lV~E~~~gg 196 (506)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.48 E-value=1.9e-06 Score=85.70 Aligned_cols=138 Identities=12% Similarity=0.134 Sum_probs=80.0
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC--CCCccceeE------EEEeCCeE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD--HPFLPTLYS------HFETDKFS 186 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~------~~~~~~~~ 186 (506)
-++.|+.|..+.||++... +..+++|+.... . ..+..|.++++.|. .-.|++++. +....+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456777789999999764 345999998752 1 22334555555542 112333333 22456778
Q ss_pred EEEEeecCCCChH---------------HHHhhCCCC--C--------C-CHH--------H------------------
Q 010603 187 CLLMEFCSGGDLH---------------TLRQRQPGK--H--------F-SEQ--------A------------------ 214 (506)
Q Consensus 187 ~lV~E~~~gg~L~---------------~~l~~~~~~--~--------~-~e~--------~------------------ 214 (506)
++||||++|..+. .+....... + + .+. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 111111000 0 0 110 0
Q ss_pred -----HHHHHHHHHHHHHHHH-------------hCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 215 -----TRFYASEVLLALEYLH-------------MMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 215 -----~~~i~~qil~aL~yLH-------------~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
...+..++..++++|+ ..+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223444666665 3579999999999999888899999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5e-06 Score=83.50 Aligned_cols=86 Identities=13% Similarity=0.078 Sum_probs=56.8
Q ss_pred EEEeEE-eecCceEEEEEEEc--c----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-C--CCccceeEEEEeC
Q 010603 114 RLLKKL-GCGDIGSVYLAELR--D----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-H--PFLPTLYSHFETD 183 (506)
Q Consensus 114 ~i~~~L-G~G~fG~Vy~a~~~--~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~ 183 (506)
..++.| +.|....+|+.... . +++.+++|+..............+.+|..+|+.|. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 446788 88999999998754 1 15678999865432000000123567888888774 2 3577888877655
Q ss_pred ---CeEEEEEeecCCCChH
Q 010603 184 ---KFSCLLMEFCSGGDLH 199 (506)
Q Consensus 184 ---~~~~lV~E~~~gg~L~ 199 (506)
+..|+||||++|..|.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999887654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.01 E-value=6e-05 Score=74.46 Aligned_cols=77 Identities=19% Similarity=0.213 Sum_probs=61.1
Q ss_pred EEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC---CCCccceeEEEEeCCeEEEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD---HPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 190 (506)
.-++.|+.|.+..+|+... ++..|+||+.... ....+..|.+.|+.|. ...|++++.+....+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3467899999999999975 3678899987542 2445678999988873 367889999888888999999
Q ss_pred eecCCCCh
Q 010603 191 EFCSGGDL 198 (506)
Q Consensus 191 E~~~gg~L 198 (506)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.4e-05 Score=78.61 Aligned_cols=77 Identities=16% Similarity=0.175 Sum_probs=46.2
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchh--hch-h-HHHHHHHHHHHHHhc---CCCCccceeEEEEeCCeEE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGML--AGR-K-KLMRAQTEREILSLL---DHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~--~~~-~-~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~ 187 (506)
-++.||.|..+.||++.. +++.++||......- ... . ...+...|.+++..+ ....+.+++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 357899999999999964 467899994322100 000 0 001122344443332 334667777765 56778
Q ss_pred EEEeec-CC
Q 010603 188 LLMEFC-SG 195 (506)
Q Consensus 188 lV~E~~-~g 195 (506)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.85 E-value=3.9e-05 Score=75.14 Aligned_cols=132 Identities=13% Similarity=0.065 Sum_probs=75.3
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc-cceeEEEEeCCeEEEEEeec-
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL-PTLYSHFETDKFSCLLMEFC- 193 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~- 193 (506)
++.|+.|....+|++ ..|++|+...... ......+|..+++.+...++ .+++++. .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 688999999999999 4688998765321 11112458877777642222 4666543 33457899999
Q ss_pred CCCChHHH------------------HhhCCCCCC----C-HHHHHHHHHH--------------HHHHHHH----HHh-
Q 010603 194 SGGDLHTL------------------RQRQPGKHF----S-EQATRFYASE--------------VLLALEY----LHM- 231 (506)
Q Consensus 194 ~gg~L~~~------------------l~~~~~~~~----~-e~~~~~i~~q--------------il~aL~y----LH~- 231 (506)
+|..|... ++... ..+ . ...+..+..+ +...+.. +..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSG-AVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSC-CCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCC-CCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 66555310 11111 111 1 1111111111 1111221 111
Q ss_pred ---CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 232 ---MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 232 ---~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..++|+|+.|.||| ..++.+.|+||..+.
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 24899999999999 667789999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.83 E-value=8.8e-05 Score=73.13 Aligned_cols=144 Identities=19% Similarity=0.158 Sum_probs=81.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC--ccceeEE------EEe
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF--LPTLYSH------FET 182 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~ 182 (506)
+...-++.|+.|....||++... +..+++|+..... ....+..|.++++.|.... +.+++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 34456778889999999999765 3368899987531 1123445777777663211 3333321 233
Q ss_pred CCeEEEEEeecCCCChHH-----------H---Hhh-CCC--CC----CC---HHHH-H-----------HHHHHHHHHH
Q 010603 183 DKFSCLLMEFCSGGDLHT-----------L---RQR-QPG--KH----FS---EQAT-R-----------FYASEVLLAL 226 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~-----------~---l~~-~~~--~~----~~---e~~~-~-----------~i~~qil~aL 226 (506)
.+..++||+|++|..+.. . ++. ... .. .. +... . .+...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 467799999998865311 0 111 000 00 01 0000 0 0011234455
Q ss_pred HHHHh-------CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 227 EYLHM-------MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 227 ~yLH~-------~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
++++. .++||+|+.+.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 55552 469999999999999977666899999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00024 Score=68.92 Aligned_cols=79 Identities=16% Similarity=0.087 Sum_probs=55.0
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC---CCccceeEEEEeCCeEEE
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH---PFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~~~~~~l 188 (506)
...-++.+|.|..+.||++... +|+.|.+|+-..... .....+..|.+.|+.|.- --+++++++ . .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceE
Confidence 4667899999999999999875 488999998654321 112345679999998842 234555553 2 2478
Q ss_pred EEeecCCCCh
Q 010603 189 LMEFCSGGDL 198 (506)
Q Consensus 189 V~E~~~gg~L 198 (506)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=73.49 Aligned_cols=75 Identities=17% Similarity=0.309 Sum_probs=45.9
Q ss_pred EeEEeecCceEEEEEEEcc--------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC-ccceeEEEEeCCeE
Q 010603 116 LKKLGCGDIGSVYLAELRD--------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF-LPTLYSHFETDKFS 186 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~ 186 (506)
++.|+.|....||++.... .++.|++|+..... ........|.++++.|...+ +.++++.+ . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 4678889899999998753 13689999876432 11112356888888774333 45777654 2 2
Q ss_pred EEEEeecCCCCh
Q 010603 187 CLLMEFCSGGDL 198 (506)
Q Consensus 187 ~lV~E~~~gg~L 198 (506)
++||||++|..|
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00035 Score=68.95 Aligned_cols=137 Identities=15% Similarity=0.071 Sum_probs=78.3
Q ss_pred eEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCC--CccceeEE-----EEeCCeEEEE
Q 010603 117 KKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP--FLPTLYSH-----FETDKFSCLL 189 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~-----~~~~~~~~lV 189 (506)
+.|+ |....||++... +|+.+++|+...... ....+..|..+++.|... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 888899988654 366799999864321 123455688887776321 23444442 2335667899
Q ss_pred EeecCCCChH-----H------H---Hhh----CCC---CCCCHHHH----------------------HHHHHHHHHHH
Q 010603 190 MEFCSGGDLH-----T------L---RQR----QPG---KHFSEQAT----------------------RFYASEVLLAL 226 (506)
Q Consensus 190 ~E~~~gg~L~-----~------~---l~~----~~~---~~~~e~~~----------------------~~i~~qil~aL 226 (506)
|||++|..+. . . ++. .+. ..+..... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875432 0 0 111 000 01111100 01112222222
Q ss_pred HHH----HhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 227 EYL----HMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 227 ~yL----H~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
+-+ ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234589999999999999 4 89999999874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00018 Score=73.03 Aligned_cols=137 Identities=18% Similarity=0.205 Sum_probs=82.9
Q ss_pred eEEeecCceEEEEEEEcc-------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEE
Q 010603 117 KKLGCGDIGSVYLAELRD-------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 188 (506)
+.|..|-...+|++.... .++.|.||+.... ......+.+|.++++.|. +.-..++++++.. .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 567778889999998742 3578999986432 112334457999988874 3334677776653 29
Q ss_pred EEeecCCCChHH--------------HHh---hC--C-CCCC--CHHHHHHHHHHHHH-------------------HHH
Q 010603 189 LMEFCSGGDLHT--------------LRQ---RQ--P-GKHF--SEQATRFYASEVLL-------------------ALE 227 (506)
Q Consensus 189 V~E~~~gg~L~~--------------~l~---~~--~-~~~~--~e~~~~~i~~qil~-------------------aL~ 227 (506)
||||++|..|.. .+. .. + ++.. -..++..+..++-. .++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998865531 111 11 0 1111 23555556554422 233
Q ss_pred HHH----h----CCeEEccCCCCcEEEecC----CCEEEeecCCcc
Q 010603 228 YLH----M----MGVVYRDLKPENVLVRED----GHIMLSDFDLSL 261 (506)
Q Consensus 228 yLH----~----~giiHrDLKp~NILl~~~----~~vkl~DFGla~ 261 (506)
.|. . ..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 2 249999999999999887 789999999884
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00029 Score=72.75 Aligned_cols=75 Identities=20% Similarity=0.241 Sum_probs=50.4
Q ss_pred EEeEEeecCceEEEEEEEcc-------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC-ccceeEEEEeCCeE
Q 010603 115 LLKKLGCGDIGSVYLAELRD-------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF-LPTLYSHFETDKFS 186 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~ 186 (506)
-++.|+.|-...||++.... .++.|.+|+..... . ...+..|..+++.|...+ .+++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---T--ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---C--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---c--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35778889999999998753 25789999884311 1 123346888888874333 4677776542
Q ss_pred EEEEeecCCCCh
Q 010603 187 CLLMEFCSGGDL 198 (506)
Q Consensus 187 ~lV~E~~~gg~L 198 (506)
.+||||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00027 Score=70.04 Aligned_cols=137 Identities=13% Similarity=0.076 Sum_probs=71.2
Q ss_pred EeEEeecCceE-EEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC--CCccceeEEEEeCCeEEEEEee
Q 010603 116 LKKLGCGDIGS-VYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH--PFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 116 ~~~LG~G~fG~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 192 (506)
++.|+.|+... +|+.... +|+.+++|....... ..+..|+.+++.|.. -.+.+++.+-...+ ++|||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 35566665554 6676532 256777876543210 123457777776632 23566766533333 789999
Q ss_pred cCCCChHHHHhhC---------------------CC---CCCCHHHHH--------HHH------------HHHHHHHHH
Q 010603 193 CSGGDLHTLRQRQ---------------------PG---KHFSEQATR--------FYA------------SEVLLALEY 228 (506)
Q Consensus 193 ~~gg~L~~~l~~~---------------------~~---~~~~e~~~~--------~i~------------~qil~aL~y 228 (506)
+.+..+.+++... .. ..+...... .+. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776664433211 00 112221110 000 011122233
Q ss_pred H------HhCCeEEccCCCCcEEEecC----CCEEEeecCCcc
Q 010603 229 L------HMMGVVYRDLKPENVLVRED----GHIMLSDFDLSL 261 (506)
Q Consensus 229 L------H~~giiHrDLKp~NILl~~~----~~vkl~DFGla~ 261 (506)
+ +...++|+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 3 23469999999999999875 689999999884
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00093 Score=69.46 Aligned_cols=76 Identities=13% Similarity=0.206 Sum_probs=50.0
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc-cceeEEEEeCCeEEEEEeec
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL-PTLYSHFETDKFSCLLMEFC 193 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 193 (506)
-++.|+.|-...+|++.....+..|++|+..... ...+ ...+|..+|+.|...++ .++++++. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 3578888999999999876545789999875431 1111 12468999998864444 57777763 2 2599999
Q ss_pred CCCCh
Q 010603 194 SGGDL 198 (506)
Q Consensus 194 ~gg~L 198 (506)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0019 Score=59.58 Aligned_cols=59 Identities=14% Similarity=0.075 Sum_probs=44.6
Q ss_pred ChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEccCCCCcEEEecCCCEEEee
Q 010603 197 DLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH-MMGVVYRDLKPENVLVREDGHIMLSD 256 (506)
Q Consensus 197 ~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH-~~giiHrDLKp~NILl~~~~~vkl~D 256 (506)
+|.++++.. +.+++|+++|.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.+
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 688888775 479999999999999999987762 11212333457889999999887764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0017 Score=64.61 Aligned_cols=72 Identities=13% Similarity=0.074 Sum_probs=45.8
Q ss_pred EeEE--eecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC---CCCccceeEE------EEeCC
Q 010603 116 LKKL--GCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD---HPFLPTLYSH------FETDK 184 (506)
Q Consensus 116 ~~~L--G~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~------~~~~~ 184 (506)
++.| |.|....||++.... | .|++|+...... ..|+.+++.|. -|+|++.+.. ....+
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~-g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g 94 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSES-K-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKH 94 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSS-C-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSS
T ss_pred eEEeeccCccccceEEEEeCC-C-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECC
Confidence 3455 334468999997653 4 899998765431 34666666552 2335555432 34467
Q ss_pred eEEEEEeecCCCCh
Q 010603 185 FSCLLMEFCSGGDL 198 (506)
Q Consensus 185 ~~~lV~E~~~gg~L 198 (506)
..++||||++|..+
T Consensus 95 ~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 95 FKIIAYPFIHAPNG 108 (339)
T ss_dssp EEEEEEECCCCCBT
T ss_pred EEEEEEeccCCCcC
Confidence 88999999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0073 Score=61.96 Aligned_cols=76 Identities=16% Similarity=0.305 Sum_probs=49.8
Q ss_pred EEeEEeecCceEEEEEEEccC-------CceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeE
Q 010603 115 LLKKLGCGDIGSVYLAELRDM-------GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFS 186 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 186 (506)
-++.|..|-...+|++..... ++.|++|+..... .......+|.++++.|. +.-..++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 346777888899999987631 5789999865431 11112346888888774 333556666442 2
Q ss_pred EEEEeecCCCCh
Q 010603 187 CLLMEFCSGGDL 198 (506)
Q Consensus 187 ~lV~E~~~gg~L 198 (506)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.21 E-value=0.13 Score=52.11 Aligned_cols=28 Identities=32% Similarity=0.472 Sum_probs=24.4
Q ss_pred eEEccCCCCcEEEe------cCCCEEEeecCCcc
Q 010603 234 VVYRDLKPENVLVR------EDGHIMLSDFDLSL 261 (506)
Q Consensus 234 iiHrDLKp~NILl~------~~~~vkl~DFGla~ 261 (506)
++|+|+.+.|||+. +++.+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 68999999999993 46689999999984
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.34 E-value=1.5 Score=40.19 Aligned_cols=83 Identities=13% Similarity=0.098 Sum_probs=60.4
Q ss_pred cCCCCccceeEEEEeCCeEEEEEeecC-CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEE
Q 010603 168 LDHPFLPTLYSHFETDKFSCLLMEFCS-GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLV 246 (506)
Q Consensus 168 l~hpnIv~l~~~~~~~~~~~lV~E~~~-gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl 246 (506)
..||+.+.. .+-++++.+.+.++.-. +-++.. + +.++....+.++.+|+...++++ .=+|-=|.|+||++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f 112 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFF 112 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEE
Confidence 368888876 56667776666666543 223332 2 24678888888888888775444 34888899999999
Q ss_pred ecCCCEEEeecCC
Q 010603 247 REDGHIMLSDFDL 259 (506)
Q Consensus 247 ~~~~~vkl~DFGl 259 (506)
+.++.+++.--|+
T Consensus 113 ~~~~~p~i~~RGi 125 (215)
T 4ann_A 113 TRDGLPIAKTRGL 125 (215)
T ss_dssp CTTSCEEESCCEE
T ss_pred cCCCCEEEEEccC
Confidence 9999999998886
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.15 E-value=0.081 Score=54.83 Aligned_cols=63 Identities=6% Similarity=0.000 Sum_probs=17.9
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEE------EEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAM------KVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAi------K~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
+.+.|| ||.||++........||+ |.++..... .+....+.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEE
Confidence 445666 999999999865567888 665443322 233445677888999999999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.23 E-value=2.8 Score=38.46 Aligned_cols=83 Identities=7% Similarity=-0.065 Sum_probs=59.7
Q ss_pred CCCCccceeEEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCeEEccCCCCcEEEe
Q 010603 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE-YLHMMGVVYRDLKPENVLVR 247 (506)
Q Consensus 169 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~-yLH~~giiHrDLKp~NILl~ 247 (506)
.||++ -..+-.+++.+.+.++.-+++.=+..++ .++....+.++.+|+.... ++ ..-+|-=|.|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 67877 4445577777777777653333333332 4677888888887777655 44 4558888999999999
Q ss_pred cCCCEEEeecCCc
Q 010603 248 EDGHIMLSDFDLS 260 (506)
Q Consensus 248 ~~~~vkl~DFGla 260 (506)
.++.++|.-.|+-
T Consensus 119 ~~~~p~i~hRGi~ 131 (219)
T 4ano_A 119 RALEPFFLHVGVK 131 (219)
T ss_dssp TTCCEEESCCEET
T ss_pred CCCcEEEEEcCCc
Confidence 9999999999974
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=80.28 E-value=3.5 Score=40.22 Aligned_cols=74 Identities=19% Similarity=0.267 Sum_probs=44.4
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEccCCCCcEEEecCCC-EEEeecC
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG-----VVYRDLKPENVLVREDGH-IMLSDFD 258 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g-----iiHrDLKp~NILl~~~~~-vkl~DFG 258 (506)
...++|||.+|..|..+-...-...+.++..+.+. -+-+++++..++ +-+.--.|.|||++.++. +.++|-+
T Consensus 156 ~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~~~~IDhn 233 (342)
T 1cja_A 156 ANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPIDSK 233 (342)
T ss_dssp SEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECSCC
T ss_pred cceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCChhheEEeCCCCeEEEEcCC
Confidence 46699999998777653211100123344433322 145677777664 111225789999987655 8899999
Q ss_pred Cc
Q 010603 259 LS 260 (506)
Q Consensus 259 la 260 (506)
++
T Consensus 234 ~a 235 (342)
T 1cja_A 234 II 235 (342)
T ss_dssp CC
T ss_pred cc
Confidence 87
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 506 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-23 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-26 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-16 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-13 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-16 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-15 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-22 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-25 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-25 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-17 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-17 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-17 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-17 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-12 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-15 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-31 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-15 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-15 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-15 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-14 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-14 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-08 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-17 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-51
Identities = 61/348 (17%), Positives = 114/348 (32%), Gaps = 52/348 (14%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F + +LG G+ G V+ + G + A K++ + + + E ++L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSP 64
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH- 230
++ Y F +D + ME GG L + ++ EQ + V+ L YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE 122
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCI 290
+++RD+KP N+LV G I L DF +S +
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---------------------------GQL 155
Query: 291 DPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD--SLPVLIAEPTSARSM 348
+ S + P + + + SD S+ + + E R
Sbjct: 156 IDSMANSFVGTRSYMSPERLQGTHYSVQ-------------SDIWSMGLSLVEMAVGRYP 202
Query: 349 SFVGTHEYLAP-EIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
+ L + +G + G E L +V +P
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
S +D + L+K+P +R ++ H F + +
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDA 306
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 156 bits (396), Expect = 2e-44
Identities = 71/348 (20%), Positives = 119/348 (34%), Gaps = 60/348 (17%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-LLDH 170
++L++KLG G V+ A +K++ K + + E +IL L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRGG 89
Query: 171 PFLPTLYSHFE--TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
P + TL + + L+ E + D L Q ++ RFY E+L AL+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 229 LHMMGVVYRDLKPENVLV-REDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQP 287
H MG+++RD+KP NV++ E + L D+ L+ + + +
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 288 SCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347
D + + SL ++A +
Sbjct: 205 QMYDYSLDM------------------------------------WSLGCMLASMIFRKE 228
Query: 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL 407
F G Y I G+ + + EL G +R+ V
Sbjct: 229 PFFHGHDNYDQLVRIA-KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287
Query: 408 KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
+ +S A D + LL D Q RL A E +HP+F +V
Sbjct: 288 Q----HLVSPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVK 327
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 6e-44
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 4/149 (2%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ ++ +LG G G VY A+ ++ L A KV+D + M E +IL+ DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV---EIDILASCDHP 69
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ L F + +L+EFC+GG + + + +E + + L AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RDLK N+L DG I L+DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVS 157
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (243), Expect = 2e-23
Identities = 28/116 (24%), Positives = 46/116 (39%), Gaps = 10/116 (8%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGD-----GHGSAVDWWTFGIFFYELLLGRTPFKGNGN 395
T R SF+GT ++APE++ + + D W+ GI E+ P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220
Query: 396 RETLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
L + +P + S S KD ++ L K+ R +++ QHPF
Sbjct: 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFV 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-41
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 10/181 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F+ K LG G +V LA +A+K+++K + K+ ER+++S LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
F LY F+ D+ + + G+L ++ F E TRFY +E++ ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291
G+++RDLKPEN+L+ ED HI ++DF + S + R +S+ +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVL--------SPESKQARANSFVGTAQYVS 178
Query: 292 P 292
P
Sbjct: 179 P 179
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 3e-36
Identities = 45/129 (34%), Positives = 64/129 (49%), Gaps = 4/129 (3%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
E AR+ SFVGT +Y++PE++ + D W G Y+L+ G PF+
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
Query: 401 NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK--RGATEIKQHPFFESVNWALI 458
++ FPE A+DL+ LLV D KRLG + G +K HPFFESV W +
Sbjct: 221 KIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
Query: 459 RSTHPPEIP 467
PP++
Sbjct: 279 HQQTPPKLT 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-41
Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 2/151 (1%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L F + + LG G G+VYLA + + A+KV+ K L + + E EI S L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HP + LY +F L++E+ G ++ Q+ F EQ T Y +E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
H V++RD+KPEN+L+ G + ++DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWS 153
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 9e-29
Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 10/135 (7%)
Query: 322 VKSEKTSLTNSDSLPV----LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFG 377
+K E L ++ L + S+R + GT +YL PE+I G H VD W+ G
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 191
Query: 378 IFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGF 437
+ YE L+G+ PF+ N +ET + FP+ ++ A+DLI LL +P +R
Sbjct: 192 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPML 249
Query: 438 KRGATEIKQHPFFES 452
+ E+ +HP+ +
Sbjct: 250 R----EVLEHPWITA 260
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 61/379 (16%), Positives = 115/379 (30%), Gaps = 69/379 (18%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ K +G G G VY A+L D G L A+K + + E +I+ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCN 74
Query: 173 LPTLYSHFET------DKFSCLLMEFCSGGDLHTLRQR-QPGKHFSEQATRFYASEVLLA 225
+ L F + + + L++++ R + + + Y ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIM-LSDFDLSLRCFVSPKLVQSSDDPACRISSYC 284
L Y+H G+ +RD+KP+N+L+ D ++ L DF + + V R
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 285 IQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344
+ + + S ++AE
Sbjct: 195 FGATDYTSSIDVW------------------------------------SAGCVLAELLL 218
Query: 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG 404
+ + + EII+ G + + E +
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK--------------A 264
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPP 464
P A L LL P RL E H FF+ + ++ +
Sbjct: 265 HPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGR 320
Query: 465 EIPKPVDLSFINHKQKTPI 483
+ P + + P+
Sbjct: 321 DTPALFNFTTQELSSNPPL 339
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (376), Expect = 3e-41
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L H+ + ++LG G G V+ R G FA K + + ++ + + E + +S+L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HP L L+ FE D ++ EF SGG+L + K SE Y +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 230 HMMGVVYRDLKPENVLV--REDGHIMLSDFDLS 260
H V+ DLKPEN++ + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 118 bits (297), Expect = 3e-30
Identities = 47/172 (27%), Positives = 65/172 (37%), Gaps = 13/172 (7%)
Query: 322 VKSEKTSLTNSDSLPVLIAEPTSARSM-------SFVGTHEYLAPEIIRGDGHGSAVDWW 374
+K E T S + + + + GT E+ APE+ G G D W
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 209
Query: 375 TFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIRGLLVKDPQ 432
+ G+ Y LL G +PF G + ETL NV + S IS KD IR LL+ DP
Sbjct: 210 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 269
Query: 433 KRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKPVDLSFINHKQKTPIP 484
R+ + +HP+ N S P + S P P
Sbjct: 270 TRM----TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEP 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-41
Identities = 65/359 (18%), Positives = 114/359 (31%), Gaps = 66/359 (18%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLDHPF 172
L LG G +VY A ++ + A+K + G + K + RE +L L HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L F L+ +F ++ + + Y L LEYLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
+++RDLKP N+L+ E+G + L+DF L+ +S P + + P
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLA----------KSFGSPNRAYTHQVVTRWYRAP 169
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD--SLPVLIAEPTSARSMSF 350
+ D ++ ++AE
Sbjct: 170 ---------ELLFGARMYGVG------------------VDMWAVGCILAELLLRVPFLP 202
Query: 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP 410
+ I G + W + P +
Sbjct: 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF------------- 249
Query: 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEIPKP 469
S+ DLI+GL + +P R+ AT+ + +F + T ++P+P
Sbjct: 250 --SAAGDDLLDLIQGLFLFNPCARI----TATQALKMKYFSNRPGP----TPGCQLPRP 298
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (372), Expect = 1e-40
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 7/164 (4%)
Query: 99 QCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA 158
Q V+ K G + ++ +L++LG G G V+ + G +F K ++ + +
Sbjct: 18 QPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN- 75
Query: 159 QTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFY 218
E I++ L HP L L+ FE L++EF SGG+L + K SE Y
Sbjct: 76 --EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINY 132
Query: 219 ASEVLLALEYLHMMGVVYRDLKPENVLVR--EDGHIMLSDFDLS 260
+ L+++H +V+ D+KPEN++ + + + DF L+
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 108 bits (270), Expect = 1e-26
Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 8/154 (5%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
T E+ APEI+ + G D W G+ Y LL G +PF G + ETL NV
Sbjct: 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 243
Query: 406 PLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHP 463
+F E SS+S AKD I+ LL K+P+KRL + +HP+ + + L ++
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHSNL--TSRI 297
Query: 464 PEIPKPVDLSFINHKQKTPIPQNDKGAADSDRSS 497
P I K ++ SS
Sbjct: 298 PSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSS 331
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 2e-40
Identities = 40/149 (26%), Positives = 61/149 (40%), Gaps = 2/149 (1%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
F L+++G G G+VY A + A+K M +K E L L HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ + + L+ME+C G L + K E L L YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS 133
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RD+K N+L+ E G + L DF +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.1 bits (244), Expect = 2e-23
Identities = 29/127 (22%), Positives = 46/127 (36%), Gaps = 15/127 (11%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHG---SAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
+ SFVGT ++APE+I G VD W+ GI EL + P L+++
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTH 462
+ S ++ + L K PQ R + + +H F
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE----VLLKHRFV--------LRER 274
Query: 463 PPEIPKP 469
PP +
Sbjct: 275 PPTVIMD 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 1e-39
Identities = 63/382 (16%), Positives = 127/382 (33%), Gaps = 59/382 (15%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L ++ LK +G G G V A + A+K + + + RA E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 170 HPFLPTLYSHFETDKFS------CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
H + +L + F K L+ME ++ + + ++L
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQML 129
Query: 224 LALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSY 283
+++LH G+++RDLKP N++V+ D + + DF L+ + + ++ Y
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----------RTAGTSFMMTPY 178
Query: 284 CIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343
+ P L + + + + S+ ++ E
Sbjct: 179 VVTRYYRAPEVILGMGYKENV--------------------------DIWSVGCIMGEMV 212
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV 403
+ + + ++I G + R + G LF
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL-TFPKLFPDS 271
Query: 404 GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHP 463
P + A+DL+ +LV DP KR+ + QHP+
Sbjct: 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINV-----WYDPAE 322
Query: 464 PEIPKPVDLSFINHKQKTPIPQ 485
E P P +++ I +
Sbjct: 323 VEAPPPQIYDKQLDEREHTIEE 344
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-39
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
+ + L++ LG G G V LA R A+K++D + + E I +L+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
H + Y H L +E+CSGG+L + E + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
H +G+ +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLA 150
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 1e-24
Identities = 25/124 (20%), Positives = 48/124 (38%), Gaps = 6/124 (4%)
Query: 329 LTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGR 387
+++ V GT Y+APE+++ H VD W+ GI +L G
Sbjct: 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 388 TPFKGNGNRETLF-NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446
P+ + + + + I A L+ +LV++P R+ +IK+
Sbjct: 204 LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP----DIKK 259
Query: 447 HPFF 450
++
Sbjct: 260 DRWY 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (361), Expect = 5e-39
Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
L + F + + +G G G VY D G ++AMK +DK + ++ A ER +LSL
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 168 L---DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
+ D PF+ + F T +++ +GGDLH + FSE RFYA+E++L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIIL 118
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYC 284
LE++H VVYRDLKP N+L+ E GH+ +SD L+ F K S
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 177
Query: 285 IQPSCIDPAC 294
+ D +
Sbjct: 178 QKGVAYDSSA 187
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 112 bits (282), Expect = 4e-28
Identities = 49/176 (27%), Positives = 90/176 (51%), Gaps = 10/176 (5%)
Query: 338 LIAEPTSARSMSFVGTHEYLAPEII-RGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR 396
L + + + + VGTH Y+APE++ +G + S+ DW++ G ++LL G +PF+ + +
Sbjct: 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 397 ET---LFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLG-FKRGATEIKQHPFFES 452
+ + ++ P+ S S + L+ GLL +D +RLG RGA E+K+ PFF S
Sbjct: 213 DKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
Query: 453 VNWALI--RSTHPPEIPKPVDLSFINHKQKTPIPQND-KGAADSDRSSGPFLDFEF 505
++W ++ + PP IP +++ + + D KG D + +F
Sbjct: 271 LDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPL 326
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-38
Identities = 66/373 (17%), Positives = 113/373 (30%), Gaps = 57/373 (15%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
+ L +G G G V A A+K + + R E +IL H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRH 65
Query: 171 PFLPTLYSHFETDKFS----CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
+ + L+ G DL+ L + Q H S ++ ++L L
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGL 122
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQ 286
+Y+H V++RDLKP N+L+ + + DF L+ ++ D ++ Y
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLTEYVAT 175
Query: 287 PSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346
P E K + S+ ++AE S R
Sbjct: 176 RWYRAP--------EIMLNSKGYTKS-----------------IDIWSVGCILAEMLSNR 210
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406
+ + I+ G S D L P K LF
Sbjct: 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF------ 264
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEI 466
+ A DL+ +L +P KR+ + HP+ E
Sbjct: 265 ------PNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLEQYYDPSDEPIAEAPF 314
Query: 467 PKPVDLSFINHKQ 479
++L + ++
Sbjct: 315 KFDMELDDLPKEK 327
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-38
Identities = 72/374 (19%), Positives = 133/374 (35%), Gaps = 70/374 (18%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+R L+ +G G G+V A G A+K + + + RA E +L + H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHE 77
Query: 172 FLPTLYSHFETDKFS------CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
+ L F D+ L+M F ++ + E +F ++L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLGEDRIQFLVYQMLKG 133
Query: 226 LEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCI 285
L Y+H G+++RDLKP N+ V ED + + DF L + ++ Y +
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL-------------ARQADSEMTGYVV 180
Query: 286 QPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345
P LN + S+ ++AE +
Sbjct: 181 TRWYRAP-------------------EVILNWMRYTQTVDIW------SVGCIMAEMITG 215
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+++ H EI++ G A + + P + ++
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL----- 270
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPE 465
++ S A +L+ +LV D ++R+ A E HP+FES++ + P+
Sbjct: 271 -------TNASPLAVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHD----TEDEPQ 315
Query: 466 IPKPVDLSFINHKQ 479
+ K D SF + +
Sbjct: 316 VQKYDD-SFDDVDR 328
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 4e-38
Identities = 37/184 (20%), Positives = 72/184 (39%), Gaps = 6/184 (3%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
+ +K+G G G+VY A G A++ M+ ++ ++ E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P + + ++ME+ +GG L + E E L ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH 133
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCI 290
V++RD+K +N+L+ DG + L+DF + + ++ +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 291 DPAC 294
P
Sbjct: 194 GPKV 197
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-26
Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 5/111 (4%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
P ++ + VGT ++APE++ +G VD W+ GI E++ G P+ L+
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 401 NVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
+ + +S +D + L D +KR K E+ QH F
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAK----ELLQHQFL 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 7e-38
Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 10/191 (5%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ +L +G G G + G + K +D G + + +E +L L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 173 LPTLYSHF--ETDKFSCLLMEFCSGGDLHTL--RQRQPGKHFSEQATRFYASEVLLALEY 228
+ Y T+ ++ME+C GGDL ++ + + ++ E+ +++ LAL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 229 LHMMG-----VVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSY 283
H V++RDLKP NV + ++ L DF L+ ++ +S
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 284 CIQPSCIDPAC 294
+ +
Sbjct: 185 QMNRMSYNEKS 195
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (237), Expect = 9e-23
Identities = 26/112 (23%), Positives = 45/112 (40%), Gaps = 7/112 (6%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
I ++ + +FVGT Y++PE + + D W+ G YEL PF +E
Sbjct: 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222
Query: 399 LFNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPF 449
+ G+ + P S ++I +L R + EI ++P
Sbjct: 223 AGKIREGKFRRIPY--RYSDELNEIITRMLNLKDYHRPSVE----EILENPL 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-38
Identities = 69/339 (20%), Positives = 121/339 (35%), Gaps = 57/339 (16%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ L+K+G G G+V+ A+ R+ + A+K + A E +L L H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKN 62
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ L+ +DK L+ EFC + + + ++L L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
V++RDLKP+N+L+ +G + L++F L+ ++ P S+ + P
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLA----------RAFGIPVRCYSAEVVTLWYRPP 170
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352
+K + S + AE +A F G
Sbjct: 171 -------------------DVLFGAKLYSTSIDMWSAG------CIFAELANAGRPLFPG 205
Query: 353 THEY-LAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE 411
I R G + W + L P+ +L NVV
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSM-----TKLPDYKPYPMYPATTSLVNVV-------- 252
Query: 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450
++ +DL++ LL +P +R+ A E QHP+F
Sbjct: 253 -PKLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYF 286
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (346), Expect = 1e-37
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 9/156 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLM------RAQTEREIL 165
++ + LG G V + +A+K++D E +IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 166 SLL-DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
+ HP + L +ET+ F L+ + G+L + SE+ TR +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ LH + +V+RDLKPEN+L+ +D +I L+DF S
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 98.6 bits (245), Expect = 1e-23
Identities = 41/117 (35%), Positives = 50/117 (42%), Gaps = 12/117 (10%)
Query: 343 TSARSMSFVGTHEYLAPEIIRG------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR 396
+ GT YLAPEII G+G VD W+ G+ Y LL G PF
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 397 ETLFNVVGQPLKF--PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
L ++ +F PE S KDL+ LV PQKR A E HPFF+
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (346), Expect = 2e-37
Identities = 57/151 (37%), Positives = 94/151 (62%), Gaps = 2/151 (1%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
L F++L+ LG G G V+L R G +AMKV+ K ++ K++ ER +LS++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 170 HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
HPF+ ++ F+ + ++M++ GG+L +L ++ F +FYA+EV LALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYL 120
Query: 230 HMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
H ++YRDLKPEN+L+ ++GHI ++DF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (300), Expect = 6e-31
Identities = 42/129 (32%), Positives = 69/129 (53%), Gaps = 5/129 (3%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+ + GT +Y+APE++ + ++DWW+FGI YE+L G TPF + +T ++
Sbjct: 157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216
Query: 406 PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR-GATEIKQHPFFESVNWA--LIRSTH 462
L+FP + KDL+ L+ +D +RLG + G ++K HP+F+ V W L R+
Sbjct: 217 ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 274
Query: 463 PPEIPKPVD 471
P P
Sbjct: 275 TPYEPPIQQ 283
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-37
Identities = 32/150 (21%), Positives = 64/150 (42%), Gaps = 6/150 (4%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
G + +++G G G+VY + A+K+++ ++L + E +L H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 63
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
+ + T ++ ++C G L+ K F A + ++YLH
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH 121
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+++RDLK N+ + ED + + DF L+
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.6 bits (201), Expect = 7e-18
Identities = 30/112 (26%), Positives = 50/112 (44%), Gaps = 11/112 (9%)
Query: 343 TSARSMSFVGTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETL 399
S + G+ ++APE+IR + + D + FGI YEL+ G+ P+ NR+ +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 400 FNVVGQPLKFPE----GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
+VG+ P+ S+ A K L+ L K +R F +I
Sbjct: 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP----QILAS 266
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 69/351 (19%), Positives = 115/351 (32%), Gaps = 57/351 (16%)
Query: 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD 169
+ + L K+G G G V+ A R G A+K + + A E +IL LL
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 170 HPFLPTLYSHFETDKFS--------CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASE 221
H + L T L+ +FC L SE +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQM 125
Query: 222 VLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRIS 281
+L L Y+H +++RD+K NVL+ DG + L+DF L+ + + R +
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR------AFSLAKNSQPNRYT 179
Query: 282 SYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341
+ + P L + + + ++AE
Sbjct: 180 NRVVTLWYRPPELLLG-------------------------ERDYGPPIDLWGAGCIMAE 214
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
+ + T ++ I + G + W + L + ++ L
Sbjct: 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 274
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
V P A DLI LLV DP +R+ + + H FF S
Sbjct: 275 YVRDPY-----------ALDLIDKLLVLDPAQRI----DSDDALNHDFFWS 310
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-37
Identities = 57/183 (31%), Positives = 93/183 (50%), Gaps = 3/183 (1%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL-LDHP 171
F L K LG G G V+LAE + FA+K + K ++ + E+ +LSL +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
FL ++ F+T + +ME+ +GGDL Q F FYA+E++L L++LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS 121
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291
G+VYRDLK +N+L+ +DGHI ++DF + + + I+ + +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 292 PAC 294
+
Sbjct: 182 HSV 184
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-33
Identities = 55/172 (31%), Positives = 87/172 (50%), Gaps = 12/172 (6%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF 400
A++ +F GT +Y+APEI+ G + +VDWW+FG+ YE+L+G++PF G E
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 401 NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI-- 458
++ +P + AKDL+ L V++P+KRLG +I+QHP F +NW +
Sbjct: 214 SIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELER 268
Query: 459 RSTHPPEIPK---PVDLSFINHK--QKTPIPQNDKGAADSDRSSGPFLDFEF 505
+ PP PK P D S + + + P A + F +F F
Sbjct: 269 KEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSF 320
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-36
Identities = 68/343 (19%), Positives = 114/343 (33%), Gaps = 55/343 (16%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+F+ ++K+G G G VY A + G + A+K + A E +L L+HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHP 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ L T+ L+ EF + + Y ++L L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI-KSYLFQLLQGLAFCHS 120
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCID 291
V++RDLKP+N+L+ +G I L+DF L+ ++ P + +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLA----------RAFGVPVRTYTHEVVTLWYRA 170
Query: 292 PACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351
P L K + SL + AE + R++
Sbjct: 171 P-------------------EILLGCKYYSTAVDIW------SLGCIFAEMVTRRALFPG 205
Query: 352 GTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE 411
+ I R G V W G+ P + +
Sbjct: 206 DSEIDQLFRIFRTLGTPDEVVWP--GVTSMPDYKPSFPKWARQDFSKVV----------- 252
Query: 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454
+ + L+ +L DP KR+ A HPFF+ V
Sbjct: 253 -PPLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-36
Identities = 64/353 (18%), Positives = 116/353 (32%), Gaps = 68/353 (19%)
Query: 112 HFRLLKKLGCGDIGSVYLA-ELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-- 168
+ + ++G G G V+ A +L++ G A+K + + E +L L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTIREVAVLRHLET 66
Query: 169 -DHPFLPTLYSHFETDKFS-----CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
+HP + L+ + L+ E + P + + ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQL 125
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISS 282
L L++LH VV+RDLKP+N+LV G I L+DF L+ ++S
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-----------RIYSFQMALTS 174
Query: 283 YCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342
+ P L + + S+ + AE
Sbjct: 175 VVVTLWYRAPEV--------------------LLQSSYATPVDLWSVG------CIFAEM 208
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
+ + + +I+ G DW P R+ +
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---------------PRDVALPRQAFHSK 253
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
QP++ + I KDL+ L +P KR+ A HP+F+ +
Sbjct: 254 SAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 3e-36
Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 8/200 (4%)
Query: 65 GKSSLSTGDANEASFRSACLSKPHKGNDMKWDAVQCVKSKDGDLGLGHFRLLKKLGCGDI 124
G ++ + + + S + L+K + KW+ L F +K LG G
Sbjct: 1 GNAAAAKKGSEQESVKEF-LAKAKEDFLKKWE-----TPSQNTAQLDQFDRIKTLGTGSF 54
Query: 125 GSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184
G V L + ++ G +AMK++DK + K++ E+ IL ++ PFL L F+ +
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENV 244
++ME+ +GG++ + +R FSE RFYA++++L EYLH + ++YRDLKPEN+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172
Query: 245 LVREDGHIMLSDFDLSLRCF 264
L+ + G+I ++DF + R
Sbjct: 173 LIDQQGYIQVTDFGFAKRVK 192
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 6e-28
Identities = 55/171 (32%), Positives = 80/171 (46%), Gaps = 13/171 (7%)
Query: 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET 398
A+ R+ + GT E LAPEII G+ AVDWW G+ YE+ G PF + +
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 399 LFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR-GATEIKQHPFFESVNWAL 457
+V ++FP S S KDL+R LL D KR G + G +IK H +F + +W
Sbjct: 247 YEKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 458 I--RSTHPPEIPK---PVDLSFINHKQKTPIPQNDKGAADSDRSSGPFLDF 503
I R P IPK P D S + + + + +++ F +F
Sbjct: 305 IYQRKVEAPFIPKFKGPGDTSNFD-----DYEEEEIRVSINEKCGKEFTEF 350
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 133 bits (335), Expect = 3e-36
Identities = 34/186 (18%), Positives = 78/186 (41%), Gaps = 13/186 (6%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
+ L + LG G + V+LA + A+KV+ + +R + E + + L+H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 171 PFLPTLYSHFETD----KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
P + +Y E + ++ME+ G L + + + + ++ AL
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQAL 124
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQ 286
+ H G+++RD+KP N+++ + + DF ++ + + S + + ++
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA-------RAIADSGNSVTQTAAVIGT 177
Query: 287 PSCIDP 292
+ P
Sbjct: 178 AQYLSP 183
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 90.2 bits (223), Expect = 8e-21
Identities = 25/94 (26%), Positives = 44/94 (46%), Gaps = 2/94 (2%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
+ ++ + +GT +YL+PE RGD + D ++ G YE+L G PF G+ +
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226
Query: 403 VGQPLKFPE--GSSISFAAKDLIRGLLVKDPQKR 434
V + P +S ++ L K+P+ R
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 132 bits (333), Expect = 7e-36
Identities = 61/340 (17%), Positives = 114/340 (33%), Gaps = 59/340 (17%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ L+K+G G G VY A+ G FA+K + E IL L H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKE-DEGIPSTTIREISILKELKHSN 61
Query: 173 LPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMM 232
+ LY T K L+ E L + + + ++L + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 233 GVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
V++RDLKP+N+L+ +G + ++DF L+ P + + + P
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF----------GIPVRKYTHEIVTLWYRAP 169
Query: 293 ACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352
+ + ++ + S+ + AE + +
Sbjct: 170 DVLMG-------------------------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204
Query: 353 THEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE- 411
+ I R G ++ +W P + V +PL +
Sbjct: 205 SEADQLMRIFRILGTPNSKNW---------------PNVTELPKYDPNFTVYEPLPWESF 249
Query: 412 GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
+ + DL+ +L DP +R+ A + +H +F+
Sbjct: 250 LKGLDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 2e-35
Identities = 57/186 (30%), Positives = 88/186 (47%), Gaps = 18/186 (9%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ LG G V LAE + L A+K + K L G++ + E +L + HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHP 67
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ L +E+ L+M+ SGG+L + ++E+ +VL A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 125
Query: 232 MGVVYRDLKPENVLVR---EDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPS 288
+G+V+RDLKPEN+L ED IM+SDF LS +DP +S+ C P
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-----------KMEDPGSVLSTACGTPG 174
Query: 289 CIDPAC 294
+ P
Sbjct: 175 YVAPEV 180
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (270), Expect = 8e-27
Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 8/140 (5%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+ GT Y+APE++ + AVD W+ G+ Y LL G PF + + ++
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224
Query: 406 PLKF--PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHP 463
+F P IS +AKD IR L+ KDP+KR + QHP+ +
Sbjct: 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF----TCEQALQHPWIA--GDTALDKNIH 278
Query: 464 PEIPKPVDLSFINHKQKTPI 483
+ + + +F K K
Sbjct: 279 QSVSEQIKKNFAKSKWKQAF 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-35
Identities = 45/180 (25%), Positives = 71/180 (39%), Gaps = 13/180 (7%)
Query: 117 KKLGCGDIGSVYLAELRDM--GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP 174
+LGCG+ GSV R A+KV+ +G + E +I+ LD+P++
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIV 72
Query: 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
L + + L+ME GG LH + +V + ++YL
Sbjct: 73 RLIGVCQAEAL-MLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPAC 294
V+RDL NVL+ + +SDF LS K + + D S+ P C
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLS-------KALGADDSYYTARSAGKWPLKWYAPEC 183
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 1e-16
Identities = 19/113 (16%), Positives = 41/113 (36%), Gaps = 5/113 (4%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETL 399
+ + ++ APE I S D W++G+ +E L G+ P+K E +
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
Query: 400 FNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFE 451
+ G+ ++ P L+ + + R F + + ++
Sbjct: 223 AFIEQGKRMECPPE--CPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 3e-35
Identities = 59/187 (31%), Positives = 97/187 (51%), Gaps = 2/187 (1%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
+ + F LK LG G G V L + G +AMK++ K ++ + ++ TE +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
HPFL L F+T C +ME+ +GG+L R+ F+E+ RFY +E++ ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALE 119
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQP 287
YLH VVYRD+K EN+++ +DGHI ++DF L +++ ++ ++
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 288 SCIDPAC 294
+ A
Sbjct: 180 NDYGRAV 186
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 58/179 (32%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
A +F GT EYLAPE++ + +G AVDWW G+ YE++ GR PF +
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR-GATEIKQHPFFESVNWALI-- 458
++ + ++FP ++S AK L+ GLL KDP++RLG A E+ +H FF S+NW +
Sbjct: 217 ILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274
Query: 459 RSTHPPEIPK---PVDLSFIN------HKQKTPIPQNDKGA---ADSDRSSGPFLDFEF 505
+ PP P+ VD + + TP + D D F DF++
Sbjct: 275 KKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDY 333
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (329), Expect = 3e-35
Identities = 35/149 (23%), Positives = 62/149 (41%), Gaps = 4/149 (2%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ KLG G G VY + A+K + + + E ++ + HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHP 73
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L L + ++ EF + G+L + + S + A+++ A+EYL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV E+ + ++DF LS
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLS 162
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.8 bits (165), Expect = 3e-13
Identities = 15/101 (14%), Positives = 33/101 (32%)
Query: 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRE 397
L+ T ++ APE + + D W FG+ +E+ +
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
Query: 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
++ ++ + + +L+R +P R F
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFA 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-35
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 6/149 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
LK+LG G G V + R A+K++ +G + + + E +++ L H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIE---EAKVMMNLSHE 59
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L LY + ++ E+ + G L + + F Q +V A+EYL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES 118
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL N LV + G + +SDF LS
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.0 bits (189), Expect = 2e-16
Identities = 23/115 (20%), Positives = 43/115 (37%), Gaps = 8/115 (6%)
Query: 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGN 393
L + + S+ + PE++ S D W FG+ +E+ LG+ P++
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 394 GNRETLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
N ET ++ G L P S ++ + +R FK + +
Sbjct: 206 TNSETAEHIAQGLRLYRPHL--ASEKVYTIMYSCWHEKADERPTFK----ILLSN 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 7e-35
Identities = 42/200 (21%), Positives = 77/200 (38%), Gaps = 11/200 (5%)
Query: 96 DAVQCVKSKDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMG---CLFAMKVMDKGMLAGR 152
D + V+ ++ + ++ + +G G+ G V L+ G A+K + G +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70
Query: 153 KKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSE 212
++ +E I+ DHP + L ++ EF G L + ++ G+ +
Sbjct: 71 RR--DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TV 127
Query: 213 QATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272
+ ++YL M V+RDL N+LV + +SDF LS F+ +
Sbjct: 128 IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS--RFLED---DT 182
Query: 273 SDDPACRISSYCIQPSCIDP 292
SD I P
Sbjct: 183 SDPTYTSALGGKIPIRWTAP 202
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 75.2 bits (184), Expect = 1e-15
Identities = 28/121 (23%), Positives = 50/121 (41%), Gaps = 5/121 (4%)
Query: 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPF 390
S L ++PT ++ + APE I+ SA D W++GI +E++ G P+
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 391 KGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK---RGATEIKQH 447
N++ + N + Q + P A L+ KD R F ++ ++
Sbjct: 235 WDMTNQD-VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
Query: 448 P 448
P
Sbjct: 294 P 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-35
Identities = 29/149 (19%), Positives = 63/149 (42%), Gaps = 6/149 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+L+++LG G G V++ A+K + +G ++ E ++ L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQ 68
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L LY+ + ++ E+ G L + G + A+++ + ++
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
++RDL+ N+LV + ++DF L+
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 1e-15
Identities = 20/120 (16%), Positives = 37/120 (30%), Gaps = 6/120 (5%)
Query: 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG 394
L LI + ++ APE I D W+FGI E++
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 395 NRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ--HPFFES 452
+ + + + + L+R + P+ R F ++ FF +
Sbjct: 215 TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFD----YLRSVLEDFFTA 270
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-34
Identities = 61/161 (37%), Positives = 99/161 (61%), Gaps = 7/161 (4%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAEL---RDMGCLFAMKVMDKGMLAGRKKLM-RAQTERE 163
+G+ +F LLK LG G G V+L D G L+AMKV+ K + + K +TER+
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 164 ILSLLDH-PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEV 222
+L + PFL TL+ F+T+ L++++ +GG+L T ++ F+E + Y E+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEI 138
Query: 223 LLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263
+LALE+LH +G++YRD+K EN+L+ +GH++L+DF LS
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 58/142 (40%), Positives = 80/142 (56%), Gaps = 7/142 (4%)
Query: 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGD--GHGSAVDWWTFGIFFYELLLGRTPFK 391
L + R+ F GT EY+AP+I+RG GH AVDWW+ G+ YELL G +PF
Sbjct: 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
Query: 392 GNGNRETLFNVVGQPLKF--PEGSSISFAAKDLIRGLLVKDPQKRLGF-KRGATEIKQHP 448
+G + + + + LK P +S AKDLI+ LL+KDP+KRLG R A EIK+H
Sbjct: 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293
Query: 449 FFESVNWALI--RSTHPPEIPK 468
FF+ +NW + + P P
Sbjct: 294 FFQKINWDDLAAKKVPAPFKPV 315
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-34
Identities = 41/194 (21%), Positives = 84/194 (43%), Gaps = 18/194 (9%)
Query: 110 LGHFRLLKK-LGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-L 167
+ +++ + LG G G V + FA+K++ + +A+ E E+
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 61
Query: 168 LDHPFLPTLYSHFET----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVL 223
P + + +E K ++ME GG+L + Q + + F+E+ +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 224 LALEYLHMMGVVYRDLKPENVLV---REDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRI 280
A++YLH + + +RD+KPEN+L R + + L+DF + + S + + +
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-KETTSHNSLTTPCYTPYYV 180
Query: 281 SSYCIQPSCIDPAC 294
+ + P D +C
Sbjct: 181 APEVLGPEKYDKSC 194
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 1e-22
Identities = 36/148 (24%), Positives = 59/148 (39%), Gaps = 17/148 (11%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+ T Y+APE++ + + + D W+ G+ Y LL G PF N + +
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 406 ------PLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIR 459
PE S +S K LIR LL +P +R+ TE HP+ ++
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWI-------MQ 277
Query: 460 STHPPEIPKPVDLSFINHKQKTPIPQND 487
ST P+ P K++ + +
Sbjct: 278 STKVPQTPLHTSRVLKEDKERWEDVKEE 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-34
Identities = 39/193 (20%), Positives = 80/193 (41%), Gaps = 23/193 (11%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF 172
+ ++G G +VY + A + L + + R + E E+L L HP
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPN 69
Query: 173 LPTLYSHFET----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
+ Y +E+ K L+ E + G L T +R K + R + ++L L++
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQF 127
Query: 229 LHMMG--VVYRDLKPENVLVR-EDGHIMLSDFDLSL-------------RCFVSPKLVQS 272
LH +++RDLK +N+ + G + + D L+ F++P++ +
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE 187
Query: 273 SDDPACRISSYCI 285
D + + ++ +
Sbjct: 188 KYDESVDVYAFGM 200
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 25/136 (18%), Positives = 55/136 (40%), Gaps = 11/136 (8%)
Query: 322 VKSEKTSLTNSDSLPVLI-----AEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTF 376
+K + +T + ++ + + +GT E++APE+ + +VD + F
Sbjct: 140 LKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAF 198
Query: 377 GIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSS-ISFAAKDLIRGLLVKDPQKRL 435
G+ E+ P+ N ++ V +K K++I G + ++ +R
Sbjct: 199 GMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 258
Query: 436 GFKRGATEIKQHPFFE 451
K ++ H FF+
Sbjct: 259 SIK----DLLNHAFFQ 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-34
Identities = 32/151 (21%), Positives = 64/151 (42%), Gaps = 7/151 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
+ + + LG G+ G V+ + K + + + E IL++ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHR 61
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
+ L+ FE+ + ++ EF SG D+ +E+ Y +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 232 MGVVYRDLKPENVLV--REDGHIMLSDFDLS 260
+ + D++PEN++ R I + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 8e-25
Identities = 43/145 (29%), Positives = 63/145 (43%), Gaps = 17/145 (11%)
Query: 329 LTNSDSLPVLIAEPTSARSM-------SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFY 381
S + I E AR + EY APE+ + D +A D W+ G Y
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVY 194
Query: 382 ELLLGRTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKR 439
LL G PF N++ + N++ F E IS A D + LLVK+ + R+
Sbjct: 195 VLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---- 250
Query: 440 GATEIKQHPFF----ESVNWALIRS 460
A+E QHP+ E V+ +IR+
Sbjct: 251 TASEALQHPWLKQKIERVSTKVIRT 275
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 44/188 (23%), Positives = 70/188 (37%), Gaps = 12/188 (6%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDM---GCLFAMKVMDKGMLAGRKKLMRAQTEREI 164
+G RLL+KLG G G V E A+K + +L+ + + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 165 LSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLL 224
+ LDH L LY T ++ E G L ++ G HF YA +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAE 122
Query: 225 ALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYC 284
+ YL ++RDL N+L+ + + DF L + + +DD
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------RALPQNDDHYVMQEHRK 175
Query: 285 IQPSCIDP 292
+ + P
Sbjct: 176 VPFAWCAP 183
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-17
Identities = 17/99 (17%), Positives = 34/99 (34%), Gaps = 1/99 (1%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETL 399
+ + APE ++ A D W FG+ +E+ G+ P+ G + L
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
Query: 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
+ + + P +++ P+ R F
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-33
Identities = 39/151 (25%), Positives = 62/151 (41%), Gaps = 8/151 (5%)
Query: 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
L + +LL+ +G G+ G V L + R G A+K + E +++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQ 56
Query: 168 LDHPFLPTLYSHF-ETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
L H L L E ++ E+ + G L + + ++ +V A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257
EYL V+RDL NVLV ED +SDF
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 4e-17
Identities = 22/106 (20%), Positives = 45/106 (42%), Gaps = 8/106 (7%)
Query: 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNV 402
S+ + ++ APE +R + D W+FGI +E+ GR P+ ++ + V
Sbjct: 154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
Query: 403 V-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
G + P+G A ++++ D R F ++++
Sbjct: 214 EKGYKMDAPDG--CPPAVYEVMKNCWHLDAAMRPSFL----QLREQ 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-33
Identities = 39/148 (26%), Positives = 64/148 (43%), Gaps = 6/148 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
++++G G G V+L + A+K + +G + + + E E++ L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIE---EAEVMMKLSHP 60
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L LY CL+ EF G L + Q F+ + +V + YL
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE 119
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDL 259
V++RDL N LV E+ I +SDF +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 4e-17
Identities = 14/113 (12%), Positives = 37/113 (32%), Gaps = 4/113 (3%)
Query: 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG 394
+ + + S ++ +PE+ + S D W+FG+ +E+ N
Sbjct: 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 395 NRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
+ + + + + S ++ + P+ R F + +
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS----RLLRQ 255
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-33
Identities = 38/178 (21%), Positives = 74/178 (41%), Gaps = 13/178 (7%)
Query: 117 KKLGCGDIGSVYLAELRD--MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLP 174
K+LG G+ G+V + + A+K++ K E ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK-DELLAEANVMQQLDNPYIV 71
Query: 175 TLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGV 234
+ E + + L+ME G L+ Q+ +H ++ +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 235 VYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDP 292
V+RDL NVL+ + +SDF LS K +++ ++ + P
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLS-------KALRADENYYKAQTHGKWPVKWYAP 179
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 8e-21
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 5/111 (4%)
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVV-G 404
++ APE I S D W+FG+ +E G+ P++G E + G
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455
+ + P G DL+ D + R GF ++ +++ VN
Sbjct: 227 ERMGCPAG--CPREMYDLMNLCWTYDVENRPGFAA-VELRLRNYYYDVVNE 274
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-32
Identities = 65/372 (17%), Positives = 116/372 (31%), Gaps = 68/372 (18%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
++ L +G G GSV A G A+K + + + R E +L + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHE 77
Query: 172 FLPTLYSHFET-----DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
+ L F + L+ G DL+ + + Q ++ +F ++L L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQ 286
+Y+H +++RDLKP N+ V ED + + DF L+ ++ R +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAPEIMLN 192
Query: 287 PSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346
+ + S+ ++AE + R
Sbjct: 193 WMHYNQTV------------------------------------DIWSVGCIMAELLTGR 216
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406
++ H I+R G A + N +F
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF------ 270
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTHPPEI 466
+ A DL+ +LV D KR+ A + H +F +
Sbjct: 271 ------IGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYFAQY-----HDPDDEPV 315
Query: 467 PKPVDLSFINHK 478
P D SF +
Sbjct: 316 ADPYDQSFESRD 327
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-32
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHP 171
RL KLG G G V++ A+K + G + + ++ E +++ L H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQ---EAQVMKKLRHE 72
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM 231
L LY+ + ++ E+ S G L + + GK+ A+++ + Y+
Sbjct: 73 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 232 MGVVYRDLKPENVLVREDGHIMLSDFDLS 260
M V+RDL+ N+LV E+ ++DF L+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLA 160
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.9 bits (199), Expect = 1e-17
Identities = 26/135 (19%), Positives = 43/135 (31%), Gaps = 14/135 (10%)
Query: 335 LPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNG 394
L LI + ++ APE D W+FGI EL
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218
Query: 395 NRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ--HPFFES 452
+ + V + + P + DL+ K+P++R F+ ++ +F
Sbjct: 219 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE----YLQAFLEDYF-- 272
Query: 453 VNWALIRSTHPPEIP 467
ST P P
Sbjct: 273 ------TSTEPQYQP 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-31
Identities = 31/171 (18%), Positives = 60/171 (35%), Gaps = 24/171 (14%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
K LG G G V A + A+K++ ++ +E ++LS
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVLS 81
Query: 167 -LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKH---------------- 209
L +H + L + ++ E+C GDL +R+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 210 FSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ ++ +V + +L ++RDL N+L+ + DF L+
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 2e-12
Identities = 22/103 (21%), Positives = 42/103 (40%), Gaps = 1/103 (0%)
Query: 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGN 395
+ + + +++APE I + D W++GIF +EL LG +P+ G
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 396 RETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
+ ++ + + D+++ DP KR FK
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-31
Identities = 37/152 (24%), Positives = 61/152 (40%), Gaps = 7/152 (4%)
Query: 112 HFRLLKKLGCGDIGSVYLAELR---DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
L + +G G G V+ + A+K ++ + E +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMRQF 65
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
DHP + L T+ ++ME C+ G+L + Q + + YA ++ AL Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 229 LHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
L V+RD+ NVLV + + L DF LS
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 1e-15
Identities = 29/116 (25%), Positives = 48/116 (41%), Gaps = 8/116 (6%)
Query: 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKG 392
L + + T ++ +++APE I SA D W FG+ +E+L+ G PF+G
Sbjct: 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212
Query: 393 NGNRETLFNVV-GQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
N + + + G+ L P L+ DP +R F E+K
Sbjct: 213 VKNNDVIGRIENGERLPMPPN--CPPTLYSLMTKCWAYDPSRRPRFT----ELKAQ 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-31
Identities = 35/176 (19%), Positives = 64/176 (36%), Gaps = 29/176 (16%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMG-----CLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
+ K LG G G V A + A+K++ + + ++ +E ++++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMMT 95
Query: 167 -LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKH---------------- 209
L H + L L+ E+C GDL + + K
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 210 -----FSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+ + +A +V +E+L V+RDL NVLV + + DF L+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 3e-16
Identities = 17/112 (15%), Positives = 42/112 (37%), Gaps = 5/112 (4%)
Query: 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGN 395
++++ + +++APE + + D W++GI +E+ LG P+ G
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 396 RETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
+ ++ K + + +++ D +KR F +
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP----NLTSF 320
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-31
Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 7/156 (4%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLM---RAQTEREILSL 167
+++ LG G GSVY A+K ++K ++ +L R E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 168 LD--HPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLA 225
+ + L FE L++E + G E+ R + +VL A
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEA 122
Query: 226 LEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLS 260
+ + H GV++RD+K EN+L+ + G + L DF
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 5e-22
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 13/107 (12%)
Query: 348 MSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406
F GT Y PE IR HG + W+ GI Y+++ G PF+ + ++
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ 220
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453
+ F + +S + LIR L P R F+ EI+ HP+ + V
Sbjct: 221 VFFRQ--RVSSECQHLIRWCLALRPSDRPTFE----EIQNHPWMQDV 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 9e-31
Identities = 36/159 (22%), Positives = 73/159 (45%), Gaps = 9/159 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLM---RAQTEREILSLL 168
++ ++LG G V + G +A K + K ++ + + E IL +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 169 DHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEY 228
HP + TL+ +E L++E +GG+L + + +E+ + ++L + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 229 LHMMGVVYRDLKPENVLVREDG----HIMLSDFDLSLRC 263
LH + + + DLKPEN+++ + I + DF L+ +
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-29
Identities = 45/125 (36%), Positives = 67/125 (53%), Gaps = 8/125 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ 405
+ GT E++APEI+ + G D W+ G+ Y LL G +PF G+ +ETL NV
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 406 PLKFPEG--SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW--ALIRST 461
+F + S+ S AKD IR LLVKDP+KR+ + + QHP+ + + AL +
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ----DSLQHPWIKPKDTQQALSSAW 287
Query: 462 HPPEI 466
P+
Sbjct: 288 SHPQF 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-30
Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 4/150 (2%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGM--LAGRKKLMRAQTEREILSLLDH 170
F+ +K LG G G+VY G + V K + K E +++ +D+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 171 PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLH 230
P + L T L+ + G L + + Q + ++ + YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 231 MMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+V+RDL NVLV+ H+ ++DF L+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLA 158
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 3e-15
Identities = 24/143 (16%), Positives = 54/143 (37%), Gaps = 9/143 (6%)
Query: 338 LIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNR 396
L AE + +++A E I + D W++G+ +EL+ G P+ G
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PA 219
Query: 397 ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFF---ESV 453
+ +++ + + P+ + ++ + D R F+ E+ +
Sbjct: 220 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFR----ELIIEFSKMARDPQ 275
Query: 454 NWALIRSTHPPEIPKPVDLSFIN 476
+ +I+ +P P D +F
Sbjct: 276 RYLVIQGDERMHLPSPTDSNFYR 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (293), Expect = 4e-30
Identities = 38/189 (20%), Positives = 68/189 (35%), Gaps = 29/189 (15%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
+ ++ +G G G V+ A + + A+K++ + A + Q E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMA 71
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQ--------------------- 205
D+P + L K CLL E+ + GDL+ +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 206 -PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264
S A +V + YL V+RDL N LV E+ + ++DF LS +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 265 VSPKLVQSS 273
+
Sbjct: 192 SADYYKADG 200
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 49/352 (13%), Positives = 104/352 (29%), Gaps = 80/352 (22%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
+ ++LG G G VY + + A+K +++ A ++ + E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMK 78
Query: 167 LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
+ + L + + ++ME + GDL
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK--------------------------- 111
Query: 227 EYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQ 286
YL + + M + + + K V +
Sbjct: 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH-----------RDLA 160
Query: 287 PSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346
A V + + + +
Sbjct: 161 ARNCMVAEDFTVKIGDFGMTR-----------------------------DIYETDYYRK 191
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETLFNVV-G 404
+ +++PE ++ + D W+FG+ +E+ L P++G N + L V+ G
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ--HPFFESVN 454
L P+ + +L+R +P+ R F + IK+ P F V+
Sbjct: 252 GLLDKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-29
Identities = 36/163 (22%), Positives = 62/163 (38%), Gaps = 15/163 (9%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-LLDHP 171
+ +G G+ G V A ++ G + A + E E+L L HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 172 FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQR--------------QPGKHFSEQATRF 217
+ L E + L +E+ G+L ++ S Q
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 218 YASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+A++V ++YL ++RDL N+LV E+ ++DF LS
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 6e-15
Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 4/106 (3%)
Query: 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN 401
+ ++A E + + + D W++G+ +E++ L+
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 402 VVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447
+ Q + + + DL+R + P +R F +I
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA----QILVS 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (286), Expect = 4e-29
Identities = 31/156 (19%), Positives = 63/156 (40%), Gaps = 13/156 (8%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
H+++ +++G G G ++ A+K + R + + E LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAG 59
Query: 171 -PFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
+P +Y + + L+++ L G+ FS + A ++L ++ +
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSI 117
Query: 230 HMMGVVYRDLKPENVLVRE-----DGHIMLSDFDLS 260
H +VYRD+KP+N L+ I + DF +
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 62.1 bits (150), Expect = 2e-11
Identities = 13/95 (13%), Positives = 24/95 (25%), Gaps = 6/95 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKG---NGNRETLFNV 402
+ GT Y++ G D G F L G P++G N++ +
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 403 VGQPLKFP---EGSSISFAAKDLIRGLLVKDPQKR 434
+ P + +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 9e-29
Identities = 58/374 (15%), Positives = 123/374 (32%), Gaps = 46/374 (12%)
Query: 106 GD-LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREI 164
G+ + L++KLG G +V+LA+ AMK++ + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 165 -------LSLLDHPFLPTLYSHFET---DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQA 214
+ + L HF + +++ G +L L ++ +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 215 TRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSS 273
+ + ++LL L+Y+H G+++ D+KPENVL+ + + + +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-NLIQIKIADLGNACWYDEH 185
Query: 274 DDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSD 333
+ + Y + P +C + E S T D
Sbjct: 186 YTNSIQTREYR----SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 334 SLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGN 393
I + +G P + +G + + + G+ L P +
Sbjct: 242 DHIAQI--------IELLGEL----PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE-- 287
Query: 394 GNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453
+V+ + KF + D + +L DP+KR A + HP+ +
Sbjct: 288 -------DVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLK-- 332
Query: 454 NWALIRSTHPPEIP 467
+ + P+
Sbjct: 333 DTLGMEEIRVPDRE 346
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 1e-28
Identities = 33/154 (21%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH 170
+RL +K+G G G +YL G A+K+ + K + E +I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 171 P-FLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYL 229
+PT+ ++ ++ME + FS + A +++ +EY+
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 230 HMMGVVYRDLKPENVLVREDGH---IMLSDFDLS 260
H ++RD+KP+N L+ + + DF L+
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.1 bits (181), Expect = 3e-15
Identities = 12/113 (10%), Positives = 27/113 (23%), Gaps = 7/113 (6%)
Query: 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVV-- 403
+ + GT Y + G D + G LG P++G
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 404 -GQPLKFP---EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452
+ + P + + + ++ ++ F
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQ 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 24/171 (14%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDM-------GCLFAMKVMDKGMLAGRKKLMRAQTEREI 164
L K LG G G V LAE + A+K++ K L +E E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 165 LS-LLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTL--------------RQRQPGKH 209
+ + H + L D +++E+ S G+L P +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 210 FSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
S + A +V +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 7e-15
Identities = 21/99 (21%), Positives = 45/99 (45%), Gaps = 2/99 (2%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELL-LGRTPFKGNGNRETL 399
++ + +++APE + + D W+FG+ +E+ LG +P+ G E L
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 246
Query: 400 FNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
F ++ + + + S+ + ++R P +R FK
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-27
Identities = 39/187 (20%), Positives = 65/187 (34%), Gaps = 14/187 (7%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKGMLAGRKKLMRAQTEREILSL 167
K +G G+ G VY L+ A+K + G ++ E I+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 168 LDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
H + L K ++ E+ G L + + G FS + ++
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMK 124
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQP 287
YL M V+RDL N+LV + +SDF LS ++++ + S I
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLS-------RVLEDDPEATYTTSGGKIPI 177
Query: 288 SCIDPAC 294
P
Sbjct: 178 RWTAPEA 184
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 2e-14
Identities = 17/92 (18%), Positives = 31/92 (33%)
Query: 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP 406
+ + APE I SA D W+FGI +E++ + + +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 407 LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFK 438
+ P A L+ ++ +R F
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFA 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 37/184 (20%), Positives = 71/184 (38%), Gaps = 23/184 (12%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRDM-----GCLFAMKVMDKGMLAGRKKLMRAQTEREILS 166
+L K LG G G V A+ + A+K++ +G + +E +IL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 71
Query: 167 LLDHPFLPTLYSH--FETDKFSCLLMEFCSGGDLHTLRQRQPGK--------------HF 210
+ H + +++EFC G+L T + + +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 211 SEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270
+ + Y+ +V +E+L ++RDL N+L+ E + + DF L+ + P V
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 271 QSSD 274
+ D
Sbjct: 192 RKGD 195
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.7 bits (172), Expect = 5e-14
Identities = 41/248 (16%), Positives = 80/248 (32%), Gaps = 18/248 (7%)
Query: 208 KHFSEQATRFYASEVLLALEYLH------MMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261
+ + R SE+ + + H ++G + P V+V LS + S
Sbjct: 53 EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 112
Query: 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPR-FLNSKTT 320
R P V D ++ + A + C+ R L S+
Sbjct: 113 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD-LAARNILLSEKN 171
Query: 321 KVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFF 380
VK + + + +P R +++APE I + D W+FG+
Sbjct: 172 VVK-----ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226
Query: 381 YELLLG-RTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKR 439
+E+ +P+ G E + + + + + +P +R F
Sbjct: 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS- 285
Query: 440 GATEIKQH 447
E+ +H
Sbjct: 286 ---ELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-26
Identities = 36/185 (19%), Positives = 68/185 (36%), Gaps = 25/185 (13%)
Query: 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSL--LDH 170
L + +G G G V+ + R G A+K+ ++ E EI L H
Sbjct: 5 IVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS------REERSWFREAEIYQTVMLRH 56
Query: 171 PFLPTLYSHFETDKFS----CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLAL 226
+ + D + L+ ++ G L R + + A L
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGL 113
Query: 227 EYLHM--------MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPAC 278
+LHM + +RDLK +N+LV+++G ++D L++R + + + +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 279 RISSY 283
Y
Sbjct: 174 GTKRY 178
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.3 bits (127), Expect = 2e-08
Identities = 18/124 (14%), Positives = 35/124 (28%), Gaps = 26/124 (20%)
Query: 341 EPTSARSMSFVGTHEYLAPEIIRGDGH------GSAVDWWTFGIFFYELLLGRTPFK--- 391
+ VGT Y+APE++ + D + G+ F+E+ +
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 392 -----------GNGNRETLFNVVGQPLKFPE------GSSISFAAKDLIRGLLVKDPQKR 434
+ + E + VV + P ++R + R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 435 LGFK 438
L
Sbjct: 283 LTAL 286
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-25
Identities = 34/183 (18%), Positives = 70/183 (38%), Gaps = 10/183 (5%)
Query: 112 HFRLLKKLGCGDIGSVYLAELRD---MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL 168
HF + +G G G VY L D A+K +++ G + TE I+
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDF 85
Query: 169 DHPFLPTLY-SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALE 227
HP + +L ++ +++ + GDL + + + F +V ++
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMK 144
Query: 228 YLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQP 287
+L V+RDL N ++ E + ++DF L+ R + + ++ +
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-RDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 288 SCI 290
+
Sbjct: 204 ESL 206
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 5e-16
Identities = 20/134 (14%), Positives = 46/134 (34%), Gaps = 11/134 (8%)
Query: 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV 402
+ +++A E ++ + D W+FG+ +EL+ P + N +
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246
Query: 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALIRSTH 462
+ Q + + +++ + R F E+ + I ST
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS----ELVSR--ISA-----IFSTF 295
Query: 463 PPEIPKPVDLSFIN 476
E V+ +++N
Sbjct: 296 IGEHYVHVNATYVN 309
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.7 bits (188), Expect = 6e-17
Identities = 29/161 (18%), Positives = 51/161 (31%), Gaps = 30/161 (18%)
Query: 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK---------------KLMRAQ 159
+ K +G G +V+ +K G + +K + A+
Sbjct: 4 IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 160 TEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYA 219
E L L +P +Y+ +LME + +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELI---------DAKELYRVRVENPDEVL 109
Query: 220 SEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260
+L + + G+V+ DL NVLV + I + DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 506 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.96 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-67 Score=528.21 Aligned_cols=280 Identities=38% Similarity=0.715 Sum_probs=250.2
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||+++++|++++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 56789999999999999999999999999999999999877666667788899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+|||||+||+|.+++... +.++|..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 999999999999998876 68999999999999999999999999999999999999999999999999998542110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
....
T Consensus 159 ----------------------------------------------------------------------------~~~~ 162 (337)
T d1o6la_ 159 ----------------------------------------------------------------------------GATM 162 (337)
T ss_dssp ----------------------------------------------------------------------------TCCB
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0112
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+....+.+|. .+++++++||.+||
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L 240 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLL 240 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHT
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHhhc
Confidence 3458999999999999999999999999999999999999999999998888888888888776 69999999999999
Q ss_pred hcCCCCccCCCC-ChHHhhcCCCCCCCCcchhc--cCCCCCCCC
Q 010603 428 VKDPQKRLGFKR-GATEIKQHPFFESVNWALIR--STHPPEIPK 468 (506)
Q Consensus 428 ~~dP~~R~s~~~-~a~ell~hp~f~~~~~~~~~--~~~~~~~p~ 468 (506)
++||.+|++..+ +++|+++||||+.++|..+. ...||..|.
T Consensus 241 ~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~ 284 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCC
Confidence 999999997532 58999999999999998663 334555554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-67 Score=515.92 Aligned_cols=278 Identities=35% Similarity=0.632 Sum_probs=244.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||+++++|++++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999998876655666778899999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--- 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--- 162 (288)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC---
Confidence 999999999988876 679999999999999999999999999999999999999999999999999986421100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
......+.
T Consensus 163 ------------------------------------------------------------------------~~~~~~~~ 170 (288)
T d1uu3a_ 163 ------------------------------------------------------------------------KQARANSF 170 (288)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 01112345
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcC
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKD 430 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~d 430 (506)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .+++++++||.+||+.|
T Consensus 171 ~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 248 (288)
T d1uu3a_ 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLD 248 (288)
T ss_dssp CCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--TCCHHHHHHHHTTSCSS
T ss_pred cCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCC
Confidence 7999999999999999999999999999999999999999999988888899888877775 69999999999999999
Q ss_pred CCCccCCCC--ChHHhhcCCCCCCCCcchhccCCCCCCC
Q 010603 431 PQKRLGFKR--GATEIKQHPFFESVNWALIRSTHPPEIP 467 (506)
Q Consensus 431 P~~R~s~~~--~a~ell~hp~f~~~~~~~~~~~~~~~~p 467 (506)
|.+|||+.+ ...++++||||++++|+.+....||.+|
T Consensus 249 P~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 249 ATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 999998421 1234799999999999998887777665
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-65 Score=511.30 Aligned_cols=275 Identities=35% Similarity=0.723 Sum_probs=246.3
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46789999999999999999999999999999999988766656667788999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
|||||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence 99999999999988876 6789999999999999999999999999999999999999999999999999854210
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
...
T Consensus 157 -----------------------------------------------------------------------------~~~ 159 (316)
T d1fota_ 157 -----------------------------------------------------------------------------VTY 159 (316)
T ss_dssp -----------------------------------------------------------------------------CBC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 012
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|. .+++++++||.+||.
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLIT 237 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhh
Confidence 347999999999999999999999999999999999999999999998988898888777765 699999999999999
Q ss_pred cCCCCccCC-CCChHHhhcCCCCCCCCcchhc--cCCCCCCC
Q 010603 429 KDPQKRLGF-KRGATEIKQHPFFESVNWALIR--STHPPEIP 467 (506)
Q Consensus 429 ~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p 467 (506)
.||.+|++. .++++++|+||||++++|+.+. ...+|..|
T Consensus 238 ~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p 279 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP 279 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred hCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCC
Confidence 999999753 3479999999999999998663 33445444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-65 Score=497.91 Aligned_cols=258 Identities=34% Similarity=0.571 Sum_probs=234.8
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+++|+.++|||||++++++.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 45788999999999999999999999999999999998876665666777889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 83 ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-- 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 158 (263)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred EEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC--
Confidence 999999999999998875 5799999999999999999999999999999999999999999999999999843110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 159 -----------------------------------------------------------------------------~~~ 161 (263)
T d2j4za1 159 -----------------------------------------------------------------------------SRR 161 (263)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 011
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .+++++++||.+||
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L 239 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLL 239 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHT
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHc
Confidence 2347999999999999999999999999999999999999999999888888888888777775 69999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+.||.+||| ++|+|+||||+.
T Consensus 240 ~~dp~~R~t----~~eil~hp~~~~ 260 (263)
T d2j4za1 240 KHNPSQRPM----LREVLEHPWITA 260 (263)
T ss_dssp CSSGGGSCC----HHHHHTCHHHHH
T ss_pred cCCHhHCcC----HHHHHcCcCcCC
Confidence 999999997 999999999963
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-64 Score=507.88 Aligned_cols=279 Identities=37% Similarity=0.675 Sum_probs=248.3
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34578999999999999999999999999999999998876665666778899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCC
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~ 267 (506)
+||||+.||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 118 ~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 999999999999998876 5799999999999999999999999999999999999999999999999999964210
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
..
T Consensus 194 ------------------------------------------------------------------------------~~ 195 (350)
T d1rdqe_ 194 ------------------------------------------------------------------------------RT 195 (350)
T ss_dssp ------------------------------------------------------------------------------CB
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
...+||+.|||||++.+..|+.++|||||||+||||+||++||.+.+....+.++......+|. .+++++.+||.+||
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLL 273 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHS
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHh
Confidence 2347999999999999999999999999999999999999999999888888888887777665 69999999999999
Q ss_pred hcCCCCcc-CCCCChHHhhcCCCCCCCCcchhc--cCCCCCCCCCC
Q 010603 428 VKDPQKRL-GFKRGATEIKQHPFFESVNWALIR--STHPPEIPKPV 470 (506)
Q Consensus 428 ~~dP~~R~-s~~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~~ 470 (506)
..||.+|+ +.++++++||+||||++++|..+. ...+|.+|...
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~ 319 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred hhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCC
Confidence 99999996 445679999999999999998653 33556666543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-64 Score=501.06 Aligned_cols=274 Identities=37% Similarity=0.752 Sum_probs=237.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHH-hcCCCCccceeEEEEeCCeEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-LLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~l 188 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.++. .++|||||++++++++++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 468999999999999999999999999999999998876555555666677777765 6899999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPK 268 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~ 268 (506)
|||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 99999999999999876 67999999999999999999999999999999999999999999999999998532110
Q ss_pred cccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcc
Q 010603 269 LVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSM 348 (506)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (506)
....+
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (320)
T d1xjda_ 157 ---------------------------------------------------------------------------DAKTN 161 (320)
T ss_dssp ---------------------------------------------------------------------------TCCBC
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01122
Q ss_pred ccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 349 SFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 349 ~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .+++++++||.+||+
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSC
T ss_pred ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHhcc
Confidence 347999999999999999999999999999999999999999999988888888877777765 689999999999999
Q ss_pred cCCCCccCCCCCh-HHhhcCCCCCCCCcchhc--cCCCCCCCC
Q 010603 429 KDPQKRLGFKRGA-TEIKQHPFFESVNWALIR--STHPPEIPK 468 (506)
Q Consensus 429 ~dP~~R~s~~~~a-~ell~hp~f~~~~~~~~~--~~~~~~~p~ 468 (506)
.||.+||+ + .++++||||+.++|+.+. ...||..|.
T Consensus 240 ~dP~~R~s----~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~ 278 (320)
T d1xjda_ 240 REPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPK 278 (320)
T ss_dssp SSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC-----
T ss_pred cCCCCCcC----HHHHHHhCchhccCCHHHHHhcCCCCCCCCC
Confidence 99999998 5 489999999999998653 334555554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-64 Score=490.10 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=219.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+++.+|+++|+.++|||||++++++.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 46799999999999999999999999999999999875432 2345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.......
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 158 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc-
Confidence 9999999999998754 6799999999999999999999999999999999999999999999999999964311100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (271)
T d1nvra_ 159 --------------------------------------------------------------------------ERLLNK 164 (271)
T ss_dssp --------------------------------------------------------------------------ECCBCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011234
Q ss_pred cccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHH-HHHhCCCCCCCCCCCCCHHHHHHHHHHh
Q 010603 350 FVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETL-FNVVGQPLKFPEGSSISFAAKDLIRGLL 427 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~-~~i~~~~~~~p~~~~~s~~~~~li~~~L 427 (506)
.+||+.|||||++.+..| +.++|||||||+||||++|++||......... ..+.......+....+++++++||.+||
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHc
Confidence 589999999999998876 67899999999999999999999876554333 3444444444444578999999999999
Q ss_pred hcCCCCccCCCCChHHhhcCCCCCC
Q 010603 428 VKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 428 ~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+.||++||| ++|+|+||||+.
T Consensus 245 ~~dP~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 245 VENPSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp CSSTTTSCC----HHHHTTCTTTTC
T ss_pred CCChhHCcC----HHHHhcCHhhCc
Confidence 999999997 999999999963
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.8e-63 Score=502.07 Aligned_cols=279 Identities=34% Similarity=0.626 Sum_probs=231.4
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHH---HHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRA---QTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~---~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+ ..|+.+++.++|||||+++++|.+++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 467899999999999999999999999999999999987655433333333 34566777889999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999999999876 679999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.
T Consensus 159 ~------------------------------------------------------------------------------- 159 (364)
T d1omwa3 159 K------------------------------------------------------------------------------- 159 (364)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHH---HHHHhCCCCCCCCCCCCCHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRET---LFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+....+. ...+......+| ..++++++
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~ 237 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELR 237 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC--SSSCHHHH
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC--CCCCHHHH
Confidence 01123479999999999975 5689999999999999999999999987654332 222333344444 36999999
Q ss_pred HHHHHHhhcCCCCccCC-CCChHHhhcCCCCCCCCcchhc--cCCCCCCCCC
Q 010603 421 DLIRGLLVKDPQKRLGF-KRGATEIKQHPFFESVNWALIR--STHPPEIPKP 469 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~-~~~a~ell~hp~f~~~~~~~~~--~~~~~~~p~~ 469 (506)
+||.+||+.||.+||++ ...|+|+|+||||++++|..+. ...||.+|..
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~ 289 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 289 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCC
Confidence 99999999999999985 3458999999999999998653 3345555543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-63 Score=490.39 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=224.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
++|++++.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 469999999999999999999999999999999986543 23456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 999999999988763 6999999999999999999999999999999999999999999999999998642110
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (293)
T d1yhwa1 170 -------------------------------------------------------------------------QSKRSTM 176 (293)
T ss_dssp -------------------------------------------------------------------------TCCBCCC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0112234
Q ss_pred ccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHHHhhc
Q 010603 351 VGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG-QPLKFPEGSSISFAAKDLIRGLLVK 429 (506)
Q Consensus 351 ~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~~~s~~~~~li~~~L~~ 429 (506)
+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.. ....++.+..+++++++||.+||..
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 256 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccC
Confidence 799999999999999999999999999999999999999998888777766653 3334444457999999999999999
Q ss_pred CCCCccCCCCChHHhhcCCCCCC
Q 010603 430 DPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 430 dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||.+||| ++|+|+||||+.
T Consensus 257 dP~~R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 257 DVEKRGS----AKELLQHQFLKI 275 (293)
T ss_dssp STTTSCC----HHHHTTCGGGGG
T ss_pred ChhHCcC----HHHHhcCHhhCC
Confidence 9999997 999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-63 Score=496.68 Aligned_cols=263 Identities=25% Similarity=0.433 Sum_probs=220.6
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
++..++|++++.||+|+||+||+|+++.+|+.||||++++... .....++.+|+.+|+.++|||||+++++|.+++++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456789999999999999999999999999999999986532 34456788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
|||||||+||+|.+++.+. +.+++..++.++.||+.||+|||+ +|||||||||+||||+.+|++||+|||+|+....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999999999876 579999999999999999999997 5999999999999999999999999999964210
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.
T Consensus 158 -------------------------------------------------------------------------------~ 158 (322)
T d1s9ja_ 158 -------------------------------------------------------------------------------S 158 (322)
T ss_dssp -------------------------------------------------------------------------------H
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHH-------------------------
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLF------------------------- 400 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~------------------------- 400 (506)
...+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+...
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 1224589999999999999999999999999999999999999997755432211
Q ss_pred -----------------HHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 401 -----------------NVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 401 -----------------~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
.+............++.++++||.+||+.||.+||| |+|+|+||||+..+|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAE 307 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHHS
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCcc
Confidence 011111000111247899999999999999999997 9999999999876654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-62 Score=484.22 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=224.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLM 190 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 190 (506)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+++|+.++|||||++++++.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 35999999999999999999999999999999998653 334456778999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccc
Q 010603 191 EFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLV 270 (506)
Q Consensus 191 E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 270 (506)
|||+||+|.+++... .+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 999999999987654 257999999999999999999999999999999999999999999999999998532100
Q ss_pred cCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccc
Q 010603 271 QSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSF 350 (506)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (506)
.....+.
T Consensus 164 -------------------------------------------------------------------------~~~~~~~ 170 (288)
T d2jfla1 164 -------------------------------------------------------------------------IQRRDSF 170 (288)
T ss_dssp -------------------------------------------------------------------------HHHHTCC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011234
Q ss_pred ccCCCCccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCC-CCCCCCCCCCHHHHHHHH
Q 010603 351 VGTHEYLAPEIIR-----GDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQP-LKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 351 ~GT~~Y~APE~l~-----~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~s~~~~~li~ 424 (506)
+||+.|||||++. +..|+.++|||||||+||||++|++||.+.+..+.+.++.... ..++....+++++++||.
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~ 250 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 7999999999984 4568999999999999999999999999998888888877553 334444578999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+||+.||.+||| ++|+|+||||+.
T Consensus 251 ~~L~~dp~~R~t----~~ell~hp~~~~ 274 (288)
T d2jfla1 251 KCLEKNVDARWT----TSQLLQHPFVTV 274 (288)
T ss_dssp HHSCSSTTTSCC----HHHHTTSGGGCC
T ss_pred HHccCChhHCcC----HHHHhcCcccCC
Confidence 999999999997 999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-62 Score=482.25 Aligned_cols=264 Identities=30% Similarity=0.473 Sum_probs=229.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch---hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR---KKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSC 187 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 187 (506)
++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+++|+.++|||||+++++|++++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999987644322 23567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC----CEEEeecCCcccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG----HIMLSDFDLSLRC 263 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~----~vkl~DFGla~~~ 263 (506)
||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999998876 5799999999999999999999999999999999999999877 5999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (293)
T d1jksa_ 168 DFG----------------------------------------------------------------------------- 170 (293)
T ss_dssp TTS-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKD 421 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~ 421 (506)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......++. ...++.++++
T Consensus 171 -~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (293)
T d1jksa_ 171 -NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249 (293)
T ss_dssp -CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred -ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence 0112347999999999999999999999999999999999999999999999888888877666543 2468999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcchh
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWALI 458 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~~ 458 (506)
||.+||+.||.+||| ++|+|+||||+..+|...
T Consensus 250 li~~~L~~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 250 FIRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHHTTSCSSGGGSCC----HHHHHHSTTTCC------
T ss_pred HHHHHccCChhHCcC----HHHHhcCcccCCCChhHh
Confidence 999999999999997 999999999999888653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-62 Score=492.37 Aligned_cols=263 Identities=32% Similarity=0.449 Sum_probs=231.8
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 188 (506)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.|+|||||+++++|++++.+||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46789999999999999999999999999999999987542 334567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec--CCCEEEeecCCccccccC
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE--DGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~--~~~vkl~DFGla~~~~~~ 266 (506)
|||||+||+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+. +|.+||+|||+|+.+...
T Consensus 101 vmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999999988654 357999999999999999999999999999999999999964 578999999998542110
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..
T Consensus 180 ------------------------------------------------------------------------------~~ 181 (350)
T d1koaa2 180 ------------------------------------------------------------------------------QS 181 (350)
T ss_dssp ------------------------------------------------------------------------------SC
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC--CCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~s~~~~~li~ 424 (506)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......++.. ..+++++++||.
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 223579999999999999999999999999999999999999999999888888888766555432 468999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCCCCcch
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFESVNWAL 457 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~~ 457 (506)
+||+.||.+||| ++|+|+||||+..+|..
T Consensus 262 ~~L~~dP~~R~t----~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 262 KLLLADPNTRMT----IHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHCCSSGGGSCC----HHHHHHSTTTSCTTCCS
T ss_pred HHccCChhHCcC----HHHHhcCcccCCCCCCC
Confidence 999999999997 99999999999887653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-62 Score=485.70 Aligned_cols=257 Identities=33% Similarity=0.499 Sum_probs=214.7
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999998765432 234577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe---cCCCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR---EDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~---~~~~vkl~DFGla~~~~~~ 266 (506)
||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||+. .++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 9999999999999765 6799999999999999999999999999999999999995 478999999999853210
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
...
T Consensus 163 -----------------------------------------------------------------------------~~~ 165 (307)
T d1a06a_ 163 -----------------------------------------------------------------------------GSV 165 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------CCe
Confidence 001
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~li~ 424 (506)
..+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+....+....+......++ ....+++++++||.
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 245 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHH
Confidence 2235799999999999999999999999999999999999999999988888888887765554 33579999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+||+.||.+||| ++|+|+||||+.
T Consensus 246 ~~L~~dP~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 246 HLMEKDPEKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp HHSCSSGGGSCC----HHHHHHSTTTTS
T ss_pred HHccCCHhHCcC----HHHHhcCHhhCC
Confidence 999999999997 999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-62 Score=485.03 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=226.9
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLME 191 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 191 (506)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||++++++.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 39999999999999999999999999999999988766556667788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcccc
Q 010603 192 FCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQ 271 (506)
Q Consensus 192 ~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 271 (506)
||.+|+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-------
Confidence 99999998776654 679999999999999999999999999999999999999999999999999984310
Q ss_pred CCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccc
Q 010603 272 SSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFV 351 (506)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (506)
.....+
T Consensus 167 --------------------------------------------------------------------------~~~~~~ 172 (309)
T d1u5ra_ 167 --------------------------------------------------------------------------PANSFV 172 (309)
T ss_dssp --------------------------------------------------------------------------SBCCCC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 011247
Q ss_pred cCCCCccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 352 GTHEYLAPEIIRG---DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 352 GT~~Y~APE~l~~---~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..+.......+....+++++++||.+||+
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 252 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTC
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCc
Confidence 9999999999974 3589999999999999999999999999888888888776655444455789999999999999
Q ss_pred cCCCCccCCCCChHHhhcCCCCCC
Q 010603 429 KDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.||.+||| ++|+|+||||..
T Consensus 253 ~dP~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 253 KIPQDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp SSGGGSCC----HHHHTTCHHHHS
T ss_pred CChhHCcC----HHHHHhCHHhcC
Confidence 99999997 999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-62 Score=476.87 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=214.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe--CCeEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET--DKFSCL 188 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 188 (506)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|+.++|||||++++++.+ .+.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 5699999999999999999999999999999999876543 3445678899999999999999999999864 567899
Q ss_pred EEeecCCCChHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 189 LMEFCSGGDLHTLRQRQ--PGKHFSEQATRFYASEVLLALEYLHMMG-----VVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~--~~~~~~e~~~~~i~~qil~aL~yLH~~g-----iiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
|||||+||+|.+++... .+..+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988642 2467999999999999999999999976 9999999999999999999999999986
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.+...
T Consensus 163 ~~~~~--------------------------------------------------------------------------- 167 (269)
T d2java1 163 ILNHD--------------------------------------------------------------------------- 167 (269)
T ss_dssp HC------------------------------------------------------------------------------
T ss_pred ecccC---------------------------------------------------------------------------
Confidence 42110
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
.......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+.+.++....... .+..+++++++
T Consensus 168 --~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~ 244 (269)
T d2java1 168 --TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-IPYRYSDELNE 244 (269)
T ss_dssp ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-CCTTSCHHHHH
T ss_pred --CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCcccCHHHHH
Confidence 001223579999999999999999999999999999999999999999988888887777654432 22379999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
||.+||+.||.+||+ ++|+|+|||+
T Consensus 245 li~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 245 IITRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred HHHHHcCCChhHCcC----HHHHHhCCcC
Confidence 999999999999997 9999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-61 Score=486.90 Aligned_cols=258 Identities=31% Similarity=0.460 Sum_probs=228.4
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+|+++|+.|+|||||+++++|++++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999987542 2345677899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEe--cCCCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVR--EDGHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~--~~~~vkl~DFGla~~~~~~~ 267 (506)
||||+||+|.+++... +..+++..++.|+.||+.||+|||++|||||||||+||||+ .+|.+||+|||+|+.+...
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999999999876654 35799999999999999999999999999999999999998 5789999999999642110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 183 -----------------------------------------------------------------------------~~~ 185 (352)
T d1koba_ 183 -----------------------------------------------------------------------------EIV 185 (352)
T ss_dssp -----------------------------------------------------------------------------SCE
T ss_pred -----------------------------------------------------------------------------Cce
Confidence 012
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~s~~~~~li~~ 425 (506)
....||+.|||||++.+..|+.++|||||||+||||+||++||.+.+..+.+.++......++. ...+++++++||.+
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 265 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 2347999999999999999999999999999999999999999999998888888877665553 24799999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
||+.||.+||| ++|+|+||||+..
T Consensus 266 ~L~~dp~~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 266 LLQKEPRKRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp TSCSSGGGSCC----HHHHHTSTTTSSC
T ss_pred HccCChhHCcC----HHHHhcCHhhCCC
Confidence 99999999997 9999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-61 Score=468.26 Aligned_cols=252 Identities=22% Similarity=0.392 Sum_probs=214.5
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe----CCeEEE
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET----DKFSCL 188 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~l 188 (506)
|++.++||+|+||+||+|+++.+++.||+|++.+.... ....+.+.+|+++|+.++|||||+++++|++ ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 47888999999999999999999999999999876443 3445678899999999999999999999975 457899
Q ss_pred EEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEccCCCCcEEEe-cCCCEEEeecCCcccccc
Q 010603 189 LMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMG--VVYRDLKPENVLVR-EDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 189 V~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~g--iiHrDLKp~NILl~-~~~~vkl~DFGla~~~~~ 265 (506)
|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence 99999999999999875 57999999999999999999999999 99999999999997 47899999999984210
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
..
T Consensus 167 ------------------------------------------------------------------------------~~ 168 (270)
T d1t4ha_ 167 ------------------------------------------------------------------------------AS 168 (270)
T ss_dssp ------------------------------------------------------------------------------TT
T ss_pred ------------------------------------------------------------------------------CC
Confidence 01
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHH-hCCCCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV-VGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i-~~~~~~~p~~~~~s~~~~~li~ 424 (506)
.....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+......+.+. ............+++++++||.
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence 1234589999999999875 5999999999999999999999999877666555444 4332222223468899999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
+||..||++||| ++|+|+||||+
T Consensus 248 ~~l~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 248 GCIRQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp HHSCSSGGGSCC----HHHHHTSGGGC
T ss_pred HHccCCHhHCcC----HHHHhCCcccC
Confidence 999999999997 99999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-59 Score=461.06 Aligned_cols=259 Identities=31% Similarity=0.444 Sum_probs=226.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc------hhHHHHHHHHHHHHHhcC-CCCccceeEEEEe
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG------RKKLMRAQTEREILSLLD-HPFLPTLYSHFET 182 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 182 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... +.....+.+|+.+|+.++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367999999999999999999999999999999998754322 223346788999999997 9999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
++++|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999876 5799999999999999999999999999999999999999999999999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
....
T Consensus 160 ~~~~---------------------------------------------------------------------------- 163 (277)
T d1phka_ 160 LDPG---------------------------------------------------------------------------- 163 (277)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred CCCCccccccCCCCccchhhcC------CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--CCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRG------DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--GSS 414 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~------~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~ 414 (506)
......+||+.|+|||++.+ ..|+.++||||+||+||||++|+.||.+.+..+.+..+......++. ...
T Consensus 164 --~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (277)
T d1phka_ 164 --EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241 (277)
T ss_dssp --CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred --CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 01123479999999999963 34788999999999999999999999999888888888876655443 347
Q ss_pred CCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 415 ISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 415 ~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
+|+++++||.+||+.||.+||+ ++|||+||||+.
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~ 275 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQ 275 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCT
T ss_pred CCHHHHHHHHHHccCChhHCcC----HHHHHcCHHHHH
Confidence 9999999999999999999997 999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-60 Score=471.97 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=226.6
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998753 2234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC--CCEEEeecCCccccccCC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED--GHIMLSDFDLSLRCFVSP 267 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~--~~vkl~DFGla~~~~~~~ 267 (506)
||||.||+|.+++... +..+++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999998765 2479999999999999999999999999999999999999854 48999999998542110
Q ss_pred ccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCc
Q 010603 268 KLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARS 347 (506)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (506)
...
T Consensus 158 -----------------------------------------------------------------------------~~~ 160 (321)
T d1tkia_ 158 -----------------------------------------------------------------------------DNF 160 (321)
T ss_dssp -----------------------------------------------------------------------------CEE
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 011
Q ss_pred cccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCC--CCCCHHHHHHHHH
Q 010603 348 MSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEG--SSISFAAKDLIRG 425 (506)
Q Consensus 348 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~s~~~~~li~~ 425 (506)
...+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+.+.++......++.. ..+++++++||.+
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 240 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence 23479999999999999999999999999999999999999999999988888888777666532 3689999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
||..||.+||| ++|+|+||||+.
T Consensus 241 ~L~~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 241 LLVKERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp TSCSSGGGSCC----HHHHHHSHHHHS
T ss_pred HccCChhHCcC----HHHHhcCHhhcc
Confidence 99999999997 999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-59 Score=467.12 Aligned_cols=257 Identities=28% Similarity=0.385 Sum_probs=210.9
Q ss_pred EEeEEeecCceEEEEEEEccCCceEEEEEeccchhhch--hHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEee
Q 010603 115 LLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGR--KKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEF 192 (506)
Q Consensus 115 i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 192 (506)
.+++||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|+.++|||||+++++|.+++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 57899999999999999999999999999976543221 1234678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccC
Q 010603 193 CSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQS 272 (506)
Q Consensus 193 ~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 272 (506)
|.++++..++.. ...+++..++.+++||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC------
Confidence 988887766543 367999999999999999999999999999999999999999999999999998532110
Q ss_pred CCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCcccccc
Q 010603 273 SDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVG 352 (506)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 352 (506)
.......+|
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~g 162 (299)
T d1ua2a_ 154 -----------------------------------------------------------------------NRAYTHQVV 162 (299)
T ss_dssp -----------------------------------------------------------------------CCCCCCSCC
T ss_pred -----------------------------------------------------------------------cccccceec
Confidence 001123479
Q ss_pred CCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC--CC---------------CC
Q 010603 353 THEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL--KF---------------PE 411 (506)
Q Consensus 353 T~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~--~~---------------p~ 411 (506)
|+.|||||++.+. .|+.++|||||||+||||++|.+||.+.+..+++.++.. .+. .+ +.
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ua2a_ 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242 (299)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred ChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCC
Confidence 9999999998755 589999999999999999999999999988887766542 110 00 00
Q ss_pred ------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 412 ------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 412 ------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
...+++++++||.+||+.||++||| |+|+|+||||++..
T Consensus 243 ~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRP 287 (299)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSS
T ss_pred CChHHhcccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCCC
Confidence 1246889999999999999999997 99999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=459.47 Aligned_cols=262 Identities=30% Similarity=0.452 Sum_probs=216.7
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|++++.||+|+||+||+|+++.+|+.||||++++.... .....++.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 46899999999999999999999999999999999765432 23346778899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||. |.+..++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--- 155 (298)
T d1gz8a_ 80 FEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--- 155 (298)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred EeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---
Confidence 99995 45555555555578999999999999999999999999999999999999999999999999998542110
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (298)
T d1gz8a_ 156 --------------------------------------------------------------------------VRTYTH 161 (298)
T ss_dssp --------------------------------------------------------------------------SBCTTC
T ss_pred --------------------------------------------------------------------------ccccee
Confidence 011223
Q ss_pred cccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC---------------CCC
Q 010603 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL---------------KFP 410 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~---------------~~p 410 (506)
.+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+.++.. .+. .++
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 47999999999988776 48899999999999999999999999888777766542 110 000
Q ss_pred C---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 411 E---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 411 ~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
. ...++.++++||.+||+.||.+||| |+|||+||||++++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDVT 290 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTCC
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccCC
Confidence 0 1256889999999999999999997 99999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=465.09 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=212.6
Q ss_pred cccCCeEEEe-EEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHH-hcCCCCccceeEEEEe---
Q 010603 108 LGLGHFRLLK-KLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILS-LLDHPFLPTLYSHFET--- 182 (506)
Q Consensus 108 ~~~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~--- 182 (506)
..+++|++++ .||+|+||+||+|+++.+|+.||||++++. ..+.+|++++. .++|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3467899986 599999999999999999999999999653 23567998865 5589999999999976
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CCCEEEeecC
Q 010603 183 -DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DGHIMLSDFD 258 (506)
Q Consensus 183 -~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFG 258 (506)
..++|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+|||++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 467999999999999999998776678999999999999999999999999999999999999986 5679999999
Q ss_pred CccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccc
Q 010603 259 LSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVL 338 (506)
Q Consensus 259 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (506)
+|+.....
T Consensus 160 ~a~~~~~~------------------------------------------------------------------------ 167 (335)
T d2ozaa1 160 FAKETTSH------------------------------------------------------------------------ 167 (335)
T ss_dssp TCEECCCC------------------------------------------------------------------------
T ss_pred eeeeccCC------------------------------------------------------------------------
Confidence 98542110
Q ss_pred ccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHH----hCCCCCCCCC--
Q 010603 339 IAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV----VGQPLKFPEG-- 412 (506)
Q Consensus 339 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~~~p~~-- 412 (506)
......+||+.|||||++.+..|+.++|||||||+||+|+||++||.+.+..+....+ ......+|..
T Consensus 168 ------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 168 ------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp ------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred ------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 0112347999999999999999999999999999999999999999877655444333 2333444432
Q ss_pred CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 413 SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 413 ~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
..+++++++||.+||+.||++||+ +.|+|+||||..
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 358999999999999999999997 999999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=452.63 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=213.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchh---HHHHHHHHHHHHHhcC--CCCccceeEEEEeCCe
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRK---KLMRAQTEREILSLLD--HPFLPTLYSHFETDKF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~ 185 (506)
++|++.+.||+|+||+||+|+++.+|+.||||++++....... ...++.+|+.+|+.++ |||||+++++|++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999999999999999999876543221 1233567999999986 8999999999999999
Q ss_pred EEEEEeecCC-CChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecC-CCEEEeecCCcccc
Q 010603 186 SCLLMEFCSG-GDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRED-GHIMLSDFDLSLRC 263 (506)
Q Consensus 186 ~~lV~E~~~g-g~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~-~~vkl~DFGla~~~ 263 (506)
+|+||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 6788887765 679999999999999999999999999999999999999954 79999999998532
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 162 ~~------------------------------------------------------------------------------ 163 (273)
T d1xwsa_ 162 KD------------------------------------------------------------------------------ 163 (273)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCCccccccCCCCccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGH-GSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
...++.+||+.|||||++.+..| +.++|||||||+||||++|+.||.+.. .+......++. .+++++++|
T Consensus 164 -~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~--~~s~~~~~l 234 (273)
T d1xwsa_ 164 -TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ--RVSSECQHL 234 (273)
T ss_dssp -SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS--CCCHHHHHH
T ss_pred -ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCC--CCCHHHHHH
Confidence 01223479999999999987765 678999999999999999999997532 23445555554 699999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
|.+||..||++||| ++|+|+||||+++.
T Consensus 235 i~~~L~~dp~~R~s----~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 235 IRWCLALRPSDRPT----FEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHTCSSGGGSCC----HHHHHTSGGGSSCC
T ss_pred HHHHccCCHhHCcC----HHHHhcCHhhCCCC
Confidence 99999999999997 99999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-58 Score=453.46 Aligned_cols=258 Identities=19% Similarity=0.272 Sum_probs=221.0
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
.+++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+++.+|+++|+.++|||||++++++.+++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 35566778999999999999999999999999999999997653 33456789999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999999988777889999999999999999999999999999999999999999999999999985421
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
....
T Consensus 167 ~~~~---------------------------------------------------------------------------- 170 (287)
T d1opja_ 167 GDTY---------------------------------------------------------------------------- 170 (287)
T ss_dssp SSSS----------------------------------------------------------------------------
T ss_pred CCCc----------------------------------------------------------------------------
Confidence 1000
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
.......||+.|||||++.+..|+.++|||||||+||||++|..||........+.+++......+....+++++++||.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence 00112358999999999999999999999999999999999777665555555555555455555555679999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhc
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+||+.||++||| ++|+++
T Consensus 251 ~cl~~dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 251 ACWQWNPSDRPS----FAEIHQ 268 (287)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHH
Confidence 999999999998 788865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-57 Score=447.58 Aligned_cols=260 Identities=23% Similarity=0.410 Sum_probs=216.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC----eE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----FS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~ 186 (506)
++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+++|+.++|||||++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56999999999999999999999999999999998876666666778899999999999999999999998654 48
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
|||||||+||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999988776 67999999999999999999999999999999999999999999999999987532111
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ....
T Consensus 165 ~~--------------------------------------------------------------------------~~~~ 170 (277)
T d1o6ya_ 165 GN--------------------------------------------------------------------------SVTQ 170 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc--------------------------------------------------------------------------cccc
Confidence 00 0111
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC--CCCCCCHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP--EGSSISFAAKDLIR 424 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~~~s~~~~~li~ 424 (506)
....+||+.|||||++.+..|+.++|||||||+||||+||++||.+.+..+.+.+++......+ ....+++++.+||.
T Consensus 171 ~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 250 (277)
T d1o6ya_ 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250 (277)
T ss_dssp --------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHH
Confidence 2345899999999999999999999999999999999999999999988888877776544332 23579999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+||++||.+||+ +|++++ |+|+
T Consensus 251 ~~L~~dp~~R~~---sa~~l~-~~l~ 272 (277)
T d1o6ya_ 251 KALAKNPENRYQ---TAAEMR-ADLV 272 (277)
T ss_dssp HHTCSSGGGSCS---SHHHHH-HHHH
T ss_pred HHccCCHhHCHh---HHHHHH-HHHH
Confidence 999999999995 255554 5554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-57 Score=454.89 Aligned_cols=261 Identities=19% Similarity=0.276 Sum_probs=219.4
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCc-----eEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGC-----LFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 179 (506)
+++..++|++++.||+|+||+||+|+++.+++ .||+|++.+... ......+.+|+.+|+.+ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 34566789999999999999999999876554 699999876432 23345678899999988 89999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEcc
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQPG---------------------KHFSEQATRFYASEVLLALEYLHMMGVVYRD 238 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------~~~~e~~~~~i~~qil~aL~yLH~~giiHrD 238 (506)
+.+.+.+|||||||++|+|.++++.... ..+++..++.|+.||+.||+|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9999999999999999999999876432 3589999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccc
Q 010603 239 LKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318 (506)
Q Consensus 239 LKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (506)
|||+|||++.++++||+|||+|+.......
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~-------------------------------------------------- 219 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------------------------------- 219 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------------------------------------------
T ss_pred CchhccccccCCeEEEeeccccccccCCCc--------------------------------------------------
Confidence 999999999999999999999954221100
Q ss_pred ccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHH
Q 010603 319 TTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRE 397 (506)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~ 397 (506)
........||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+
T Consensus 220 -------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 220 -------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp -------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred -------------------------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 001123468999999999999999999999999999999997 899999888777
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 398 ~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
.+.+++.....++.+..+++++++||.+||+.||++||| ++||++|
T Consensus 275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 777777676666666689999999999999999999998 8898875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=450.05 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=213.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccC-CceEEEEEeccchhhchhHHHHHHHHHHHHHhc---CCCCccceeEEEEe---
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDM-GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL---DHPFLPTLYSHFET--- 182 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~--- 182 (506)
.++|+++++||+|+||+||+|++..+ ++.||||++++..... .....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 35799999999999999999999765 6779999997654322 1222345677776665 89999999999853
Q ss_pred --CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCc
Q 010603 183 --DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLS 260 (506)
Q Consensus 183 --~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla 260 (506)
..++|++||||.++.+.... ......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 35789999999887765443 344578999999999999999999999999999999999999999999999999997
Q ss_pred cccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCccccc
Q 010603 261 LRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIA 340 (506)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (506)
+.....
T Consensus 164 ~~~~~~-------------------------------------------------------------------------- 169 (305)
T d1blxa_ 164 RIYSFQ-------------------------------------------------------------------------- 169 (305)
T ss_dssp CCCCGG--------------------------------------------------------------------------
T ss_pred hhhccc--------------------------------------------------------------------------
Confidence 431100
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC--CCC-----
Q 010603 341 EPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL--KFP----- 410 (506)
Q Consensus 341 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~--~~p----- 410 (506)
......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+++. .+. .++
T Consensus 170 ----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 170 ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp ----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred ----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 011234799999999999999999999999999999999999999999888877766542 110 000
Q ss_pred ---------------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 411 ---------------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 411 ---------------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
....+++.+++||.+||+.||++||| |+|+|+||||+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLER 301 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchh
Confidence 11357899999999999999999997 999999999998764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=456.27 Aligned_cols=273 Identities=41% Similarity=0.797 Sum_probs=227.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEE---ccCCceEEEEEeccchhh-chhHHHHHHHHHHHHHhcCC-CCccceeEEEEe
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAEL---RDMGCLFAMKVMDKGMLA-GRKKLMRAQTEREILSLLDH-PFLPTLYSHFET 182 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~---~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~ 182 (506)
+.+++|++++.||+|+||+||+|++ +.+|+.||||++++.... .......+.+|+++|++++| |||+++++++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 5678899999999999999999997 447899999999875432 22334556789999999976 899999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
...+|+||||+.+|+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999998876 5789999999999999999999999999999999999999999999999999864
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
+....
T Consensus 179 ~~~~~--------------------------------------------------------------------------- 183 (322)
T d1vzoa_ 179 FVADE--------------------------------------------------------------------------- 183 (322)
T ss_dssp CCGGG---------------------------------------------------------------------------
T ss_pred hcccc---------------------------------------------------------------------------
Confidence 31110
Q ss_pred CCCCccccccCCCCccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHH----hCCCCCCCCCCCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDG--HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNV----VGQPLKFPEGSSIS 416 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~--~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~~~p~~~~~s 416 (506)
........||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+..+....+ ......+|. .++
T Consensus 184 -~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~~s 260 (322)
T d1vzoa_ 184 -TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMS 260 (322)
T ss_dssp -GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TSC
T ss_pred -cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--cCC
Confidence 00122347999999999998654 688999999999999999999999876554433333 233344443 699
Q ss_pred HHHHHHHHHHhhcCCCCccCCC-CChHHhhcCCCCCCCCcchhcc
Q 010603 417 FAAKDLIRGLLVKDPQKRLGFK-RGATEIKQHPFFESVNWALIRS 460 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~~-~~a~ell~hp~f~~~~~~~~~~ 460 (506)
+++++||.+||++||.+||++. .+|+|+|+||||+.++|..+..
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~ 305 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 305 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh
Confidence 9999999999999999999864 3699999999999999986644
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-57 Score=442.74 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=216.2
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
++++..++|++++.||+|+||+||+|+++ +++.||||++++.. ...+.+.+|+++|+.++|||||++++++. ++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cC
Confidence 45566788999999999999999999986 47889999997653 23356789999999999999999999875 45
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||++|+|.+++.......+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67999999999999998766544579999999999999999999999999999999999999999999999999996431
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
....
T Consensus 161 ~~~~---------------------------------------------------------------------------- 164 (272)
T d1qpca_ 161 DNEY---------------------------------------------------------------------------- 164 (272)
T ss_dssp SSCE----------------------------------------------------------------------------
T ss_pred CCcc----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLG-RTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
.......||+.|||||++.+..|+.++|||||||+||||+|| .+||...+..+.+..+... ...+.+..+++++.+||
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLM 243 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCcccChHHHHHHH
Confidence 001223699999999999999999999999999999999995 5556666666666665543 34444457999999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc--CCCCC
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ--HPFFE 451 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~--hp~f~ 451 (506)
.+||+.||++||| ++++++ |+||.
T Consensus 244 ~~cl~~~P~~Rpt----~~ei~~~L~~~ft 269 (272)
T d1qpca_ 244 RLCWKERPEDRPT----FDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTCSSGGGSCC----HHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcC----HHHHHHHhhhhhh
Confidence 9999999999998 888887 67774
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=443.68 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=211.8
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK 184 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 184 (506)
++++..++|++++.||+|+||+||+|+.+ ..||||+++..... ....+.+.+|+++|+.++|||||++++++. .+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 45677788999999999999999999765 35999999765433 345677889999999999999999999865 45
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 689999999999999998764 3579999999999999999999999999999999999999999999999999985321
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
... ..
T Consensus 156 ~~~---------------------------------------------------------------------------~~ 160 (276)
T d1uwha_ 156 RWS---------------------------------------------------------------------------GS 160 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccC---------------------------------------------------------------------------Cc
Confidence 100 00
Q ss_pred CCccccccCCCCccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCC----CCCCCCH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGD---GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFP----EGSSISF 417 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~---~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~s~ 417 (506)
......+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++......| ....+++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 112345799999999999753 589999999999999999999999998877766655543332222 2346899
Q ss_pred HHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 418 AAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 418 ~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
++.+||.+||..||.+||| ++|+++|
T Consensus 241 ~l~~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999999998 8888875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-56 Score=441.74 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=214.8
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|+++++||+|+||+||+|+++ +|+.||||++++.... .....++.+|+.+|+.++|||||+++++|..++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 468999999999999999999986 6899999999775432 33456788899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.++.|..+.... +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC---
Confidence 9999887777765544 78999999999999999999999999999999999999999999999999998542110
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (286)
T d1ob3a_ 154 --------------------------------------------------------------------------VRKYTH 159 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------ccccce
Confidence 001123
Q ss_pred cccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CCC--------C-------C-
Q 010603 350 FVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QPL--------K-------F- 409 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~~--------~-------~- 409 (506)
.+||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+..+.+.++.. .+. . +
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 3699999999999865 469999999999999999999999998887777665532 110 0 0
Q ss_pred --------CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 410 --------PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 410 --------p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
.....++++++|||++||+.||++||| |+|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 011357899999999999999999997 999999999973
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-56 Score=442.87 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=211.2
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEccCCc---eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGC---LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE 181 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 181 (506)
..++..++|++.+.||+|+||+||+|+++.+++ .||||.+..... ....+.+.+|+++|+.++|||||++++++.
T Consensus 20 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp SCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 345677889999999999999999999987665 588998875432 344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 182 TDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 182 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.++.+|||||||++|+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 999999999999999999988764 3579999999999999999999999999999999999999999999999999996
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
.+......
T Consensus 177 ~~~~~~~~------------------------------------------------------------------------ 184 (299)
T d1jpaa_ 177 FLEDDTSD------------------------------------------------------------------------ 184 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred EccCCCCc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred CCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHH
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAK 420 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~ 420 (506)
..........||+.|||||++.+..|+.++|||||||+||||+| |++||.+.+..+.+..+... ...+....++.++.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~ 263 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLPPPMDCPSALH 263 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCCHHHH
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHH
Confidence 00001122368999999999999999999999999999999998 89999998888777776643 34445557999999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+||.+||+.||.+||+ +.|++++
T Consensus 264 ~li~~cl~~~P~~RPs----~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPK----FGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999998 6777653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=451.20 Aligned_cols=257 Identities=30% Similarity=0.438 Sum_probs=211.3
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK----- 184 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 184 (506)
.++|+++++||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4679999999999999999999999999999999986533 3455677889999999999999999999998665
Q ss_pred -eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 185 -FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 185 -~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
++||||||| +++|..+++. ..+++..++.+++||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7788887765 47999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
..
T Consensus 172 ~~------------------------------------------------------------------------------ 173 (346)
T d1cm8a_ 172 DS------------------------------------------------------------------------------ 173 (346)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC-------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP------------- 406 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~------------- 406 (506)
..+..+||+.|||||++.+. .++.++|||||||+||||++|++||.+.+..+.+..+.. ..
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred --ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 01234799999999999875 468999999999999999999999998877665544321 10
Q ss_pred -------CCCC------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 407 -------LKFP------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 407 -------~~~p------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
.... ....+++++++||.+||..||.+||| |+|||+||||+.+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC-
T ss_pred hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCC
Confidence 0000 11357899999999999999999997 999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-56 Score=432.52 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=206.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|++++.||+|+||+||+|+++. ++.||||++++... ..+.+.+|+++|+.++|||||++++++..++.+|||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3579999999999999999999874 67899999986532 234678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||++|+|.+++... ...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+......
T Consensus 79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-- 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-- 155 (263)
T ss_dssp EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC--
Confidence 9999999999988764 3578999999999999999999999999999999999999999999999999985421100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (263)
T d1sm2a_ 156 --------------------------------------------------------------------------YTSSTG 161 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------ceeecc
Confidence 001122
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..||+.|||||++.+..|+.++|||||||+||||+| |.+||...+..+.+..+... ...+.+..+++++.+||.+||+
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHHHHHHcc
Confidence 469999999999999999999999999999999999 57777777766666666543 2333334789999999999999
Q ss_pred cCCCCccCCCCChHHhhcC
Q 010603 429 KDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~h 447 (506)
.||++||+ ++|+++|
T Consensus 241 ~~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 241 ERPEDRPA----FSRLLRQ 255 (263)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CCHhHCcC----HHHHHHH
Confidence 99999998 8898875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=437.07 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=208.0
Q ss_pred eEEeecCceEEEEEEEcc--CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEEEeecC
Q 010603 117 KKLGCGDIGSVYLAELRD--MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 117 ~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
++||+|+||+||+|.++. +++.||||+++.... .....+++.+|+++|+.++|||||+++++++++ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 579999999999998753 467899999976543 234456789999999999999999999999754 5789999999
Q ss_pred CCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCccccCCC
Q 010603 195 GGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSD 274 (506)
Q Consensus 195 gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 274 (506)
+|+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~---- 164 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---- 164 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE----
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc----
Confidence 99999998875 679999999999999999999999999999999999999999999999999996432111000
Q ss_pred CcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccccccCC
Q 010603 275 DPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTH 354 (506)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 354 (506)
.......||+
T Consensus 165 ----------------------------------------------------------------------~~~~~~~gt~ 174 (277)
T d1xbba_ 165 ----------------------------------------------------------------------KAQTHGKWPV 174 (277)
T ss_dssp ----------------------------------------------------------------------EC----CCCG
T ss_pred ----------------------------------------------------------------------ccccccCCCc
Confidence 0012236999
Q ss_pred CCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCC
Q 010603 355 EYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQK 433 (506)
Q Consensus 355 ~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~ 433 (506)
.|||||++.+..|+.++|||||||+||||++ |++||.+.+..+....+..+. ..+.+..+++++.+||.+||+.||++
T Consensus 175 ~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dp~~ 253 (277)
T d1xbba_ 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVEN 253 (277)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred eecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcccCHHHHHHHHHHcCCCHhH
Confidence 9999999999999999999999999999997 899999988877766665432 33333479999999999999999999
Q ss_pred ccCCCCChHHh---hcCCCCCCC
Q 010603 434 RLGFKRGATEI---KQHPFFESV 453 (506)
Q Consensus 434 R~s~~~~a~el---l~hp~f~~~ 453 (506)
||+ ++++ |+|+|++.+
T Consensus 254 RPs----~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 254 RPG----FAAVELRLRNYYYDVV 272 (277)
T ss_dssp SCC----HHHHHHHHHHHHHHHH
T ss_pred CcC----HHHHHHHhhCHHhhcC
Confidence 998 5565 677776543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=442.58 Aligned_cols=263 Identities=27% Similarity=0.336 Sum_probs=210.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-------
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------- 182 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------- 182 (506)
+++|+++++||+|+||+||+|+++.+|+.||||++.+.... .....++.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 57899999999999999999999999999999999775433 3345667889999999999999999999855
Q ss_pred -CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 183 -DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 183 -~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.+++|+|||||.++.+..+... ...+++..++.+++||+.||+|||++|||||||||+||||+.++.+||+|||+++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4568999999977766644333 3689999999999999999999999999999999999999999999999999985
Q ss_pred ccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccC
Q 010603 262 RCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAE 341 (506)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (506)
........
T Consensus 166 ~~~~~~~~------------------------------------------------------------------------ 173 (318)
T d3blha1 166 AFSLAKNS------------------------------------------------------------------------ 173 (318)
T ss_dssp ECCC----------------------------------------------------------------------------
T ss_pred eccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred CCCCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCCCCCC--C------
Q 010603 342 PTSARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPLKFPE--G------ 412 (506)
Q Consensus 342 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~------ 412 (506)
........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+......++. .
T Consensus 174 -~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 252 (318)
T d3blha1 174 -QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252 (318)
T ss_dssp --CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC
T ss_pred -ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchh
Confidence 00011234799999999999876 6899999999999999999999999988877666554321111000 0
Q ss_pred ----------------------CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCC
Q 010603 413 ----------------------SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFES 452 (506)
Q Consensus 413 ----------------------~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~ 452 (506)
...+++++|||.+||+.||++||| |+|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~ 310 (318)
T d3blha1 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWS 310 (318)
T ss_dssp -------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSS
T ss_pred hhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhcc
Confidence 013678899999999999999997 999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=446.96 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=208.3
Q ss_pred CeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe------CCe
Q 010603 112 HFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------DKF 185 (506)
Q Consensus 112 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~ 185 (506)
+|+.+++||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 49999999999999999999999999999999976531 12369999999999999999999854 336
Q ss_pred EEEEEeecCCCChHHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCcccc
Q 010603 186 SCLLMEFCSGGDLHTLRQR-QPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRC 263 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~-~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~ 263 (506)
+|||||||+++.+..+... .....+++..++.|++||+.||+|||++|||||||||+||||+.++ .+||+|||+|..+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999976654444322 3346799999999999999999999999999999999999999875 8999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
...
T Consensus 174 ~~~----------------------------------------------------------------------------- 176 (350)
T d1q5ka_ 174 VRG----------------------------------------------------------------------------- 176 (350)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CCCccccccCCCCccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC-------------
Q 010603 344 SARSMSFVGTHEYLAPEIIRGD-GHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP------------- 406 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~------------- 406 (506)
....+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||...+..+.+..+.. .+
T Consensus 177 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 177 -EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp -SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred -cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 011234799999999998764 689999999999999999999999998887777665531 10
Q ss_pred -CCCC----------CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCC
Q 010603 407 -LKFP----------EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVN 454 (506)
Q Consensus 407 -~~~p----------~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~ 454 (506)
..++ ....+++++.+||.+||..||++||| |.|+|+||||+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGG
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhcccc
Confidence 1111 11357899999999999999999997 99999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=433.75 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=215.7
Q ss_pred ccCCeEEEeE-EeecCceEEEEEEEccC--CceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 109 GLGHFRLLKK-LGCGDIGSVYLAELRDM--GCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 109 ~~~~y~i~~~-LG~G~fG~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..++|.+.+. ||+|+||+||+|.++.+ +..||||++++.. .....+++.+|+++|+.++|||||++++++.+ +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 3456888885 99999999999987643 4579999997653 23456678899999999999999999999975 45
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+|||||||++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 89999999999999987654 35799999999999999999999999999999999999999999999999999965321
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.... ..
T Consensus 162 ~~~~--------------------------------------------------------------------------~~ 167 (285)
T d1u59a_ 162 DDSY--------------------------------------------------------------------------YT 167 (285)
T ss_dssp CSCE--------------------------------------------------------------------------EC
T ss_pred cccc--------------------------------------------------------------------------cc
Confidence 1100 00
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+. ..+.+..+++++.+||.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~ 246 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYALMS 246 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCcCCHHHHHHHH
Confidence 0112368999999999999999999999999999999998 999999988877777776442 22333479999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhcCCCCC
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQHPFFE 451 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~hp~f~ 451 (506)
+||..||++||++. .+.+.|+|+|+.
T Consensus 247 ~cl~~~p~~RPs~~-~i~~~L~~~~~~ 272 (285)
T d1u59a_ 247 DCWIYKWEDRPDFL-TVEQRMRACYYS 272 (285)
T ss_dssp HTTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHH-HHHHHHHHHHHH
Confidence 99999999999853 244557888874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-55 Score=440.49 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=209.0
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeC--CeE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETD--KFS 186 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~ 186 (506)
.++|+++++||+|+||+||+|+++.+|+.||||++++.. ..++.+|+++|+.+. ||||++++++|... ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 367999999999999999999999999999999997532 345778999999995 99999999999854 579
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC-CEEEeecCCcccccc
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG-HIMLSDFDLSLRCFV 265 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~-~vkl~DFGla~~~~~ 265 (506)
|+|||||.+++|..+. +.+++..++.+++||+.||+|||++|||||||||+||||+.++ .+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999997653 4699999999999999999999999999999999999999765 589999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
. .
T Consensus 183 ~------------------------------------------------------------------------------~ 184 (328)
T d3bqca1 183 G------------------------------------------------------------------------------Q 184 (328)
T ss_dssp T------------------------------------------------------------------------------C
T ss_pred C------------------------------------------------------------------------------C
Confidence 0 0
Q ss_pred CccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHH---hCC----------C----
Q 010603 346 RSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNV---VGQ----------P---- 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i---~~~----------~---- 406 (506)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|+.||...... +....+ ++. .
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 112347999999999988764 799999999999999999999999765432 222111 110 0
Q ss_pred ------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCcc
Q 010603 407 ------------------LKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNWA 456 (506)
Q Consensus 407 ------------------~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~~ 456 (506)
...+....++++++|||++||+.||.+||| |+|||+||||+++.|+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCCC
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 000111347899999999999999999997 9999999999999884
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=433.37 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=215.1
Q ss_pred CCCCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC
Q 010603 104 KDGDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD 183 (506)
Q Consensus 104 ~~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 183 (506)
..+++..++|++++.||+|+||+||+|+++.+ +.||||+++.... ..+.+.+|+.+|+.++|||||++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 44567778999999999999999999999865 5799999976532 23567889999999999999999999854
Q ss_pred CeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccc
Q 010603 184 KFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRC 263 (506)
Q Consensus 184 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~ 263 (506)
+.+|+|||||++|+|..++.......+++..++.|+.||+.||+|||++||+||||||+||||+.++++||+|||+|+..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 56789999999999999887654567999999999999999999999999999999999999999999999999998542
Q ss_pred ccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCC
Q 010603 264 FVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPT 343 (506)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (506)
....
T Consensus 164 ~~~~---------------------------------------------------------------------------- 167 (285)
T d1fmka3 164 EDNE---------------------------------------------------------------------------- 167 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCC-CCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 010603 344 SARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGR-TPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDL 422 (506)
Q Consensus 344 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~l 422 (506)
........||+.|+|||++.+..++.++|||||||+||||++|. +||.+....+.+..+.. ....+....+++++++|
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~l 246 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDL 246 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHH
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCCcccCHHHHHH
Confidence 00112246999999999999999999999999999999999965 45555555555555553 33444555799999999
Q ss_pred HHHHhhcCCCCccCCCCChHHhhc--CCCCCC
Q 010603 423 IRGLLVKDPQKRLGFKRGATEIKQ--HPFFES 452 (506)
Q Consensus 423 i~~~L~~dP~~R~s~~~~a~ell~--hp~f~~ 452 (506)
|.+||+.||++||+ +++|++ |+||..
T Consensus 247 i~~cl~~dP~~Rps----~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 247 MCQCWRKEPEERPT----FEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHTCSSGGGSCC----HHHHHHHHHTTTSC
T ss_pred HHHHcccCHhHCcC----HHHHHHHHhhhhcC
Confidence 99999999999997 889877 788864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=426.77 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=216.9
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
.++|+++++||+|+||+||+|+++ +++.||||++++... ....+.+|+.+++.++|||||++++++.+++.+++|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 357999999999999999999986 678999999987543 234678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
|||+.+|+|..++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+....
T Consensus 78 ~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-- 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-- 154 (258)
T ss_dssp EECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS--
T ss_pred EEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC--
Confidence 9999999999986654 3578999999999999999999999999999999999999999999999999985321100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (258)
T d1k2pa_ 155 --------------------------------------------------------------------------YTSSVG 160 (258)
T ss_dssp --------------------------------------------------------------------------CCCCCC
T ss_pred --------------------------------------------------------------------------ceeecc
Confidence 001112
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+...++... ...+.+..+++++.+||.+||+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~ 239 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWH 239 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccccHHHHHHHHHHcc
Confidence 369999999999999999999999999999999998 89999999988877777654 3444445789999999999999
Q ss_pred cCCCCccCCCCChHHhhcC
Q 010603 429 KDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~h 447 (506)
.||++||| ++++++|
T Consensus 240 ~dP~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 240 EKADERPT----FKILLSN 254 (258)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CCHhHCcC----HHHHHHH
Confidence 99999998 8898886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=427.51 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=217.2
Q ss_pred cCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeEEEE
Q 010603 110 LGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 110 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 189 (506)
+++|+++++||+|+||+||+|+++.+|+.||||++++... ......++.+|+.+|+.++|||||++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4689999999999999999999999999999999976543 345667889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||++.+++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--
T ss_pred eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--
Confidence 9999999998887665 789999999999999999999999999999999999999999999999999985421100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.....
T Consensus 156 ---------------------------------------------------------------------------~~~~~ 160 (292)
T d1unla_ 156 ---------------------------------------------------------------------------RCYSA 160 (292)
T ss_dssp ---------------------------------------------------------------------------SCCCS
T ss_pred ---------------------------------------------------------------------------cccee
Confidence 00112
Q ss_pred cccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCC-CCCcHHHHHHHh---CCCC-----------------
Q 010603 350 FVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFK-GNGNRETLFNVV---GQPL----------------- 407 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~-~~~~~~~~~~i~---~~~~----------------- 407 (506)
..+++.|+|||++.+.. ++.++|||||||++|||++|+.||. +.+..+.+..+. ..+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 35788999999998765 6999999999999999999999864 444444444332 1110
Q ss_pred -------CCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 408 -------KFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 408 -------~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
.......+++.+++||.+||+.||.+||| |+|+|+||||+++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSSC
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcCC
Confidence 00011357889999999999999999997 9999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=439.86 Aligned_cols=259 Identities=26% Similarity=0.381 Sum_probs=208.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCC-----e
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDK-----F 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~ 185 (506)
.+|++++.||+|+||+||+|+++.+|+.||||++++.. .....+++.+|+++|+.|+|||||++++++.... +
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999998643 2345567889999999999999999999997654 3
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+||+ ||+.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4555 556699999999764 699999999999999999999999999999999999999999999999999854211
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
... ...
T Consensus 162 ~~~--------------------------------------------------------------------------~~~ 167 (345)
T d1pmea_ 162 DHD--------------------------------------------------------------------------HTG 167 (345)
T ss_dssp GGC--------------------------------------------------------------------------BCC
T ss_pred CCc--------------------------------------------------------------------------cce
Confidence 100 001
Q ss_pred CccccccCCCCccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhC---CC---------------
Q 010603 346 RSMSFVGTHEYLAPEIIRG-DGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVG---QP--------------- 406 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~---~~--------------- 406 (506)
.....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||.+.+..+....... .+
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhc
Confidence 1223479999999999854 5679999999999999999999999988776555443321 00
Q ss_pred --CCCCC---------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 407 --LKFPE---------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 407 --~~~p~---------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
...+. ...+++++++||.+||+.||.+||+ |+|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 301 (345)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred ccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccC
Confidence 00110 1257889999999999999999997 9999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=424.95 Aligned_cols=258 Identities=22% Similarity=0.260 Sum_probs=207.4
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEccCC----ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRDMG----CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
++....|++.++||+|+||+||+|.++.++ ..||||+++.... ......+.+|+++|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 455567999999999999999999988654 4699999976432 2344567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
.+.+++|||||.+|+|.+++... ...+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999999887654 36799999999999999999999999999999999999999999999999999964
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
+......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (283)
T d1mqba_ 160 LEDDPEA------------------------------------------------------------------------- 166 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCCcc-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC-CCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPF-KGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
........||+.|||||++.+..|+.++|||||||+||||++|..|| ...+..+.+..+. .....+....++..+.+
T Consensus 167 -~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~ 244 (283)
T d1mqba_ 167 -TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQ 244 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBHHHHH
T ss_pred -ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchhhHHHHHH
Confidence 00112336899999999999999999999999999999999965554 4445444444444 44455555679999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhc
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
||.+||..||++||+ +.||++
T Consensus 245 li~~cl~~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 245 LMMQCWQQERARRPK----FADIVS 265 (283)
T ss_dssp HHHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHHCcCCHhHCcC----HHHHHH
Confidence 999999999999998 778766
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=423.34 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=209.6
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCC---ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMG---CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET 182 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 182 (506)
+++..++|++++.||+|+||+||+|++..++ ..||||+++... .......+.+|+++|+.++|||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4566678999999999999999999987543 568899886543 2344567889999999999999999999995
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
++.+|||||||.+|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 56789999999999999987654 35799999999999999999999999999999999999999999999999999854
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
.....
T Consensus 158 ~~~~~--------------------------------------------------------------------------- 162 (273)
T d1mp8a_ 158 MEDST--------------------------------------------------------------------------- 162 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCc---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKD 421 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~ 421 (506)
........||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+.+..+.+..+.... ..+.+..+++++.+
T Consensus 163 -~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 163 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHH
T ss_pred -ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 001123468999999999999999999999999999999998 899999998888888777543 23444579999999
Q ss_pred HHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 422 LIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 422 li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
||.+||..||++||| +.||++|
T Consensus 241 li~~cl~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHcCCCHhHCcC----HHHHHHH
Confidence 999999999999998 8888875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=424.83 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=209.9
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccC-C--ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCe
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDM-G--CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKF 185 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~--~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 185 (506)
..++|++++.||+|+||+||+|++..+ + ..||||++++.........+.+.+|+.+|+.++|||||++++++.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 346799999999999999999987633 2 3689999988766666677889999999999999999999999975 46
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred hheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 789999999999998776542 5699999999999999999999999999999999999999999999999999864321
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.... ..
T Consensus 164 ~~~~--------------------------------------------------------------------------~~ 169 (273)
T d1u46a_ 164 NDDH--------------------------------------------------------------------------YV 169 (273)
T ss_dssp -CCE--------------------------------------------------------------------------EE
T ss_pred CCCc--------------------------------------------------------------------------ce
Confidence 1100 00
Q ss_pred CccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 010603 346 RSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIR 424 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~ 424 (506)
......||..|+|||++.+..|+.++|||||||++|||+| |++||.+.+..+.+..+......++....++.++++||.
T Consensus 170 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 249 (273)
T d1u46a_ 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 249 (273)
T ss_dssp C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHH
T ss_pred ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHH
Confidence 1123368889999999999999999999999999999998 899999999999888888777777766789999999999
Q ss_pred HHhhcCCCCccCCCCChHHhhc
Q 010603 425 GLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 425 ~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+||..||++||| +.+|++
T Consensus 250 ~cl~~dp~~RPt----~~ei~~ 267 (273)
T d1u46a_ 250 QCWAHKPEDRPT----FVALRD 267 (273)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcCCChhHCcC----HHHHHH
Confidence 999999999998 777753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=429.15 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=205.2
Q ss_pred CcccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEE
Q 010603 107 DLGLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHF 180 (506)
Q Consensus 107 ~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 180 (506)
++..++|+++++||+|+||+||+|++.. +++.||||+++.... ....+.+.+|..++..+ +|+|||.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 4556789999999999999999999764 357899999976432 23345566777777665 789999999988
Q ss_pred EeC-CeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEE
Q 010603 181 ETD-KFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVL 245 (506)
Q Consensus 181 ~~~-~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NIL 245 (506)
..+ ..+|+|||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 654 57899999999999999987642 235899999999999999999999999999999999999
Q ss_pred EecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccc
Q 010603 246 VREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSE 325 (506)
Q Consensus 246 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (506)
|+.++++||+|||+|+.......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~--------------------------------------------------------- 189 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPD--------------------------------------------------------- 189 (299)
T ss_dssp ECGGGCEEECC------CCSCTT---------------------------------------------------------
T ss_pred ECCCCcEEEccCcchhhcccccc---------------------------------------------------------
Confidence 99999999999999964211100
Q ss_pred cccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCCCCCcHHHHHHHhC
Q 010603 326 KTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLG-RTPFKGNGNRETLFNVVG 404 (506)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG-~~Pf~~~~~~~~~~~i~~ 404 (506)
.......+||+.|||||++.+..|+.++|||||||++|||++| .+||.+....+.+..++.
T Consensus 190 ------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 190 ------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp ------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred ------------------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 0112234799999999999999999999999999999999986 578888776666666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 405 QPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 405 ~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
....++....+++++++||.+||+.||++||| ++|+++|
T Consensus 252 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 44444444579999999999999999999997 8999886
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=438.42 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=210.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeC-----Ce
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETD-----KF 185 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 185 (506)
++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+++|+.++|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 579999999999999999999999999999999987543 234456788999999999999999999999643 23
Q ss_pred EEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCcccccc
Q 010603 186 SCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFV 265 (506)
Q Consensus 186 ~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~ 265 (506)
.++||||+.||+|.+++.. +.+++..++.+++||+.||+|||++|||||||||+|||++.+|.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC-
Confidence 4566777789999999865 479999999999999999999999999999999999999999999999999984210
Q ss_pred CCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCC
Q 010603 266 SPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSA 345 (506)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (506)
.
T Consensus 173 -------------------------------------------------------------------------------~ 173 (348)
T d2gfsa1 173 -------------------------------------------------------------------------------D 173 (348)
T ss_dssp -------------------------------------------------------------------------------G
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred CccccccCCCCccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCCCC-----------------
Q 010603 346 RSMSFVGTHEYLAPEIIRGDG-HGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQPL----------------- 407 (506)
Q Consensus 346 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 407 (506)
...+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 012347999999999987765 68999999999999999999999998887766655442111
Q ss_pred ------CCCC------CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCC
Q 010603 408 ------KFPE------GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESV 453 (506)
Q Consensus 408 ------~~p~------~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~ 453 (506)
..+. ...++++++|||.+||+.||.+||| |+|||+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQY 307 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCC
Confidence 1111 1257899999999999999999997 9999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=441.26 Aligned_cols=259 Identities=26% Similarity=0.371 Sum_probs=206.5
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe------
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET------ 182 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------ 182 (506)
.+++|+++++||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|+.++|||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 34789999999999999999999999999999999987643 34556678899999999999999999999963
Q ss_pred CCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccc
Q 010603 183 DKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLR 262 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~ 262 (506)
..++|+|||||.++.| ..+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||+++.
T Consensus 94 ~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 94 FQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp CCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 4689999999965544 4443 4689999999999999999999999999999999999999999999999998743
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
...
T Consensus 169 ~~~----------------------------------------------------------------------------- 171 (355)
T d2b1pa1 169 AGT----------------------------------------------------------------------------- 171 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHHHhCC-----------------
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFNVVGQ----------------- 405 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 405 (506)
.......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+......+++..
T Consensus 172 -~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred -ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 01122347999999999999999999999999999999999999999988766655444310
Q ss_pred -----CCCCC--------------C----CCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcCCCCCCCCc
Q 010603 406 -----PLKFP--------------E----GSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQHPFFESVNW 455 (506)
Q Consensus 406 -----~~~~p--------------~----~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~hp~f~~~~~ 455 (506)
..... . ....++++++||++||..||++||| |+|||+||||+...+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGGCC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCCC
Confidence 00000 0 0013567899999999999999997 999999999986433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=420.36 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=209.3
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEE-eCC
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFE-TDK 184 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~ 184 (506)
+++.+++|++++.||+|+||.||+|+++ |..||||++++. ...+.+.+|+++|+.++|||||++++++. ..+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 5788899999999999999999999986 789999999764 33456789999999999999999999885 456
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccc
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCF 264 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~ 264 (506)
.+||||||+++|+|.+++.......+++..++.++.||+.||.|||+++||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 78999999999999999876544568999999999999999999999999999999999999999999999999985311
Q ss_pred cCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCC
Q 010603 265 VSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTS 344 (506)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (506)
.
T Consensus 155 ~------------------------------------------------------------------------------- 155 (262)
T d1byga_ 155 S------------------------------------------------------------------------------- 155 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 010603 345 ARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLI 423 (506)
Q Consensus 345 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li 423 (506)
......||+.|+|||++.+..|+.++|||||||++|||+| |++||...+..+.+..+..+ ...+....+++++++||
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li 233 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVM 233 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHH
T ss_pred -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHHH
Confidence 0112258899999999999999999999999999999998 79999888877777776543 33334447899999999
Q ss_pred HHHhhcCCCCccCCCCChHHhhc
Q 010603 424 RGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 424 ~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+||..||.+||| +.++++
T Consensus 234 ~~cl~~dP~~Rps----~~~l~~ 252 (262)
T d1byga_ 234 KNCWHLDAAMRPS----FLQLRE 252 (262)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHcccCHhHCcC----HHHHHH
Confidence 9999999999998 778876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=427.50 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=206.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCc----eEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEeCCeE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGC----LFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFETDKFS 186 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 186 (506)
.+|+++++||+|+||+||+|+++.+|+ .||+|.++... .....+++.+|+++|+.++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 469999999999999999999988876 47777776432 234456788999999999999999999999865 56
Q ss_pred EEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccC
Q 010603 187 CLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 187 ~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~ 266 (506)
+++|||+.+|+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 7888999999999887764 467999999999999999999999999999999999999999999999999999643211
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
.. ...
T Consensus 165 ~~---------------------------------------------------------------------------~~~ 169 (317)
T d1xkka_ 165 EK---------------------------------------------------------------------------EYH 169 (317)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 001
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHHhCCCCCCCCCCCCCHHHHHHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNVVGQPLKFPEGSSISFAAKDLIRG 425 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~s~~~~~li~~ 425 (506)
.....||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..+....+..+ ...+.+..+++++.+||.+
T Consensus 170 ~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~ 248 (317)
T d1xkka_ 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVYMIMVK 248 (317)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCCCCCTTBCHHHHHHHHH
T ss_pred ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHH
Confidence 122369999999999999999999999999999999998 89999988777665555433 3334445799999999999
Q ss_pred HhhcCCCCccCCCCChHHhhcC
Q 010603 426 LLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 426 ~L~~dP~~R~s~~~~a~ell~h 447 (506)
||..||.+||+ +.|+++|
T Consensus 249 cl~~dP~~RPs----~~eil~~ 266 (317)
T d1xkka_ 249 CWMIDADSRPK----FRELIIE 266 (317)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred hCCCChhhCcC----HHHHHHH
Confidence 99999999998 8899887
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-53 Score=419.35 Aligned_cols=259 Identities=21% Similarity=0.297 Sum_probs=217.2
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHF 180 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 180 (506)
.++..++|++++.||+|+||+||+|+++ .+++.||||++++... .....++.+|+++|+.++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3445567999999999999999999976 3567899999976432 34456788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCChHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEcc
Q 010603 181 ETDKFSCLLMEFCSGGDLHTLRQRQP----------------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRD 238 (506)
Q Consensus 181 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrD 238 (506)
...+..++||||+.+|+|.+++.... ...+++..+..|+.||+.||+|||++||||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999987532 23589999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccc
Q 010603 239 LKPENVLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSK 318 (506)
Q Consensus 239 LKp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (506)
|||+||||+.++++||+|||+|+.......
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-------------------------------------------------- 195 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-------------------------------------------------- 195 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC--------------------------------------------------
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc--------------------------------------------------
Confidence 999999999999999999999864321100
Q ss_pred ccccccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCC-CCCCCCCcHH
Q 010603 319 TTKVKSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGR-TPFKGNGNRE 397 (506)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~-~Pf~~~~~~~ 397 (506)
....+...||+.|||||++.+..|+.++|||||||+||||++|. +||.+.+..+
T Consensus 196 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 196 -------------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp -------------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred -------------------------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 00112347999999999999999999999999999999999985 6898888888
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 398 TLFNVVGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 398 ~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.+..+..+. ..+....+++++.+||.+||+.||.+||| +.||++
T Consensus 251 ~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 251 VIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 887777554 23334579999999999999999999998 777754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=420.95 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=211.9
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCce--EEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEEEEeCC
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCL--FAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSHFETDK 184 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 184 (506)
+..++|++.++||+|+||+||+|+++.+|.. ||||.++... .....+.+.+|+++|+.+ +|||||++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4557899999999999999999999988875 6677765432 233455688999999998 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCC
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQ--------------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDG 250 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~--------------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~ 250 (506)
.+|||||||++|+|.++++.. ....+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998754 236799999999999999999999999999999999999999999
Q ss_pred CEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCC
Q 010603 251 HIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLT 330 (506)
Q Consensus 251 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (506)
.+||+|||+|+.....
T Consensus 165 ~~kl~DfG~a~~~~~~---------------------------------------------------------------- 180 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---------------------------------------------------------------- 180 (309)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred ceEEcccccccccccc----------------------------------------------------------------
Confidence 9999999998532100
Q ss_pred CCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCC-CCCCCCCcHHHHHHHhCCCCCC
Q 010603 331 NSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGR-TPFKGNGNRETLFNVVGQPLKF 409 (506)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~-~Pf~~~~~~~~~~~i~~~~~~~ 409 (506)
.......||+.|+|||.+.+..|+.++|||||||+||||++|. +||.+.+..+.+..+..+ ..+
T Consensus 181 --------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~ 245 (309)
T d1fvra_ 181 --------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRL 245 (309)
T ss_dssp --------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCC
T ss_pred --------------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCC
Confidence 0011236899999999999999999999999999999999965 678888777776666543 334
Q ss_pred CCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhcC
Q 010603 410 PEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 410 p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~h 447 (506)
+.+..+++++++||.+||+.||++||+ +.||++|
T Consensus 246 ~~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 246 EKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 444579999999999999999999998 8899986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=416.79 Aligned_cols=259 Identities=23% Similarity=0.309 Sum_probs=212.5
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEccCC-------ceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCcccee
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELRDMG-------CLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLY 177 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 177 (506)
+++..++|++++.||+|+||.||+|++..++ ..||||+++++.. ......+.+|..++.++ +|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4567788999999999999999999987554 4799999987542 33456677888888777 899999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQP--------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
+++.+++.+|+|||||.+|+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999987642 2468999999999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
||++.++.+||+|||+++......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~-------------------------------------------------------- 189 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHID-------------------------------------------------------- 189 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCC--------------------------------------------------------
T ss_pred eeecCCCCeEeccchhhccccccc--------------------------------------------------------
Confidence 999999999999999985432110
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
........+||+.|+|||++.++.|+.++|||||||+||||++ |.+||.+.+..+.+..+
T Consensus 190 -------------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i 250 (299)
T d1fgka_ 190 -------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250 (299)
T ss_dssp -------------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred -------------------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 0011223479999999999999999999999999999999998 79999888777666555
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
.. ...++....+++++++||.+||+.||.+||| +.||++
T Consensus 251 ~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 251 KE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp HT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred Hc-CCCCCCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 43 3444445579999999999999999999998 888876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=417.89 Aligned_cols=260 Identities=20% Similarity=0.295 Sum_probs=218.8
Q ss_pred CCcccCCeEEEeEEeecCceEEEEEEEc-----cCCceEEEEEeccchhhchhHHHHHHHHHHHHHhc-CCCCccceeEE
Q 010603 106 GDLGLGHFRLLKKLGCGDIGSVYLAELR-----DMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLL-DHPFLPTLYSH 179 (506)
Q Consensus 106 ~~~~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 179 (506)
+++..++|++.++||+|+||.||+|+++ .+++.||||++++... ......+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3456678999999999999999999874 4567899999986542 33455678899999998 79999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCc
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQP----------------GKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPEN 243 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~N 243 (506)
+.+.+.+|||||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999987642 2368999999999999999999999999999999999
Q ss_pred EEEecCCCEEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccc
Q 010603 244 VLVREDGHIMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVK 323 (506)
Q Consensus 244 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (506)
||++.++.+||+|||+++.+.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~------------------------------------------------------- 200 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN------------------------------------------------------- 200 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-------------------------------------------------------
T ss_pred ccccccCcccccccchheeccCCCc-------------------------------------------------------
Confidence 9999999999999999854211100
Q ss_pred cccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCCCcHHHHHHH
Q 010603 324 SEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLL-GRTPFKGNGNRETLFNV 402 (506)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~ellt-G~~Pf~~~~~~~~~~~i 402 (506)
.......+||+.|||||++.+..++.++|||||||+||||+| |.+||.+....+.+.++
T Consensus 201 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~ 260 (311)
T d1t46a_ 201 --------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260 (311)
T ss_dssp --------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred --------------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 001123479999999999999999999999999999999998 67778777777777777
Q ss_pred hCCCCCCCCCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 403 VGQPLKFPEGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 403 ~~~~~~~p~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+......+....+++++.+||.+||+.||.+||+ +++|++
T Consensus 261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 6555555555578999999999999999999998 788775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=414.28 Aligned_cols=266 Identities=19% Similarity=0.271 Sum_probs=222.2
Q ss_pred CCCcccCCeEEEeEEeecCceEEEEEEEcc-----CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEE
Q 010603 105 DGDLGLGHFRLLKKLGCGDIGSVYLAELRD-----MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSH 179 (506)
Q Consensus 105 ~~~~~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 179 (506)
++++..++|++++.||+|+||+||+|.++. ++..||||++++.. .......+.+|+++|+.++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 356777889999999999999999999863 35789999998643 23445567899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCC
Q 010603 180 FETDKFSCLLMEFCSGGDLHTLRQRQ--------PGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGH 251 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~~l~~~--------~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~ 251 (506)
+..++..++|||||.+|+|.+++... ....+++..+..++.||+.||.|||+++||||||||+||||+.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999987642 1235789999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCC
Q 010603 252 IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTN 331 (506)
Q Consensus 252 vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (506)
+||+|||+|+.......
T Consensus 172 ~Kl~DFGla~~~~~~~~--------------------------------------------------------------- 188 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY--------------------------------------------------------------- 188 (308)
T ss_dssp EEECCTTCCCGGGGGGC---------------------------------------------------------------
T ss_pred EEEeecccceeccCCcc---------------------------------------------------------------
Confidence 99999999854211100
Q ss_pred CCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCCCCCcHHHHHHHhCCCCCCC
Q 010603 332 SDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLG-RTPFKGNGNRETLFNVVGQPLKFP 410 (506)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p 410 (506)
.......+||+.|||||.+.+..|+.++|||||||+||||+|| ++||.+.+..+.+..+.... ..+
T Consensus 189 ------------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~ 255 (308)
T d1p4oa_ 189 ------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLD 255 (308)
T ss_dssp ------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCC
T ss_pred ------------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCC
Confidence 0011233699999999999999999999999999999999998 58898888888887776543 333
Q ss_pred CCCCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc------CCCCCC
Q 010603 411 EGSSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ------HPFFES 452 (506)
Q Consensus 411 ~~~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~------hp~f~~ 452 (506)
....+++.+.+||.+||+.||.+||+ +.+|++ +|+|+.
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcC----HHHHHHHHHHhcCCCCcC
Confidence 44579999999999999999999998 677776 666654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=402.25 Aligned_cols=253 Identities=16% Similarity=0.226 Sum_probs=202.3
Q ss_pred EEEeEEeecCceEEEEEEEccCC---ceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCccceeEEEEe-CCeEEEE
Q 010603 114 RLLKKLGCGDIGSVYLAELRDMG---CLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFLPTLYSHFET-DKFSCLL 189 (506)
Q Consensus 114 ~i~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV 189 (506)
.+.++||+|+||+||+|++..++ ..||||++++.. ......++.+|+++|++++|||||++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999987643 358999997532 34556778999999999999999999999765 5689999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeecCCccccccCCcc
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDFDLSLRCFVSPKL 269 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DFGla~~~~~~~~~ 269 (506)
||||++|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||||++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999999987754 356788889999999999999999999999999999999999999999999998643211100
Q ss_pred ccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCCccc
Q 010603 270 VQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSARSMS 349 (506)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (506)
.......
T Consensus 187 -------------------------------------------------------------------------~~~~~~~ 193 (311)
T d1r0pa_ 187 -------------------------------------------------------------------------SVHNKTG 193 (311)
T ss_dssp -------------------------------------------------------------------------CTTCTTC
T ss_pred -------------------------------------------------------------------------cceeccc
Confidence 0001122
Q ss_pred cccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH-HHHHHHhCCCCCCCCCCCCCHHHHHHHHHHhh
Q 010603 350 FVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR-ETLFNVVGQPLKFPEGSSISFAAKDLIRGLLV 428 (506)
Q Consensus 350 ~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~~~s~~~~~li~~~L~ 428 (506)
..||+.|+|||++.+..++.++|||||||+||||+||..||...... +....+..+ ...+....+++.+.+||.+||.
T Consensus 194 ~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~~li~~cl~ 272 (311)
T d1r0pa_ 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLYEVMLKCWH 272 (311)
T ss_dssp SSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHHHHHHHHHHcC
Confidence 36999999999999999999999999999999999987777654333 333444433 2333334789999999999999
Q ss_pred cCCCCccCCCCChHHhhcC
Q 010603 429 KDPQKRLGFKRGATEIKQH 447 (506)
Q Consensus 429 ~dP~~R~s~~~~a~ell~h 447 (506)
.||++||+ +.|+++|
T Consensus 273 ~dP~~RPs----~~ei~~~ 287 (311)
T d1r0pa_ 273 PKAEMRPS----FSELVSR 287 (311)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CCHhHCcC----HHHHHHH
Confidence 99999998 8888887
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-51 Score=405.80 Aligned_cols=262 Identities=18% Similarity=0.258 Sum_probs=200.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCC-ccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPF-LPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV 189 (506)
++|++++.||+|+||+||+|+++.+|+.||||++...... .++..|+++++.++|+| |+.+.+++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 3699999999999999999999999999999998764321 23567999999997766 55556667888899999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec---CCCEEEeecCCccccccC
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE---DGHIMLSDFDLSLRCFVS 266 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~---~~~vkl~DFGla~~~~~~ 266 (506)
|||| +++|...+... .+.+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.....
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 66776665543 367999999999999999999999999999999999999864 457999999999653211
Q ss_pred CccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCCCCCC
Q 010603 267 PKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEPTSAR 346 (506)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (506)
..... .....
T Consensus 160 ~~~~~----------------------------------------------------------------------~~~~~ 169 (299)
T d1ckia_ 160 RTHQH----------------------------------------------------------------------IPYRE 169 (299)
T ss_dssp TTCCB----------------------------------------------------------------------CCCCB
T ss_pred ccccc----------------------------------------------------------------------eeccc
Confidence 10000 00111
Q ss_pred ccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcHHHHHH---HhCCCCCCC---CCCCCCHHHH
Q 010603 347 SMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNRETLFN---VVGQPLKFP---EGSSISFAAK 420 (506)
Q Consensus 347 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~~~~~~---i~~~~~~~p---~~~~~s~~~~ 420 (506)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||........... ........+ ....+++++.
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 249 (299)
T d1ckia_ 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFA 249 (299)
T ss_dssp CCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHH
T ss_pred cCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHH
Confidence 2345899999999999999999999999999999999999999987654433222 111111111 1236899999
Q ss_pred HHHHHHhhcCCCCccCCCCChHHhhcCCCC
Q 010603 421 DLIRGLLVKDPQKRLGFKRGATEIKQHPFF 450 (506)
Q Consensus 421 ~li~~~L~~dP~~R~s~~~~a~ell~hp~f 450 (506)
+||.+||..||++||++. .+.++|+|+|.
T Consensus 250 ~li~~cl~~~p~~RP~~~-~i~~~l~~~~~ 278 (299)
T d1ckia_ 250 TYLNFCRSLRFDDKPDYS-YLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHSCTTCCCCHH-HHHHHHHHHHH
T ss_pred HHHHHHccCChhHCcCHH-HHHHHHHHHHH
Confidence 999999999999999842 24566777765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-49 Score=392.34 Aligned_cols=252 Identities=17% Similarity=0.222 Sum_probs=202.4
Q ss_pred ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC-CCccceeEEEEeCCeEE
Q 010603 109 GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-PFLPTLYSHFETDKFSC 187 (506)
Q Consensus 109 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 187 (506)
.-++|+++++||+|+||+||+|+++.+|+.||||++.+... ...+.+|+++++.|+| +||+.+++++......|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 34679999999999999999999999999999999876432 1235678899999965 89999999999999999
Q ss_pred EEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEec-----CCCEEEeecCCccc
Q 010603 188 LLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVRE-----DGHIMLSDFDLSLR 262 (506)
Q Consensus 188 lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~-----~~~vkl~DFGla~~ 262 (506)
+||||| +++|.+++... +..+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+.
T Consensus 78 ~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 999999 89999988764 357999999999999999999999999999999999999974 57899999999965
Q ss_pred cccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCcccccCC
Q 010603 263 CFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLPVLIAEP 342 (506)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (506)
......... .
T Consensus 156 ~~~~~~~~~----------------------------------------------------------------------~ 165 (293)
T d1csna_ 156 YRDPVTKQH----------------------------------------------------------------------I 165 (293)
T ss_dssp SBCTTTCCB----------------------------------------------------------------------C
T ss_pred cccCccccc----------------------------------------------------------------------e
Confidence 321110000 0
Q ss_pred CCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH---HHHHHHhCCCCCCC---CCCCCC
Q 010603 343 TSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR---ETLFNVVGQPLKFP---EGSSIS 416 (506)
Q Consensus 343 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~p---~~~~~s 416 (506)
........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... +.+..+.......+ ....++
T Consensus 166 ~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (293)
T d1csna_ 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245 (293)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSC
T ss_pred eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCC
Confidence 001123458999999999999999999999999999999999999999865432 22333322111111 013588
Q ss_pred HHHHHHHHHHhhcCCCCccCC
Q 010603 417 FAAKDLIRGLLVKDPQKRLGF 437 (506)
Q Consensus 417 ~~~~~li~~~L~~dP~~R~s~ 437 (506)
+++.+|+..|+..+|++||++
T Consensus 246 ~~l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 246 EEFYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp HHHHHHHHHHHHCCTTCCCCH
T ss_pred HHHHHHHHHHhcCCcccCcCH
Confidence 999999999999999999973
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=390.73 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=189.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHH--HHHhcCCCCccceeEEEEeCC----
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTERE--ILSLLDHPFLPTLYSHFETDK---- 184 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~--il~~l~hpnIv~l~~~~~~~~---- 184 (506)
++|.+.+.||+|+||.||+|++. |+.||||+++... .....+|.+ .+..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 46999999999999999999874 8999999997542 122333444 456789999999999997654
Q ss_pred eEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCeEEccCCCCcEEEecCCCEEEee
Q 010603 185 FSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM--------MGVVYRDLKPENVLVREDGHIMLSD 256 (506)
Q Consensus 185 ~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~--------~giiHrDLKp~NILl~~~~~vkl~D 256 (506)
.+|||||||++|+|.+++++. .+++..+..++.|++.||+|||+ +|||||||||+||||+.++++||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 689999999999999999874 69999999999999999999996 5999999999999999999999999
Q ss_pred cCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCccccccccccccccccCCCCCCCc
Q 010603 257 FDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKVKSEKTSLTNSDSLP 336 (506)
Q Consensus 257 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (506)
||+++.+.......
T Consensus 152 FGl~~~~~~~~~~~------------------------------------------------------------------ 165 (303)
T d1vjya_ 152 LGLAVRHDSATDTI------------------------------------------------------------------ 165 (303)
T ss_dssp CTTCEEEETTTTEE------------------------------------------------------------------
T ss_pred cCccccccCCCcce------------------------------------------------------------------
Confidence 99986532211100
Q ss_pred ccccCCCCCCccccccCCCCccchhhcCCC------CCcchhHHHHHHHHHHHhcCCCCCCCCC--------------cH
Q 010603 337 VLIAEPTSARSMSFVGTHEYLAPEIIRGDG------HGSAVDWWTFGIFFYELLLGRTPFKGNG--------------NR 396 (506)
Q Consensus 337 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~~DiWSlGvil~elltG~~Pf~~~~--------------~~ 396 (506)
.......+||+.|||||++.+.. ++.++|||||||+||||+||..||.... ..
T Consensus 166 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 166 -------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp -------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred -------eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 00122357999999999997653 5779999999999999999998874321 12
Q ss_pred HHHHHHh-CCCCC--CCCC---CCCCHHHHHHHHHHhhcCCCCccCCCCChHHhhc
Q 010603 397 ETLFNVV-GQPLK--FPEG---SSISFAAKDLIRGLLVKDPQKRLGFKRGATEIKQ 446 (506)
Q Consensus 397 ~~~~~i~-~~~~~--~p~~---~~~s~~~~~li~~~L~~dP~~R~s~~~~a~ell~ 446 (506)
+.+.... ....+ ++.. ......+.+|+.+||+.||++||| +.||++
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~ 290 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 2233332 22221 1111 112345889999999999999998 778776
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-48 Score=393.78 Aligned_cols=262 Identities=23% Similarity=0.374 Sum_probs=200.5
Q ss_pred CCCc-ccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-----------CCC
Q 010603 105 DGDL-GLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-----------HPF 172 (506)
Q Consensus 105 ~~~~-~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------hpn 172 (506)
.|+. ..++|+++++||+|+||+||+|+++.+|+.||||++++... ....+.+|+.+|+.++ |+|
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 4554 33679999999999999999999999999999999987532 2345677888887765 578
Q ss_pred ccceeEEEEe--CCeEEEEEeecCCCCh-HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEccCCCCcEEEec
Q 010603 173 LPTLYSHFET--DKFSCLLMEFCSGGDL-HTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-MGVVYRDLKPENVLVRE 248 (506)
Q Consensus 173 Iv~l~~~~~~--~~~~~lV~E~~~gg~L-~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-~giiHrDLKp~NILl~~ 248 (506)
||++++++.. ....+++|+++..+.+ ...........+++..++.++.||+.||+|||+ .||+||||||+||||+.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 9999998864 4567777777655543 334444555789999999999999999999998 89999999999999987
Q ss_pred CCC------EEEeecCCccccccCCccccCCCCcccccCcccCCCCCCCCCCCCCccCCCCCCCCCCCCCcccccccccc
Q 010603 249 DGH------IMLSDFDLSLRCFVSPKLVQSSDDPACRISSYCIQPSCIDPACKLPVCVEPSCLQPSCFKPRFLNSKTTKV 322 (506)
Q Consensus 249 ~~~------vkl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (506)
++. +||+|||.|.....
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~--------------------------------------------------------- 184 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE--------------------------------------------------------- 184 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB---------------------------------------------------------
T ss_pred cCcccccceeeEeeccccccccc---------------------------------------------------------
Confidence 664 99999999843110
Q ss_pred ccccccCCCCCCCcccccCCCCCCccccccCCCCccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCCCcH------
Q 010603 323 KSEKTSLTNSDSLPVLIAEPTSARSMSFVGTHEYLAPEIIRGDGHGSAVDWWTFGIFFYELLLGRTPFKGNGNR------ 396 (506)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSlGvil~elltG~~Pf~~~~~~------ 396 (506)
.....+||+.|+|||++.+..|+.++||||+||+++||++|+.||......
T Consensus 185 -----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 185 -----------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp -----------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred -----------------------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 012237999999999999999999999999999999999999999754321
Q ss_pred HHHH---HHhCCC---------------------CCCC----------------CCCCCCHHHHHHHHHHhhcCCCCccC
Q 010603 397 ETLF---NVVGQP---------------------LKFP----------------EGSSISFAAKDLIRGLLVKDPQKRLG 436 (506)
Q Consensus 397 ~~~~---~i~~~~---------------------~~~p----------------~~~~~s~~~~~li~~~L~~dP~~R~s 436 (506)
+.+. .+++.. .... .....+++++|||.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 1111 111110 0000 01124567999999999999999998
Q ss_pred CCCChHHhhcCCCCCCCC
Q 010603 437 FKRGATEIKQHPFFESVN 454 (506)
Q Consensus 437 ~~~~a~ell~hp~f~~~~ 454 (506)
|+|||+||||++..
T Consensus 322 ----a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 322 ----AGGLVNHPWLKDTL 335 (362)
T ss_dssp ----HHHHHTCGGGTTCT
T ss_pred ----HHHHhcCcccCCCC
Confidence 99999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=7.3e-28 Score=221.38 Aligned_cols=135 Identities=22% Similarity=0.200 Sum_probs=106.9
Q ss_pred eEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhc---------------hhHHHHHHHHHHHHHhcCCCCcccee
Q 010603 113 FRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAG---------------RKKLMRAQTEREILSLLDHPFLPTLY 177 (506)
Q Consensus 113 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~---------------~~~~~~~~~E~~il~~l~hpnIv~l~ 177 (506)
|.+.++||+|+||+||+|++. +|+.||||+++...... .........|...|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999986 58999999986432110 11123345688889999999999988
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeEEccCCCCcEEEecCCCEEEeec
Q 010603 178 SHFETDKFSCLLMEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHMMGVVYRDLKPENVLVREDGHIMLSDF 257 (506)
Q Consensus 178 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~~giiHrDLKp~NILl~~~~~vkl~DF 257 (506)
++.. .++||||+++..+.. +++..+..++.||+.+|+|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 7532 379999998876643 4445567899999999999999999999999999999965 4999999
Q ss_pred CCccc
Q 010603 258 DLSLR 262 (506)
Q Consensus 258 Gla~~ 262 (506)
|+|..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 99853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=4.3e-08 Score=91.86 Aligned_cols=139 Identities=17% Similarity=0.128 Sum_probs=92.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEeCCeEEEE
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFETDKFSCLL 189 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 189 (506)
..|++++..+-++.+.||+... .++.+.||+....... ....+.+|..+|+.|. +--+.+++.+...++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 4588888766666789998863 3667889987654322 2223566888888774 43467888888889999999
Q ss_pred EeecCCCChHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 010603 190 MEFCSGGDLHTLRQRQPGKHFSEQATRFYASEVLLALEYLHM-------------------------------------- 231 (506)
Q Consensus 190 ~E~~~gg~L~~~l~~~~~~~~~e~~~~~i~~qil~aL~yLH~-------------------------------------- 231 (506)
|++++|..+....... .. ...++.++...|..||+
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999998875432110 00 11122222222333331
Q ss_pred ---------------------CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 232 ---------------------MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 232 ---------------------~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 128999999999999977666799999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.19 E-value=3.2e-06 Score=84.02 Aligned_cols=80 Identities=18% Similarity=0.216 Sum_probs=50.3
Q ss_pred EeEEeecCceEEEEEEEccCCceEEEEEeccch-hhc---hhHHHHHHHHHHHHHhcC-C--CCccceeEEEEeCCeEEE
Q 010603 116 LKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGM-LAG---RKKLMRAQTEREILSLLD-H--PFLPTLYSHFETDKFSCL 188 (506)
Q Consensus 116 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-~~~---~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~~~~~l 188 (506)
.+.||.|....||++....+++.|+||.-.... ... .....+...|.++|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999988878899999654311 000 112344567888887663 2 345566543 4455678
Q ss_pred EEeecCCCC
Q 010603 189 LMEFCSGGD 197 (506)
Q Consensus 189 V~E~~~gg~ 197 (506)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=4.3e-06 Score=77.29 Aligned_cols=137 Identities=17% Similarity=0.069 Sum_probs=83.1
Q ss_pred EEeecCc-eEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC--CCccceeEEEEeCCeEEEEEeecC
Q 010603 118 KLGCGDI-GSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH--PFLPTLYSHFETDKFSCLLMEFCS 194 (506)
Q Consensus 118 ~LG~G~f-G~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~~~ 194 (506)
.+..|.. +.||+.... ++..+.+|.-.... ...+..|+++|+.|.. --+.+++.+..+++..++|||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455553 689998764 36678899865432 1235668888877742 336778888888889999999998
Q ss_pred CCChHH--------------HHhh-C----CCCCCC--HHHH-----HHH---------------HHHHHHHHHHHHh--
Q 010603 195 GGDLHT--------------LRQR-Q----PGKHFS--EQAT-----RFY---------------ASEVLLALEYLHM-- 231 (506)
Q Consensus 195 gg~L~~--------------~l~~-~----~~~~~~--e~~~-----~~i---------------~~qil~aL~yLH~-- 231 (506)
|.++.. .+.+ + ....+. .... ..+ .......+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 876532 1111 0 000000 0000 000 0011122333332
Q ss_pred -----CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 232 -----MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 232 -----~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
..+||+|+.|.|||++.++.+-|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 238999999999999987667899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.40 E-value=0.00027 Score=69.64 Aligned_cols=78 Identities=22% Similarity=0.313 Sum_probs=52.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcc-------CCceEEEEEeccchhhchhHHHHHHHHHHHHHhcC-CCCccceeEEEEe
Q 010603 111 GHFRLLKKLGCGDIGSVYLAELRD-------MGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLD-HPFLPTLYSHFET 182 (506)
Q Consensus 111 ~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~ 182 (506)
+++++ +.|+-|-.-.+|++.... ..+.|.+++.... .. .....+|..+++.+. +.-..++++++..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 33544 678889999999998753 2456888876532 11 223457888988884 4444578887753
Q ss_pred CCeEEEEEeecCCCCh
Q 010603 183 DKFSCLLMEFCSGGDL 198 (506)
Q Consensus 183 ~~~~~lV~E~~~gg~L 198 (506)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.23 E-value=0.00055 Score=65.41 Aligned_cols=69 Identities=12% Similarity=0.050 Sum_probs=44.8
Q ss_pred ceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCCCCc-----cce--eEEEEeCCeEEEEEeecCCC
Q 010603 124 IGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDHPFL-----PTL--YSHFETDKFSCLLMEFCSGG 196 (506)
Q Consensus 124 fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l--~~~~~~~~~~~lV~E~~~gg 196 (506)
--.||++... +|..|++|+.+.... ...++..|...|..|....| +.. -..+...+..+.|++++.|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3589999875 488899999876532 23445668888777642211 111 12345677889999999764
Q ss_pred C
Q 010603 197 D 197 (506)
Q Consensus 197 ~ 197 (506)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.96 E-value=0.0023 Score=60.34 Aligned_cols=147 Identities=18% Similarity=0.108 Sum_probs=79.7
Q ss_pred cccCCeEEEeEEeecCceEEEEEEEccCCceEEEEEeccchhhchhHHHHHHHHHHHHHhcCC-----CCccceeE---E
Q 010603 108 LGLGHFRLLKKLGCGDIGSVYLAELRDMGCLFAMKVMDKGMLAGRKKLMRAQTEREILSLLDH-----PFLPTLYS---H 179 (506)
Q Consensus 108 ~~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-----pnIv~l~~---~ 179 (506)
..++...-++.|..|---+.|+..... ..|++|+..+.. ....+..|+++|..|.. |..+...+ +
T Consensus 15 Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~ 87 (316)
T d2ppqa1 15 YDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL 87 (316)
T ss_dssp BCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred CCCCCceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcc
Confidence 345666767778888889999997663 459999987532 11233456677666632 22222111 2
Q ss_pred EEeCCeEEEEEeecCCCChHH-----------H---Hhh-CC------CCCC------------------CHHHHHHHHH
Q 010603 180 FETDKFSCLLMEFCSGGDLHT-----------L---RQR-QP------GKHF------------------SEQATRFYAS 220 (506)
Q Consensus 180 ~~~~~~~~lV~E~~~gg~L~~-----------~---l~~-~~------~~~~------------------~e~~~~~i~~ 220 (506)
.........++.++.|..... . +.. .. .... ........+.
T Consensus 88 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 167 (316)
T d2ppqa1 88 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR 167 (316)
T ss_dssp EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred eeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHH
Confidence 233456667777776644311 0 000 00 0000 0111111222
Q ss_pred HHHHHHHHHHh----CCeEEccCCCCcEEEecCCCEEEeecCCcc
Q 010603 221 EVLLALEYLHM----MGVVYRDLKPENVLVREDGHIMLSDFDLSL 261 (506)
Q Consensus 221 qil~aL~yLH~----~giiHrDLKp~NILl~~~~~vkl~DFGla~ 261 (506)
.+...+.-.+. .|+||+|+.++|||++.+...-|+||+.+.
T Consensus 168 ~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 168 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 23333333332 479999999999999988777899999884
|